cell_line_id,drug_id,response
SUP-T11,71680916,4.421204696881959
KP-4,5460769,4.107177099702386
KHM-1B,25195348,3.649934480073114
NCI-H1395,19582717,5.560683797956257
MOLP-8,11612883,2.388158793316403
JHUEM-1,5746,-0.2635718518174069
MDST8,654092,-1.4293910300938224
BT 440,36314,4.091183712277337
RKO,52947716,-6.611161073849914
RKO,56963564,0.5825206420774123
Granta-519,107970,1.5911312599666134
KMS-21-BM,104842,-4.168559861040884
SNU-C2A,31703,-0.0946328592211857
HEL,12003241,-0.3954740832299299
T98G,24797083,0.553813070444095
F-36P,6918328,-2.195368020697059
SK-HEP-1,445091,4.514173662724111
Hep-G2,3815108,3.2270973506014182
SK-CO-1,vorinostat-carboplatin (1-1 mol-mol),2.626947191906058
JHUEM-1,24775005,3.1126003458253835
SU-DHL-1,JQ-1-vorinostat (2-1 mol-mol),1.047000957100153
PaTu 8902,selumetinib-navitoclax (8-1 mol-mol),2.7909772109313677
EB1,7251185,1.2528756695525531
T98G,702558,6.617377182304874
HCC15,24775005,4.257174534281358
JHUEM-1,57519531,1.6681057858796855
BT 248,11497983,5.371692371312494
SNU-C2A,676352,2.319745016384436
HuP-T3,6450551,3.7588607556856006
ST486,24797083,1.1881537134690277
SNU-C2A,49850262,3.588151288220849
SNU-C2A,135398516,3.0955588345779894
PE/CA-PJ49,25183872,-2.3917341598703232
SaOS-2,72376,-1.862865015628177
HARA [Human squamous cell lung carcinoma],9911830,2.811378702432749
JHUEM-2,71466445,5.178747074886277
SK-MEL-2,24901704,4.250191014208499
Mino,104842,-6.786846619272012
Panc 02.03,3062316,2.5231792980774
KMS-21-BM,11717001,2.7255805844503955
MOLP-8,6918837,-6.2821371699611515
SW48,1242560,3.5610164041067645
Hep-G2,4096211,2.329353731718805
KMS-21-BM,9444,3.934296026563206
L3.3,11404337,0.7171912876466348
SNU-1079,4917,2.2262765580321395
RCC10RGB,3062316,3.7206614033239833
JHUEM-1,piperlongumine-MST-312 (1-1 mol-mol),0.9237173809025055
IA-LM,25262965,-3.1838216959830796
BICR 22,3038522,1.9324211832044784
SW1573,4096211,3.236722527011662
SUP-T11,5287620,-2.1547593944362657
L3.3,1716436,3.5741303666735633
LS180,navitoclax-pluripotin (1-1 mol-mol),-0.4771322903655018
HT-1376,selumetinib-navitoclax (8-1 mol-mol),3.0473141814061715
DLD-1,selumetinib-GDC-0941 (4-1 mol-mol),3.851473421315054
NCI-H2452,2733526,3.4563089712221
JHUEM-2,426756,3.730602205252296
U-BLC1,navitoclax-pluripotin (1-1 mol-mol),-1.6962997081856257
L3.3,71466380,3.127104498422419
F-36P,23725625,5.61536820400509
SNU-1079,sirolimus-bortezomib (250-1 mol-mol),-1.4435273189765718
WM115,44197249,3.814304480361476
HARA [Human squamous cell lung carcinoma],ISOX-bortezomib (250-1 mol-mol),0.5382016887520487
Granta-519,JQ-1-UNC0638 (2-1 mol-mol),-1.2323689665878552
SW948,216345,3.8478701746280506
F-36P,176870,2.9171808936950465
BT 440,53392493,3.2800666553754168
RKN,2858523,3.2318364946727653
HuH-6,selumetinib-JQ-1 (4-1 mol-mol),2.3851782535908628
T98G,3503,1.1152470336789169
HARA [Human squamous cell lung carcinoma],11507802,1.3937860028408913
L3.3,73707398,1.2944525096848456
LCLC-97TM1,17759555,4.8791087487812606
YD-15,JQ-1-vorinostat (2-1 mol-mol),-1.4484565557476476
ALL-SIL,24771867,-3.516684419884963
JHUEM-7,5329102,1.651009676583094
PK-1,462382,1.099709320502161
WM115,11455910,0.9860510612095932
MKN1,23725625,5.766690916587828
MOLP-8,11485656,1.8270206697288176
MOLM-13,9866186,-0.4750218873797177
Daudi,445091,3.707432883595851
SEM,5329102,-2.9466084154190124
U-BLC1,9868037,3.998089604427344
RERF-LC-MS,9907093,3.840365222907794
LCLC-97TM1,selumetinib-decitabine (4-1 mol-mol),4.710076676704391
BT 440,72193861,3.787884680731709
IA-LM,49836020,4.225846480888235
IA-LM,JQ-1-navitoclax (2-1 mol-mol),0.4623829149690596
HuP-T3,445643,4.0158423100173986
RKO,5351362,1.5688417029382893
SU-DHL-1,25262965,-0.1887460090186497
Mino,675434,3.83423250538531
PE/CA-PJ49,44486219,4.085358173139104
KLE,168313047,2.8113927253020203
BT 440,5281321,1.9233768254501769
MOLP-8,3552672,2.5417747800161483
Daudi,selumetinib-UNC0638 (4-1 mol-mol),2.5339399670169827
HCC15,24771867,-1.1106317715549263
HARA [Human squamous cell lung carcinoma],16115403,-4.2638303939611335
COR-L95,25161177,5.647598761093448
MKN1,168313047,2.7173386518663127
LMSU,25062766,1.5653135657494996
BFTC-909,16219061,3.736019824418232
LCLC-97TM1,3503,2.904492448420953
SNU-626,11178236,-3.526493344549712
KPL-1,11609586,3.1157263699642717
KP-3,65064,4.409027805588154
RKN,5287620,-2.679516494579474
ST486,10296883,2.054791984575977
IA-LM,5281321,-0.2514769440259956
SK-HEP-1,24964624,3.121305411780932
SaOS-2,9884685,-0.6485333929619777
SNU-886,31703,0.9003298590117994
MOLP-8,44566777,0.3680572795114795
KHM-1B,25150857,0.9778770077521932
K-562,3081361,1.217245739162405
PE/CA-PJ49,4917,3.662887432440365
DLD-1,262093,2.7792650333384072
SEM,135421197,0.5141119166667375
HuP-T3,53392493,2.0684681956337654
SW48,11404337,-1.6842588085779022
RKO,24771867,6.323343540042099
MDST8,11497983,4.366208744407351
U-BLC1,54596558,3.717524944398739
TTC-709,3025944,4.075614367670093
Daudi,6918638,-1.8107043721369585
RERF-LC-MS,107970,3.001301355490032
F-36P,selumetinib-MK-2206 (8-1 mol-mol),0.8527414288582023
NCI-H2452,56963564,2.315469414243469
MOLP-8,JQ-1-UNC0638 (2-1 mol-mol),-1.954296009625891
MOLM-13,4259181,-1.5110532495146267
RERF-LC-MS,5566,3.05978093065268
HEL,44607531,1.529117499700861
SNU-1272,89928392,2.766641438672422
BFTC-909,25262965,-1.7887871070762158
ML-1 [Human thyroid carcinoma],26596,-0.6105391992480588
KP-4,5978,-4.324853556330347
BICR 31,46191454,1.7584497327325264
JHUEM-1,5287969,-2.4361126347599966
SK-LMS-1,24180125,3.932034764154328
SK-LMS-1,568763,0.9265341496938512
UACC-812,426756,4.999419351863596
NCI-H1395,439501,0.2163751108150007
SW1271,9911463,3.695583497273472
F-36P,1242560,2.9452724039039366
KLE,54618164,4.225211860569233
COR-L105,219104,4.205860409291191
MOLP-8,46943432,-0.8980695552897974
MOLM-13,11626560,-0.3289224093786886
SU-DHL-1,73707398,0.2992121771474305
HCC15,doxorubicin-navitoclax (2-1 mol-mol),-1.4188615279170478
KLE,24748573,2.547641121756725
KP-4,241158,1.8280076583022216
HCC1500,9907093,4.182225492860836
SW1573,JQ-1-vorinostat (2-1 mol-mol),2.32143209708559
SNU-C2A,tanespimycin-bortezomib (250-1 mol-mol),-0.6320265615754446
SK-LMS-1,17755052,2.8417893313361433
LS180,serdemetan-SCH-529074 (1-1 mol-mol),1.4143670518957836
ST486,11455910,-0.3463533308218484
NCI-H1568,5746,-0.0019321539800122
SW1271,navitoclax-birinapant (1-1 mol-mol),0.1602834101021188
HEL,10385095,1.0320529067741009
P31/FUJ,374536,-2.654779926412406
KU-19-19,119607,4.136898976237774
LMSU,17755052,3.9730762231411703
BT 440,3038522,3.678252908051195
EB1,10113978,1.040521182114955
KHM-1B,11167602,5.170482443949449
HCC1500,11656518,1.3375266797474916
LMSU,selumetinib-vorinostat (8-1 mol-mol),4.672884739471154
DLD-1,53232,3.780376964004165
NCI-H1568,44819697,-2.651253194329211
KP-4,57519531,2.7718546379882154
SNU-886,11213558,0.3239659195711419
COR-L105,6918328,0.8369476830507139
PaTu 8988t,1750826,2.46453979570572
NCI-H1568,vorinostat-navitoclax (4-1 mol-mol),0.9474025116898376
HCC1500,6438330,2.8683818740810088
HEL,11214940,0.9295508638766669
JHUEM-2,9825149,2.196350767149206
Mino,5311,-0.1516234540317863
JHUEM-2,10410894,2.911683629902095
KHM-1B,JQ-1-MK-0752 (1-1 mol-mol),-0.8214903492404299
HCC15,104842,-2.640027553911029
L3.3,637858,2.497804094781357
BICR 22,53495165,-1.022289455565369
SK-HEP-1,JQ-1-vorinostat (2-1 mol-mol),1.4434630535263555
SW948,11167602,-0.1815305116238505
SaOS-2,119607,5.401113896800015
SK-MEL-2,9866186,1.79871033508337
LMSU,135398516,3.1825333446331547
MKN1,5746,2.180272366897216
SNU-1272,637858,3.0444768805463465
U-BLC1,selumetinib-piperlongumine (8-1 mol-mol),-0.8535195374185828
SW1271,444795,4.935671262335122
JHUEM-7,24753719,4.234902187840303
LS411N,107970,2.4864618038552724
SNU-1272,24785538,2.381533689270871
RERF-LC-MS,3025944,4.157794890121567
IGROV-1,5282054,3.614574021382022
MOLP-8,5284373,1.9803114216772224
SW1271,46907787,1.639327018501732
K-562,tretinoin-carboplatin (2-1 mol-mol),5.512334561910439
IA-LM,carboplatin-UNC0638 (2-1 mol-mol),4.065848381548882
ALL-SIL,5351362,0.9273092220520184
PE/CA-PJ49,10113978,4.077453278392179
MDST8,docetaxel-tanespimycin (2-1 mol-mol),-2.250770682375198
LCLC-97TM1,54618164,4.1848187977728
SK-HEP-1,123631,3.617013696107864
LS180,1641662,3.031869457755623
L3.3,119182,-1.782056546640076
SEM,3011155,5.750051022389146
LCLC-97TM1,46199207,3.402623883365983
LMSU,57519531,3.754499553388688
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384
ALL-SIL,168312962,1.491579787235829
HT-1376,46907787,2.915425637626166
IGROV-1,135398516,1.9751898057484376
SK-OV-3,4261,3.2658157069367615
Panc 02.03,11707110,-0.717341284128793
P31/FUJ,4261,-0.12536828191131
Daudi,53481919,2.490259403593742
MDST8,navitoclax-birinapant (1-1 mol-mol),-0.9553214738186762
ML-1 [Human thyroid carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),2.9053104812744186
JHUEM-1,49766530,0.8981374764595749
SUP-T11,11213558,3.4117386984116744
Hep-G2,11214940,1.620296702627768
SW1573,12003241,-0.6702221198842615
SUP-T11,54618164,3.811166364183871
COR-L95,11238147,1.8523673489534709
PE/CA-PJ34 (clone C12),445643,3.973961211408011
TTC-709,3854666,1.2966503099263071
SW48,452548,-3.152923699933953
KP-4,168312962,0.839288879554725
ALL-SIL,46224516,1.508509192124363
COR-L105,selumetinib-MK-2206 (8-1 mol-mol),1.6265269022274589
PE/CA-PJ34 (clone C12),23582824,0.3149365494632303
ST486,11640390,3.0457675316091204
HARA [Human squamous cell lung carcinoma],46199207,3.289640650109998
SUP-T11,16725315,3.256117734528027
PK-1,46398810,3.220206848594368
UACC-812,docetaxel-tanespimycin (2-1 mol-mol),-4.467025086254145
ML-1 [Human thyroid carcinoma],24856436,-1.6469735215058778
DLD-1,11404337,-0.813522825038391
SK-MEL-2,285033,0.8066514843785048
Daudi,6918837,-6.333799665630375
K-562,57330099,5.557476297558147
MOLM-13,3038522,-2.559283473550591
KMS-21-BM,5282054,2.5454084081854083
SNU-C2A,124202324,2.388865450360117
BICR 31,tanespimycin-bortezomib (250-1 mol-mol),0.0232172753211841
SEM,54649381,3.0580730250658283
SU-DHL-6,9903786,1.8029536633965553
Daudi,151289,0.3893937359913983
NCI-H1395,135999136,4.46612092216275
MOLP-8,51037431,3.96461280344528
BT 248,11396600,1.9236183524788075
L3.3,54613361,-0.6336215633441857
BICR 31,11152667,-0.7818812516610519
HT-1376,46843906,2.465316519237626
LS180,46907787,-0.2837252988913812
PaTu 8902,16725315,5.393152185048805
Panc 02.03,6914657,-4.005158687469553
HuP-T3,54613361,5.307179038572215
BT 440,135875424,2.9900391536065354
NCI-H1395,11707110,3.0530004675688964
PaTu 8902,107970,2.826401466277882
RKO,25183872,-1.1635703485572924
PK-1,676352,2.2294680506272067
PE/CA-PJ49,11234052,4.7998888543845615
RCC10RGB,135659046,5.776465120313546
SNU-886,56946209,-2.6397102799841012
BICR 31,16725315,5.360398456728244
U-BLC1,11719255,3.376330054734909
F-36P,327653,3.3003434117548105
JHUEM-2,2708,2.6131077375000196
IA-LM,216239,1.6797579071033788
LCLC-97TM1,selumetinib-navitoclax (8-1 mol-mol),3.8256626967827385
Mino,UNC0638-navitoclax (1-1 mol-mol),-2.2285256214754647
LMSU,241158,4.2548793295703025
PE/CA-PJ49,9935249,3.146155709540263
COR-L105,6610216,4.21117605455994
COR-L105,10427712,4.508625829006449
NCI-H2452,6610355,4.992583267176856
KP-3,72376,-2.1111556340636843
SK-MEL-2,5328940,3.274148741678988
MKN1,9935249,3.838267685606268
EB1,3465537,1.4429875061757191
L3.3,168313016,5.4672449278411595
PaTu 8988t,11364421,0.0778741703331701
PE/CA-PJ49,1716436,3.7947980371388854
JHUEM-7,31703,-1.6318454147160704
BT 440,1750826,0.861613701124945
JHUEM-7,serdemetan-SCH-529074 (1-1 mol-mol),2.0625230900739657
RKN,3552672,1.948192158503618
SEM,5287620,-2.250994542245304
F-36P,72199292,0.7918763584575162
Granta-519,46174525,4.2506809125564615
SW1271,44819697,-0.8585090240358869
SNU-1079,navitoclax-MST-312 (1-1 mol-mol),1.4479629561326222
WM115,44486219,4.206639028474801
BT 440,5282054,4.544699382504878
JHUEM-1,11238147,1.6136740231679916
MOLP-8,6918736,-3.613498069188207
SEM,salermide-PLX-4032 (12-1 mol-mol),4.3063302243904085
EB1,5278396,2.709790912512087
KHM-1B,9907093,3.851614847193926
LS411N,navitoclax-pluripotin (1-1 mol-mol),0.0808011312818899
F-36P,6918638,-0.9703997893287856
F-36P,docetaxel-tanespimycin (2-1 mol-mol),-5.066633140613987
SUP-T11,16736978,-1.6145147111182303
DLD-1,11626560,2.3959010728409837
LS411N,49836020,4.501659667614969
SNU-C2A,54649381,3.695698896689231
WM115,9927531,5.125567810288171
RERF-LC-Ad1,400769,0.0163383776885635
SW1271,24797083,1.5469513987685792
HCC1500,1566236,1.5057997400762737
SK-OV-3,serdemetan-SCH-529074 (1-1 mol-mol),2.3877296872918334
RERF-LC-Ad1,6623618,2.970461552664049
LCLC-97TM1,5566,3.3253657103683976
NCI-H1568,1242560,2.6554382745340046
KP-3,54618771,0.4281141975114925
U-BLC1,serdemetan-SCH-529074 (1-1 mol-mol),1.9000903403135183
NCI-H1395,54649381,3.0165140825256884
SK-LMS-1,24901704,3.714674503706264
ST486,5311281,0.879365866849189
RKO,11717001,3.92417498432234
SW1271,11612883,2.3755529899406604
Daudi,11396600,1.6595042173405945
Ishikawa (Heraklio) 02 ER-,3384730,2.22085280352865
RERF-LC-Ad1,66577038,3.626450370462214
P31/FUJ,60700,-1.8341903870446763
KPL-1,448949,3.6381511247977536
MOLM-13,JQ-1-MK-0752 (1-1 mol-mol),-1.5133138249776965
DLD-1,selumetinib-MK-2206 (8-1 mol-mol),4.721543243345423
T98G,9933475,1.5303269678260305
BFTC-909,sirolimus-bortezomib (250-1 mol-mol),1.9272227302236649
KHM-1B,49850262,2.854623177297442
ML-1 [Human thyroid carcinoma],2858523,3.273643216387516
IGROV-1,3552672,2.134472496867482
Granta-519,637858,1.0013506713179747
PE/CA-PJ34 (clone C12),2742550,3.898499868649933
PE/CA-PJ34 (clone C12),6852167,2.080023831418778
RERF-LC-MS,24753719,5.208830602571573
ST486,11609586,1.4967205858934938
BICR 22,10385095,0.7738978245677988
HuH-6,123631,2.0233996258497293
IA-LM,216468,5.467489395679956
HARA [Human squamous cell lung carcinoma],46398810,2.9743064800682912
DLD-1,72193861,2.4947889704379356
ML-1 [Human thyroid carcinoma],JQ-1-navitoclax (2-1 mol-mol),0.5559974390910295
PE/CA-PJ34 (clone C12),702558,5.513865527518569
SK-HEP-1,5738263,4.7811273930471065
Mino,11955716,-2.6826182707421653
SNU-1272,11152667,1.552242826912863
SU-DHL-1,44632017,-0.1440136540504316
JHUEM-7,54613361,-0.8057680403927349
SK-MEL-2,1566236,1.8049776049740816
HEL,selumetinib-navitoclax (8-1 mol-mol),-0.2593426680751931
EB1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.096386446893736
JHUEM-1,3634881,3.007381075515879
PaTu 8902,11152667,1.2355675895718252
RCC10RGB,53245473,3.741106102916085
RERF-LC-MS,637858,3.156110522031532
LMSU,25105715,3.7531762313471466
IGROV-1,crizotinib-PLX-4032 (2-1 mol-mol),2.0296160065449858
HuP-T3,selumetinib-MK-2206 (8-1 mol-mol),2.743935040601299
MOLP-8,23635314,-4.658988245687028
HCC1500,241158,4.347158152842418
NCI-H1568,16065773,2.3280951044534923
COR-L105,24771867,3.297975412837562
PE/CA-PJ49,57519531,2.123608665735884
Mino,5311281,1.2497600850318282
COR-L105,11625818,4.2515796910784385
RERF-LC-MS,JQ-1-MK-0752 (1-1 mol-mol),3.600892214686445
IGROV-1,2841722,3.834853118277962
SaOS-2,51039095,1.985897726070115
KP-4,9907093,4.376940232486132
LS180,navitoclax-sorafenib (1-1 mol-mol),3.51212583776398
COR-L105,44589607,3.154557065472522
U-BLC1,5470400,-0.7028475874551648
F-36P,navitoclax-gemcitabine (1-1 mol-mol),-1.0394701152082435
HARA [Human squamous cell lung carcinoma],54626689,4.600126869473187
LS411N,9911463,4.267700407985282
IGROV-1,4378219,2.016502068118561
KLE,6918289,2.4096746231988995
Daudi,135659046,3.1156448500687923
KU-19-19,16722836,2.3762239171314894
IGROV-1,10410894,3.2660402181528263
Panc 02.03,49793307,-1.288996397670963
HuP-T3,SNX-2112-bortezomib (250-1 mol-mol),0.0780901353743998
SNU-1079,31703,-1.0076470486083364
MOLM-13,3136844,3.815118683612459
MOLP-8,6914657,-3.275680842626438
JHUEM-1,107970,2.1854656376588415
K-562,9887053,4.062685534067952
ML-1 [Human thyroid carcinoma],16038120,1.3266996549374028
NCI-H1568,52947716,-4.502411459776945
BFTC-909,11178236,-2.4757289909406683
SNU-C2A,54613361,-0.2228807141202547
Daudi,6610355,3.6984054922795906
KMS-21-BM,49766530,-1.7820478851785848
HT-1376,24771867,3.215322136386946
SNU-C2A,erlotinib-PLX-4032 (2-1 mol-mol),3.746708317630982
HuP-T3,10184653,2.026243337908569
U-BLC1,24775005,3.7380487839362937
F-36P,4259181,-1.8222583165697372
IA-LM,36462,3.5803800151684384
SU-DHL-6,46907787,-0.6700724490980451
SNU-1079,71466445,1.115113066325304
MKN1,216239,2.4816916329988894
HCC15,10231331,4.227224330005602
RERF-LC-Ad1,168313047,3.647095781351058
Hep-G2,613753,3.545634028634973
LS180,135398516,1.9815935031047112
MDST8,53495165,-1.6914230136545845
F-36P,2858523,2.6013714757914306
SW48,135411,0.1882785626851766
COR-L105,11485656,1.8131666015075352
HCC15,1239801,5.074899811919598
KLE,11640390,2.1380206941615514
JHUEM-1,24771867,2.37978547366131
KPL-1,2842253,5.812067226212684
EB1,42642645,-0.3146100978873946
SK-CO-1,11497983,-2.036472499029009
KMS-21-BM,445091,1.9046504937410844
F-36P,11234052,3.4123035226721035
KLE,444795,4.58251515525995
Granta-519,2742550,3.255820788990773
ALL-SIL,16720766,-0.6951675656481376
COR-L105,11175137,3.2551565890936165
ST486,6438330,0.1697349500146095
RCC10RGB,decitabine-navitoclax (2-1 mol-mol),2.143538063867694
BICR 22,ISOX-bortezomib (250-1 mol-mol),1.660291867951594
KP-3,44259,2.0024502475067414
IGROV-1,409805,5.990596261907717
Panc 02.03,11485656,5.602754460209725
KPL-1,9825149,2.775534472693956
SK-MEL-2,11964036,2.999902032518692
Granta-519,54619267,3.910643053444693
COR-L95,navitoclax-gemcitabine (1-1 mol-mol),-4.597005855092225
HuH-6,6610216,3.4772585756777357
Hep-G2,24964624,2.457583201626236
JHUEM-1,49793307,-5.396928734943919
KHM-1B,9825149,-1.748191139364394
BICR 22,6252,-0.1324642168432157
KP-4,16725315,3.490304952293189
MDST8,11404337,0.5498361952050128
SaOS-2,60750,-3.1697993298632183
SNU-1079,15983966,0.9839783710688907
SEM,navitoclax-gemcitabine (1-1 mol-mol),-6.263167217210504
U-BLC1,3543504,4.614178471564823
SW948,11717001,4.275182691709766
MDST8,11175137,2.5746086097463974
IGROV-1,322968,4.140599241163106
HCC1500,1242560,3.704354238917139
MOLM-13,9911830,-0.5537570191991712
SUP-T11,56963564,-1.4250286836544834
COR-L105,16038120,1.5247864010803889
SNU-886,46907787,3.408086497020091
PE/CA-PJ34 (clone C12),54618771,0.3330928840466188
COR-L105,45279963,3.905008730311125
WM115,148198,-2.543343591950365
IGROV-1,2749,2.0319044408234954
K-562,4477,-0.1635303329058878
SK-LMS-1,25105715,3.7582919754579938
SK-HEP-1,25227462,1.4628952719758763
JHUEM-2,44185566,0.4181490844439907
SEM,5460769,-1.0690415880949575
JHUEM-1,71466380,1.7046833971140851
KP-3,54619238,4.3217818182091365
Mino,71466380,3.1164895629530753
Panc 02.03,23582824,1.3457270338170706
SK-HEP-1,241158,4.116654148222159
SK-CO-1,168313047,0.9150038640573646
KP-3,10302451,2.012637643935689
Granta-519,9823820,3.571742016367909
SK-CO-1,159324,2.1120355222347738
ST486,400769,-1.9675436724388284
SK-CO-1,10385095,1.4661007046294967
JHUEM-2,25062766,-0.7515344079152008
NCI-H2452,71304818,2.7948147605911218
SK-LMS-1,6450551,3.8959522130422135
MOLP-8,4578,4.125075782233611
PE/CA-PJ49,168312962,3.718091644443816
EB1,49793307,-4.918053791870009
Mino,6917907,-5.79053360764326
NCI-H2452,11455910,0.7111396076654327
KLE,5280436,4.013094882120016
HARA [Human squamous cell lung carcinoma],6917907,-4.425737266076785
LS180,10074640,3.3464344717087333
T98G,3384730,3.641663706501406
MDST8,71466578,3.80352554053155
LS411N,6184667,3.0967158778150465
SW948,11317348,1.1175502037929408
SK-LMS-1,24771867,4.309064190513273
KLE,15983966,-4.1530046682155435
U-BLC1,4705,-2.296462105953433
MDST8,119607,4.705186592802013
F-36P,navitoclax-pluripotin (1-1 mol-mol),-1.2293372555397408
SW48,11507802,0.6466338181730511
KP-3,4096211,0.4234896505440504
IA-LM,alisertib-navitoclax (2-1 mol-mol),-2.012462769104639
WM115,5702613,3.6693021536028367
KP-3,11717001,4.714706744036414
F-36P,5494449,1.3820344603189991
LMSU,25183872,-1.684481128175181
SK-CO-1,23725625,2.337747507524157
K-562,2749,1.8349792189296796
IA-LM,3825829,4.571991496451351
BT 440,135421197,3.1509992040487074
KU-19-19,104842,-1.861779032385676
PE/CA-PJ34 (clone C12),25183872,-0.4619037978479324
SK-HEP-1,12001922,2.448252559355595
HEL,135440466,1.1488755358131115
Panc 02.03,6918328,1.3018368822202735
SaOS-2,72734382,4.901362762899978
EB1,6918736,-0.8856675287681746
SUP-T11,3384730,1.2900261597441636
SNU-626,6610216,4.899097524700605
HuP-T3,135421197,1.625440100707307
PK-1,5329102,2.657136687636097
BT 248,25227462,1.1845227545958306
HCC1500,3384730,2.626558190955656
IGROV-1,51037431,5.669320749085174
BFTC-909,4917,2.929839520827846
WM115,637858,1.77843641117838
MDST8,44589607,2.007770745404649
LCLC-97TM1,5282054,3.1900504557345664
PE/CA-PJ34 (clone C12),65628,4.231511653332105
JHUEM-7,JQ-1-vorinostat (2-1 mol-mol),-1.265812269763504
ES-2,2749,2.8308554039766536
HuP-T3,46199207,3.4499209547515433
BICR 31,25262965,-3.4333038857773093
LCLC-97TM1,6914657,-1.7973267784986633
KP-3,9926054,1.9542215923866435
KLE,426756,4.4338865892288295
MOLM-13,9823820,-0.5140029045699521
RCC10RGB,327653,3.228661308812885
Ishikawa (Heraklio) 02 ER-,322968,4.539754063131236
MKN1,60750,3.276884817569131
NCI-H1568,4705,2.022283964907955
HuH-6,navitoclax-sorafenib (1-1 mol-mol),2.0318635234589464
T98G,12001922,2.433944283223996
SW948,selumetinib-MK-2206 (8-1 mol-mol),-0.5060345185709773
Hep-G2,navitoclax-gemcitabine (1-1 mol-mol),1.7377855458966929
PK-1,53392493,3.3889436152731265
RKO,6914657,-2.9196237708628505
EB1,4096211,0.8105231642452959
WM115,72734382,5.455243998512052
JHUEM-1,16722836,2.09409728221148
L3.3,54143018,0.1799627669965377
JHUEM-7,71304818,2.591667999650727
JHUEM-7,262093,2.8461427698978197
T98G,9884685,2.6740995473938467
SW48,46398810,2.2376864399879
PE/CA-PJ34 (clone C12),753704,4.689094474093603
LS411N,2945648,3.381909997555915
LS411N,JQ-1-UNC0638 (2-1 mol-mol),1.029472619372517
DLD-1,ISOX-bortezomib (250-1 mol-mol),0.5958830222343071
SaOS-2,selumetinib-PLX-4032 (8-1 mol-mol),4.990111037976576
ALL-SIL,421610,2.937759224643201
COR-L95,11404337,0.1032061359669597
SNU-1272,alisertib-navitoclax (2-1 mol-mol),1.6439535972099484
WM115,11427553,3.734660617826416
HCC15,122327,4.313110702061898
Daudi,9444,3.424690286905087
Granta-519,4521392,4.382822475618979
PK-1,selumetinib-JQ-1 (4-1 mol-mol),1.9861622648896295
SW48,31703,-4.626106549902408
RKN,10127622,5.371150210721622
SK-LMS-1,navitoclax-MST-312 (1-1 mol-mol),0.8198989880129489
Mino,44498493,4.4262129486717585
KHM-1B,387447,-5.058175638788416
SNU-886,11964036,2.034434534905483
ALL-SIL,71466445,2.2002248480614925
MDST8,656346,0.9697505348816438
BT 440,SNX-2112-bortezomib (250-1 mol-mol),-2.6659930457402585
Daudi,71680916,3.7291665773697
HEL,135398516,1.4688857829361923
HARA [Human squamous cell lung carcinoma],168312962,2.6720428895447412
JHUEM-7,11626560,1.4043790745396552
JHUEM-1,2828334,5.792048813859486
HuH-6,9911830,2.45331857773806
ES-2,31703,-0.4833258107497754
PE/CA-PJ34 (clone C12),2749,1.5513879621362283
P31/FUJ,9936388,-7.166815071220185
HuH-6,3062316,1.846642462729649
HARA [Human squamous cell lung carcinoma],42611257,3.5357302300548716
HCC15,11625818,4.624206979967606
LCLC-97TM1,42611257,3.4642891468760957
LCLC-97TM1,5311,1.9621633752287055
RERF-LC-MS,52912189,3.970931922009392
Mino,11647372,2.0622770979241727
BICR 22,9915743,0.3047863731286212
PE/CA-PJ34 (clone C12),10127622,3.216554947417576
PE/CA-PJ34 (clone C12),3825829,4.057915478742878
Granta-519,11612883,3.2575401906490895
HuH-6,2749,1.802545748037483
LCLC-97TM1,vorinostat-carboplatin (1-1 mol-mol),3.53516680468747
NCI-H2452,3543504,4.306818718463235
RERF-LC-Ad1,10184653,2.5913648583184905
SK-CO-1,676352,2.6575015884388704
U-BLC1,16736978,0.3334262754334804
COR-L105,docetaxel-tanespimycin (2-1 mol-mol),0.3286281168811693
RKN,71304818,2.008207131108322
SK-MEL-2,9926054,1.8796163413954976
LMSU,alisertib-navitoclax (2-1 mol-mol),2.7596802469800026
IGROV-1,67156097,0.1763939852409119
HT-1376,navitoclax-MST-312 (1-1 mol-mol),2.418418137946028
PE/CA-PJ49,9825149,2.059569205901066
IGROV-1,51039095,1.7163430299301403
SK-MEL-2,5351362,3.093189377228118
P31/FUJ,JQ-1-MK-0752 (1-1 mol-mol),-0.1535880671922636
PE/CA-PJ49,24901704,4.643738871205813
SNU-626,119182,1.65038296776794
SNU-626,11238147,4.5126248251659264
YD-15,16722836,0.5375976878782693
ST486,5284329,3.115499256854347
SEM,409805,3.7048315559445575
IGROV-1,72193861,2.0623829231433293
Daudi,tretinoin-navitoclax (4-1 mol-mol),3.599991807714322
KP-3,168313047,2.5997698738150072
NCI-H1568,11167602,1.5259281753697294
U-BLC1,24753719,4.182183061493439
NCI-H1568,52912189,3.4016367932827563
BT 248,1641662,4.808188715890419
SU-DHL-1,107985,-3.306496987383706
HuH-6,135875424,3.823839910626804
P31/FUJ,73707386,2.311695228129917
WM115,9884685,-1.925323313513864
HuH-6,168312962,-1.6618574852452217
BT 440,5746,3.5420198911840344
SaOS-2,16722836,0.8662367041162377
RERF-LC-Ad1,9444,4.3231726239662045
PaTu 8902,46843906,4.340257675131653
PK-1,3634881,5.460028348575964
BT 440,72376,-1.4009448884993407
EB1,11507802,0.474188948926459
BFTC-909,656346,-0.1018552101429806
SUP-T11,55283,2.1913852029030156
PE/CA-PJ49,71466445,3.0052586534681645
COR-L95,54618305,4.5292428127427575
SNU-1079,119607,3.736865279973388
LMSU,12001922,2.4559246423075707
KLE,crizotinib-PLX-4032 (2-1 mol-mol),3.0491582374844723
KP-4,11625818,5.13819427873932
PaTu 8988t,selumetinib-MK-2206 (8-1 mol-mol),3.0176221561167096
Daudi,24772860,-3.9771177154169304
BFTC-909,9911463,4.114346930944119
LCLC-97TM1,44197249,3.7483906325702545
L3.3,1242560,3.353722310779613
BFTC-909,6918837,-1.9878509916437357
RERF-LC-MS,24797083,0.2985814331764478
HT-1376,46199207,3.330223103473416
SNU-C2A,24901704,3.4309285343979505
T98G,11955716,-0.058314158431459
Ishikawa (Heraklio) 02 ER-,44819697,-1.0059186995092202
Ishikawa (Heraklio) 02 ER-,241158,3.6664689500376353
SNU-1272,navitoclax-sorafenib (1-1 mol-mol),0.9627190131227148
P31/FUJ,135928012,4.893710575363991
DLD-1,6918878,5.1268525240877105
P31/FUJ,53232,3.343897726239282
K-562,navitoclax-MST-312 (1-1 mol-mol),0.8745280332695038
ST486,24821094,2.7326204055495817
SNU-1079,44507138,0.8687557252119305
SNU-C2A,9840324,6.974905535813454
MOLP-8,25062766,1.6722099464266416
SEM,11178236,-5.071502076951621
SEM,54618771,-1.6874791122177024
PaTu 8902,JQ-1-vorinostat (2-1 mol-mol),2.024407809701968
DLD-1,doxorubicin-navitoclax (2-1 mol-mol),-0.8147678801057705
DLD-1,JQ-1-UNC0638 (2-1 mol-mol),2.3834003327656106
LMSU,10296883,4.275438301361486
SNU-886,53245473,3.705172438832396
ALL-SIL,tanespimycin-bortezomib (250-1 mol-mol),0.6461816419253308
SK-CO-1,262093,3.1807391377127376
SK-LMS-1,16038120,2.334826379041828
KMS-21-BM,9911463,2.539829104515626
LS180,72376,-2.8322202153843703
SK-CO-1,carboplatin-etoposide (40-17 mol-mol),1.570074747334896
SK-LMS-1,375860,0.2604054406638652
KU-19-19,6918328,0.0154884073180988
SK-HEP-1,107985,-2.2891993358893856
LMSU,11222830,1.917017236141016
PaTu 8988t,216239,1.832862266271042
NCI-H1395,5278396,4.323134607051869
SW1573,vorinostat-navitoclax (4-1 mol-mol),1.892054443323453
JHUEM-2,25195348,1.9981816441048272
PaTu 8902,156414,2.7243668654536206
KHM-1B,400769,-0.7563953043015217
Daudi,16659841,2.946181230411034
LS180,123631,2.1427319304120624
BFTC-909,10385095,0.9839595624316404
Hep-G2,11626560,1.6326140498169086
NCI-H1568,241158,1.943489424131273
UACC-812,44589607,1.3537953197929582
JHUEM-2,135398516,1.025605941316658
SEM,448949,-1.6287077587171075
Granta-519,11960529,3.2261057296158593
SNU-626,654092,0.4669198120386104
LCLC-97TM1,25062766,2.2139494005881293
LCLC-97TM1,5291,3.6350350305332424
MOLM-13,44491742,3.7695621371445975
KHM-1B,6914657,-6.231607767095075
P31/FUJ,3025986,-2.3655111331800067
PaTu 8988t,2749,1.558615062570056
IGROV-1,2113511,5.982902824257526
Daudi,54639126,5.221444108043
DLD-1,54626689,4.853059608644546
KMS-21-BM,9927531,3.894276575541364
NCI-H1395,25262965,-4.1064506045953095
HuP-T3,selumetinib-PLX-4032 (8-1 mol-mol),4.085577653340594
U-BLC1,71466445,2.8221839412497864
HCC15,9868037,2.5640614102548556
LMSU,65064,5.4965008599922145
BT 440,11485656,2.455280972559295
PaTu 8902,6918837,-2.118913626513807
ALL-SIL,23725625,2.2136327630148736
SK-LMS-1,262093,2.881429058515633
TTC-709,11640390,3.647695262908313
COR-L105,11455910,0.425998653780944
K-562,16013152,3.768503882504226
KHM-1B,72734382,4.262414843982703
Daudi,67156097,-2.7448600083467163
SW48,6610216,4.461301788418361
SEM,73707438,3.837123399224833
SK-MEL-2,4477,0.6174311430568699
JHUEM-7,12001922,1.974346294613864
LMSU,docetaxel-tanespimycin (2-1 mol-mol),-0.129764308689889
JHUEM-1,selumetinib-MK-2206 (8-1 mol-mol),2.243824592241807
L3.3,9840324,5.709572906398099
KHM-1B,24964624,-1.4057417627664983
BICR 22,11977753,-1.1105881150796446
Daudi,753704,2.787779434331829
SK-LMS-1,3825829,4.897973293918553
ES-2,serdemetan-SCH-529074 (1-1 mol-mol),2.5174690778362607
SNU-C2A,selumetinib-UNC0638 (4-1 mol-mol),2.9947960449569546
COR-L105,46943432,2.471907312248233
IA-LM,16736978,1.926640001137528
Mino,11152667,-1.4239628293556983
IGROV-1,176870,1.8349827429681411
SK-MEL-2,selumetinib-GDC-0941 (4-1 mol-mol),1.2441784901384163
SK-CO-1,148198,-1.1611262776602205
SEM,16219061,1.294188336335581
HARA [Human squamous cell lung carcinoma],219104,4.732621852676119
YD-15,446155,1.552080627477238
Mino,10077130,1.912343347725037
IGROV-1,46943432,4.105714883822214
Ishikawa (Heraklio) 02 ER-,654092,0.6103847361282962
JHUEM-2,56963564,-1.5272814894896607
LS411N,168312962,3.224541058203402
LS411N,1641662,3.6634193785306337
HEL,vorinostat-navitoclax (4-1 mol-mol),-0.226382947191329
Mino,136227924,1.7493984310197022
LCLC-97TM1,26596,-2.266692800551727
SEM,60700,-4.28197010474707
HEL,151289,0.2321343459174182
Daudi,1285940,3.7558538743643792
MOLP-8,2749,1.3302247490678565
RERF-LC-MS,10427712,4.250983789220692
WM115,16725315,4.630500047502962
Granta-519,9840324,5.864872193260208
HuP-T3,25262965,3.989652761156405
NCI-H2452,11719255,2.41462187851326
KP-3,tanespimycin-bortezomib (250-1 mol-mol),-0.1312023090499479
JHUEM-1,5281321,-2.169930112482954
COR-L105,1641662,3.72017777917812
SaOS-2,89928392,1.2892186505806515
PE/CA-PJ34 (clone C12),11717001,4.9585803256068655
YD-15,119182,-1.6685612341110985
LS411N,969516,3.2917111714105647
Panc 02.03,carboplatin-etoposide (40-17 mol-mol),3.971241945633474
NCI-H2452,327653,3.049758242791241
LS180,4521392,3.9983682640735094
L3.3,4788,5.85214112282752
IA-LM,2113511,5.955012720035456
SNU-1079,54618164,3.1553824878915955
Ishikawa (Heraklio) 02 ER-,6918878,3.724210290974002
EB1,9926054,1.6799735914328415
HCC15,11167602,2.587200682435675
SNU-886,969516,2.757505683401957
RCC10RGB,9911830,4.5526597563763795
P31/FUJ,168312962,2.530788243280419
ML-1 [Human thyroid carcinoma],136227331,5.904689393841422
ML-1 [Human thyroid carcinoma],11609586,2.006327876020203
PE/CA-PJ34 (clone C12),52947716,2.849675512601996
JHUEM-2,44259,-0.1050980796979092
Granta-519,9933475,1.54115480203428
HuP-T3,73707398,1.153693297692098
ES-2,9911830,3.057885215196293
NCI-H1395,216468,5.017239605699041
SaOS-2,409805,5.764413924489168
SEM,selumetinib-vorinostat (8-1 mol-mol),0.5449202862000408
KU-19-19,984333,-0.867877464903324
ST486,4578,4.241160888004425
HARA [Human squamous cell lung carcinoma],5351362,1.123570314509272
LCLC-97TM1,selumetinib-PLX-4032 (8-1 mol-mol),3.0304859741823944
P31/FUJ,navitoclax-pluripotin (1-1 mol-mol),-1.7547710657643
KP-4,2126,3.9104129832919545
SW48,6918837,-4.354568378072889
LCLC-97TM1,16741245,5.12826814210941
NCI-H2452,11507802,3.578778888517491
HEL,11175137,3.15338888234114
BICR 22,60750,-4.532323865382038
Granta-519,44491742,4.018752292224149
SK-HEP-1,12003241,-1.7510835313415607
F-36P,11364421,-5.822340620557665
PE/CA-PJ34 (clone C12),216345,4.0155895974355555
SNU-C2A,322968,3.161849213962463
SU-DHL-6,36314,1.1358641594844867
HuP-T3,11152667,0.3145958176635
Granta-519,15547703,2.599412791530534
SUP-T11,9884685,-1.4007483875875175
Hep-G2,selumetinib-JQ-1 (4-1 mol-mol),-0.7772498513580158
BT 248,11609586,2.7692010936053064
DLD-1,5287620,-2.523274862308663
F-36P,navitoclax-PLX-4032 (1-1 mol-mol),2.2332176352158744
IA-LM,25126798,4.097105087874825
SUP-T11,400769,-0.8139461250828363
MOLP-8,119182,-1.11255726511749
EB1,644241,2.100204883262369
KLE,135984461,1.6662233005465323
PK-1,241158,4.411269356882099
BICR 31,65064,5.259646525120305
COR-L105,6917907,-5.504495586582428
DLD-1,11455910,2.1228676329479397
LMSU,11640390,3.606539387611797
SEM,selumetinib-MK-2206 (8-1 mol-mol),0.6180470677405737
LCLC-97TM1,11238147,1.840896458617422
HEL,51039095,2.698396554100347
PaTu 8902,44185566,2.9137350944736653
KLE,23725625,2.7746440048356
SNU-1079,9926054,1.5049009904469195
LMSU,107985,-1.9062813049718328
Daudi,53495165,-3.885820769064659
PK-1,219104,4.16519425298015
PK-1,11364421,1.9835440279526784
KHM-1B,126941,-4.224902593800319
SK-LMS-1,9907093,6.302813167842978
KHM-1B,73707440,5.196065246508486
BICR 31,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7385932494474976
KLE,selumetinib-MK-2206 (8-1 mol-mol),2.611642542572268
MOLP-8,439501,-2.9296652389863267
Panc 02.03,4259181,2.0313571914007604
PaTu 8902,126941,-2.2828817630557228
RKN,5328940,2.201806852003849
PaTu 8988t,SNX-2112-bortezomib (250-1 mol-mol),-1.5745385961478635
HARA [Human squamous cell lung carcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.5629845870291592
EB1,17755052,0.6336317253978269
COR-L95,246676,4.317733637680926
K-562,135928012,4.4390204871751004
MOLP-8,56946209,-6.528820954061854
SNU-886,JQ-1-navitoclax (2-1 mol-mol),-7.589926641213618
SK-LMS-1,11427553,3.5159920643615745
SW948,selumetinib-decitabine (4-1 mol-mol),0.3455932815007744
KP-4,4261,3.627604600241331
JHUEM-7,5291,3.7790279347789264
HuH-6,6917907,-2.9186696281533595
COR-L105,135421197,1.9442341701951136
HARA [Human squamous cell lung carcinoma],374536,3.8012573814376567
ES-2,66577038,3.784037133384112
IA-LM,selumetinib-MK-2206 (8-1 mol-mol),3.1087327611966185
ML-1 [Human thyroid carcinoma],56649450,4.029501942502391
RCC10RGB,5280436,4.525748645562069
LMSU,1242560,3.6890056089090937
NCI-H1568,31703,-1.6950574450364193
SW1271,148198,-2.630785543453804
Granta-519,11964036,1.5223427206827596
SUP-T11,9911830,2.1480309662360377
JHUEM-2,409805,3.9028131887521225
MOLM-13,16725315,3.788691115651132
Panc 02.03,1716436,3.766168811644757
PE/CA-PJ49,135398516,2.6308812592012467
SaOS-2,JQ-1-UNC0638 (2-1 mol-mol),1.2943206739427773
HT-1376,9956119,4.362997861729858
MKN1,444795,6.668552685441613
PK-1,selumetinib-tretinoin (2-1 mol-mol),2.218584857934803
K-562,1566236,1.8179642124055264
RCC10RGB,409805,6.020159348453613
PE/CA-PJ49,148124,-8.481770349273331
HuP-T3,navitoclax-MST-312 (1-1 mol-mol),0.8342028342455182
L3.3,126941,-2.2408794553514735
ST486,72193861,-0.2927296600984866
HCC1500,11175137,2.755904594476177
HCC1500,11494412,1.8019649514762912
HCC15,10127622,3.735977541508184
BT 440,navitoclax-gemcitabine (1-1 mol-mol),0.5217075963146808
HARA [Human squamous cell lung carcinoma],4096211,1.410240196225579
SK-HEP-1,168312962,-1.3309808369359073
HuH-6,5278396,3.033079204920288
SEM,1317464,3.839801567359689
COR-L105,24180719,3.693037976394381
Daudi,46943432,0.8866201698678313
U-BLC1,46215462,1.4818328353489547
NCI-H1395,piperlongumine-MST-312 (1-1 mol-mol),1.204552153931692
KPL-1,6918289,3.2449861305612258
HuH-6,50905018,3.9012541367446274
Ishikawa (Heraklio) 02 ER-,6918736,-2.3716869662510462
HCC15,BRD-K27188169-navitoclax (2-1 mol-mol),-0.2430288225821102
Granta-519,24180125,1.2477770260094014
RKN,9967941,2.6996754619948065
SNU-C2A,11497983,6.230107895974052
RKN,135398516,1.9656218312143572
JHUEM-1,SNX-2112-bortezomib (250-1 mol-mol),-2.861404990129526
KU-19-19,16115403,-3.194116920729502
SW948,56949517,5.5880132005349505
NCI-H1568,44632017,0.9967277604489184
PE/CA-PJ34 (clone C12),2729026,3.095265123820331
COR-L95,11175137,2.52315362607855
NCI-H1568,676352,1.7505105304855018
Hep-G2,6852167,3.060489701170588
PE/CA-PJ34 (clone C12),navitoclax-gemcitabine (1-1 mol-mol),-0.7545233222413882
NCI-H2452,126941,-2.0674603287446964
NCI-H2452,4477,0.2060981637085811
SaOS-2,vorinostat-navitoclax (4-1 mol-mol),1.3300754000959574
LS411N,vorinostat-carboplatin (1-1 mol-mol),2.115093899053651
KHM-1B,4378219,1.8511847617722708
BICR 31,11647372,2.8607835505972035
WM115,52912189,2.2242444616857417
EB1,44185566,1.3505541550150353
COR-L105,2729026,3.0417945234466863
COR-L95,65064,3.24172080303354
IGROV-1,54613361,1.0826132998561049
NCI-H1568,53232,2.5527200815554587
IGROV-1,9884685,-0.088911709267569
KPL-1,11364421,2.267489563844266
KP-4,6918736,-1.4678476306173975
HARA [Human squamous cell lung carcinoma],104842,-3.702627319243614
SW948,16720766,3.3510678765666517
ALL-SIL,135928012,2.5698772014589992
Mino,219104,1.9513354332512027
IGROV-1,ISOX-bortezomib (250-1 mol-mol),0.8859012184952701
COR-L95,56946209,-6.902335125637694
IA-LM,49867926,4.185996432673056
SW948,11625818,3.962309646097391
SNU-886,135928012,0.9415972865486992
IA-LM,4259181,2.3536383664390734
KPL-1,11647372,0.8404884126414128
NCI-H1568,4259181,0.5766231269303183
SW948,6438330,3.286047925562068
NCI-H1395,16038120,3.027555805242751
P31/FUJ,15547703,2.950164329068843
COR-L95,1750826,-0.7485912803642704
Mino,126941,-4.417965625987865
HEL,51037431,1.91843497941606
BT 440,6505803,-2.620705612839711
JHUEM-1,54618164,3.7597599948507217
EB1,doxorubicin-navitoclax (2-1 mol-mol),-3.517016618504088
BICR 22,vorinostat-navitoclax (4-1 mol-mol),0.9224898382798205
Granta-519,462382,0.1364457210972633
LCLC-97TM1,11719255,2.8064116850649774
U-BLC1,4477,1.5666772078185005
IGROV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0361645465839266
SUP-T11,4788,5.570985550847602
ES-2,11178236,-2.8372799618596205
MOLP-8,1242560,2.9421278446513393
ES-2,54619267,4.070741479649249
SK-MEL-2,409805,5.943118564665864
WM115,9911463,2.5241618652619007
RKO,3025986,-0.6013959236761957
PaTu 8902,5335621,4.440333682211631
NCI-H2452,19582717,3.9299005055458793
YD-15,44185566,1.644735880641646
PE/CA-PJ49,11707110,2.840144820082537
SNU-C2A,4917,3.185028518819387
JHUEM-7,1566236,1.715043210679705
Mino,25105715,3.062355034521067
Ishikawa (Heraklio) 02 ER-,9926054,2.558951101727927
SNU-C2A,3543504,6.320917836146873
NCI-H2452,171352865,2.832902682703541
COR-L105,5566,3.258554573596101
BFTC-909,11647372,1.2423847125416496
Daudi,3503,0.8148417795144576
COR-L105,25183872,-0.7403581245059931
ALL-SIL,375860,-1.552794194023853
HuP-T3,72193861,3.3106720937076233
BT 440,5738263,3.8184113197298584
SK-LMS-1,65064,5.781704969284795
NCI-H1568,ISOX-bortezomib (250-1 mol-mol),0.1016439372832729
SNU-626,navitoclax-piperlongumine (1-1 mol-mol),2.1549714667863955
SW1271,6438330,2.1351654373433764
SU-DHL-6,25262965,-2.983432395440536
F-36P,53495165,-1.808011952813931
SU-DHL-1,serdemetan-SCH-529074 (1-1 mol-mol),1.762662031403703
RERF-LC-Ad1,navitoclax-gemcitabine (1-1 mol-mol),2.5531217714066177
BICR 22,JQ-1-UNC0638 (2-1 mol-mol),1.3883099593452988
HT-1376,24856436,0.3954473133820807
SU-DHL-1,44489367,4.533806271256096
DLD-1,448949,2.683372467843814
MDST8,31703,-1.4422735490012837
MKN1,selumetinib-piperlongumine (8-1 mol-mol),4.460463612356188
ML-1 [Human thyroid carcinoma],568763,0.2556406277244685
JHUEM-7,11152667,-1.617539087588013
IA-LM,10302451,4.177351274859187
EB1,72734382,4.318817296884159
BT 440,selumetinib-BRD-A02303741 (4-1 mol-mol),1.4420311432960429
SNU-886,6438330,2.3407499785849524
SW48,11214940,3.1705360221414134
RCC10RGB,10074640,3.4095283906874956
HCC1500,carboplatin-UNC0638 (2-1 mol-mol),3.485346920824326
COR-L105,25227462,0.5095099099095757
RERF-LC-Ad1,11175137,4.230605816025899
COR-L95,66577038,3.0490878420221934
LS180,46191454,1.5509574675684803
RCC10RGB,65064,5.251967206688168
BT 248,3081361,2.663958705985954
IGROV-1,72376,-2.111352545322758
JHUEM-1,3136844,4.104089180564857
MOLM-13,89183176,2.661461024404157
Mino,11494412,-0.5549437780850603
Mino,5328940,0.2661217011017847
NCI-H1395,JQ-1-vorinostat (2-1 mol-mol),1.5410924011287808
ST486,439501,-3.700540877794945
HT-1376,25154868,5.257345349926592
Ishikawa (Heraklio) 02 ER-,984333,1.1633965766946808
LCLC-97TM1,doxorubicin-navitoclax (2-1 mol-mol),-1.1891183752031609
RKO,3384730,1.0492755436091918
T98G,3385,5.098670730124117
SW948,11656518,-0.9054812480406104
ALL-SIL,2949965,1.286096946783907
ST486,44495899,4.655536662054399
JHUEM-1,10385095,0.0269931721526632
ML-1 [Human thyroid carcinoma],selumetinib-tretinoin (2-1 mol-mol),1.8296865613090936
SK-LMS-1,3634881,3.6033137231613055
SNU-1272,16722836,2.182874461062422
F-36P,11964036,0.4602829644770974
RERF-LC-MS,selumetinib-BRD-A02303741 (4-1 mol-mol),3.278081284431068
K-562,5287620,-0.244838249137823
Hep-G2,10302451,3.0105378640601037
Granta-519,3825829,3.4773445434270243
TTC-709,135398738,5.002224412866271
PK-1,2708,7.605897390855717
BT 440,11656518,2.651360804152017
KP-4,54143018,-0.6876943348633362
MOLP-8,10385095,0.909191851453096
COR-L95,135928012,3.4969711227856397
IGROV-1,selumetinib-JQ-1 (4-1 mol-mol),0.7800599487705251
UACC-812,25161177,3.457735095549926
SK-HEP-1,11178236,-5.847785565222589
SNU-1079,selumetinib-decitabine (4-1 mol-mol),-1.4385664512984988
SW1573,16741245,2.047879460545898
HuH-6,446155,3.636791974865142
T98G,16659841,4.447078070891928
SK-MEL-2,9956119,4.152729077258935
ES-2,11609586,4.007877014311376
MKN1,vorinostat-carboplatin (1-1 mol-mol),3.3950736290855663
K-562,vorinostat-navitoclax (4-1 mol-mol),0.9167311998987592
K-562,89183176,3.981701702250952
P31/FUJ,9915743,-0.8907797257006451
WM115,3503,1.3325075362119865
EB1,16659841,2.47390628333119
PaTu 8988t,44202524,3.9754310935930968
SW948,9952709,2.6604018004594514
Granta-519,56946209,-6.359988120178517
Mino,89928392,-0.3907665293577761
NCI-H1568,navitoclax-piperlongumine (1-1 mol-mol),1.526760839095053
SNU-1079,3634881,2.045508748419143
Daudi,613000,1.9882519691431488
HT-1376,11364421,1.5175686573889164
Ishikawa (Heraklio) 02 ER-,selumetinib-UNC0638 (4-1 mol-mol),5.032208541868087
RERF-LC-MS,374536,3.716253113618047
LS180,72734382,4.032476699930466
Daudi,1566236,1.0534301581716357
BFTC-909,9868037,3.24226767674478
HuP-T3,107985,-4.90392348596967
JHUEM-7,107970,1.950560118304485
PE/CA-PJ34 (clone C12),serdemetan-SCH-529074 (1-1 mol-mol),2.712414122638107
SEM,JQ-1-MK-0752 (1-1 mol-mol),-2.5626704583038276
BICR 22,crizotinib-PLX-4032 (2-1 mol-mol),2.04605335326416
SEM,8515,3.1734533469366064
IGROV-1,168312962,3.022863957843741
KP-4,23635314,-1.4803709011127404
IGROV-1,3081361,0.99973562532788
Ishikawa (Heraklio) 02 ER-,11222830,1.865706051670166
BFTC-909,5311,1.6846521587280363
JHUEM-1,3062316,-1.5047707559217187
BT 440,10113978,0.8575650107857979
NCI-H2452,2841722,4.2339337769073175
NCI-H1568,navitoclax-gemcitabine (1-1 mol-mol),-4.7036832419339865
Mino,4378219,3.5909916747536976
RERF-LC-MS,5278396,3.382202757419261
JHUEM-1,26596,-1.2940313289426515
JHUEM-1,135999136,1.801917523699696
KLE,10127622,3.079839364113069
COR-L95,44607531,1.1147625805359247
SaOS-2,135440466,1.1747227113697256
RCC10RGB,285033,2.114091727684993
KMS-21-BM,selumetinib-MK-2206 (8-1 mol-mol),-1.8498740007589043
SW1573,448949,2.6434946381292703
SK-CO-1,11964036,1.41955554287601
SK-HEP-1,24901704,5.545234809796251
JHUEM-7,10184653,0.8524941419446748
RD-ES,doxorubicin-navitoclax (2-1 mol-mol),-2.982578059380771
RERF-LC-MS,71751553,4.213964581210796
SW1573,11178236,-2.507507612037206
HCC15,6450551,1.6627728253820353
HT-1376,53392493,2.8411684406542976
SU-DHL-1,54619267,3.144461009217004
PE/CA-PJ34 (clone C12),11719255,3.7761142192038353
SEM,82146,3.5358695310229704
KP-4,5566,3.0849581277118157
P31/FUJ,11626560,0.2148563033664798
Ishikawa (Heraklio) 02 ER-,44484440,3.323935553013314
COR-L105,119607,5.370152891195211
JHUEM-2,6914657,-1.558714035546877
NCI-H2452,11427553,2.818972077820031
JHUEM-1,46926350,-4.530422385663853
MKN1,11222830,0.8896176067256898
HuP-T3,2871966,0.5817483683031975
Granta-519,439501,-6.00499370561019
LMSU,1641662,4.120981858702554
Hep-G2,serdemetan-SCH-529074 (1-1 mol-mol),1.77689814586136
RCC10RGB,JQ-1-UNC0638 (2-1 mol-mol),2.5689754136574425
SW948,navitoclax-sorafenib (1-1 mol-mol),1.76041571963915
RERF-LC-Ad1,24951314,3.0210341675900736
SNU-C2A,104842,-2.7821653757613705
BICR 22,2945648,3.5832925483527625
NCI-H1568,11228183,4.140816994678141
TTC-709,44607531,1.4725599520903556
U-BLC1,54613361,0.7923564384135392
SEM,11964036,-0.8070570708115667
JHUEM-2,16725315,3.2164288963347416
SEM,23725625,1.850131021404486
KLE,2708,3.7521843050752457
COR-L95,89928392,1.3878824566143364
BICR 22,2871966,0.0284401826322965
HEL,46199207,2.3973871372245372
HCC1500,52912189,2.5783780690097857
KU-19-19,52947716,-4.518413756843173
ES-2,1750826,-3.8422947183514338
ML-1 [Human thyroid carcinoma],5280436,5.01828711367565
MKN1,46398810,2.9568457644401094
JHUEM-7,208908,1.9888781233805737
NCI-H1568,7326481,2.864470016727109
RKN,53232,2.2291100881655037
JHUEM-1,6505803,-0.0330531463180682
JHUEM-1,4917,3.514310013813243
SNU-1079,6917907,-6.176639145928203
U-BLC1,11612883,4.05910275674666
KU-19-19,4477,-0.0533500132034658
JHUEM-2,3543504,3.8244041190644698
SK-OV-3,107970,2.5604111984812152
BICR 22,1242560,3.7933374150058015
KP-3,SNX-2112-bortezomib (250-1 mol-mol),-2.18950982339932
ALL-SIL,5738263,2.854339564213428
BT 440,9823820,0.1668818861449572
HEL,5329102,1.6539669706420914
LS411N,selumetinib-BRD-A02303741 (4-1 mol-mol),3.2423717644429577
SaOS-2,3854666,0.6354016080385003
KHM-1B,44486219,3.979705310962138
DLD-1,2858523,3.228930126327987
P31/FUJ,107985,-4.114404549725097
SK-HEP-1,54619267,4.307302877095537
MOLP-8,11213558,1.2108381509164672
LS180,6914657,-4.58065814502937
HEL,71466380,3.121887792191312
KLE,638278,2.977843699594415
COR-L105,25154868,4.769445801979145
LCLC-97TM1,25105715,3.527934306265534
KP-3,11485656,2.673409024797461
SNU-C2A,5281321,-2.179404879105997
Hep-G2,vorinostat-carboplatin (1-1 mol-mol),2.5677353378270453
SW1271,16013152,5.485365595141675
ALL-SIL,1750826,-2.8707446972397483
SW48,44632017,-0.021210675828241
NCI-H1568,4578,4.166510450069308
SW948,24180125,1.460789729891403
BT 440,135999136,2.163125999503531
Mino,JQ-1-navitoclax (2-1 mol-mol),-2.926836894763339
COR-L105,25161177,3.712985248467103
P31/FUJ,57519531,1.451496749892495
ALL-SIL,6918837,-4.772645295536399
RKO,16720766,-1.2722083569090707
Daudi,11707110,2.6257952816009498
T98G,selumetinib-GDC-0941 (4-1 mol-mol),2.822030636893018
PaTu 8988t,24785538,3.127280515757933
SNU-C2A,5566,2.923837870126543
SEM,969516,-0.0005595502936996
SK-LMS-1,11455910,0.8292842204783425
L3.3,613753,4.077511547969464
PaTu 8988t,selumetinib-vorinostat (8-1 mol-mol),4.764605515620316
HEL,46174525,3.393297616528365
SUP-T11,JQ-1-navitoclax (2-1 mol-mol),0.5450942888323753
Mino,10410894,1.3441982081715471
MDST8,17759555,5.018522859633252
SW1271,53392493,2.79081275696651
COR-L95,carboplatin-UNC0638 (2-1 mol-mol),3.064030034312791
SU-DHL-1,9927531,2.969590320438058
SK-LMS-1,53495165,1.3391504782497183
JHUEM-2,119607,3.813155972845812
SNU-886,262093,3.428603865365944
Daudi,445455,3.7530002864178416
SW948,24951314,0.7675285489701543
IA-LM,JQ-1-carboplatin (1-1 mol-mol),4.993034474620053
SK-CO-1,9866186,-0.7388742913087788
PE/CA-PJ49,52912189,2.038214782345057
KMS-21-BM,100016,3.297202365361246
RERF-LC-MS,60700,0.497286081450591
HuH-6,3552672,1.8037663077695305
BFTC-909,11364421,-5.034674750215906
Hep-G2,6918328,-0.5211746327374635
SW1573,49766530,-2.79322841384178
BT 440,44137675,4.39574012550054
SUP-T11,49793307,-4.2414983376474495
U-BLC1,5329102,1.5011225870124678
COR-L105,vorinostat-carboplatin (1-1 mol-mol),4.069993227019241
SNU-886,tanespimycin-bortezomib (250-1 mol-mol),0.3789441066781652
HuH-6,selumetinib-BRD-A02303741 (4-1 mol-mol),5.214321512724216
BT 248,71304818,1.6499217451033
MDST8,25126798,3.890491738661291
JHUEM-7,11960529,4.681162039691551
HCC1500,3543504,4.272332537756205
PE/CA-PJ34 (clone C12),7251185,3.0082102919143705
BT 248,5287620,-3.0713737356172484
JHUEM-1,4261,2.037541396229649
COR-L95,25062766,3.209944577871265
ML-1 [Human thyroid carcinoma],5351362,1.4214743835970418
SK-CO-1,44632017,0.9847861620501556
NCI-H2452,navitoclax-piperlongumine (1-1 mol-mol),2.2697751233857058
HuH-6,10427712,4.199975366399499
KPL-1,2733526,3.414809942071795
KMS-21-BM,135999136,1.2444015260094663
NCI-H2452,445455,4.8000860101003235
JHUEM-7,15953870,4.009699489789049
ML-1 [Human thyroid carcinoma],446155,2.0206180645356766
HuP-T3,439501,-2.469428626730465
BT 440,9903786,3.1498376271679533
RERF-LC-MS,9884685,0.4531053665233772
PE/CA-PJ34 (clone C12),54596490,5.097353286236204
ST486,54618164,2.876081696628776
RKO,5281321,1.9988379902215376
NCI-H2452,10410894,4.350169635958685
KPL-1,702558,5.6318633290688895
ST486,ISOX-bortezomib (250-1 mol-mol),-0.1931979659878492
HuP-T3,24951314,1.4235135044150102
SaOS-2,71466445,4.363709574185696
SK-LMS-1,25183872,-1.7193752658392725
BICR 31,44185566,3.0664042381745946
EB1,5311281,1.4726368115654755
NCI-H1568,11625818,3.359978935972883
BICR 31,3552672,2.13577451695998
HT-1376,1750826,0.2160707645686562
P31/FUJ,decitabine-carboplatin (1-1 mol-mol),1.8939659397992608
BT 248,3634881,2.1213928087500413
HT-1376,selumetinib-JQ-1 (4-1 mol-mol),2.138060477374947
EB1,46943432,5.750857255240241
JHUEM-1,11175137,1.572236037462264
HARA [Human squamous cell lung carcinoma],11640390,3.0925981241806983
ML-1 [Human thyroid carcinoma],55283,2.9349831464401936
LCLC-97TM1,119182,-0.294501899208461
ALL-SIL,52947716,-0.7216046839402591
JHUEM-1,322968,2.6511291741011513
SK-MEL-2,5287969,-0.7648343703299985
RKO,11640390,5.295981617059328
RKO,25150857,2.5785304193211247
RKO,erlotinib-PLX-4032 (2-1 mol-mol),3.5689359084165124
ALL-SIL,1716436,3.0252724323132374
JHUEM-1,selumetinib-vorinostat (8-1 mol-mol),2.3736389824492035
RCC10RGB,262093,2.8343922904091134
SNU-C2A,54619267,4.111469802462641
SNU-626,46907787,1.3860019611329613
TTC-709,446155,2.5844471601976045
HARA [Human squamous cell lung carcinoma],135411,-0.5831763791629045
KLE,10385095,2.1345695418673354
SK-HEP-1,439501,-2.4482777943885856
KLE,vorinostat-navitoclax (4-1 mol-mol),-1.450020647356142
RKN,71466380,6.199959456698308
Hep-G2,73707398,1.4703050959367814
F-36P,2126,4.498073793778368
JHUEM-1,135421197,1.216827050882974
HARA [Human squamous cell lung carcinoma],19582717,3.08314824082211
SNU-1272,11364421,0.105074823044801
RERF-LC-MS,1242560,3.610791422912421
SK-CO-1,ISOX-bortezomib (250-1 mol-mol),-0.2509608033573304
PE/CA-PJ49,9823820,3.972273865868368
ES-2,448949,2.621037804842498
RERF-LC-Ad1,44202524,4.3484891149380696
JHUEM-2,11964036,-0.0631534142249398
Panc 02.03,66577038,3.3089612685646985
DLD-1,9868037,3.074628293738507
LCLC-97TM1,52947716,-3.0616129604635565
SU-DHL-1,20959075,-3.3128713931491087
TTC-709,54454,2.0595981741250053
KHM-1B,104842,-4.441757010359471
U-BLC1,54626689,4.734211145760804
BICR 22,2113511,7.552062733189383
SW948,25126798,3.357341035223679
HEL,3854666,0.8085723321900852
HCC15,168313047,3.1265794948701338
TTC-709,5311,1.254948452303708
DLD-1,5470400,-4.388800758121273
WM115,107985,-2.5041726579949857
KP-3,46398810,2.326486242571873
SEM,44491742,3.581981402307046
SK-LMS-1,71680916,5.050337566069936
KPL-1,262093,3.0634356984830298
WM115,42611257,-0.3600732192588895
HT-1376,71304818,3.1573788020170506
BT 248,24748573,2.3039416185334556
SK-LMS-1,53232,1.4394485400514911
HCC15,60700,-1.3823438115431317
SNU-886,2858523,3.0096792141672837
COR-L95,alisertib-navitoclax (2-1 mol-mol),-1.2067075871406427
PaTu 8902,navitoclax-MST-312 (1-1 mol-mol),2.8235677032410873
SW48,60750,-4.2221568193195225
NCI-H1568,262093,2.8880881470868585
PE/CA-PJ34 (clone C12),selumetinib-navitoclax (8-1 mol-mol),1.660781192604045
PaTu 8902,53392493,3.316041661234319
EB1,241158,1.457261035728942
PK-1,6918638,1.0537426259825138
Granta-519,11647372,1.7523915142224398
SNU-886,285033,-1.8858880502892013
SK-HEP-1,8515,5.0523689066797495
Hep-G2,4261,1.86720235378862
SW1271,decitabine-navitoclax (2-1 mol-mol),4.244493551272361
LS180,702558,5.586038369213652
IGROV-1,15983966,1.7101486625531308
ES-2,3062316,3.134570778527314
SK-CO-1,6505803,-2.970063061644963
SaOS-2,navitoclax-piperlongumine (1-1 mol-mol),1.6017048786640289
PaTu 8988t,11485656,1.82057121616084
KU-19-19,2874250,6.302627434426347
SNU-626,5281321,0.4251658125871718
MOLM-13,11175137,0.3158641445144168
WM115,644241,2.021542714802758
SW48,52947716,1.8444935422046616
NCI-H1568,10302451,3.040030486332468
TTC-709,11977753,-2.2895104683574115
COR-L95,44185566,2.2555949878605484
SNU-886,44819697,2.856258446406514
F-36P,24964624,2.456724302627339
LS411N,16725315,5.1123164266785714
BICR 22,25195348,4.085059979970886
SaOS-2,5311281,0.944453452900516
SW1271,613753,3.197731710568041
LMSU,168313016,4.430377140485892
IA-LM,9840324,5.344700856558617
Hep-G2,446155,4.188968045550805
KP-3,136227924,3.03068470875373
LCLC-97TM1,439501,-2.367039612081251
LS180,9825149,2.508714096118433
EB1,46191454,0.023536490727772
PK-1,46926350,-4.313102219783032
EB1,44607530,1.0707369070475543
DLD-1,9967941,3.78749272359618
T98G,4477,0.1742361091374477
ST486,11964036,0.8876496274789005
TTC-709,753704,4.304313213179598
COR-L105,9911830,1.908645944756667
Granta-519,25126798,3.857539921377872
KHM-1B,6918289,1.9648890084430677
K-562,11238147,1.4367734907149323
U-BLC1,241158,3.6969065198741378
SK-CO-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6721111669479054
Hep-G2,107985,-3.632879499618416
IGROV-1,4705,3.3098412390054603
RERF-LC-MS,1716436,4.437154842045929
COR-L95,6918638,0.5429028056483723
JHUEM-1,17755052,0.5709594065607718
BICR 22,11507802,1.0844954054416946
JHUEM-7,44495899,4.33874446499724
Daudi,54626689,2.8292455243221264
COR-L105,148124,3.589067174421039
HEL,selumetinib-JQ-1 (4-1 mol-mol),-0.6322408734916383
KMS-21-BM,3634881,2.1435596542076243
SNU-886,5281321,-2.4775522134293846
IGROV-1,9825149,2.5588021380929553
LS180,2113511,7.0742493322433955
MOLP-8,16038120,-1.6086793301450355
KU-19-19,67291369,2.2261044123877656
COR-L105,carboplatin-etoposide (40-17 mol-mol),5.23047829437091
HARA [Human squamous cell lung carcinoma],6505803,-0.6058988133854029
MDST8,navitoclax-gemcitabine (1-1 mol-mol),0.2783653553106409
Granta-519,44462760,4.300929542453815
Ishikawa (Heraklio) 02 ER-,selumetinib-GDC-0941 (4-1 mol-mol),4.857183586946226
Mino,25227462,-5.636785999770103
MDST8,tretinoin-navitoclax (4-1 mol-mol),1.0614057430446846
EB1,53232,2.03119735569033
KU-19-19,17755052,6.06318579738538
KP-3,JQ-1-vorinostat (2-1 mol-mol),1.5663032703740083
SNU-626,124202324,4.083837031973643
MDST8,11214940,-0.3312007430689519
SaOS-2,57519531,1.7793183342968584
NCI-H1395,57519531,3.1803418993490715
SUP-T11,100016,5.673603064365157
L3.3,5351362,1.6156165657787482
BFTC-909,erlotinib-PLX-4032 (2-1 mol-mol),4.45664321306644
SUP-T11,11640390,4.336020397588223
EB1,3101542,3.8410371195942727
F-36P,71304818,1.4076344368323763
LCLC-97TM1,44493528,4.18527882332477
LS180,decitabine-navitoclax (2-1 mol-mol),3.265284502098727
SW48,10231331,-2.95597966611556
SW948,24797083,1.9027092264791332
YD-15,54143018,-0.6465801491931648
IGROV-1,11238147,2.1723642292765084
COR-L95,17755052,2.817022282186957
KP-4,4259181,0.4203041141920705
KP-4,6623618,1.8349774868149575
LS180,25126798,3.79328534931886
IGROV-1,71304818,2.4878074097553378
ES-2,9866186,-0.1669723264631903
SK-HEP-1,10302451,4.165168773877425
HCC15,25102847,1.68346873279249
SK-OV-3,15983966,-3.6834707194333927
HCC1500,54143018,1.195335139641603
KP-3,selumetinib-GDC-0941 (4-1 mol-mol),1.1487168771210745
COR-L105,11364421,-0.5536252833264237
HuH-6,285033,-2.4566818750598913
RKN,148198,-1.0178445286580065
KU-19-19,400769,-0.482585358097733
SUP-T11,6918328,-0.5143134507877517
COR-L105,7326481,3.3886978035876547
COR-L105,44819697,1.466179589978979
SW1271,5281672,5.179464513143849
PaTu 8988t,3634881,3.651211463421112
YD-15,54619267,4.674626534362502
IA-LM,11404337,0.4340662777154989
LMSU,piperlongumine-MST-312 (1-1 mol-mol),1.415881107955257
NCI-H1568,5287969,-2.4053225408736405
PE/CA-PJ34 (clone C12),selumetinib-decitabine (4-1 mol-mol),1.8573238716263332
ML-1 [Human thyroid carcinoma],60750,0.2716917716617745
JHUEM-2,3825829,2.0785445935498372
KP-4,tretinoin-carboplatin (2-1 mol-mol),4.750587250577382
COR-L105,54619267,4.07987987500145
F-36P,52912189,-0.3399802306262523
SK-OV-3,9907093,4.994966956142975
SNU-C2A,25262965,-0.3594793734693025
Ishikawa (Heraklio) 02 ER-,25126798,4.156514336307419
ALL-SIL,11167602,0.1759872916057691
MOLM-13,49836020,-0.1965532240483963
HCC15,52947716,3.127529556956005
U-BLC1,tretinoin-navitoclax (4-1 mol-mol),1.6030503767802384
U-BLC1,25150857,2.0880739091550944
JHUEM-7,selumetinib-JQ-1 (4-1 mol-mol),0.2978252775763586
SW1573,4261,3.544037815747042
JHUEM-1,11455910,-0.2565923916493475
MKN1,5282054,4.268160731455379
MOLM-13,6184667,1.666374934082413
SK-HEP-1,3854666,3.0622551399292264
SNU-886,6450551,0.4843129346186465
Granta-519,241158,3.1692083740262373
MOLP-8,5978,-7.284134927472065
YD-15,44620216,3.6814553352367594
LS180,10302451,1.4669812473297774
RKO,16065773,3.3120716405166615
HuH-6,5281321,-0.6331149697916452
MOLM-13,24964624,0.892926396159225
T98G,7251185,3.848587364016307
SNU-1079,JQ-1-navitoclax (2-1 mol-mol),-3.089815586024049
KU-19-19,11427553,3.4053411651543035
SK-CO-1,44137675,3.0714779264964074
P31/FUJ,6852167,1.016015239887951
HCC1500,5351362,1.2955308259083285
KMS-21-BM,10127622,-2.327722790141741
ML-1 [Human thyroid carcinoma],11964036,2.920411614995081
JHUEM-2,6852167,1.1461018937250853
MOLM-13,252682,7.80657372951634
F-36P,44507138,1.3156161082270532
RERF-LC-Ad1,46398810,3.150870182853183
HARA [Human squamous cell lung carcinoma],57330099,4.527264318285619
HCC1500,44607530,1.2894809747133489
SW1271,3025944,4.184087558749553
HCC15,44493528,4.34604946513687
P31/FUJ,6918736,-1.9353169891324984
SUP-T11,676352,1.7051018224484045
EB1,9823820,1.4639106429804898
DLD-1,452548,0.9371198403607534
ML-1 [Human thyroid carcinoma],168313016,5.516575315061805
KLE,71304818,2.924630717517275
Mino,3543504,3.083969513905799
K-562,24856436,0.0017034666231649
Mino,1242560,2.508321818330107
LS180,216468,-0.2416288368660945
DLD-1,31703,0.8686261261900794
EB1,65628,2.3225973087067255
KLE,9825149,2.9770455391230506
SU-DHL-6,11507802,0.7208159532280615
YD-15,crizotinib-PLX-4032 (2-1 mol-mol),1.1211378597709745
SNU-1272,2749,1.9740368038979512
SW948,5291,4.046310039203204
ML-1 [Human thyroid carcinoma],46398810,2.1486791434985344
SK-LMS-1,216239,1.7029023614878849
HCC15,11152667,0.1037945221143532
EB1,ISOX-bortezomib (250-1 mol-mol),0.1171788423273786
K-562,selumetinib-GDC-0941 (4-1 mol-mol),2.3648746020483284
Daudi,piperlongumine-MST-312 (1-1 mol-mol),0.9306925214047892
L3.3,89928392,2.03013195184945
PE/CA-PJ34 (clone C12),56649450,1.6238624024089472
SUP-T11,selumetinib-navitoclax (8-1 mol-mol),3.8701198637976346
JHUEM-1,119607,3.8046911657142384
SaOS-2,49766530,0.3706728408995327
SNU-626,53232,1.763122549837097
MKN1,16038120,1.614155901091974
SUP-T11,salermide-PLX-4032 (12-1 mol-mol),5.220667621958139
SU-DHL-1,168313016,5.361416197440646
HCC15,168312962,2.4994502868710677
IGROV-1,24797083,1.5319862293819655
SNU-C2A,navitoclax-sorafenib (1-1 mol-mol),2.018016044361031
WM115,71751553,4.133313051647094
JHUEM-1,25062766,1.9032733927886565
KP-3,176870,3.779573670811729
SUP-T11,3025986,-0.957925472229826
SW1271,24951314,2.0404240106098723
JHUEM-7,navitoclax-sorafenib (1-1 mol-mol),1.8815532041113092
Granta-519,SNX-2112-bortezomib (250-1 mol-mol),-3.1352941908416243
SaOS-2,676352,2.2074841133021432
NCI-H1395,53232,3.2747143495441433
YD-15,6610216,4.291781319192343
P31/FUJ,322968,1.4419696378870497
SU-DHL-1,10127622,2.7675483211751466
COR-L105,44137675,1.808161252080405
PaTu 8988t,11625818,4.482422780967983
HARA [Human squamous cell lung carcinoma],156414,2.353598180094054
Panc 02.03,16038120,1.606654693103348
BICR 22,3854666,0.9977305103930704
Daudi,46398810,1.6020476162665716
KMS-21-BM,262093,1.4735879820093536
COR-L95,984333,1.162546188419483
WM115,1317464,3.7806694387813753
K-562,71680916,4.727537128358906
BICR 31,25183872,-0.4870171412848909
COR-L105,11626560,2.2911739511823503
SW1271,9936388,2.2656701786136315
MOLM-13,135421197,0.945680487717708
SK-HEP-1,136227924,3.6301481247272287
PE/CA-PJ34 (clone C12),104842,-4.003781154796879
K-562,375860,-0.3542925626582329
SK-OV-3,9887053,4.42879128381072
JHUEM-2,439501,-3.5756847183572704
LS180,9936388,-5.017955750811216
SW48,9935249,1.3330175828473068
SW1271,11214940,1.5931636594582963
BT 440,2858523,2.9291604180246136
BICR 31,serdemetan-SCH-529074 (1-1 mol-mol),3.0027631707479467
RKO,67156097,-1.3338800856316015
LCLC-97TM1,51039095,2.799665973949055
MOLM-13,54143018,-1.3895840664016086
Granta-519,5738263,2.4520737989935246
SNU-886,4261,-0.0852092865807919
JHUEM-2,selumetinib-UNC0638 (4-1 mol-mol),3.5337234948384615
SW1271,2828334,6.430891789984985
T98G,11404337,0.3579674680524426
COR-L105,salermide-PLX-4032 (12-1 mol-mol),5.562133960836907
U-BLC1,11955716,-1.5729119023907896
HuH-6,7326481,2.131784973016732
HCC15,3136844,4.306118753112888
EB1,1239801,2.8487914234338008
IGROV-1,54454,2.453541831966438
BICR 22,9935249,5.2884064452137585
BICR 22,72376,-2.4643814155147634
KPL-1,1750826,3.0111594136399007
HARA [Human squamous cell lung carcinoma],71304818,2.9544117211144147
ML-1 [Human thyroid carcinoma],selumetinib-MK-2206 (8-1 mol-mol),-0.7620404937141786
SK-OV-3,25022340,0.9085118587340768
MKN1,126941,-2.9650300183113174
HARA [Human squamous cell lung carcinoma],11167602,3.2969276962649823
P31/FUJ,11238147,2.0504580426090286
Mino,24180719,3.160868152372625
SEM,151289,0.5470981042649448
NCI-H2452,44607531,1.7526351480007742
EB1,6918878,1.1658178771655108
MKN1,6914657,-4.286769673413239
SW48,selumetinib-navitoclax (8-1 mol-mol),-2.7874089121789662
WM115,119607,3.834781850796951
JHUEM-1,42642645,1.3772977583210164
KMS-21-BM,135875424,2.842121058769458
KP-4,148198,-2.7737316499717353
IGROV-1,71466445,2.3758001916617797
SaOS-2,54618164,4.337585482929099
SaOS-2,46843906,2.56299568717197
SW1573,navitoclax-sorafenib (1-1 mol-mol),1.0822173392973782
LCLC-97TM1,2841722,4.284298549740087
EB1,salermide-PLX-4032 (12-1 mol-mol),4.422770635750399
LS411N,36462,3.380504085081747
COR-L95,637858,1.3348673917451612
KP-4,5282054,3.3464630345919355
PK-1,serdemetan-SCH-529074 (1-1 mol-mol),2.4445820477780207
HuP-T3,10113978,4.191114511390656
BT 248,3038522,2.764297682711703
SNU-1272,71466445,5.534293199033029
DLD-1,2708,5.116725923480377
L3.3,44137675,3.3686484205760783
YD-15,156414,-0.6443248940127515
JHUEM-2,60750,-4.413077776986758
Daudi,selumetinib-vorinostat (8-1 mol-mol),1.8930359660265372
T98G,carboplatin-etoposide (40-17 mol-mol),4.216662168080638
MOLM-13,24772860,-4.1681928866236415
WM115,9823820,4.472944540337913
MOLM-13,3676137,4.483658238026924
MOLP-8,49766530,-0.668776240648524
SW1271,107970,2.3235168881670285
PaTu 8988t,16065773,3.154821962511545
Daudi,tretinoin-carboplatin (2-1 mol-mol),4.019264736178175
SK-OV-3,JQ-1-UNC0638 (2-1 mol-mol),4.235651526458717
PE/CA-PJ34 (clone C12),25262965,-2.594783363003755
Panc 02.03,selumetinib-UNC0638 (4-1 mol-mol),4.3993780952510955
RERF-LC-MS,selumetinib-PLX-4032 (8-1 mol-mol),2.4830780225250413
KMS-21-BM,24180125,2.4218956668209732
NCI-H2452,11364421,-0.8742390414707
RERF-LC-Ad1,17759555,3.957571120556156
DLD-1,9825149,3.139997388606059
NCI-H2452,4788,5.30317679490816
P31/FUJ,11396600,3.188193103342261
SW48,2130404,2.4705566813277215
SU-DHL-6,322968,0.8712022459195665
SK-LMS-1,9935249,3.6088412338145366
BICR 22,107985,-3.867593954539223
COR-L105,46215462,2.588599789838095
PaTu 8988t,5287969,-2.0890298278516513
SaOS-2,9866186,1.0217998308229927
KHM-1B,1317464,5.275687871305658
SEM,46224516,1.5959166317590987
SW948,16065773,2.2305150921307653
RERF-LC-MS,tretinoin-carboplatin (2-1 mol-mol),4.86238533641819
WM115,10127622,-0.9383410403940764
PE/CA-PJ34 (clone C12),44491742,3.733326745267952
WM115,2733526,4.043531113233861
T98G,9911463,4.1746073665153105
NCI-H1395,11317348,4.623534055604914
BT 248,8515,3.628450909279232
PaTu 8902,49850262,5.593248228762752
HCC1500,54613361,2.498230028210423
KP-4,54613361,-1.758234906082912
Ishikawa (Heraklio) 02 ER-,5311,1.3231498429720774
SK-MEL-2,25062766,3.5768693362394126
SaOS-2,ISOX-bortezomib (250-1 mol-mol),1.126416426166952
Daudi,5746,-2.3170879531966273
PK-1,71304818,2.258744275310597
SNU-886,439501,-0.6078207224909147
MDST8,6610355,3.7892287954147457
SK-OV-3,219104,6.736269406359778
L3.3,135411,0.9568641453583406
MOLP-8,49793307,-5.094504062696007
NCI-H1568,54626689,4.298451601405369
IGROV-1,156414,1.4212019235656712
L3.3,10127622,6.808802938866309
KP-3,5291,3.900265250367686
Daudi,4477,-0.8111056564008632
KHM-1B,4917,2.355684811244976
K-562,135398738,1.706304792848783
MOLM-13,57330099,4.105312173478173
SEM,6918837,-6.186756041819131
SW1271,42642645,0.8738549597199083
SK-CO-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8128298123800823
JHUEM-7,7326481,2.983877429785858
NCI-H1568,decitabine-carboplatin (1-1 mol-mol),4.2821372470380545
SNU-C2A,16720766,1.7064080314575911
EB1,216345,2.33265754444178
KP-3,24951314,1.9737514152663609
JHUEM-7,selumetinib-piperlongumine (8-1 mol-mol),2.711360769969603
ML-1 [Human thyroid carcinoma],selumetinib-vorinostat (8-1 mol-mol),1.7610539005616883
EB1,11175137,1.8388112791689468
Granta-519,16725315,3.130545070245978
ML-1 [Human thyroid carcinoma],73707386,3.645367416812384
NCI-H1395,2945648,2.6727068131011285
SUP-T11,20959075,-3.398169508902793
EB1,44486219,3.4840808960157292
DLD-1,navitoclax-MST-312 (1-1 mol-mol),0.8838318351576322
PK-1,25102847,3.150710162474454
RKO,3854666,1.2691133577357363
SaOS-2,119182,-1.602754826097209
ML-1 [Human thyroid carcinoma],49793307,-2.0238665574613024
Granta-519,9843750,4.294258272153345
LMSU,439501,-3.1304465735998153
HuH-6,72376,-2.7312100719772094
MDST8,5329102,2.639161266907228
Daudi,selumetinib-JQ-1 (4-1 mol-mol),0.1373274073902578
JHUEM-7,984333,1.1979599882445968
SW48,36314,-6.6979677874770065
RKO,9825149,2.459088339864112
MOLM-13,9911463,2.5287579203643986
KP-4,11640390,4.34325096954633
KP-4,navitoclax-PLX-4032 (1-1 mol-mol),3.1090656860064456
RERF-LC-MS,44566777,0.4059341966526995
SK-OV-3,10184653,1.9718742380811307
KLE,42642645,1.516537245777594
JHUEM-7,24951314,1.2473556697176558
HCC1500,16219061,2.7461663809715375
Mino,5978,-6.408583809412523
BT 440,2708,5.697152569142541
SK-HEP-1,9926054,1.934364320328667
KMS-21-BM,6918736,-2.133845502859017
IGROV-1,24901704,3.0789156375765936
BICR 31,9933475,1.7480026685414405
COR-L95,3552672,1.407232830890507
NCI-H2452,ISOX-bortezomib (250-1 mol-mol),1.6045376494936
COR-L105,66577038,3.4359280481345755
KP-4,11234052,4.267357628081607
Mino,12001922,1.9054218463923691
PE/CA-PJ34 (clone C12),25195348,3.3119594159536874
TTC-709,46224516,2.0486951473158177
JHUEM-1,71466578,3.958028013102111
COR-L105,24753719,4.356648297258706
ALL-SIL,24978538,-2.389127379896269
Hep-G2,44607531,2.793402038765765
SU-DHL-1,3025986,-2.176216514163443
LMSU,216468,4.5440038894644115
ST486,10184653,1.155009181144878
IA-LM,3062316,1.9598487648076035
MOLP-8,448949,2.0087568721459146
HCC15,89928392,2.045660123087396
SK-CO-1,16720766,-0.9325558438762483
IGROV-1,11485656,1.900409616013456
PE/CA-PJ49,navitoclax-pluripotin (1-1 mol-mol),-0.7727749404031732
Mino,135928012,3.1712921803995164
HCC15,44137675,4.493981948720765
SNU-C2A,151289,1.8688563093712731
PE/CA-PJ34 (clone C12),3136844,4.07403193003179
NCI-H1395,24180719,5.770511312321668
SaOS-2,5284373,3.659507244236858
COR-L95,44589607,1.7004659608333377
PaTu 8988t,16659841,4.413190590676007
MDST8,5311,1.1196330054843209
HARA [Human squamous cell lung carcinoma],3825829,3.0637384073868787
HuH-6,selumetinib-GDC-0941 (4-1 mol-mol),2.3732024399993965
ST486,10410894,1.6323559547239364
K-562,168313200,4.769830643466651
SU-DHL-1,36314,4.070517798024083
SEM,2749,0.1715728235618304
COR-L95,219104,2.3748233222255144
JHUEM-7,selumetinib-decitabine (4-1 mol-mol),4.060789479990773
Granta-519,44566777,1.2837383493022634
ES-2,60700,-0.6839821647176875
WM115,45279963,3.6868070952026506
SNU-626,JQ-1-navitoclax (2-1 mol-mol),0.413892658855744
HuP-T3,10127622,4.169685865232827
SaOS-2,54454,3.299905279612609
COR-L105,71466445,5.452991683251573
SK-HEP-1,crizotinib-PLX-4032 (2-1 mol-mol),2.841663753001873
COR-L105,19582717,3.403236730524823
PE/CA-PJ34 (clone C12),10184653,-3.1495831813545165
K-562,11625818,4.129982389727392
LCLC-97TM1,3384730,2.793888789676347
KLE,navitoclax-pluripotin (1-1 mol-mol),-4.415890697426241
BICR 31,4917,3.733916426719056
JHUEM-7,4788,5.917235759280994
PaTu 8902,54619267,4.2510877724746585
PE/CA-PJ34 (clone C12),5328940,0.4121607573919046
SK-MEL-2,11626560,2.7990546336968296
JHUEM-1,44185566,2.925738774203668
ALL-SIL,25102847,-0.1309610459144975
KLE,54626689,4.672839373899824
MKN1,445643,3.8020869644474455
MOLM-13,23939,5.7894293981406
KPL-1,54686904,4.161163124304449
COR-L95,2828334,5.963676169995917
HuH-6,44137675,4.634555742771081
PaTu 8988t,44137675,4.243997881661858
HARA [Human squamous cell lung carcinoma],675434,4.319126364052166
SW948,5978,-3.22198817122066
PK-1,135398738,5.819901631774554
RKN,375860,0.0559819210079563
NCI-H1568,49836020,3.1231470101883336
Ishikawa (Heraklio) 02 ER-,15983966,-3.783445074049707
NCI-H1568,12001922,1.1909466973303815
PK-1,10231331,4.583437812683764
PE/CA-PJ49,6852167,2.2001528743044094
HuP-T3,135411,0.8125735513868637
NCI-H1568,119607,3.825066299684422
KHM-1B,124202324,1.1821842907851436
WM115,9825149,1.8328544820090609
WM115,104842,-0.2362637011987665
P31/FUJ,327653,2.543614095842417
PK-1,168313200,4.316243084639225
PE/CA-PJ49,9840324,5.81623015366044
RKO,11396600,3.504834935214814
PK-1,72376,-0.7828635321876178
SNU-886,107985,-2.815059265270472
JHUEM-1,3025944,4.031027114827012
SK-CO-1,135440466,-1.3303352220830715
KMS-21-BM,375860,-1.2608056103151717
HCC1500,sirolimus-bortezomib (250-1 mol-mol),0.0140631270051885
BT 440,46926350,-3.727097166710165
BT 440,119607,5.971118004031545
SNU-C2A,6610216,4.343391029884027
P31/FUJ,23635314,-1.6494447832357666
RERF-LC-MS,carboplatin-etoposide (40-17 mol-mol),1.469978322286411
SW1271,46215462,2.0233113088179406
U-BLC1,1242560,3.537003968396124
F-36P,11626560,0.1654219236827562
MOLP-8,969516,1.8716619229833695
U-BLC1,24748573,1.2623688757070817
LMSU,sirolimus-bortezomib (250-1 mol-mol),0.3355197835459403
KMS-21-BM,11497983,0.5646725411562087
K-562,135999136,3.657737204061429
ST486,5280436,0.6963882734082394
YD-15,568763,0.289416927087021
SW1271,9866186,1.0057234740027048
TTC-709,6917907,-6.558226847705593
BICR 31,5278396,4.450921628721945
PE/CA-PJ49,5281321,-0.2336539299049501
PE/CA-PJ34 (clone C12),4788,5.839985662068601
HuP-T3,462382,0.4397112913332706
T98G,11178236,-1.5751655332876828
PK-1,15953870,4.487454213572285
KHM-1B,4477,-0.1092447779535195
PE/CA-PJ34 (clone C12),3634881,3.34497371174834
PK-1,42642645,1.5487015676648606
SW48,44202524,0.7134579720144102
IGROV-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6574753619864233
LMSU,11214940,4.711725342258078
HARA [Human squamous cell lung carcinoma],6610216,4.810637550807952
KMS-21-BM,6450551,0.5858214957382045
SK-LMS-1,JQ-1-navitoclax (2-1 mol-mol),0.6994679974610346
YD-15,1641662,2.949332224975215
SNU-886,decitabine-navitoclax (2-1 mol-mol),-8.577955246496893
LCLC-97TM1,3025944,4.079230434060959
SW48,46174525,4.111785915347283
SNU-886,11427553,2.479878788580837
HCC15,11396600,3.725702968544969
JHUEM-7,36462,0.060815321002826
BT 440,navitoclax-piperlongumine (1-1 mol-mol),2.9274947437586287
SaOS-2,2949965,2.5764816921436067
LMSU,9823820,5.175471992537328
COR-L95,selumetinib-navitoclax (8-1 mol-mol),1.0752689694736437
NCI-H1568,10296883,3.9462373745058863
COR-L105,SNX-2112-bortezomib (250-1 mol-mol),-1.6644703388391169
JHUEM-7,10385095,0.8646007643870881
JHUEM-1,23635314,-4.214043211539386
EB1,5460769,0.545957183213574
SNU-1272,216239,2.083500892876492
KMS-21-BM,4917,2.2122670003045384
Panc 02.03,216345,4.682043945218969
JHUEM-1,54613361,-0.4484255168839311
Daudi,26596,-3.612902475241139
JHUEM-7,44566777,-0.2375299751384852
NCI-H2452,262093,3.2163720661137942
SNU-1079,159324,1.9215483474213175
ST486,5282054,2.1030528386141434
PaTu 8902,9936388,2.1491039356268966
SaOS-2,4477,0.5134457679146515
ES-2,16038120,2.859271798850067
Ishikawa (Heraklio) 02 ER-,135398516,2.3719819376312805
RERF-LC-MS,4096211,1.8582313750529689
SK-HEP-1,53232,2.505434368946379
KHM-1B,6610355,4.543219092687797
MKN1,5738263,4.323546474412867
SUP-T11,9915743,0.5825260386012178
SaOS-2,crizotinib-PLX-4032 (2-1 mol-mol),1.6526017036303646
SNU-C2A,1716436,4.909406061303966
F-36P,24180125,3.032691070219076
SEM,984333,-2.6792255714981295
KU-19-19,439501,-2.2192304341921205
SW48,11222830,1.1015320686905217
P31/FUJ,71680916,4.420716560192731
ST486,doxorubicin-navitoclax (2-1 mol-mol),-2.354978438886773
JHUEM-7,11609586,1.0506407698142153
IGROV-1,73707398,0.8848064516600974
DLD-1,11152667,1.1045398350406073
BICR 31,176870,3.2718013899021607
PaTu 8902,72193861,3.6637635590803384
SW48,10427712,4.323791553226545
HuP-T3,5470400,-0.4965810223867313
SK-MEL-2,11178236,-2.757521949601896
BFTC-909,3385,6.578023483143935
LS411N,5278396,4.113687735714835
SUP-T11,54678924,1.1962337114380377
SNU-1079,216345,1.415588229218145
WM115,carboplatin-etoposide (40-17 mol-mol),5.807621476943687
SNU-1079,15547703,1.9530375739532593
BT 440,10074640,3.093338832802375
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404
KP-4,6252,0.7313578355314097
P31/FUJ,36462,-0.6599401629031103
IA-LM,24964624,2.660053298461781
KP-4,124202324,2.9493285207276436
Granta-519,4477,0.7960263088071861
KPL-1,216345,2.695087671900052
WM115,675434,4.127717546006753
ST486,11238147,3.1871267114909307
F-36P,135984461,3.5381976593553444
SW48,2708,3.1864056833879726
P31/FUJ,11964036,1.0580497047985076
NCI-H1395,2828334,6.054247002865052
SK-CO-1,4096211,1.2314360568652074
KLE,168312962,2.4682903625486077
Mino,72199292,2.008218488754736
Granta-519,24748573,3.0643863299071668
KP-3,452548,0.6875214499833094
HCC1500,salermide-PLX-4032 (12-1 mol-mol),5.277831355050616
JHUEM-1,3384730,2.2905212228217846
MDST8,6918736,-3.3936356144084066
BT 440,11222830,1.3087461754228495
IGROV-1,3062316,-2.2361832227909075
KLE,11396600,3.656351561000123
KP-3,676352,2.8106194565981877
Daudi,136227331,3.813653547789358
PE/CA-PJ34 (clone C12),54619267,4.022513572459868
JHUEM-1,2871966,-1.863722122127946
MDST8,3385,6.506797592159471
MOLP-8,3101542,4.39402228569031
JHUEM-1,24901704,2.8385195356934587
PaTu 8988t,19582717,5.440280671607156
L3.3,44185566,3.1226996854840836
SNU-C2A,12001922,1.6949887555097172
ALL-SIL,54618771,-0.3818526805852408
EB1,navitoclax-PLX-4032 (1-1 mol-mol),1.058844209786815
SK-LMS-1,107985,-2.0791216357249054
KP-4,4917,3.466459044932804
SW948,9911463,3.099005262739027
NCI-H1568,navitoclax-pluripotin (1-1 mol-mol),-0.6791877741589081
MKN1,2945648,1.811620684937032
HEL,4259181,-1.3539346499127438
Panc 02.03,702558,5.477624163348055
RCC10RGB,9911463,4.415558893727306
SNU-C2A,15983966,-3.8138398631454065
SEM,426756,3.493351005002034
SNU-1079,selumetinib-vorinostat (8-1 mol-mol),4.808622110594304
LMSU,16659841,3.696369337873645
KLE,57519531,1.524352024978553
P31/FUJ,2828334,6.241721397046506
KHM-1B,49766530,-2.233986045015649
BFTC-909,53232,2.9810373365160316
KU-19-19,1750826,-1.6748688873644846
WM115,54454,3.1744679186495963
LS180,5329102,2.7428602070947266
HuH-6,24785538,1.4373800989543823
HT-1376,6623618,2.7971374800806097
K-562,25102847,1.0686863962440132
NCI-H2452,51039095,3.311280338748592
TTC-709,56963564,0.244593349874186
SaOS-2,107985,-4.209612864808627
JHUEM-1,3038522,2.01481584481735
ST486,tretinoin-navitoclax (4-1 mol-mol),0.9900843050762654
ST486,9549297,1.570861673109888
RERF-LC-MS,24180719,3.6010609924552455
P31/FUJ,9967941,3.859476565836545
ALL-SIL,19582717,3.9660864037028793
JHUEM-2,216468,-0.6245683284635581
BICR 31,448949,3.395825088667814
KP-4,644241,3.5135167482418703
YD-15,327653,3.7258295405325814
IGROV-1,9926054,1.8111808945519428
MOLM-13,44632017,0.3571286974750209
RKO,984333,1.1849980625737155
BICR 31,tretinoin-carboplatin (2-1 mol-mol),5.271330190091957
LS180,5311281,2.3621140012684014
IGROV-1,5328940,0.347812751869877
SU-DHL-1,126941,-4.504729002827146
PE/CA-PJ34 (clone C12),2746,3.651379195242312
LS180,49850262,4.041689005821524
RKO,selumetinib-GDC-0941 (4-1 mol-mol),1.3988498652301435
SW48,10113978,2.97157913395206
SK-MEL-2,446155,1.2117234530094174
SK-LMS-1,5287969,-1.7845602058689602
COR-L95,227681,2.232633220711044
KP-4,11317348,2.67436986374534
T98G,JQ-1-carboplatin (1-1 mol-mol),2.716924678196497
P31/FUJ,carboplatin-etoposide (40-17 mol-mol),0.2579285765316561
SNU-C2A,445091,4.863379518047038
SW1271,65064,3.2018268639765908
Daudi,2733487,3.89488184101632
SNU-626,1716436,3.5555443266706868
SEM,11626560,-0.667786957756766
F-36P,6852167,2.0711670211251016
HT-1376,452548,1.0708967512554488
JHUEM-7,3384730,5.064840535114842
MDST8,4096211,1.945430248625456
MOLM-13,56963564,-0.6687647359934185
HEL,navitoclax-birinapant (1-1 mol-mol),-0.6071790485634636
JHUEM-7,24180125,3.52789412824338
LMSU,4096211,2.6268822987004947
KMS-21-BM,5738263,2.5075098654505794
SNU-C2A,216468,0.387575555453136
F-36P,753704,4.385108951205176
PE/CA-PJ49,sirolimus-bortezomib (250-1 mol-mol),0.2701469855669
BT 248,5328940,2.875094995002875
SEM,53393127,4.163322375685533
SNU-C2A,374536,4.103445525441604
Daudi,216468,0.1519487612341026
ES-2,107970,2.4145055108152262
KMS-21-BM,107970,1.3348974715071786
KP-4,119182,-1.1774371415684783
COR-L105,11494412,3.277457630260471
BICR 31,31703,-0.4867862372580436
SNU-1079,11612883,2.194341586448379
P31/FUJ,49793307,-4.015617000908982
TTC-709,24821094,2.315731572423229
DLD-1,44607531,1.9642497313136584
ALL-SIL,6450551,-1.4599471288533186
YD-15,11485656,1.939430156438133
HuH-6,44202524,1.8893519929647953
F-36P,24951314,-0.2370026650646734
LS411N,selumetinib-JQ-1 (4-1 mol-mol),-0.8055713738039206
ES-2,ISOX-bortezomib (250-1 mol-mol),0.47049232974689
SW1271,36462,1.4389686814792042
IGROV-1,selumetinib-JQ-1 (4-1 mol-mol),0.7800599487705251
SW1271,17755052,4.188603356762487
HARA [Human squamous cell lung carcinoma],9444,4.21141613858085
Granta-519,9967941,4.009641048767512
HCC1500,25105715,3.368057340132644
JHUEM-1,11609586,2.525407870162776
JHUEM-1,156422,4.118106174891977
Ishikawa (Heraklio) 02 ER-,16722836,2.35144602605202
Daudi,ISOX-bortezomib (250-1 mol-mol),-0.1612683603405773
HEL,2858523,2.985624119180162
SNU-886,11507802,1.52809997396743
SaOS-2,3543504,4.845259948636094
SNU-1079,135398516,-0.00953526196939
HEL,71466578,3.2881122758034413
BT 440,9926054,3.075570735220903
MOLM-13,44185566,-0.1979234147827578
RKO,46215462,1.869666408515056
PaTu 8988t,16720766,0.7633491404380248
KMS-21-BM,11683005,2.750519560554551
T98G,5311,2.3985854894401033
MDST8,17755052,0.7758841708349149
Ishikawa (Heraklio) 02 ER-,9936388,-5.11124273822625
SW948,doxorubicin-navitoclax (2-1 mol-mol),-0.3830277458226139
YD-15,3825829,3.492354939220674
JHUEM-2,135875424,3.27601343648584
KP-4,638278,3.287352596500583
BT 440,2742550,3.3908982659384668
PE/CA-PJ49,2874250,5.065168424533156
Granta-519,16741245,4.459375532286075
LCLC-97TM1,36462,0.8347023875377979
KHM-1B,6918736,-1.6456969223035287
EB1,1750826,-3.6121625508064352
JHUEM-1,54619267,3.7252906850282184
Ishikawa (Heraklio) 02 ER-,2113511,6.44696553925794
SK-LMS-1,11719255,5.678568573801583
TTC-709,9803433,4.240977643093152
BT 440,11317348,1.5096052388542998
NCI-H1395,24771867,4.164021178387528
HEL,24785538,4.025400084811953
SU-DHL-1,piperlongumine-MST-312 (1-1 mol-mol),0.8193437205412945
KP-4,24748573,1.4715994589045538
SK-CO-1,54613361,-1.1953747905350511
HCC1500,selumetinib-GDC-0941 (4-1 mol-mol),3.80127350150034
Daudi,25105715,2.455657378323054
JHUEM-7,136227924,2.4332957155572688
SK-CO-1,3038522,3.74499401693701
LS411N,11625818,4.428513603720294
EB1,52947716,2.093175769449623
SW948,445643,4.022773961540602
COR-L105,135984461,4.336047626093702
SUP-T11,124202324,1.9765054457795648
NCI-H1568,71466578,4.264938806787537
PK-1,JQ-1-UNC0638 (2-1 mol-mol),4.5303725923568035
HuP-T3,11364421,1.6783982807514195
Daudi,49867926,3.659415180241599
JHUEM-7,969516,2.4810699197008654
HARA [Human squamous cell lung carcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.7875744304636512
SUP-T11,5329102,1.8842782945909935
SW948,11404337,1.0073661261070797
PK-1,11234052,5.981540141876907
SNU-626,57519531,2.111678516386025
SU-DHL-6,5278396,3.0928075812605123
LMSU,4378219,1.9748882526366265
DLD-1,49793307,-2.9912921519162783
SW48,JQ-1-vorinostat (2-1 mol-mol),0.3555995079043024
PaTu 8988t,24964624,3.238300662516523
F-36P,9826308,-0.816867239417293
Granta-519,135411,0.2246473977843227
LS411N,3025986,-2.0648766502168843
SK-LMS-1,SNX-2112-bortezomib (250-1 mol-mol),-1.3853939234705217
HEL,BRD-K58730230,4.651487565209977
K-562,148124,-7.41486725283878
NCI-H1395,409805,5.969168563416671
K-562,10302451,0.1323934402367818
K-562,1641662,2.591871767435193
ML-1 [Human thyroid carcinoma],54618164,4.279062995535924
Daudi,156422,2.1936092532092295
BFTC-909,44491742,4.0640318167931255
JHUEM-7,675434,3.8524415825681193
PaTu 8988t,doxorubicin-navitoclax (2-1 mol-mol),-0.3664110079346409
SNU-1079,25126798,4.080919623068527
Ishikawa (Heraklio) 02 ER-,2729026,3.1323352085072553
KMS-21-BM,57330099,3.68335756106968
MOLP-8,135398744,7.476327693514706
Ishikawa (Heraklio) 02 ER-,51039095,4.172119129991119
HT-1376,navitoclax-gemcitabine (1-1 mol-mol),3.4170756870749313
L3.3,23635314,-2.194996881934531
U-BLC1,24772860,-2.52128932774433
IGROV-1,54618164,4.2184521751950115
SNU-1079,135875424,3.1645684861148977
JHUEM-1,637858,1.3497979097457864
HCC1500,selumetinib-vorinostat (8-1 mol-mol),2.561295167839282
PE/CA-PJ49,4477,0.7414062724597128
PaTu 8988t,4259181,-1.3402011211504403
ST486,15953870,3.034939497181702
F-36P,104842,-2.852946463282151
L3.3,46191454,1.113033924578524
RCC10RGB,selumetinib-navitoclax (8-1 mol-mol),2.731385168920209
KU-19-19,31703,-0.69897788572983
KP-3,135398516,3.623149887917262
BT 440,15547703,3.1409564751099515
SK-HEP-1,5460769,6.10306620405049
ES-2,selumetinib-JQ-1 (4-1 mol-mol),3.5375386475265116
SEM,1239801,2.628378122820145
K-562,11404337,1.5978316825317844
NCI-H2452,9840324,6.282829349463256
PE/CA-PJ49,3025944,4.226348773499964
EB1,16038120,1.513696936230556
SK-MEL-2,46926350,-3.526858160660795
HEL,JQ-1-carboplatin (1-1 mol-mol),-0.4400207777249079
KU-19-19,11214940,3.3843502872937106
MOLM-13,3815108,3.4784839929418343
EB1,11964036,0.2605538318341719
SK-LMS-1,46174525,4.419894327285046
U-BLC1,24951314,0.635161986006478
IGROV-1,16065773,3.3717508464278585
Daudi,6252,0.2227136884944618
PE/CA-PJ34 (clone C12),53232,2.457629300419982
SK-OV-3,1641662,4.382504296977698
MOLP-8,11238147,1.6731293567937424
K-562,44462760,3.6560426907742896
F-36P,JQ-1-MK-0752 (1-1 mol-mol),-0.2106666428219584
BT 440,49836020,4.914023334980662
RKO,9911463,3.963116579454927
KU-19-19,387447,-3.0100561484626738
LS180,219104,3.901138037988577
JHUEM-2,doxorubicin-navitoclax (2-1 mol-mol),-4.885684024936746
KP-3,6917907,-5.628880878854727
PE/CA-PJ49,2949965,2.63001949752774
SaOS-2,selumetinib-UNC0638 (4-1 mol-mol),4.750362941139615
L3.3,16722836,1.76831050763334
LMSU,54619267,4.386146647321598
KLE,UNC0638-navitoclax (1-1 mol-mol),-2.745432149551299
LS180,11609586,3.254650235567635
RKO,3025944,4.391654014934833
TTC-709,11213558,3.92281579797375
ML-1 [Human thyroid carcinoma],16720766,0.621696324806819
SW1573,11640390,3.5338327701281176
ML-1 [Human thyroid carcinoma],6917907,-7.443362541349426
NCI-H2452,navitoclax-pluripotin (1-1 mol-mol),-1.4411429928004444
LMSU,4788,5.893858428733075
LCLC-97TM1,2708,5.63991197078878
PE/CA-PJ49,16720766,0.7184318893810459
ES-2,11640390,3.6882915374500618
HuP-T3,262093,3.018266583248783
SNU-C2A,navitoclax-piperlongumine (1-1 mol-mol),1.4285403691116243
PaTu 8902,3503,3.0706473844938422
HCC15,6918328,-0.0257689511183662
COR-L105,24797083,1.0360227961267732
P31/FUJ,9887053,2.876589254443052
WM115,446155,1.535185995815247
COR-L105,613753,3.1601590793812
LCLC-97TM1,tanespimycin-bortezomib (250-1 mol-mol),-0.5611743356408021
IGROV-1,10385095,1.0670946713416192
LMSU,SNX-2112-bortezomib (250-1 mol-mol),-0.6329010440725568
NCI-H2452,6252,4.582294901932163
MOLP-8,72193861,1.011292170776
LS411N,JQ-1-vorinostat (2-1 mol-mol),0.7731890132640523
KP-4,4477,-0.7302470770365643
PK-1,7251185,3.053929603549229
IGROV-1,26596,2.910298792762654
RERF-LC-MS,11640390,2.8932892314821927
SW1573,selumetinib-piperlongumine (8-1 mol-mol),4.823355107887568
ML-1 [Human thyroid carcinoma],9444,3.622178437751676
MOLP-8,carboplatin-etoposide (40-17 mol-mol),0.4522049028656168
RKO,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7729264296394276
SNU-626,421610,4.343998064633828
SNU-C2A,11228183,1.2595569575087493
KMS-21-BM,54613361,-1.5960425867785353
HT-1376,969516,3.25217674077473
SK-OV-3,168313047,2.892407732266751
Daudi,9926054,1.7776420054693636
EB1,9907093,3.01126538222068
COR-L105,2749,1.1758378373045044
NCI-H1395,6450551,6.187307607667542
SK-CO-1,6918837,-2.3986996753086305
KHM-1B,selumetinib-tretinoin (2-1 mol-mol),1.4198257519630046
IGROV-1,12003241,-2.0122972114546904
KP-3,5351362,0.7719002325908333
TTC-709,16720766,-1.6667151221076502
HCC15,9866186,0.9811967871114916
MOLP-8,selumetinib-decitabine (4-1 mol-mol),-1.0628389373049278
KLE,262093,2.3874885119076668
WM115,9887053,3.7520086754622657
COR-L105,9933475,1.7212192557919994
MDST8,9967941,4.864965348465847
NCI-H1395,JQ-1-UNC0638 (2-1 mol-mol),2.0863626902926065
KU-19-19,5566,3.5813761109507154
PE/CA-PJ34 (clone C12),9933475,1.703658812980445
JHUEM-2,36462,-2.2677125501048176
HT-1376,3552672,2.0925062801240175
SEM,3543504,3.2145269894533315
MDST8,navitoclax-pluripotin (1-1 mol-mol),-0.7687489339577367
ALL-SIL,168313016,2.945013463521221
RKN,JQ-1-vorinostat (2-1 mol-mol),1.810431860868636
LCLC-97TM1,216239,3.3274661005628636
SNU-1079,54619238,4.661832197572435
UACC-812,9935249,3.1921366544842
JHUEM-2,6252,-2.182850545186158
KU-19-19,46398810,3.059016393641159
JHUEM-2,5287620,-2.822738689858959
HCC15,selumetinib-vorinostat (8-1 mol-mol),1.4639379045779866
Daudi,24901704,1.6931015271472445
DLD-1,5738263,3.656381180088742
UACC-812,navitoclax-sorafenib (1-1 mol-mol),2.1784288698451473
YD-15,400769,-1.3107482588402013
SU-DHL-1,135440466,0.4118800450630493
BT 440,6917907,3.216762153918859
DLD-1,216468,4.384442382070829
IGROV-1,5311,1.0068816368200209
SK-LMS-1,11178236,-3.975478551896793
DLD-1,56946209,-3.3090279675975713
NCI-H1395,6610355,4.529724434844308
JHUEM-1,25126798,3.873176593510927
RERF-LC-MS,5329102,2.8374518121885637
PK-1,969516,2.8949137844195834
KHM-1B,26596,-2.1296194509234576
LS180,selumetinib-UNC0638 (4-1 mol-mol),1.869156071766359
Granta-519,10302451,3.667767303482806
Ishikawa (Heraklio) 02 ER-,36462,2.657616435798718
KP-4,10385095,0.8824730127283659
HCC1500,alisertib-navitoclax (2-1 mol-mol),-1.6435253227103
EB1,5287969,-2.775505225518309
PE/CA-PJ49,448949,1.8927168169114004
NCI-H1568,4096211,1.8643847121139272
ML-1 [Human thyroid carcinoma],11612883,2.523942692100722
BT 248,54626689,4.44361910749143
LS180,44487872,4.564049669792266
ALL-SIL,JQ-1-vorinostat (2-1 mol-mol),0.0034804556832889
BT 440,24748573,2.634047558404378
ES-2,crizotinib-PLX-4032 (2-1 mol-mol),2.9620556855075897
SW948,135411,1.551236240082995
BT 248,3552672,1.5840638178238662
PE/CA-PJ34 (clone C12),3081361,0.8218652425695582
PaTu 8988t,216345,4.148994433618168
LS180,9935249,3.57280690269837
LMSU,445643,3.9937426860066982
UACC-812,46926350,-4.425607795744521
K-562,46224516,3.0237589268452396
SW948,16013152,4.211275799279611
KMS-21-BM,10077130,3.029744008568662
BICR 22,10074640,3.373223414806136
HT-1376,54649381,4.652232038250366
KHM-1B,navitoclax-sorafenib (1-1 mol-mol),2.457676578610422
Granta-519,54618164,3.794628352719798
K-562,49793307,-5.346924391172112
IGROV-1,54678924,1.4704159748793169
COR-L105,selumetinib-tretinoin (2-1 mol-mol),2.682328410307197
IA-LM,24785538,2.950939703376364
KPL-1,16115403,3.601981503686262
HARA [Human squamous cell lung carcinoma],5278396,3.775794457804869
ALL-SIL,262093,0.6753795238054565
F-36P,46174525,1.9220505685064824
SK-HEP-1,49793307,-1.6219654789172164
TTC-709,9926054,1.3747627831999318
SEM,123631,1.8586141248102523
UACC-812,9915743,-6.921665690083625
MOLP-8,24964624,0.5129160642166024
SW48,16725315,4.089936042929296
EB1,54596558,3.950994200659219
BT 440,25105715,3.5651514695026565
P31/FUJ,25102847,1.6695774391929423
Mino,11238147,1.72457905436784
MOLM-13,216468,0.0785275755512733
LMSU,46843906,3.905857502626125
KLE,15547703,3.00093446443795
PE/CA-PJ34 (clone C12),selumetinib-JQ-1 (4-1 mol-mol),1.4884609912866928
HCC1500,135421197,1.2704457907642457
COR-L95,445643,4.015431140089913
Granta-519,9826308,-1.279512827450026
HuH-6,409805,3.23994143121387
HARA [Human squamous cell lung carcinoma],9549297,1.8946305959472185
Hep-G2,168312962,-0.8172908968582097
RERF-LC-Ad1,54649381,3.845102321657733
HCC15,44589607,3.4730057914725005
SK-CO-1,73707398,0.894037962240185
RERF-LC-MS,46191454,1.934559197398404
U-BLC1,JQ-1-UNC0638 (2-1 mol-mol),1.2651325369809692
PaTu 8902,44491742,4.263402068757711
PaTu 8902,53481919,4.066569856261274
PE/CA-PJ49,123631,1.961042341269847
HCC1500,4521392,5.662319691471263
PE/CA-PJ49,16736978,2.0157573091231957
BICR 22,11364421,-5.708558910936986
LCLC-97TM1,6610216,4.478615539127516
BICR 22,52912189,1.443997008169696
SW1271,11404337,-3.6050810245472382
IGROV-1,969516,2.460805405371151
LS411N,25062766,1.7796504921777256
IGROV-1,11977753,-2.2284230058029433
KLE,135440466,2.96482384763011
SW48,JQ-1-UNC0638 (2-1 mol-mol),0.4200169651809782
IA-LM,54618164,4.43488746250501
SU-DHL-1,135398738,3.5570959576905983
KHM-1B,selumetinib-PLX-4032 (8-1 mol-mol),4.453771782553302
PE/CA-PJ34 (clone C12),selumetinib-tretinoin (2-1 mol-mol),1.4850534564898672
HCC1500,23725625,5.012282150953445
Hep-G2,10184653,1.7532809843488162
SW948,56973724,2.5267361451247647
ES-2,71304818,2.6883736131668727
COR-L105,2742550,3.8597521863519257
HCC1500,selumetinib-navitoclax (8-1 mol-mol),0.8768646792211049
ES-2,JQ-1-vorinostat (2-1 mol-mol),1.9791145975275324
SW948,11485656,1.7814283284456571
LS180,56963564,-0.4927248320174067
RKO,9866186,0.3829002704071885
Daudi,44202524,1.1056351253600936
JHUEM-7,71466445,4.651705041978002
ST486,25183872,-2.9718221443103348
NCI-H1568,11964036,0.8982081488420575
LMSU,6450551,2.7750286997333515
MOLM-13,9915743,0.7456385275428815
Panc 02.03,4788,6.040807258084593
SU-DHL-1,10410894,1.885737679840171
WM115,3062316,1.2654694678882143
HuP-T3,148198,-3.5090934063696153
SEM,11214940,0.7713690657909067
HCC1500,24748573,2.217224851211772
RKN,44185566,3.394049733904779
WM115,73707371,4.316198918387243
HARA [Human squamous cell lung carcinoma],2749,1.5155233624959286
JHUEM-7,387447,-4.291919985887575
COR-L95,119607,5.444677320305195
YD-15,52912189,1.0810265830749906
EB1,156414,0.9475806167822072
SW1271,3543504,5.279434126076659
RKN,613753,3.037549827357118
MOLP-8,9933475,1.6461417731910544
SU-DHL-1,374536,2.32669265560356
NCI-H2452,11222830,1.0864314168284432
BICR 31,16736978,1.5520316002325725
JHUEM-2,44484440,3.1148170237219475
Ishikawa (Heraklio) 02 ER-,36314,2.7572740805853537
SEM,216468,-1.0998833452832146
SNU-1079,6610216,3.35756036881602
BFTC-909,11656518,3.71751997684089
SW48,49793307,-4.357023521296349
ST486,16736978,1.6842631532337946
KPL-1,2841722,4.006541295970442
HCC15,676352,2.734399334153108
K-562,9933475,1.5582186007451084
COR-L105,1716436,2.5827881779858797
SNU-1079,969516,2.728802871373119
BT 440,5329102,1.8012739518185714
LMSU,5287969,-1.920405728904364
PE/CA-PJ34 (clone C12),3854666,0.7943523247128464
MOLP-8,71751553,4.257415338539138
Mino,135875424,2.8874232883749578
YD-15,5460769,-2.912025087128814
U-BLC1,12003241,-2.3919609664555543
MOLP-8,11427553,-1.470461076327197
HARA [Human squamous cell lung carcinoma],5329102,2.385019760073336
HCC1500,65064,3.4319990575629484
BICR 22,54678924,2.835542995017498
SaOS-2,52947716,3.1327874038156636
RERF-LC-MS,327653,4.17889189356682
KP-4,60700,-2.446672768416198
RERF-LC-MS,216468,3.2358353560937267
LS180,637858,2.1359320280537704
ALL-SIL,navitoclax-PLX-4032 (1-1 mol-mol),-1.20714893159784
IGROV-1,erlotinib-PLX-4032 (2-1 mol-mol),3.0086678924768404
PK-1,tanespimycin-gemcitabine (1-1 mol-mol),-0.1902594806619319
HCC15,25154868,4.699010678354358
KP-4,5280436,3.7994826485786786
BFTC-909,1716436,3.115342072857748
BT 248,doxorubicin-navitoclax (2-1 mol-mol),-1.9120530478094175
KP-3,124202324,2.4407993053685413
Ishikawa (Heraklio) 02 ER-,124202324,2.794171738884469
F-36P,9549297,1.1194969839421791
WM115,208908,3.0871953707393662
COR-L95,5287969,-1.974656124599848
MOLP-8,9907093,3.7363465424365567
RCC10RGB,5738263,4.593697299478501
ES-2,5281321,2.5532277521075213
KHM-1B,11222830,0.8303711779930824
SU-DHL-1,446155,1.7989638936827528
Granta-519,51037431,4.032962229357369
RERF-LC-Ad1,54454,3.700489737063693
BFTC-909,24771867,4.730369684143592
KHM-1B,208908,2.253244414744992
T98G,57519531,4.177627141845852
YD-15,3081361,0.3523407367045946
BT 248,9933475,1.8575466823142976
JHUEM-1,445455,5.56217875287028
HuH-6,10074640,1.937571079310012
SW1271,9926054,1.9992649208496855
SUP-T11,24771867,-1.2217891109870544
SNU-626,3025986,0.0718671542502976
JHUEM-7,3689413,-2.2301251225415255
IA-LM,46843906,4.034671652936036
JHUEM-2,11404337,-1.101426517745614
JHUEM-2,4096211,-0.0871446915143139
PaTu 8902,3634881,3.736044150449037
HARA [Human squamous cell lung carcinoma],5311281,2.4258881489706217
MKN1,serdemetan-SCH-529074 (1-1 mol-mol),2.5207611017639526
TTC-709,11964036,0.1969436118100658
SNU-626,123631,2.575845591879761
COR-L105,89928392,1.7234999745886912
PK-1,44607531,1.4991509850663989
Panc 02.03,6917907,-5.450554920776264
SK-LMS-1,24785538,2.5373488880819157
ALL-SIL,216345,2.7239648031314108
Mino,salermide-PLX-4032 (12-1 mol-mol),4.6699024952141
Mino,24180125,1.2507747465119918
Granta-519,5311281,1.2060114833285496
RKN,25150857,2.829513348324473
SUP-T11,selumetinib-PLX-4032 (8-1 mol-mol),4.750009230091211
EB1,25105715,3.3033535935375222
SK-MEL-2,navitoclax-piperlongumine (1-1 mol-mol),2.7599618684552283
RERF-LC-MS,702558,6.005509402748126
KHM-1B,66577038,2.058186544179473
Granta-519,44202524,0.8355806814666445
SNU-1272,15953870,3.4362338657153835
IGROV-1,65064,4.920352624378345
HCC15,82146,4.430619158397189
Ishikawa (Heraklio) 02 ER-,42642645,4.32459394836607
RERF-LC-Ad1,9911830,3.638980358065119
YD-15,25262965,-0.705707241132904
HuH-6,selumetinib-MK-2206 (8-1 mol-mol),2.801074227347629
T98G,24772860,-0.8753356838785967
IGROV-1,135984461,4.285945029851472
ES-2,72193861,1.8658422089037705
LMSU,10322450,5.4992145641719095
SW1573,tretinoin-navitoclax (4-1 mol-mol),3.744579099862024
PE/CA-PJ49,11213558,1.0158445908271905
SNU-886,135440466,1.015207658153798
RKN,25183872,-1.1518449365963386
JHUEM-1,25183872,-1.9099589722773085
KMS-21-BM,9866186,0.0048971804935007
SNU-C2A,9825149,1.7904527753049424
SW1271,6450551,2.703162256598128
COR-L95,SNX-2112-bortezomib (250-1 mol-mol),-1.5926355912839212
KHM-1B,675434,3.385795736646719
SNU-886,17759555,4.113713798253048
RKN,656346,1.677354805367284
MOLP-8,3503,1.781914224283778
COR-L105,2828334,6.248355208389406
ES-2,10302451,3.824196852311708
T98G,252682,7.544632124427767
NCI-H1395,46926350,-3.2144597586965515
BFTC-909,docetaxel-tanespimycin (2-1 mol-mol),0.450361572300305
SNU-C2A,9903786,2.8672741986738193
MOLP-8,135875424,3.0291075959050233
KP-3,15953870,3.990399169996875
ST486,3634881,1.1124787385052084
HCC15,24748573,2.004363812639911
MKN1,11404337,1.138047347798436
Ishikawa (Heraklio) 02 ER-,3815108,3.586440325889441
EB1,676352,1.5701530578627685
RERF-LC-MS,selumetinib-MK-2206 (8-1 mol-mol),2.1861340415515076
JHUEM-1,16219061,2.452790252844544
HARA [Human squamous cell lung carcinoma],89928392,1.691456490518517
Mino,135398738,1.1644349157405138
IGROV-1,56649450,0.515518984822669
KU-19-19,9444,4.28834999434395
Granta-519,3552672,2.198733357723822
SW948,66577038,2.9537896679300655
NCI-H2452,119607,5.591396796149955
RKN,selumetinib-tretinoin (2-1 mol-mol),7.09288474093864
HuP-T3,2729026,2.9922624267509317
SK-LMS-1,navitoclax-sorafenib (1-1 mol-mol),1.3547584780395672
SK-HEP-1,71466578,6.341226391578653
Daudi,24785538,-0.3082535888445589
IGROV-1,5280436,3.2616766817665086
RERF-LC-MS,7251185,3.4578262740878976
HCC15,156414,2.365134958139565
BICR 22,piperlongumine-MST-312 (1-1 mol-mol),1.342404351806
BICR 31,10127622,3.719060323270891
SaOS-2,15547703,3.066966974063678
KLE,navitoclax-birinapant (1-1 mol-mol),-3.2783800505738956
Daudi,decitabine-carboplatin (1-1 mol-mol),0.1639659484946293
HCC15,alisertib-navitoclax (2-1 mol-mol),-2.6533611611755177
SU-DHL-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.028973070586865
PK-1,10427712,4.350806912072792
KPL-1,9444,4.257461435385723
SU-DHL-1,3689413,-2.511818154735677
COR-L105,56946209,-4.798718381888378
IGROV-1,5978,-1.5618214380165825
BFTC-909,11222830,1.7098036316197358
SK-LMS-1,71751553,5.37247176250955
JHUEM-7,25195348,3.048899669301698
JHUEM-1,71751553,4.152599364438323
F-36P,49793307,-4.29454366268948
PK-1,36314,1.7649703216405916
NCI-H1395,16736978,1.0598222504477564
IGROV-1,216239,2.21703825410177
SEM,5284373,0.4038831266174929
MDST8,135440466,3.3221976295713342
PE/CA-PJ34 (clone C12),11404337,0.4327507632811037
SK-LMS-1,16659841,5.969922386844165
P31/FUJ,44632017,0.6534437162154956
DLD-1,216345,4.392381035560927
IGROV-1,219104,3.803083685328391
SK-LMS-1,2746,4.054624823156548
YD-15,3543504,4.447942368886322
SaOS-2,637858,1.716758511666406
WM115,crizotinib-PLX-4032 (2-1 mol-mol),-0.0688201401017855
Hep-G2,159324,2.69530902129888
TTC-709,285033,-4.930163606440454
JHUEM-1,375860,-0.7048271059992764
LMSU,387447,-4.878284727647071
PE/CA-PJ49,445091,4.310249844064028
COR-L95,24753719,4.203119149122614
KP-3,25154868,4.324427303858612
HCC1500,3025944,3.928139296588046
SNU-1272,11612883,3.2902813327971936
Panc 02.03,56946209,-4.513446270471167
SUP-T11,25126798,4.099350977397734
SNU-626,54649381,3.859528019524815
T98G,46398810,3.5025548505945205
L3.3,3081361,5.558675862138055
HuP-T3,25126798,3.926602492728053
SEM,4578,3.613772546494987
PaTu 8988t,3011155,4.341218756124128
SW48,20959075,-3.67297247887529
HCC1500,JQ-1-navitoclax (2-1 mol-mol),-0.2605650300766051
BICR 22,44486219,3.936553836391045
PK-1,613753,3.369423883345818
RERF-LC-MS,6918736,-1.8242544668906209
PE/CA-PJ49,50905018,4.362942896292534
NCI-H2452,selumetinib-PLX-4032 (8-1 mol-mol),3.036066268275686
SUP-T11,60700,-2.6967810264335683
SNU-1079,24856436,-1.8099280676551273
RKO,44137675,4.282234128328841
IA-LM,11626560,2.8197095065502515
SW948,2746,1.2183078272507333
NCI-H1395,15547703,3.241893522159582
ST486,374536,0.5049857055827843
RD-ES,alisertib-navitoclax (2-1 mol-mol),-1.283701127097962
NCI-H1568,168313200,3.516432771095034
SK-LMS-1,1750826,-2.158580742507532
IA-LM,262093,2.9896562434219627
F-36P,44620216,3.708967098139917
MOLP-8,4261,-0.435327551985223
KMS-21-BM,12001922,1.228508044183715
ST486,9907093,3.397462966634316
HEL,2708,3.2519957529556716
JHUEM-2,446155,0.677931281644922
Hep-G2,25062766,1.9430883989406535
BICR 31,selumetinib-tretinoin (2-1 mol-mol),0.9632535907950592
LCLC-97TM1,erlotinib-PLX-4032 (2-1 mol-mol),2.856806725221915
MOLM-13,51039095,-0.7255439577713276
IGROV-1,426756,6.142776526139055
EB1,46174525,4.12922009291835
NCI-H2452,25154868,4.866167054223791
PK-1,216468,3.6298116497377904
DLD-1,15953870,3.351188075983659
PaTu 8902,4705,3.6244040622068256
ML-1 [Human thyroid carcinoma],25105715,3.821272786179671
Daudi,135421197,0.2989842149032058
IGROV-1,10427712,3.944243047938238
COR-L95,24978538,-1.547703636473998
KHM-1B,9911463,3.1729521589558125
SaOS-2,52912189,2.036463757447864
PaTu 8902,452548,0.9739796251952438
IGROV-1,52912189,2.3966568144845666
SU-DHL-1,387447,-5.562438756444553
HCC15,135398516,2.1695814103654696
KPL-1,11404337,1.240920910385959
SK-CO-1,6610216,4.838209270425191
MOLM-13,5351362,0.6925875902125201
HCC15,46191454,1.8626809755345697
SEM,10074640,2.905756912957373
SW948,9825149,1.8114941973110277
PE/CA-PJ34 (clone C12),11364421,-5.934192321219949
LMSU,54596490,4.907866417372536
Daudi,54639665,4.383406013207389
SEM,25150857,1.6285052261344466
U-BLC1,piperlongumine-MST-312 (1-1 mol-mol),1.4942214870224884
JHUEM-1,10074640,2.5717556918265663
F-36P,9956119,2.2251243859436007
MKN1,107970,2.535523742229024
HEL,2828334,6.1216048061751795
BICR 22,71466445,3.433479198461154
SUP-T11,23939,2.343723991946995
ALL-SIL,9826308,-0.8056632694679019
NCI-H2452,57519531,1.3990882913061125
BICR 22,54613361,0.4978505675466737
DLD-1,16038120,2.08438873224447
L3.3,44589607,3.517286764473911
U-BLC1,24797083,1.654589676677536
SK-MEL-2,2945648,3.473513810202376
SNU-C2A,4788,5.879258113124047
SEM,46191454,0.071038860902165
PE/CA-PJ34 (clone C12),9926054,1.748247929323894
SK-OV-3,135440466,2.5162908691834405
MKN1,66577038,3.545685233953748
U-BLC1,49766530,0.1451945306283898
SW48,JQ-1-MK-0752 (1-1 mol-mol),-0.7749163681319219
SW48,6852167,2.2630322871527913
JHUEM-1,1566236,1.8042145554615676
JHUEM-2,alisertib-navitoclax (2-1 mol-mol),-3.235712989354387
RKO,11404337,-0.3534280477619294
KP-4,12003241,-0.2003950722684058
SK-LMS-1,selumetinib-JQ-1 (4-1 mol-mol),2.2731779644264645
F-36P,56946209,-4.996007031858833
ALL-SIL,5291,-1.9713425457655045
K-562,salermide-PLX-4032 (12-1 mol-mol),5.074335009677914
KPL-1,10302451,4.018734113992757
BT 248,52947716,0.6891318567706715
IGROV-1,24771867,1.9944882740161016
KMS-21-BM,4477,-0.169579785111348
Mino,6505803,-0.2823157410063563
MOLM-13,46224516,1.6904951862054391
SW48,119607,5.387394946551996
Panc 02.03,ISOX-bortezomib (250-1 mol-mol),1.22897027092613
BICR 22,49836020,2.6142262300183305
BICR 22,16720766,0.4876582946813295
SEM,9911463,3.141152403249145
SUP-T11,16038120,1.5024944109728615
HARA [Human squamous cell lung carcinoma],159324,3.9851922367796937
SK-CO-1,123631,1.846760097113305
Hep-G2,9840324,5.75050852869845
EB1,11364421,-6.605639336280616
BFTC-909,36462,4.374665451212183
LS180,vorinostat-carboplatin (1-1 mol-mol),3.0396864380779327
RKO,5328940,1.7974237645790871
RCC10RGB,ISOX-bortezomib (250-1 mol-mol),1.8255695347909304
ALL-SIL,5281321,-2.461016259028612
Hep-G2,46907787,3.3643071732848
P31/FUJ,568763,-0.9310646254211032
SNU-1079,148198,-3.7175883561835295
KHM-1B,2733526,2.638104564736822
HuP-T3,selumetinib-UNC0638 (4-1 mol-mol),3.11768337000848
HuH-6,10410894,3.4965296894584035
KHM-1B,24951314,0.1876551064877586
F-36P,5329102,1.0717618201026256
HCC15,crizotinib-PLX-4032 (2-1 mol-mol),0.980759868979001
KPL-1,409805,3.94742453602603
Mino,25102847,1.483514091327799
NCI-H1395,6852167,3.4323108551980748
WM115,3081361,1.7542351340434374
Panc 02.03,676352,3.0262590525496895
MKN1,navitoclax-PLX-4032 (1-1 mol-mol),2.878163910665722
JHUEM-2,24753719,2.2917062172444203
Panc 02.03,44462760,5.147948611944762
COR-L95,11228183,-1.8408108773608771
Hep-G2,71466380,3.1584053277092696
WM115,56973724,4.208743527700851
KU-19-19,vorinostat-carboplatin (1-1 mol-mol),2.5196906513135913
F-36P,selumetinib-vorinostat (8-1 mol-mol),0.7634512600897306
HEL,65628,4.10911337005638
Daudi,11612883,1.1925703345745973
RCC10RGB,24856436,4.070420512574028
COR-L105,46199207,3.6604959991625825
Granta-519,25195348,3.9328442274761217
PE/CA-PJ49,46199207,3.3536883371230526
Mino,2871966,-0.3004733438104812
T98G,135411,0.5395204002071603
NCI-H1568,1750826,-3.116085482779225
PE/CA-PJ34 (clone C12),135411,0.6306768615973338
SNU-C2A,327653,2.894995491136924
IA-LM,12001922,1.9531449792239188
SK-LMS-1,5460769,5.744937264039862
YD-15,60700,-1.7978114705078707
IGROV-1,19582717,6.764352444432722
HCC15,10113978,2.260363506948615
SK-HEP-1,10074640,3.7857764861964935
SNU-C2A,72376,-2.8098132479938287
PaTu 8988t,6918328,1.905296387062238
HuP-T3,24785538,1.540895569713237
BICR 31,5281321,1.1837918014475457
SK-LMS-1,448949,2.3077393619428186
SUP-T11,107985,-3.2197393672196477
MOLM-13,216345,0.0865178974102724
HCC15,448949,2.8674184346568414
T98G,3025944,4.553541592645743
NCI-H1395,135398516,2.0913666591316216
K-562,44566777,1.311822236929868
HEL,452548,-1.769607447996444
JHUEM-1,navitoclax-pluripotin (1-1 mol-mol),-0.3291591423796584
SU-DHL-1,11507802,0.9378608618407872
SU-DHL-6,2113511,5.89050983447184
SaOS-2,54613361,0.0035364978270003
L3.3,73707438,4.465616964273929
Mino,4578,3.980827928195005
KP-3,241158,4.0882665535753375
T98G,24901704,3.5469447353207686
TTC-709,44566777,-0.3801521064031551
TTC-709,doxorubicin-navitoclax (2-1 mol-mol),-2.851583064207084
SaOS-2,24748573,1.7294478830476196
HARA [Human squamous cell lung carcinoma],9868037,3.8920643368101713
HuP-T3,49766530,1.2218451996302029
KMS-21-BM,17755052,0.9551514201494564
HEL,262093,2.3252232523203995
SaOS-2,tretinoin-navitoclax (4-1 mol-mol),2.244909484198112
U-BLC1,10231331,-1.9285312072374636
MOLP-8,675434,3.835070621627746
RKN,16725315,3.256745916563384
RERF-LC-MS,5746,1.1068525081764873
RERF-LC-Ad1,52912189,6.211834521603204
YD-15,24772860,-2.654794947206065
SaOS-2,11964036,0.5086023979470407
COR-L105,selumetinib-navitoclax (8-1 mol-mol),1.996235021345007
SUP-T11,3689413,-2.394245997939745
U-BLC1,135411,1.129772715841648
LCLC-97TM1,126941,-2.218385477362075
HCC15,54618771,1.6567762934530044
PE/CA-PJ34 (clone C12),241158,3.3825380068249276
RKO,2113511,4.623772297498578
JHUEM-1,444795,5.327264163388397
RKN,9929138,7.419607622812729
HCC1500,5460769,5.1304942195737935
COR-L95,31703,-3.0462560513884203
HCC1500,46224516,1.0534131743048871
PK-1,24797083,1.5597544623097392
Panc 02.03,5328940,2.397017671249583
LCLC-97TM1,11404337,-1.4043223473519348
KHM-1B,44495899,-1.7944693078792426
T98G,16065773,3.525130208561218
LMSU,11507802,1.3946784970655006
HCC1500,42642645,1.451455976812008
IGROV-1,51037431,5.669320749085174
SW1573,107970,2.0608182724975266
T98G,navitoclax-MST-312 (1-1 mol-mol),2.290204633592026
SW948,46191454,4.338482378206047
KMS-21-BM,73707438,4.028177254974698
Granta-519,11455910,0.302072347623865
COR-L105,2113511,6.080993735084838
ST486,16065773,1.8485212717597483
KLE,11612883,3.331847823409616
SEM,44484893,-1.5339295370272434
SW948,ISOX-bortezomib (250-1 mol-mol),0.2235113953706366
Mino,46398810,2.164825340893422
SUP-T11,serdemetan-SCH-529074 (1-1 mol-mol),0.8875545118500988
IGROV-1,448949,2.098499309472767
BT 248,11178236,-4.1971988945266965
NCI-H1568,107970,1.680617581032042
SK-OV-3,24797083,1.6169926593639932
ML-1 [Human thyroid carcinoma],vorinostat-navitoclax (4-1 mol-mol),0.5480043604957033
SW948,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.798210383310514
IGROV-1,4259181,0.1937358171291443
LS180,135875424,4.384751932486372
MKN1,3025944,4.373304392304888
UACC-812,54765302,2.961863639252158
U-BLC1,156422,3.8806740428141375
RERF-LC-Ad1,568763,-0.0216703206795301
SW1271,49867926,6.0238397416149345
HT-1376,1641662,3.757056289005276
SU-DHL-1,3025944,3.851371371046294
KLE,159324,3.6720597167388
KHM-1B,49793307,-3.3171088772826707
SNU-886,702558,5.095529116539229
SW48,9967941,4.423983829284398
ST486,6917907,-6.252745365867533
U-BLC1,9926054,1.6248687315541563
SNU-1079,54618771,-1.146333378136814
L3.3,3385,2.739789505554014
SEM,3689413,-0.1393923728957227
SNU-886,sirolimus-bortezomib (250-1 mol-mol),1.314176922115052
SNU-626,4259181,1.842335226683514
RERF-LC-Ad1,3854666,3.753707482876592
PK-1,16736978,1.852367939030181
SEM,72376,-3.684920591192524
SW1573,11609586,3.686627979451031
Panc 02.03,16065773,3.1661848504472023
SUP-T11,44607530,1.6657176618521052
KP-3,441298,2.7597429791451553
MKN1,tretinoin-navitoclax (4-1 mol-mol),3.7934216430561913
PE/CA-PJ34 (clone C12),6610355,3.907121985476104
RCC10RGB,135421197,4.393109316582631
IGROV-1,24785538,1.106246320450551
HuP-T3,5278396,4.193223405360703
IA-LM,24901704,3.940918836251392
SUP-T11,71466578,4.5956017680002805
SNU-C2A,72193861,0.8475081380845664
MKN1,11647372,1.0750324392100072
SK-HEP-1,11214940,1.8009666315936252
K-562,11364421,-5.792707438494169
PE/CA-PJ34 (clone C12),126941,-0.8332093183770951
EB1,44819697,-2.88949156207373
LS411N,3384730,4.573317632228089
LCLC-97TM1,568763,-0.0784771886342085
HCC1500,9936388,-2.5304598124234365
HCC15,5311,0.7792586953300233
EB1,10322450,2.387875240843174
SU-DHL-1,54686904,3.5039759810509676
HuH-6,9952709,3.5347132188678194
U-BLC1,5328940,-0.5008352229599174
PaTu 8988t,11626560,2.010870886496287
HuP-T3,2749,2.009482044490881
RD-ES,decitabine-navitoclax (2-1 mol-mol),1.2163283937451477
PE/CA-PJ49,15547703,3.0197989993314134
RKO,60750,-2.2331483998906654
HCC15,5287620,-1.6098111318920385
SK-LMS-1,72193861,2.7252079033502676
SK-LMS-1,148198,-3.2983357402975484
ES-2,44589607,3.4622397617006553
HEL,654092,-1.523294365181231
SK-HEP-1,71304818,1.6350171624170464
SU-DHL-1,448949,1.2808073887625644
U-BLC1,6436223,-5.201308955909959
K-562,5281321,0.5422415972342122
F-36P,2708,4.819851744198275
NCI-H1568,selumetinib-JQ-1 (4-1 mol-mol),2.397330498930178
LCLC-97TM1,5351362,1.316382729979947
MOLP-8,5460769,1.8843864880791628
LMSU,12003241,-1.0531077396215482
KMS-21-BM,208908,1.2834263042220255
HuH-6,25022340,4.2852369152563465
SaOS-2,56963564,-0.1924881408966614
RKN,446155,3.7628691651204234
KMS-21-BM,1750826,-3.123000235422456
BT 248,11238147,1.7431248737974965
ES-2,navitoclax-pluripotin (1-1 mol-mol),0.0056589942338626
HEL,doxorubicin-navitoclax (2-1 mol-mol),-1.6523771973343595
SUP-T11,72376,-3.956914665570725
NCI-H1568,16038120,0.8714631615296456
SNU-1079,3025944,2.950394135007143
Daudi,25102847,1.3031740879242997
PE/CA-PJ34 (clone C12),387447,-4.003769145095816
SNU-C2A,23635314,-1.648813618010062
LS411N,25154868,4.929077040033465
SW1573,crizotinib-PLX-4032 (2-1 mol-mol),2.8041804107820796
PE/CA-PJ49,23582824,0.0936319598104117
ML-1 [Human thyroid carcinoma],54649381,4.324070376451948
LS411N,9915743,2.8294092926119028
PK-1,31703,0.2230975896082642
Panc 02.03,BRD-K55473186,4.513191364064351
SNU-626,3689413,-0.5930983813401607
TTC-709,2949965,1.6078460115931117
L3.3,3854666,3.761529361474975
SW1271,JQ-1-vorinostat (2-1 mol-mol),1.5175672893366323
SK-HEP-1,selumetinib-navitoclax (8-1 mol-mol),3.029292695644022
PE/CA-PJ49,24772860,-2.410818078519462
EB1,6917907,-5.913221221082924
SK-LMS-1,6918837,-1.8023788120750237
SU-DHL-6,4917,2.9501994456287792
KLE,3025986,-0.967724412977758
Daudi,16741245,3.410771008602035
YD-15,44486219,4.157777395065993
MOLP-8,3062316,1.3489297980566397
NCI-H2452,selumetinib-UNC0638 (4-1 mol-mol),4.804967854809725
RERF-LC-MS,25183872,-0.4545636564638026
DLD-1,36462,3.118491670951203
T98G,10296883,3.86323730718366
HEL,JQ-1-UNC0638 (2-1 mol-mol),-0.0647820501822815
MOLP-8,60700,-2.8082015295780858
F-36P,107970,1.5167035192895906
KP-4,selumetinib-UNC0638 (4-1 mol-mol),5.20699540536324
YD-15,9911830,2.5298238484943463
KMS-21-BM,9823820,2.088412617289889
KLE,11404337,-0.1549034777249487
NCI-H2452,637858,1.8545349692582156
LCLC-97TM1,11626560,0.938916298027116
HuP-T3,136227924,2.888640375816574
LMSU,67156097,1.321844393975608
SK-LMS-1,2742550,3.9277163858782913
IA-LM,5284329,5.1954673618886655
JHUEM-1,15953870,3.7236524190335007
RKO,104842,-2.5196749638548
SK-LMS-1,148124,-4.355018265532959
LMSU,serdemetan-SCH-529074 (1-1 mol-mol),2.8216668636447313
HT-1376,676352,2.572095719151888
LMSU,5280436,2.317492118597427
SaOS-2,11494412,0.4895123820960489
JHUEM-2,11364421,-3.814565400218792
IA-LM,9926054,3.212619063516659
SK-MEL-2,11152667,-0.6797547387468098
KMS-21-BM,3825829,2.831962906161111
Mino,4261,-1.5584732563663717
PE/CA-PJ34 (clone C12),10427712,4.368954658182041
MOLM-13,doxorubicin-navitoclax (2-1 mol-mol),-5.382475006616194
PE/CA-PJ49,11612883,2.5815525377879553
MDST8,23635314,-2.200660522590374
PE/CA-PJ34 (clone C12),11977753,0.3576222008658177
SNU-1079,44185566,1.166699437599331
SaOS-2,alisertib-navitoclax (2-1 mol-mol),-0.6198148244275179
RKN,4261,1.529955054772996
SW48,11396600,3.829401994456863
KMS-21-BM,73707398,-1.1120298197741494
KHM-1B,tretinoin-carboplatin (2-1 mol-mol),2.496287811338483
LS411N,JQ-1-navitoclax (2-1 mol-mol),0.3997266798331875
F-36P,2733526,2.8578336314026855
HCC1500,16659841,5.303826701580757
SK-LMS-1,12003241,-1.0710207153229787
HARA [Human squamous cell lung carcinoma],24901704,2.881552784728447
BICR 31,JQ-1-vorinostat (2-1 mol-mol),1.378421076759701
MOLP-8,10231331,1.2198029486879254
SUP-T11,107970,0.8330523143812344
COR-L95,16725315,5.004914745056217
HEL,16115403,-4.756245139541522
WM115,11717001,-1.1241138002933555
SNU-886,3062316,2.775013755019221
KP-3,4917,3.138622063765874
PK-1,3825829,5.213929131853521
ES-2,3025944,4.593217686071414
ES-2,6918328,0.6176873794798242
SaOS-2,11626560,1.1465195781021866
BFTC-909,9907093,4.635414583134371
KP-4,6918328,1.3801914149197738
HCC1500,66577038,2.9555971550997935
BT 440,6914657,-4.886122408506012
U-BLC1,11707110,-5.827413989058985
HuH-6,568763,0.010968839087061
BT 440,10302451,3.8215818132063233
EB1,11656518,-0.846782753396359
SUP-T11,44819697,3.2865222275889687
IA-LM,285033,0.5092837727748464
IA-LM,4917,4.737499942891754
KMS-21-BM,11364421,-4.900438830739458
F-36P,23635314,-3.564510141174552
BICR 22,44632017,0.9263322393180023
RKN,navitoclax-pluripotin (1-1 mol-mol),0.1191364332542713
PE/CA-PJ49,135659046,3.5549002552522175
HARA [Human squamous cell lung carcinoma],docetaxel-tanespimycin (2-1 mol-mol),-6.628155731353656
SW1573,89928392,2.032641459256584
MOLP-8,119607,5.472499710124238
COR-L105,46398810,3.2483226376094194
EB1,24964624,0.1267928261695604
HCC15,decitabine-navitoclax (2-1 mol-mol),0.0974547037094189
HCC1500,135999136,4.086589117257826
WM115,11497983,4.51521868458229
SK-HEP-1,46926350,-4.110479335135347
RKO,322968,3.8471310775605216
LS180,25262965,-0.0916364033105869
SEM,JQ-1-vorinostat (2-1 mol-mol),-2.448022035749378
ST486,6184667,1.7124474858661771
HCC1500,246676,4.424448695399937
NCI-H1395,2729026,3.1697601093173136
SNU-626,3815108,3.197702009634793
PE/CA-PJ49,462382,0.1339696850034375
COR-L105,104842,-0.9230389281504464
SK-HEP-1,navitoclax-piperlongumine (1-1 mol-mol),1.24584260367843
LMSU,6438330,2.2496708259228364
T98G,57330099,4.6528141724314835
U-BLC1,46843906,2.634427974942752
SK-CO-1,6610355,4.767157937449789
IGROV-1,676352,2.310492141650647
F-36P,5278396,1.755453997739571
KPL-1,135421197,3.0565693123686617
SW48,262093,2.726859331273406
HCC15,55508,3.481008151195261
TTC-709,44137675,3.849724835732186
JHUEM-2,JQ-1-MK-0752 (1-1 mol-mol),0.7250944588980283
HCC1500,2126,3.801078614960916
PaTu 8988t,24951314,3.0808050806085188
YD-15,9825149,2.060903710273313
SNU-1079,25102847,1.4864452123394032
JHUEM-7,67156097,-2.2957753342542127
TTC-709,46843906,2.02382915817762
EB1,44607531,1.0745772162477114
RKN,11455910,3.815213247766997
KP-4,52912189,3.5083218883418272
SEM,56949517,5.249537038012084
PE/CA-PJ49,156414,1.3413488116629748
SW1573,3062316,2.075650426956439
SK-HEP-1,5287620,-1.0463187584720948
HARA [Human squamous cell lung carcinoma],25102847,2.0322740825170555
PE/CA-PJ49,42642645,0.7462290895329329
MOLP-8,24779724,4.381900106399647
NCI-H1395,10385095,0.8966814857932361
BT 440,67156097,6.097932450233736
Panc 02.03,107985,-4.238430695688479
IA-LM,322968,2.7570489193637018
SEM,72734382,1.9390760938253868
ST486,135875424,2.429416484956845
KP-4,637858,2.2303750130637163
YD-15,54618771,0.7976995145825885
SNU-1272,72734382,5.027303621851128
DLD-1,6917907,-4.395550086588434
K-562,448949,1.070656561881704
SK-LMS-1,107970,3.0105847397664403
PE/CA-PJ49,11719255,3.701933769080067
F-36P,969516,2.435122967405124
JHUEM-2,10113978,0.3488880191805407
BT 248,45279963,3.7107289938294135
L3.3,6918837,-1.6341527445290025
LS180,54649381,3.823257143411622
IGROV-1,5281321,-1.4962463697398798
NCI-H1568,42642645,1.4281976900349445
SK-HEP-1,selumetinib-GDC-0941 (4-1 mol-mol),2.75141710768083
K-562,44185566,1.8580861510177096
SW48,637858,1.3097623359774897
MKN1,2733526,3.4246555383946538
SK-LMS-1,72376,-1.9296704821697563
SK-HEP-1,613753,3.3794099216210203
SUP-T11,426756,4.179760574246382
DLD-1,11234052,4.342474587524998
U-BLC1,46224516,1.9040191125908303
ML-1 [Human thyroid carcinoma],selumetinib-piperlongumine (8-1 mol-mol),2.412069402111766
RERF-LC-Ad1,322968,3.2350252408465843
Hep-G2,15983966,-0.5733589489944111
PE/CA-PJ49,135875424,3.843300837205347
COR-L105,11234052,4.539846823478364
PE/CA-PJ34 (clone C12),11609586,2.637959736879632
IGROV-1,72193861,2.0623829231433293
SW1271,3503,3.0280256153278606
NCI-H1568,57330099,4.373464200171548
MOLM-13,1750826,-3.2515027143289728
SW1271,11222830,1.3106603955640226
RERF-LC-MS,445091,4.218142840499499
ES-2,2742550,5.454114961101578
BICR 31,3062316,-1.406162609577698
SEM,568763,-0.2568424606167109
PE/CA-PJ34 (clone C12),216468,0.8117185056100308
HEL,25126798,0.3968700607761156
COR-L95,5738263,2.419040765220329
SK-CO-1,36462,0.7476665664464673
MKN1,selumetinib-GDC-0941 (4-1 mol-mol),2.452796078251995
WM115,49766530,-0.6421157759153451
SW1271,ISOX-bortezomib (250-1 mol-mol),1.0601498198738095
BFTC-909,46901937,4.445112058189045
L3.3,10296883,4.354494828099719
SW1271,136227331,4.376300443457216
JHUEM-2,4261,1.2877936440834217
COR-L95,25262965,1.4716002732306153
COR-L105,5281672,4.46136628199001
WM115,73707398,1.178086440828875
Granta-519,6852167,2.2648312753409887
ST486,selumetinib-navitoclax (8-1 mol-mol),2.2275122117425172
U-BLC1,11625818,3.491019662875128
RERF-LC-MS,46174525,5.020740506928848
SW48,navitoclax-PLX-4032 (1-1 mol-mol),2.4409762203438117
RCC10RGB,44202524,4.922768729279552
NCI-H1395,11152667,2.8212920431399597
BFTC-909,BRD-K27188169,5.152610673434624
SUP-T11,25150857,1.081405311220829
ML-1 [Human thyroid carcinoma],44607530,1.6401891623478355
IA-LM,439501,-4.16745845294267
Mino,426756,4.371092406144052
RKN,25262965,-0.5506090189051945
HT-1376,73707398,3.190908649969745
JHUEM-7,5335621,4.966853078493816
JHUEM-1,selumetinib-BRD-A02303741 (4-1 mol-mol),4.7919569288892525
JHUEM-1,72376,-2.3883357188790173
ST486,2858523,2.4745249548097337
SW48,3385,1.919145280274203
RERF-LC-MS,12001922,2.43602915295576
IGROV-1,568763,0.665047061839467
P31/FUJ,10385095,1.5135865779060806
HT-1376,6184667,6.190853494854013
KMS-21-BM,11647372,-0.3776664380463557
HuP-T3,12001922,2.3367896101102907
HCC1500,1641662,3.3816027924522487
HARA [Human squamous cell lung carcinoma],25195348,4.01900560130828
P31/FUJ,1242560,3.8275456086274127
SK-LMS-1,46926350,-3.8599934013437434
SNU-C2A,9866186,0.2753749949177641
RERF-LC-Ad1,16038120,1.845587377613844
EB1,445455,3.7129330547138473
DLD-1,676352,3.019957311659369
BT 440,alisertib-navitoclax (2-1 mol-mol),1.711623709435909
KP-4,56946209,-3.866030178778536
NCI-H1568,57519531,1.3161148530355309
SW1271,42611257,4.308869978455437
KMS-21-BM,44819697,-1.115344970269501
Daudi,10184653,1.026270071695755
SK-LMS-1,445091,4.624083252406995
ES-2,navitoclax-MST-312 (1-1 mol-mol),1.2229679310681298
TTC-709,JQ-1-vorinostat (2-1 mol-mol),0.9311027794697188
SNU-1079,11396600,3.205631918167514
K-562,2858523,2.745068324935018
F-36P,216239,1.5044375551912257
IA-LM,crizotinib-PLX-4032 (2-1 mol-mol),2.5646441197957555
HARA [Human squamous cell lung carcinoma],11152667,-1.8717886502550631
BICR 22,12001922,2.2523981699696165
KU-19-19,tanespimycin-bortezomib (250-1 mol-mol),0.8089732350000719
T98G,445091,4.6728588795105495
PK-1,25126798,3.9486704587806263
BT 440,3676137,5.799532659934221
UACC-812,5978,-2.554443854158195
MOLP-8,753704,3.0200894206550877
ALL-SIL,5394,4.4345454375843625
RCC10RGB,navitoclax-PLX-4032 (1-1 mol-mol),2.769034348653669
WM115,selumetinib-navitoclax (8-1 mol-mol),-2.2824841087283954
NCI-H2452,44137675,2.6709050374584846
BICR 31,52912189,2.5113420173615464
SNU-626,4788,6.087756217664229
WM115,72199292,4.562209520612744
BICR 22,25154868,5.114547534217177
SW48,25262965,-0.5589271325062998
EB1,24901704,2.3051635190586026
SNU-C2A,16038120,0.810344489730768
U-BLC1,168312962,0.5939691972963214
IGROV-1,4705,3.3098412390054603
BT 248,10302451,3.817813130063646
KLE,54618771,1.0287660425791825
LS180,SNX-2112-bortezomib (250-1 mol-mol),-0.5067570232278682
MKN1,15983966,1.6236538954570403
COR-L95,11955716,-2.3894028875885778
BICR 31,241158,4.31214680273537
RCC10RGB,25062766,2.0619451400109265
ST486,salermide-PLX-4032 (12-1 mol-mol),5.0000725066379506
HCC1500,25262965,-5.244904140838402
PE/CA-PJ49,374536,1.0284025610078626
KP-4,11485656,2.2916969527324778
SNU-886,71680916,4.355410406943834
PaTu 8988t,285033,-2.1993510069972215
KMS-21-BM,11396600,-4.473822501630397
PaTu 8988t,44566777,-0.8532538772982161
SW948,71466445,3.954398511848749
IGROV-1,6610216,4.310938387105607
PaTu 8902,11497983,4.394920409770125
JHUEM-2,15953870,1.6685712254078513
SW48,11612883,0.3553002535249436
BT 440,24821094,2.8947229708297524
SaOS-2,tanespimycin-bortezomib (250-1 mol-mol),-1.2470778221654188
U-BLC1,3081361,-0.737851819488783
HEL,9868037,2.50949616555346
HEL,11178236,-0.8324730036537664
RERF-LC-MS,60750,-4.1612389836176
ST486,23939,4.856499642604405
T98G,1716436,3.6619972730594736
Granta-519,carboplatin-etoposide (40-17 mol-mol),-0.2598184919405968
LMSU,54618164,5.037763382519864
SaOS-2,24901704,3.518814077302041
COR-L95,6914657,-4.192308975603822
COR-L105,262093,2.940873643596252
U-BLC1,25262965,-2.024303118353496
LS180,44486219,4.325065743764261
RKN,10074640,3.313081701902331
T98G,9967941,1.809106049760069
BFTC-909,5746,0.5111824642409613
K-562,8515,4.039482215632923
PaTu 8988t,31703,0.1373281877500042
MDST8,135984461,4.124255066625015
LMSU,11656518,3.057433571616044
SK-LMS-1,piperlongumine-MST-312 (1-1 mol-mol),2.31506192799256
WM115,107970,1.780812210779262
HARA [Human squamous cell lung carcinoma],44507138,3.9193587835112
YD-15,42642645,0.8105684027384998
IGROV-1,327653,3.667792542405671
YD-15,46907787,-0.7954794802454365
L3.3,20959075,-2.193253801628986
P31/FUJ,89183176,3.539325961528454
RCC10RGB,6438330,2.9900078425794385
EB1,6505803,0.7002035239944829
RKN,5280436,4.161667428331563
COR-L105,445455,4.3186388426275535
LS411N,24785538,0.7817075732213645
SUP-T11,11167602,2.323687506743599
Daudi,11152667,-2.9472151872913104
P31/FUJ,448949,2.0159916590055067
Daudi,11609586,-0.3532025604686024
SW948,46926350,-4.641976408237662
SW1271,72193861,2.914678902909763
JHUEM-1,168313200,2.223638194513654
PaTu 8902,25126798,4.210533326596683
F-36P,44484893,4.1243901120060915
PK-1,3689413,-0.025358625846968
HuH-6,11612883,2.519792130975147
SUP-T11,322968,0.4567494641696093
ST486,135421197,0.3717374472748143
NCI-H1395,675434,4.314501346602578
COR-L105,11955716,-2.257823880116287
HCC15,46224516,2.679221759698836
HCC15,135423438,2.37991378319322
PE/CA-PJ49,alisertib-navitoclax (2-1 mol-mol),-1.398570786240834
TTC-709,568763,-0.4513804297290633
Daudi,421610,1.7509728437935097
IGROV-1,selumetinib-MK-2206 (8-1 mol-mol),1.1145818568790276
Hep-G2,9926054,1.3870503906392218
JHUEM-7,46398810,1.861705663086365
KP-4,6914657,-4.054574917998354
SaOS-2,11238147,2.85636627636287
RD-ES,JQ-1-navitoclax (2-1 mol-mol),0.2470246492884772
IGROV-1,374536,0.7022324251593053
PK-1,11494412,1.9575571881437173
SU-DHL-1,51039095,1.7422871999086744
IA-LM,72193861,3.820444995189443
U-BLC1,44202524,2.8119930222855043
HEL,5738263,3.378820716395454
RCC10RGB,BRD9876-MK-1775 (4-1 mol-mol),3.486807022828034
HuH-6,135423438,1.011063885151324
Ishikawa (Heraklio) 02 ER-,25262965,-0.8603136764139806
SW948,6852167,2.188206161672083
KHM-1B,16038120,-2.393017359341735
SUP-T11,46907787,1.0254127656245202
MKN1,123631,1.493426842220155
K-562,71751553,5.367911183247371
JHUEM-2,46398810,1.5745703441014811
PE/CA-PJ49,selumetinib-navitoclax (8-1 mol-mol),2.4477082122700655
BFTC-909,71304818,3.116417285157316
SW948,25227462,-0.2382390684396511
HuH-6,11625818,3.6235112682820247
SK-OV-3,637858,3.830307013284548
KHM-1B,5978,-4.717973613430777
SNU-C2A,54143018,0.3273230112931994
RKN,49766530,-3.8574490235665584
NCI-H1568,9933475,1.8521331470520848
BFTC-909,decitabine-navitoclax (2-1 mol-mol),5.107856917496857
KU-19-19,17759555,3.7275461226555566
KLE,6918328,-0.4270629798657607
ST486,1317464,3.598486902453788
MKN1,2842253,5.330990915414376
LS411N,44589607,3.372730635507476
PE/CA-PJ49,67291369,1.7434258549595576
JHUEM-7,25126798,3.738067975046635
KP-4,6450551,1.734325636888487
SNU-C2A,5328940,1.6140254641791676
RKO,vorinostat-carboplatin (1-1 mol-mol),4.42147496708757
SK-LMS-1,4705,3.2417588485362554
SNU-1079,10127622,-1.295622834297664
T98G,tanespimycin-bortezomib (250-1 mol-mol),-0.015927454797827
SW1271,5278396,3.101008990901291
BT 248,135440466,3.298497559431859
TTC-709,54649381,3.8552287348177954
TTC-709,2708,4.813026515837837
U-BLC1,16065773,3.327685442207103
LCLC-97TM1,46398810,1.8633773855233131
SK-CO-1,6852167,2.111498553552754
Hep-G2,3025944,3.632600142557463
SEM,11455910,-0.3463344343386808
RERF-LC-Ad1,72376,-0.2773768081931954
SW1573,5479543,3.675213844165782
COR-L95,12003241,2.921570030601445
Panc 02.03,9911463,4.953148943637795
P31/FUJ,crizotinib-PLX-4032 (2-1 mol-mol),0.7828925550397006
RERF-LC-MS,3384730,3.247206310046507
ST486,11214940,0.1640391340843134
IGROV-1,51039095,1.7163430299301403
SNU-1079,11960529,3.712685161467204
YD-15,104842,-5.0355787198131985
Hep-G2,119607,5.22772984823061
SK-MEL-2,tretinoin-carboplatin (2-1 mol-mol),4.856655744975525
MKN1,135421197,0.9793646210495068
KU-19-19,89928392,2.8864230284497747
F-36P,262093,1.6746033026960565
SK-CO-1,216468,0.6363757446548435
TTC-709,9887053,2.1821926159541136
LCLC-97TM1,3038522,2.979698040139259
BICR 22,6914657,-3.057028291966878
PK-1,11222830,1.7533679532707835
MDST8,3815108,3.655140825789689
L3.3,2858523,3.1166554672991604
KLE,9840324,5.142146685631956
HEL,11364421,-3.0976744543470067
T98G,637858,3.480538395341526
SNU-1079,44137675,2.410585163354866
SW1573,10074640,3.956421484938757
LS180,6610355,3.640469161520063
Daudi,2858523,2.224035136584194
BICR 22,135875424,4.925705128316808
LMSU,11626560,2.53911445992309
JHUEM-1,1239801,4.049795928842536
SK-OV-3,23582824,0.9299959314677436
K-562,5282054,3.5952240521498062
DLD-1,5460769,4.378806727859053
NCI-H2452,44589607,3.0010828964799208
LS180,638278,3.5544678930796656
KP-3,31703,0.3868565544209454
MOLP-8,426756,3.5390437920539117
HARA [Human squamous cell lung carcinoma],11964036,1.505983259630614
SaOS-2,selumetinib-MK-2206 (8-1 mol-mol),3.420103401204114
Ishikawa (Heraklio) 02 ER-,44607531,1.9403149482163755
LMSU,462382,0.7289653516874284
L3.3,vorinostat-navitoclax (4-1 mol-mol),2.138826011171234
U-BLC1,6918328,-1.2318997053702574
SK-HEP-1,selumetinib-PLX-4032 (8-1 mol-mol),4.995301598954557
BICR 31,71466380,5.422644788319504
PaTu 8988t,53392493,3.5279637137541524
SNU-C2A,11222830,1.4512931815373908
UACC-812,6610216,4.947422623598504
SW1271,16038120,0.5203426502283315
SUP-T11,16722836,1.173860371527485
Mino,16065773,1.600157444452853
IGROV-1,67156097,0.1763939852409119
U-BLC1,135398516,1.8602604180936948
UACC-812,216239,2.3945159107119767
PE/CA-PJ49,25195348,2.0573199261864556
HCC15,serdemetan-SCH-529074 (1-1 mol-mol),2.4880259252589543
DLD-1,25183872,-1.1278418617914523
ALL-SIL,36462,-1.376242093473402
BICR 31,1750826,0.6511109819152475
IGROV-1,56649450,0.515518984822669
SNU-886,10385095,1.1038149480439057
Hep-G2,5351362,2.6024956401093684
HARA [Human squamous cell lung carcinoma],66577038,3.5726698245106445
PaTu 8988t,6918837,-0.8891471976747255
ML-1 [Human thyroid carcinoma],9936388,-4.434207119356507
F-36P,44819697,-2.361192365773356
NCI-H1568,2828334,5.9155051642717
SUP-T11,753704,4.064127852197216
EB1,11612883,2.060509512377648
SNU-886,2733526,4.210800511502518
Mino,16725315,3.102334229880721
KMS-21-BM,439501,-2.3809491999533003
MOLP-8,56973724,1.5171827826362807
SNU-1272,322968,5.073692716750646
U-BLC1,49867930,4.355452370036162
MOLP-8,2729026,2.779201693602774
P31/FUJ,753704,3.2802738483106766
SaOS-2,25183872,-0.102413301755783
MKN1,3815108,3.203756873238669
NCI-H1395,selumetinib-JQ-1 (4-1 mol-mol),2.8235760807369177
NCI-H2452,decitabine-navitoclax (2-1 mol-mol),4.538424362545292
LCLC-97TM1,9825149,1.404394440199107
SNU-1079,11507802,2.804782361832328
SEM,56963564,-0.810126734608135
T98G,71304818,1.543365468954366
WM115,9929138,6.7694003006369226
RERF-LC-MS,2746,3.2731211053052647
COR-L95,5351362,0.837381680047442
HCC15,ISOX-bortezomib (250-1 mol-mol),1.036560789961647
F-36P,36314,4.061634155708799
RCC10RGB,3101542,4.48788654191394
RERF-LC-Ad1,2729026,3.1916819737077544
BICR 31,44566777,1.4466588952743178
WM115,5746,-0.962904812763719
F-36P,44202524,1.2582090673086783
KMS-21-BM,72376,-3.154352485466452
HEL,9903786,1.206049982415758
KMS-21-BM,42642645,-0.0520859605675617
NCI-H1568,44486219,3.435494584556288
SK-CO-1,124202324,2.795373404058925
BT 248,3465537,1.7130202551321618
MOLM-13,5329102,-5.212236525427112
SEM,156422,3.246663813247162
SEM,168313016,1.967017226052083
SNU-1272,9967941,2.3662546374553486
SaOS-2,10427712,4.893681366378875
SW48,409805,3.4729287041870127
HCC15,216345,4.3772403070959705
NCI-H2452,46215462,2.291566037713401
L3.3,25150857,3.2841029560324246
MKN1,25126798,4.839897208084308
SU-DHL-1,55283,1.0511806970329092
SK-LMS-1,9927531,4.694028683387814
RERF-LC-Ad1,11364421,2.25691448448964
JHUEM-1,navitoclax-MST-312 (1-1 mol-mol),0.2064229232305313
SW48,navitoclax-birinapant (1-1 mol-mol),1.0401381719181744
HARA [Human squamous cell lung carcinoma],56946209,-3.7436646215458182
MDST8,24821094,3.627663013095859
HCC15,9911463,3.642862209488471
KHM-1B,9826308,0.2290503887290589
BICR 31,navitoclax-gemcitabine (1-1 mol-mol),3.844959889456845
BT 248,702558,5.9883095131036495
PE/CA-PJ34 (clone C12),11494412,-0.047975107536018
BT 440,44607530,1.0933674841903558
SW948,11178236,-0.7120713487548671
HCC1500,5329102,1.6369795361395487
SU-DHL-1,11364421,-4.160715855029451
ST486,49766530,-3.0199322417978065
JHUEM-1,44202524,1.299727491963103
Mino,56963564,0.2052949458099494
SU-DHL-1,176870,3.225718242496366
SK-LMS-1,4096211,2.5339124248624945
WM115,2742550,3.774256401917875
F-36P,67156097,-2.789845146939418
SW48,12003241,-0.9746028071684796
NCI-H1568,11494412,0.631822071405162
SUP-T11,5281672,2.7104542988859825
JHUEM-7,676352,1.6647076610932632
WM115,25102847,1.9091464851380515
SK-MEL-2,tanespimycin-bortezomib (250-1 mol-mol),2.677378887587516
SNU-626,49766530,-0.2308457798178905
BT 248,navitoclax-MST-312 (1-1 mol-mol),0.9766831627739164
COR-L105,23725625,5.8274909459435165
Granta-519,9956119,4.186560294974692
COR-L95,72193861,1.6807669427950571
IA-LM,6917907,0.442667441503668
Mino,6918837,-5.570643171214475
SW1573,53232,-0.4627324496874346
U-BLC1,42611257,3.316161385368875
JHUEM-7,4259181,0.2879228284005847
TTC-709,6918328,0.2174530684404474
Panc 02.03,19582717,5.117031119305748
RCC10RGB,227681,3.758665689171896
SUP-T11,49766530,-4.92791110390187
KPL-1,2729026,2.3691733295571407
KLE,6184667,2.425235268333095
EB1,crizotinib-PLX-4032 (2-1 mol-mol),1.147459224355429
WM115,24901704,3.629786211252992
Mino,676352,1.5507928548431975
SNU-886,135875424,2.126718157354228
ES-2,5978,-0.6044843574314512
U-BLC1,57519531,1.6274110066173642
ST486,446155,1.417996447180306
HARA [Human squamous cell lung carcinoma],4477,-0.0807211341972061
K-562,637858,1.3097643671251342
SW948,613753,3.0653891790249617
Granta-519,9926054,1.8135939424605243
PK-1,16065773,2.849553088678906
SK-CO-1,55508,3.57241133457179
HCC1500,5426,4.174536858194301
BT 440,9825149,2.0276154195178937
IGROV-1,4521392,5.131794979216607
SEM,11625818,5.278130050580437
UACC-812,6918878,3.827620339158657
SK-LMS-1,selumetinib-MK-2206 (8-1 mol-mol),2.784478857426877
SaOS-2,sirolimus-bortezomib (250-1 mol-mol),1.8011935542733906
SNU-C2A,100016,6.499335908465164
ST486,decitabine-navitoclax (2-1 mol-mol),-2.2177211499318856
PE/CA-PJ49,6252,-0.003406228879289
KU-19-19,72193861,2.401782330602402
HuH-6,24797083,1.0369386363025452
KP-3,11238147,2.2063710897494
WM115,5281321,0.1495893125543727
ES-2,3503,3.101999435580302
PK-1,400769,-1.1065677160323073
ML-1 [Human thyroid carcinoma],3038522,3.665928761402901
SEM,446155,3.622162137038395
P31/FUJ,31703,-2.5575864334968976
EB1,2126,3.1979910356066408
HEL,decitabine-navitoclax (2-1 mol-mol),-1.4855622179945482
ALL-SIL,44589607,0.5481515481681011
ST486,6505803,1.144321831733621
JHUEM-1,9926054,1.7870789981263362
F-36P,3025986,-1.286215975867841
PaTu 8988t,11955716,-2.6731660557009267
ES-2,9444,3.6781446777200495
IGROV-1,5738263,4.037832478240785
HARA [Human squamous cell lung carcinoma],126941,-2.554285063423382
BFTC-909,650361,3.8112149600795706
SW948,16725315,5.2631267850751335
Panc 02.03,25102847,3.3458680072040603
T98G,219104,4.8393755230740165
BICR 31,216239,4.655547148927136
SK-HEP-1,51039095,3.60670356936783
IGROV-1,9907093,2.687959785702283
SNU-626,44137675,4.561831342632874
ML-1 [Human thyroid carcinoma],126941,-2.044263255039902
YD-15,71304818,2.544733972069095
LCLC-97TM1,49766530,0.6419783818490065
SEM,119182,-4.118292279963464
Granta-519,2113511,5.634502761977105
ES-2,tanespimycin-gemcitabine (1-1 mol-mol),3.722544465012504
COR-L95,322968,2.331837213900703
RKO,ISOX-bortezomib (250-1 mol-mol),0.9877489052510549
EB1,10127622,5.260313736651841
SW48,60700,-1.9747801062936423
SaOS-2,46907787,1.5905885991562354
LMSU,969516,2.7485422702500215
Mino,327653,2.450086744090126
LS411N,5311,1.0830647686053458
NCI-H1568,5278396,3.684546625455108
P31/FUJ,2858523,2.921593087757198
MOLP-8,25102847,1.798391543473315
KP-3,11178236,-3.5199262782907543
LMSU,219104,4.323800749255201
HCC15,57330099,4.175732386995395
LCLC-97TM1,16013152,5.423690206414697
SW1271,16065773,2.6188234772001886
RERF-LC-MS,52947716,-5.597592816818683
MOLM-13,11167602,-1.7638454235436123
JHUEM-7,66577038,3.1107179638386175
SEM,serdemetan-SCH-529074 (1-1 mol-mol),1.7105647593027902
NCI-H2452,vorinostat-carboplatin (1-1 mol-mol),3.5311802496777576
Granta-519,3038522,1.8764454398289976
SW1573,54626689,3.958399976383255
SK-MEL-2,24785538,3.271955441237361
K-562,445455,4.202279962055385
SNU-C2A,2945648,3.234542105429148
HT-1376,168312962,3.6948080069277136
SNU-C2A,216345,4.0797279978914025
HuH-6,selumetinib-UNC0638 (4-1 mol-mol),2.461770585371879
SK-CO-1,25262965,-3.291258197582341
Granta-519,54618771,-0.1786557603441652
HuH-6,119607,3.922125538100533
ML-1 [Human thyroid carcinoma],216345,4.790115930225849
EB1,46907787,0.9817237925855196
SEM,9907093,3.7735778111244698
HuP-T3,42642645,1.566786855324099
SNU-C2A,sirolimus-bortezomib (250-1 mol-mol),0.2009996133577312
BT 248,3825829,4.117903271720201
MOLM-13,44589607,2.917529465117915
JHUEM-2,25102847,0.8999144091780689
ES-2,6918837,-1.9637066131758496
JHUEM-1,176870,3.377080183153913
KP-4,piperlongumine-MST-312 (1-1 mol-mol),1.2024606545381415
SUP-T11,448949,2.1682945727967726
ML-1 [Human thyroid carcinoma],10385095,1.881738472046862
SU-DHL-6,753704,4.418086475877281
MKN1,4259181,1.0548548306280776
SNU-C2A,107970,2.380782463123486
SU-DHL-6,6918837,-4.716152603392634
Ishikawa (Heraklio) 02 ER-,20959075,-3.257755435634251
P31/FUJ,46199207,2.4446101047156215
SNU-626,3384730,4.233912562970088
PE/CA-PJ49,24785538,0.8106468414354372
SaOS-2,156422,4.313289259132858
BFTC-909,5282054,4.21714099973987
SNU-886,tanespimycin-gemcitabine (1-1 mol-mol),2.0847122709866097
RCC10RGB,9803433,4.221770064596342
Granta-519,UNC0638-navitoclax (1-1 mol-mol),-1.1089217343766455
SUP-T11,navitoclax-PLX-4032 (1-1 mol-mol),2.2857930151064
RKN,89183176,6.327700475537756
HuH-6,3634881,2.7992621716410877
BFTC-909,16038120,1.74161234898449
HCC1500,71466445,3.970736335461394
Granta-519,25062766,1.8322611726564384
SUP-T11,46215462,1.316331202586794
SK-OV-3,216345,4.761928129554225
SNU-886,24978538,-8.014318851835679
KMS-21-BM,16736978,0.4694782671845031
EB1,60700,-3.786153698251355
EB1,702558,3.0897393848422143
HuH-6,57519531,3.657383540689732
Granta-519,11609586,-2.485330170292811
SK-HEP-1,6918878,4.4325993547595655
MKN1,969516,4.261303643173592
SUP-T11,5311,0.7318881288484842
P31/FUJ,676352,1.6175160353980318
UACC-812,25227462,-0.2916299121927669
F-36P,selumetinib-PLX-4032 (8-1 mol-mol),1.4374450103461651
RERF-LC-MS,54596558,4.400747096440468
F-36P,11455910,-0.4221924181382917
Daudi,9911830,-0.0057102646081846
COR-L95,72376,-2.5853838467146493
SNU-C2A,452548,1.5210445741049985
LCLC-97TM1,135875424,3.9585615026829823
SK-LMS-1,11507802,1.4126896513922915
ST486,56946209,-6.505806204995903
P31/FUJ,49850262,2.7073676452568427
HEL,10410894,1.686960620182283
SEM,selumetinib-piperlongumine (8-1 mol-mol),1.0176958248446395
LS180,10127622,1.4423864514133429
LS411N,16038120,1.458068935835204
KP-3,16725315,3.7411302570306457
ML-1 [Human thyroid carcinoma],136227924,2.8741817701449506
Ishikawa (Heraklio) 02 ER-,54686904,4.48248797889717
IGROV-1,11214940,1.360660548899077
Panc 02.03,969516,3.806573436208542
EB1,9952709,2.2488081994818283
BICR 22,JQ-1-navitoclax (2-1 mol-mol),1.0465005615278271
SW48,656346,-0.2718986936332406
KHM-1B,serdemetan-SCH-529074 (1-1 mol-mol),1.1284922177320384
SW948,285033,-0.875487938395224
Panc 02.03,4261,3.516583077320981
SK-MEL-2,10385095,1.309860426299206
SW48,49766530,3.606492941369466
NCI-H1395,11494412,4.0372714005300026
SW48,16038120,-1.7922421690180796
Mino,10385095,0.494040271373144
LMSU,3038522,2.183221848979368
DLD-1,11612883,3.4504566706429887
HuH-6,6438330,2.87247854532873
RKN,navitoclax-MST-312 (1-1 mol-mol),0.5631499209413128
KHM-1B,5311,0.4270442632867264
HuH-6,24775005,3.546351901691818
HuH-6,selumetinib-vorinostat (8-1 mol-mol),2.590919017707307
ML-1 [Human thyroid carcinoma],46199207,3.5690585114534024
WM115,2945648,2.5851994154769025
BFTC-909,vorinostat-carboplatin (1-1 mol-mol),0.6014624935477999
Hep-G2,navitoclax-piperlongumine (1-1 mol-mol),2.9586079970104984
HuH-6,9866186,3.494955881423772
BICR 22,25227462,-3.180570489875023
SNU-C2A,2729026,2.906016985017416
U-BLC1,2708,5.288827591526708
SEM,675434,3.717379386242577
IGROV-1,5460769,1.6083174601829917
Hep-G2,71466578,4.87571024377078
SEM,25154868,5.025601551325329
TTC-709,docetaxel-tanespimycin (2-1 mol-mol),-3.841573814783536
K-562,753704,4.7227938780788525
K-562,ISOX-bortezomib (250-1 mol-mol),0.3376370593793573
BT 248,sirolimus-bortezomib (250-1 mol-mol),0.4320618504093114
SNU-886,ISOX-bortezomib (250-1 mol-mol),1.1872724485340942
NCI-H1395,selumetinib-BRD-A02303741 (4-1 mol-mol),5.369939363502549
HuP-T3,4788,5.894927949545096
SK-OV-3,42642645,1.640931292575566
PaTu 8988t,11222830,1.761666424308375
NCI-H1395,6918638,1.485308761584704
BFTC-909,448949,2.818327130228084
U-BLC1,selumetinib-JQ-1 (4-1 mol-mol),-1.24963956980548
NCI-H1395,445643,4.969337372862375
SK-LMS-1,44185566,3.1100046298830035
HEL,serdemetan-SCH-529074 (1-1 mol-mol),2.278758279722759
SNU-626,65628,4.324270511481314
WM115,5281672,6.287836255113029
Hep-G2,9911463,3.8113421260686735
ES-2,445091,6.481811595499941
ST486,4378219,2.040688019208728
BT 440,57519531,3.839956708351082
PE/CA-PJ49,11152667,-0.7755260151132314
Daudi,3384730,1.441294292217556
SaOS-2,navitoclax-pluripotin (1-1 mol-mol),-0.5587106095561101
Ishikawa (Heraklio) 02 ER-,439501,-2.4484029207577347
LS180,6252,-0.5438897009285958
Ishikawa (Heraklio) 02 ER-,44507138,3.541152927968452
NCI-H1395,637858,2.3715473340173774
SaOS-2,3025944,4.435896212894107
SaOS-2,25161177,4.43427627730954
LS180,JQ-1-UNC0638 (2-1 mol-mol),0.673634242684319
HARA [Human squamous cell lung carcinoma],6918328,1.494996835192892
BFTC-909,11228183,3.298719229946038
Panc 02.03,navitoclax-sorafenib (1-1 mol-mol),3.063115591562286
Granta-519,135659046,3.900512348834848
LS180,126941,-2.6871715133008385
MOLM-13,3081361,0.9632978577503784
JHUEM-7,16722836,0.6728003897520018
SNU-1079,135398738,4.193729551418584
PE/CA-PJ49,6917907,-5.829346001088612
JHUEM-2,123631,2.094693084729789
TTC-709,42642645,-0.8563424771463005
WM115,9936388,-1.175666523167262
TTC-709,46943432,2.6440206287673513
HARA [Human squamous cell lung carcinoma],119182,-1.5549760643936197
IGROV-1,15953870,2.712793598656007
RKN,10410894,1.511663597063748
LMSU,7251185,3.0971316330728778
KHM-1B,6450551,1.2159742345507
IA-LM,6918638,0.61198230609435
SNU-1272,3025944,5.229392036537965
MKN1,1716436,3.450749639836205
JHUEM-1,3543504,3.921032562112613
SW1271,56946209,-4.174123648346971
BICR 22,67156097,-1.5899611273150889
PE/CA-PJ49,10127622,4.589894926216337
PK-1,5978,-0.3689544862555906
SW1271,2749,2.846909316544141
YD-15,49793307,-2.967529261529928
KU-19-19,65628,4.405271017285275
MOLM-13,5566,2.591289759721003
Ishikawa (Heraklio) 02 ER-,6610355,5.455627286955898
HCC1500,89928392,1.0051530188155344
SW948,25102847,1.6816963863778185
ALL-SIL,10427712,3.5706749567785625
U-BLC1,135440466,1.2632168220423792
BT 248,15953870,3.6832035377423216
IGROV-1,2749,2.0319044408234954
ST486,31703,-1.6761008828346815
PE/CA-PJ34 (clone C12),54613361,0.0290460408179859
LS411N,selumetinib-piperlongumine (8-1 mol-mol),1.1466452951203283
PE/CA-PJ34 (clone C12),16038120,0.98561045029006
HCC15,SNX-2112-bortezomib (250-1 mol-mol),-3.246727097806559
SaOS-2,1242560,3.6046854082724034
RCC10RGB,123631,3.672101761387351
HuH-6,1239801,3.944819781911546
SaOS-2,JQ-1-MK-0752 (1-1 mol-mol),2.214313979092396
SW48,carboplatin-etoposide (40-17 mol-mol),-0.9429596789262168
ML-1 [Human thyroid carcinoma],400769,0.4240275581269139
MOLM-13,23725625,2.3173082013566204
SK-CO-1,15547703,3.920131639479481
RERF-LC-Ad1,12001922,2.2096549629967424
PK-1,11152667,1.060142887302552
SK-CO-1,navitoclax-pluripotin (1-1 mol-mol),-0.9841338872717872
SaOS-2,71729975,2.29546286795302
KU-19-19,12003241,-0.0608702413973226
PE/CA-PJ34 (clone C12),119182,-0.6317231418312041
SK-MEL-2,1716436,3.9824529155827655
PE/CA-PJ49,54618164,4.029217614638186
MKN1,441298,3.18669807991014
SK-CO-1,568763,0.0338205510733868
SU-DHL-1,984333,1.5848171755072842
SNU-626,1750826,-1.183980705598525
RERF-LC-MS,49766530,0.7744144603938863
JHUEM-7,9926054,1.641999407547345
HuH-6,9915743,1.4192862158653652
SU-DHL-6,11152667,-4.5064226702829
T98G,123631,3.184422615137275
HCC15,2130404,2.6093174666871293
KHM-1B,52912189,-0.4693344925919332
MKN1,11485656,3.044092336546056
MKN1,2729026,2.926096340291589
KMS-21-BM,60700,-2.168223135970232
RKN,11626560,2.593417875894138
PE/CA-PJ49,3136844,3.894534312555505
Ishikawa (Heraklio) 02 ER-,selumetinib-JQ-1 (4-1 mol-mol),4.45456930685315
NCI-H1568,navitoclax-MST-312 (1-1 mol-mol),0.8258625122307741
SNU-1079,446155,2.9597200248589055
Daudi,44137675,1.0044684727898117
SW948,54619267,3.654776559833868
SK-LMS-1,10322450,5.260294901094195
SK-LMS-1,24753719,4.4754402870161485
MKN1,1750826,-1.8622445541668773
KHM-1B,20959075,-3.335325508403103
L3.3,60700,-1.0594098724228993
MOLP-8,selumetinib-UNC0638 (4-1 mol-mol),0.7931432464838661
JHUEM-7,6917907,-5.779408240081831
RCC10RGB,4259181,1.719089746142662
SU-DHL-1,9887053,2.0473441666614156
JHUEM-7,11640390,3.5194655079391857
SK-OV-3,9911463,4.2249846626647125
JHUEM-2,54618771,-0.9670015993235072
JHUEM-1,selumetinib-JQ-1 (4-1 mol-mol),1.9844934160703236
KPL-1,10184653,2.2125442042708485
YD-15,9907093,3.981442580941136
HCC15,49766530,0.5190445493569186
Mino,alisertib-navitoclax (2-1 mol-mol),-3.6624360155074327
PE/CA-PJ49,216345,4.295730817362929
Granta-519,3385,2.090684083959823
RKO,54613361,0.2998145946125954
SNU-1079,656346,1.692383898162899
HT-1376,11175137,3.719526763106748
TTC-709,44589607,2.278244498821904
HEL,3384730,1.593743887858678
NCI-H1568,11977753,-3.4091025242198696
SNU-1272,9840324,5.6851374422445335
SK-OV-3,285033,-0.1977879636486448
KP-3,24964624,3.0611588104793057
T98G,10074640,2.7702205308825865
L3.3,10410894,2.582309203973784
Daudi,3385,1.70419989930712
KHM-1B,71680916,4.347689376486287
NCI-H1568,9825149,1.6639399446813206
YD-15,16741245,6.014646857410196
PE/CA-PJ49,10385095,0.7863644844399451
HT-1376,5351362,2.854211011204774
SNU-1272,969516,3.722830166507094
IGROV-1,654092,-1.340387623873854
SNU-886,73707398,1.147330182406101
PE/CA-PJ34 (clone C12),613753,3.1668131618299444
KP-4,24856436,0.6663554557266653
YD-15,448949,1.8558710123079216
Mino,448949,-0.9045161656585446
SW1271,126941,-2.215477966101826
JHUEM-1,5280436,2.3030762443317117
SNU-1272,navitoclax-MST-312 (1-1 mol-mol),2.3385631446874897
IGROV-1,6852167,1.5305143027352028
HEL,11626560,1.0872099702081388
SW948,126941,-3.436390914894009
F-36P,10385095,0.4233873484016709
RKN,107985,-3.0900461086436404
P31/FUJ,12001922,1.6134382673725098
Daudi,11404337,-3.064654238522792
EB1,6610216,3.5568648182048523
JHUEM-1,44819697,-1.2775900918456382
SaOS-2,6438330,2.0981522234577064
LS411N,126941,-2.790198017582557
HCC1500,10302451,3.7658874637842135
BT 248,56963564,4.0439806336642175
BICR 31,4259181,2.3774772051226685
NCI-H1395,25126798,4.167853501092747
MOLM-13,11656518,1.5202718128538335
PE/CA-PJ34 (clone C12),123631,-0.1749534582660772
COR-L95,148124,-0.3758104123213183
MOLP-8,53232,1.5052202963885184
NCI-H2452,3038522,3.3601174997652725
SUP-T11,4259181,0.0925220155978016
F-36P,2742550,3.2568507775815525
HCC1500,erlotinib-PLX-4032 (2-1 mol-mol),3.588293308391856
SW948,16722836,1.2939108289094092
PE/CA-PJ49,54454,3.1575698747952576
NCI-H1395,327653,3.4863341416729847
HT-1376,9444,4.168181508826009
HEL,439501,-2.350875236844296
Ishikawa (Heraklio) 02 ER-,24951314,1.737053047356394
NCI-H2452,445091,5.08182727911324
RKO,9840324,5.302067215897717
SaOS-2,44489675,3.960447273667139
Hep-G2,262093,4.425755335049499
SK-MEL-2,6438330,2.47559376570888
PE/CA-PJ49,4096211,1.6961227521771136
ML-1 [Human thyroid carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),2.479159740244691
HuH-6,9549297,0.2280880199146276
Mino,135398516,1.1230856191144136
DLD-1,selumetinib-navitoclax (8-1 mol-mol),2.3919195850938877
BICR 22,46901937,4.667354689676901
LCLC-97TM1,2746,2.92478275020961
P31/FUJ,selumetinib-JQ-1 (4-1 mol-mol),-1.737174960648273
Daudi,44491742,3.5549145676591314
BICR 31,374536,2.383890315264743
JHUEM-1,5978,-3.2797223848146735
TTC-709,219104,2.175791373554699
Hep-G2,135440466,2.0493223992937653
NCI-H2452,17759555,4.398260875691204
LS411N,25183872,0.0970121311419586
Panc 02.03,23725625,6.172373492037936
Granta-519,65064,2.9178387202883735
SK-LMS-1,6505803,0.606445374310417
COR-L105,11222830,1.704570553497338
EB1,25062766,0.8084101266139235
NCI-H1568,5394,4.198509108960074
KP-4,3081361,3.8659709447157815
P31/FUJ,135984461,4.1454221372139894
K-562,49836020,4.414855158615189
HEL,4788,5.03605552733545
KMS-21-BM,52912189,-1.5191575103828827
SNU-886,54454,-1.127756504065537
HEL,selumetinib-GDC-0941 (4-1 mol-mol),3.377819044796062
JHUEM-7,26596,-1.8551798961299688
LS411N,6610216,4.962940577428159
ST486,73707398,-1.0150997686400067
NCI-H1568,23635314,-3.8228905075414055
HCC1500,5328940,1.924598719414512
KP-3,638278,4.144592396497575
SNU-C2A,navitoclax-pluripotin (1-1 mol-mol),-1.0872924581964742
EB1,11396600,2.2409379442223134
BFTC-909,44589607,3.3115887945185496
NCI-H1395,46907787,2.4653160178838354
RERF-LC-Ad1,carboplatin-UNC0638 (2-1 mol-mol),3.9915096293079912
MOLM-13,5281321,-2.338854439084819
JHUEM-1,56649450,2.1478206838782734
BT 248,54596558,3.9995548839878503
MOLP-8,71466380,3.4619880715079603
KMS-21-BM,25150857,1.6617981493963905
K-562,439501,-2.3563528898814905
LMSU,24821094,3.02517753591971
JHUEM-1,4378219,1.963327649705112
SNU-C2A,25183872,-1.5032317089308973
LCLC-97TM1,44819697,0.4394946813834864
HCC1500,9956119,4.194319271525248
IGROV-1,JQ-1-UNC0638 (2-1 mol-mol),1.7292829396313356
L3.3,9911830,2.6705572013337195
HCC1500,6505803,-1.3038553273576796
SK-CO-1,16038120,-1.5377645940979283
MOLP-8,46398810,1.7248083632166018
SUP-T11,65628,3.35493935784814
RKN,73707386,3.296207724675486
HuP-T3,6918638,1.0959798369911515
SK-CO-1,72734382,5.327408257337546
P31/FUJ,alisertib-navitoclax (2-1 mol-mol),-2.72541188794455
SU-DHL-1,23725625,3.354193732931358
Ishikawa (Heraklio) 02 ER-,vorinostat-carboplatin (1-1 mol-mol),3.535417221406592
SNU-C2A,60700,-0.4791192240280689
SW948,4378219,2.7444419460246716
Granta-519,6610216,4.381057854502396
SK-MEL-2,5278396,4.053684378742761
SK-MEL-2,selumetinib-piperlongumine (8-1 mol-mol),1.895997873157988
SaOS-2,25126798,4.16568157244383
L3.3,11497983,4.314112910656769
MOLP-8,11719255,2.3085103352777057
KHM-1B,6623618,1.2635861125154564
PK-1,375860,0.1836341615687206
SU-DHL-1,969516,2.44648475018104
HuP-T3,9884685,1.9355517940144655
SU-DHL-1,54618164,3.660876980117255
EB1,25262965,-5.401983919719103
JHUEM-2,49850262,1.988251823028623
P31/FUJ,4788,5.1911977113578285
MKN1,9825149,2.89070535521207
SEM,19582717,2.6237313520594996
ST486,46943432,0.4282456426671725
IGROV-1,10074640,3.2681490579824426
U-BLC1,9444,4.765545650697124
LS180,46224516,3.8200366067107714
BT 248,387447,-5.028656036950466
K-562,24753719,4.107201496626299
HCC1500,46926350,-3.99988450675712
KLE,216239,3.024053239186479
LS411N,11175137,2.6624545374598
IGROV-1,71466578,4.017291197092763
SEM,54626689,4.433727990073252
Granta-519,10184653,0.998312657126817
MDST8,selumetinib-MK-2206 (8-1 mol-mol),0.7033297936486181
MOLP-8,6918328,-3.583816044173495
KPL-1,31703,3.752141967667925
SW948,56649450,1.940604714075546
BFTC-909,374536,2.594742723017773
KU-19-19,44185566,3.361767971446376
NCI-H2452,1750826,0.2631697114156899
ST486,322968,0.1762369313125943
BT 440,11717001,3.9059704307694822
T98G,31703,0.9528571123330905
LCLC-97TM1,24180719,3.1823264447338837
SW1573,docetaxel-tanespimycin (2-1 mol-mol),2.3053158054818077
KU-19-19,navitoclax-piperlongumine (1-1 mol-mol),2.9388781180521124
RKO,675434,4.252493680505022
BT 248,7251185,2.921625124470224
RERF-LC-MS,vorinostat-navitoclax (4-1 mol-mol),1.7393887492524955
ST486,5284616,1.5895308992293555
HCC15,25105715,3.3758270019314147
HuP-T3,6610216,4.722811341582641
MOLP-8,156422,3.6985484587412394
PE/CA-PJ49,219104,4.033917827909158
SK-HEP-1,6917907,-0.2672796642005143
JHUEM-1,selumetinib-tretinoin (2-1 mol-mol),4.864438296025416
SW948,984333,0.954004982504914
PE/CA-PJ49,5479543,3.6121733345315503
BT 248,262093,2.0571072545208926
HT-1376,3825829,4.798908151638593
SNU-1079,46224516,1.872195617119162
PaTu 8988t,51039095,3.672985699080835
PE/CA-PJ34 (clone C12),16013152,4.240449393705453
SK-LMS-1,19582717,4.843506763590673
ES-2,5282054,4.143674792930119
ST486,5738263,2.264084949892642
Granta-519,selumetinib-BRD-A02303741 (4-1 mol-mol),7.197937797796196
Ishikawa (Heraklio) 02 ER-,44589607,3.631751905999827
MOLM-13,10385095,0.2048351805935088
KMS-21-BM,168313016,1.80428760603686
WM115,2842253,4.366205978966029
NCI-H1568,navitoclax-birinapant (1-1 mol-mol),1.7942101393430023
F-36P,2945648,1.3106918687552636
LMSU,53392493,3.125828973482696
SUP-T11,6918289,-0.0450544438553809
JHUEM-1,2126,3.777131358505326
U-BLC1,55508,2.4791155334158295
BT 440,1566236,1.7318288618334623
MKN1,51039095,3.5171039544447296
IGROV-1,135423438,0.764137689665023
RKO,16725315,5.119694523443236
PE/CA-PJ49,2828334,6.088984241737005
MDST8,11609586,4.829072296940778
F-36P,carboplatin-UNC0638 (2-1 mol-mol),3.5835517234153076
SUP-T11,56973724,1.2143855253010731
COR-L95,7251185,1.1216187825494426
RERF-LC-MS,51039095,3.2453184174795324
P31/FUJ,17759555,3.626728737883383
HCC1500,5113032,4.590685122922873
ST486,54143018,0.6555929031380681
P31/FUJ,16741245,4.043144814115882
HCC15,5746,0.6503914795852271
PE/CA-PJ34 (clone C12),462382,1.1999827824546994
RKO,10074640,2.8357111382750646
HuH-6,753704,4.928049338034241
WM115,10322450,3.651827454662003
LS180,11404337,-0.0678179476465551
Daudi,46191454,-0.8094751773550651
P31/FUJ,selumetinib-tretinoin (2-1 mol-mol),-0.8330243559244562
P31/FUJ,44202524,1.0280075167408849
PE/CA-PJ34 (clone C12),selumetinib-piperlongumine (8-1 mol-mol),3.000431938444702
ALL-SIL,44185566,1.0410692737439569
SNU-1079,16722836,-0.2043649421172318
ES-2,54613361,1.0155796497449754
TTC-709,71466445,4.102542258005533
PE/CA-PJ49,5328940,1.2749025619233272
PaTu 8902,54618164,4.284638344065584
SUP-T11,24772860,-2.3071005995680047
COR-L95,46224516,1.2687748324677306
U-BLC1,46398810,1.68437619307633
COR-L105,56949517,4.666554440626914
BICR 31,piperlongumine-MST-312 (1-1 mol-mol),1.564015805040982
MKN1,24771867,2.464440877621751
BICR 22,45279963,3.757910341256097
Hep-G2,5566,2.9766368191633545
BT 440,6610216,4.135662592287223
ST486,135398738,2.5191815500575783
KP-4,11228183,3.542329746983204
HEL,9911463,3.4775133545177774
HCC1500,navitoclax-PLX-4032 (1-1 mol-mol),-0.625964193644412
BICR 22,JQ-1-MK-0752 (1-1 mol-mol),2.0389244155422577
Granta-519,5287969,-2.420005986832857
BT 440,9868037,4.283687628506758
IGROV-1,71466578,4.017291197092763
Daudi,1323703,3.9745876209629354
SNU-1272,4259181,2.0481969958420683
KPL-1,56973724,3.257189577137636
COR-L95,9956119,3.960527548011759
SW48,15953870,2.1672009909649415
SW48,5278396,2.530949009900888
WM115,10296883,3.9273376390568138
NCI-H2452,10302451,4.286596307748033
SW948,9915743,1.1952390119197474
SW1271,9903786,4.005340236032604
LS411N,49793307,-3.1894754739686455
HT-1376,10302451,2.517064396144774
TTC-709,6610216,4.616312272440149
Daudi,126941,-4.413815937813151
EB1,JQ-1-navitoclax (2-1 mol-mol),0.8497877798512334
LMSU,100016,7.332455698517509
KP-4,10127622,5.552568613540639
SU-DHL-1,89183176,5.662525063156772
BICR 31,SNX-2112-bortezomib (250-1 mol-mol),-2.620347476140509
PE/CA-PJ34 (clone C12),3552672,5.59200043016104
Ishikawa (Heraklio) 02 ER-,navitoclax-gemcitabine (1-1 mol-mol),1.238528181550802
SK-CO-1,216239,2.5779715954988656
SaOS-2,24889392,3.914866726590468
LS180,3025944,4.8838055311701805
SW48,11626560,-0.4765255311776857
SNU-626,25150857,2.623402927560063
DLD-1,613753,3.438216696367693
RKN,168313047,2.366456695786382
NCI-H1568,4788,5.820003751306211
RKN,65628,4.337575078598336
LS411N,5311281,3.759327828108219
RKN,23725625,4.172652901782409
BFTC-909,168312962,2.436518653578315
LMSU,156414,1.5302250641749746
JHUEM-1,vorinostat-navitoclax (4-1 mol-mol),1.0770271404772866
BT 440,6852167,5.5047187061926035
K-562,56946209,-4.819463057676977
KLE,176870,4.949336345274128
SNU-C2A,44819697,3.216433373728939
K-562,navitoclax-piperlongumine (1-1 mol-mol),1.084720053726158
Daudi,11647372,-0.1839602824658907
SNU-1272,4261,0.7733171013559388
SW948,5479543,0.3482839273666757
Ishikawa (Heraklio) 02 ER-,navitoclax-pluripotin (1-1 mol-mol),0.2772952365006154
SU-DHL-1,11626560,-1.697644171575415
BICR 22,71466380,4.042212978424107
HCC1500,selumetinib-UNC0638 (4-1 mol-mol),3.968035032331931
MOLP-8,BRD-A02303741-navitoclax (2-1 mol-mol),3.766843844868067
PK-1,1641662,3.9468527121638126
MOLP-8,9967941,2.6295638429027206
BT 248,44819697,-0.5101915766327456
ST486,53392493,1.8902594002232371
KMS-21-BM,135398516,1.2242835020073743
LMSU,ISOX-bortezomib (250-1 mol-mol),0.2979423367293473
SW1271,piperlongumine-MST-312 (1-1 mol-mol),2.322149279280664
NCI-H2452,25183872,0.970145395005522
RCC10RGB,navitoclax-MST-312 (1-1 mol-mol),1.0881941253840328
RERF-LC-MS,sirolimus-bortezomib (250-1 mol-mol),0.955955259392996
SNU-1079,carboplatin-etoposide (40-17 mol-mol),3.4538992664320647
YD-15,46398810,2.0104053127959287
HCC15,8515,2.8931769079597767
KP-3,10074640,3.2800025366089183
SK-HEP-1,7251185,3.0945137710223687
SUP-T11,5328940,1.3171215460696426
KHM-1B,2945648,1.137982843837139
HuP-T3,3689413,-1.422602865458103
TTC-709,104842,-4.440352877616776
HuH-6,selumetinib-PLX-4032 (8-1 mol-mol),4.529552905493584
HCC1500,2113511,4.626117550925971
HARA [Human squamous cell lung carcinoma],445091,4.978549366904043
SW1573,5351362,2.395315345585997
SaOS-2,16725315,3.258166087647875
SK-HEP-1,44566777,0.1035402456781041
SUP-T11,carboplatin-UNC0638 (2-1 mol-mol),1.6030932561366602
ML-1 [Human thyroid carcinoma],9887053,4.856845998315694
KHM-1B,10074640,2.3153156166587783
SEM,24889392,-0.6485372818048298
NCI-H2452,54618771,2.226699645078912
RKN,5329102,3.127163305072316
BFTC-909,JQ-1-vorinostat (2-1 mol-mol),1.4357033395957943
IGROV-1,selumetinib-MK-2206 (8-1 mol-mol),1.1145818568790276
NCI-H1568,5287620,-3.0605655272876104
IGROV-1,5329102,1.2794664511054334
SU-DHL-1,71680916,6.473574001994787
ST486,5281672,3.718518427502421
COR-L105,25262965,-4.3344847799771
SW48,3503,2.2068347221848605
BICR 31,36462,3.088359748996336
SK-HEP-1,24753719,4.401042857593667
RCC10RGB,navitoclax-gemcitabine (1-1 mol-mol),-0.0681716439191075
Hep-G2,285033,2.524821694424631
EB1,24889392,2.6194018384729167
IA-LM,16659841,3.92216274325252
WM115,24771867,3.628628048718056
SK-CO-1,67156097,0.6545128366700663
SUP-T11,3815108,2.540491338453958
SEM,24748573,1.745245431773973
KP-4,3062316,2.9758786475429195
RKN,selumetinib-vorinostat (8-1 mol-mol),2.829001792073934
Mino,9933475,1.4897788599448063
SaOS-2,navitoclax-sorafenib (1-1 mol-mol),2.1552340524690843
IGROV-1,71466380,4.863636874274779
Hep-G2,25262965,-2.000044227384341
SUP-T11,53495165,-2.046285895641683
HCC1500,selumetinib-piperlongumine (8-1 mol-mol),2.4825259194039173
BT 440,4259181,1.1118800854766548
F-36P,51037431,2.339373613406673
U-BLC1,44607531,-0.9523564870108362
BT 248,6450551,3.394353011187604
LMSU,44185566,3.2605987232959035
KP-4,25102847,0.8930602765096312
JHUEM-7,5287620,-2.16834390542723
JHUEM-1,753704,4.792367544517261
L3.3,446155,3.865906870912223
HuH-6,24748573,2.0533053265663783
Daudi,5281321,-4.970506938945455
BFTC-909,12003241,-0.8371396827795129
SNU-886,322968,1.7797157277210858
SaOS-2,44185566,3.018169617675811
KP-3,46191454,2.2158866738690493
PE/CA-PJ34 (clone C12),135875424,2.9771289784544934
SK-MEL-2,crizotinib-PLX-4032 (2-1 mol-mol),3.064457715489462
L3.3,2874250,6.457091097770646
SW48,54619238,4.554849733994691
HuH-6,JQ-1-MK-0752 (1-1 mol-mol),3.28211708959703
LMSU,11178236,-3.271286165721627
U-BLC1,4096211,1.3270919348772547
Granta-519,25227462,-6.0432717278136066
L3.3,65064,4.762523259447735
KPL-1,445643,3.8321937446775975
HCC1500,72376,-0.7270592073375387
SK-OV-3,3689413,0.6002437290843657
HARA [Human squamous cell lung carcinoma],122327,4.478573115200279
COR-L105,71466380,4.962997689396809
ES-2,5351362,1.049887468603672
U-BLC1,51037431,2.0526878195489084
K-562,56649450,4.352548214039191
ALL-SIL,2828334,5.780519190951295
BT 440,4788,6.103280669831681
MOLP-8,5746,-0.9490954024297016
LS411N,9935249,3.5378716054356927
KU-19-19,148198,-3.572091199224797
ES-2,JQ-1-carboplatin (1-1 mol-mol),4.854592360478168
Granta-519,navitoclax-piperlongumine (1-1 mol-mol),-0.8573381901716745
Granta-519,navitoclax-MST-312 (1-1 mol-mol),-0.2022371646874937
RERF-LC-MS,54619267,3.9836959677109354
RKO,piperlongumine-MST-312 (1-1 mol-mol),2.2495159802497864
SUP-T11,2842253,3.791555091694294
SK-CO-1,445455,4.388752059403359
ML-1 [Human thyroid carcinoma],42611257,2.85876832372032
BT 248,10074640,2.9402331094049265
BFTC-909,6914657,-4.61933610547547
IGROV-1,54619267,3.9701367924453455
HT-1376,216345,4.831373821109563
NCI-H2452,6918289,-3.5458030779688277
DLD-1,46199207,2.8279676685400585
SK-LMS-1,216468,3.93467689992105
SW48,654092,0.3720639788768654
LS180,10184653,1.1411409682713576
F-36P,5284616,2.6318514901590815
SW1573,4259181,2.0061423198913766
SEM,71466578,1.2445916775629704
BICR 22,5978,-3.054007840707858
HT-1376,3689413,2.4091899536551264
Hep-G2,5287620,-1.53536683394514
ST486,57519531,1.464103803527511
SK-CO-1,446155,2.509492168961503
YD-15,4477,-0.0758490279270278
HuP-T3,piperlongumine-MST-312 (1-1 mol-mol),1.4346079723069378
MOLP-8,6917907,-6.199761218038622
WM115,6610216,3.675624927368402
BICR 22,11964036,1.4111698106068242
IGROV-1,135440466,0.9791523710816318
SU-DHL-1,46224516,1.9664047258697153
ML-1 [Human thyroid carcinoma],656346,1.1399678324227185
NCI-H2452,156422,4.888821376667332
BICR 22,446155,3.7361559304721106
BFTC-909,3038522,3.685618431455981
RKO,46907787,4.104881837237831
IGROV-1,123631,1.7694522866439453
LS411N,5280436,4.183720769167266
HARA [Human squamous cell lung carcinoma],15983966,-4.087930187377121
PE/CA-PJ49,15953870,3.8672773648321015
JHUEM-7,25227462,-6.059565497478323
T98G,11626560,2.976682091749677
ES-2,3825829,4.313229749640832
HEL,5311,0.0816485968486221
SU-DHL-1,327653,2.51842673185387
SNU-C2A,24785538,2.88485844102806
MOLM-13,8515,0.8268618162227004
MOLP-8,25183872,-1.6811002192977054
Granta-519,11228183,-2.3490545548585335
LS411N,sirolimus-bortezomib (250-1 mol-mol),1.8501035907850776
SaOS-2,5470400,4.204063595869918
ST486,2126,3.772558979069144
BFTC-909,5738263,3.1091802601858185
SK-CO-1,20959075,-3.269929661945314
SK-OV-3,9956119,5.08600620496794
WM115,tretinoin-navitoclax (4-1 mol-mol),3.8155470378280008
BICR 31,5978,2.6862960741960693
SUP-T11,11214940,1.116305704205143
JHUEM-2,3815108,1.92532326549014
MKN1,72376,2.5047148531683465
RERF-LC-MS,375860,-0.2896823379882159
Mino,9803433,4.282514646270307
Mino,sirolimus-bortezomib (250-1 mol-mol),-0.0680495630332059
SK-OV-3,selumetinib-piperlongumine (8-1 mol-mol),4.999927979817729
COR-L105,44202524,4.8543272504702895
PK-1,selumetinib-navitoclax (8-1 mol-mol),2.666558292784983
U-BLC1,11214940,1.1680394882735312
SK-LMS-1,10302451,4.013028906163852
JHUEM-2,6918837,-2.823391838775777
MOLP-8,44137675,1.775364766844489
IGROV-1,9907093,2.687959785702283
LCLC-97TM1,10385095,1.2595894653665305
NCI-H1395,285033,-0.7222597352874329
SNU-1272,15983966,2.6541351995098545
SNU-626,11626560,2.716229764119407
HCC1500,serdemetan-SCH-529074 (1-1 mol-mol),0.9549823890456136
P31/FUJ,3038522,3.230912995410489
PaTu 8988t,5281321,0.6032906637165831
YD-15,11640390,2.887797753742397
SNU-C2A,25195348,3.931936606394857
HEL,9866186,-1.054303819018661
HCC15,carboplatin-etoposide (40-17 mol-mol),1.5999978710207647
KMS-21-BM,crizotinib-PLX-4032 (2-1 mol-mol),0.993913402729558
PE/CA-PJ49,5978,-4.082783454175707
SW948,2708,5.7755473109613265
SNU-C2A,11626560,1.3975687980215967
JHUEM-2,2749,0.7132247071642328
KPL-1,71304818,2.901545594424028
PaTu 8988t,3025944,4.261130932115319
SK-HEP-1,3689413,-2.4602386660304143
BT 440,135398516,2.138130552039711
PE/CA-PJ49,11228183,3.178093510570805
SU-DHL-1,selumetinib-BRD-A02303741 (4-1 mol-mol),4.3225967046124065
JHUEM-1,2945648,0.8500613597923787
ML-1 [Human thyroid carcinoma],24771867,3.392643461506865
RKO,6252,0.5352436981906653
SNU-C2A,6610355,3.5678223826530755
SU-DHL-1,4521392,5.192178694848648
Daudi,72376,-4.854665282210012
RKN,4259181,0.9508926940780028
ML-1 [Human thyroid carcinoma],4096211,3.147888642031647
HARA [Human squamous cell lung carcinoma],44819697,3.9048868362328264
SNU-1079,322968,2.932362951759812
SW1271,36314,-4.053350989931705
TTC-709,navitoclax-MST-312 (1-1 mol-mol),1.0174708382780444
SUP-T11,carboplatin-etoposide (40-17 mol-mol),0.8394857653232721
KP-4,11656518,1.3199340179722183
JHUEM-1,carboplatin-UNC0638 (2-1 mol-mol),3.6106720911913777
RERF-LC-Ad1,6918837,-0.1903099145343919
L3.3,53495165,2.194695518305113
COR-L105,1750826,-1.9007119452090728
HuP-T3,salermide-PLX-4032 (12-1 mol-mol),5.718732466752557
Granta-519,46215462,0.9491023197189584
JHUEM-1,3385,4.523867747352724
SEM,262093,0.379936046646312
SW1271,3676137,4.713113076263269
KP-4,3854666,1.6469581431730445
DLD-1,51039095,3.716202422670088
JHUEM-2,969516,2.36090050095647
IA-LM,5278396,3.9030690758091904
L3.3,51037431,2.2305263064792396
NCI-H2452,24775005,5.579264227156813
K-562,23635314,-4.3400265171433725
COR-L105,6852167,2.71981320036177
KLE,36462,1.5319564725809691
Panc 02.03,16741245,4.354855972582246
SU-DHL-1,2733487,6.186604270067288
Granta-519,26596,-3.6955660538224784
SW1271,JQ-1-UNC0638 (2-1 mol-mol),1.8151113798618133
ALL-SIL,176870,2.444675771693443
LCLC-97TM1,19582717,4.783105330370089
HuP-T3,119607,5.841541098284191
PE/CA-PJ34 (clone C12),54618305,4.348682714943588
HT-1376,3543504,4.617572720413111
RKN,selumetinib-UNC0638 (4-1 mol-mol),3.946775123673676
SEM,53495165,-1.8232376140676845
P31/FUJ,637858,0.7903103947120294
SUP-T11,208908,2.227001092906748
BT 440,6438330,2.9511856168718236
KP-3,25062766,2.7557599627308274
COR-L95,5329102,1.6379635813529434
SEM,16659841,1.8965739479385648
PE/CA-PJ34 (clone C12),navitoclax-MST-312 (1-1 mol-mol),0.8797788073810391
BICR 31,5291,3.978522058600436
NCI-H1395,36314,2.584917869739777
LS180,6852167,2.255231171645259
IA-LM,89928392,1.436934436501384
JHUEM-7,42642645,-0.2590687534288647
RKO,docetaxel-tanespimycin (2-1 mol-mol),-5.095252166768177
T98G,3038522,1.500756263608253
BICR 22,9903786,3.2901982519836213
SNU-626,9903786,4.459436811322819
Ishikawa (Heraklio) 02 ER-,126941,-3.615737340907348
EB1,5702613,2.3105758271967205
SUP-T11,BRD-A02303741-carboplatin (1-1 mol-mol),4.324081570705741
SK-CO-1,3384730,3.2619898650330272
SEM,44566777,-0.7801941037699254
SW48,17755052,-0.4852421045975616
PK-1,selumetinib-vorinostat (8-1 mol-mol),2.9485876327218077
JHUEM-1,46398810,2.997685542945823
COR-L105,568763,0.9810834095142736
HCC1500,9866186,3.137309558941867
HCC15,124202324,2.163317754038658
SK-MEL-2,24180125,4.1729350383120485
HCC1500,6917907,-5.345696307345718
LMSU,11364421,1.7536295583512325
HCC1500,23635314,-1.1425681705854864
Granta-519,126941,-4.311277898608593
SU-DHL-1,tretinoin-carboplatin (2-1 mol-mol),3.205630539300333
SW948,24771867,-2.1331828785420166
SEM,3025986,-1.9982195321080336
HARA [Human squamous cell lung carcinoma],638278,3.613202989039307
LCLC-97TM1,10410894,3.7243046596553344
COR-L95,11609586,-0.6075050167057128
MKN1,11683005,3.928473196837359
SUP-T11,5311281,2.8875275564844367
SEM,selumetinib-GDC-0941 (4-1 mol-mol),0.0721321703925677
MOLM-13,9952709,2.652499766566874
HCC15,24951314,1.20775234306688
BFTC-909,11175137,1.859642091823866
F-36P,613753,2.8186280637661
PaTu 8988t,tanespimycin-bortezomib (250-1 mol-mol),-0.2002957463821567
Ishikawa (Heraklio) 02 ER-,5281321,0.3871069593768498
SaOS-2,9444,4.299296809659387
JHUEM-2,3025986,-2.4600518937464932
SEM,15547703,1.7172948756521211
PE/CA-PJ34 (clone C12),11234052,4.957821880358116
Daudi,71576739,4.751042411789338
SU-DHL-1,6505803,-0.92520479323989
SU-DHL-1,11214940,-0.4959690036226346
ES-2,54649381,4.212438503442145
MKN1,72193861,3.5411058816058385
JHUEM-7,2733526,4.791818477991272
IA-LM,71466578,5.490140561499378
JHUEM-1,4259181,0.4565714749709281
SNU-1079,4261,-1.0444909029623235
RERF-LC-MS,262093,3.104487938727744
SNU-1079,654092,-0.1986700262896328
KP-3,6505803,-1.05905255098836
SW1271,71466380,4.990835020791986
BT 440,6918638,3.62148033116424
HuH-6,54618305,4.039870782585062
TTC-709,65064,3.2113610043911045
HT-1376,SNX-2112-bortezomib (250-1 mol-mol),0.9445763234958032
TTC-709,6918837,-2.7481034610239075
Panc 02.03,135411,0.8368106867561712
LMSU,56649450,5.764663213375745
PK-1,10385095,1.3878392375696291
KLE,25154868,4.76220314265069
RERF-LC-MS,8515,3.770178660744851
HCC15,45100309,5.717971650422449
KLE,89183176,-2.483352111006337
Ishikawa (Heraklio) 02 ER-,51037431,1.7275160058582717
BT 248,11647372,0.9807519416972552
SUP-T11,24753719,3.652693276768125
KMS-21-BM,3025986,-2.5579584152589443
COR-L95,54618771,1.9587299059916856
MKN1,54686904,4.262826472248201
SK-LMS-1,25126798,3.9652724672274746
LCLC-97TM1,16736978,1.4629436365964008
JHUEM-7,11977753,-4.885412245364533
MKN1,676352,2.293019939896114
JHUEM-1,JQ-1-vorinostat (2-1 mol-mol),1.3377897656334348
IGROV-1,9825149,2.5588021380929553
IGROV-1,227681,3.5439813498262347
KMS-21-BM,25105715,2.083931354064936
EB1,5291,2.1049945538712267
ST486,crizotinib-PLX-4032 (2-1 mol-mol),0.8702213644601388
RERF-LC-MS,44489675,3.7548789887197183
MOLP-8,3136844,3.797428854524256
COR-L95,5746,-1.1189080553056585
BICR 22,135398516,2.7677082767193117
KU-19-19,tanespimycin-gemcitabine (1-1 mol-mol),1.208542786585586
BT 440,selumetinib-decitabine (4-1 mol-mol),2.0826681332942916
ALL-SIL,57330099,4.126515702027515
BT 248,5280436,3.4551701194558935
SW48,135398738,2.3509294796071454
JHUEM-1,11977753,-2.450081699903921
PK-1,24964624,3.103253918247308
KHM-1B,decitabine-navitoclax (2-1 mol-mol),0.777035437815577
WM115,2113511,5.303490143807845
Daudi,2729026,1.2833432455886875
Mino,23635314,-4.625478914727077
P31/FUJ,100016,5.4217002529902185
IGROV-1,71466445,2.3758001916617797
SK-LMS-1,6918878,4.8128232448975705
ALL-SIL,6918878,-0.682122479171039
Daudi,73707371,3.866210661620395
ML-1 [Human thyroid carcinoma],60700,-3.146668380067059
SW48,11364421,-4.967269122022574
HCC15,selumetinib-JQ-1 (4-1 mol-mol),1.0945511889039805
SEM,navitoclax-pluripotin (1-1 mol-mol),-2.998871592273369
U-BLC1,10127622,-2.536800622098886
LS411N,135411,0.7383506227122603
SK-LMS-1,241158,4.676834411951693
K-562,3634881,3.4419902111623473
KP-3,selumetinib-UNC0638 (4-1 mol-mol),5.045746353952506
EB1,400769,-4.403678077832908
KU-19-19,969516,2.8919422545546043
LMSU,168312962,4.105800122245941
Daudi,135999136,4.063293138043838
SU-DHL-1,12001922,1.0574025128990867
HCC15,carboplatin-UNC0638 (2-1 mol-mol),3.871381279129182
MDST8,11427553,3.108888701151444
SNU-C2A,26596,-0.6540146277819451
PK-1,9915743,1.3307464414908754
BT 440,24951314,2.0860733032682233
KP-4,15983966,-3.659286023589941
COR-L95,navitoclax-pluripotin (1-1 mol-mol),-0.7248049337705845
HuP-T3,9840324,6.187364891887578
SUP-T11,9967941,3.9867352947543377
RERF-LC-MS,5281321,-2.2570738048063257
UACC-812,16725315,4.601797708491857
PE/CA-PJ34 (clone C12),11222830,1.6303913144002309
LMSU,9936388,2.8786407463456656
WM115,53481919,3.625694730030069
WM115,3136844,4.4781621433894925
ES-2,5470400,0.3359302640063447
SEM,44185566,0.8758222102990114
SUP-T11,11175137,1.7636400435185362
SK-HEP-1,135999136,5.290710201924687
SK-OV-3,72734382,4.397767647147488
NCI-H1395,10322450,2.951434286433811
SU-DHL-1,4096211,0.0680701310214702
SK-CO-1,2749,0.8616454488616467
Mino,11178236,-4.576642678682091
COR-L105,4477,0.3499366832640422
U-BLC1,11964036,0.1210785313796934
SUP-T11,selumetinib-GDC-0941 (4-1 mol-mol),2.192774933353548
PE/CA-PJ34 (clone C12),24785538,-0.2008088807094913
SW948,24785538,-1.2786696026485709
BICR 22,25161177,4.685384367036766
SEM,44507138,-0.6979596604838103
KPL-1,216468,3.620109491433164
SNU-886,selumetinib-decitabine (4-1 mol-mol),0.1903285486813963
ST486,2945648,2.5090662310029335
Granta-519,11955716,-3.0537796337487064
ALL-SIL,10127622,5.469150259822909
SK-CO-1,11238147,1.2924304468719774
HT-1376,49836020,5.287165459832521
IGROV-1,11427553,2.926316692603687
BICR 22,54618164,4.171441086739322
F-36P,3081361,3.1232778040570177
KLE,5566,3.110078979332344
BFTC-909,57519531,3.2286550647211025
SaOS-2,1750826,-1.0374385524430834
SU-DHL-1,71466445,3.7763473385017994
SW1271,6852167,3.737297660761554
PE/CA-PJ49,322968,4.844964817248369
KP-4,3543504,4.022018926398087
PK-1,72193861,4.036401255544588
SW948,9549297,1.722924191719054
HT-1376,6918328,0.4944247951863489
KMS-21-BM,46191454,-2.8033109618487577
BICR 31,72376,-0.802396523967939
SK-HEP-1,56946209,-4.57873882670014
RKO,24964624,3.0430796891613903
Mino,702558,3.3847756452007554
NCI-H2452,54143018,0.9899128272921088
SU-DHL-6,60750,-4.821248170588626
HEL,44259,1.31343744649104
MDST8,3038522,4.546677862508445
PE/CA-PJ34 (clone C12),11396600,3.27217842552133
KPL-1,445455,4.377014151102969
PE/CA-PJ49,9926054,1.8069972619127008
SNU-1079,6918878,-1.3866850537838704
Daudi,72193861,0.2314245956601211
KP-3,4259181,-0.2815852402422203
NCI-H2452,4096211,2.487981551988898
HuH-6,6918289,2.6271371063151707
LCLC-97TM1,carboplatin-etoposide (40-17 mol-mol),1.252125961208134
Daudi,208908,1.616008502166041
LS411N,46191454,1.665967132338862
Panc 02.03,262093,3.467425891303458
COR-L95,462382,0.8255977399878551
IGROV-1,16736978,0.1982875499977011
JHUEM-1,56946209,-4.809374777827429
MDST8,107985,-3.301997074358414
ST486,6918878,0.2973468061587639
COR-L105,navitoclax-gemcitabine (1-1 mol-mol),-0.9402734681791266
ML-1 [Human thyroid carcinoma],65064,4.907366569161651
RKO,54618164,4.0326978900214705
MOLP-8,5311,0.4432260076750803
SNU-C2A,135421197,5.231431749442163
SK-HEP-1,5291,4.1108608913621545
KMS-21-BM,3552672,2.9554427048607472
SNU-886,5702613,4.595415249382652
SK-LMS-1,4477,0.1265946384524251
KP-4,135423438,2.950077613704309
JHUEM-1,9915743,0.9861539346224674
F-36P,9840324,7.22634630161736
JHUEM-2,23939,4.6153893374592245
SaOS-2,107970,2.235066344736828
F-36P,5978,-4.757316859640084
SEM,11494412,-0.8044371012013913
SNU-626,12001922,2.047071853515294
KHM-1B,16722836,0.0780331724282444
KP-4,24771867,0.2854190310309647
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905
Granta-519,6252,-5.172240666242431
IGROV-1,285033,-1.3538783590767758
RKO,serdemetan-SCH-529074 (1-1 mol-mol),2.0344925203933006
KLE,3503,3.2050182631848094
SEM,tretinoin-navitoclax (4-1 mol-mol),-1.6039122831909487
T98G,doxorubicin-navitoclax (2-1 mol-mol),0.8364198659983065
NCI-H1568,46191454,1.7726304550427152
PaTu 8902,24856436,4.585148807200659
WM115,5351362,0.9981168658111552
IA-LM,387447,-4.406032561698067
MOLM-13,656346,-0.3431029585418202
COR-L105,637858,2.3247583240908405
T98G,24753719,3.9354730231291186
Daudi,448949,1.1283153338590814
SEM,613753,2.3547167164197247
SW948,42642645,-0.386998084672917
LMSU,53232,0.1669358057766225
BFTC-909,JQ-1-carboplatin (1-1 mol-mol),5.2410563732595845
PE/CA-PJ49,selumetinib-BRD-A02303741 (4-1 mol-mol),4.735000987700845
HCC1500,52947716,-7.376885049387286
MDST8,439501,-2.351670240427255
KMS-21-BM,3081361,2.42476328791383
RERF-LC-MS,25161177,4.303824118845859
KMS-21-BM,3815108,1.8997692353311173
SU-DHL-1,3634881,1.9377929493272257
RKO,46398810,2.934390735401444
BFTC-909,carboplatin-etoposide (40-17 mol-mol),3.649517561488253
U-BLC1,135659046,3.900294549540867
PE/CA-PJ34 (clone C12),BRD-A02303741-navitoclax (2-1 mol-mol),3.842627181356933
HuH-6,4705,2.6985150624088967
KP-4,9826308,0.2172163721214547
HCC15,159324,2.6315252421023536
PaTu 8988t,serdemetan-SCH-529074 (1-1 mol-mol),3.002094874495684
HARA [Human squamous cell lung carcinoma],11612883,2.0711773248440783
BT 248,156414,1.4948422332158926
SNU-886,44185566,3.1834094102423083
SEM,3825829,3.0657110006972026
Daudi,2949965,1.2926680931891954
RKO,23725625,3.9986828157613616
SK-MEL-2,19582717,3.5846085030570394
HEL,16722836,0.561669465799647
Panc 02.03,11175137,3.7353172411310696
KU-19-19,6918878,0.8609723302141853
Granta-519,docetaxel-tanespimycin (2-1 mol-mol),-8.26947994699302
SW48,3854666,0.5343434371102147
SK-HEP-1,11626560,2.7034566874481745
NCI-H1395,5281321,-3.249479550606142
ML-1 [Human thyroid carcinoma],navitoclax-sorafenib (1-1 mol-mol),2.2930044306717954
SUP-T11,10427712,3.7597943327495504
NCI-H2452,3825829,3.8827569930751937
BFTC-909,126941,-2.0975077483758415
NCI-H2452,24951314,1.9717681393720747
HCC15,54454,0.5186235809490349
BICR 31,4096211,1.2121831781068038
SK-CO-1,6914657,-1.8836208914019363
SW48,44493528,3.8128145383765992
EB1,24775005,3.1491505618147766
COR-L95,BRD-A02303741-navitoclax (2-1 mol-mol),0.0270607892224954
SW1271,168312962,3.6054980890180746
HARA [Human squamous cell lung carcinoma],5566,3.127581032716584
JHUEM-7,23635314,-4.250939063965602
Panc 02.03,135440466,3.0724615257354153
PaTu 8988t,navitoclax-piperlongumine (1-1 mol-mol),3.1694697801552025
SNU-1079,selumetinib-JQ-1 (4-1 mol-mol),-3.26610855773864
BFTC-909,11427553,2.7610941057010754
JHUEM-2,241158,3.3547536689663904
LS411N,ISOX-bortezomib (250-1 mol-mol),0.5408045393266885
SW1271,44493528,4.286060334293371
Granta-519,JQ-1-MK-0752 (1-1 mol-mol),-0.0004173872761687
LS180,49836020,0.6204023867713871
LMSU,613753,3.288100775967615
JHUEM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.535997961075801
HEL,148198,-3.399100076616297
Ishikawa (Heraklio) 02 ER-,5351362,1.1794354622901426
ML-1 [Human thyroid carcinoma],19582717,3.041392892734857
L3.3,9444,4.344069420298931
Granta-519,3543504,5.0961511485487705
KHM-1B,selumetinib-GDC-0941 (4-1 mol-mol),-0.3982194737494156
PE/CA-PJ49,9884685,0.5185977592735194
MKN1,10385095,1.5634257957183793
HuH-6,25126798,4.097187365226722
SEM,10385095,0.8510184643991832
SEM,53232,2.5377599613466746
HCC1500,3038522,2.0060085934463108
RKO,4917,3.097539294413192
ST486,71466578,3.065665347033744
KHM-1B,JQ-1-vorinostat (2-1 mol-mol),-0.1758433625327752
PE/CA-PJ49,72734382,4.152703498048938
Ishikawa (Heraklio) 02 ER-,72376,-1.85894734544105
RCC10RGB,168312962,4.335962117924443
SEM,25102847,-1.3835697041248178
SaOS-2,104842,-4.966916923279438
Panc 02.03,753704,5.09544361232119
KHM-1B,5280436,3.274905702190878
TTC-709,6914657,-5.982635417750229
PaTu 8988t,439501,-3.4446792284706347
LS180,5282054,4.115839158247494
IA-LM,5287620,-0.8479822353163541
KHM-1B,44259,0.3168726025779862
RCC10RGB,6610216,4.531223922644925
SK-OV-3,vorinostat-carboplatin (1-1 mol-mol),3.580838266034329
HuP-T3,selumetinib-tretinoin (2-1 mol-mol),3.9566869559335585
KMS-21-BM,11404337,-1.2049963736057572
SW1271,9911830,2.7072275961126997
WM115,11719255,3.1992621528929166
KHM-1B,alisertib-navitoclax (2-1 mol-mol),-2.308284106027781
TTC-709,374536,2.464209943291182
RCC10RGB,42642645,2.104174802814935
K-562,72376,-2.627875463605781
KU-19-19,selumetinib-vorinostat (8-1 mol-mol),1.3262473417693337
JHUEM-7,56963564,-0.4105683890675542
HCC1500,9549297,1.8848953505663728
HCC1500,44241473,4.374636754710865
Hep-G2,25183872,0.2185171281580754
HuP-T3,2708,5.229598766149438
P31/FUJ,9866186,-0.5408158091236333
RERF-LC-MS,11657048,4.330866638894723
HEL,119182,-2.1951032337756935
KLE,54686904,4.3325881562773185
RCC10RGB,10296883,4.350673741830848
MDST8,10385095,1.2575537617816142
JHUEM-2,24856436,-0.237886555639794
Mino,decitabine-navitoclax (2-1 mol-mol),-3.7664399124443326
SK-LMS-1,11657048,4.444916823006313
SK-LMS-1,doxorubicin-navitoclax (2-1 mol-mol),-0.4074219237190608
SK-CO-1,23635314,-1.3218098525260824
ES-2,6184667,4.3291621512051215
BICR 22,72199289,4.441607504718354
MOLP-8,9911830,1.992368688928045
SW48,24772860,-4.097111396936187
Ishikawa (Heraklio) 02 ER-,9911463,4.4894975893783435
SNU-1079,11404337,-1.3798089381866616
COR-L105,8515,4.561371818511258
IGROV-1,15547703,3.339928221860449
SU-DHL-1,656346,-0.4085927723055031
Ishikawa (Heraklio) 02 ER-,375860,-0.5414643002476628
COR-L105,168313200,3.683873258385797
Daudi,46224516,0.8162026590632436
Granta-519,5287620,-2.8216901996678985
PE/CA-PJ34 (clone C12),11626560,2.4969016411570117
PE/CA-PJ49,19582717,2.9784501499232414
P31/FUJ,JQ-1-vorinostat (2-1 mol-mol),-0.2741289026450685
L3.3,sirolimus-bortezomib (250-1 mol-mol),2.0691121038567144
UACC-812,11640390,4.086462739167014
Mino,54619267,2.854011246875485
K-562,17755052,3.8994339695870326
T98G,25062766,1.5850239420600067
BICR 31,selumetinib-GDC-0941 (4-1 mol-mol),-0.0760223515380139
KLE,16741245,4.352629336159379
LS180,656346,-0.0089884994203474
LS411N,selumetinib-UNC0638 (4-1 mol-mol),2.4499191002493315
SU-DHL-1,5311281,2.996662642824561
JHUEM-2,2113511,5.9871705583058334
JHUEM-1,44495899,4.493107133969548
SK-LMS-1,16065773,3.944700611122238
RCC10RGB,25161177,5.612412997721579
K-562,3854666,0.2872946014041473
P31/FUJ,9825149,2.400010374644864
HT-1376,55508,3.2481872564761343
SNU-1272,4788,6.041801756981533
PE/CA-PJ34 (clone C12),10322450,3.5530253232214664
SW1271,11964036,1.1602803966527862
LCLC-97TM1,176870,1.9757247403033509
SNU-626,6917907,-4.278790271589654
K-562,168313016,4.482960220744853
BICR 22,selumetinib-PLX-4032 (8-1 mol-mol),3.113612897977895
SNU-1272,selumetinib-GDC-0941 (4-1 mol-mol),3.373247687277942
HT-1376,6918289,4.73385328417071
SW1573,285033,-0.3175288260868649
BICR 31,4788,6.181654669045445
KMS-21-BM,selumetinib-decitabine (4-1 mol-mol),-3.128681562286672
JHUEM-2,vorinostat-carboplatin (1-1 mol-mol),3.4390869080162334
HuH-6,135440466,1.8204896983814465
LS411N,11404337,-0.9351547419605356
RERF-LC-MS,9967941,1.5454786965180345
Mino,49867930,6.219061286561844
JHUEM-2,serdemetan-SCH-529074 (1-1 mol-mol),0.6480976107635519
Granta-519,56973724,1.8473061894805545
K-562,11507802,0.4095176942133114
JHUEM-2,23725625,-0.644874648190934
F-36P,44607531,1.5258917718947242
DLD-1,salermide-PLX-4032 (12-1 mol-mol),5.607934148487059
SNU-626,doxorubicin-navitoclax (2-1 mol-mol),-1.0649977294153905
SW1271,1750826,-3.093550008900348
T98G,11152667,-0.8592432480151526
JHUEM-2,168313047,2.071360615522528
KP-4,2874250,4.410468325412545
JHUEM-1,219104,2.162529386301591
ES-2,5311,1.4338942161654769
P31/FUJ,135398738,-0.0291234665218711
LMSU,navitoclax-PLX-4032 (1-1 mol-mol),3.8157620441746833
WM115,5329102,1.7959886386080517
HT-1376,60700,4.083391886097115
MOLM-13,5470400,-0.3466627309634489
WM115,navitoclax-PLX-4032 (1-1 mol-mol),-0.9695757520165332
JHUEM-1,6917907,-5.631737681539283
EB1,135999136,3.88645183006867
PK-1,60700,0.6775524509847881
Granta-519,44607531,0.7355881041308102
RCC10RGB,5566,3.997570642857795
KU-19-19,24964624,3.8522438290321768
WM115,1641662,3.4019570651475557
SNU-886,3552672,3.544596634627867
KP-4,15547703,3.1306886492492665
BICR 22,5282054,4.223594396310054
U-BLC1,navitoclax-PLX-4032 (1-1 mol-mol),0.8256161695521534
BT 440,navitoclax-pluripotin (1-1 mol-mol),-2.109087392544739
BICR 31,10231331,3.776464743887352
TTC-709,46191454,-0.5335315531213275
HuH-6,4096211,2.7601716482973093
RKO,3825829,4.017808531984142
EB1,72193861,-0.2883411576288737
Daudi,10322450,2.3131627402631905
L3.3,SNX-2112-bortezomib (250-1 mol-mol),1.42333058116923
BICR 22,285033,-4.068757657270757
SUP-T11,3543504,4.358739303266537
KLE,136227924,3.154327848580928
SU-DHL-1,5281321,-1.7372628502658949
SK-MEL-2,12001922,1.5880296179795197
RKO,5287620,-1.9975210326345276
RERF-LC-Ad1,navitoclax-pluripotin (1-1 mol-mol),-0.2842869888478678
BT 440,676352,2.039008885740375
Hep-G2,11625818,5.989869211242665
F-36P,7251185,1.8592585927365437
SNU-886,9926054,2.2284003182480774
Panc 02.03,53232,6.367991743549877
SaOS-2,9826308,0.4955218987390744
EB1,446155,2.1012091625162044
HuP-T3,10074640,3.8159838645365807
SW948,4259181,0.2292867461834122
HARA [Human squamous cell lung carcinoma],11222830,1.4006503885864872
IGROV-1,568763,0.665047061839467
ALL-SIL,decitabine-carboplatin (1-1 mol-mol),-0.0286812837112609
MOLM-13,322968,2.556875190594409
ALL-SIL,9903786,1.532435199339551
Mino,52947716,-7.975452562141386
SW1573,409805,6.568626512075582
LS180,1750826,1.061711606063746
PK-1,12003241,-0.8622642153841519
HuP-T3,46191454,1.9484889201022677
KP-4,serdemetan-SCH-529074 (1-1 mol-mol),2.40284921565821
ML-1 [Human thyroid carcinoma],24901704,3.6288922396747743
MKN1,44259,1.156342792293837
HEL,216345,3.87635579429504
BICR 31,2749,2.2358137088107033
SaOS-2,3385,7.1536746080698395
HT-1376,262093,3.325962410010009
WM115,11626560,1.643291568999912
EB1,126941,-4.509951058236764
BFTC-909,selumetinib-GDC-0941 (4-1 mol-mol),1.742559417066922
ML-1 [Human thyroid carcinoma],36462,0.3533243941090192
Granta-519,24964624,2.975569692960617
HARA [Human squamous cell lung carcinoma],16038120,0.7093520184689783
COR-L105,6918638,0.8528151020185122
RCC10RGB,9825149,2.634802111166888
JHUEM-7,71576739,4.492980004205545
HCC1500,44493528,4.240662848371031
SUP-T11,156414,0.8844395337826703
COR-L105,44489675,3.747818158649104
F-36P,17755052,1.0539195463747784
SUP-T11,16065773,0.8615488655642451
SK-CO-1,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1356145956067642
P31/FUJ,selumetinib-piperlongumine (8-1 mol-mol),0.6855922532418997
ES-2,5566,3.5766257956225047
BICR 31,2746,4.041774334142006
MDST8,51037431,3.453193232905579
PE/CA-PJ49,637858,1.923825301062206
K-562,676352,1.515837042857868
BT 440,135423438,-0.018963982293905
LCLC-97TM1,73707386,3.587652793939767
SK-CO-1,54618164,4.180915062416914
YD-15,9887053,6.205576358236465
SaOS-2,5329102,1.942826181308244
HT-1376,10184653,1.1451621912438723
SU-DHL-1,doxorubicin-navitoclax (2-1 mol-mol),-3.969153330724774
LCLC-97TM1,151289,0.9235530786043882
KP-3,107985,-4.13659757249414
BICR 22,400769,0.1100780529561809
L3.3,49793307,-1.834464681937742
PE/CA-PJ49,44607531,0.2655934961567524
Panc 02.03,docetaxel-tanespimycin (2-1 mol-mol),-0.6813802759264704
SK-CO-1,400769,-0.6897300489229926
ES-2,12001922,1.915519006547152
PE/CA-PJ49,5282054,3.6745843820414312
SW1271,56973724,2.58013716529859
BT 248,73707398,1.2475621750333084
LCLC-97TM1,2945648,2.6479910997037934
JHUEM-2,10074640,2.730515186193989
SU-DHL-1,439501,-2.3864560258185916
NCI-H1568,148198,-4.9953315451672005
RKO,11507802,1.7455765117352984
Panc 02.03,216239,3.7763245170365183
SEM,208908,2.0616953187944835
HCC1500,9825149,1.9829642871568696
NCI-H2452,53232,3.5381177646863837
MKN1,11427553,3.201973428574581
SNU-1079,9967941,2.344349432017568
MOLP-8,11494412,0.4734092912657368
Granta-519,9911463,3.5000933341892733
RERF-LC-Ad1,4259181,1.1969151495318886
MKN1,11234052,4.400169016615842
SK-CO-1,10410894,3.775604170297083
KPL-1,doxorubicin-navitoclax (2-1 mol-mol),3.854233844435268
Ishikawa (Heraklio) 02 ER-,5287620,-1.536457961348177
Mino,decitabine-carboplatin (1-1 mol-mol),-0.3688996488925483
Granta-519,navitoclax-pluripotin (1-1 mol-mol),-1.5381813072816537
MDST8,5328940,2.138158341424683
SaOS-2,1716436,3.427239396926117
HuP-T3,9887053,4.07990532641299
PE/CA-PJ34 (clone C12),navitoclax-birinapant (1-1 mol-mol),3.3511739424223457
JHUEM-1,82146,3.9055611768386727
NCI-H1568,24772860,2.3104914540479324
ST486,72734382,2.9588132377970484
Ishikawa (Heraklio) 02 ER-,89928392,2.014161684087825
JHUEM-2,9967941,3.3587963214407206
LCLC-97TM1,135999136,4.356650968290631
HuH-6,16065773,3.0221668979765823
IGROV-1,4378219,2.016502068118561
YD-15,6623618,2.2755514803945713
Mino,1750826,-4.596687864391328
BICR 22,46199207,3.899734747403315
BICR 31,9915743,-0.3251640044425866
NCI-H2452,613753,2.817247196569438
P31/FUJ,46174525,2.51911302821391
P31/FUJ,5335621,3.2282922271331613
IGROV-1,5278396,3.119031774261392
HuP-T3,16038120,1.51216352382263
LCLC-97TM1,17755052,0.1986775459223547
SUP-T11,2841722,4.220692636146607
PaTu 8988t,66577038,3.1818565141070625
PaTu 8988t,54618771,0.599962301527202
SK-CO-1,46191454,1.747962727561699
SW48,46907787,-1.5740012638710297
ALL-SIL,11485656,1.390704841990788
RERF-LC-MS,selumetinib-piperlongumine (8-1 mol-mol),3.579320132644808
YD-15,11152667,-1.1817729874123373
SK-CO-1,4788,5.843658659854095
SNU-1272,44607531,2.5999559202839384
IGROV-1,16725315,4.890680859998698
LMSU,66577038,3.684475971972106
SW1271,24821094,3.627509655063773
Daudi,navitoclax-pluripotin (1-1 mol-mol),-3.474702671481659
WM115,216468,3.848857711215856
SaOS-2,24779724,4.377738848523283
YD-15,11427553,0.461876926178492
HCC15,675434,4.852455641097197
SK-CO-1,46398810,2.9216967746168625
LS180,JQ-1-vorinostat (2-1 mol-mol),0.4669519655203766
Panc 02.03,123631,3.5560371664842325
SK-CO-1,448949,1.9523830928265349
RKO,285033,-2.0365968290915393
SW48,2749,0.8385534684858028
IA-LM,navitoclax-gemcitabine (1-1 mol-mol),-0.1598122581920494
EB1,136227924,2.1314721571590876
HCC1500,54618164,3.7944844711277264
Panc 02.03,2858523,3.458791746781272
NCI-H1395,65064,5.358143004384587
NCI-H1395,53392493,1.9985896329089852
SEM,55508,1.472940159532621
SK-MEL-2,44202524,4.211687473295859
PaTu 8902,piperlongumine-MST-312 (1-1 mol-mol),2.709357535529884
JHUEM-1,selumetinib-GDC-0941 (4-1 mol-mol),1.6430470914092763
COR-L95,4261,0.3666433774913241
SNU-626,44543605,3.698096651896814
HEL,126941,-3.7945695708983664
SK-MEL-2,168313200,3.8202183973722144
HCC1500,54596490,4.413271545106012
SEM,2729026,1.911580026509944
HuH-6,9840324,5.8941834141601355
BFTC-909,375860,-1.1901103647211757
COR-L95,9866186,0.0204391385842873
BT 440,24785538,0.4908336669280176
BICR 22,66577038,2.5300885228037813
SW948,9826308,0.2428169991227084
SEM,11238147,1.513546731102789
F-36P,42642645,0.6290792205748662
TTC-709,carboplatin-UNC0638 (2-1 mol-mol),2.806069599788359
SK-LMS-1,11717001,5.185088162172401
MOLM-13,73707440,5.976327057082507
PaTu 8902,5291,3.72219732976082
EB1,11626560,1.1874502887373797
RERF-LC-MS,5470400,2.5584942331402623
SW1573,16725315,3.253832365815957
SU-DHL-1,3552672,1.9257473882600096
TTC-709,216468,0.9149866353865022
HCC15,60750,0.68669542572171
SW48,5328940,0.1162920415883012
PaTu 8988t,4378219,1.99751885903338
HEL,241158,3.370113308144609
MOLP-8,53495165,-2.6639864548579535
MKN1,25105715,3.7041160776905255
LS411N,46943432,5.879073426568822
LS180,ISOX-bortezomib (250-1 mol-mol),0.5409757723847333
SK-HEP-1,selumetinib-UNC0638 (4-1 mol-mol),4.697700742307761
DLD-1,44507138,4.282634732170979
Panc 02.03,4521392,4.25988041093388
SW1271,5951923,6.143368489838077
IGROV-1,selumetinib-PLX-4032 (8-1 mol-mol),2.802309242721903
HARA [Human squamous cell lung carcinoma],44185566,2.9912273208606552
Hep-G2,71304818,2.021799775788192
RERF-LC-MS,11717001,4.567893424272946
NCI-H1568,25102847,1.8020479238639409
U-BLC1,3854666,3.2538263988952534
MOLM-13,44137675,1.768154079183361
RKO,10427712,4.823698606341804
BICR 22,6852167,2.9570859917106533
ALL-SIL,vorinostat-navitoclax (4-1 mol-mol),-1.3745471945547945
KLE,49766530,-2.017018761794788
KP-4,675434,4.172438441595691
SW1271,124202324,3.327062905972079
TTC-709,11396600,2.7906512267667325
HuH-6,11234052,5.772317683974108
SUP-T11,9926054,1.9086268061731997
WM115,400769,0.2375153529743729
Ishikawa (Heraklio) 02 ER-,6917907,-4.484514294841452
RKN,3038522,4.332475047921768
SW1271,4096211,3.040458805184357
SK-LMS-1,11626560,2.695648756973684
BICR 31,60700,1.4006980690412227
PE/CA-PJ49,156422,4.985705106414774
Granta-519,448949,1.64880276038625
Mino,2746,0.8044795617412364
HEL,11964036,0.787171767074348
TTC-709,216239,1.9459708874338972
BT 440,11625818,5.081365955355518
HARA [Human squamous cell lung carcinoma],11485656,2.214748392282881
SUP-T11,445091,3.4955893601650443
PE/CA-PJ49,3384730,2.3774538016412765
JHUEM-2,5566,2.521388946736791
BICR 22,11485656,1.7887481250962165
LMSU,984333,0.4760983232851017
HEL,44202524,1.7623585771552046
SK-MEL-2,969516,4.129726264744313
PE/CA-PJ49,4259181,0.0577258955195342
COR-L105,3503,2.4932686195421625
HuH-6,122327,3.939550906419659
Mino,5278396,2.8139792481200887
LS180,4788,5.917574515812926
JHUEM-1,7326481,2.358641201971992
KHM-1B,25154868,3.944420162324233
IGROV-1,219104,3.803083685328391
PE/CA-PJ49,107970,2.309472784516984
SEM,erlotinib-PLX-4032 (2-1 mol-mol),2.337772510139529
PE/CA-PJ34 (clone C12),6505803,-2.153335195822847
SK-MEL-2,2729026,2.9654254504210296
NCI-H1395,5284373,3.990100299544354
IGROV-1,11152667,-1.4116509977729443
LCLC-97TM1,JQ-1-MK-0752 (1-1 mol-mol),0.5638595279312849
YD-15,JQ-1-MK-0752 (1-1 mol-mol),-4.4815441358619506
F-36P,89928392,0.656396533220538
HuP-T3,11485656,3.0565489144797224
HuH-6,42642645,0.2881824801123396
PK-1,25227462,0.4635933656986956
BT 248,67156097,4.587573075901519
NCI-H1568,9907093,3.7800753982052697
LCLC-97TM1,10184653,1.174063194948861
MDST8,16038120,1.9679009346440888
SNU-886,4917,3.2978202495952336
L3.3,135875424,3.974579804692541
MDST8,navitoclax-PLX-4032 (1-1 mol-mol),-1.0125849451326647
NCI-H1568,216239,1.54277692538335
BT 248,53232,4.253838861384023
SK-LMS-1,9823820,5.654385345746234
LCLC-97TM1,5280436,3.0011603005672804
IGROV-1,selumetinib-UNC0638 (4-1 mol-mol),2.5141275878807563
KP-4,54619267,3.864319528912707
Granta-519,5281321,-3.900138103622144
NCI-H2452,6917907,-3.4621989648593696
KP-4,441298,0.2346253273061312
HCC1500,135659046,2.9858139057826905
P31/FUJ,3825829,3.1586120375796516
NCI-H1568,selumetinib-piperlongumine (8-1 mol-mol),3.9234194964704185
JHUEM-2,2858523,2.3881760804302283
BT 248,156422,4.367304785746438
PE/CA-PJ34 (clone C12),252682,7.281153515089364
SW1271,JQ-1-navitoclax (2-1 mol-mol),1.3503657606474289
F-36P,241158,2.4015613346017113
SK-HEP-1,7326481,2.0213225214426505
PaTu 8988t,JQ-1-navitoclax (2-1 mol-mol),1.798415555135888
HCC1500,3634881,3.181593200231373
HuP-T3,5311,2.274555641774389
PE/CA-PJ34 (clone C12),46398810,2.398216250372749
P31/FUJ,969516,2.490551298955204
KP-4,15953870,3.4462713281416697
HT-1376,24797083,1.208101031005895
LCLC-97TM1,25183872,-1.9138026924081315
WM115,54619267,3.5599503094850244
EB1,46224516,1.2082757629459668
SNU-1272,UNC0638-navitoclax (1-1 mol-mol),1.3009701153803632
HuH-6,31703,-2.1593832981169596
JHUEM-1,5284373,2.7410727276645455
HARA [Human squamous cell lung carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),3.6972893846800545
SaOS-2,17755052,-0.5339241699834809
SW948,decitabine-navitoclax (2-1 mol-mol),2.8681609289857155
KLE,54143018,-0.8237191874413499
SaOS-2,19582717,4.316823865856345
SNU-1079,11214940,0.3480905778740038
COR-L105,25105715,3.731140483220641
T98G,vorinostat-navitoclax (4-1 mol-mol),0.847839782822366
SK-HEP-1,5278396,4.037206436677834
HCC15,erlotinib-PLX-4032 (2-1 mol-mol),4.047611661511117
ST486,BRD-A02303741-navitoclax (2-1 mol-mol),0.4757461851197356
COR-L105,6918837,-2.1114263163326177
IGROV-1,25262965,-3.18785020602057
HuP-T3,6505803,1.3238670991795596
NCI-H1568,11214940,1.6761106979183067
HCC15,44543605,4.452652862359365
Hep-G2,selumetinib-vorinostat (8-1 mol-mol),-0.2891046147054946
SW48,46199207,2.9489751610364405
NCI-H1395,tanespimycin-gemcitabine (1-1 mol-mol),4.210954263258385
ES-2,11485656,2.323063224970118
P31/FUJ,104842,-4.465734156959207
MOLM-13,24180719,3.226510234308061
LMSU,5470400,3.850959102601626
HCC15,12003241,-1.0460858766179792
KP-3,6438330,1.362030480673537
IGROV-1,10231331,1.9104831176724932
HT-1376,72193861,3.7212302506952617
SEM,135411,-1.7060706905647656
IGROV-1,107970,2.287061680908213
KP-3,JQ-1-carboplatin (1-1 mol-mol),5.58247855672367
BT 248,selumetinib-BRD-A02303741 (4-1 mol-mol),5.279106159978606
LCLC-97TM1,46907787,1.8795083111860824
BT 248,4788,5.6007343352714605
KP-4,selumetinib-piperlongumine (8-1 mol-mol),4.1237332827341815
IGROV-1,5278396,3.119031774261392
SK-CO-1,5329102,2.034917542642271
RERF-LC-Ad1,16722836,2.166524022697494
SK-HEP-1,11152667,2.375581084403437
JHUEM-1,6918328,0.8432683060538492
WM115,2126,3.806678244062894
SW1271,selumetinib-decitabine (4-1 mol-mol),1.699127774006886
K-562,6918736,-3.666344542032524
Granta-519,6450551,1.162651959279597
NCI-H2452,5479543,3.804245584293823
Daudi,11497983,1.6119133198716458
EB1,119607,3.9396002979440574
WM115,4521392,4.32247006400087
JHUEM-1,9826308,0.846815983516655
MOLM-13,24901704,-2.733844077576574
ES-2,241158,4.7150295600490235
Daudi,56973724,1.9677776982823123
Mino,selumetinib-vorinostat (8-1 mol-mol),1.4107779642854583
HCC1500,613753,3.153964202511791
Granta-519,5460769,2.1422187145203897
SUP-T11,24901704,1.86992687555414
RCC10RGB,53495165,3.554009618530711
PaTu 8902,3854666,4.137852419807088
Hep-G2,374536,1.5546394927769718
Granta-519,151289,0.2062194994497177
MOLP-8,5479543,3.0970965636903327
LCLC-97TM1,4096211,1.6170661636178802
LCLC-97TM1,SNX-2112-bortezomib (250-1 mol-mol),-1.5766290939625012
SW48,9907093,2.826389946725867
MOLP-8,5281672,3.2641398124752063
SW948,6610355,3.913576061403015
EB1,426756,2.3098212979972623
SU-DHL-1,5746,-2.2023974745237815
KHM-1B,31703,-2.376235984768286
L3.3,6918328,0.6582944097969459
F-36P,2729026,2.1465892266491915
MKN1,9911463,4.154655732863371
MOLM-13,10410894,3.311191932806664
SW1573,3384730,1.5192292760027193
U-BLC1,135999136,4.0618059262308615
IGROV-1,navitoclax-piperlongumine (1-1 mol-mol),2.320051681006032
SNU-C2A,54686904,4.7476194574447055
SNU-1272,452548,2.9795464172377923
NCI-H2452,54649381,5.966732082850981
COR-L105,JQ-1-navitoclax (2-1 mol-mol),0.1739680576486409
KMS-21-BM,10074640,2.489576879316322
SNU-886,81146,5.0685074142197175
BFTC-909,9444,3.603329432205708
RERF-LC-MS,SNX-2112-bortezomib (250-1 mol-mol),-2.268317507970671
SW1271,9952709,3.6093754742197706
IGROV-1,4788,5.801051990484709
PK-1,9444,4.293575763510528
JHUEM-7,448949,1.0789337294372523
Hep-G2,10427712,4.820719836314107
KP-3,49766530,-2.4187443119050904
K-562,3825829,2.9396673791475587
KP-4,2113511,4.734439041389162
COR-L105,53232,1.738169806280081
Daudi,25195348,1.3194617548918357
NCI-H1568,46199207,1.8853593558521984
RCC10RGB,135440466,4.497503570362309
SEM,119607,5.617200032788747
SU-DHL-1,navitoclax-birinapant (1-1 mol-mol),1.3479254816656925
KMS-21-BM,24964624,0.8814825331889035
NCI-H1568,3062316,1.133797551734723
Panc 02.03,56649450,3.905458120664549
RKN,44589607,3.09715941328701
MOLM-13,568763,-0.9067431163570788
MOLP-8,444795,3.9342801961368417
RCC10RGB,navitoclax-piperlongumine (1-1 mol-mol),1.8990680206310235
COR-L95,selumetinib-piperlongumine (8-1 mol-mol),2.799372777395438
COR-L105,vorinostat-navitoclax (4-1 mol-mol),0.9761778131002136
SEM,46926350,-4.492601003803031
IGROV-1,6918878,1.6706182189896102
BFTC-909,piperlongumine-MST-312 (1-1 mol-mol),1.831832453388112
ES-2,24964624,2.357600705233518
F-36P,285033,-4.537676332607244
U-BLC1,11396600,3.266285635126102
BICR 22,5280436,0.2666608642372045
BFTC-909,3081361,3.110656330811392
YD-15,5328940,-0.4907657926049647
PaTu 8988t,45279963,4.21642269895433
BT 248,445091,5.158109648340294
TTC-709,16722836,0.7803946658396634
NCI-H1395,100016,6.569605836811141
MDST8,613753,3.2461287764543085
U-BLC1,2828334,6.203940678763353
L3.3,753704,5.0689754221003875
LS411N,6917907,-5.419583860239815
PE/CA-PJ34 (clone C12),4477,0.7585627353016603
HCC15,5335621,5.428336568471036
Mino,11396600,2.601097362695862
SW48,71466380,4.3724837890251935
SK-OV-3,66577038,3.416512813520814
RCC10RGB,49766530,-1.6086406954404375
HuP-T3,16722836,1.72068374216493
SNU-886,124202324,2.9202052759291024
BT 440,11178236,-2.489979626048817
KLE,156414,1.5892150248130086
TTC-709,241158,3.209768010669518
JHUEM-7,44493528,4.303413387370261
MOLM-13,168313016,3.5509192860421592
SU-DHL-1,675434,3.83709506639581
P31/FUJ,9911463,3.6551866379259743
SNU-1079,10184653,-3.572937208942853
KPL-1,10090485,4.9304207959347455
P31/FUJ,445455,5.725867195241275
KPL-1,2126,6.03207918293843
KP-4,carboplatin-UNC0638 (2-1 mol-mol),4.225238646639508
KMS-21-BM,navitoclax-gemcitabine (1-1 mol-mol),-4.671065415340098
TTC-709,135875424,2.6743897511272454
T98G,sirolimus-bortezomib (250-1 mol-mol),0.3680606799164068
MOLP-8,285033,-4.447286141218139
BT 440,2729026,1.3918697008275802
RKN,107970,2.600341318615175
IA-LM,4788,5.899787929501101
NCI-H1395,25227462,2.331405873777041
RKO,71680916,5.910552922648844
K-562,9825149,1.660902694463834
RCC10RGB,4261,3.441062261939301
JHUEM-7,219104,3.3113513931291036
KHM-1B,119182,-1.6156103715295518
JHUEM-2,219104,2.7306063406546772
IGROV-1,387447,-3.9508602289798658
WM115,54618164,3.776567993994872
LS180,44607531,1.744731406430345
NCI-H2452,123631,2.1406097245383062
K-562,262093,3.1056763935044813
HuH-6,54686904,4.260975524107613
Mino,44493528,3.6548963085027
U-BLC1,10074640,2.3894733144484737
JHUEM-7,216239,1.9657689443394817
MDST8,24180719,2.4870372971011374
WM115,66577038,2.911239385644133
HuH-6,5284616,2.8902880290279307
YD-15,5978,-2.2253316412101327
SU-DHL-1,6918328,-0.7249486298416586
NCI-H2452,135999136,4.5117873079445205
ML-1 [Human thyroid carcinoma],9823820,3.655965927562111
PaTu 8902,11609586,3.6092581559147185
IGROV-1,11497983,4.37450324471555
RKN,387447,-2.9807645129134066
LS180,6184667,4.288388758455988
SEM,11717001,4.301730945883233
RKO,JQ-1-vorinostat (2-1 mol-mol),0.9623246898976432
SUP-T11,44185566,1.2085408317875403
NCI-H1568,5460769,1.1324377767406906
HT-1376,11152667,-0.1959046835831934
SUP-T11,5282054,0.8935278494537103
ML-1 [Human thyroid carcinoma],374536,-3.4857090018028956
HuP-T3,3025986,0.0333046209415895
PE/CA-PJ49,9907093,4.805229613005566
KP-4,6918837,-1.774783385584419
IGROV-1,11625818,2.877471533668122
SaOS-2,122327,5.211292969638739
BICR 31,46943432,4.176233154169203
HuH-6,24180125,2.007302619499647
HCC1500,10427712,5.196976599700856
EB1,24748573,1.050427107410724
TTC-709,387447,-4.251430137664213
SNU-C2A,656346,1.1924255505229702
SNU-1079,53232,-0.1935003899624099
K-562,9866186,0.7861847855254385
RKO,10231331,2.816804700080647
NCI-H1568,126941,-1.411149621431801
HCC1500,9933475,1.9677534910437375
NCI-H1395,9903786,3.8864807174358984
JHUEM-2,9887053,1.6256778729362749
KLE,71466578,4.494231116067741
TTC-709,10427712,3.621385443331173
ALL-SIL,53245473,2.8781179496967666
MKN1,46224516,3.0677970199309517
K-562,135423438,0.8826240773524879
BFTC-909,9956119,4.255413767268681
HCC1500,9884685,1.9086372211674376
P31/FUJ,71304818,2.235751993715144
IGROV-1,tanespimycin-gemcitabine (1-1 mol-mol),-0.5447128478899342
MOLP-8,5470400,0.1664110443814662
ML-1 [Human thyroid carcinoma],9967941,2.6659391926085183
SK-LMS-1,462382,0.9703247285669422
SUP-T11,52912189,1.5901937066645562
KHM-1B,5566,2.2801989314066637
SW48,44819697,-2.186530212001632
SW48,12001922,1.4259296039497584
KHM-1B,637858,1.18497480261582
NCI-H1568,24951314,0.6613293075425478
IGROV-1,selumetinib-vorinostat (8-1 mol-mol),2.2605882474472057
PE/CA-PJ49,piperlongumine-MST-312 (1-1 mol-mol),1.2466935058482151
ES-2,4259181,-0.5646450757791253
BT 248,ISOX-bortezomib (250-1 mol-mol),0.8192035269806958
KMS-21-BM,71680916,3.700307850057433
PE/CA-PJ49,6450551,3.0510152388664435
SW1573,51039095,4.568767182944777
SUP-T11,375860,-0.2294135177837117
BFTC-909,46224516,1.8849058086882595
Hep-G2,5311281,3.757916922752933
SU-DHL-1,52947716,-4.8688827763192135
IGROV-1,262093,3.169376516915595
MOLM-13,selumetinib-PLX-4032 (8-1 mol-mol),2.341131850097057
PE/CA-PJ34 (clone C12),3503,2.1595052777982437
SNU-886,20959075,-1.9195531644083397
WM115,24821094,1.6911725066550027
COR-L105,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9364869385558905
JHUEM-7,46199207,2.803889105727764
NCI-H1395,135421197,1.2810683988074232
SK-LMS-1,3552672,1.8445236305168005
HuH-6,2874250,4.955506100986112
SaOS-2,53325874,4.45514535643454
SaOS-2,4261,1.4562926555721387
Daudi,selumetinib-BRD-A02303741 (4-1 mol-mol),4.766499662103581
TTC-709,9956119,3.943115485311812
T98G,568763,1.5650915594276915
SK-CO-1,9907093,3.652313916117519
SaOS-2,613753,3.192322830330122
SNU-886,9967941,1.858584505430476
BFTC-909,148198,-2.03933057080943
MOLM-13,49793307,-4.691237884437231
ML-1 [Human thyroid carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-2.7240522304333763
F-36P,71466380,3.4604908744094547
L3.3,6918736,-1.7247535795274376
COR-L105,135411,0.974173137304268
RERF-LC-MS,135411,0.496828330774242
SK-OV-3,16725315,5.283554915030345
SNU-C2A,36462,2.7016140630002714
RERF-LC-Ad1,136227924,3.427007002266959
SK-CO-1,3854666,3.8596661393399927
LS180,51039095,2.999333495393298
KP-4,3676137,3.93966074498979
RERF-LC-MS,135440466,2.007932851474071
SW1271,SNX-2112-bortezomib (250-1 mol-mol),-1.3790138823522573
LS411N,446155,3.6642844723827266
HCC15,72193861,-0.2523453521741511
PE/CA-PJ34 (clone C12),445455,5.711009055392974
BFTC-909,52947716,3.1995758728854224
SK-HEP-1,9933475,2.440596541444364
SNU-626,52912189,2.2617456684928836
F-36P,11717001,3.933635402889622
T98G,2749,2.7744515514379953
MOLM-13,702558,4.671896667990455
Hep-G2,46199207,3.164086950692396
P31/FUJ,375860,-1.2092771030706315
Panc 02.03,57519531,5.330694472788803
SK-MEL-2,selumetinib-tretinoin (2-1 mol-mol),2.535897414945112
SNU-1272,44185566,3.1177568139661314
COR-L105,selumetinib-decitabine (4-1 mol-mol),2.222127008727221
HCC1500,11238147,3.2515653100317023
SEM,49846579,-5.376308546778199
KP-4,9936388,-5.247407210845399
F-36P,445643,3.4312235548009777
RKO,11427553,3.456895276763714
HARA [Human squamous cell lung carcinoma],24771867,-1.145662696893675
EB1,421610,2.351969054601748
KMS-21-BM,71466445,2.8050552373531694
HCC15,9927531,3.758901572486559
Panc 02.03,107970,3.0394503344184214
BICR 22,6917907,-5.724798000333263
KP-4,49766530,-2.33091907235806
Mino,3081361,1.5829486381821456
P31/FUJ,219104,1.0946129740431632
MOLP-8,selumetinib-BRD-A02303741 (4-1 mol-mol),0.9308410221976412
ML-1 [Human thyroid carcinoma],421610,2.367130129227347
P31/FUJ,SNX-2112-bortezomib (250-1 mol-mol),-3.0882098716957223
Mino,10127622,4.688317768254317
COR-L105,23582824,0.3539942370445449
SNU-C2A,4259181,-0.464833946452518
JHUEM-2,44507138,1.756229675422757
JHUEM-2,11609586,-0.3444487907537759
PE/CA-PJ34 (clone C12),9911463,3.905990041696765
HT-1376,10127622,6.930544919482676
RERF-LC-MS,selumetinib-vorinostat (8-1 mol-mol),2.5829848762682865
F-36P,JQ-1-UNC0638 (2-1 mol-mol),-0.2349092718581727
SNU-886,selumetinib-MK-2206 (8-1 mol-mol),1.439939334739481
Hep-G2,44507138,3.1613379759015845
NCI-H1568,135999136,4.3721543597322405
HuP-T3,11404337,1.0495167124251128
MOLM-13,2729026,2.3347481789683564
SEM,5351362,0.4245704934919823
IGROV-1,9935249,3.330117761231163
EB1,16725315,2.861390545597478
T98G,36462,3.3490251622126985
IGROV-1,16038120,0.2864038103759729
LMSU,123631,3.4845106075088763
HuH-6,JQ-1-vorinostat (2-1 mol-mol),0.5471749050950293
NCI-H2452,11167602,2.565240148317103
EB1,navitoclax-MST-312 (1-1 mol-mol),0.5994604079357847
Granta-519,4788,5.939837006566146
HARA [Human squamous cell lung carcinoma],9935249,3.837366541191349
Daudi,2842253,3.640131040983124
PaTu 8988t,9911463,4.367264855700764
JHUEM-1,71576739,-5.876778978234732
IA-LM,613753,3.1957676281974328
SNU-1079,25262965,-2.3639975793660435
HCC1500,168312962,0.9454061370050444
F-36P,44137675,4.491528939355425
KPL-1,400769,0.2020609001649669
Granta-519,52912189,-1.096728840522365
JHUEM-2,136227924,1.8669676160402808
K-562,67291369,1.5957287334193675
HuP-T3,1750826,-1.878047057258104
ST486,16725315,3.0750448150577525
KP-4,9952709,2.7166093245907916
RCC10RGB,24180125,2.398663234613943
T98G,5746,1.107765435086682
SW1271,5566,3.0013167075914344
LMSU,9803433,4.684361429379855
P31/FUJ,126941,-4.476387704672624
ML-1 [Human thyroid carcinoma],UNC0638-navitoclax (1-1 mol-mol),2.518264645027629
HCC1500,44486219,3.883233561942222
JHUEM-2,1641662,1.7900217116429995
KPL-1,4259181,1.2075981381395555
SW1573,24964624,5.100144587499453
LCLC-97TM1,crizotinib-PLX-4032 (2-1 mol-mol),1.007977471964547
KLE,452548,0.408592435214394
Daudi,42642645,-0.8700738631175318
EB1,66577038,2.447618227318336
L3.3,navitoclax-gemcitabine (1-1 mol-mol),-4.48479777241671
COR-L95,carboplatin-etoposide (40-17 mol-mol),-0.214243666427535
TTC-709,439501,-6.296451607950602
HARA [Human squamous cell lung carcinoma],5746,1.191361240850758
SNU-886,9884685,0.7167053677402274
SEM,5287969,-1.544606693116113
SW1271,969516,2.705669665349302
SEM,702558,2.631789406831085
SNU-1079,54619267,2.100871713582415
NCI-H1395,11626560,2.322318216024447
KLE,25183872,1.4445815878101878
COR-L95,6918837,-4.56092327324237
SK-CO-1,25154868,4.619527339846263
RKO,159324,3.5523933893017583
HCC1500,168313200,1.6452616775244175
IGROV-1,4788,5.801051990484709
SK-LMS-1,16736978,2.241037962984953
KU-19-19,5746,1.6270456089520258
TTC-709,53495165,-1.2359732972556168
RERF-LC-MS,46398810,3.3112335021243977
IGROV-1,6438330,2.7487580937365683
PaTu 8988t,123631,3.803217986992814
LCLC-97TM1,5278396,4.167561166456711
SEM,54618164,3.8944596685913138
U-BLC1,637858,1.4857976283615233
WM115,71680916,4.535911767348542
NCI-H2452,322968,3.869715934392993
YD-15,984333,0.3200203884110615
SUP-T11,135411,0.1630530414261487
SNU-626,serdemetan-SCH-529074 (1-1 mol-mol),2.4555125222672154
BT 440,25102847,2.10572893733292
NCI-H1568,2708,3.449118605167301
Daudi,5470400,3.6690588756853706
NCI-H1568,3038522,2.281352774411324
L3.3,168312962,-1.2002539688883909
PE/CA-PJ49,119182,-1.5966059849702965
K-562,24951314,0.9405452740645998
BICR 31,44137675,3.031084694210408
SaOS-2,82146,4.466197629976123
ALL-SIL,BRD-A02303741-navitoclax (2-1 mol-mol),-0.9236991288199824
SEM,42642645,-5.09846827798555
F-36P,26596,-3.451633292118186
KHM-1B,11404337,0.2779693874185021
HuP-T3,5738263,4.055810266621769
KHM-1B,crizotinib-PLX-4032 (2-1 mol-mol),0.397018981574428
U-BLC1,3634881,2.8740669562735017
BT 248,5978,2.367827241369892
COR-L95,11494412,1.7619372096243109
Granta-519,11507802,0.4974969144595386
WM115,2949965,2.619280368742809
HCC15,613753,3.363668001401703
HCC1500,107985,-3.8501888791364034
WM115,54678924,1.8194282087981308
Daudi,135398516,-0.2737475793919353
PaTu 8902,5280436,5.000479378124589
RKN,439501,-1.5558449248177562
ES-2,44259,0.7106224966865724
RCC10RGB,5287620,-0.3857243809023412
Daudi,5566,2.2518803351891616
SNU-1272,5470400,5.593661886100306
RERF-LC-Ad1,119607,5.958194091123051
KP-3,10385095,2.538896937216095
COR-L105,31703,0.0245204691354453
SNU-626,42642645,1.2892729471191988
LS180,44507138,3.917968702075208
Daudi,11964036,0.3747037141940179
PE/CA-PJ49,vorinostat-navitoclax (4-1 mol-mol),0.9022905377904028
K-562,16659841,3.212428083743772
JHUEM-1,selumetinib-UNC0638 (4-1 mol-mol),4.624513649302269
JHUEM-1,10231331,4.962562844927884
MOLM-13,54618771,-0.6841479707721928
YD-15,25195348,3.9832138588300614
T98G,3062316,-1.1979151836017738
JHUEM-2,9915743,-0.2350251959157376
NCI-H1568,49793307,-3.5648882234860895
T98G,49867930,4.633960080116903
SK-HEP-1,navitoclax-gemcitabine (1-1 mol-mol),-0.1291553978520299
Ishikawa (Heraklio) 02 ER-,56963564,0.444961258730385
SNU-886,56963564,0.781074966857933
PE/CA-PJ49,126941,-1.2096415189212373
F-36P,ISOX-bortezomib (250-1 mol-mol),-0.2185374276167514
BFTC-909,vorinostat-navitoclax (4-1 mol-mol),1.5579626952552863
PE/CA-PJ49,702558,5.79167098378283
KU-19-19,selumetinib-decitabine (4-1 mol-mol),2.1660518976484853
SW1271,107985,-2.924919788256343
COR-L95,2746,2.78697970441755
JHUEM-1,11222830,1.1626263482792354
IGROV-1,104842,-1.6690343627553987
COR-L95,16038120,0.5843691628917023
HARA [Human squamous cell lung carcinoma],73707398,1.6371281450925783
SK-LMS-1,71466380,6.298027250001301
HCC1500,123631,1.5682585338280497
PaTu 8902,322968,4.547287257097872
YD-15,11364421,-4.1684681419403855
HARA [Human squamous cell lung carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.4213259806317335
BT 248,9911830,3.0671224453630326
T98G,53325874,5.417642881876093
SUP-T11,2733487,6.04056146184322
Daudi,11167602,1.0022899570414256
ALL-SIL,10074640,-0.3353589360570669
MKN1,6918837,-1.988883342097649
T98G,445643,4.1457781862877665
SEM,44489675,3.2608943672828827
JHUEM-1,613000,2.1907630085416527
COR-L95,57519531,1.325264870307383
LCLC-97TM1,46191454,0.3820919964810073
KMS-21-BM,5284373,-0.900425841058089
ALL-SIL,439501,-2.349752310116714
IGROV-1,25126798,3.9275606774720817
WM115,24753719,4.6734048968266775
SEM,24771867,-2.7357477254631744
HCC15,36314,-6.084589216701663
HEL,16720766,-1.3120587580234824
SU-DHL-1,11222830,1.179409628644554
HuP-T3,3634881,3.0028113890745707
K-562,5738263,2.3545721599917027
YD-15,3634881,3.662216377276044
DLD-1,66577038,3.527308931113456
SK-CO-1,16725315,3.5012946679092853
RKN,327653,3.2518035953304434
ST486,448949,-0.1344135695791558
RKO,24772860,-3.046302255649564
HARA [Human squamous cell lung carcinoma],1750826,2.2891380116234616
KPL-1,25150857,2.418316868872833
MKN1,BRD-K27188169-navitoclax (2-1 mol-mol),3.65775160677675
SNU-1079,67156097,-1.1315045734783522
BT 440,sirolimus-bortezomib (250-1 mol-mol),2.4257327980261936
HuH-6,25154868,3.2145897259557232
MKN1,64971,2.410114882396598
SNU-C2A,selumetinib-GDC-0941 (4-1 mol-mol),0.0090429135503482
NCI-H1568,piperlongumine-MST-312 (1-1 mol-mol),1.2489252589958966
L3.3,11609586,3.8992408569207018
SK-CO-1,15953870,2.1343083972614725
F-36P,40482356,5.08817235841337
RERF-LC-Ad1,selumetinib-PLX-4032 (8-1 mol-mol),4.111152215390761
BICR 22,71751553,4.276876209585518
BT 440,613753,3.6655201361535865
K-562,24964624,2.9615918690112717
SNU-1079,676352,1.6182629874601375
RKO,11222830,1.6656419736189183
PK-1,selumetinib-GDC-0941 (4-1 mol-mol),1.3787528368135669
SNU-886,11455910,-0.4283095081187237
RCC10RGB,25105715,3.76392637454814
PE/CA-PJ34 (clone C12),alisertib-navitoclax (2-1 mol-mol),-0.593506063139588
ALL-SIL,54618164,3.625474128679928
SUP-T11,15953870,0.8580958185661772
MKN1,71304818,3.4605022810240373
NCI-H1395,44819697,2.3149017923532607
HARA [Human squamous cell lung carcinoma],25183872,-0.077265330214196
SU-DHL-1,49793307,-4.256389272054101
SK-HEP-1,9915743,2.4580731883892293
PE/CA-PJ49,11507802,0.6371620778932344
SaOS-2,10410894,2.56650375580144
HT-1376,JQ-1-vorinostat (2-1 mol-mol),1.9712053180734133
KPL-1,446155,4.499683887576063
ML-1 [Human thyroid carcinoma],9926054,2.0491703403306056
COR-L95,44491742,4.146782751375218
TTC-709,5328940,1.6339727674706483
SK-OV-3,44137675,2.687297746540291
HT-1376,31703,0.1354478243408471
LMSU,erlotinib-PLX-4032 (2-1 mol-mol),3.803932013345548
SU-DHL-1,4477,-0.6876815909262691
RKN,5311,1.8833679583763572
COR-L105,11640390,3.408966388045623
SUP-T11,navitoclax-pluripotin (1-1 mol-mol),-0.2072439051485336
RCC10RGB,637858,2.3286326267725084
Hep-G2,46191454,0.5545112986492189
HARA [Human squamous cell lung carcinoma],16722836,2.4020375260133595
ML-1 [Human thyroid carcinoma],54454,2.7684179569761422
NCI-H1395,54678924,1.3168571915404212
NCI-H1568,serdemetan-SCH-529074 (1-1 mol-mol),1.1632168234026012
SU-DHL-1,6852167,2.266746993939426
HARA [Human squamous cell lung carcinoma],2945648,3.3865607820212316
HuP-T3,49793307,-5.3581383477853555
SK-CO-1,5282054,3.655593178279643
JHUEM-1,6918736,-0.9233724626393044
JHUEM-1,387447,-5.311102118487854
RKO,2841722,4.522769482159767
Granta-519,65628,2.6603144373939154
SU-DHL-1,637858,0.6782178889909583
RKN,9911830,3.6623648245681744
EB1,25102847,1.1626074251865095
ALL-SIL,tretinoin-navitoclax (4-1 mol-mol),0.1560826957318693
MDST8,ISOX-bortezomib (250-1 mol-mol),1.0361241685592786
DLD-1,44632017,1.0905079057608726
BICR 22,9884685,0.2149660223226223
COR-L105,46907787,0.7742744471044445
BT 440,tanespimycin-gemcitabine (1-1 mol-mol),-1.0652410889426145
SEM,16720766,-0.2754839165177884
RCC10RGB,navitoclax-sorafenib (1-1 mol-mol),2.209619948834929
RKO,54618771,2.3159310195777985
HCC1500,6450551,2.2317386689521816
BT 248,2945648,2.911977762170341
U-BLC1,17755052,-1.1917075699811657
NCI-H1395,5291,4.092601973794721
BICR 22,10296883,3.888864516393213
PE/CA-PJ34 (clone C12),1566236,1.827252089315036
U-BLC1,151289,1.013855043294461
Daudi,10302451,1.2926011902861492
Daudi,tanespimycin-gemcitabine (1-1 mol-mol),-4.635562978503933
SaOS-2,JQ-1-carboplatin (1-1 mol-mol),1.527244446829994
NCI-H1395,72376,-0.6047916144496074
SK-MEL-2,6918328,0.4245734425761685
HuH-6,73707371,5.986852511360619
ST486,9866186,0.762341598952278
Granta-519,216239,2.502983600228736
SUP-T11,216239,2.3106930756155686
RERF-LC-MS,selumetinib-JQ-1 (4-1 mol-mol),1.7940148785234815
NCI-H2452,4521392,4.554150979099382
U-BLC1,navitoclax-gemcitabine (1-1 mol-mol),-1.5992704494160137
SEM,4096211,0.9150772033108496
IGROV-1,123631,1.7694522866439453
Ishikawa (Heraklio) 02 ER-,49850262,5.359083107897465
SK-LMS-1,613753,3.286520760006206
IGROV-1,5566,3.174346862827938
YD-15,11964036,-0.3311795510721697
MDST8,72193861,1.790495642839322
NCI-H1395,42642645,1.8763678628327745
SNU-1079,46191454,1.063999579052141
PE/CA-PJ49,54618305,4.991417436766986
NCI-H1395,25102847,3.3934069433864953
BT 440,54618795,3.657500949047848
SUP-T11,10113978,2.606600773289018
SUP-T11,44507138,1.7558493176596632
JHUEM-1,selumetinib-decitabine (4-1 mol-mol),4.227210737843531
COR-L95,400769,-0.6446482680437077
TTC-709,24180719,4.144847836584859
KP-4,216239,1.917012450499876
EB1,9903786,1.1512361945239595
F-36P,156414,1.5553832514314012
SaOS-2,5287620,-1.8033063725700844
COR-L95,6917907,-5.619348954097505
WM115,9840324,5.544544164897635
COR-L105,selumetinib-UNC0638 (4-1 mol-mol),1.9595144972930605
SW948,10322450,3.138867511839475
K-562,25126798,3.746183025237492
L3.3,241158,3.9670067644952702
LS180,5335621,4.412574333730147
SK-CO-1,9911830,2.5560928673864676
BICR 31,selumetinib-vorinostat (8-1 mol-mol),3.0204654665417237
Hep-G2,60750,-4.7110516524032775
SK-CO-1,9825149,2.4273154495027147
HuP-T3,tretinoin-navitoclax (4-1 mol-mol),4.772875046445671
BT 440,25183872,-0.5838343714145469
KU-19-19,10074640,3.725362653690234
NCI-H1568,24901704,3.012455129702266
PaTu 8902,216345,4.855612410794221
LCLC-97TM1,44202524,1.0559659544617075
MOLP-8,9884685,-1.6145757941110517
SNU-1079,168313047,1.6078099879380714
SaOS-2,11656518,3.53164758658959
ALL-SIL,5280436,2.610850174870569
EB1,JQ-1-UNC0638 (2-1 mol-mol),0.1085444566940209
U-BLC1,46174525,3.195176493749016
ML-1 [Human thyroid carcinoma],10231331,4.187669502210677
ST486,selumetinib-vorinostat (8-1 mol-mol),1.5457849466336735
U-BLC1,25105715,2.524669860230104
ES-2,119607,5.319144630563891
LMSU,676352,2.426612440121004
KHM-1B,navitoclax-birinapant (1-1 mol-mol),2.2294776266179057
HARA [Human squamous cell lung carcinoma],JQ-1-vorinostat (2-1 mol-mol),2.5839829159057848
COR-L105,16659841,4.469572921203622
SK-LMS-1,BRD-A02303741-navitoclax (2-1 mol-mol),2.6053449830229645
KLE,9826308,0.0278909201933885
SW48,11625818,2.5740084903132914
COR-L95,135875424,3.0866900102445816
NCI-H2452,10074640,3.4255764700713685
SK-CO-1,60750,-4.4937571478067495
JHUEM-1,11494412,0.6922251980518859
SNU-886,11404337,1.5055907567781088
Hep-G2,1242560,4.268302796379108
BICR 22,374536,2.9550889228261386
MOLP-8,2126,5.134995770793403
Mino,tretinoin-carboplatin (2-1 mol-mol),2.2016982485522094
JHUEM-2,11656518,2.8770372084240616
NCI-H2452,5566,2.960608772215372
Daudi,54618771,-0.114332288085178
NCI-H1568,44137675,2.485428235347338
SUP-T11,8515,4.480563126453878
BICR 31,24771867,6.325583215176513
KMS-21-BM,54618771,-0.9009155156599936
ES-2,3025986,0.0931368853890803
HCC1500,135875424,3.5744445956281483
K-562,vorinostat-carboplatin (1-1 mol-mol),2.490945525629646
DLD-1,15983966,3.2435898871735502
ES-2,24951314,1.54020747726803
BT 440,11234052,2.6956355305583237
KMS-21-BM,57519531,1.0196702395325234
IGROV-1,753704,6.461140333581179
SUP-T11,9911463,3.242593830976794
SW48,11497983,-4.007853458767396
MOLM-13,25195348,1.114215790958376
Daudi,441298,1.3514709590925575
SK-OV-3,124202324,3.0713957973247186
PK-1,46199207,3.76880654988429
BFTC-909,23635314,-1.3241610546701814
F-36P,56973724,0.8082785050993208
SUP-T11,selumetinib-UNC0638 (4-1 mol-mol),2.7168124426987683
SNU-C2A,46199207,3.549903217031589
COR-L95,71304818,2.943301589855332
EB1,3676137,3.2848006899389275
SNU-626,5328940,2.319530807754569
SW1271,44607530,2.17277245139498
RERF-LC-MS,219104,4.628133490361187
NCI-H2452,31703,-0.2834256058580119
Daudi,462382,-0.0525304302162242
JHUEM-1,16659841,2.9044183592708985
SU-DHL-1,25183872,-2.297532702486321
K-562,54618164,3.946994253297547
SK-HEP-1,568763,1.0235069184223942
EB1,71466578,2.0016794803836153
JHUEM-1,16741245,3.4427876861433115
SW48,docetaxel-tanespimycin (2-1 mol-mol),-8.123886258687621
Daudi,BRD-A02303741-navitoclax (2-1 mol-mol),3.127125631555358
BT 440,216345,2.3016415528860015
Panc 02.03,2828334,6.385741192046609
HCC15,5702613,2.8473188935914835
PaTu 8902,11625818,4.430115392870615
COR-L105,53392493,2.0389615313780256
RKN,3062316,2.6330403907451863
UACC-812,6505803,-4.59801553223132
UACC-812,16736978,0.0217391388778129
Mino,9911463,2.4278795242831253
BFTC-909,5278396,3.473037688340168
SW948,73707398,1.7510146080607218
BICR 22,107970,2.71438120007047
SW1271,984333,0.5174855517327741
IGROV-1,9967941,2.9735049794712545
SW948,tanespimycin-bortezomib (250-1 mol-mol),-2.5529889563934693
JHUEM-7,5280436,2.292992298066188
SW948,135984461,4.375312800732864
L3.3,176870,2.4076894274707947
PK-1,sirolimus-bortezomib (250-1 mol-mol),1.545806469698299
LS180,5280436,4.14000298943632
SNU-886,selumetinib-piperlongumine (8-1 mol-mol),-0.4939497647937791
SNU-626,navitoclax-sorafenib (1-1 mol-mol),1.79094359528806
MOLP-8,219104,2.0853040324344536
KLE,44507138,1.5092224182482787
MOLP-8,1716436,2.7387406442001287
MOLM-13,171352865,4.594115651620468
KU-19-19,10127622,1.068304480617998
KU-19-19,5460769,4.3332822587900255
LS180,675434,4.417044491450032
RERF-LC-MS,vorinostat-carboplatin (1-1 mol-mol),3.78748525663286
SK-HEP-1,66577038,3.45712203265648
LMSU,6918638,1.4149573073550044
KMS-21-BM,selumetinib-PLX-4032 (8-1 mol-mol),-1.8723975135837776
L3.3,5287620,-1.4617046509205764
SW1271,3689413,-1.2412691685690602
COR-L95,10296883,4.074268886544182
HCC1500,5287620,-3.8084705838741306
BT 440,44607531,1.4357038359084118
SNU-1079,5746,1.3132706117611423
MKN1,3081361,2.4810565695651707
RCC10RGB,JQ-1-navitoclax (2-1 mol-mol),1.088443536961304
WM115,serdemetan-SCH-529074 (1-1 mol-mol),1.0432203411705916
KP-4,selumetinib-navitoclax (8-1 mol-mol),3.470743491394599
NCI-H1395,53495165,1.995718788623105
SW948,vorinostat-navitoclax (4-1 mol-mol),1.0335682598311662
PK-1,53232,2.5424903874895604
SW1271,46843906,3.0036733058278298
SW1271,10184653,2.439662406391272
SK-CO-1,31703,-2.259601900898513
COR-L105,10074640,3.626128603914542
MOLP-8,11152667,-1.9226575172330305
KP-4,2858523,2.9879328846735036
NCI-H1395,6917907,2.884455684924325
SW948,56646779,5.261847054930003
PK-1,107985,-2.929309788812076
MOLP-8,9825149,0.6088991704164435
ALL-SIL,piperlongumine-MST-312 (1-1 mol-mol),1.1188007214876046
RKN,1641662,3.781184529562369
Daudi,1750826,-5.008838903624334
RERF-LC-MS,24856436,0.2419222597799965
COR-L105,6184667,3.4155069342084916
KLE,126941,-0.581421523160804
HARA [Human squamous cell lung carcinoma],151289,0.6137813450564443
ES-2,439501,-2.264854435064497
BT 248,6852167,2.795606288509473
MOLP-8,568763,-0.8505432933185847
Granta-519,piperlongumine-MST-312 (1-1 mol-mol),1.116794346695572
SK-OV-3,54618771,2.5849230632376923
SW1271,135398516,2.256973153183445
SK-MEL-2,53232,2.229796867506251
MOLM-13,44819697,-1.7672663076184636
KP-4,5328940,2.0031094895324486
SUP-T11,25062766,2.0603504390529146
LCLC-97TM1,24748573,2.1629406196043894
NCI-H1568,10113978,1.8126489257310032
JHUEM-7,46943432,1.400588495445252
EB1,23635314,-3.815969901953721
Mino,16736978,1.267358435560582
SK-LMS-1,6918638,1.135857739605079
ALL-SIL,SNX-2112-bortezomib (250-1 mol-mol),-3.319111432428944
COR-L95,1566236,1.7351682171374878
SK-LMS-1,15547703,4.5011010864651135
PaTu 8988t,54619267,4.243668204976347
ES-2,613753,3.1401685507517616
BICR 31,73707398,2.635299985295534
TTC-709,5291,4.229496145934408
P31/FUJ,24978538,-1.1674360999825653
SNU-1079,6914657,-5.175598645380975
JHUEM-7,3136844,4.744963133957354
HuP-T3,25227462,0.1487181406442073
ES-2,638278,3.341610529335466
Daudi,439501,-2.973914496380735
NCI-H1568,67156097,-1.7914617240991686
WM115,36314,3.85550299796777
PE/CA-PJ49,12001922,2.488213828418306
NCI-H1395,71680916,4.653034119360089
SUP-T11,16219061,2.499531566047248
SEM,2828334,4.508628490160364
SNU-1079,89183176,1.5216036496035734
MOLP-8,409805,3.552664043240888
SW48,24753719,4.052743892866938
Hep-G2,9936388,0.9252852669938214
KP-3,25102847,2.719985343062399
SW48,3825829,3.1303188593692854
PaTu 8988t,54613361,0.5051194448617704
KPL-1,156414,2.530967902679832
RERF-LC-Ad1,44819697,0.2089459186593415
SK-CO-1,44493528,4.973545843770428
MOLP-8,44202524,1.1617664844294235
SEM,54618305,4.259603919662889
P31/FUJ,11656518,-0.8295634521320199
HARA [Human squamous cell lung carcinoma],11625818,4.840804819194981
SNU-1272,168313047,3.3416788102138995
SK-MEL-2,6914657,-2.613888672277605
KP-4,107985,-3.0581190073780524
SNU-1272,46901937,3.721598697481184
LS180,36314,2.4476112429633403
SK-CO-1,119182,-2.3548964470523974
SNU-886,6852167,1.7356740395835049
LS411N,72376,-2.6969507034435236
EB1,5281321,-4.515223085602061
BICR 31,51037431,4.633533363663127
ML-1 [Human thyroid carcinoma],72376,-3.175400377997246
SNU-886,15547703,2.7270775608273174
T98G,6918638,1.4380012949673455
HCC1500,46907787,2.786329845885891
MOLP-8,2708,2.5820066460748015
HEL,10113978,2.6394190696879662
HEL,1641662,3.192273244328466
KP-3,24856436,1.0476355516063085
JHUEM-7,156414,1.092092573669373
LS411N,12001922,2.0246848718715604
ALL-SIL,56963564,-1.2928564241979046
ALL-SIL,168313047,1.973173862571291
JHUEM-1,11152667,-1.2363443703261163
COR-L95,3038522,2.051786867518871
LS411N,25102847,2.9606059837222767
SW48,5566,2.216391660090734
HARA [Human squamous cell lung carcinoma],637858,2.3831379320922728
ST486,alisertib-navitoclax (2-1 mol-mol),-2.0785451290035515
SW48,6917907,-5.957551707769467
RKN,246676,4.414592383854902
IGROV-1,285033,-1.3538783590767758
KHM-1B,71466380,4.706065807266485
PaTu 8988t,11609586,2.9135578891851233
SNU-1079,24180719,1.6141219894609071
P31/FUJ,19582717,2.23583270668625
SNU-1079,46199207,2.139479675388116
SK-OV-3,71304818,3.289226671933847
SW48,9903786,0.6824641791663469
SW48,107985,-4.220376672084107
ALL-SIL,49836020,-3.56746653346715
BT 440,selumetinib-MK-2206 (8-1 mol-mol),1.2760644732022657
DLD-1,327653,3.308553284717408
SUP-T11,11683005,1.773957752861062
HARA [Human squamous cell lung carcinoma],24772860,-1.3203429479269333
Mino,9444,3.624046582491275
JHUEM-7,24180719,2.9437043979916413
MOLM-13,7326481,3.309466894819375
EB1,10074640,1.6970496591640802
PaTu 8988t,387447,-4.215036300164339
IGROV-1,10231331,1.9104831176724932
NCI-H1568,salermide-PLX-4032 (12-1 mol-mol),5.036103452561945
WM115,6852167,1.3860811523021286
SW48,11175137,0.8049020199472112
NCI-H1568,6918837,-3.937828464321892
SK-MEL-2,11222830,3.608357188274662
ALL-SIL,409805,3.511042482554543
BFTC-909,11485656,2.882750602975944
SNU-886,644241,2.771156867357371
BT 440,6436223,-5.465283704909745
BT 440,446155,4.350242360255502
HCC1500,6610216,3.984830656845064
MDST8,46191454,-0.3052251724831438
NCI-H2452,52947716,2.3907771066336543
COR-L95,135411,0.6709946332822974
SNU-1272,49766530,0.1675221070029884
Hep-G2,11497983,4.251359027932584
Mino,25262965,-3.440473877593767
SK-LMS-1,2945648,3.017032092447854
JHUEM-7,3025944,3.7681035622574255
RERF-LC-MS,11497983,4.204546577264711
MDST8,3025986,-2.3601391308628368
K-562,10113978,1.9599198523990544
L3.3,984333,-1.3131333034824293
SNU-1079,54686904,4.24278648486264
MDST8,66577038,3.4472401917824387
RCC10RGB,6917907,3.54732574828972
SU-DHL-1,54618305,4.34503505735179
RERF-LC-MS,selumetinib-navitoclax (8-1 mol-mol),2.77400767356552
RERF-LC-MS,navitoclax-piperlongumine (1-1 mol-mol),3.552905574656644
SEM,carboplatin-etoposide (40-17 mol-mol),-1.5762350099115583
SNU-886,44589607,2.7373909096390743
F-36P,4578,3.81890859322444
WM115,448949,1.6539360415615445
ALL-SIL,216239,1.0502640873271551
HuP-T3,docetaxel-tanespimycin (2-1 mol-mol),1.3630986120545014
SEM,doxorubicin-navitoclax (2-1 mol-mol),-4.027940922325109
LMSU,72734382,6.104130077489303
IA-LM,53325874,6.131967715828746
JHUEM-2,4477,-0.1477511731481989
EB1,51039095,1.2853048692249915
ML-1 [Human thyroid carcinoma],16219061,3.525142786131821
P31/FUJ,119182,-2.8125390579467244
KLE,3689413,-1.503166424361693
SU-DHL-1,11717001,3.585470860794662
MOLP-8,168313016,3.7646553629166304
HT-1376,135440466,2.6249935396158324
ML-1 [Human thyroid carcinoma],11485656,3.567697107596816
SW1271,9823820,4.369434873409536
LMSU,31703,0.876277005526271
Mino,54618771,0.6228570132231963
SK-CO-1,51037431,2.025162533854422
SNU-1079,5282054,3.4171189758182794
SW48,11964036,-0.90016316876993
Granta-519,702558,4.9740995052838874
ALL-SIL,UNC0638-navitoclax (1-1 mol-mol),-1.2077799570565213
NCI-H1568,6918328,-2.169641972219076
JHUEM-7,285033,-3.151788648314247
HuH-6,navitoclax-gemcitabine (1-1 mol-mol),1.81736616695954
SUP-T11,navitoclax-birinapant (1-1 mol-mol),2.0416356659378443
KHM-1B,9915743,0.5787442773030028
Daudi,637858,0.7785119720749748
SW948,53495165,0.2015090818079991
SW1573,46398810,3.5765453048302933
MOLP-8,637858,0.6022882265593398
NCI-H1568,3825829,3.749474944576795
MOLM-13,4788,4.00969340257961
KMS-21-BM,6918289,-6.193056217428985
SU-DHL-1,135398516,1.716785738144405
DLD-1,11656518,2.617011890058304
HCC1500,2945648,3.001490751925554
KHM-1B,9967941,3.052222735088891
SaOS-2,SNX-2112-bortezomib (250-1 mol-mol),-2.769432838518552
SK-LMS-1,168312962,-2.079743636604986
PK-1,1242560,4.419765782746706
HEL,46943432,0.8947528664895825
F-36P,15547703,2.366853340094686
RKN,3689413,-4.085525957083088
COR-L95,45279963,4.007720953160328
KMS-21-BM,8515,3.650954647618241
EB1,2858523,2.881387727364013
LS180,11364421,-2.9792456594346945
JHUEM-7,tanespimycin-bortezomib (250-1 mol-mol),-0.0825179950707132
SW948,51039095,-2.1737453378627567
HEL,135421197,2.810551353794614
KLE,65628,4.416189153864011
SK-OV-3,doxorubicin-navitoclax (2-1 mol-mol),-0.6082867931514424
HuP-T3,5351362,1.4959503226370765
BT 248,6505803,-0.8385222866943476
P31/FUJ,selumetinib-decitabine (4-1 mol-mol),-0.417260560947631
PK-1,65064,5.609726384984117
SUP-T11,9952709,2.9506885783893333
SU-DHL-1,6623618,1.9512254956144048
SK-MEL-2,6852167,4.028362425471942
TTC-709,9933475,-1.2890214550860426
ES-2,11404337,1.4427511575724656
SUP-T11,42642645,-0.4427499325757069
SEM,322968,1.9591491826764695
BICR 22,31703,-2.104947288409208
JHUEM-2,107970,2.1315490396390793
ST486,216468,0.6164466246996555
P31/FUJ,BRD-A02303741-navitoclax (2-1 mol-mol),0.458289206697817
PE/CA-PJ34 (clone C12),JQ-1-UNC0638 (2-1 mol-mol),1.4419134854320173
IA-LM,17755052,4.247702528352723
IGROV-1,17755052,-1.0246415273055465
WM115,navitoclax-birinapant (1-1 mol-mol),2.982568846631371
SNU-C2A,9826308,0.6110056188097591
BT 440,46224516,2.2018057901006505
MKN1,44507138,1.773088829006807
IGROV-1,3503,2.453392942972796
EB1,374536,1.4973094684424462
KLE,66577038,4.579092184923065
YD-15,5566,2.8809126922241273
BICR 31,10302451,2.0763164615496232
COR-L95,JQ-1-vorinostat (2-1 mol-mol),1.1858087423050925
KHM-1B,159324,1.2436512528819574
MOLM-13,2841722,4.084965304911922
COR-L105,9549297,5.541569761250669
KP-3,16722836,1.35953951460932
COR-L95,4705,3.007858501345706
L3.3,322968,4.952946424555438
KHM-1B,54639665,4.391144139421017
BT 248,25154868,4.640538278810453
KP-4,vorinostat-carboplatin (1-1 mol-mol),3.567594716721618
SUP-T11,JQ-1-carboplatin (1-1 mol-mol),1.338159132216547
SK-HEP-1,54626689,5.252317432323977
BICR 22,24964624,2.8366894332481127
KMS-21-BM,9936388,-8.048894686182319
JHUEM-2,107985,-3.927953160479623
JHUEM-7,15547703,2.9203929854808317
K-562,3384730,2.2830550335302555
PE/CA-PJ34 (clone C12),selumetinib-BRD-A02303741 (4-1 mol-mol),2.3443290551447173
RKN,46224516,3.695788234754723
MKN1,44202524,4.09882185461357
U-BLC1,24856436,-1.8954976220669848
JHUEM-7,6252,-0.6838813235058673
Panc 02.03,44607531,1.9299895981807216
KHM-1B,71304818,1.1498757447247578
L3.3,57519531,2.574296584662942
SEM,71466445,-0.7002004774951326
MOLM-13,11317348,-4.1893096196029465
LS411N,60700,1.793788628592944
EB1,9911830,0.792353471304689
ALL-SIL,9967941,3.4348481015027628
SK-HEP-1,46907787,5.1061569205326505
RKN,5351362,2.529766574998156
HuH-6,107970,0.8073577315762971
HuP-T3,31703,0.4675615226322689
SaOS-2,6610355,4.596244040557677
LMSU,4917,3.70267650395279
BICR 31,25195348,4.130650271984148
SUP-T11,5746,-1.3212071705854629
MOLP-8,73707438,3.908454567487333
MDST8,3503,3.3556251865549065
COR-L95,439501,-1.1523844892623298
SEM,5335621,4.131642173212617
MKN1,16725315,4.046311118129106
HARA [Human squamous cell lung carcinoma],selumetinib-piperlongumine (8-1 mol-mol),4.925037100159097
P31/FUJ,5281321,-2.503740446113486
U-BLC1,135984461,1.880488153301068
BICR 22,selumetinib-piperlongumine (8-1 mol-mol),3.0599254943264116
NCI-H1395,5746,0.9154814139320177
ES-2,51039095,3.6844792465477543
BICR 22,2729026,3.062923067871907
SW1573,51037431,1.8928004764191728
ML-1 [Human thyroid carcinoma],285033,-2.470992399828971
RERF-LC-MS,16741245,3.282184197465347
TTC-709,66577038,2.555466077605601
ML-1 [Human thyroid carcinoma],71466380,5.169213277707957
SUP-T11,4917,2.264791440824784
SK-HEP-1,11427553,3.604603983851784
SW948,alisertib-navitoclax (2-1 mol-mol),-1.9206127672365017
SaOS-2,36462,1.0480120523183942
T98G,45279963,3.652550672204272
JHUEM-1,5113032,3.375794291108245
IGROV-1,124202324,2.2563058955522157
P31/FUJ,54618771,-0.1557090961755644
Mino,11404337,-2.29299189538819
SNU-1079,66577038,2.349365675521391
SNU-1079,219104,3.5432868612254533
KP-3,navitoclax-piperlongumine (1-1 mol-mol),1.4843522372680005
SNU-1272,3384730,4.452220632140668
HCC15,6918837,-3.491973763742546
RERF-LC-MS,10302451,4.085913110869725
SUP-T11,44486219,4.292304379203043
WM115,9866186,1.4274901944164853
RCC10RGB,3634881,4.1231622503065495
MOLP-8,tretinoin-carboplatin (2-1 mol-mol),4.454701733266676
LMSU,44607531,1.6909486121434856
SK-OV-3,56946209,-2.3996417591607235
TTC-709,5287620,-1.912830488778938
BT 440,4917,2.281828222009655
Daudi,9907093,2.3595872536278977
UACC-812,135421197,0.8848266315498433
COR-L105,11707110,-2.3960237918310967
KHM-1B,navitoclax-piperlongumine (1-1 mol-mol),1.2579870657882444
NCI-H2452,crizotinib-PLX-4032 (2-1 mol-mol),2.3217431804401607
RKN,selumetinib-GDC-0941 (4-1 mol-mol),1.8547441727402172
BT 248,44241473,4.372252470027867
BICR 22,5287620,-2.2777736835755076
HEL,135398738,1.3240045179008624
SK-CO-1,3825829,3.015639513793665
LMSU,navitoclax-sorafenib (1-1 mol-mol),3.2151070813962286
BT 248,5284373,1.9481267041892785
SK-LMS-1,6914657,-2.5359699625386685
BFTC-909,135398516,3.047749913114312
T98G,5978,6.56505381084649
Granta-519,252682,6.242071482699392
RERF-LC-MS,piperlongumine-MST-312 (1-1 mol-mol),1.31949560405159
MKN1,selumetinib-navitoclax (8-1 mol-mol),4.6565860812721445
KLE,49850262,3.3302068182628393
SU-DHL-1,241158,1.6235055790866513
Mino,10302451,2.7399249984312863
U-BLC1,5284616,3.0292921082923283
SK-LMS-1,tretinoin-navitoclax (4-1 mol-mol),2.6933978808882513
PaTu 8988t,8515,4.36808886077581
NCI-H1568,44489675,3.7863062268563064
MDST8,135875424,6.383148165610491
IA-LM,24771867,1.1290385026114922
HuH-6,11964036,0.4761107486723485
PaTu 8902,12001922,1.8953174279693872
HCC1500,8515,5.3989297102528715
MDST8,4259181,0.8851574645315519
SK-OV-3,16038120,1.745962946040546
Hep-G2,31703,-1.2144454026470897
SNU-C2A,11964036,0.5386060198553341
T98G,5329102,1.9421632700221176
SK-CO-1,25126798,3.6561952188996503
TTC-709,119607,4.04464011329007
HCC1500,4261,0.9221319619811188
NCI-H1395,16722836,3.221617987091192
WM115,613753,3.1291419252746877
SK-LMS-1,tanespimycin-bortezomib (250-1 mol-mol),0.2402445839028043
IGROV-1,6505803,-0.2382223795960626
F-36P,3038522,1.925088588066263
ES-2,25183872,-0.7861241254856819
Ishikawa (Heraklio) 02 ER-,25183872,-0.6917709030872379
KU-19-19,49766530,0.1366302187334878
BICR 22,11494412,0.8036857209518554
ST486,44566777,-1.2416581029269471
KHM-1B,9926054,1.3720275885206477
U-BLC1,6852167,1.3413398534081005
HCC1500,11955716,2.281516197797272
MOLP-8,71680916,4.479993680298279
ML-1 [Human thyroid carcinoma],3025944,4.339456842576773
KLE,17759555,3.4987624371380095
HT-1376,49850262,5.641111918891337
YD-15,44607531,0.7819779475536448
BICR 22,15983966,-4.391384426150851
SK-HEP-1,selumetinib-tretinoin (2-1 mol-mol),6.787404934084747
BT 440,66577038,2.6901743565672667
PE/CA-PJ34 (clone C12),36462,2.153519991196826
RERF-LC-MS,9866186,0.0636323256725951
IGROV-1,54613361,1.0826132998561049
K-562,4259181,-0.7813149193344907
SW48,6438330,1.214777505056659
LS180,54618305,4.3130332958468385
K-562,5746,1.9738407973257048
YD-15,16038120,0.91657211934172
SK-LMS-1,54618771,1.3800871170557885
F-36P,selumetinib-navitoclax (8-1 mol-mol),-0.8154676755119981
SK-MEL-2,24797083,1.36450464232491
COR-L95,3081361,3.577896308939448
BT 248,10385095,1.1706577035646757
KU-19-19,ISOX-bortezomib (250-1 mol-mol),0.6477518582997711
MOLM-13,navitoclax-sorafenib (1-1 mol-mol),-4.200053856490793
SK-LMS-1,3038522,2.3745353119009245
HARA [Human squamous cell lung carcinoma],2113511,5.545523050638764
NCI-H2452,alisertib-navitoclax (2-1 mol-mol),-1.045230676490147
SNU-626,44589607,2.7284235395572716
K-562,53495165,-1.204911447319433
BT 248,11317348,2.524808263877468
SK-CO-1,JQ-1-vorinostat (2-1 mol-mol),1.937629549480178
F-36P,11955716,-1.7667530597393375
RD-ES,439501,-2.2858768035402623
JHUEM-1,448949,1.6433609493415986
HCC15,3676137,4.952150033317278
PaTu 8988t,46398810,3.220252132938068
IA-LM,ISOX-bortezomib (250-1 mol-mol),0.3247346059672509
PE/CA-PJ49,11178236,-3.28089539885458
SNU-886,46191454,2.868449433002464
SNU-1079,49766530,-2.354055789977545
BFTC-909,9927531,5.31835549136936
Panc 02.03,16722836,2.9028860212849565
NCI-H1568,doxorubicin-navitoclax (2-1 mol-mol),-2.631367093813306
Granta-519,3011155,5.044202810550695
IGROV-1,3825829,4.144093606877803
HARA [Human squamous cell lung carcinoma],11404337,-1.2743672881567891
Ishikawa (Heraklio) 02 ER-,4521392,4.6311388218344
P31/FUJ,sirolimus-bortezomib (250-1 mol-mol),0.0617669843942014
WM115,11238147,1.7518250261640556
TTC-709,selumetinib-tretinoin (2-1 mol-mol),3.860901900620269
HEL,6610355,4.700351008256091
SEM,11364421,-5.764014401440725
Ishikawa (Heraklio) 02 ER-,613753,3.335868497846011
JHUEM-7,9915743,2.288162918918336
COR-L105,10410894,5.46795970795096
K-562,135421197,2.032823128578147
HuP-T3,25105715,3.756943800954468
BICR 22,11717001,4.533318725499836
L3.3,11625818,4.38532777510286
KP-4,24964624,3.280275889697183
ML-1 [Human thyroid carcinoma],168313047,1.965548883908303
TTC-709,5113032,4.543744430272274
BICR 22,176870,3.0604023761484154
PE/CA-PJ34 (clone C12),71466380,4.94810327160088
U-BLC1,10077130,4.239693755977397
LMSU,11964036,2.78018409031856
EB1,9927531,2.850216647233053
COR-L105,9823820,3.977631180290917
RERF-LC-Ad1,25126798,4.287589780864176
P31/FUJ,66577038,3.0536576112540916
HuP-T3,11612883,3.639610964764467
ST486,selumetinib-BRD-A02303741 (4-1 mol-mol),4.959791809996256
NCI-H1395,5460769,5.87662281780079
PaTu 8988t,12001922,2.536714978511883
P31/FUJ,24771867,-2.604308550432203
P31/FUJ,3634881,2.159990781463395
SNU-1272,16725315,4.676116134552396
SW1271,11640390,3.706316930576478
Granta-519,984333,0.7513060576966085
SEM,9887053,1.384456155351722
COR-L95,46398810,2.3153378536205036
NCI-H2452,4259181,1.4154165902225178
DLD-1,107970,2.55803516550686
HCC15,docetaxel-tanespimycin (2-1 mol-mol),-6.454135481670954
RERF-LC-MS,3503,1.2198018250646854
KP-4,5284616,2.9251067954202243
BFTC-909,168313047,1.967772312792883
NCI-H1568,49766530,-3.205306991379519
SW948,selumetinib-JQ-1 (4-1 mol-mol),-0.7293969321677569
SEM,136227924,1.2424830449991908
EB1,54639665,4.325181348836959
DLD-1,23635314,-1.0950575794853177
IGROV-1,44491742,4.406671418311328
KHM-1B,44493528,1.720576936641076
JHUEM-2,135411,-0.9973417905819366
KHM-1B,135398516,0.0363584972585632
SaOS-2,54596490,5.687426160237218
KP-3,5281321,-0.7568226828261236
SNU-1272,168313016,6.45685474572034
TTC-709,675434,4.232970829916789
Granta-519,46843906,0.846372381562089
SNU-626,selumetinib-vorinostat (8-1 mol-mol),4.212223566347579
KPL-1,42642645,1.6320283481891475
SNU-1079,25195348,2.421634615846981
SK-OV-3,46398810,2.6339706660379205
WM115,25154868,2.4497388117539773
BT 440,12001922,1.1865564955535637
SNU-1272,19582717,3.9947115976130423
K-562,navitoclax-gemcitabine (1-1 mol-mol),-0.2101297783462078
BT 440,100016,6.480442369798277
BICR 31,123631,1.818021308876907
LMSU,54618771,1.0017714306772694
KHM-1B,10410894,4.907000133376468
L3.3,piperlongumine-MST-312 (1-1 mol-mol),2.794540893097308
KP-4,445643,3.533968483343183
HuP-T3,60750,3.212181181151216
SNU-1272,54619267,4.134812215155654
SK-LMS-1,123631,3.0949156571459846
WM115,71304818,2.065667497969779
SU-DHL-1,11964036,1.0253922980362349
SW1271,9444,4.046685913234064
IA-LM,1716436,3.827820678542469
HARA [Human squamous cell lung carcinoma],3854666,0.7328632401261175
BT 440,168313200,1.843181494702656
Granta-519,selumetinib-decitabine (4-1 mol-mol),1.299817261369256
SW48,44137675,1.8984167228990951
IGROV-1,11364421,-2.1205062036040982
EB1,9549297,1.0779160190945176
PK-1,6917907,-5.6585198704616335
PaTu 8902,3465537,3.540732953494624
HT-1376,11626560,2.3412532504919095
HCC1500,54618771,1.4039271563223086
NCI-H1568,23725625,5.336887169251221
BICR 31,9936388,2.7244047649519074
IGROV-1,49850262,4.068828647042517
Hep-G2,6610216,4.162282260552703
HCC15,5280436,4.320878094694944
COR-L95,46215462,1.6156782364555438
HuH-6,55508,3.9489723485353943
SW948,25022340,4.946878477600784
MKN1,24856436,0.5963194200594403
SNU-C2A,12003241,-1.200287436461147
SNU-1272,25183872,3.9601685379854583
P31/FUJ,3025944,3.8644283212627895
KMS-21-BM,89928392,-0.7524792586813996
SK-CO-1,5978,-3.732613512446313
LS411N,19582717,5.192972758226466
DLD-1,24753719,4.894891523802126
SNU-1079,984333,-0.1497006779785539
KPL-1,1239801,4.724645492304647
Mino,9866186,-1.1603525203531226
SaOS-2,26596,-1.8442798913702467
MOLM-13,6610216,4.131122051839403
SK-LMS-1,carboplatin-etoposide (40-17 mol-mol),4.22674999899941
KU-19-19,3025944,4.41555498235696
HT-1376,navitoclax-piperlongumine (1-1 mol-mol),2.4108326806477325
KP-3,969516,2.9201293282085894
HCC15,11497983,1.686538707374479
HCC1500,216468,3.3608861469702735
NCI-H2452,56649450,2.972344092085675
SK-OV-3,25262965,0.4953902890441227
JHUEM-1,11364421,-3.393706318437751
ES-2,docetaxel-tanespimycin (2-1 mol-mol),0.2337833280437146
HCC15,10184653,1.3258142209068642
SU-DHL-1,3825829,2.249840075454991
WM115,49867926,3.8689880289876446
SNU-1272,72193861,3.3833778859953294
KHM-1B,selumetinib-JQ-1 (4-1 mol-mol),-1.6661106827496956
NCI-H1395,3634881,3.864261643428736
K-562,285033,-3.792012978388577
SEM,5743,-3.3598270412643347
Granta-519,53495165,-2.785106410212646
JHUEM-1,2729026,3.136040969077724
SU-DHL-1,5335621,3.5965276677583846
NCI-H1568,1566236,1.6523344134899465
HCC15,25195348,3.62058364960133
JHUEM-7,10074640,2.4809812187935436
LCLC-97TM1,7326481,3.961997196958484
SU-DHL-1,JQ-1-UNC0638 (2-1 mol-mol),2.5998168320155712
KP-4,446155,0.7205006970910534
JHUEM-2,6610355,3.4132053105914912
SNU-626,vorinostat-carboplatin (1-1 mol-mol),3.664618406656166
LS411N,9887053,4.348393626170801
LS180,208908,2.3350670945107783
IA-LM,54454,3.681506421747591
F-36P,25161177,4.314066575280123
RKN,4378219,1.9905206425028277
WM115,selumetinib-tretinoin (2-1 mol-mol),-1.0607687385354925
ML-1 [Human thyroid carcinoma],2949965,3.680012286367402
EB1,445643,3.6401857827499255
Mino,9840324,5.439202689619101
SK-MEL-2,322968,2.8493986496250474
IGROV-1,216345,3.498629789107092
KPL-1,3815108,2.3775517667577466
SW948,5282054,2.5738720751419746
PaTu 8902,66577038,3.2739824602509304
U-BLC1,alisertib-navitoclax (2-1 mol-mol),-0.4877991566949172
SNU-886,11175137,2.2177679587104935
Mino,11167602,5.227056331573394
SNU-1079,24901704,2.162675238514815
COR-L105,1566236,2.352597865521479
MDST8,selumetinib-piperlongumine (8-1 mol-mol),2.2463644977006423
MOLM-13,46191454,-2.5774836063329905
HCC15,72734382,4.010055800269774
SU-DHL-1,navitoclax-MST-312 (1-1 mol-mol),0.7019716882253797
MKN1,selumetinib-BRD-A02303741 (4-1 mol-mol),6.743662510734921
SNU-1272,46398810,3.303753409066687
SUP-T11,doxorubicin-navitoclax (2-1 mol-mol),-2.9114197656630267
SaOS-2,53232,1.3253237607162072
KU-19-19,9936388,2.972521935644637
F-36P,46907787,-0.7684715218448218
BFTC-909,selumetinib-JQ-1 (4-1 mol-mol),1.1253035869238386
KHM-1B,3815108,2.9895861179131704
PaTu 8988t,selumetinib-PLX-4032 (8-1 mol-mol),6.546714585900996
SNU-626,11175137,2.299174509303915
KHM-1B,107970,1.817903354032074
SU-DHL-6,445643,2.4790626422724107
SNU-1272,1716436,3.918709850381952
ML-1 [Human thyroid carcinoma],89183176,4.271882086089193
HCC1500,208908,1.6399748300125228
KMS-21-BM,3385,1.0208946995343324
P31/FUJ,4917,2.744589019426067
ST486,sirolimus-bortezomib (250-1 mol-mol),-0.4662724333620547
HuP-T3,241158,3.8412641522091144
JHUEM-1,426756,5.613783178531091
ES-2,702558,5.148585022291465
KMS-21-BM,3689413,-1.8694843012427496
Ishikawa (Heraklio) 02 ER-,53232,3.2781803661222573
HT-1376,6852167,4.054024650572562
ST486,6610216,3.852624167573134
U-BLC1,71304818,1.9253367581409448
YD-15,selumetinib-GDC-0941 (4-1 mol-mol),0.264386559718112
SaOS-2,46224516,2.521923040225463
LS180,54618771,0.643112685351952
F-36P,10074640,2.646000171966742
Daudi,23725625,2.2816125857144978
Panc 02.03,25227462,-1.0518848939229315
SNU-C2A,71304818,2.650889021512621
WM115,462382,0.0353255606914336
SaOS-2,135875424,3.0421388786055727
MKN1,613753,3.651226835590354
KMS-21-BM,216239,1.5494979566439628
SNU-886,selumetinib-JQ-1 (4-1 mol-mol),2.185309080254947
Granta-519,10113978,3.360346958971763
SU-DHL-1,51037431,2.2415500634191763
PE/CA-PJ49,24771867,1.9864075317158347
MKN1,selumetinib-vorinostat (8-1 mol-mol),3.560075936672011
SNU-886,10231331,-0.2281959370366189
SW1271,135440466,1.7072517695379112
HuH-6,25262965,-1.1884839841648316
ST486,24856436,-1.098879490541606
HuH-6,11228183,1.6027138840839377
BT 440,11626560,2.0253983805752087
Mino,135398744,6.764750512167438
BT 248,57519531,6.254880017804167
BICR 31,208908,2.9880095911503983
NCI-H1568,11719255,3.5544275615483087
SU-DHL-1,4259181,-1.4222017445817885
ST486,46199207,1.969983516960853
JHUEM-1,15983966,-4.055691842312736
KMS-21-BM,241158,1.877362835227471
EB1,6918638,-0.9960989613224034
EB1,9956119,2.5286121552624077
NCI-H1568,135984461,4.216726883570129
JHUEM-1,5566,3.10042753361478
HuH-6,2742550,3.1145719555139126
Daudi,navitoclax-piperlongumine (1-1 mol-mol),0.8768236288563281
RERF-LC-Ad1,126941,-1.292812823712893
JHUEM-2,10385095,1.0298503293450711
Mino,vorinostat-carboplatin (1-1 mol-mol),1.5152769001725366
K-562,25195348,2.6278567451650394
SW948,6918638,-0.8188756331889222
U-BLC1,135875424,3.992147868924357
UACC-812,216345,3.8515167014354152
PE/CA-PJ49,44202524,1.2298795357846335
KPL-1,11427553,3.0935844955837
PaTu 8988t,446155,5.325372031764619
RERF-LC-MS,selumetinib-tretinoin (2-1 mol-mol),3.2790865080217397
NCI-H1568,54618771,0.8004506686595156
HCC15,9823820,3.975711917882334
RCC10RGB,9935249,3.9754060705766943
LMSU,selumetinib-JQ-1 (4-1 mol-mol),3.5274573633732773
U-BLC1,11647372,-0.7158987806449347
PE/CA-PJ49,tanespimycin-gemcitabine (1-1 mol-mol),-1.6818636747930154
F-36P,16720766,-0.5694610734161567
SK-OV-3,3854666,3.321518045263264
SNU-886,6918878,0.4224764612922807
Daudi,135928012,2.6114481479622516
U-BLC1,1750826,-1.732292337274564
Mino,135999136,1.739858930997736
ST486,9915743,0.8352161269515779
RERF-LC-MS,selumetinib-UNC0638 (4-1 mol-mol),2.6397170445300433
SNU-C2A,16722836,0.8791852269941703
Mino,6918878,-0.6688566059846761
SNU-C2A,4261,1.853298571891691
HT-1376,2858523,3.213242068224276
HCC1500,44491742,3.6723474636183537
Hep-G2,10113978,2.1536070556409252
NCI-H1395,1716436,2.423237318066945
K-562,54626689,4.3954029102592145
KLE,54618305,4.289261640342655
SW948,11152667,-0.307089718187717
NCI-H1568,984333,0.7198134332239758
Granta-519,selumetinib-tretinoin (2-1 mol-mol),5.148474908350203
HT-1376,44607530,1.4255097288169996
U-BLC1,10302451,-0.4891280402389555
IGROV-1,44507138,2.359177395411688
Mino,19582717,2.329558498889067
COR-L105,44566777,0.9614143121394376
PE/CA-PJ34 (clone C12),5470400,-0.1416170344108112
HCC1500,25126798,3.9309577641895137
LS411N,5470400,-0.4509258648896809
TTC-709,24964624,1.072110674342651
PaTu 8902,11427553,3.388107623793881
SNU-1272,4917,3.2346611590060608
KHM-1B,11396600,1.492899305921399
BICR 31,JQ-1-carboplatin (1-1 mol-mol),2.1121797103281876
LS411N,11364421,-0.88941081068058
JHUEM-2,122327,5.761587808510063
JHUEM-7,44607530,1.0267127591964027
JHUEM-1,sirolimus-bortezomib (250-1 mol-mol),0.1143622651277921
Panc 02.03,6918638,1.5939476449475074
IA-LM,73707398,1.4255919606814562
DLD-1,5311281,0.6421466505794678
Granta-519,54613361,-0.5306815642640709
IGROV-1,176870,1.8349827429681411
SK-OV-3,24821094,3.4952627197751744
ES-2,46191454,2.892162996934662
SaOS-2,5566,3.2892304449964125
BFTC-909,44486219,4.380685277356905
MKN1,73707398,3.3076884656453283
SW1271,52947716,2.875834451056303
SNU-1272,4477,1.2199769171135058
LS180,20959075,-3.038194424999374
BICR 22,2708,5.160276397343071
LS411N,24856436,0.7977520405714393
KP-3,17755052,1.8053835671636087
RKO,3062316,2.656751778030552
IGROV-1,2841722,3.834853118277962
SW948,9967941,3.223093544556301
WM115,5291,3.6779708977342263
ML-1 [Human thyroid carcinoma],262093,3.5917492591420737
NCI-H2452,11152667,-1.2581393219211725
U-BLC1,60700,-0.6361475577198398
EB1,24797083,-0.1480396435491002
JHUEM-2,JQ-1-vorinostat (2-1 mol-mol),0.2405388169212164
SK-HEP-1,54454,2.662573207119838
PaTu 8902,46398810,2.87785673961289
BT 248,JQ-1-UNC0638 (2-1 mol-mol),2.2588808320886917
MOLM-13,4096211,0.3628379797080729
SK-LMS-1,5978,-0.7912582712366475
Ishikawa (Heraklio) 02 ER-,carboplatin-etoposide (40-17 mol-mol),3.7008294636817953
EB1,24772860,-2.7839607060978793
PK-1,5287620,-0.2435321015638469
F-36P,11396600,3.0952958144122724
SaOS-2,31703,-1.4545352226195103
SK-LMS-1,6917907,-5.745443884408125
NCI-H2452,89928392,1.3829077368930702
PaTu 8902,sirolimus-bortezomib (250-1 mol-mol),1.4421927553258482
BT 248,6610216,3.912037893092857
ST486,24785538,-0.3743246391614628
SU-DHL-1,216468,2.865615091111303
NCI-H1395,11178236,-3.24243996776791
L3.3,selumetinib-JQ-1 (4-1 mol-mol),7.047753882053292
BFTC-909,5335621,5.263558209813896
HT-1376,71466578,5.661275932189064
TTC-709,44632017,1.9375786474995371
JHUEM-1,10184653,1.5433981058688493
IGROV-1,984333,0.6618578113050116
SaOS-2,53393127,5.00574224434263
SNU-886,16038120,0.7187516548960445
SNU-886,72376,-2.8445678356407043
LS180,26596,-1.3053249122689552
PaTu 8902,216239,3.2515461693373946
RERF-LC-MS,216239,1.5111459083459036
IGROV-1,327653,3.667792542405671
JHUEM-2,11222830,1.620839091624105
PE/CA-PJ34 (clone C12),613000,2.377303032798795
T98G,2733487,6.7149981633744495
MDST8,25062766,1.7641764997703038
COR-L105,tanespimycin-bortezomib (250-1 mol-mol),0.350179088814853
HT-1376,9915743,2.2155128053194777
SW948,9911830,2.1163810502856344
SW948,25262965,-4.786935998048743
Granta-519,17755052,3.698735089058188
SUP-T11,11238147,3.374339395074343
HARA [Human squamous cell lung carcinoma],969516,2.3775549977258836
SW1271,navitoclax-MST-312 (1-1 mol-mol),1.6729617215063168
LMSU,selumetinib-decitabine (4-1 mol-mol),5.339480518693171
BICR 31,65628,4.368112552275168
LS411N,1716436,3.6051806229528394
HEL,31703,-1.5815868160580933
ALL-SIL,46191454,0.8221974593607395
PE/CA-PJ34 (clone C12),2945648,3.1110047210534533
SNU-C2A,54618771,1.0947392287826
IGROV-1,46843906,3.392503571349757
MDST8,52912189,0.1558018738717314
SK-LMS-1,7251185,3.044185157926379
SK-HEP-1,73707398,1.730256970360003
NCI-H2452,969516,2.821538204226011
PE/CA-PJ34 (clone C12),5280436,1.7888326138899853
Daudi,9825149,1.5190393381512124
JHUEM-7,44819697,-0.2962478078392037
HEL,49766530,-2.395534265113236
SU-DHL-1,445643,3.1136870030048116
Granta-519,25102847,2.235988678650905
SU-DHL-1,8515,3.677486404661737
SK-CO-1,decitabine-carboplatin (1-1 mol-mol),2.301340396249523
NCI-H1568,73707398,1.0000031751048108
NCI-H1395,374536,5.636718886348253
RKN,44607531,3.612700906890815
DLD-1,11175137,3.4034296785854905
RKO,448949,2.722052887717566
SaOS-2,123631,3.143555798261004
HuH-6,44241473,4.289282436830392
RERF-LC-MS,docetaxel-tanespimycin (2-1 mol-mol),-5.54075092456557
EB1,6918328,-1.291683877284327
KP-4,10427712,4.668928673169826
HCC15,445455,6.40486213649735
KP-4,11427553,2.2511460729021224
DLD-1,25102847,3.098721073023642
ML-1 [Human thyroid carcinoma],54639126,4.430736107428324
JHUEM-2,44197249,3.765464693875827
ST486,6852167,1.0597481979076584
Mino,3136844,3.4566917217945163
MOLM-13,16720766,-3.0154852550238473
F-36P,2842253,5.772324984676271
SU-DHL-1,52912189,2.819399061651446
KP-3,1641662,3.91303788853309
KLE,alisertib-navitoclax (2-1 mol-mol),-2.1079832786046486
IGROV-1,6918328,-0.5330006254346346
HARA [Human squamous cell lung carcinoma],67156097,-1.978765302962937
SUP-T11,68056272,2.3981646913873726
JHUEM-7,168313016,6.3518310954698824
PE/CA-PJ34 (clone C12),19582717,5.2106352925132375
ST486,54618771,-1.8169523642360077
Granta-519,168312962,2.8455100129937447
RCC10RGB,24748573,3.544482176439233
NCI-H1568,71576739,4.4464222538448075
KHM-1B,erlotinib-PLX-4032 (2-1 mol-mol),2.9494241751240353
LMSU,24951314,3.1918307701084276
IGROV-1,ISOX-bortezomib (250-1 mol-mol),0.8859012184952701
MOLP-8,3025944,3.977744021049233
KMS-21-BM,46224516,1.3863498421306613
SEM,56946209,-6.723586049186012
MDST8,navitoclax-sorafenib (1-1 mol-mol),0.2125187849150193
JHUEM-2,44632017,-0.5253203089752084
KLE,9907093,4.3310456736816185
JHUEM-2,135421197,0.9907591998948792
SW48,3025944,3.8378875325919513
Mino,52912189,-1.259006145969778
KHM-1B,11640390,-1.4659593094548573
P31/FUJ,5460769,2.718083541162644
PaTu 8902,56946209,-3.5225671286307585
IGROV-1,11964036,-0.1609353030421705
HCC1500,327653,2.623652361439541
EB1,5280436,1.3830770839708402
BICR 22,11640390,3.3009766271386014
SNU-1079,11609586,1.8727170902297885
JHUEM-7,2746,3.3298840403754153
IGROV-1,400769,-0.5589612210030486
HuP-T3,24821094,3.9398095537443023
HuP-T3,BRD-A02303741-navitoclax (2-1 mol-mol),4.136817383870447
RKN,54618771,1.93479648501244
NCI-H1395,168313016,6.368341181188219
Daudi,BRD-A02303741-carboplatin (1-1 mol-mol),4.3065470056962765
JHUEM-2,44137675,2.3051773346998305
PaTu 8988t,73707398,1.170719580837983
HARA [Human squamous cell lung carcinoma],10113978,3.460603354098383
Panc 02.03,10231331,3.962628244123872
HCC1500,387447,-5.435802195710178
K-562,25150857,2.2256112733235978
COR-L95,135398516,3.161482452438301
MOLP-8,46191454,-2.2442719810217984
HEL,BRD-A02303741-navitoclax (2-1 mol-mol),-1.272488077546847
KHM-1B,3503,2.6165416338561633
MKN1,409805,5.673588155962679
BICR 22,4259181,0.3497439952553443
SEM,54678924,1.6439221988057715
SU-DHL-1,49836020,5.336381428124731
P31/FUJ,246676,3.344572915959865
MOLP-8,UNC0638-navitoclax (1-1 mol-mol),1.623066033495539
BT 440,vorinostat-navitoclax (4-1 mol-mol),3.6422677005862
WM115,JQ-1-MK-0752 (1-1 mol-mol),1.4273161009607245
WM115,carboplatin-UNC0638 (2-1 mol-mol),3.608353626656174
SK-CO-1,135875424,3.678629656731489
PE/CA-PJ49,3634881,3.4602619031598945
SW948,3552672,1.903682389315955
JHUEM-2,11455910,0.0999331855360444
NCI-H1568,selumetinib-BRD-A02303741 (4-1 mol-mol),5.032258587314436
NCI-H2452,JQ-1-navitoclax (2-1 mol-mol),0.3722844908497442
HCC15,selumetinib-decitabine (4-1 mol-mol),4.297917027036863
JHUEM-1,JQ-1-carboplatin (1-1 mol-mol),1.8045893002317055
KHM-1B,9840324,5.635096396232016
P31/FUJ,6610355,3.438139996915945
NCI-H1568,446155,2.3736727750277455
HCC15,107985,-2.9906891972859415
Hep-G2,4705,3.661377424610174
JHUEM-7,11625818,3.132369782082216
Daudi,6918328,-3.006382851838594
SNU-C2A,89928392,1.041142054686715
KMS-21-BM,25183872,-2.4048626821771495
U-BLC1,1641662,3.2170527970325957
Daudi,25161177,4.237474374185298
LS180,selumetinib-navitoclax (8-1 mol-mol),0.5338849490491672
RCC10RGB,vorinostat-carboplatin (1-1 mol-mol),4.3210323450827275
HCC1500,374536,2.8802619944250765
SU-DHL-1,400769,-1.357151076144479
MOLP-8,16725315,4.20287759788283
K-562,SNX-2112-bortezomib (250-1 mol-mol),-3.0816368014715434
MDST8,24753719,4.799692184779076
Hep-G2,10074640,2.639791541844783
Panc 02.03,25195348,3.9334722209588735
SNU-626,5566,3.2130428836367337
IA-LM,5328940,2.67230513268953
KMS-21-BM,11167602,0.9421858410696404
HARA [Human squamous cell lung carcinoma],387447,-4.146769649621688
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905
BT 248,6438330,0.9229397913759128
Granta-519,676352,1.633141874861156
HCC15,49793307,-2.657858659953827
K-562,16065773,1.923835638804153
JHUEM-7,decitabine-navitoclax (2-1 mol-mol),1.3680027102230077
RERF-LC-MS,23582824,0.1470987082457378
SW948,9907093,4.923675844906718
HuP-T3,374536,4.193584653265312
EB1,BRD-A02303741-navitoclax (2-1 mol-mol),2.5285554091076894
WM115,11396600,2.8854117577089378
SK-LMS-1,9911830,2.533802245803789
ES-2,5280436,3.7233148681353367
JHUEM-1,11167602,1.7927694326745718
IGROV-1,16722836,0.856484234547582
BT 440,60700,2.7244202410382576
LS411N,89183176,4.7846004508379085
LS411N,selumetinib-MK-2206 (8-1 mol-mol),1.1332062725089502
HCC15,6917907,-3.7751611818797897
F-36P,24797083,0.9430750906805656
PK-1,71751553,5.428390787076589
ST486,11485656,1.65014245999224
NCI-H1568,637858,1.7833024505225796
EB1,4259181,-0.1411659668037445
KP-3,4261,1.3326527073710714
LMSU,5284616,3.630952322980812
PK-1,322968,4.827383825591596
SK-MEL-2,selumetinib-UNC0638 (4-1 mol-mol),2.1798950072084393
PaTu 8902,5329102,2.5341846500240246
Daudi,54765302,2.540510911033338
RERF-LC-MS,100016,6.56071523320666
ST486,17755052,2.012231307671272
PE/CA-PJ49,568763,0.8663774214435017
HT-1376,3038522,4.242089732027218
NCI-H1568,387447,-3.95080818095812
HARA [Human squamous cell lung carcinoma],168313047,3.4416690801744574
SaOS-2,11612883,2.0316436721768087
BT 248,11640390,5.783520002908773
SK-OV-3,135411,1.6318689765112546
IGROV-1,208908,2.822483792004996
Mino,5460769,1.2525165030578538
HuH-6,11222830,1.0838611710470012
RKN,51037431,2.467401650082352
LMSU,44566777,0.4597072613973534
MOLM-13,3025944,3.8428716966726992
BT 248,9952709,2.726522372177628
PaTu 8902,135421197,2.3024316473658004
MDST8,969516,2.598297465814476
Ishikawa (Heraklio) 02 ER-,navitoclax-sorafenib (1-1 mol-mol),4.342881691852438
ST486,24951314,0.203724932464806
KMS-21-BM,selumetinib-piperlongumine (8-1 mol-mol),-1.3439353608745053
MOLM-13,60750,-4.5529472050787545
U-BLC1,2746,2.5365215352469175
KPL-1,4917,2.8852847088791664
L3.3,9956119,3.8207787288773063
SK-CO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.9815172513006872
IGROV-1,9915743,-0.4757488934941289
BICR 31,56946209,-4.213875977630207
MDST8,124202324,2.333625526818204
TTC-709,24797083,1.196737949402667
KPL-1,9927531,4.948797048783531
BFTC-909,46907787,2.3649992203474515
Daudi,12003241,-4.903510386182724
DLD-1,4378219,2.3905672314053388
T98G,24964624,3.080930817112252
JHUEM-2,46191454,-1.1701828086942605
PaTu 8902,969516,4.108056616445131
RKO,24951314,1.467797052763695
SW48,439501,-2.266376314928653
YD-15,sirolimus-bortezomib (250-1 mol-mol),1.709895595212298
IGROV-1,5311281,3.3250623444804206
KP-3,54619267,4.412752492905837
BFTC-909,9825149,2.463033939289578
LS180,2858523,3.002923184305197
PE/CA-PJ49,44589607,2.270791693100932
HEL,decitabine-carboplatin (1-1 mol-mol),0.001071059904297
ALL-SIL,selumetinib-navitoclax (8-1 mol-mol),-0.8393067870593486
PaTu 8902,10074640,3.6154267469790304
TTC-709,11507802,1.3342133575694413
ES-2,4378219,1.9762325092315076
LS180,135421197,1.2375553911833763
ML-1 [Human thyroid carcinoma],3081361,2.035617561629102
HuP-T3,4259181,1.3598984416642497
L3.3,54619267,4.657132666629917
MOLM-13,9840324,5.573129737038137
SNU-886,168312962,-3.108064596774625
NCI-H2452,docetaxel-tanespimycin (2-1 mol-mol),0.4791468482228301
KHM-1B,11152667,-2.085888250346346
SNU-626,31703,-0.811913917680978
RCC10RGB,7251185,2.312506998895348
EB1,67156097,-2.9939393054888748
MKN1,3038522,4.143517526823981
LCLC-97TM1,23725625,2.954034200595367
T98G,52912189,2.8531945169265027
PE/CA-PJ49,176870,2.630140398370365
RKO,24797083,0.8657042008278414
SEM,selumetinib-decitabine (4-1 mol-mol),-1.996234931247303
RKN,selumetinib-piperlongumine (8-1 mol-mol),3.808395082066658
F-36P,53232,0.800098170999657
L3.3,11178236,-1.5128667899079982
KHM-1B,6917907,-6.365498814306295
Ishikawa (Heraklio) 02 ER-,doxorubicin-navitoclax (2-1 mol-mol),-1.2154033059078049
SK-LMS-1,72734382,5.544812622658924
HARA [Human squamous cell lung carcinoma],45100309,5.833200435543825
ALL-SIL,24951314,0.1921049921473096
KMS-21-BM,3099980,0.6719115659308136
NCI-H1568,tretinoin-navitoclax (4-1 mol-mol),4.46686431300974
SNU-1079,2828334,4.988540629590607
K-562,16725315,4.409558206085648
ML-1 [Human thyroid carcinoma],9825149,3.1128843906344117
SU-DHL-1,9915743,1.482861419138649
TTC-709,selumetinib-MK-2206 (8-1 mol-mol),2.732174462466561
SW1271,4917,2.7806051488376293
Granta-519,vorinostat-carboplatin (1-1 mol-mol),1.7690430171361815
KMS-21-BM,6918878,-0.4417684198636811
TTC-709,JQ-1-MK-0752 (1-1 mol-mol),1.7642984627769602
KPL-1,5328940,2.2539272050201298
COR-L95,3062316,3.2830028596837217
MDST8,10074640,3.541716125988611
U-BLC1,45279963,3.4594747913429833
IGROV-1,44185566,2.2104732991243248
SNU-626,46943432,4.418446938895329
SU-DHL-6,57519531,1.2127003418717253
JHUEM-1,9935249,3.046679227327208
KP-4,selumetinib-vorinostat (8-1 mol-mol),2.6285521395824527
SK-CO-1,241158,4.831010946536929
SW948,46843906,2.6248020109336023
RERF-LC-MS,6610216,4.063402980130349
RERF-LC-MS,46843906,4.323049782377064
NCI-H1568,selumetinib-UNC0638 (4-1 mol-mol),2.7760221243911016
LCLC-97TM1,piperlongumine-MST-312 (1-1 mol-mol),1.3069230942291734
JHUEM-2,6918878,2.764621675413101
KP-3,17759555,4.298399189301517
RCC10RGB,selumetinib-vorinostat (8-1 mol-mol),3.237241333738756
Mino,6852167,1.220926429953778
HCC15,24180719,4.303391195547382
RKO,selumetinib-navitoclax (8-1 mol-mol),2.1856811512057885
ST486,navitoclax-sorafenib (1-1 mol-mol),0.9462669053259696
SEM,9926054,1.3281424685311425
ES-2,1641662,3.780407503070853
Mino,4096211,1.2252655187490238
KP-3,11455910,1.1515388808863225
Mino,BRD-A02303741-navitoclax (2-1 mol-mol),-2.5532061684657283
MOLP-8,6505803,0.6382990348001342
SK-MEL-2,24964624,3.210375357246789
Daudi,5278396,2.816567405543214
RKO,66577038,3.1469091340303637
MOLP-8,54143018,0.5860183196437395
JHUEM-7,11175137,1.5119865026515042
SNU-C2A,25126798,3.87567316495145
SaOS-2,24856436,0.4386880001360848
BICR 31,9866186,1.254760755448308
SNU-886,SNX-2112-bortezomib (250-1 mol-mol),-2.93847148542514
RCC10RGB,11257553,3.6405008146732434
SW48,JQ-1-navitoclax (2-1 mol-mol),-0.920123495664676
RKO,57330099,4.8516025997257275
P31/FUJ,54649500,4.423311343715707
Ishikawa (Heraklio) 02 ER-,6918328,0.9359121656795372
SUP-T11,36314,-7.892385117900424
KHM-1B,613753,3.0054296749373095
SW948,10302451,4.082058519290096
L3.3,107985,-3.199791523822717
WM115,2746,3.2273654457979957
KLE,12003241,-1.9975693903430911
KU-19-19,654092,0.6096416345891582
PaTu 8988t,10296883,3.999790485906541
BICR 22,54143018,1.1733542553992964
YD-15,25183872,-1.0751783845070153
DLD-1,637858,1.8547650248451624
PE/CA-PJ34 (clone C12),52912189,3.061596603136192
JHUEM-2,11178236,-4.23214352620966
MDST8,71466445,2.0942740576673593
PaTu 8902,36462,3.471634301287976
SNU-626,2729026,3.046244986768741
YD-15,3025986,-1.398619011678152
SNU-1079,8515,2.981643349971088
NCI-H1395,969516,2.7506221381545823
LS411N,44632017,5.0127460000138
COR-L95,9911830,2.1813921058815553
KP-3,15547703,3.502054897992746
SNU-1079,24753719,1.4594897792984398
KLE,15953870,2.3268887568767767
ALL-SIL,9911830,-2.857836139869332
WM115,3465537,1.2344570371137795
NCI-H2452,navitoclax-birinapant (1-1 mol-mol),2.13598555906201
SNU-1079,3825829,2.842759975194076
SU-DHL-1,54454,0.0220955119836291
HARA [Human squamous cell lung carcinoma],9927531,4.552330692797245
MOLP-8,24821094,3.654707766369703
HuH-6,54143018,0.5994070856497759
MOLP-8,6852167,0.8455390099609336
HT-1376,JQ-1-UNC0638 (2-1 mol-mol),4.120192714503884
JHUEM-2,675434,4.2663922079585
Panc 02.03,11222830,1.865607722872823
RERF-LC-Ad1,selumetinib-tretinoin (2-1 mol-mol),4.153167483660677
MDST8,2746,2.514425635914287
Granta-519,1716436,2.7310795448836904
PE/CA-PJ34 (clone C12),445091,4.329153580227635
Daudi,selumetinib-tretinoin (2-1 mol-mol),4.819941209079035
RERF-LC-MS,11625818,4.251014876931036
P31/FUJ,4378219,1.2412027933720209
HCC15,3062316,2.729530034687651
LS180,9903786,2.2166672873522857
EB1,451668,3.669311964237795
DLD-1,54613361,1.601263134511963
DLD-1,46191454,3.388749186280266
PaTu 8902,16065773,3.37985868216597
LS411N,9911830,3.118029057589745
LCLC-97TM1,6438330,3.0238187505324885
KU-19-19,25062766,2.9321374053838807
ST486,40482356,6.907176194464358
JHUEM-7,216468,-0.983442120709978
JHUEM-7,3825829,4.01020461765645
HCC1500,10074640,2.968051262406446
P31/FUJ,6505803,0.2535639265329721
PE/CA-PJ49,107985,-3.897981701971708
EB1,JQ-1-MK-0752 (1-1 mol-mol),3.126454253173981
SEM,SNX-2112-bortezomib (250-1 mol-mol),-3.272404633264421
NCI-H2452,387447,-3.2957708741809975
Hep-G2,3081361,2.5045314139497723
MOLM-13,11228183,-2.7074565632423546
SU-DHL-6,5566,0.7122829809928822
COR-L95,24785538,1.0654849938174582
RERF-LC-MS,ISOX-bortezomib (250-1 mol-mol),0.403542566479009
WM115,4578,4.221194502857287
SK-LMS-1,46215462,2.820393358220259
JHUEM-7,6918638,0.5834631364682521
F-36P,676352,0.8457962157972794
LMSU,46191454,1.9443488630816397
Ishikawa (Heraklio) 02 ER-,4788,5.988608898736073
COR-L105,4578,4.590840204947243
K-562,374536,0.780579010414565
BT 248,25183872,-1.6442953183353304
COR-L105,60700,0.1425021915553204
K-562,46926350,-4.162486097405079
SW1573,4705,3.887877577681455
LCLC-97TM1,637858,1.4157632634757724
Mino,3465537,1.332066458036503
SK-LMS-1,9825149,2.845623074931724
WM115,46926350,-4.284670953339827
HuH-6,11364421,-1.4165801810905576
KLE,4788,5.329574441575628
F-36P,10231331,0.4784045802967716
SNU-626,24785538,2.6967755441202086
SNU-626,72193861,3.2985367518716644
RERF-LC-MS,15547703,2.8085711207925015
Mino,10427712,3.590995303616826
SNU-886,12003241,-3.694795257520175
NCI-H1568,11497983,3.872384435522252
MDST8,4788,5.889593740712007
MKN1,135984461,5.649993285948901
IGROV-1,8515,2.1861539315976053
KP-3,49793307,-2.5564965350010467
RKN,24772860,-0.333409077824626
SK-MEL-2,selumetinib-PLX-4032 (8-1 mol-mol),2.2995519126398336
F-36P,89183176,3.776226370950465
PaTu 8988t,322968,4.849886698333752
KLE,selumetinib-PLX-4032 (8-1 mol-mol),4.210157254606348
RERF-LC-MS,16720766,0.5604118097796991
EB1,71466445,3.091644056319097
F-36P,44589607,1.6796405733460815
NCI-H1395,3062316,3.8693774304021433
SW948,6505803,-1.4287073835677784
BICR 22,462382,1.3729135623232431
JHUEM-1,16013152,3.7061091021254624
PE/CA-PJ34 (clone C12),676352,1.767200093931116
LS180,322968,4.435040308321651
SaOS-2,11152667,-0.1732170298835725
JHUEM-7,selumetinib-BRD-A02303741 (4-1 mol-mol),4.810620689703725
ML-1 [Human thyroid carcinoma],49846579,3.632639122540709
NCI-H1395,12003241,1.698262392733821
HCC1500,227681,1.895909952215359
KHM-1B,1750826,-3.7148108552334977
Hep-G2,753704,5.097151878686146
SU-DHL-1,57330099,3.736750567984075
PaTu 8902,crizotinib-PLX-4032 (2-1 mol-mol),2.4716529657314252
COR-L95,11977753,-0.4790698517891548
HARA [Human squamous cell lung carcinoma],6450551,1.1333007709837388
L3.3,navitoclax-MST-312 (1-1 mol-mol),2.4950782279808656
SW1573,11427553,4.057369297610019
LS411N,selumetinib-decitabine (4-1 mol-mol),2.113542613262742
YD-15,15983966,-4.0997970477277015
LS180,12001922,1.7594619366424422
SaOS-2,12001922,2.1147367002170494
SU-DHL-1,3543504,3.7817510655567625
BICR 31,24901704,3.914024172074534
MOLM-13,5287620,-2.884996470216499
Mino,24901704,1.8112550019620224
BICR 31,25102847,2.842271629600241
ST486,135398516,2.709624258983276
COR-L95,10113978,3.7452762075447104
LS180,selumetinib-GDC-0941 (4-1 mol-mol),-1.227348326224306
MOLP-8,vorinostat-navitoclax (4-1 mol-mol),0.8660372331148116
ML-1 [Human thyroid carcinoma],1750826,-1.3031865689994189
MOLP-8,decitabine-carboplatin (1-1 mol-mol),0.1349258094123646
SNU-1079,448949,-0.7999826930692893
COR-L105,168312962,3.0410731046381065
T98G,ISOX-bortezomib (250-1 mol-mol),0.3373198130988178
LCLC-97TM1,10322450,3.85878970197106
JHUEM-1,71680916,4.238246093006963
HCC1500,25161177,4.357780519617112
EB1,10410894,1.7531270563454704
HuH-6,135659046,4.749269186947959
SUP-T11,11719255,2.179694488682667
SK-CO-1,9967941,1.837567054996146
HT-1376,44185566,2.6983022313069256
F-36P,doxorubicin-navitoclax (2-1 mol-mol),-0.9945665155657868
COR-L95,5311,1.4789786210040632
ML-1 [Human thyroid carcinoma],2733526,3.914729894927785
ST486,107985,-3.099452908911552
LCLC-97TM1,72193861,0.688846554638978
SW48,4096211,0.1208358665406906
LS411N,135875424,4.300305751936665
SK-CO-1,42642645,0.466262192383588
IGROV-1,1566236,2.765820903157784
HCC15,10410894,4.508285516741203
U-BLC1,135421197,1.4306901409483936
ES-2,piperlongumine-MST-312 (1-1 mol-mol),1.551924376571452
IGROV-1,6450551,2.579641476451469
YD-15,107985,-3.0618096206093934
JHUEM-1,89928392,1.5169025601833217
IGROV-1,452548,0.0422661560146271
COR-L95,216345,3.729430833860697
Daudi,navitoclax-gemcitabine (1-1 mol-mol),-4.251556973738435
LS180,2945648,3.723684880750219
SK-MEL-2,24856436,0.8500320632837244
RKO,9936388,0.8183869926163714
HuP-T3,10231331,2.6811135289001236
PaTu 8902,44493528,4.360494725244959
Panc 02.03,45279963,4.323488067826322
MDST8,BRD-K27188169-navitoclax (2-1 mol-mol),-1.2819787508049554
BFTC-909,44507138,2.8704731321552734
ALL-SIL,49766530,-2.347000417785464
SU-DHL-1,6918289,4.3249644726818275
NCI-H2452,54626689,4.879011133008654
HCC1500,4917,1.9149154714535184
LCLC-97TM1,15547703,3.011827246330581
SEM,24753719,1.9867479465315392
MOLM-13,71304818,2.1544936448447873
PE/CA-PJ49,24753719,4.080575528970359
SU-DHL-1,4917,2.4666047815714154
PK-1,2746,4.301846105037093
NCI-H2452,56946209,-3.558178980562316
U-BLC1,selumetinib-PLX-4032 (8-1 mol-mol),-0.5947223355616104
RKN,1750826,-6.055252220387113
RKO,25105715,3.388469834531371
RCC10RGB,46191454,4.887818963424851
LS411N,3815108,3.549037613932863
Mino,5284373,1.2001528174039091
PE/CA-PJ34 (clone C12),26596,-1.1037163261022582
Ishikawa (Heraklio) 02 ER-,44202524,1.731534383129628
HEL,56946209,-4.040477533762366
BICR 22,122327,5.571410232221064
PE/CA-PJ49,49766530,3.753784618730391
Hep-G2,15547703,3.001617990319869
TTC-709,56649450,2.6399332496219285
ST486,11977753,-2.4857301695139653
BFTC-909,969516,2.723005004244225
KU-19-19,selumetinib-JQ-1 (4-1 mol-mol),-0.4288095691894706
SK-LMS-1,168313200,3.682470833996821
RKO,24856436,0.2423564692967549
PE/CA-PJ49,57330099,4.42307803385474
JHUEM-2,57519531,0.620117232957552
BT 440,5494449,2.229454421121353
SU-DHL-6,5746,-1.2123840023346684
F-36P,BRD-A02303741-navitoclax (2-1 mol-mol),0.9323482933380044
KP-4,216468,0.9574586264454517
SU-DHL-1,135411,-2.10627226052293
SK-OV-3,1716436,3.636442167288748
DLD-1,3038522,4.03443848352327
KP-3,387447,-4.22311088168715
IGROV-1,44543605,3.88270235241076
K-562,6914657,-3.91828110768511
HARA [Human squamous cell lung carcinoma],9866186,-0.525705997781229
KP-3,11222830,1.836638607658496
NCI-H2452,25262965,-3.6663688304344695
MKN1,9936388,1.1004986908741188
HARA [Human squamous cell lung carcinoma],navitoclax-MST-312 (1-1 mol-mol),0.8639589641874816
MOLM-13,11404337,-1.791363376051536
RKO,36462,3.4370564574699185
KHM-1B,67156097,-2.0770884732643493
IGROV-1,446155,3.750396425244744
COR-L95,72734382,4.117898969233179
SNU-1079,54613361,-0.8233510163738982
K-562,11396600,3.7562155275673415
U-BLC1,9907093,3.7694183097886698
LCLC-97TM1,4705,3.0319662392534057
Daudi,2130404,3.4806417402967993
L3.3,5328940,2.2327140114261597
UACC-812,vorinostat-navitoclax (4-1 mol-mol),1.8866466886365112
SNU-1272,24779724,4.452113053156204
MDST8,327653,3.1544218347658375
KMS-21-BM,568763,-0.4606557706637524
SNU-C2A,selumetinib-MK-2206 (8-1 mol-mol),0.1362658446899266
SK-CO-1,11656518,0.968890652064466
K-562,5311281,3.9022564066083967
Mino,439501,-5.730054140979018
KHM-1B,3854666,1.0178761505547558
KMS-21-BM,salermide-PLX-4032 (12-1 mol-mol),4.639253842956264
SNU-626,16722836,1.833423163596504
JHUEM-1,44607530,1.2775699747989442
ALL-SIL,carboplatin-etoposide (40-17 mol-mol),-0.158708138675103
MOLP-8,selumetinib-PLX-4032 (8-1 mol-mol),1.1163083218110827
PE/CA-PJ34 (clone C12),49766530,5.059286998332617
RKO,445091,4.342692134156949
MOLM-13,9935249,2.7939558009041283
YD-15,9911463,3.7436865426032786
SUP-T11,56649450,3.5680360925198435
SK-CO-1,selumetinib-navitoclax (8-1 mol-mol),-1.2361376975305869
RCC10RGB,selumetinib-JQ-1 (4-1 mol-mol),3.398592660488386
SU-DHL-1,124202324,2.3695119203399906
COR-L105,9884685,2.6443959528770167
BICR 31,10113978,4.990782635230478
HuH-6,44185566,1.1806836877742046
HEL,crizotinib-PLX-4032 (2-1 mol-mol),1.5778515450818191
MOLP-8,6610355,3.5622833697709178
LCLC-97TM1,2749,2.4194398786749067
Daudi,5311,0.1794409230409946
KLE,11485656,3.08308998793154
KPL-1,9929138,5.414616490149542
HuP-T3,2113511,6.036487802507154
F-36P,387447,-5.355947455324157
P31/FUJ,452548,-2.598049093653093
SaOS-2,16065773,3.691866894593861
T98G,SNX-2112-bortezomib (250-1 mol-mol),-0.4369766847794586
JHUEM-1,135659046,3.513270809180088
SK-LMS-1,285033,-0.1351823927020098
Ishikawa (Heraklio) 02 ER-,159324,3.630524948383921
RERF-LC-MS,65064,5.274588293813746
HuP-T3,89928392,1.747135585577409
P31/FUJ,56963564,-0.6738396792941169
KP-3,24785538,0.9837076258398504
LS180,5746,0.8609008276830991
KHM-1B,25062766,1.5737082616521652
BICR 22,11707110,-2.2145574606059912
PK-1,5291,3.8679744170187176
Mino,11234052,1.8502095178714597
BT 440,2871966,1.4747477278008914
Daudi,9952709,2.2307089742515713
SW48,3543504,4.30466926238752
JHUEM-1,327653,3.274496077374958
SW48,11427553,0.5193301330840923
PE/CA-PJ34 (clone C12),4578,4.231677990703362
LMSU,2871966,3.076557585193087
WM115,56649450,1.7070260970326938
IGROV-1,89928392,1.4824233552493276
LMSU,3136844,4.51908400506557
SNU-1272,salermide-PLX-4032 (12-1 mol-mol),6.075030129905205
KMS-21-BM,10322450,3.0637099399177936
SW1271,72376,-1.909620961604672
SaOS-2,5278396,3.8495121754699686
K-562,42642645,-0.9952706094252596
Panc 02.03,446155,2.721578883226381
RERF-LC-MS,44462760,4.251912039026111
SEM,44607530,0.9041857053195362
PK-1,49793307,-2.315935462617515
BFTC-909,3503,3.411270469206907
MOLM-13,104842,-5.846939346357726
T98G,9926054,1.93846990860498
HuH-6,53495165,1.9983135618266576
EB1,5328940,-0.0807538452331429
K-562,11656518,1.1460195934444493
HCC15,76446078,6.244123044550032
COR-L95,6438330,1.555078701387849
COR-L95,9926054,2.0133423062539726
BICR 31,462382,1.217928478873545
UACC-812,46199207,3.606176782545976
JHUEM-7,135984461,4.346774383555173
SW1271,16725315,3.214819296898604
SNU-626,5311281,2.9526487212659394
BICR 22,3385,1.594485383262216
SUP-T11,11964036,0.0977761223949774
HEL,11234052,1.6482548628813194
SW1271,49793307,-1.6735159246770874
KP-3,46943432,0.0179698171752152
HEL,3025944,4.107185950107739
T98G,11507802,5.234414968498332
SK-CO-1,1641662,2.678789461404506
RKN,71680916,6.446363106372924
KPL-1,123631,1.6581500982193478
NCI-H1395,24951314,2.24574697242026
IA-LM,25183872,-0.4633226224219731
IGROV-1,6918837,-2.9804518885508635
HEL,252682,5.808471376099282
PE/CA-PJ34 (clone C12),5278396,3.888828333623774
U-BLC1,73707398,0.5348084909882532
SNU-1079,24180125,2.198682285744919
SU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),0.2178646036916351
MOLM-13,374536,0.9670025892080272
PE/CA-PJ34 (clone C12),piperlongumine-MST-312 (1-1 mol-mol),1.2365607449836908
NCI-H2452,168313047,2.588327036215806
SNU-1272,3825829,5.135605064206703
KLE,11152667,-1.6090314572433455
Mino,71466578,1.5916084235024313
Granta-519,4917,3.021022166883331
ML-1 [Human thyroid carcinoma],JQ-1-UNC0638 (2-1 mol-mol),2.6444298637243167
JHUEM-7,56946209,-4.688751747414188
DLD-1,3025944,5.509632820568493
MOLM-13,selumetinib-GDC-0941 (4-1 mol-mol),-1.09695682780189
PE/CA-PJ49,9933475,1.7173266599177646
L3.3,5282054,4.901570069575592
BICR 31,262093,3.397835562493394
LS411N,12003241,-0.0946051023392001
HCC1500,5282054,2.2651950194203323
HCC15,322968,4.854333863324092
HT-1376,5566,3.445341367443684
U-BLC1,5278396,3.5710717379135186
RCC10RGB,9936388,2.3235560801623465
F-36P,71729975,0.6879338879700845
NCI-H2452,46199207,3.026577128215497
Granta-519,9444,3.3091580955395146
IGROV-1,53392493,2.352084848618059
COR-L95,151289,3.0372683791028705
PE/CA-PJ34 (clone C12),10113978,3.852320224098887
JHUEM-7,25150857,3.01223903868364
NCI-H1568,216468,4.700562763036761
WM115,25195348,4.859937697346287
SaOS-2,2858523,3.094677154220442
ST486,tanespimycin-gemcitabine (1-1 mol-mol),-3.4445179365013407
PK-1,135440466,2.6617362783984877
SW1271,421610,4.471416490511734
BICR 31,637858,2.611871003184785
SW948,11175137,1.686043515242534
MDST8,11625818,2.7981930885976705
Panc 02.03,11609586,3.3931905350155915
Granta-519,selumetinib-UNC0638 (4-1 mol-mol),2.20466638812085
SNU-1272,2729026,3.2131573278118015
PaTu 8902,9825149,2.767587999144615
F-36P,6450551,1.828299759657417
BT 440,46174525,5.413129699946668
HCC1500,6918837,-4.362896894201754
JHUEM-7,5978,-3.12331603933377
BFTC-909,navitoclax-PLX-4032 (1-1 mol-mol),3.5024450661652153
SaOS-2,5282054,3.07206551989859
SK-OV-3,navitoclax-birinapant (1-1 mol-mol),-5.0727238052406705
JHUEM-1,445091,4.0758921754397
SK-CO-1,72376,-3.2194985981528808
Panc 02.03,carboplatin-UNC0638 (2-1 mol-mol),5.105759320304772
WM115,10302451,3.6553280898048905
JHUEM-7,17755052,0.3051122815290938
Granta-519,613000,2.2510291651452143
SaOS-2,11222830,1.0878926350484104
PE/CA-PJ49,73707398,0.9781921467778038
KPL-1,selumetinib-JQ-1 (4-1 mol-mol),4.46971279886646
KLE,124202324,2.798176787230371
Ishikawa (Heraklio) 02 ER-,216345,4.678844005480184
T98G,9908783,6.020804052787346
IA-LM,54678924,1.6007306497128662
KP-4,2708,3.142602714561915
HT-1376,322968,4.608025516492299
HEL,119607,4.922739390517752
SNU-C2A,5746,2.2848265402697066
PE/CA-PJ49,24180125,3.249476496714235
KMS-21-BM,3476986,5.487797690397508
HCC1500,6918328,-0.2689126411143879
YD-15,4917,3.043940074583325
PK-1,675434,4.3132375193175765
TTC-709,262093,1.587813672786524
KMS-21-BM,4259181,-1.425243005712458
HuP-T3,crizotinib-PLX-4032 (2-1 mol-mol),2.5650363225974315
LS180,3062316,2.327440880417239
LCLC-97TM1,11317348,1.7152030009838672
SaOS-2,6918736,-1.8799034133096575
PE/CA-PJ34 (clone C12),11964036,1.19521304461458
PE/CA-PJ49,53392493,2.005132316425773
SUP-T11,11612883,2.445903529488693
SaOS-2,12003241,-0.699813042979073
T98G,107985,-3.0074244908782792
YD-15,65628,3.895219828692723
LS180,10113978,3.7861477365363383
SNU-886,11317348,1.5463436352740425
PK-1,17755052,3.6199706745445983
SW48,54618359,4.4319552735559
PaTu 8902,ISOX-bortezomib (250-1 mol-mol),1.241492124971151
NCI-H1395,12001922,2.192187193874862
HEL,387447,-4.961191552031455
KLE,19582717,2.474003523492041
JHUEM-1,56973724,4.53063892027977
RKN,6610216,4.220445612403551
P31/FUJ,656346,-0.3707458386499477
T98G,9866186,0.6243188532944074
Granta-519,selumetinib-JQ-1 (4-1 mol-mol),0.6993639444129659
KP-3,5287620,-2.370573295409063
PaTu 8902,navitoclax-gemcitabine (1-1 mol-mol),4.2969329187245
MOLP-8,9952709,2.638563783306324
SaOS-2,11455910,0.8777485884783317
Mino,17755052,0.7577840200703942
K-562,10184653,1.719293175029272
Granta-519,4259181,-0.7648884727300508
BICR 22,4521392,3.4098909359208625
KP-3,9967941,4.115981052336778
F-36P,439501,-3.1981830153040223
HCC15,2874250,4.519421691404506
SaOS-2,6918638,1.2055090485954645
EB1,135659046,2.7495616978120543
MOLM-13,9868037,0.9756233042827712
KMS-21-BM,16720766,-1.1720303743156792
HCC15,navitoclax-sorafenib (1-1 mol-mol),0.4047669070332462
MOLP-8,16659841,2.203571056365997
JHUEM-1,11507802,1.1591697762351658
EB1,alisertib-navitoclax (2-1 mol-mol),-0.9682002738121244
SNU-626,5329102,2.214840660009075
KPL-1,135398516,4.801907534209755
SNU-626,vorinostat-navitoclax (4-1 mol-mol),1.026977686916281
LS411N,656346,4.206497662771029
KMS-21-BM,72193870,2.756891957264465
RKO,5460769,5.660789679983863
BICR 31,6610355,4.797647038745592
SUP-T11,51037431,2.820928990185522
HuH-6,15983966,-0.6783560152530209
ML-1 [Human thyroid carcinoma],17755052,4.154119256233629
RKO,11964036,1.8153618806471208
SNU-1272,3062316,3.6318670446165817
NCI-H2452,7326481,3.286880233884326
NCI-H1395,9907093,4.0773524584978285
PK-1,3062316,1.4530647420678928
HuH-6,24964624,1.221239710337194
RCC10RGB,44491742,5.1484686760969645
HT-1376,11222830,2.1653574749080033
IGROV-1,50905018,6.092412272559071
BICR 31,9884685,0.303781088019613
Panc 02.03,3081361,3.1546648300373357
KMS-21-BM,123631,1.940987674728978
BFTC-909,25126798,3.8219929141120166
MOLM-13,66890843,1.9738756301734208
SUP-T11,451668,1.3938581388304887
HCC1500,24180125,3.164669305988548
PE/CA-PJ34 (clone C12),568763,0.9098247878075588
SK-HEP-1,53392493,3.66906541895257
KP-3,9903786,3.3194843074548843
SEM,6252,-2.7487715463047926
RERF-LC-MS,2945648,2.437954541344266
KLE,73707386,3.2783445744557307
SEM,3634881,2.315957933723583
PE/CA-PJ34 (clone C12),selumetinib-vorinostat (8-1 mol-mol),2.6799974676882883
KLE,9549297,3.198164194460754
HEL,25150857,2.447529551071105
YD-15,6610355,3.9653937685920377
BICR 22,65064,5.333446499438452
SNU-626,171352865,4.322528070997792
PaTu 8988t,carboplatin-UNC0638 (2-1 mol-mol),3.665220724432894
SNU-C2A,119182,0.0685345194350557
P31/FUJ,123631,2.0303759233077017
HCC1500,tanespimycin-gemcitabine (1-1 mol-mol),2.493780816473477
KP-3,11964036,1.3831682790065782
T98G,selumetinib-piperlongumine (8-1 mol-mol),5.510198416226096
IGROV-1,11175137,1.8411496230681277
KU-19-19,44241473,5.030815161961597
SEM,219104,1.121871934400501
SW48,72193861,-0.4534629909928462
NCI-H2452,selumetinib-vorinostat (8-1 mol-mol),3.054936641040398
MOLM-13,5311281,1.6146001182421037
KMS-21-BM,5335621,3.803450956376304
HCC1500,9915743,1.9340540182592263
SW1271,tanespimycin-bortezomib (250-1 mol-mol),1.119789259321392
SW1271,crizotinib-PLX-4032 (2-1 mol-mol),1.7792866548085249
LS180,4096211,2.1975503712063604
LMSU,JQ-1-navitoclax (2-1 mol-mol),3.886973336392811
ES-2,72376,-1.3769425144110463
NCI-H2452,66577038,3.355972963473848
TTC-709,25126798,3.698570674158291
WM115,JQ-1-UNC0638 (2-1 mol-mol),1.9415560976310364
HCC15,11175137,3.485795641541794
K-562,navitoclax-pluripotin (1-1 mol-mol),-4.5842278555306395
HuP-T3,2945648,2.5475895191101197
DLD-1,5328940,2.8599294289802346
Panc 02.03,6450551,4.166761052507323
K-562,2708,5.362475494708341
SUP-T11,2708,2.153197900582886
RKN,219104,3.4277527780329096
EB1,11640390,2.87834292997415
F-36P,4521392,3.975306023502133
RKO,16722836,2.0172870973895085
UACC-812,439501,-1.4243957864326813
Ishikawa (Heraklio) 02 ER-,navitoclax-piperlongumine (1-1 mol-mol),3.301350382542222
ST486,135398744,6.173673764709001
Mino,11317348,0.8775503511446432
ST486,46907787,-1.2194061813967136
MOLP-8,11222830,0.9410853080031706
TTC-709,24180125,2.733519633655364
WM115,1239801,4.563824386797348
Hep-G2,51039095,2.027774881018878
Daudi,11717001,4.763561920962392
HARA [Human squamous cell lung carcinoma],24785538,-0.0579889747329333
COR-L95,16736978,-0.5228132160938015
L3.3,675434,4.909949648038981
NCI-H1395,5282054,4.370285426965396
Ishikawa (Heraklio) 02 ER-,46199207,3.81756219854224
IGROV-1,11213558,0.52356811652227
MDST8,44202524,1.4033794041893788
SU-DHL-6,10113978,2.1190356124222194
SK-HEP-1,4917,3.764636353681369
HCC15,452548,-2.1001752731425727
EB1,6852167,1.278793864374466
KPL-1,44185566,2.631794854802452
SW48,46191454,-0.9829938197758128
T98G,67156097,6.154839204171127
SEM,52912189,-3.2555480793236713
Hep-G2,136227924,2.2133800896817304
MOLM-13,4521392,4.5803067712490115
HuH-6,10127622,5.538561515374968
KPL-1,46199207,2.793115522774936
JHUEM-1,19582717,3.3751667146402813
HuP-T3,25062766,2.4453672011464023
COR-L105,107985,-4.244896937866387
SU-DHL-1,89928392,0.4021872915525221
T98G,navitoclax-piperlongumine (1-1 mol-mol),3.288412389636167
BICR 22,55508,4.44611517999926
ML-1 [Human thyroid carcinoma],135659046,3.731165476589243
L3.3,16720766,-1.973453330210062
MOLM-13,675434,3.665195693175508
SK-HEP-1,6610216,4.694225049802747
IGROV-1,navitoclax-piperlongumine (1-1 mol-mol),2.320051681006032
SU-DHL-1,49766530,-4.824875359994143
SEM,9908783,4.605938150893541
HEL,12001922,1.658840092002429
HCC15,46398810,2.6134237903958093
NCI-H1568,3136844,4.658915015928919
Ishikawa (Heraklio) 02 ER-,5278396,4.139600704573638
NCI-H2452,24821094,3.1123469452418537
LS180,3543504,4.376890558116308
ALL-SIL,9927531,4.600523700119875
BICR 31,11167602,4.451308398956488
SW1271,16219061,4.25548468975063
SK-MEL-2,6918638,1.2677051834629418
SNU-1079,navitoclax-birinapant (1-1 mol-mol),1.0214062767782386
PaTu 8988t,448949,1.751499890417066
WM115,2858523,2.9957579985597467
RCC10RGB,11364421,1.2845393833467151
SK-CO-1,984333,1.8899562330111348
COR-L105,72376,-1.002534224494363
NCI-H1568,168312962,2.190321562510239
L3.3,23725625,5.56548732943537
NCI-H1395,5978,1.0563157186154253
EB1,2842253,3.5583326608907866
SaOS-2,2746,3.4161371679978436
Hep-G2,4259181,-1.079856384384839
U-BLC1,65628,6.23836675001552
PE/CA-PJ49,11404337,0.0513303948007028
Panc 02.03,51039095,3.661030142872421
SK-MEL-2,46199207,3.970946890203047
SK-CO-1,65628,3.554197618459022
COR-L105,16725315,5.297524124299076
F-36P,11213558,0.4261945217851935
Hep-G2,selumetinib-MK-2206 (8-1 mol-mol),-0.3910940132297484
LCLC-97TM1,JQ-1-carboplatin (1-1 mol-mol),1.024195349701644
RCC10RGB,46224516,2.231293839634299
SEM,135999136,1.8493753189775255
RKN,9956119,4.4432647969313
RKN,16065773,2.958619348149216
NCI-H1395,25154868,5.12981371240632
JHUEM-7,25062766,1.192560693708174
NCI-H1395,11612883,3.2235820919891256
WM115,17755052,0.4002517605741686
KMS-21-BM,sirolimus-bortezomib (250-1 mol-mol),-4.769329635088173
WM115,168313200,2.1363369230808593
KPL-1,44543605,3.788385509320272
BICR 31,ISOX-bortezomib (250-1 mol-mol),1.0654896454992784
WM115,navitoclax-MST-312 (1-1 mol-mol),0.1056862983661574
SEM,5280436,2.6493290705242636
LCLC-97TM1,9903786,1.8016114643921617
Mino,2945648,2.259258145223806
SaOS-2,49867926,4.146129188416838
RKO,25126798,4.002843113400742
PE/CA-PJ34 (clone C12),25154868,5.263511922776674
ALL-SIL,219104,1.1543769867483644
Granta-519,tretinoin-navitoclax (4-1 mol-mol),0.0394078475475117
JHUEM-7,25102847,1.6787689105881445
SK-OV-3,3062316,0.5292744016150154
LMSU,46199207,3.57619912371696
SK-OV-3,11178236,-2.424602318267421
LS180,9887053,3.1718141126704618
Ishikawa (Heraklio) 02 ER-,46191454,2.4738901058464204
BFTC-909,25183872,0.7872065650622051
EB1,89928392,-0.1504481018713839
NCI-H1568,2945648,2.136721092573253
DLD-1,3025986,2.1865375673538923
L3.3,3025944,4.713949011742796
RKO,1716436,3.795795915163565
SW948,65064,5.291153994733523
Mino,25183872,-2.1035796462294147
T98G,44137675,3.425827674042774
SUP-T11,3825829,3.0652515569380383
PaTu 8988t,salermide-PLX-4032 (12-1 mol-mol),5.538923116384137
SK-CO-1,16115403,-4.417233339728943
NCI-H1395,9911830,2.6279117929683142
SaOS-2,400769,-0.6660591873157414
SW1271,2733526,3.2893803459487594
BICR 31,4521392,4.267019749412992
SNU-626,76446078,4.013389722449539
SNU-1079,17755052,0.2638791341098958
P31/FUJ,25154868,4.728907139536709
F-36P,3543504,3.2168651709779565
HEL,676352,2.4086189638079643
EB1,1641662,2.2092464324988295
SUP-T11,10074640,2.625545574516373
BT 440,969516,3.070781887522255
EB1,26596,-3.5599614403908264
PaTu 8902,BRD-K27188169,4.434214541500356
HuH-6,675434,3.404210845727937
HuH-6,11609586,2.059242562823038
SNU-1079,44589607,1.1200712029676403
U-BLC1,12001922,1.5273545678847515
SK-LMS-1,6610216,4.4083288999249
KU-19-19,44607531,3.044914521934579
RKO,selumetinib-tretinoin (2-1 mol-mol),2.520120690265609
SK-CO-1,72193861,-0.1340038294528125
KHM-1B,168312962,-1.6342091010648556
HCC15,selumetinib-UNC0638 (4-1 mol-mol),3.167456472626372
TTC-709,67156097,-1.454627155308474
SEM,5311281,0.7085042450698669
WM115,135423438,3.926483426744841
MKN1,11167602,3.133021795040565
RERF-LC-MS,135875424,2.839581382146162
PaTu 8988t,46926350,-4.145321949318386
SNU-886,135398516,0.5445365742758462
Daudi,23582824,-0.638376916275564
NCI-H1395,11625818,4.225783797548463
ST486,11396600,2.643350967918509
Panc 02.03,168313200,4.226618217059218
SNU-C2A,5281672,4.254717485697718
U-BLC1,5280436,3.339744446622362
KHM-1B,676352,1.5366481423958254
NCI-H1568,11175137,2.3278621292073067
COR-L105,11152667,-0.3968124554752262
IA-LM,5281672,4.428935042775787
HT-1376,15953870,5.904213661909733
PE/CA-PJ49,2746,2.1917494925150653
JHUEM-7,24901704,3.3697536869757547
IGROV-1,3062316,-2.2361832227909075
SU-DHL-1,5281672,4.30860315799997
U-BLC1,56973724,1.882694655173753
F-36P,2746,1.451851668810028
HuP-T3,tretinoin-carboplatin (2-1 mol-mol),5.021357813866161
BICR 31,11625818,3.9395546041344858
PE/CA-PJ49,9903786,3.1609136015972847
JHUEM-2,17759555,3.3633080658935666
ML-1 [Human thyroid carcinoma],5311281,2.103239185945236
NCI-H1568,445643,3.6093957886383814
NCI-H1568,4477,0.3996701755478256
RKO,36314,-4.63858923378885
KMS-21-BM,9908783,4.045820821938091
Daudi,675434,3.694219652985114
SK-LMS-1,6918328,0.6345903625341753
MDST8,60750,-4.217127024403589
WM115,9903786,3.894434750277636
RCC10RGB,5282054,3.6705963985990993
KMS-21-BM,11222830,0.1140953572441275
HCC1500,262093,2.85046563878574
PE/CA-PJ49,36462,0.5276653245054587
BFTC-909,4259181,-0.0277162117211437
JHUEM-1,67291369,3.2666914453146036
COR-L95,252682,6.347695054422412
LS180,9911463,3.681535048080384
SK-HEP-1,1566236,1.7725788045776691
PK-1,148124,-4.413253648153995
LCLC-97TM1,6918736,-2.1743152466595626
U-BLC1,9866186,1.1447317171995584
SW948,10231331,-0.4116197219649379
YD-15,107970,2.3819608381605097
COR-L105,selumetinib-vorinostat (8-1 mol-mol),2.277448874031188
KU-19-19,52912189,3.155674258646967
PaTu 8988t,44185566,3.1955818251601493
KP-3,4521392,4.3351469054542
DLD-1,36314,-2.102607662676067
KHM-1B,24180125,1.7183751461282626
NCI-H1395,3689413,-2.5246792207692073
ALL-SIL,31703,-2.84181702758724
SNU-C2A,JQ-1-carboplatin (1-1 mol-mol),1.666650905200112
MOLP-8,67156097,-2.505693621695456
P31/FUJ,12003241,-0.93015536828776
F-36P,5328940,1.0447195004483243
U-BLC1,vorinostat-navitoclax (4-1 mol-mol),0.2224871783482785
HARA [Human squamous cell lung carcinoma],44607531,1.5873617953354324
SNU-1079,54649381,2.4249067376910487
HuP-T3,72376,-1.771653200109272
COR-L95,vorinostat-carboplatin (1-1 mol-mol),3.640391778924097
ML-1 [Human thyroid carcinoma],3062316,-4.511354956700351
SK-CO-1,54649381,3.727346200170898
BICR 31,4578,4.306546690441069
HEL,24856436,0.2549549224561803
SK-LMS-1,54618305,4.344599681263995
SNU-1272,6918837,-2.3331308300912332
K-562,selumetinib-vorinostat (8-1 mol-mol),2.188537608414777
ST486,135984461,1.4882803556489697
Granta-519,selumetinib-vorinostat (8-1 mol-mol),1.614961732306094
NCI-H1568,568763,0.1547040002068053
BT 440,44491742,6.048012757107985
F-36P,vorinostat-carboplatin (1-1 mol-mol),1.774978167214653
YD-15,24856436,-0.4728294565710809
SNU-626,46199207,3.623615592983929
SaOS-2,10184653,1.5674189620168135
BICR 22,carboplatin-etoposide (40-17 mol-mol),1.4257688352427802
BT 440,3384730,1.5806592764461214
DLD-1,24785538,2.2934479783420634
SK-CO-1,10127622,-1.7782095442547816
KMS-21-BM,10090485,6.2796330049991855
RKO,6450551,2.9764230599456782
TTC-709,969516,2.3194828274206607
RCC10RGB,11222830,2.1708629162803654
MOLM-13,439501,-2.531564352317227
KU-19-19,5328940,2.592216165266187
SEM,53481919,3.689698909946728
SK-CO-1,BRD-A02303741-navitoclax (2-1 mol-mol),1.7439599678595026
KU-19-19,navitoclax-pluripotin (1-1 mol-mol),-0.1990402991745543
TTC-709,tanespimycin-bortezomib (250-1 mol-mol),0.5220611379237968
SNU-1079,208908,-0.5689318385789366
LMSU,6184667,3.2634858273175764
BT 248,11222830,0.9088188698521174
LS411N,46224516,2.772468105753273
JHUEM-2,9911830,0.7349841579012222
COR-L95,3465537,1.5360689669151406
NCI-H2452,650361,3.725817753027947
SNU-886,2949965,3.980374171773664
SNU-886,445643,4.49357862319239
MOLP-8,135423438,1.7176055832456645
Daudi,15953870,2.3174310256528017
HEL,25062766,1.0860006913119025
LS411N,9866186,0.9541786681011424
NCI-H2452,72193861,1.1802568558602904
KPL-1,11656518,4.1371204841159255
SW1573,104842,-2.57352069349058
SW48,1750826,1.3136286655933227
LMSU,4477,0.3546299550753337
HCC15,25262965,-1.0400697166295236
SNU-C2A,136227924,3.0438027551295352
SW948,156414,1.6424995325300082
HEL,49793307,-3.822273429090704
F-36P,11152667,-1.3463503839028206
SNU-1079,1242560,3.148675903497322
IGROV-1,JQ-1-MK-0752 (1-1 mol-mol),1.6911705649982345
KMS-21-BM,445643,2.6014857845557344
SNU-1272,serdemetan-SCH-529074 (1-1 mol-mol),2.457882821768218
KU-19-19,15983966,3.017543110767297
KMS-21-BM,2841722,3.83649114332806
Granta-519,445643,4.101892829369416
WM115,44462760,-6.607584862322745
KHM-1B,16741245,2.621472982126402
JHUEM-1,3676137,4.859385791226391
JHUEM-1,54765302,3.0111946318569873
COR-L95,16722836,1.6737270586986386
HuP-T3,19582717,-4.617931701404403
SK-LMS-1,9887053,6.082946871961119
ST486,vorinostat-carboplatin (1-1 mol-mol),1.5032147964557698
U-BLC1,25062766,2.0742242294505773
MOLP-8,135984461,3.690365922940533
WM115,25105715,3.143290836206988
SU-DHL-1,6610355,4.337111630655639
Ishikawa (Heraklio) 02 ER-,44185566,3.1940323665900645
BT 440,9911830,1.1775891461683867
P31/FUJ,107970,2.0437014771117425
BICR 31,9903786,2.10396775229317
HCC15,119607,5.6213928119464285
K-562,53392493,1.9280012389180945
JHUEM-2,2729026,0.9479802445067816
ST486,11960529,4.217440816132792
Granta-519,erlotinib-PLX-4032 (2-1 mol-mol),4.2552857521313925
SEM,10322450,3.0556839954997685
SNU-1079,119182,-0.7297363065701116
LMSU,54454,1.1076118788914329
JHUEM-7,10113978,2.9707685491739357
SNU-1079,10231331,-1.013778330631948
ML-1 [Human thyroid carcinoma],4788,6.371899932480547
SaOS-2,6184667,2.75971928345779
HCC1500,49867930,4.391361036771465
HCC1500,156422,3.756088196252004
T98G,2874250,5.042683855782759
LS180,2729026,2.858515315971793
UACC-812,9926054,1.7122964049751828
NCI-H1395,119607,5.849828221842235
ST486,67291369,0.3038991286078646
BFTC-909,2945648,3.347829093032643
RCC10RGB,piperlongumine-MST-312 (1-1 mol-mol),2.4761046612469944
COR-L95,10427712,3.3507411292398315
HCC1500,73707371,6.057238887548947
SU-DHL-1,5566,2.363543718324467
JHUEM-2,216345,0.0070552160229057
RCC10RGB,navitoclax-pluripotin (1-1 mol-mol),0.1501865832808995
SW1271,44137675,2.993655891868926
PaTu 8988t,10385095,1.1295524511895831
KP-3,crizotinib-PLX-4032 (2-1 mol-mol),2.2756585160938796
IGROV-1,107970,2.287061680908213
SK-MEL-2,3025986,0.1982340345845162
LCLC-97TM1,3081361,3.200154540210029
JHUEM-7,11178236,-3.5105066295157843
MDST8,24797083,1.659668465713326
MOLM-13,100016,3.967621300341963
SW48,6914657,-5.582748420606011
RKN,54454,2.1815674244706407
SW1271,54686904,4.077781574312711
TTC-709,11364421,-3.4066637158935125
MDST8,tanespimycin-gemcitabine (1-1 mol-mol),1.2757210463641129
Mino,9915743,-0.1014414753917248
LCLC-97TM1,11152667,-1.9849905525936635
RKO,6610355,5.147293026177706
JHUEM-1,56949517,4.369780447649173
SEM,421610,2.11087969336726
HuP-T3,11234052,4.425621489915021
KHM-1B,439501,-2.4289183886287535
BICR 31,11485656,2.9684140094972387
HCC15,445643,3.643779771767104
PK-1,11497983,5.705254129621959
SK-MEL-2,10302451,4.273835624093029
TTC-709,24785538,0.9272709188684776
JHUEM-7,44632017,0.9432703317183572
ST486,71751553,4.101372984675863
PK-1,doxorubicin-navitoclax (2-1 mol-mol),0.6258666947641467
ST486,3038522,1.9470580434789493
PE/CA-PJ49,46843906,3.0340645343525954
BFTC-909,alisertib-navitoclax (2-1 mol-mol),3.1464879320843635
PK-1,73707398,1.4410973874230182
YD-15,637858,2.2450013527302235
Granta-519,6918878,0.9437787040623058
F-36P,24772860,-2.6351824640153763
SU-DHL-1,16720766,-1.7997333167058054
COR-L95,navitoclax-MST-312 (1-1 mol-mol),0.0334777259745642
RKO,11626560,1.596896929931414
IGROV-1,44589607,3.0909001492794377
HEL,168313047,1.7739787927154282
IGROV-1,11964036,-0.1609353030421705
SK-HEP-1,969516,2.3030983588134917
U-BLC1,25126798,4.060565052504092
SK-MEL-2,11612883,4.120849200953437
SNU-1272,25126798,4.058669238010608
U-BLC1,5113032,4.033373960258414
TTC-709,9843750,4.363875911309475
LS411N,68056272,3.648680202626129
WM115,navitoclax-piperlongumine (1-1 mol-mol),2.2126166903364037
Mino,15953870,2.630005403588916
HEL,2749,1.5352641298417238
MOLM-13,135398516,0.1807695197937267
Daudi,176870,1.9898427065198672
HEL,10427712,4.076538081897971
U-BLC1,navitoclax-birinapant (1-1 mol-mol),0.4113142120682386
PE/CA-PJ49,3038522,2.615741330384697
SUP-T11,3025944,3.766355129516524
ST486,25154868,3.92540083916858
SW948,24772860,-2.2115718578693495
Granta-519,2729026,1.8472912754822493
COR-L95,5394,4.313147278509764
LS411N,46907787,0.8939335106347707
ML-1 [Human thyroid carcinoma],2841722,5.015074505803474
JHUEM-2,10184653,1.0610180693773583
YD-15,navitoclax-pluripotin (1-1 mol-mol),-1.6398630495153934
HuH-6,60700,2.4593758407340163
PE/CA-PJ34 (clone C12),10385095,0.6586777190246488
KU-19-19,11485656,2.7576201496249264
IGROV-1,2858523,3.196384505087132
U-BLC1,44607530,-0.8767345647916073
SW948,702558,5.163408425848839
RERF-LC-MS,72734382,4.885789692793362
NCI-H1568,JQ-1-navitoclax (2-1 mol-mol),1.9826778797664537
JHUEM-7,23725625,6.309121610229004
YD-15,ISOX-bortezomib (250-1 mol-mol),0.5490743242833638
JHUEM-1,81146,4.485523568105648
RERF-LC-MS,11964036,1.6707185338079893
ML-1 [Human thyroid carcinoma],25154868,4.839556149748317
SNU-886,23635314,-2.1595159166484685
SW48,3038522,2.575519148977434
IGROV-1,11364421,-2.1205062036040982
U-BLC1,72376,-2.328093187326327
PK-1,24901704,4.154833466808769
Daudi,24753719,1.7041863717102288
MOLM-13,selumetinib-BRD-A02303741 (4-1 mol-mol),2.2135360458532216
F-36P,decitabine-navitoclax (2-1 mol-mol),-0.3122697597866437
SW1271,73707438,3.2742940196229022
MOLM-13,44487061,4.373293273870424
SaOS-2,568763,0.7449819257203903
SaOS-2,168313200,1.7182390433527042
K-562,15547703,3.09098547046412
BICR 22,24785538,-0.3286106781648999
SK-MEL-2,11707110,-2.099269246419877
SNU-886,441298,0.5019863351835324
SNU-1272,selumetinib-UNC0638 (4-1 mol-mol),4.820393329674523
LMSU,navitoclax-pluripotin (1-1 mol-mol),-0.1706799905389637
Hep-G2,49850262,3.2140640734627843
IGROV-1,9936388,2.10108466287406
BICR 22,4477,1.559722374810713
SK-MEL-2,6918837,-3.006204204027818
BT 440,1714884,3.655544466830947
KHM-1B,carboplatin-etoposide (40-17 mol-mol),0.9308702262934592
LCLC-97TM1,navitoclax-birinapant (1-1 mol-mol),-0.5917483578052505
SNU-1272,9911830,3.883073952142102
BICR 22,16038120,1.2563245393113998
U-BLC1,49867926,4.222084088463496
PaTu 8988t,56649450,4.324867884259214
SNU-1272,5278396,3.8944923273965113
DLD-1,6918837,-1.752309402706111
PaTu 8988t,135411,1.3050507330755643
Hep-G2,71680916,5.349288664380335
NCI-H2452,12001922,2.2907278374018296
RKO,44185566,2.4837284923488063
K-562,9826308,0.1842141800186153
RCC10RGB,5311281,4.058856975975892
KPL-1,46224516,2.007070252951892
WM115,5460769,2.9023963298546507
HCC15,119182,0.1055567812373319
BICR 22,44607531,1.5270609291983028
HARA [Human squamous cell lung carcinoma],26596,-2.1080424946580245
NCI-H1568,25262965,-4.225307409424958
SW948,5328940,1.2304763256018572
RERF-LC-Ad1,107970,2.434538597740863
PE/CA-PJ49,11497983,3.7994521825167302
Hep-G2,docetaxel-tanespimycin (2-1 mol-mol),-1.6535454004195396
Ishikawa (Heraklio) 02 ER-,9911830,3.5571735826815827
F-36P,46215462,1.4444278277820295
BT 440,carboplatin-UNC0638 (2-1 mol-mol),3.506628808231462
KP-4,36314,-5.817285417433746
JHUEM-7,52912189,0.2472065202892593
IA-LM,10296883,4.25848729020474
LCLC-97TM1,11964036,0.9095700511944136
SK-OV-3,10074640,3.759507235638381
BFTC-909,25062766,1.7422044094415416
BT 440,16725315,3.273061082786825
HT-1376,44607531,1.4291220919751153
Hep-G2,vorinostat-navitoclax (4-1 mol-mol),1.3069749829657018
TTC-709,36462,1.4655456556845978
MOLM-13,44202524,0.8413416322030352
TTC-709,10113978,1.4114913906509865
DLD-1,2126,4.733626140945716
SEM,89928392,-0.8606001711517224
KP-3,3038522,3.8887419194513537
P31/FUJ,44137675,3.225768708166513
KP-3,5329102,1.659425566170689
PaTu 8902,42642645,2.254917267204718
RKO,53232,4.485666667988006
MDST8,51039095,3.753808380930837
ALL-SIL,25150857,1.7729123360103365
SNU-886,9903786,2.951492144984292
KU-19-19,136227924,3.1447471190609217
BICR 22,9911830,2.5765146499323497
SW48,26596,-2.356334812614481
WM115,8515,4.149615392892544
KHM-1B,6918837,-4.542516260541086
TTC-709,11612883,1.5858524126565587
LMSU,216239,2.7784961545541216
JHUEM-1,5738263,2.34817392021491
ES-2,44819697,-2.2560909200579076
SEM,6505803,-1.7011482867291614
U-BLC1,56946209,-4.484604830274851
SaOS-2,3025986,-1.3703894596366477
LS411N,6623618,2.410312404439064
RKO,2749,1.3580925102381314
SW1271,9915743,1.6128868969613257
SaOS-2,44589607,3.1014372869468736
KP-4,136227924,3.1314573836961235
JHUEM-2,carboplatin-etoposide (40-17 mol-mol),-0.8758659332391241
BICR 31,9908783,4.390198834476992
RERF-LC-MS,1641662,3.403538628142178
SW948,168313200,2.3052543991742933
KLE,serdemetan-SCH-529074 (1-1 mol-mol),1.7024898854961308
KP-3,1242560,4.052837619574442
BFTC-909,16720766,-0.0189955240044846
HCC1500,46843906,3.5664723036358703
BFTC-909,5291,3.495280995080932
BT 248,16038120,1.7409517230791791
PaTu 8902,5287620,-1.817962379422155
Granta-519,24772860,-2.616849709254195
SW48,selumetinib-decitabine (4-1 mol-mol),-2.392622848847121
MOLM-13,2858523,2.990787770243497
MOLP-8,73707398,-1.5200522985211378
WM115,4788,5.364989483250021
KU-19-19,11717001,1.9129980214779312
T98G,23635314,3.4326688848184372
PaTu 8988t,3854666,2.839522644305469
MOLM-13,vorinostat-navitoclax (4-1 mol-mol),-0.987195893966014
KMS-21-BM,24748573,1.405622166140225
RKN,11222830,1.5707482267531538
SK-HEP-1,5978,1.689065603838291
ST486,54618305,3.679577166214843
LS180,374536,-1.6764778169414856
PE/CA-PJ34 (clone C12),46199207,3.406755484984745
HuP-T3,sirolimus-bortezomib (250-1 mol-mol),0.6074306873304286
KMS-21-BM,54618305,4.311138878515908
RCC10RGB,46199207,3.760684270246491
JHUEM-2,12001922,1.6985536593614663
YD-15,31703,-2.216691480384022
SW1271,49836020,-1.4027167140646708
BFTC-909,2130404,3.366307483642889
KMS-21-BM,2729026,1.6254459939074395
SW1271,3384730,3.1846503121443144
HARA [Human squamous cell lung carcinoma],selumetinib-MK-2206 (8-1 mol-mol),2.6906074312139676
SW1573,selumetinib-PLX-4032 (8-1 mol-mol),4.4065207246272005
PE/CA-PJ49,10410894,3.0820189090316443
SaOS-2,285033,-3.099559966451384
LS180,71466578,4.68838045718991
ST486,selumetinib-piperlongumine (8-1 mol-mol),2.4103404230724865
LCLC-97TM1,2126,5.523539990092585
NCI-H1568,9936388,-8.53108348301746
ST486,252682,5.837358499981462
Panc 02.03,6505803,-1.93196111296706
TTC-709,31703,-2.911257242005485
PE/CA-PJ34 (clone C12),selumetinib-PLX-4032 (8-1 mol-mol),2.847954484086583
SNU-1079,JQ-1-MK-0752 (1-1 mol-mol),-1.7447173910789562
BICR 22,9926054,1.8271931211135617
SW1573,54618164,4.339091959582753
JHUEM-2,16115403,-5.439955760525091
ST486,11404337,-3.35080317485283
SNU-1272,65064,5.250850515288352
SEM,11427553,-0.9142896779989294
TTC-709,322968,2.0710773694226567
COR-L95,9907093,4.309721999642839
HuH-6,5282054,3.3528595353918336
LCLC-97TM1,9911830,3.2250615193472085
K-562,151289,0.3703020531314545
EB1,3634881,2.291994613735314
L3.3,448949,2.9670184834605244
HCC1500,24821094,2.4557115965701257
PE/CA-PJ49,44607530,1.6054664418105014
ALL-SIL,11222830,0.8263932665864424
ALL-SIL,44490293,5.541636788423512
DLD-1,16720766,-0.1064001460740321
SUP-T11,36462,-0.1109472671926892
BFTC-909,15547703,3.647732910564925
DLD-1,9840324,5.810390987697233
KLE,3634881,3.3251841919327805
PaTu 8988t,11175137,3.61207596874577
BT 248,selumetinib-GDC-0941 (4-1 mol-mol),1.214957443871495
COR-L95,44566777,1.612039010223373
RKO,navitoclax-PLX-4032 (1-1 mol-mol),2.3429049321543083
SNU-C2A,54626689,5.282972840372123
SW48,9444,3.3118033011757806
COR-L105,52947716,1.1539739817838972
DLD-1,9444,4.307803507593221
HARA [Human squamous cell lung carcinoma],11228183,1.9492387662676105
ES-2,alisertib-navitoclax (2-1 mol-mol),2.912484234328274
SW1573,16013152,3.6979705228045354
U-BLC1,11494412,1.2654808753679463
SW1573,17759555,4.342323370433329
BT 248,piperlongumine-MST-312 (1-1 mol-mol),1.560142448953329
SW1271,11609586,3.768986685585146
YD-15,docetaxel-tanespimycin (2-1 mol-mol),-6.3571627272690705
K-562,3552672,6.190745251508109
ML-1 [Human thyroid carcinoma],151289,2.136095657957592
SW48,vorinostat-carboplatin (1-1 mol-mol),1.7573438485405597
Mino,11964036,0.4024163652138567
COR-L95,selumetinib-BRD-A02303741 (4-1 mol-mol),6.0949369940274645
KP-3,11612883,2.777490098134625
JHUEM-2,44489675,3.634377598805376
IGROV-1,57519531,2.639098862164858
IGROV-1,1716436,3.2816872421007375
KLE,568763,0.509610011546881
ML-1 [Human thyroid carcinoma],11222830,1.0897337620982457
F-36P,46398810,-0.3674107796083021
SW1573,tanespimycin-bortezomib (250-1 mol-mol),0.6931535757645308
IGROV-1,2828334,6.070696247039626
PE/CA-PJ34 (clone C12),6450551,2.8483436332661873
SW1271,53495165,2.774319130141937
SW948,67291369,3.8063591597957593
Daudi,11507802,0.3815953316544085
ES-2,46199207,3.6497799971264886
RERF-LC-MS,2708,5.106155932743474
KPL-1,25105715,3.303034201689657
SW1573,52912189,3.9296893768173065
SU-DHL-1,25154868,3.5324679540942165
BICR 31,24772860,-2.497965982707089
SK-MEL-2,9549297,3.977778608545143
TTC-709,11178236,-5.023353562243451
F-36P,11427553,1.8945760748158276
K-562,11719255,4.077642177046201
NCI-H1395,11234052,4.314713395827009
WM115,5470400,-1.5377493662522326
KU-19-19,44589607,3.6813877406069246
LS180,11626560,1.7567799331145733
KMS-21-BM,9887053,0.9712553227644046
Daudi,11427553,0.4642664556868584
HCC1500,44607531,1.3781074542184104
COR-L95,sirolimus-bortezomib (250-1 mol-mol),0.1452212598896528
SNU-886,3101542,4.147310950875089
PE/CA-PJ34 (clone C12),5335621,5.154193572953575
PaTu 8902,4259181,0.9791956381618654
PE/CA-PJ34 (clone C12),9967941,4.772694615178541
SaOS-2,216345,4.363902597199754
BFTC-909,100016,5.8134150302243865
BICR 22,56963564,0.2615280103832354
KHM-1B,638278,3.418404486503754
COR-L95,selumetinib-MK-2206 (8-1 mol-mol),3.988992383923742
LS180,613753,3.1711720082363337
BICR 22,3825829,4.259881935728516
EB1,168313200,1.71707382114801
P31/FUJ,25262965,-1.897985536240049
RKO,15953870,3.3462063589818034
ALL-SIL,26596,-3.0181503922951674
SW1271,4788,5.888244914590778
COR-L105,25150857,2.68968810352953
SK-MEL-2,42642645,1.9027852819088145
SUP-T11,4096211,-0.0144027754807787
KP-3,3503,1.914788616217679
SUP-T11,2858523,2.9394205285834625
RKO,24753719,3.882573791668401
ML-1 [Human thyroid carcinoma],11719255,2.5461185366109453
MKN1,136227924,3.2741698595271025
Granta-519,selumetinib-PLX-4032 (8-1 mol-mol),6.800610624755647
JHUEM-1,46224516,3.0297985213266982
P31/FUJ,selumetinib-PLX-4032 (8-1 mol-mol),0.7192847011043231
SNU-626,119607,5.95871824238414
PaTu 8902,613753,4.768885644214674
PaTu 8902,44589607,3.762990171329796
EB1,9911463,2.50745807911791
MOLP-8,176870,4.692998654081846
MOLP-8,216468,0.300035377459394
SEM,5281321,-3.2823659838346697
NCI-H1395,2858523,3.2706223313658445
JHUEM-1,6184667,1.946061954193184
NCI-H1568,1641662,3.419317894706959
EB1,25126798,3.0999390504271545
KMS-21-BM,168312962,-3.8165288168803193
L3.3,15983966,-2.6250326320128066
DLD-1,9911830,2.6319056960613136
HCC1500,11626560,1.5792444837322512
HCC1500,3689413,-1.6712109221216571
RKN,984333,1.094463938199557
LMSU,5311,4.122063566653656
PK-1,3854666,3.537340048707808
SK-LMS-1,10296883,4.497007332627828
T98G,25102847,1.9066411718554035
HARA [Human squamous cell lung carcinoma],9911463,4.1556235611039405
COR-L105,4788,5.897633886873905
HuP-T3,carboplatin-etoposide (40-17 mol-mol),4.278227331004969
PaTu 8988t,136227924,2.49705731140334
MKN1,702558,5.271144107983553
KP-3,11609586,2.647562513890928
LCLC-97TM1,3634881,2.947438100526324
KHM-1B,51039095,0.918931317329286
RCC10RGB,53392493,3.4706572822964072
Panc 02.03,10385095,1.3097039910351371
RERF-LC-MS,445455,4.41080153827665
PaTu 8988t,6918638,2.256433939948275
KU-19-19,24951314,1.2793314486163916
JHUEM-7,24856436,-1.8426006966748285
MDST8,25183872,-0.5549651899708961
COR-L95,JQ-1-MK-0752 (1-1 mol-mol),5.448110634286577
PE/CA-PJ49,54143018,0.3953698783249076
WM115,navitoclax-sorafenib (1-1 mol-mol),1.4633730841087864
SNU-626,60700,-1.09047066839593
Mino,24978538,1.7640647284403537
KP-3,24772860,-1.376396591458844
COR-L95,9908783,4.358103020890871
COR-L105,3552672,2.0991572824292435
KHM-1B,5291,3.0747502676954896
SK-CO-1,5566,2.706069596509063
SEM,135984461,1.5883939694151252
RERF-LC-MS,969516,2.2498421794663095
SK-LMS-1,selumetinib-navitoclax (8-1 mol-mol),2.476280866882333
HCC15,JQ-1-UNC0638 (2-1 mol-mol),2.9546017932515256
HARA [Human squamous cell lung carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.8572824243778725
NCI-H2452,452548,0.0358025934468
KMS-21-BM,11152667,-1.593157926365923
Daudi,409805,3.686040208403983
LMSU,15983966,1.8709586957084512
BFTC-909,5287620,-2.871557478653834
YD-15,9936388,-5.281829985034155
SUP-T11,1716436,0.2243543965505923
UACC-812,25183872,-0.2383295665292847
SW48,36462,-1.5563073788110886
SK-CO-1,327653,3.1822308576162692
U-BLC1,387447,-5.23576089371183
Mino,BRD-K55473186,3.89998753141564
KP-4,375860,-0.9518603940694028
KP-4,6852167,2.7219764725227753
MOLP-8,11507802,0.9747707839930404
SW48,55508,1.9258231187784565
JHUEM-2,44620216,3.1375965349747075
SNU-886,5278396,3.692331874950952
T98G,23582824,1.5745349277663985
ML-1 [Human thyroid carcinoma],5329102,1.4103281602713895
F-36P,navitoclax-piperlongumine (1-1 mol-mol),0.6141351089742836
COR-L105,16065773,2.993283969068687
ML-1 [Human thyroid carcinoma],53495165,2.320007555236624
LS180,451668,4.827094473942733
IGROV-1,36462,2.313632721410001
PE/CA-PJ34 (clone C12),448949,2.311723632816614
SUP-T11,JQ-1-vorinostat (2-1 mol-mol),0.589368080071125
EB1,24821094,0.2204984669860242
JHUEM-1,3689413,0.044302486666068
L3.3,11427553,3.3742390950754984
JHUEM-7,10296883,3.9492602271456065
KLE,11455910,3.332048563725763
RCC10RGB,selumetinib-piperlongumine (8-1 mol-mol),4.460336891472633
COR-L95,navitoclax-piperlongumine (1-1 mol-mol),-0.3992176902442844
MDST8,11719255,3.580824685094748
BICR 22,135984461,4.376718251500639
BFTC-909,selumetinib-MK-2206 (8-1 mol-mol),3.672772019831091
Granta-519,2871966,-2.0442685638601947
SNU-1079,46907787,-3.0889383409725992
Panc 02.03,136227924,3.0839082623333387
IA-LM,10074640,3.892343788144062
HuP-T3,navitoclax-piperlongumine (1-1 mol-mol),2.1493116178026157
BICR 22,10231331,2.1949493731732095
BT 248,71576739,6.051378362255083
PaTu 8902,carboplatin-UNC0638 (2-1 mol-mol),3.7190209158995273
NCI-H2452,10127622,4.466077980380041
EB1,72199292,1.406689004370545
PaTu 8902,11178236,-2.9840755573739943
Mino,10322450,2.499731281895077
MDST8,6918837,-2.3764765121755
TTC-709,11717001,4.592891953835563
KMS-21-BM,23939,4.3738413143959605
SNU-1079,72376,-2.6581102901208484
LMSU,448949,2.5624283498682594
SNU-626,5281672,4.271400030620256
ST486,SNX-2112-bortezomib (250-1 mol-mol),-2.6727579248220437
PE/CA-PJ34 (clone C12),24951314,2.349740240636077
HCC15,1716436,2.8917896521916537
Daudi,5351362,0.314899635949887
JHUEM-1,24772860,-2.3611872532983895
PE/CA-PJ34 (clone C12),2858523,2.9495363309542126
Mino,71751553,3.961570534496015
JHUEM-1,65628,4.833015195333772
PE/CA-PJ34 (clone C12),327653,3.4791017722352815
NCI-H1395,10074640,3.7402432932443137
BT 440,serdemetan-SCH-529074 (1-1 mol-mol),1.5692631702202289
SNU-886,2746,2.8162256970394295
IGROV-1,1750826,-3.124548162001242
JHUEM-2,6918736,-4.735896970447234
EB1,3854666,0.1328331375955075
BT 248,selumetinib-UNC0638 (4-1 mol-mol),4.192258549840557
SW1271,24779724,6.290779023739936
NCI-H1395,676352,2.20823720680155
SNU-1272,6852167,2.886842068916118
SW948,216468,0.513065020542466
SEM,53392493,1.476252706272148
KMS-21-BM,navitoclax-MST-312 (1-1 mol-mol),1.1139379831190477
SNU-1272,44137675,4.576444163035884
ST486,11175137,0.5931503543238732
HCC15,5738263,4.375256926251463
KP-3,11640390,3.558251661617552
Granta-519,25183872,-2.24080905771406
MOLM-13,selumetinib-navitoclax (8-1 mol-mol),-1.2398703731830696
SaOS-2,46926350,-4.2820912559124995
Hep-G2,322968,4.552458908145698
HuH-6,4378219,2.0621045138260823
COR-L105,49766530,-0.5480688242609842
JHUEM-2,44819697,-1.1731715590657616
PE/CA-PJ34 (clone C12),7326481,3.1862405320000606
DLD-1,5746,1.774205676326739
BT 248,44491742,4.160095989296475
HEL,2874250,-2.245656223692803
JHUEM-2,3689413,-0.0908621852790934
K-562,45279963,2.402740503794971
SK-LMS-1,4578,4.462106050202468
SW1271,441298,2.7117876410913073
Daudi,46215462,1.1016280052611975
BFTC-909,9915743,2.0959000942543025
Granta-519,55508,1.5366901224911111
SK-MEL-2,24951314,1.1637791949954526
HT-1376,216239,3.376554849294609
ML-1 [Human thyroid carcinoma],11507802,1.1504003941708354
TTC-709,52947716,-3.053546677964741
SUP-T11,UNC0638-navitoclax (1-1 mol-mol),1.5876304129762722
SU-DHL-1,445455,4.339452591135178
Granta-519,11222830,0.944926764715042
SK-HEP-1,135421197,3.339831791709741
COR-L105,11719255,5.177770829400177
SEM,51039095,0.5318115856558748
SaOS-2,49793307,-3.0698778362667807
PE/CA-PJ34 (clone C12),11152667,0.0112826586729411
SU-DHL-1,54618771,0.3433661921186922
SaOS-2,navitoclax-PLX-4032 (1-1 mol-mol),2.865443862493463
IGROV-1,54618164,4.2184521751950115
JHUEM-2,135398738,4.4160504383934835
NCI-H1395,104842,-0.629937294678588
ML-1 [Human thyroid carcinoma],44507138,2.4759759240399206
HCC15,4259181,-0.5021574884501439
PaTu 8902,5311,1.4468060231693458
SaOS-2,11609586,3.464015551213678
BFTC-909,26596,-1.7437210940555867
RKO,3385,4.410917651107157
SW48,5282054,3.4229655251352984
U-BLC1,UNC0638-navitoclax (1-1 mol-mol),0.3786430687179207
HEL,3025986,1.4059985389197358
HCC15,2749,2.6993987110059456
ES-2,89928392,1.5633463662717602
RERF-LC-Ad1,5329102,2.5838260577458754
BT 248,BRD-K55473186,1.6909762369263868
ST486,carboplatin-UNC0638 (2-1 mol-mol),2.9787609828786916
TTC-709,19582717,3.386993357909162
RCC10RGB,serdemetan-SCH-529074 (1-1 mol-mol),2.3426493996230424
MOLM-13,2733526,3.3430267495988693
HCC1500,71466380,5.203984730888507
SK-HEP-1,104842,-1.0887000355540395
JHUEM-7,1750826,-2.1362292193438965
F-36P,10184653,-0.1127126256435277
ST486,71466445,2.0454820833353704
SW948,5566,3.1149649258053107
Daudi,11234052,2.508646185471885
WM115,tanespimycin-gemcitabine (1-1 mol-mol),-2.08510571323105
SW48,208908,0.7661322887377208
SW48,24978538,0.0148337391131729
SNU-626,15983966,2.548958191333557
P31/FUJ,9926054,1.2698752833949425
Daudi,5287620,-2.5355659158885167
BICR 31,53325874,4.467091056736401
LMSU,46215462,1.6132445260269193
LS411N,400769,-0.3072623933562745
HCC15,7326481,6.13295321500094
LS180,6610216,4.524725364990245
HuH-6,5328940,0.8591862317680542
PE/CA-PJ34 (clone C12),409805,3.8621146596524087
BICR 31,11609586,2.804864928293696
TTC-709,54613361,0.4849147301637989
TTC-709,676352,2.0506633144845168
NCI-H1568,5351362,0.9370615420718584
NCI-H1568,selumetinib-PLX-4032 (8-1 mol-mol),3.6289743773432463
HCC1500,26596,-0.8174609850015592
JHUEM-1,10296883,3.9346694694253657
Daudi,JQ-1-UNC0638 (2-1 mol-mol),-1.821496210426365
HT-1376,148198,-2.6714995080003767
TTC-709,BRD-K55473186,1.866665574311563
Granta-519,salermide-PLX-4032 (12-1 mol-mol),5.521121579042541
BICR 31,5311281,1.899563489561116
SK-LMS-1,44137675,4.668720860798916
TTC-709,5281672,3.753371980542877
HuP-T3,11964036,1.9148977928601396
HuP-T3,6918328,0.6989696425214073
KHM-1B,327653,2.4267430839124455
ES-2,16720766,1.006505592354145
IA-LM,56963564,0.8197284064300991
SUP-T11,10077130,3.733692366728536
LMSU,19582717,5.5691455475886595
ST486,9911830,1.5676247278610147
K-562,25227462,-1.535473545694956
HARA [Human squamous cell lung carcinoma],68056272,4.667757023830857
P31/FUJ,6438330,0.60015264799364
SNU-1079,52912189,-0.8528136134688565
NCI-H1568,54143018,1.7330311939537375
MOLM-13,10184653,-1.0304513474260102
COR-L105,3081361,0.7591954413754667
SW48,3465537,3.829258919586145
SEM,4261,-1.241514720735086
SNU-C2A,54454,1.4944061321605324
LMSU,10113978,1.557712519717613
PE/CA-PJ34 (clone C12),16741245,6.228519168048979
SK-CO-1,135398516,1.0451560562277196
RKO,selumetinib-vorinostat (8-1 mol-mol),2.2625933360113826
U-BLC1,doxorubicin-navitoclax (2-1 mol-mol),-1.5471877205672229
BICR 31,11222830,2.7999268343872603
JHUEM-1,15547703,2.908603907125356
KMS-21-BM,65628,3.740044409654922
P31/FUJ,1750826,-3.787471607079622
MOLM-13,124202324,0.9453642044256088
SNU-626,6918289,2.931488765179222
LS180,445091,4.461419397707798
LMSU,57330099,5.920156910327882
KMS-21-BM,654092,-1.5504597637966335
K-562,4578,4.401657334703153
BFTC-909,31703,-0.9928331583982526
Mino,5470400,4.059299624232549
Daudi,54618164,3.154466747848232
HCC1500,375860,0.1348683063529126
MOLM-13,3385,-0.0516453787728095
Daudi,123631,1.6174763425926726
SW1573,6610355,4.129027118562099
L3.3,crizotinib-PLX-4032 (2-1 mol-mol),2.765628359334359
SEM,25022340,5.24487165377703
K-562,44589607,2.662527895237601
SW948,24964624,1.7910099631647045
LS180,387447,-4.2321913932512185
SW1271,445091,4.3767610709371025
NCI-H1395,9926054,1.836702615994444
SUP-T11,11234052,3.8965137017623217
LS411N,5328940,2.1913370268343324
ALL-SIL,46199207,2.4207183231317826
BFTC-909,644241,3.062866082016443
Ishikawa (Heraklio) 02 ER-,2858523,3.33045417034977
SK-CO-1,5738263,3.1381077819263954
HCC1500,selumetinib-BRD-A02303741 (4-1 mol-mol),5.277663522211575
PaTu 8902,3385,6.504553614083827
SW1271,5328940,1.739297434861375
Daudi,444795,4.05018196872557
SNU-626,82146,4.328245581222399
SaOS-2,9887053,4.468769125876902
SNU-1272,216345,4.229036280799805
ML-1 [Human thyroid carcinoma],6610355,5.061552725322464
ST486,613000,2.3470003758058535
MOLP-8,9936388,3.4211096692910052
SaOS-2,5746,3.648398890023908
PE/CA-PJ49,46907787,3.401972170810614
TTC-709,9825149,2.1415349786739175
PaTu 8988t,135875424,4.8815767191826325
SaOS-2,25195348,4.111342507306749
NCI-H1568,135398738,4.732110826035958
RKO,5329102,2.192208184281935
ML-1 [Human thyroid carcinoma],122327,4.584045367066115
PE/CA-PJ49,docetaxel-tanespimycin (2-1 mol-mol),-6.834195493556901
SNU-C2A,10322450,3.700200592981039
HuH-6,25105715,2.6289569583181818
WM115,11612883,3.668907379861532
HCC1500,24785538,2.8337652504333817
BT 440,24771867,2.4871048199114187
ALL-SIL,3854666,-1.067048731148745
WM115,11494412,2.975341542339242
SEM,216345,1.9480472657729433
T98G,6450551,5.307419790138827
JHUEM-2,46199207,2.815432150876674
Granta-519,9884685,-0.5481626961732873
MKN1,tretinoin-carboplatin (2-1 mol-mol),4.713800693166991
SUP-T11,51039095,2.4863274064842336
LS411N,selumetinib-vorinostat (8-1 mol-mol),0.590504538579532
KU-19-19,5287620,-2.913600334543538
F-36P,24821094,3.119617575443437
SNU-626,44819697,-0.1143568002507541
HCC1500,25227462,-1.134185511373382
SK-OV-3,9936388,2.038842599711319
JHUEM-1,25102847,2.8158022940321494
NCI-H1395,4917,3.698580311776931
BT 248,17755052,0.6696435234843453
HARA [Human squamous cell lung carcinoma],5113032,5.077717215414557
HARA [Human squamous cell lung carcinoma],46191454,0.0255281814012309
KPL-1,3038522,4.220699578983875
COR-L95,9840324,5.902997789616562
Mino,51037431,3.4405759009251953
YD-15,54454,1.2951812766144986
SK-OV-3,159324,5.082712026660022
COR-L105,5426,4.419968019169297
SK-MEL-2,selumetinib-JQ-1 (4-1 mol-mol),0.1209546449517723
JHUEM-7,5282054,3.350633038728166
HARA [Human squamous cell lung carcinoma],carboplatin-UNC0638 (2-1 mol-mol),4.127490867447662
HuP-T3,44491742,4.372770131484514
HEL,navitoclax-gemcitabine (1-1 mol-mol),-3.418603962504733
MOLM-13,5978,-4.923441638627742
KU-19-19,9911463,4.338553857034003
LS411N,SNX-2112-bortezomib (250-1 mol-mol),-2.160208901072175
ST486,89928392,-1.08857705910859
MDST8,9956119,3.20428794924567
YD-15,selumetinib-UNC0638 (4-1 mol-mol),3.541638712688106
SNU-C2A,9911463,4.1542386249666094
KLE,5738263,3.521072611240238
IGROV-1,44137675,1.8406125640672395
SNU-1079,selumetinib-navitoclax (8-1 mol-mol),-1.1600805695647078
NCI-H1568,24771867,2.7621066837370156
SEM,24821094,2.5010829781969774
NCI-H1395,148124,3.756905797674181
SW1573,3503,1.662872296112478
ALL-SIL,54143018,-1.6646130342073118
ST486,24772860,-1.8273515776506504
T98G,462382,0.9111615211781124
MKN1,11175137,4.2125127857457025
L3.3,44507138,2.7873723049829544
KU-19-19,9903786,4.470072542277405
Granta-519,67291369,2.669151289874282
U-BLC1,11485656,2.1961180988259086
TTC-709,216345,2.803756160009179
HuP-T3,126941,-4.07371973001698
EB1,44197249,1.2829816598898034
JHUEM-7,3062316,0.480363794433647
DLD-1,3825829,3.8736500372976943
IGROV-1,11175137,1.8411496230681277
LCLC-97TM1,3543504,4.4040963352609825
KP-3,123631,2.348787876732731
PaTu 8988t,10184653,1.9115764380070437
SNU-1079,6610355,2.850335263061813
BICR 31,10184653,-1.3652350776002238
PE/CA-PJ34 (clone C12),119607,5.593400059439999
PaTu 8988t,4917,3.9515789700022728
KMS-21-BM,5566,2.188649945548243
LS411N,9967941,4.95978669187673
SW948,6918837,-5.2716912634433815
SEM,11977753,-1.3254464144533478
Granta-519,19582717,3.2223711893143796
HuP-T3,753704,5.56041062328625
SNU-626,6623618,2.2547237565539797
SW948,BRD-A02303741-navitoclax (2-1 mol-mol),3.1746461495638867
SK-LMS-1,16722836,2.5423254088501044
KLE,selumetinib-BRD-A02303741 (4-1 mol-mol),3.7158414512435143
HuP-T3,44819697,0.7007171788005963
JHUEM-2,5311281,0.0421337573518187
Daudi,49766530,-5.535187194073846
RKO,168313047,1.9322709085928884
EB1,46843906,1.7826306764380624
HEL,451668,-1.9900462993769088
BICR 22,selumetinib-tretinoin (2-1 mol-mol),2.504585066651982
SNU-1079,9903786,0.8372132722803839
ALL-SIL,637858,0.2842777242368783
SW48,375860,-0.9823609780883206
Granta-519,426756,3.1337304970475865
LS411N,3038522,4.360410119835835
BICR 22,SNX-2112-bortezomib (250-1 mol-mol),-1.3459249311621435
JHUEM-1,5702613,2.995865647322937
HuH-6,444795,4.76302166283974
NCI-H2452,11626560,1.8431584922948163
KP-4,25105715,3.790415010169424
SNU-C2A,selumetinib-PLX-4032 (8-1 mol-mol),1.6934954680831615
SW48,135398516,1.3232406127849534
SW48,5329102,0.4162536894409948
TTC-709,navitoclax-pluripotin (1-1 mol-mol),-1.651064275168744
PE/CA-PJ49,11238147,2.578263887023537
U-BLC1,carboplatin-UNC0638 (2-1 mol-mol),2.641010105656614
PK-1,selumetinib-decitabine (4-1 mol-mol),6.3008074257845195
ML-1 [Human thyroid carcinoma],322968,3.685498672876688
BICR 22,11427553,3.133254296040306
U-BLC1,3465537,1.550402791454292
EB1,107985,-4.010764763700101
NCI-H2452,72376,-3.519434001557919
JHUEM-1,4578,4.507503382335759
SNU-1272,25062766,3.227496058351171
ML-1 [Human thyroid carcinoma],11238147,1.6119243998814434
SUP-T11,16741245,3.402859034140645
K-562,135984461,3.2548026411837787
Ishikawa (Heraklio) 02 ER-,67156097,-1.7291512235486406
SaOS-2,BRD-A02303741-navitoclax (2-1 mol-mol),3.697295369553163
Daudi,73707398,-0.7942959168982594
NCI-H2452,46398810,2.3683678826725387
KHM-1B,52947716,-7.453605591404808
PaTu 8902,5738263,4.741832860910815
LMSU,104842,-1.1999760069124146
ES-2,24901704,4.055757165432483
SNU-886,24785538,0.7681311411213433
JHUEM-7,9911830,1.3841062029972715
BT 248,11494412,3.557230805764516
Mino,984333,-0.7975164448808868
BT 440,262093,2.750742554492899
MOLP-8,10322450,4.082153801594249
SUP-T11,19582717,2.8616544738162104
KP-3,89928392,1.4992284192645884
HARA [Human squamous cell lung carcinoma],54618164,4.558968644978708
Ishikawa (Heraklio) 02 ER-,135421197,3.044962376223266
SW48,5287620,-2.9796019172473747
LMSU,5291,4.5569666616011
COR-L95,navitoclax-birinapant (1-1 mol-mol),-1.5627413747354164
MOLP-8,56963564,0.2564931281605764
Granta-519,375860,-0.9367901929922506
NCI-H1395,5351362,2.8626857880223757
JHUEM-2,54649381,2.2170818577793416
BT 440,51039095,-2.0142055973785933
DLD-1,135875424,4.314785833755313
SK-MEL-2,53392493,3.090478956198119
SK-CO-1,656346,-0.6691405855346803
RCC10RGB,44607531,1.912198544747903
ST486,9840324,5.960681922596635
EB1,11167602,1.3482748147027377
RKO,9823820,5.913042612438718
PE/CA-PJ49,vorinostat-carboplatin (1-1 mol-mol),1.7635048618773828
SW1271,25262965,-0.6695626057691765
SaOS-2,2742550,4.001711578380083
U-BLC1,5291,3.577276437878924
F-36P,4261,-0.0770989167686455
SW948,44491742,3.910317363967626
K-562,25105715,3.3934107563871088
K-562,3689413,1.0071697658281389
NCI-H1568,9911830,1.3917537385715242
YD-15,6918878,3.100550028921635
DLD-1,6918328,1.1596034632929284
JHUEM-1,24821094,2.8958219421397193
IGROV-1,42642645,0.3750175292659389
MOLP-8,53392493,1.8438027475223988
KHM-1B,25183872,-1.3979896685185154
KLE,11609586,0.7062994369280325
BICR 22,4788,5.9489186959823845
IGROV-1,5287620,-1.5394168430569777
LMSU,24797083,1.8363127025251853
F-36P,1750826,-1.9122301239542712
IGROV-1,446155,3.750396425244744
SEM,3465537,0.8371255640679629
LS180,15983966,-3.417830365026362
MDST8,5566,3.234550965497495
K-562,644241,-4.86229706466587
ES-2,3011155,4.465554396484419
SNU-1079,3062316,-6.25319603388786
ST486,4261,-0.7901507515420343
YD-15,44507138,1.777510390162237
SU-DHL-1,135421197,1.1384736779813156
KLE,10113978,4.613150784757447
L3.3,11626560,2.44177024695359
KU-19-19,44507138,1.5611189443326865
Panc 02.03,5281321,1.7682996743542674
SW948,44607531,1.464462944366021
KU-19-19,54649381,3.8760376098429616
Daudi,25062766,1.1734245449662122
JHUEM-7,3503,1.4827187688333288
IGROV-1,56946209,-4.416985130578084
ML-1 [Human thyroid carcinoma],49766530,-1.1158595986885904
NCI-H2452,11238147,5.37150149846425
HARA [Human squamous cell lung carcinoma],vorinostat-navitoclax (4-1 mol-mol),1.9090977342000552
HEL,3689413,-2.191477482826257
HT-1376,1317464,3.697569880447167
WM115,285033,-0.1832916587196474
SaOS-2,piperlongumine-MST-312 (1-1 mol-mol),1.0729634254150997
PE/CA-PJ34 (clone C12),56949517,4.317826888670926
SU-DHL-1,426756,3.3694285311129777
EB1,56949517,3.4321780141914933
WM115,135999136,1.8466122948256136
IA-LM,45279963,4.638115534107364
RERF-LC-Ad1,11427553,3.528122025886616
MDST8,JQ-1-UNC0638 (2-1 mol-mol),2.369730621007783
SW948,4917,3.7157271581620166
Granta-519,119182,-4.107570420442856
MDST8,56946209,-2.145438357732055
HuP-T3,9927531,4.952379772704904
MKN1,322968,3.54002667297575
HT-1376,159324,4.157820954342544
PE/CA-PJ49,445643,3.8626930631521232
RCC10RGB,72967,3.7162805539485775
RERF-LC-Ad1,5311,3.464534219485875
P31/FUJ,vorinostat-carboplatin (1-1 mol-mol),1.4493920018144175
COR-L105,25126798,3.974391104898093
KMS-21-BM,216468,0.0458128000623903
IGROV-1,676352,2.310492141650647
MOLM-13,11640390,3.605079146985929
SW1271,10302451,1.5832525718610488
HEL,123631,2.2046071754004553
Daudi,9887053,0.4273795924431001
SNU-C2A,selumetinib-navitoclax (8-1 mol-mol),0.8367709256298629
EB1,11609586,1.7632469968238649
HT-1376,2749,1.6616973918160447
HCC15,53232,1.2438342439906054
F-36P,11609586,2.595671819234626
HT-1376,6610216,4.281490165857978
KU-19-19,crizotinib-PLX-4032 (2-1 mol-mol),2.7637212964945745
MOLP-8,107970,1.7976582890286323
JHUEM-1,25161177,3.973954966097695
COR-L105,12003241,-1.8759508779616432
SW948,11222830,1.2602033369542562
EB1,selumetinib-GDC-0941 (4-1 mol-mol),0.2218139267104855
JHUEM-2,selumetinib-GDC-0941 (4-1 mol-mol),0.855828928912332
LS411N,60750,3.4958773713368725
SK-HEP-1,selumetinib-decitabine (4-1 mol-mol),7.187577119098816
COR-L95,11152667,-1.0192155235937173
RCC10RGB,136227924,3.611686331312014
Granta-519,46398810,1.929291860170987
SW1271,135999136,4.614562085611917
Mino,71466445,1.235748115046604
IGROV-1,53232,2.4872106086763393
SW1271,5329102,1.7502689549650896
Granta-519,136227924,1.3333863896282263
JHUEM-7,49766530,-0.0352390480057696
HCC15,11213558,1.313690011959325
BICR 22,54619267,3.924840101579574
MDST8,9907093,2.778674083883115
SNU-C2A,25062766,1.6192668403554755
SNU-626,19582717,5.525219427623082
SNU-1079,doxorubicin-navitoclax (2-1 mol-mol),-0.3776208958431385
JHUEM-2,89928392,0.2569271183452987
KPL-1,135423438,2.328481946215466
P31/FUJ,11175137,-0.7372235608093404
SNU-886,navitoclax-PLX-4032 (1-1 mol-mol),-7.656166203992468
U-BLC1,5978,1.6724350572543345
MDST8,36314,1.6029219233562175
PE/CA-PJ49,6184667,3.0743635737706287
PaTu 8902,2746,3.932313359375791
BT 248,19582717,6.9976074882401464
U-BLC1,24964624,1.9854399206604736
DLD-1,25262965,0.9056847648825788
JHUEM-2,452548,-3.513433821367188
P31/FUJ,3543504,4.167476980253382
NCI-H1395,5328940,2.584315328897391
SK-MEL-2,3854666,3.3106573281169664
KMS-21-BM,60168763,2.387586891456924
U-BLC1,salermide-PLX-4032 (12-1 mol-mol),4.500457696250996
MOLM-13,selumetinib-decitabine (4-1 mol-mol),-2.0497039310535548
BT 440,46843906,3.851439402951492
KHM-1B,2708,5.139604125220885
HCC1500,2749,1.6972528944159595
HCC1500,2858523,2.9580940168196372
SNU-626,4477,1.017668614554191
P31/FUJ,241158,2.9181679480161997
JHUEM-2,5746,-4.598293680200081
IGROV-1,44202524,1.8303703172382677
Hep-G2,5329102,1.3159700162106798
COR-L95,24856436,0.3013384579313291
Daudi,15983966,-4.480185591931726
BT 248,vorinostat-navitoclax (4-1 mol-mol),1.3262626080799325
MDST8,9903786,2.958137426904596
SU-DHL-1,57519531,0.9649766396601452
Mino,46943432,-0.4971400671027619
Ishikawa (Heraklio) 02 ER-,107970,3.1744092198805136
KP-3,439501,-2.4441073658124837
KLE,119182,1.982009911849402
IGROV-1,25262965,-3.18785020602057
KP-3,15983966,-3.1742686275598544
MOLM-13,135411,-0.7080955458923358
SNU-1079,73707398,1.1905051072298996
HCC15,24901704,2.315976175325417
SW1573,656346,0.5263129478884733
KP-3,66577038,3.7551165367906183
SW1573,11238147,3.4967804964098517
ES-2,216345,4.651058265801369
MOLM-13,6918837,-5.322581124261525
PK-1,16722836,2.67895362390032
MOLM-13,444795,-0.8871401586886155
HARA [Human squamous cell lung carcinoma],2733526,3.2699742840947414
SW948,44486219,4.202726475674803
ML-1 [Human thyroid carcinoma],10302451,5.152653454280482
JHUEM-1,5284616,3.06039980815146
SK-HEP-1,4259181,0.3926762831937545
MOLM-13,11152667,-8.249378694414048
HCC15,46199207,3.454904957256138
DLD-1,6852167,3.5764523935832835
KMS-21-BM,vorinostat-navitoclax (4-1 mol-mol),-0.2852579046059981
YD-15,9903786,1.471025688701345
Mino,16722836,0.7296299535363473
T98G,54626689,4.664801909720088
SNU-C2A,piperlongumine-MST-312 (1-1 mol-mol),1.5654160688863583
COR-L95,BRD-K55473186,4.076833088818027
SK-HEP-1,11612883,3.763210558313423
SW48,54619267,2.8192087316830587
JHUEM-2,sirolimus-bortezomib (250-1 mol-mol),-3.6728570307591686
SNU-C2A,60750,-3.4786133823302308
COR-L95,448949,2.666065821382702
SW1271,31703,-2.541706035799043
EB1,51037431,4.716485958866943
SW48,374536,2.9137455711630365
KP-3,2945648,-0.541885973592653
HuP-T3,25183872,-1.5149537087973208
SEM,168313200,1.52373638401344
KLE,9956119,2.1756146990139893
SNU-1079,44491742,4.118848224044972
BICR 31,71466578,6.11729815776394
PaTu 8902,JQ-1-UNC0638 (2-1 mol-mol),3.325968686418886
SW48,135440466,-0.9616456131279733
PE/CA-PJ34 (clone C12),3062316,-0.5825484419455179
Granta-519,322968,2.3569390760499234
ST486,44462760,4.556174113476003
RCC10RGB,25227462,3.0929907596871646
P31/FUJ,6917907,-6.201167718101803
PaTu 8988t,49793307,-2.0749757720441164
KLE,11656518,-1.5343189257668943
PK-1,25262965,-2.3848617415413944
HARA [Human squamous cell lung carcinoma],9884685,2.402658407469787
Granta-519,12001922,1.093482575381039
SUP-T11,6438330,0.6205409460668598
SaOS-2,54649381,4.670802712896813
BICR 31,11213558,1.307666782243681
TTC-709,9823820,1.6769625379879112
T98G,6852167,2.9321470861606533
NCI-H1568,crizotinib-PLX-4032 (2-1 mol-mol),1.1920351291695386
EB1,56649450,1.4770605778390775
RKO,selumetinib-UNC0638 (4-1 mol-mol),2.378322605916553
P31/FUJ,tanespimycin-bortezomib (250-1 mol-mol),0.0118872693017982
ST486,984333,-2.7913464382085102
SW1573,216468,2.7570678542174294
EB1,216468,-0.3222972067703157
WM115,selumetinib-UNC0638 (4-1 mol-mol),-1.6649688708670054
F-36P,2871966,1.4289930371727075
Ishikawa (Heraklio) 02 ER-,17755052,4.1414597350773015
KP-4,3384730,1.9659289598707523
YD-15,135411,0.2349376716896317
LMSU,65628,4.981021352317802
LCLC-97TM1,441298,2.906797889353979
LS180,24753719,4.21554861148433
ALL-SIL,65064,2.797289094590348
BICR 22,67291369,2.228219380635809
RERF-LC-MS,168313200,3.896073258981905
SK-HEP-1,9444,4.343802313850578
PaTu 8988t,5328940,1.37213408852796
SK-LMS-1,71304818,1.7309088009251954
BICR 22,5311,1.9321946929787237
JHUEM-1,24785538,0.9043236098922054
BICR 31,219104,4.339385963743166
IA-LM,navitoclax-birinapant (1-1 mol-mol),0.9661669112911666
SNU-626,BRD-K03911514,4.309057067858805
ALL-SIL,4477,0.1906678465210559
K-562,25154868,2.7747166739598264
SK-HEP-1,16065773,3.000790971898234
KMS-21-BM,46943432,-0.8221930725706761
TTC-709,JQ-1-navitoclax (2-1 mol-mol),1.1246353345671278
F-36P,148124,-6.364948087395455
PaTu 8902,11364421,1.1100050491651887
JHUEM-7,135398744,6.411220982649173
NCI-H1568,3081361,2.134244125445247
T98G,126941,-1.874386254352517
HCC1500,11640390,3.4842141291887234
BFTC-909,11626560,2.2197507332783735
SW948,107970,1.650733689507072
Hep-G2,11964036,2.846173129754555
EB1,11238147,1.7290959187407746
RKN,15983966,-2.847635435689191
P31/FUJ,11455910,0.7543092217738059
MDST8,71466380,4.4925072325945825
Ishikawa (Heraklio) 02 ER-,104842,-0.9454178220793432
HuP-T3,44185566,3.047929926499308
Mino,44486219,3.4156514230359187
WM115,24772860,-3.130789858430774
COR-L95,327653,2.664763845896721
TTC-709,444795,4.010443492718726
MKN1,73707371,3.8420133696618266
BICR 31,46398810,2.284799792972812
MDST8,46199207,3.2831338438462545
KP-4,122327,4.232816492077044
P31/FUJ,54143018,-1.089453758548118
SNU-886,66577038,3.44647688682178
RKN,119607,5.106543735080002
COR-L105,5746,2.3338049438674933
JHUEM-7,24797083,1.6268225461289076
ALL-SIL,alisertib-navitoclax (2-1 mol-mol),-3.0899588817168286
MOLM-13,5738263,2.9100103684660237
MKN1,60700,2.343247303580231
RERF-LC-MS,216345,4.25766275770173
YD-15,24785538,1.150016987214591
P31/FUJ,10322450,3.023071845081992
BICR 22,16065773,3.2562595111068933
HARA [Human squamous cell lung carcinoma],3136844,4.042885024123848
HuH-6,9444,3.633932701764728
RCC10RGB,2858523,3.1824977664847833
BT 440,11640390,5.76148689887496
PE/CA-PJ34 (clone C12),135984461,4.299717419292052
Ishikawa (Heraklio) 02 ER-,11612883,3.769065749220348
HEL,3634881,2.3660153954756
BICR 31,4705,2.7587837218207194
Daudi,16736978,-0.1290294552432643
HCC1500,409805,3.5957056987066407
COR-L95,11497983,3.7904455836505977
NCI-H1568,erlotinib-PLX-4032 (2-1 mol-mol),1.5802949352112503
F-36P,44486219,4.258266572630148
LMSU,6914657,-3.5331603162899707
HuP-T3,123631,3.4682236131630213
MOLM-13,6918736,-1.7098661921605196
PK-1,89928392,1.414900473790517
MOLM-13,46943432,-0.154947866345158
TTC-709,3825829,4.017884696288738
HCC1500,219104,2.0821347677363473
WM115,salermide-PLX-4032 (12-1 mol-mol),1.9364726172790967
L3.3,24771867,2.302026780280536
U-BLC1,122327,5.09606986062793
KHM-1B,1716436,3.4645640712789545
NCI-H1568,65064,3.2204713254113373
JHUEM-2,400769,-0.8496017652303414
TTC-709,3503,2.4398461872457635
BT 440,12003241,-2.6320772698218793
SW1271,16720766,0.8044088826386648
Mino,89183176,2.200230277226517
Daudi,119607,3.8512151262400978
EB1,613753,2.793606454671517
KP-3,9868037,3.7824186326212494
HCC1500,72193861,2.243893882523798
K-562,5328940,0.7651330448756731
BT 440,46907787,5.667511206840828
SaOS-2,644241,2.5011234622868415
Mino,9911830,1.0503076614334173
HEL,60700,-1.2821695146150829
RERF-LC-MS,25227462,0.8140348385016122
JHUEM-1,6852167,1.554254101027855
NCI-H1395,11485656,1.9214345391656065
MKN1,BRD-A02303741-navitoclax (2-1 mol-mol),3.361423153160033
COR-L95,4521392,4.944619543772989
KU-19-19,16720766,1.6427063989874335
ES-2,11626560,2.390859771380784
SK-OV-3,3025944,4.375754256809385
P31/FUJ,36314,-5.221113398603202
Panc 02.03,568763,0.7660787595735656
SUP-T11,44589607,1.1471522837752322
PaTu 8988t,60700,1.4149082605005396
BFTC-909,421610,2.763760389372973
IGROV-1,selumetinib-piperlongumine (8-1 mol-mol),2.9206278268520163
RERF-LC-MS,123631,2.7610356359897104
SK-LMS-1,25102847,2.448614110794131
KHM-1B,4915,4.394677312814559
IGROV-1,selumetinib-decitabine (4-1 mol-mol),3.5551285698551225
PE/CA-PJ49,42611257,3.1679792717367263
RKN,10385095,1.0188882527918253
Mino,54678924,1.078833350632611
F-36P,9884685,0.0275163434096536
PE/CA-PJ49,241158,3.9020503625286698
L3.3,969516,2.9670664389679677
K-562,carboplatin-etoposide (40-17 mol-mol),2.706166377048538
Mino,148198,-4.997781998015961
SW1271,selumetinib-vorinostat (8-1 mol-mol),1.620526536353516
Daudi,44486219,3.679556481815833
SK-CO-1,JQ-1-carboplatin (1-1 mol-mol),4.771818519750647
JHUEM-1,25195348,3.67413485378292
MKN1,sirolimus-bortezomib (250-1 mol-mol),0.957329263001516
P31/FUJ,159324,1.227532336429348
Mino,tretinoin-navitoclax (4-1 mol-mol),-3.6288399741987374
SK-CO-1,6252,-1.3434891204218062
LCLC-97TM1,656346,0.6605690440583806
Panc 02.03,SNX-2112-bortezomib (250-1 mol-mol),-0.27502478347835
RERF-LC-MS,675434,4.646232548137413
Hep-G2,selumetinib-GDC-0941 (4-1 mol-mol),-0.4461378228189951
KU-19-19,123631,3.236221278135049
MOLM-13,15983966,-4.417403089755366
HuP-T3,4917,3.663340719397695
SNU-1079,12003241,-2.81102043929997
JHUEM-1,10127622,4.186941997949632
SNU-C2A,613753,3.171743819627587
LS180,44185566,1.7571027497277631
P31/FUJ,11228183,-0.9086595542209992
WM115,9933475,1.7795579913266513
RCC10RGB,445643,3.986839371383198
PE/CA-PJ34 (clone C12),156414,-2.3095911483351004
JHUEM-1,16065773,2.284888465255553
PE/CA-PJ49,3503,2.351778774467552
LS180,11238147,1.5426585727528574
HuH-6,11719255,3.5430689342168797
SK-OV-3,6918328,0.3966751205296329
SU-DHL-1,71466578,4.395132834723917
LMSU,2945648,2.8278602599693805
ALL-SIL,135421197,0.8278001934093618
LMSU,375860,0.9440264058556476
SEM,6918878,-2.4366739995343196
BICR 31,2858523,3.440938149330432
NCI-H1568,72734382,4.159676082420196
BICR 31,10427712,4.26091650049326
K-562,5351362,1.2059406782397044
KPL-1,168313047,2.7762157880111515
Hep-G2,navitoclax-pluripotin (1-1 mol-mol),-0.1847699337637438
HEL,44589607,2.8579344181758164
SNU-C2A,10410894,4.172006075935971
U-BLC1,44491742,3.768443657215341
RERF-LC-MS,89928392,3.2509495975064193
SEM,24785538,0.2976290069751733
K-562,4705,3.481256778033869
SW948,400769,-0.4902020150535968
F-36P,54454,2.519969881307033
MKN1,2841722,3.821594677272044
RKO,46199207,3.448070090368443
L3.3,56946209,-3.919110396505915
SEM,46398810,0.2793522314631458
HuP-T3,10410894,4.484643398072658
BICR 31,969516,3.644181632779252
WM115,54618771,0.9043395114740442
LMSU,4259181,1.0604093757007595
SK-MEL-2,6610216,4.255505327986827
T98G,5328940,2.326372907998824
MKN1,44491742,4.1588945650125355
SNU-886,6610216,4.570931249301276
U-BLC1,5494449,1.776057774783635
MDST8,2749,2.5181508528519365
PE/CA-PJ34 (clone C12),49793307,-5.119931749998305
Mino,25150857,1.4207276079060136
LMSU,24785538,3.035127880697954
SW1271,4378219,1.9495591217614856
RERF-LC-MS,12003241,-0.3897829713203344
ML-1 [Human thyroid carcinoma],11683005,4.957719989216769
PaTu 8902,44620216,3.796821774118314
MOLP-8,4378219,3.751203523477959
KPL-1,44819697,-0.2842395186045565
PaTu 8988t,11152667,-0.7220641758089987
SK-OV-3,navitoclax-gemcitabine (1-1 mol-mol),0.2321972175274424
PE/CA-PJ49,2871966,-1.0203219249186255
KP-4,73707398,1.2219624501401705
SK-OV-3,60700,0.4435128165358443
LS180,168313047,2.515878081381246
K-562,400769,-0.7978860959413716
Panc 02.03,126941,-0.7071805078882285
TTC-709,23635314,-2.4879187661369113
BT 440,568763,0.2715813855104242
SUP-T11,445643,3.172800596914008
NCI-H1568,3634881,3.2529386900783024
PE/CA-PJ34 (clone C12),322968,4.7320744640732775
JHUEM-1,135411,0.7795801140018243
LCLC-97TM1,24821094,3.5658031163211996
LS411N,11485656,1.6093796612349578
HCC15,16736978,2.153897232237977
LCLC-97TM1,6610355,3.6494140877324273
IA-LM,serdemetan-SCH-529074 (1-1 mol-mol),2.9054360397422387
IGROV-1,9911830,1.9130562323799436
EB1,1566236,0.9429423424199086
F-36P,49867930,6.1506617063580205
SEM,11228183,-2.6667255532270957
SNU-626,11609586,5.376760668018337
LS411N,159324,3.2133975478450005
PE/CA-PJ34 (clone C12),5479543,3.749651315015809
BT 440,25161177,1.7627984019932852
COR-L105,selumetinib-PLX-4032 (8-1 mol-mol),2.5098576733785705
SaOS-2,322968,3.970591848140582
SNU-1079,24964624,2.3746324480564582
BICR 31,216345,4.54975912567895
HEL,3825829,3.033394475732853
COR-L105,46191454,3.4168297701439223
K-562,5113032,4.649240406472478
SNU-886,11626560,2.6362040536999514
ST486,selumetinib-tretinoin (2-1 mol-mol),4.0228747372167515
F-36P,216345,2.569444897328232
BICR 22,156414,1.4774483319728589
YD-15,6917907,-5.610268932127842
SW1573,135875424,1.8143158468632437
TTC-709,11719255,3.198315791584966
WM115,12003241,-3.303596686294694
BT 248,tretinoin-carboplatin (2-1 mol-mol),4.674619984359253
RKN,11640390,3.613472996393559
HuH-6,11455910,0.6602078622110275
HEL,23725625,2.914554844202699
COR-L95,36462,-0.8944975018350346
BT 248,2828334,5.879853395133371
HARA [Human squamous cell lung carcinoma],53232,3.05929528970331
KHM-1B,JQ-1-carboplatin (1-1 mol-mol),-0.2133455800101861
HuP-T3,11977753,3.281021154274905
SK-HEP-1,400769,0.2777482831309371
KP-3,9907093,4.849472171367946
BT 248,135398516,2.090653291947233
IGROV-1,vorinostat-carboplatin (1-1 mol-mol),2.9918987847321645
SU-DHL-1,246676,5.693727803678488
JHUEM-2,375860,-1.6699040750668208
HARA [Human squamous cell lung carcinoma],11626560,1.1307601374566012
SUP-T11,31703,-4.062652479103575
KMS-21-BM,2742550,2.736475414851647
PK-1,44566777,0.3866542647986699
PaTu 8902,selumetinib-JQ-1 (4-1 mol-mol),5.2969208566894075
RCC10RGB,44507138,4.147954700367582
LS411N,123631,3.048490743589503
MOLM-13,11213558,-2.3442824820578347
SNU-886,6184667,1.0916410821784486
ES-2,159324,3.623206092591176
MOLP-8,selumetinib-tretinoin (2-1 mol-mol),3.5259628447658495
SW48,tanespimycin-bortezomib (250-1 mol-mol),-3.595985811968766
PaTu 8988t,444795,4.288290341819835
BT 440,123631,2.1399868263151443
SK-CO-1,66577038,1.9378658470267984
SW48,24771867,-3.897611921368264
NCI-H2452,9907093,3.826391051371518
SW1271,171352865,2.2565348875691624
MKN1,135411,2.680389546140594
SU-DHL-1,11152667,-1.9410189761528236
SNU-886,54618771,-0.5899639628082597
BT 440,selumetinib-PLX-4032 (8-1 mol-mol),2.469568356521739
SK-HEP-1,148124,3.734435411699081
DLD-1,9952709,3.1250574069670325
RERF-LC-MS,107985,-3.0933260647006215
HARA [Human squamous cell lung carcinoma],44589607,3.368220225067554
ES-2,6917907,-4.897484501192692
KLE,44489367,4.867561911603137
ML-1 [Human thyroid carcinoma],36314,-4.393977809452653
L3.3,5460769,1.7814582708772182
RCC10RGB,10184653,2.2305820416370965
KP-3,24753719,4.638034647169119
LS411N,17755052,2.4732315703899226
T98G,11455910,0.2544044244043033
Granta-519,decitabine-navitoclax (2-1 mol-mol),-1.3661382782873654
YD-15,72734382,6.048639396980455
KU-19-19,24753719,4.40371401160258
PaTu 8902,72376,-1.694582331183855
HEL,72376,-3.0304513894944933
ML-1 [Human thyroid carcinoma],25150857,2.4072078224567486
SW948,9884685,3.1398548031465525
HuH-6,124202324,1.2702789255511149
TTC-709,24856436,1.2539297836858547
T98G,11214940,4.252797677777658
KMS-21-BM,16722836,0.2844686188878079
Daudi,24748573,1.578133478161721
Hep-G2,9444,4.035145780865591
COR-L95,4917,3.3160135329409406
SNU-626,selumetinib-MK-2206 (8-1 mol-mol),5.044556239697318
KMS-21-BM,387447,-6.5544559619500955
SUP-T11,4261,1.8230084374179292
HuH-6,12001922,1.1856032378119004
JHUEM-1,10302451,3.0563523137347386
SK-CO-1,2708,2.7526164010571152
Daudi,5479543,1.606221989903471
KHM-1B,2130404,2.712460002003977
PaTu 8902,vorinostat-navitoclax (4-1 mol-mol),1.8599454099065449
MOLP-8,44632017,0.8356757219547752
SW1271,9868037,2.9396003878324857
EB1,navitoclax-piperlongumine (1-1 mol-mol),0.8956278254367742
Ishikawa (Heraklio) 02 ER-,4259181,-1.51348893728215
COR-L95,11455910,1.0154509596480157
IGROV-1,445091,5.8777802446160825
IA-LM,107970,1.9308025720075177
BICR 31,15953870,5.115358479555731
U-BLC1,445643,3.6564234762287753
SNU-1079,11640390,3.9191018823307657
JHUEM-2,26596,-3.440401418336309
Ishikawa (Heraklio) 02 ER-,66577038,3.761717076144853
PE/CA-PJ34 (clone C12),675434,4.380294227135041
JHUEM-1,carboplatin-etoposide (40-17 mol-mol),3.511278086752702
HEL,135984461,1.7610482730169696
MKN1,56973724,3.44685961210167
HCC15,vorinostat-carboplatin (1-1 mol-mol),2.4228610420151853
PaTu 8988t,5311,3.6038975682992422
MOLP-8,navitoclax-pluripotin (1-1 mol-mol),-0.3360266341011599
RCC10RGB,BRD-A02303741-navitoclax (2-1 mol-mol),1.3031528560505037
SK-CO-1,11228183,0.9546983133897222
IGROV-1,JQ-1-MK-0752 (1-1 mol-mol),1.6911705649982345
NCI-H1568,selumetinib-vorinostat (8-1 mol-mol),2.593817270705759
ML-1 [Human thyroid carcinoma],441298,2.939924630100921
BICR 22,42642645,1.569820729256039
KHM-1B,24775005,4.409922848852168
RERF-LC-MS,387447,-4.351660250848144
BT 248,421610,3.3246840566564484
SU-DHL-1,carboplatin-etoposide (40-17 mol-mol),-0.8202872264800385
RKO,676352,2.3070338313311547
HEL,66577038,3.4935326109734217
RERF-LC-MS,25062766,1.7296886540377192
HT-1376,1716436,2.2352154911916826
Mino,16219061,1.1508668062940444
TTC-709,sirolimus-bortezomib (250-1 mol-mol),0.2718728202081833
RKN,52947716,-5.912196482956353
T98G,selumetinib-PLX-4032 (8-1 mol-mol),4.447685908581679
SW48,56973724,0.919295357428288
T98G,15983966,2.357104816945284
LS180,66577038,2.8527700320727725
BT 248,selumetinib-JQ-1 (4-1 mol-mol),2.943393356661563
K-562,7251185,2.894408284149289
ALL-SIL,sirolimus-bortezomib (250-1 mol-mol),0.3093926374933456
SNU-1079,168312962,1.6902364028725867
HT-1376,123631,1.6426293055914376
ML-1 [Human thyroid carcinoma],3025986,-0.9166044093803444
PK-1,15547703,4.352850880309098
MOLM-13,6918878,-0.6248914400619264
PK-1,SNX-2112-bortezomib (250-1 mol-mol),-2.452800900941345
SNU-1272,9911463,4.2598402664697685
IGROV-1,135421197,1.96820638017286
YD-15,piperlongumine-MST-312 (1-1 mol-mol),3.225494785069345
RKN,11404337,0.6786980557761386
SU-DHL-1,6918878,1.5556600104975795
MOLM-13,176870,1.4073018577806429
SaOS-2,44566777,0.9896093397626105
COR-L105,5470400,0.2171168006478052
JHUEM-7,71751553,3.8993350668195874
LS180,44632017,0.4358481157568056
KMS-21-BM,374536,-3.263973560371936
RCC10RGB,16065773,4.176477311044804
BICR 31,156414,0.5699919561712937
ST486,11719255,1.8164025208034495
SW1271,tanespimycin-gemcitabine (1-1 mol-mol),1.3087817847802907
HCC15,JQ-1-navitoclax (2-1 mol-mol),-0.7343032708143507
Daudi,54596490,4.948926549609605
NCI-H2452,11317348,1.7824301660124695
ES-2,969516,2.833424573941631
IGROV-1,60700,0.4424479122017752
IA-LM,135421197,2.370501142960713
TTC-709,5329102,1.914234859629825
NCI-H2452,135423438,1.816833708086427
NCI-H2452,6918837,-2.3246752526945413
HuP-T3,409805,5.703463345532586
PK-1,navitoclax-piperlongumine (1-1 mol-mol),2.439572673358856
Daudi,UNC0638-navitoclax (1-1 mol-mol),1.2047563677281543
WM115,3025944,4.015069634557516
BICR 22,10127622,2.812639951672956
RCC10RGB,16741245,4.755009504271123
LMSU,10074640,3.239182097688426
BT 440,selumetinib-vorinostat (8-1 mol-mol),2.9296723538082543
MOLM-13,selumetinib-JQ-1 (4-1 mol-mol),-6.008931443997215
BFTC-909,1641662,3.805506520632872
T98G,9907093,4.000361553566613
SK-HEP-1,3136844,5.506062707172487
SNU-1272,11507802,4.459274197083698
MOLM-13,5335621,3.915836728943439
SUP-T11,11656518,1.6910327877106373
SNU-626,11626927,4.210211162636467
ALL-SIL,6918736,-2.784980550106597
NCI-H2452,selumetinib-navitoclax (8-1 mol-mol),2.20402438215903
SUP-T11,6252,1.184500528355623
KMS-21-BM,54618164,2.5308412572805836
SK-OV-3,5311,1.582209129738937
SNU-1079,44489675,3.538154911300256
NCI-H1568,4378219,1.8995328874154
KLE,5311,0.8745221025044583
Mino,BRD-A02303741-carboplatin (1-1 mol-mol),6.067201614268015
KP-3,25150857,1.525204608043172
LMSU,3503,1.6210474530909185
YD-15,6918837,-2.40837440530221
PaTu 8988t,135440466,2.5529183901912456
P31/FUJ,208908,3.0114989034455415
MOLM-13,55508,1.530825081139479
ALL-SIL,15983966,-4.919474478826657
YD-15,5282054,4.105580966227819
KMS-21-BM,44185566,1.2609774746078743
SNU-626,4261,1.9426458515987195
TTC-709,3634881,2.3648885918962748
ALL-SIL,72193861,-0.8088702984298154
Granta-519,135875424,2.983761714085865
Mino,31703,-3.4550388642767804
Mino,6438330,0.2946996472314958
YD-15,JQ-1-navitoclax (2-1 mol-mol),-0.7132805867221397
Panc 02.03,25062766,3.7424097220448207
LS411N,5282054,4.11513360382112
WM115,9956119,3.8110537513046423
Daudi,10077130,1.7104594990439606
PaTu 8902,54618771,-1.3103145579416535
JHUEM-7,54678924,1.7960871559050613
LS411N,6610355,5.174673905344729
HARA [Human squamous cell lung carcinoma],446155,2.5576922800664006
Daudi,11364421,-5.814557541528941
EB1,56946209,-7.6403287422829536
SNU-886,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1159003486040796
U-BLC1,23582824,-0.5070986745999825
Hep-G2,89183176,5.542677270745169
YD-15,5281321,-0.8533413879413473
SW48,10090485,5.377611493091081
RERF-LC-MS,252682,6.464777279315186
JHUEM-7,7251185,2.276113292965344
RERF-LC-MS,25195348,2.310586589861769
LS411N,57330099,4.386912904802011
NCI-H1395,5470400,-0.4743897093415642
SNU-886,445091,2.7467604761461097
SNU-626,3062316,4.0041317683316615
RERF-LC-MS,5351362,3.2669953777859493
SaOS-2,5281321,-2.1045144226453134
MKN1,46907787,2.3395662903789236
Ishikawa (Heraklio) 02 ER-,3025986,0.0796425766319246
SW948,navitoclax-gemcitabine (1-1 mol-mol),0.2837649103664914
HCC1500,15953870,3.698430879415157
F-36P,selumetinib-piperlongumine (8-1 mol-mol),0.8828234525060702
KP-4,676352,2.009740808043753
ST486,24748573,0.9358694929901594
EB1,3062316,-5.6031484725767955
ST486,9935249,0.774563781013363
BICR 31,107985,-2.559614665868775
SU-DHL-1,5978,-4.006589870739168
SK-HEP-1,387447,-3.995016034956776
SNU-886,5351362,1.18697411300336
HARA [Human squamous cell lung carcinoma],11609586,3.326388879496588
BICR 22,44491742,3.912327775797625
NCI-H2452,10113978,2.1292579793865167
SW1271,selumetinib-MK-2206 (8-1 mol-mol),0.1264422257766406
F-36P,9823820,3.346943023702952
HCC1500,JQ-1-vorinostat (2-1 mol-mol),1.1801971963023554
SNU-C2A,crizotinib-PLX-4032 (2-1 mol-mol),2.1600712253537324
KPL-1,6610216,4.881878965578164
MDST8,JQ-1-vorinostat (2-1 mol-mol),0.5745237647612197
SNU-886,49867926,2.0094382345952377
PaTu 8988t,10074640,3.912219918984309
TTC-709,4578,4.285325846451085
RKO,25102847,3.0524897378806033
K-562,446155,2.553560117982406
HuP-T3,3062316,-3.5835263694309862
BICR 31,selumetinib-piperlongumine (8-1 mol-mol),5.193629730371027
HCC15,selumetinib-MK-2206 (8-1 mol-mol),0.2516850341197869
COR-L105,9915743,-1.8659407955600968
SU-DHL-1,676352,1.6127382742380425
EB1,16741245,4.843171965598496
JHUEM-7,374536,2.8371018707127065
Mino,16038120,0.7971993664500123
JHUEM-2,11960529,2.2382057603638694
SK-CO-1,15983966,-2.8914318783251733
BFTC-909,6450551,3.0302116860685886
HEL,salermide-PLX-4032 (12-1 mol-mol),3.70170985200322
LCLC-97TM1,6852167,1.822160840349085
JHUEM-1,135423438,4.272448858092011
JHUEM-7,24771867,-0.3037567272373623
SK-LMS-1,3025944,4.18904978597071
K-562,1716436,3.607306146681396
ALL-SIL,6917907,-6.413711962559719
L3.3,24856436,2.4877361998822924
SW48,44505237,4.455085659285412
MOLP-8,4788,5.509648062033256
KU-19-19,49793307,-2.3409308252506777
SUP-T11,3081361,2.6672960851256917
BT 248,72193861,2.013908806167315
IGROV-1,46843906,3.392503571349757
LS411N,selumetinib-navitoclax (8-1 mol-mol),0.3933540744124401
NCI-H1568,23582824,0.2708211860244319
P31/FUJ,156414,0.8249508749632878
PK-1,168313016,5.489792964329215
HuH-6,10322450,3.486001071319901
HCC1500,vorinostat-carboplatin (1-1 mol-mol),3.9041081325977616
BT 248,salermide-PLX-4032 (12-1 mol-mol),3.4628856053275623
NCI-H1395,24901704,3.973165668688871
ES-2,2729026,3.009799911387396
YD-15,374536,0.3727262379763149
Panc 02.03,24951314,2.3006835537528585
HuH-6,11238147,3.2820495901869347
RERF-LC-MS,46199207,3.61094494328213
SEM,10427712,3.915195829350839
MOLM-13,docetaxel-tanespimycin (2-1 mol-mol),-6.839014739935568
JHUEM-1,44589607,2.059570099961588
IGROV-1,25102847,1.7007012555618253
SUP-T11,24180719,2.870555565285409
COR-L95,9884685,1.274087436172542
RKO,5738263,3.4166283525852523
BICR 31,446155,3.004688823756655
PE/CA-PJ49,9911830,2.222449473418187
MOLP-8,3081361,3.002632255231731
KU-19-19,124202324,2.2262797687523266
COR-L95,241158,4.468160037389037
L3.3,4096211,2.2417011569185763
PaTu 8902,selumetinib-UNC0638 (4-1 mol-mol),4.723826632745484
SK-OV-3,9926054,2.1800400954819716
KP-3,5311281,4.894081294772208
SEM,375860,-0.9031870337732496
NCI-H2452,285033,-1.1649166052412432
F-36P,10410894,2.953395042792216
MDST8,SNX-2112-bortezomib (250-1 mol-mol),-1.5360671270430672
SaOS-2,3136844,3.967600163436525
YD-15,selumetinib-PLX-4032 (8-1 mol-mol),3.177241952280951
Granta-519,36462,-1.2340392932323463
Granta-519,24785538,0.1958729752370936
PK-1,6852167,3.144204149712558
WM115,5566,2.8846390038255127
SK-LMS-1,135440466,3.2849983532836653
IGROV-1,31703,-1.792518264692263
HCC1500,3025986,-0.5847488606379614
BT 440,11497983,4.277226637438273
T98G,5566,3.0750150695937646
K-562,2828334,5.968313970587813
Ishikawa (Heraklio) 02 ER-,387447,-4.209171325852115
JHUEM-1,tretinoin-navitoclax (4-1 mol-mol),3.017309249052791
HCC15,navitoclax-gemcitabine (1-1 mol-mol),-0.4507382221714274
LS411N,72193861,2.8187845663214848
SU-DHL-6,11964036,-0.1529025297927845
KMS-21-BM,71466380,2.666350669245069
LS180,6918837,-2.789669873343886
SK-LMS-1,15953870,4.449149497882856
DLD-1,54619267,4.218672699125601
Granta-519,445455,5.050402748491994
ST486,54596558,3.765835490999893
LS411N,9926054,1.9376785020428349
MOLM-13,135398738,2.371405234005272
BICR 22,53392493,3.288173891171126
F-36P,46191454,0.986768186878591
SU-DHL-1,crizotinib-PLX-4032 (2-1 mol-mol),-1.5954357785960134
HARA [Human squamous cell lung carcinoma],2126,5.112984415511083
KMS-21-BM,5470400,-3.0285053585997694
F-36P,54618771,0.2911241423131909
PE/CA-PJ49,151289,0.769726200239813
KHM-1B,9903786,1.5275790345873377
MOLP-8,9823820,3.862667538801475
SW948,219104,3.4463785749905886
KHM-1B,2949965,3.6440598201563423
Daudi,56649450,2.7731175257265757
RKO,446155,4.170579555483674
COR-L95,2708,4.088828930735336
HARA [Human squamous cell lung carcinoma],11427553,0.5044011516017802
HT-1376,16038120,1.522574680159769
SW948,6610216,4.184431800680971
SU-DHL-1,vorinostat-navitoclax (4-1 mol-mol),1.2163104495485748
KP-4,9823820,4.4368014972500065
JHUEM-7,753704,4.187441379139962
SNU-626,11364421,2.3574689575179213
MDST8,24978538,-1.5034064763640302
DLD-1,10302451,3.8037310408669502
PE/CA-PJ34 (clone C12),637858,1.319722583622998
IGROV-1,navitoclax-pluripotin (1-1 mol-mol),-0.9669423716100508
NCI-H1395,4705,3.4784735381586183
PE/CA-PJ34 (clone C12),71751553,4.188621560003168
YD-15,135875424,3.8226191901992377
KP-4,alisertib-navitoclax (2-1 mol-mol),0.7704039917355672
JHUEM-7,72734382,4.444949272371647
MKN1,2126,5.32395796494467
BT 248,73707438,3.693804860778579
HuH-6,11640390,3.0178165812974074
JHUEM-7,2749,1.3082739323619237
Granta-519,vorinostat-navitoclax (4-1 mol-mol),-1.0034104350750142
PE/CA-PJ49,6505803,-1.5018082269654205
RERF-LC-MS,44607531,1.5104561529736475
MDST8,16065773,2.461320056751215
KMS-21-BM,4261,-0.8275132093694819
EB1,5311,0.5159644123966424
Daudi,11955716,-2.451420398730992
PE/CA-PJ49,serdemetan-SCH-529074 (1-1 mol-mol),2.62655069783554
Daudi,44566777,-1.3909109996970672
PE/CA-PJ34 (clone C12),44607531,-0.1890255077191596
WM115,53495165,2.3633352174150155
MOLM-13,10077130,2.656845569256352
LCLC-97TM1,11364421,-5.841421445385269
MOLM-13,9887053,0.5396890830211841
IGROV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.258983073493191
NCI-H1395,11396600,4.124168749082167
IGROV-1,46191454,1.3777495915525844
Granta-519,5328940,0.7430401080732436
SW1271,54618305,4.440463475812739
Mino,16659841,3.307784180084336
EB1,carboplatin-etoposide (40-17 mol-mol),-0.2766740669613047
COR-L95,23725625,3.551891881441416
Hep-G2,44498493,5.1826431923254335
RCC10RGB,46843906,4.246883034106686
Granta-519,2945648,2.528276278220214
SNU-1079,71466578,1.4841993991089113
JHUEM-7,44489675,4.154647994164329
SNU-626,135440466,2.646579155045852
JHUEM-2,10427712,3.830457001294499
Granta-519,11977753,-6.302388202708452
Ishikawa (Heraklio) 02 ER-,6918837,-2.157882723850199
SU-DHL-6,15953870,2.4587311871536315
MOLM-13,10322450,2.9930800125873045
SK-LMS-1,9926054,2.9005897081408833
SK-MEL-2,navitoclax-pluripotin (1-1 mol-mol),0.1902174859900846
LCLC-97TM1,6505803,0.2281876141434561
WM115,9967941,2.88500943866673
K-562,44202524,1.302888790519651
TTC-709,46907787,1.4773024325483866
K-562,252682,6.220409267483573
HCC15,49867926,4.259454552862098
BICR 22,25183872,-0.1596442578279089
PE/CA-PJ34 (clone C12),5113032,5.000018786320908
RKO,17755052,3.988455753476612
IA-LM,selumetinib-piperlongumine (8-1 mol-mol),4.519292467442182
PaTu 8988t,5566,2.9380975134161553
NCI-H1395,navitoclax-gemcitabine (1-1 mol-mol),2.205005883298022
K-562,219104,3.3686951285077273
UACC-812,BRD-A02303741-carboplatin (1-1 mol-mol),6.034191295751065
WM115,100016,7.477930972064711
KMS-21-BM,navitoclax-PLX-4032 (1-1 mol-mol),0.9023311303175272
BICR 22,serdemetan-SCH-529074 (1-1 mol-mol),1.6325628481893268
SU-DHL-6,46191454,-0.3846699961999978
LS180,124202324,2.088899784140079
KU-19-19,navitoclax-MST-312 (1-1 mol-mol),0.8014531944430209
K-562,4261,1.1039684536741017
SUP-T11,67291369,4.062378618332075
NCI-H2452,5282054,2.993265650723398
MOLP-8,168312962,1.5743557083321402
Granta-519,969516,1.9567849087702365
NCI-H1568,25062766,1.9660972036535989
MOLM-13,448949,-0.3738099635599754
JHUEM-2,73707398,0.772116909696958
Ishikawa (Heraklio) 02 ER-,10427712,4.3109673498215555
SUP-T11,9927531,4.66163575559017
HT-1376,54454,3.2888396758527225
KPL-1,54649381,3.5935561223347783
SW48,11647372,-0.0986138935854908
T98G,53392493,3.670535161091578
Ishikawa (Heraklio) 02 ER-,24772860,-2.041697460836392
MOLP-8,selumetinib-piperlongumine (8-1 mol-mol),0.460809914604767
PE/CA-PJ34 (clone C12),56946209,-4.043732138060434
DLD-1,44589607,3.1686853218199333
SW1573,selumetinib-vorinostat (8-1 mol-mol),4.856763743237327
RERF-LC-MS,11977753,-0.575574044510787
HuH-6,JQ-1-carboplatin (1-1 mol-mol),1.9936450141574449
LS180,49793307,-3.6014942577594415
SW948,3854666,3.050289300885683
HARA [Human squamous cell lung carcinoma],4917,3.022180747101803
SW1271,navitoclax-PLX-4032 (1-1 mol-mol),5.386120495356167
JHUEM-7,1716436,3.3976454809646426
WM115,5278396,3.4301399168519153
HCC1500,JQ-1-carboplatin (1-1 mol-mol),3.891416287519206
HCC1500,11485656,2.6610961572019103
RKO,sirolimus-bortezomib (250-1 mol-mol),1.0887451358800992
Daudi,2945648,2.1407869976239087
Mino,JQ-1-MK-0752 (1-1 mol-mol),-0.8090660778541161
U-BLC1,23635314,-1.5969175745266249
SNU-1272,carboplatin-UNC0638 (2-1 mol-mol),5.070275489272453
MOLM-13,3689413,-2.8005667715254017
JHUEM-2,72193861,-1.5707802548725245
RKN,3543504,4.234888347098623
ST486,25227462,-4.673839290855529
IGROV-1,24964624,0.5052308994941754
PaTu 8988t,676352,1.787056590779638
RERF-LC-MS,10385095,0.7812016081678173
WM115,4259181,1.0090630393378868
KMS-21-BM,156414,1.1553403018808577
MOLP-8,navitoclax-gemcitabine (1-1 mol-mol),-4.985488409488958
L3.3,3689413,1.7908878640591075
PE/CA-PJ49,9927531,5.215467759359
KMS-21-BM,9877608,6.031837359251096
KP-3,2828334,6.180015821773138
SaOS-2,1239801,5.3522865443092575
Granta-519,44137675,2.975150065736677
RERF-LC-Ad1,5566,3.2885825128552857
T98G,1474550,5.862074316554119
JHUEM-7,3552672,1.9150315294075648
SK-MEL-2,salermide-PLX-4032 (12-1 mol-mol),5.301884495923358
Daudi,11455910,-1.173613913103254
UACC-812,11152667,2.562952126743398
SaOS-2,16219061,3.147835700454569
P31/FUJ,erlotinib-PLX-4032 (2-1 mol-mol),2.316286260335057
SaOS-2,71304818,3.198114510015862
IGROV-1,57330099,4.391385744785918
LCLC-97TM1,2729026,2.4668071198749555
HCC1500,5281672,4.190998095776345
NCI-H1568,9884685,-0.6579514975056241
SEM,3385,2.486221343421728
ML-1 [Human thyroid carcinoma],53392493,2.260380394132801
LS411N,107985,-2.091782559178726
MKN1,5278396,3.495031074331329
BT 248,2729026,1.163283415080523
COR-L95,42642645,0.7279572059378924
LS180,5566,2.7460265721966897
HuH-6,doxorubicin-navitoclax (2-1 mol-mol),-1.0509808876757971
T98G,2858523,3.1666797769320185
F-36P,3025944,3.798423785278045
COR-L95,104842,-6.859012992539376
K-562,702558,5.364922414830515
NCI-H2452,vorinostat-navitoclax (4-1 mol-mol),0.733087868835974
LCLC-97TM1,9929138,5.774162864206733
LS411N,31703,0.7183186901084707
DLD-1,6918736,2.0920056603282844
LMSU,24901704,3.2406983382817387
ST486,25161177,3.6542766567424336
WM115,23725625,4.964211357698685
KLE,71466380,4.290621032590563
HEL,piperlongumine-MST-312 (1-1 mol-mol),1.46077164854103
KLE,9911463,3.5004519168580828
L3.3,24964624,2.8332468869362115
MKN1,11152667,-0.4741120582989742
U-BLC1,24978538,0.1580179953716878
SaOS-2,24978538,2.44958290959275
HCC15,UNC0638-navitoclax (1-1 mol-mol),-0.269925552433359
PaTu 8902,2858523,3.3217981805434196
Mino,57519531,0.8811473119395662
JHUEM-7,82146,4.339540493770147
HARA [Human squamous cell lung carcinoma],135398516,1.8495805389969304
Ishikawa (Heraklio) 02 ER-,11214940,1.485318631794352
SW48,65628,3.988389614478155
PE/CA-PJ49,6914657,-2.970553124332036
ST486,9936388,-7.5497220296798275
PE/CA-PJ49,46191454,1.6379354990764687
Granta-519,9903786,1.2937892753152922
IGROV-1,71304818,2.4878074097553378
COR-L95,25105715,3.673741872436949
SK-MEL-2,5280436,1.683380720570961
HuP-T3,6918837,-1.8626358392084263
PaTu 8988t,72376,-1.956580109455481
NCI-H2452,46907787,3.091101876271566
SNU-1079,3854666,1.692119471543111
SW948,23725625,5.544404993552476
K-562,25062766,2.5223735702376753
PK-1,11404337,1.355004976466392
SNU-1272,3689413,0.1489687776606243
SNU-886,67291369,0.2726616209500875
SaOS-2,753704,5.53840358060444
NCI-H2452,56973724,2.8465784993073564
HT-1376,15547703,2.997010865877806
ST486,5329102,1.6383134541411664
Granta-519,71466578,4.383489061930637
SW948,11609586,2.9863433458317714
HEL,71466445,1.5745300131733593
ES-2,navitoclax-birinapant (1-1 mol-mol),3.546924160071774
Daudi,5329102,1.2784768117884069
KHM-1B,2828334,5.467256536463017
JHUEM-2,42642645,-1.8281765677467343
HCC15,409805,6.461768980239098
Daudi,2871966,-2.2343916463272873
KP-4,44185566,2.8136768451579117
LMSU,6852167,2.6209493875982277
SUP-T11,9903786,1.3476542683573176
HCC15,selumetinib-piperlongumine (8-1 mol-mol),4.822467978355287
RERF-LC-MS,135421197,1.554065103888189
SW1271,selumetinib-tretinoin (2-1 mol-mol),2.7817516989696855
SNU-1079,11717001,3.8109348224977806
BT 248,23582824,0.3842375588836932
RKN,serdemetan-SCH-529074 (1-1 mol-mol),2.47980812948558
PaTu 8988t,25150857,2.5954794764360343
P31/FUJ,11152667,-2.5755274762926095
BFTC-909,ISOX-bortezomib (250-1 mol-mol),1.0929987126714282
U-BLC1,25183872,-1.979048033726497
BICR 31,2828334,6.263113325647995
MDST8,selumetinib-GDC-0941 (4-1 mol-mol),0.8218915121525238
IGROV-1,11507802,1.5049911819213722
SEM,46907787,-3.1211446232519178
Hep-G2,6914657,-1.7030868105501842
Daudi,11485656,1.7254760898020216
Granta-519,11152667,-3.975154363660797
KP-3,sirolimus-bortezomib (250-1 mol-mol),1.5261353801171291
LMSU,25262965,-0.9564445185198788
RERF-LC-Ad1,selumetinib-UNC0638 (4-1 mol-mol),4.185176714709013
PK-1,168312962,3.597216331624645
SW48,11640390,-0.422464249163724
IA-LM,2828334,6.3387056990337705
HEL,36462,0.8349109175120154
LS411N,4477,1.0450277541726452
NCI-H2452,16219061,3.733701707144141
DLD-1,60750,1.607533009970746
RKO,16741245,1.399079485469943
NCI-H1568,445455,4.330931204553833
EB1,selumetinib-tretinoin (2-1 mol-mol),5.035316659512484
K-562,15983966,-4.450185495623787
T98G,969516,2.9258845164556937
ES-2,135999136,4.341769517673809
HCC1500,4096211,2.7054358198440345
KP-4,3689413,-2.736369445880075
JHUEM-1,156414,1.11415290016218
EB1,selumetinib-UNC0638 (4-1 mol-mol),3.3687835247674327
SU-DHL-1,46191454,-0.3713761809994262
SUP-T11,409805,3.2172414171416177
SNU-626,71304818,3.343906498413937
Ishikawa (Heraklio) 02 ER-,24785538,3.0614053546462356
Hep-G2,ISOX-bortezomib (250-1 mol-mol),0.639259182735851
HT-1376,107985,-2.5673845406867635
KP-3,168312962,3.7073929511460704
JHUEM-2,71680916,4.0051816248452425
IGROV-1,387447,-3.9508602289798658
KHM-1B,25105715,2.694355871197866
NCI-H1568,71751553,3.6437596116554887
HARA [Human squamous cell lung carcinoma],selumetinib-vorinostat (8-1 mol-mol),4.369788913914824
WM115,46199207,3.650123600055899
SaOS-2,71680916,4.865393442781168
LMSU,9907093,4.778478105374332
COR-L95,9823820,4.611798945344124
HuP-T3,44589607,2.433680498088492
SK-HEP-1,vorinostat-navitoclax (4-1 mol-mol),1.9601053638256545
BT 248,6914657,-2.576788872604972
F-36P,135999136,1.2589377775362909
LMSU,327653,3.6010830884894824
BT 440,11152667,0.0173379430865997
IGROV-1,3634881,2.769147818550815
EB1,135440466,1.4982029672387829
T98G,9840324,5.357755173108126
Hep-G2,6623618,1.7960151363036378
PE/CA-PJ34 (clone C12),984333,0.8782712724781023
ES-2,2828334,6.318052178028057
JHUEM-1,148124,-4.41926729244999
JHUEM-1,9952709,2.3662824404613136
COR-L105,54626689,5.0742986339862926
JHUEM-1,navitoclax-PLX-4032 (1-1 mol-mol),2.1640702034348407
HEL,176870,2.3693727744318887
PE/CA-PJ34 (clone C12),40482356,5.160347507354427
U-BLC1,10296883,3.798592374745875
LCLC-97TM1,9549297,2.332709006301325
LMSU,400769,0.2687008392096283
COR-L105,24180125,3.5925931777332676
MOLP-8,89928392,0.1045876418070581
T98G,2113511,5.297556366060103
PE/CA-PJ49,navitoclax-PLX-4032 (1-1 mol-mol),3.158588149700127
BICR 22,3025986,-2.8899356497226756
ALL-SIL,400769,-0.758162988868875
SEM,445091,4.25698967514786
BFTC-909,71466380,5.267829049221599
MOLM-13,24951314,-0.2336633009541456
JHUEM-7,16065773,2.5862180470687792
MOLP-8,3038522,2.029025514425164
RKN,16741245,1.555254881894904
SNU-C2A,675434,4.992238634791749
F-36P,24753719,4.27265638786198
COR-L105,71751553,4.255827287979035
U-BLC1,216468,3.692275461999379
MOLP-8,60750,-8.573260651984995
LMSU,3081361,2.668477326227084
Ishikawa (Heraklio) 02 ER-,969516,3.393138280317756
HCC15,navitoclax-birinapant (1-1 mol-mol),-0.4439511388855052
T98G,11427553,2.2379154595681716
MKN1,JQ-1-carboplatin (1-1 mol-mol),4.3566594896883934
BICR 22,24772860,-1.3590035600374548
ES-2,BRD-A02303741-navitoclax (2-1 mol-mol),4.806667982133514
TTC-709,54618164,4.259345795297247
LCLC-97TM1,5470400,0.2889153362640624
BICR 31,53232,3.653430995715962
LMSU,vorinostat-carboplatin (1-1 mol-mol),4.433531570096117
BICR 31,8515,4.104799625743522
COR-L105,10127622,2.236200578684094
NCI-H1568,5328940,0.3466597705312412
SNU-1079,44259,-1.9953707016841284
U-BLC1,2742550,3.0998896662106676
SUP-T11,6505803,1.7392273117289616
MOLP-8,135421197,1.7506124789909805
SW1573,54454,1.176648172779268
NCI-H2452,11964036,2.1879069513719087
MKN1,JQ-1-navitoclax (2-1 mol-mol),2.749733325802968
MOLM-13,44493528,3.9608078939228175
JHUEM-1,46907787,1.7226050110198932
PK-1,25183872,-0.3372458176862003
SK-HEP-1,11396600,5.84824704867975
WM115,46215462,1.6800224060395437
Granta-519,23939,5.101725753715152
NCI-H1395,24964624,3.1015144047697367
BICR 22,46907787,3.4905986586009843
HEL,10184653,1.0835446596032057
LS411N,9903786,3.6806866285220017
SW48,9840324,6.311735261945371
EB1,7326481,2.478820540010552
KHM-1B,12001922,1.027456865676835
TTC-709,148124,-6.07552333900772
SNU-1272,409805,6.302573635067764
HCC15,24753719,5.171121417544096
SW948,11507802,1.163064588903486
PE/CA-PJ34 (clone C12),4261,2.8870037717787307
BT 248,24889392,1.8419989874192408
KP-4,11455910,-0.3156101411278702
SNU-C2A,24964624,2.353132011393135
U-BLC1,1716436,2.6251881995647
L3.3,24785538,3.6784067404983394
JHUEM-7,selumetinib-vorinostat (8-1 mol-mol),2.3580216719117284
PE/CA-PJ49,54613361,-0.71410826322886
SUP-T11,644241,2.523966392128261
SEM,637858,0.6523373975707702
COR-L105,2733487,7.427108299628283
SaOS-2,439501,-2.8243657156627724
UACC-812,5287969,-2.4803922230812527
SNU-1272,11626560,2.412334917468919
JHUEM-2,159324,-0.5047456010637043
Granta-519,66577038,2.6663435544296346
RERF-LC-MS,6918837,-3.051376318733669
NCI-H1568,11152667,-1.392140833696634
KU-19-19,49850262,4.263742487880845
BICR 31,selumetinib-navitoclax (8-1 mol-mol),2.9853512378124023
SaOS-2,156414,1.509432711545826
KU-19-19,navitoclax-gemcitabine (1-1 mol-mol),-0.4466146105667509
KP-4,216345,4.1905872453643065
NCI-H1395,49793307,-1.2890393548834251
KP-3,54454,0.8356021258126708
T98G,9915743,3.11701457310986
SK-LMS-1,23582824,0.2043847791768318
PE/CA-PJ49,5351362,0.8409386836986219
KMS-21-BM,171352865,3.938056850653091
SNU-1272,24964624,2.8014320140467124
Granta-519,216468,0.2159572219264565
KP-4,46191454,1.4148922556494763
NCI-H1395,5287620,-5.195854195125387
PE/CA-PJ34 (clone C12),2708,4.740071919144502
F-36P,selumetinib-JQ-1 (4-1 mol-mol),-1.0872575264771165
L3.3,452548,-0.800912327932342
P31/FUJ,3136844,4.357504973194935
SNU-1272,73707398,1.7046938678660917
HT-1376,25126798,4.126637753023154
MOLP-8,6918638,-1.572747132532541
LS411N,445643,4.311506480272609
MOLM-13,25126798,1.909946064109967
SNU-C2A,3503,1.8789659454377132
BICR 22,9927531,5.395078942533075
SU-DHL-6,3385,2.96945431954736
KMS-21-BM,15983966,-4.449441892873976
SNU-C2A,44589607,2.7199836852786454
SW948,49766530,-0.6875988061214425
MOLP-8,5287620,-5.023262566828496
SW48,selumetinib-JQ-1 (4-1 mol-mol),-4.010422232345994
SW1271,5746,1.8306286254207629
ST486,navitoclax-gemcitabine (1-1 mol-mol),-4.563955781694775
SU-DHL-1,4788,5.095368657375766
UACC-812,44607531,-0.3950460021726514
F-36P,44491742,3.961170859118446
KP-4,151289,0.3587584967433216
SK-CO-1,10074640,3.0297361304753143
IGROV-1,65064,4.920352624378345
P31/FUJ,9444,3.558733501871851
MOLP-8,16722836,0.6223558214261112
LCLC-97TM1,11647372,-0.3650454903758569
MKN1,25262965,1.903013291156093
COR-L95,9911463,4.18924595414168
SK-MEL-2,5282054,4.421155329713266
TTC-709,carboplatin-etoposide (40-17 mol-mol),2.5263373745073947
MOLM-13,3634881,2.324290549736021
SK-LMS-1,54596558,4.453206380701554
SNU-C2A,1641662,3.864395506454434
IGROV-1,1242560,3.902441161940491
LS411N,702558,5.325144902608101
BT 248,3689413,-0.3734654016267222
MOLM-13,969516,1.839627080728713
KPL-1,72193861,4.087587478013103
IGROV-1,50905018,6.092412272559071
PE/CA-PJ34 (clone C12),11625818,4.760944363107288
SNU-1079,107970,1.8696204302707973
SNU-1079,135421197,1.0783376836912564
JHUEM-2,9868037,1.1428293531660954
PE/CA-PJ34 (clone C12),4705,1.0597990978306746
SaOS-2,5311,1.6246857228566176
PE/CA-PJ34 (clone C12),135999136,4.2559270335643955
ML-1 [Human thyroid carcinoma],5287620,-1.9113881956575816
BICR 31,11178236,-3.7191700347439176
SNU-626,17759555,3.941545426692892
SK-MEL-2,10127622,2.552103790334664
IGROV-1,16736978,0.1982875499977011
HEL,54613361,-1.063581606127445
LS411N,409805,5.900990799691521
KHM-1B,5281672,4.060074282228128
RKN,44819697,0.8547407464301948
SaOS-2,7326481,3.920515261577408
HCC15,135411,0.5020362424433897
F-36P,135398516,1.470096295547799
SW1271,135875424,3.8663800475620542
SW948,5281321,-2.986965028390854
SUP-T11,11626560,0.8476623958280866
ML-1 [Human thyroid carcinoma],52947716,-0.2471601623530622
SUP-T11,44137675,1.4980191116174593
DLD-1,9956119,4.367748911956311
ALL-SIL,16722836,0.4684239096852854
Hep-G2,16722836,1.3885604192453562
BICR 22,3384730,2.588423009806214
SU-DHL-1,5282054,2.781862093779865
ST486,44819697,-4.448266754799611
JHUEM-1,11214940,1.904983196064144
COR-L105,10385095,2.1444085139831643
Panc 02.03,409805,5.9877775932277615
RERF-LC-MS,11707110,3.327368501952155
SNU-886,5282054,3.1814794510018514
Daudi,46199207,1.9328464692742409
SK-LMS-1,135421197,1.8226321341170344
SK-LMS-1,135875424,4.759949001069946
U-BLC1,71751553,4.056877782229039
TTC-709,54143018,-0.0232284844343782
JHUEM-2,9929138,6.79897920922461
ES-2,SNX-2112-bortezomib (250-1 mol-mol),-0.246559321719814
SK-HEP-1,9907093,4.5474965014619455
NCI-H2452,6918736,-2.096990091914002
SW948,25062766,2.473025838261029
SW1573,73707398,2.4757839790774123
U-BLC1,11167602,2.1562651935387636
WM115,19582717,5.070140237856123
U-BLC1,10184653,-4.847443212793237
LCLC-97TM1,9926054,1.7367616025320842
KLE,9935249,5.162792026951856
NCI-H1395,navitoclax-MST-312 (1-1 mol-mol),0.8378237881754972
Ishikawa (Heraklio) 02 ER-,60700,1.52119076036971
Granta-519,46907787,0.1510211143130647
TTC-709,1716436,2.751323232376299
JHUEM-7,6918878,3.0932283055268512
HCC1500,JQ-1-MK-0752 (1-1 mol-mol),3.680434993229653
SK-LMS-1,11404337,0.6927873506119244
Daudi,9866186,0.2429325896096028
HCC15,19582717,3.4575202036464665
BICR 22,3136844,4.306912771504561
JHUEM-1,7251185,1.6907560010698903
SK-LMS-1,2733526,5.0233438877930645
PaTu 8988t,15983966,3.5024124287376477
LMSU,10302451,4.092585001279765
HuH-6,654092,0.2351696609911905
WM115,24964624,1.5810045411950775
Daudi,5335621,3.7832010435602568
EB1,227681,2.748678419469421
KU-19-19,selumetinib-PLX-4032 (8-1 mol-mol),2.356754737959246
HuH-6,24901704,2.88517873500275
EB1,613000,0.8761768700549261
Hep-G2,46224516,1.405645809008333
KMS-21-BM,151289,0.0029890702920009
EB1,2746,1.806357780632162
HCC1500,67156097,1.177976655162538
LS180,6918878,3.4964027843545775
MOLP-8,4096211,1.580191863417666
JHUEM-1,439501,-3.414887087046791
P31/FUJ,6252,0.489412050489878
RERF-LC-MS,6505803,-0.6931241555509828
Ishikawa (Heraklio) 02 ER-,ISOX-bortezomib (250-1 mol-mol),0.4177142884347778
IGROV-1,24821094,1.720998716331183
BICR 31,5311,2.2783252682939876
K-562,6438330,2.2742899368871123
LMSU,60700,0.2696486188737008
HCC15,71466578,3.4480874510133708
RKO,5566,3.2270609816668308
KHM-1B,6918328,-0.972639722757723
DLD-1,4917,3.368923508075382
MOLM-13,BRD-A02303741-navitoclax (2-1 mol-mol),-0.0183785057987459
NCI-H1395,4259181,1.90835331362123
KMS-21-BM,135398738,1.718953028911251
Panc 02.03,24785538,2.724480470289088
Granta-519,3025986,-4.58955813375105
BICR 22,6918837,-3.531862368916405
PE/CA-PJ49,168313200,2.725673225296459
MKN1,11238147,3.7062494486579536
MDST8,25262965,-2.668035259531665
IA-LM,5329102,2.7310604185474654
SK-HEP-1,3385,5.476337571299632
LS180,16722836,2.063998190370722
HuP-T3,tanespimycin-gemcitabine (1-1 mol-mol),2.6296169541858694
LS180,2749,2.025296960861402
U-BLC1,44632017,1.5679363851433892
ES-2,vorinostat-carboplatin (1-1 mol-mol),3.5621633809631126
KLE,9967941,2.835048263891985
WM115,25262965,-0.2525217612691299
RERF-LC-Ad1,10302451,4.5263361411635366
PaTu 8988t,5287620,-2.232870102756846
YD-15,656346,-0.3168272587225719
SK-MEL-2,11717001,1.6786604192843333
BICR 22,1641662,3.554805763515046
HEL,11152667,-1.5416892011653274
COR-L105,doxorubicin-navitoclax (2-1 mol-mol),-0.4088475134066937
ML-1 [Human thyroid carcinoma],219104,3.7281299088831386
Granta-519,9907093,4.568904425758597
HuP-T3,56946209,-4.563482636842077
COR-L95,2126,5.99033959567007
SUP-T11,vorinostat-navitoclax (4-1 mol-mol),1.1313356416289624
JHUEM-2,44487061,4.385605582684957
SEM,11507802,-0.3844502911192904
ST486,148198,-7.753163237406848
WM115,216239,1.6966934324307903
PE/CA-PJ49,JQ-1-navitoclax (2-1 mol-mol),1.311184957137478
BT 248,82146,3.895792146901818
HARA [Human squamous cell lung carcinoma],136227924,3.047223136335837
BICR 31,6918837,-2.993188010662521
SNU-1079,16725315,3.704163868266859
WM115,3676137,5.1484929308777225
COR-L105,5113032,4.587192003158758
NCI-H2452,23635314,-2.1133256000938596
RKN,9887053,4.324470541002337
U-BLC1,crizotinib-PLX-4032 (2-1 mol-mol),1.7751379145685438
HT-1376,selumetinib-GDC-0941 (4-1 mol-mol),5.083732024121345
KP-4,JQ-1-UNC0638 (2-1 mol-mol),4.144719102429264
RCC10RGB,11427553,3.4421917630858387
KMS-21-BM,20959075,-3.858243259220936
SK-HEP-1,3025944,4.243935374614092
KHM-1B,44819697,-2.627948052735268
HEL,613753,3.431831043675297
LS180,navitoclax-birinapant (1-1 mol-mol),0.3756173230443141
LMSU,46398810,2.8230145741890977
ML-1 [Human thyroid carcinoma],135411,-0.343606028350642
WM115,6450551,3.3231751041078086
EB1,25150857,0.8727597425602195
NCI-H1395,1242560,3.324194967981579
BT 440,46398810,1.8510375709375924
LS180,11178236,-2.7486494175863703
SU-DHL-1,53232,0.8595699071174782
HT-1376,doxorubicin-navitoclax (2-1 mol-mol),0.3960665125587345
LCLC-97TM1,2742550,3.525188493197443
Daudi,1716436,1.8661291896859675
SK-OV-3,11964036,1.753508425012185
LS411N,10385095,1.4098978051841675
PE/CA-PJ34 (clone C12),24772860,-2.582582767798194
P31/FUJ,54613361,-1.6350280742113157
SU-DHL-1,638278,2.888532213305057
SW48,11228183,0.7765992306729816
Daudi,54596558,3.73872893191344
YD-15,10074640,3.174641839954514
IGROV-1,44543605,3.88270235241076
SK-OV-3,16722836,0.9083609759186712
HARA [Human squamous cell lung carcinoma],tretinoin-navitoclax (4-1 mol-mol),0.6020182307201102
P31/FUJ,168313047,1.7496121138347704
RCC10RGB,969516,5.025939213907113
COR-L95,tanespimycin-gemcitabine (1-1 mol-mol),-2.183473735098961
KLE,navitoclax-sorafenib (1-1 mol-mol),-1.1377907715980664
T98G,54454,3.231078886675242
KLE,2113511,5.3070368791783915
PE/CA-PJ49,4578,4.709804967781291
EB1,148198,-5.218004052941106
Daudi,selumetinib-MK-2206 (8-1 mol-mol),2.382051987434729
HT-1376,navitoclax-pluripotin (1-1 mol-mol),0.8648281395709134
HCC1500,crizotinib-PLX-4032 (2-1 mol-mol),2.666541156679824
PE/CA-PJ34 (clone C12),3025986,-1.608443242420705
LS180,11507802,1.428529607587261
SW1271,2746,3.8382249001906814
RERF-LC-MS,navitoclax-pluripotin (1-1 mol-mol),0.4193939180883417
SNU-626,54454,1.0675081987056323
SK-MEL-2,54454,3.4564157344921296
SW48,6918328,-0.3603149144304291
RKN,11214940,-1.342915177510304
TTC-709,9929138,5.828368594409336
BT 440,984333,0.7115850710203955
KPL-1,5282054,4.431319798690912
PK-1,9903786,5.672212413868687
NCI-H1568,24180719,2.911739165396745
SK-LMS-1,10231331,6.028475115684305
BICR 22,selumetinib-JQ-1 (4-1 mol-mol),1.538481754600391
HT-1376,3815108,3.792385903508108
K-562,11234052,2.2960989815513013
BT 248,24180125,1.9773901044414168
SU-DHL-1,107970,1.234326472603969
SNU-C2A,400769,-0.4233581014776051
Mino,216345,4.029583591343141
RERF-LC-MS,5280436,-0.2566098032119844
F-36P,9866186,1.0260521915671856
HARA [Human squamous cell lung carcinoma],10074640,3.2082861236873814
KLE,navitoclax-PLX-4032 (1-1 mol-mol),-1.3670051186656096
RERF-LC-MS,selumetinib-GDC-0941 (4-1 mol-mol),0.28876788592482
EB1,68056272,2.661083678040176
WM115,6184667,1.9705044508079528
P31/FUJ,26596,-2.2448149587984836
L3.3,5566,3.1406901276995094
RCC10RGB,216345,4.504390062805713
SNU-1272,ISOX-bortezomib (250-1 mol-mol),1.8833687902494112
WM115,3634881,2.5774509186458183
COR-L105,5328940,1.3778120925573558
NCI-H2452,135440466,3.051805385291023
P31/FUJ,51039095,1.7212337572708742
Daudi,135398738,3.444692827115736
Hep-G2,12003241,-0.7040118985216451
ST486,44491742,3.1941323124879393
SK-LMS-1,3136844,4.349436037935601
SUP-T11,6918736,-3.892986684355011
MDST8,753704,4.923832713886697
Granta-519,23725625,1.8582588361990624
IGROV-1,6438330,2.7487580937365683
BFTC-909,51037431,4.63288955594681
NCI-H1395,89928392,1.518159514357362
KP-4,decitabine-navitoclax (2-1 mol-mol),3.393653330674042
LS411N,262093,3.2594677855419456
Daudi,12001922,0.8334324910861088
U-BLC1,2945648,3.533408575700395
Ishikawa (Heraklio) 02 ER-,452548,0.8552598580228623
LS411N,10074640,3.3220574057236876
ST486,navitoclax-pluripotin (1-1 mol-mol),-1.340037617260111
COR-L105,6438330,3.2365890454650867
LS180,3689413,1.3392854552239355
IGROV-1,53495165,1.3981720287668329
RKO,10296883,4.075814636405189
JHUEM-2,702558,5.4608366361798035
MOLP-8,24951314,0.5243645664323562
JHUEM-7,10427712,3.9815551329629337
IGROV-1,25126798,3.9275606774720817
PK-1,56649450,4.119390739390521
SNU-626,JQ-1-UNC0638 (2-1 mol-mol),0.7363220478838004
BFTC-909,5281321,-1.6266730162675118
MOLP-8,123631,3.0356710048833446
LCLC-97TM1,selumetinib-MK-2206 (8-1 mol-mol),2.0492378318223508
JHUEM-2,6505803,-3.169169021996555
KHM-1B,374536,2.314533071976094
PaTu 8988t,72193861,1.5880501840541692
COR-L105,JQ-1-MK-0752 (1-1 mol-mol),0.9583306241234884
KP-4,selumetinib-JQ-1 (4-1 mol-mol),2.1555803314083635
LMSU,selumetinib-piperlongumine (8-1 mol-mol),4.680339218702476
MOLP-8,2742550,3.824247044326815
BICR 31,10074640,3.67367044204876
UACC-812,1750826,-1.5614417963348088
LS180,9907093,4.718701288752834
KHM-1B,262093,0.9728016968076376
BICR 22,25062766,1.615874512669176
JHUEM-7,salermide-PLX-4032 (12-1 mol-mol),5.137483886109144
MKN1,navitoclax-piperlongumine (1-1 mol-mol),2.1407258586171927
NCI-H2452,6852167,1.5258165813873172
ML-1 [Human thyroid carcinoma],5328940,1.048806619411155
PaTu 8988t,52912189,2.515835026596807
KU-19-19,9935249,4.318045076797651
KU-19-19,57330099,3.159149106170822
SK-OV-3,17755052,2.097752569372091
Mino,5281321,0.7265625378388493
SK-OV-3,73707386,3.7899266428434233
HEL,navitoclax-PLX-4032 (1-1 mol-mol),-1.2293549578890797
SNU-1079,1750826,-3.608493820431548
PE/CA-PJ34 (clone C12),11427553,3.5428497677945807
YD-15,126941,-2.3214184637011943
SK-HEP-1,216239,1.5998975447874937
ML-1 [Human thyroid carcinoma],387447,-2.817858817217488
RKO,3689413,3.093382349703003
KMS-21-BM,navitoclax-sorafenib (1-1 mol-mol),0.8006625100694951
HARA [Human squamous cell lung carcinoma],11647372,1.8404588933860024
ST486,168312962,1.3896163776300747
K-562,44819697,-0.9868024060185686
LS411N,322968,4.732979049951269
PE/CA-PJ49,selumetinib-vorinostat (8-1 mol-mol),1.4585612568832638
MKN1,6852167,2.386061639562249
RCC10RGB,3689413,-2.0864832427963336
T98G,71751553,5.013882600728961
T98G,65064,5.458066931520159
SK-LMS-1,53325874,4.809163620762811
KLE,doxorubicin-navitoclax (2-1 mol-mol),-2.507709419306591
MOLM-13,BRD-A02303741-carboplatin (1-1 mol-mol),3.787495781999856
BT 440,11396600,2.3245110777445728
Ishikawa (Heraklio) 02 ER-,10184653,2.033470800520247
COR-L105,409805,5.8843358134901775
JHUEM-7,4096211,1.3301455757291742
U-BLC1,52912189,2.92840539215333
ALL-SIL,11404337,-1.8413362349398936
Granta-519,135398738,2.4818536310203587
T98G,44819697,-0.0143665754180268
U-BLC1,56963564,0.2079590092549733
IGROV-1,10385095,1.0670946713416192
KHM-1B,44487061,4.467153172059052
KU-19-19,5311,0.9327005340349652
MOLP-8,6438330,1.5207659246126146
SW948,5351362,1.282672018702937
PK-1,5351362,2.6462097653713985
HuP-T3,54626689,4.821166418142214
HuP-T3,16013152,4.473149012747972
Panc 02.03,sirolimus-bortezomib (250-1 mol-mol),1.3966258084955054
RKN,67156097,-0.5718675734992968
IA-LM,241158,3.7495123409873528
LCLC-97TM1,644241,3.02487415997038
NCI-H2452,9823820,3.552631474664052
BFTC-909,2749,2.0212973698927184
HuH-6,tanespimycin-gemcitabine (1-1 mol-mol),-0.0508521521077124
Daudi,9956119,3.1347708383856827
IGROV-1,alisertib-navitoclax (2-1 mol-mol),1.5599487267475047
ALL-SIL,136227924,2.439460537978413
HEL,44507138,3.4784823626806296
Hep-G2,5470400,-2.8506942607066943
PK-1,23582824,0.8533601347639831
F-36P,25105715,3.27041361580791
LMSU,54596558,4.409593333652482
Panc 02.03,3634881,5.203302993958793
HCC15,3038522,3.407637609998807
RERF-LC-MS,JQ-1-vorinostat (2-1 mol-mol),1.4753675236489834
BT 248,89928392,0.7552276073317185
SU-DHL-1,5311,0.6388765020007606
ST486,54619267,3.149380218226297
SUP-T11,9444,3.509142419266966
RKN,16038120,2.2721636156695357
Daudi,6917907,-7.619939635694887
MOLP-8,3385,2.1758430637220334
COR-L95,2749,1.0184502693195283
PE/CA-PJ49,5311,0.6112751453740505
BICR 22,56946209,-6.158851096198738
ST486,55283,3.9639533094517048
SK-MEL-2,54619267,4.064435085283967
SU-DHL-6,72193861,0.720057034069739
ST486,16720766,0.4189560322761394
PE/CA-PJ49,6610355,4.104537207248427
BT 248,6184667,2.4270302543682307
ST486,52947716,-8.631446152545438
PE/CA-PJ49,9956119,3.948810633072343
SK-LMS-1,60700,-0.2851766330643205
SEM,241158,3.04470395214072
RCC10RGB,122327,5.581829763733156
Daudi,5284329,2.65655795986699
ES-2,176870,5.723055664278254
WM115,72376,-0.2019485443349478
HCC1500,4378219,1.8377088226049565
SK-CO-1,246676,3.87632071272349
SK-HEP-1,docetaxel-tanespimycin (2-1 mol-mol),1.7150600920964667
IGROV-1,57519531,2.639098862164858
P31/FUJ,serdemetan-SCH-529074 (1-1 mol-mol),2.3029277371957884
MOLM-13,1714884,4.557672503718371
MOLM-13,JQ-1-vorinostat (2-1 mol-mol),-0.8524574918693427
SNU-1079,400769,-0.4871778996452893
Granta-519,72193861,-0.9369484536210768
KP-4,16115403,-5.804045861316924
YD-15,3503,2.826947139630502
L3.3,8515,4.3523389716154455
RKO,5311,2.326095881991792
JHUEM-1,11719255,3.0311516875346576
SK-HEP-1,4521392,4.36382839215776
COR-L105,3062316,-0.8702764318143076
KPL-1,135440466,2.871064735958532
PE/CA-PJ49,613000,2.2856276091576704
COR-L95,387447,-4.370301659619954
COR-L105,10231331,1.4114577114599935
SK-CO-1,637858,1.8597515079418403
DLD-1,9903786,2.1877560593252343
SW1573,5282054,2.2636648441362417
L3.3,selumetinib-GDC-0941 (4-1 mol-mol),2.633566714315937
K-562,66577038,2.461713560075674
KLE,11234052,3.5359444822792896
MKN1,4788,5.41489909335113
SNU-C2A,654092,0.0600239977392283
Panc 02.03,984333,0.8671961837803726
Mino,107985,-5.05206384093963
HCC1500,9967941,2.192170342398577
NCI-H1568,5281672,4.0091617833462125
K-562,11640390,3.4084234644631244
SW1271,60750,-2.442139934484719
HARA [Human squamous cell lung carcinoma],5280436,4.238746998760762
MOLM-13,24889392,-6.717782140097413
Granta-519,11364421,-8.40665244505035
LCLC-97TM1,11612883,2.215690343731866
SK-LMS-1,26596,1.8216060443410544
ALL-SIL,serdemetan-SCH-529074 (1-1 mol-mol),2.0214253699045392
PaTu 8902,1566236,3.6887913704860535
MOLM-13,16741245,4.189200129622084
PK-1,tretinoin-navitoclax (4-1 mol-mol),-2.294563123049608
SW48,6184667,4.015043076320991
RERF-LC-MS,66577038,3.051572744120707
JHUEM-7,9866186,0.4648370468543082
K-562,71304818,1.450074212827562
KMS-21-BM,44487061,4.535573464722113
SK-LMS-1,serdemetan-SCH-529074 (1-1 mol-mol),2.855322998560242
RCC10RGB,44489675,4.041451654117508
LS411N,navitoclax-birinapant (1-1 mol-mol),3.012697957688565
SW1271,10074640,2.938380325815859
RERF-LC-MS,11626560,1.1998891680987491
T98G,selumetinib-navitoclax (8-1 mol-mol),5.4930662606952
ST486,JQ-1-UNC0638 (2-1 mol-mol),-1.007840059900225
PK-1,10113978,4.764751596728189
SNU-1272,5281672,5.145020952556211
Ishikawa (Heraklio) 02 ER-,2749,1.9668009666104345
PaTu 8988t,81146,4.470184859000855
F-36P,45279963,2.167893190826844
Ishikawa (Heraklio) 02 ER-,374536,4.692637268182497
ST486,24978538,-1.357870569523414
HCC15,11178236,-3.9629964965138584
SW48,navitoclax-pluripotin (1-1 mol-mol),-1.096538281516441
HCC15,11317348,1.1767586352696475
SUP-T11,60750,-1.8783573263324724
P31/FUJ,9903786,1.0734919883099745
PE/CA-PJ49,5738263,3.49385120973068
IGROV-1,23582824,0.3287266354391525
Granta-519,3465537,1.1430845598370274
PaTu 8988t,984333,0.9294993195358888
HCC1500,11396600,2.707080690171913
SNU-626,crizotinib-PLX-4032 (2-1 mol-mol),2.610868558767484
SK-MEL-2,135440466,3.518713620628013
NCI-H1568,6252,-1.964470857288188
NCI-H1568,7251185,1.379011815458227
JHUEM-1,4788,3.784405596480772
TTC-709,11214940,1.448814510377225
BFTC-909,UNC0638-navitoclax (1-1 mol-mol),2.418146384904106
LCLC-97TM1,55508,4.820744956173848
PaTu 8902,9903786,4.041497343746548
SEM,6852167,1.184676073870636
SW1271,12001922,2.1604198968714754
HEL,6505803,1.212867497705534
SK-HEP-1,216345,4.108495190728752
WM115,4705,2.3860154683324897
NCI-H1568,JQ-1-vorinostat (2-1 mol-mol),1.325801474857881
NCI-H1395,25150857,3.355605487128081
RERF-LC-Ad1,JQ-1-vorinostat (2-1 mol-mol),2.719518134337945
PK-1,44819697,-0.302630881650115
KP-4,5335621,5.265120466379572
COR-L105,126941,-1.5036718028706904
PaTu 8988t,9926054,1.9241127892750265
SW48,tretinoin-carboplatin (2-1 mol-mol),4.556026920056554
KMS-21-BM,25102847,1.7376436081345237
NCI-H2452,navitoclax-MST-312 (1-1 mol-mol),2.3760907472780137
MKN1,3503,2.424515328458297
NCI-H1395,11640390,4.861591383833504
L3.3,409805,5.10307456372432
SK-HEP-1,374536,4.396616434658188
IGROV-1,carboplatin-etoposide (40-17 mol-mol),3.2860353297411256
NCI-H2452,208908,2.397298909776284
MKN1,navitoclax-pluripotin (1-1 mol-mol),-0.1469888545467567
SW948,24821094,3.757524617053942
ST486,9926054,1.8361941441765457
JHUEM-2,23635314,-4.484279230419346
NCI-H1395,25195348,3.618629950214112
K-562,44491742,3.373435641850853
U-BLC1,3689413,-0.8991596677439855
RKO,24180719,5.308193040989237
Hep-G2,46398810,2.254556195261035
MOLM-13,56946209,-5.150374128805616
ST486,3825829,3.4497279801035665
MDST8,54454,0.3151053774213321
SUP-T11,135398738,4.758376559164991
SNU-C2A,selumetinib-vorinostat (8-1 mol-mol),2.556346033839852
Daudi,969516,2.18084937908482
SEM,46943432,-1.9096552724661455
COR-L105,44607531,0.2442604090297878
SaOS-2,54619267,4.116373312960232
MOLP-8,44607531,1.2227606502433142
ALL-SIL,11427553,-0.6859128537837271
SUP-T11,46398810,1.946719465000613
NCI-H1568,11427553,2.9296384487881166
SK-HEP-1,6918638,1.490993863020431
K-562,11175137,2.6421325977097663
MOLP-8,25126798,3.554030345273679
YD-15,4096211,0.8388919663956985
MOLP-8,10427712,3.937375048887725
BFTC-909,11404337,0.4468911705694049
U-BLC1,11257553,-0.0638704842022158
Hep-G2,135421197,1.3335693407455125
Daudi,19582717,2.1579117268337975
SW1573,9936388,3.0507391751654698
SW1271,156414,2.097129180606755
Daudi,11213558,0.7122197709980888
MOLM-13,135875424,3.721528356214304
JHUEM-2,4259181,-1.5019807031703976
LS411N,3062316,3.313525141236135
Panc 02.03,6438330,3.381062774421129
SNU-886,637858,1.4418078006770565
HuH-6,44493952,2.6201350917553703
MOLP-8,4705,2.7848528520877727
SEM,6184667,1.572697662015749
BT 440,57330099,4.310594582760176
SW48,675434,5.164587034175743
NCI-H1568,46215462,1.5662565779678703
PE/CA-PJ34 (clone C12),23635314,-4.428756055244555
JHUEM-1,8515,2.058426071264184
BICR 22,23635314,-3.9149935419765423
NCI-H1568,44607530,0.8979533446197012
BFTC-909,89928392,2.1120581393996116
SNU-1079,11152667,-0.9238055167208472
KMS-21-BM,5351362,0.5306159888896849
NCI-H2452,8515,2.9816658051225344
PE/CA-PJ34 (clone C12),1750826,1.4658207982474565
WM115,252682,5.883677253194902
T98G,42642645,0.8480271641084243
U-BLC1,5311,0.7427337195821986
PE/CA-PJ34 (clone C12),148198,-4.8428586798807265
HuH-6,selumetinib-tretinoin (2-1 mol-mol),6.252096877686335
SaOS-2,11507802,0.9759404440699744
NCI-H1568,9935249,0.3822057580098375
KLE,168313016,5.53335411774071
SU-DHL-1,selumetinib-vorinostat (8-1 mol-mol),1.570079304001321
DLD-1,tanespimycin-bortezomib (250-1 mol-mol),0.5980844777691691
SNU-886,selumetinib-UNC0638 (4-1 mol-mol),2.5204736993113968
SW1271,65628,4.408026608161547
MOLM-13,2742550,3.0943449980031845
KP-4,5329102,2.725759406628116
SNU-1272,2858523,2.5104124408417157
HuP-T3,56973724,4.820716068374067
JHUEM-1,11485656,1.8254780068900092
P31/FUJ,5328940,0.1000739186855886
SW1573,sirolimus-bortezomib (250-1 mol-mol),1.011264687291747
YD-15,6252,1.4770922800067572
KMS-21-BM,BRD-A02303741-carboplatin (1-1 mol-mol),3.21222652460011
U-BLC1,327653,3.5649632216548897
KU-19-19,9967941,2.4242338826427794
COR-L95,selumetinib-decitabine (4-1 mol-mol),6.271791154986272
HuH-6,6918878,0.5148205874464938
SK-CO-1,5328940,2.280320557186381
HARA [Human squamous cell lung carcinoma],6184667,2.5882672266365128
SNU-886,36314,-4.506581052227643
COR-L95,1716436,2.176954941746147
MDST8,46398810,3.011862004714757
SK-OV-3,654092,-0.1739817534251795
KP-4,16038120,1.6550753404975762
SW948,54613361,-2.2535675944820084
T98G,46843906,3.4534270415089603
KP-4,selumetinib-GDC-0941 (4-1 mol-mol),0.6661339772202117
HuP-T3,25154868,5.141210696949765
F-36P,135875424,2.6086131482089363
SK-CO-1,selumetinib-PLX-4032 (8-1 mol-mol),0.4034815942312452
RKO,124202324,3.4391315101947386
RCC10RGB,9444,4.509247284467684
SUP-T11,444795,3.188342205586965
P31/FUJ,135421197,1.0144502005310674
MOLP-8,44487872,4.385798937588512
PE/CA-PJ34 (clone C12),135440466,2.5835124352915084
TTC-709,56946209,-4.9979018218385125
PaTu 8902,448949,2.6032868845304606
KHM-1B,46199207,2.2678395325481415
Mino,6918328,-3.2797037405532987
MOLM-13,11427553,-2.505370137631637
IA-LM,60750,4.549488262081028
HT-1376,135875424,3.6702822969792193
MDST8,3825829,4.752817875520721
F-36P,vorinostat-navitoclax (4-1 mol-mol),0.0936538678270467
BT 440,ISOX-bortezomib (250-1 mol-mol),0.7268335445660418
MKN1,5329102,3.08076760786709
SW1573,JQ-1-navitoclax (2-1 mol-mol),0.4708104580132937
BICR 22,navitoclax-MST-312 (1-1 mol-mol),0.8152867092510746
COR-L105,51037431,3.876010066295024
SEM,25227462,-4.562496215443916
RKO,31703,-1.8438289452025527
JHUEM-2,9823820,-0.1137283954936936
HEL,5978,-0.5240559956879017
L3.3,123631,2.1308858538649456
Mino,selumetinib-decitabine (4-1 mol-mol),-0.4110450400232648
SW948,168312962,3.6749765666335903
IGROV-1,72734382,4.633226130326536
MKN1,25150857,2.997745632925995
SW48,216468,-0.1130169029097753
Hep-G2,44607530,1.8246078375377963
HuP-T3,216345,4.480282764347718
TTC-709,11625818,4.12216216405165
HCC15,439501,0.3030845703669018
BT 440,10296883,3.8375846267667777
P31/FUJ,638278,2.9129004591727057
BFTC-909,676352,2.5282943369079818
SK-HEP-1,60750,5.759979022694095
JHUEM-1,11396600,2.4949940260593872
NCI-H1395,44607531,1.6381567273877196
PaTu 8988t,4788,6.262210396704686
TTC-709,11152667,-0.5539552668889595
Panc 02.03,JQ-1-navitoclax (2-1 mol-mol),1.014156743517759
SK-LMS-1,4521392,5.319177274757583
NCI-H2452,doxorubicin-navitoclax (2-1 mol-mol),-1.0690798948484177
HEL,24951314,0.022330385445513
NCI-H1395,9884685,-0.0679636269907438
MOLM-13,46907787,-1.536709398859376
SaOS-2,54626689,4.533352391847383
RERF-LC-MS,10410894,3.034247655874134
KLE,10427712,3.718999940973947
SNU-626,11214940,5.773090102519011
KHM-1B,docetaxel-tanespimycin (2-1 mol-mol),-6.647221860436541
RERF-LC-MS,9903786,2.6182355767545213
BT 440,49766530,1.1711647007099082
IGROV-1,107985,-2.8971910842184516
HT-1376,piperlongumine-MST-312 (1-1 mol-mol),2.360490735547992
ES-2,9929138,5.3077403629794
WM115,10231331,-3.458943295987183
Daudi,71466578,1.924283792281082
KU-19-19,6610216,4.876021689690227
COR-L95,6918736,-0.04136223528326
MOLM-13,11625818,3.232701320691832
Granta-519,16038120,-0.1772437220791911
BICR 31,46907787,2.190433361645711
BT 440,3081361,3.192807476204052
Daudi,702558,3.2750017094913657
MOLP-8,24856436,-0.8263886484359759
SNU-626,piperlongumine-MST-312 (1-1 mol-mol),2.2683144681370604
MOLP-8,135440466,1.6989907480456066
SK-HEP-1,46843906,3.844316747572769
RKO,54626689,4.750442055573677
HARA [Human squamous cell lung carcinoma],navitoclax-gemcitabine (1-1 mol-mol),-0.596107332987684
MKN1,44185566,2.80614001419724
JHUEM-7,44498493,4.377210363637701
EB1,11178236,-7.843979586785134
Hep-G2,selumetinib-UNC0638 (4-1 mol-mol),0.8728537208894
TTC-709,168312962,-1.2875227117382129
IGROV-1,11717001,4.394306548697183
JHUEM-7,6610216,4.204761293016812
Granta-519,5291,3.886616753428741
HuP-T3,vorinostat-carboplatin (1-1 mol-mol),4.326832101925159
Hep-G2,selumetinib-navitoclax (8-1 mol-mol),0.9270338424772362
SW1271,262093,2.7991981503454495
Granta-519,1566236,1.1036082649410253
BT 248,9956119,4.3886748820117925
BT 440,doxorubicin-navitoclax (2-1 mol-mol),-1.112595103404735
BICR 22,24753719,4.1427183131543615
Panc 02.03,9926054,1.881153725115377
SNU-1272,52947716,-5.180719901739396
KHM-1B,375860,-0.460638651136882
HEL,selumetinib-UNC0638 (4-1 mol-mol),4.439373718009897
SNU-C2A,6184667,4.072884839518712
HARA [Human squamous cell lung carcinoma],6918289,2.581505632245523
LS180,54619267,4.074522434074431
SK-OV-3,5281321,-0.7098099698865428
BICR 22,selumetinib-MK-2206 (8-1 mol-mol),1.8488971729777937
KP-3,44589607,3.759468778414478
JHUEM-1,9887053,0.0424366322654341
SK-CO-1,2729026,2.8886798476744246
Granta-519,23582824,0.9303240666722092
KP-4,3815108,1.1665243369015572
BT 248,4917,1.8494335305709009
BT 248,16736978,2.1942612442020484
JHUEM-1,selumetinib-piperlongumine (8-1 mol-mol),2.6423044347648323
HuP-T3,JQ-1-navitoclax (2-1 mol-mol),2.3872748820971217
SNU-886,9911463,3.862708319776098
WM115,24978538,1.155471911978994
BFTC-909,navitoclax-gemcitabine (1-1 mol-mol),0.1512584221412147
PE/CA-PJ34 (clone C12),6252,1.334555273604778
NCI-H1568,11238147,2.925799577076833
L3.3,6610355,5.020819543145525
ALL-SIL,135398516,1.5622324093538014
COR-L95,135659046,3.614564650544248
SW1271,1285940,4.280510054640018
SW1271,6505803,0.8186340021888412
DLD-1,9866186,0.6716638683644018
SK-OV-3,SNX-2112-bortezomib (250-1 mol-mol),0.4595025269763413
RCC10RGB,UNC0638-navitoclax (1-1 mol-mol),1.9805139183388023
IGROV-1,11626560,1.7276653519578558
F-36P,11175137,2.1868285044806433
JHUEM-1,BRD-A02303741-navitoclax (2-1 mol-mol),2.915612621971813
PK-1,25150857,3.0002229440820516
LMSU,135875424,4.495921610081383
ML-1 [Human thyroid carcinoma],24748573,2.352453339172467
P31/FUJ,3552672,1.950832295752278
PE/CA-PJ49,71304818,2.6794491158142386
P31/FUJ,67291369,0.7371006748241407
LCLC-97TM1,107970,2.3018486004849907
SK-OV-3,44607531,1.947967745365508
HuH-6,17755052,0.3880058547209585
BT 248,24978538,0.997787879795877
BT 248,12001922,0.9128950259060647
BFTC-909,9936388,1.702123766125507
ALL-SIL,8515,1.9161675301812888
LCLC-97TM1,25262965,-1.937189863749451
KP-4,568763,-0.3138086722411862
Ishikawa (Heraklio) 02 ER-,vorinostat-navitoclax (4-1 mol-mol),1.7219462559221677
KP-3,135875424,4.114191182933948
SK-MEL-2,44237094,3.084282747734724
HuP-T3,ISOX-bortezomib (250-1 mol-mol),0.144245152578182
EB1,4378219,2.0850158870725304
NCI-H1395,107985,-3.679096931387758
BT 440,navitoclax-sorafenib (1-1 mol-mol),1.8718168252437324
MDST8,6914657,-1.2463021469195388
RKO,SNX-2112-bortezomib (250-1 mol-mol),-2.626179791835481
SNU-C2A,44607531,1.4840896452102874
Hep-G2,1716436,2.124902478350978
HCC1500,53392493,1.8683885031226253
MDST8,135411,0.5541309628089411
KP-4,9926054,2.5953636784587877
RERF-LC-MS,1750826,-0.5689233588179538
LCLC-97TM1,5328940,1.525932870405189
NCI-H2452,25195348,3.541594611208225
HuH-6,6623618,1.6323984444650987
ML-1 [Human thyroid carcinoma],71304818,3.0426605111728517
U-BLC1,11213558,1.528541603249197
RKO,crizotinib-PLX-4032 (2-1 mol-mol),0.8147825419497507
U-BLC1,136227924,2.288895160726179
BT 440,24797083,1.0882365988874636
HuH-6,72193861,1.7829730305005411
SaOS-2,53495165,-0.9847313398251484
SW948,11626560,1.2721393744446543
LCLC-97TM1,tanespimycin-gemcitabine (1-1 mol-mol),-1.2417811136372243
SNU-626,9911463,4.505405872194439
L3.3,25062766,2.9099713416003463
HEL,25183872,-2.1054192111007657
RCC10RGB,89928392,1.8749323034057075
Panc 02.03,10074640,3.562403354758929
KP-4,3825829,3.2044690277521592
MKN1,10410894,3.35668014866834
F-36P,24978538,0.5891913840108932
PaTu 8988t,57519531,4.351537289113079
PE/CA-PJ34 (clone C12),219104,4.13429787847428
SK-CO-1,5281321,-2.128194299198524
RERF-LC-MS,5311,1.7201713868016182
SK-MEL-2,6610355,5.831541242380359
HuP-T3,11427553,3.1840600229712037
ALL-SIL,4259181,-1.3200126273341632
HCC1500,11214940,3.550811671890936
NCI-H2452,navitoclax-PLX-4032 (1-1 mol-mol),2.336639386671478
F-36P,10127622,0.8562286429943948
HCC1500,25195348,3.452030504957034
SW1271,52912189,0.6284206808713965
MOLP-8,984333,1.0413549547234568
SW948,72734382,3.6940713099503473
IGROV-1,46943432,4.105714883822214
BICR 31,25227462,0.4256700478941367
HT-1376,44632017,4.548931923905538
RERF-LC-Ad1,5328940,2.4316696035248153
SaOS-2,2126,4.6809882623674905
YD-15,44137675,1.8126919744251384
SK-MEL-2,2858523,3.2161838291456233
HuH-6,6918736,0.4304531207020242
SaOS-2,11427553,2.020035940690151
Ishikawa (Heraklio) 02 ER-,26596,-0.9802171650937824
PK-1,11485656,1.889467088034988
PK-1,984333,1.012624839943692
MOLM-13,6914657,-6.22505002098335
NCI-H1568,24964624,2.125017418877952
HCC1500,11497983,4.502799578122533
K-562,23725625,5.2530061405843975
SaOS-2,salermide-PLX-4032 (12-1 mol-mol),4.26549663284579
RKO,136227924,3.256787131627037
JHUEM-1,984333,1.3176951887846364
IGROV-1,31703,-1.792518264692263
HEL,6438330,1.7062913765539824
SUP-T11,3136844,3.20966238052388
HT-1376,36462,3.4187537470401654
JHUEM-1,68056272,3.828931098013373
KHM-1B,135984461,4.335909278526869
T98G,4788,5.348082486857524
SK-LMS-1,navitoclax-birinapant (1-1 mol-mol),2.0684906730597703
RERF-LC-MS,25126798,3.475546322259903
LCLC-97TM1,409805,4.11204743963536
Daudi,2708,2.1654486353587266
SK-HEP-1,6914657,-2.911576812343612
SUP-T11,25154868,4.285481253628672
SNU-C2A,17755052,1.760848779162306
Ishikawa (Heraklio) 02 ER-,3543504,4.450199411331563
SUP-T11,24951314,0.8472292332578728
MOLM-13,36462,-3.0478349617512466
COR-L105,208908,1.1794902635628597
MOLP-8,44491742,4.067907034019371
Panc 02.03,89183176,4.957506748320777
Daudi,3025986,-1.684737909075286
PaTu 8902,10302451,3.9687769441396608
SNU-886,3465537,4.952996907212378
PaTu 8988t,9933475,2.2874108911255693
SW1573,5281321,-2.072955292880288
IA-LM,2733526,5.6911514373146135
Panc 02.03,6918837,-1.2317043962492993
NCI-H1568,19582717,3.4209569673427342
BT 440,selumetinib-GDC-0941 (4-1 mol-mol),0.7235694327018775
SNU-626,51039095,3.591129726299052
L3.3,3062316,1.4450663843809155
BT 440,9444,2.07228952581947
Mino,5284329,2.368517389837049
HuH-6,6852167,2.719206575723939
WM115,55508,6.132181701054794
LMSU,568763,1.244726818384242
MOLP-8,2871966,-0.632569947519592
ML-1 [Human thyroid carcinoma],decitabine-navitoclax (2-1 mol-mol),2.5515685650410216
MOLP-8,decitabine-navitoclax (2-1 mol-mol),0.2255247501063145
JHUEM-1,16720766,-0.5007760622636283
HT-1376,6505803,-1.649820321739373
HEL,6918837,-4.248380638359999
Hep-G2,3854666,3.2360339128212554
MKN1,5291,4.958888421423942
JHUEM-1,23725625,3.716605647616205
RKN,alisertib-navitoclax (2-1 mol-mol),1.493636711316015
BICR 22,136227924,2.105383482893856
SW48,135875424,3.469184081134181
COR-L95,10127622,5.649647064343883
Hep-G2,444795,7.091940765135057
PE/CA-PJ49,54626689,4.62395369924922
SU-DHL-1,60750,-4.603947913298721
SNU-886,71466578,3.8028981862440343
MKN1,9915743,2.5735660173658323
ML-1 [Human thyroid carcinoma],16065773,2.2629168527060117
PE/CA-PJ34 (clone C12),9444,4.358841089309469
DLD-1,16722836,2.7687260412305688
SNU-C2A,JQ-1-vorinostat (2-1 mol-mol),0.5591724219327301
MKN1,4917,3.1651827804799253
Mino,25062766,0.2957039446768776
SNU-626,49850262,4.006092749509864
JHUEM-7,tanespimycin-gemcitabine (1-1 mol-mol),-0.4399381866621512
SK-LMS-1,sirolimus-bortezomib (250-1 mol-mol),0.2757332914045335
SaOS-2,446155,1.978878402700164
Granta-519,tretinoin-carboplatin (2-1 mol-mol),6.438903911502162
SK-CO-1,11625818,4.187860927408271
COR-L95,676352,2.06388279354012
RKO,11719255,3.406006587740275
KLE,6852167,2.751103786046217
JHUEM-2,9444,3.6472984722267574
NCI-H1568,135875424,3.0063280878885967
IGROV-1,25195348,3.0698662305180275
KP-4,19582717,5.485304590763591
RERF-LC-MS,16659841,3.453543705685564
PK-1,107970,2.4622131815620834
Mino,208908,1.695689889994458
SW948,1641662,3.2658822910658905
BFTC-909,5351362,0.3148685714677321
EB1,9935249,-0.4672615921444373
COR-L95,24771867,5.320672645408192
MKN1,25183872,-1.648663821038974
NCI-H2452,16725315,3.1677771909290184
WM115,9926054,3.0880179510914454
ST486,vorinostat-navitoclax (4-1 mol-mol),-0.3370022309310645
PE/CA-PJ49,2708,4.888337248916052
SNU-C2A,10302451,2.484478658072876
JHUEM-1,53495165,-0.8455098155386241
BT 248,444795,4.817055384579841
IGROV-1,135875424,3.3275053166921347
LS411N,4259181,-1.386635238211632
PE/CA-PJ34 (clone C12),60700,-0.5177392228311933
ST486,53495165,-1.992782618419894
HT-1376,65064,2.364330556382453
SK-HEP-1,24821094,3.809459846332286
L3.3,16725315,5.215482090576187
P31/FUJ,tanespimycin-gemcitabine (1-1 mol-mol),-1.9905845316732809
JHUEM-7,carboplatin-etoposide (40-17 mol-mol),1.5968743771599203
JHUEM-2,56973724,1.4709075603368085
PE/CA-PJ34 (clone C12),5281321,-0.3897758283892497
ML-1 [Human thyroid carcinoma],17759555,4.838019485799326
Mino,6914657,-6.321839368914656
HCC1500,11364421,1.8102576985092016
JHUEM-2,selumetinib-vorinostat (8-1 mol-mol),2.576668042411364
WM115,11647372,-0.748702419415335
SNU-1079,navitoclax-piperlongumine (1-1 mol-mol),1.692605850682422
SK-LMS-1,2858523,3.096035867427568
IGROV-1,374536,0.7022324251593053
K-562,5311,0.9288629076778604
LS180,navitoclax-piperlongumine (1-1 mol-mol),3.251687407924036
HARA [Human squamous cell lung carcinoma],375860,-0.967052520231088
Daudi,44607531,0.7322116783883826
HARA [Human squamous cell lung carcinoma],9840324,5.741888919857564
SW1271,448949,2.9810988383972084
Ishikawa (Heraklio) 02 ER-,400769,-0.1175018825878183
KMS-21-BM,selumetinib-UNC0638 (4-1 mol-mol),-1.5035807552647436
Ishikawa (Heraklio) 02 ER-,72193861,0.7107621257665913
SU-DHL-1,42642645,0.6641769458510169
ML-1 [Human thyroid carcinoma],168312962,4.623396193395582
SW48,53232,2.98078944705874
K-562,4096211,1.5585244853649294
LS180,89183176,4.9114720653238315
SW1271,10427712,4.007366682408904
DLD-1,387447,-4.577066335044948
KHM-1B,11228183,3.292556863347854
BICR 31,JQ-1-UNC0638 (2-1 mol-mol),1.590211689658008
EB1,9933475,1.5412803909460309
SK-OV-3,72193861,3.227068856168802
K-562,148198,-4.073315546446919
ML-1 [Human thyroid carcinoma],25262965,-1.8922435286727564
SEM,374536,-3.4278771787335107
K-562,tanespimycin-bortezomib (250-1 mol-mol),-0.7275623889359331
SW948,2729026,3.020599067804879
SaOS-2,3552672,2.445112397338648
SK-MEL-2,4259181,1.4036951416401309
K-562,6918638,0.0740833242167517
BT 440,1242560,3.824471770746283
HCC15,67291369,1.6613409933263477
LCLC-97TM1,11396600,3.6456493290211425
HCC15,6438330,2.907250953014235
SW48,123631,-2.3971553119638553
RERF-LC-MS,6918638,0.4520678244574614
HCC15,54619238,5.509074276782743
HARA [Human squamous cell lung carcinoma],selumetinib-UNC0638 (4-1 mol-mol),6.072288250407716
Granta-519,5351362,0.2173676915670352
SEM,5479543,1.9736510753778953
Hep-G2,148198,-2.3541136469085493
SW1271,219104,3.9142621703193625
JHUEM-1,docetaxel-tanespimycin (2-1 mol-mol),-4.846920608903929
WM115,selumetinib-JQ-1 (4-1 mol-mol),-1.8046253833707984
Ishikawa (Heraklio) 02 ER-,5566,3.698429042799287
SW948,11497983,1.2110688984787443
L3.3,25195348,5.818157346447802
Panc 02.03,11404337,1.528571500956484
BT 248,selumetinib-vorinostat (8-1 mol-mol),3.707211778635912
F-36P,9903786,0.2788806994422486
SK-OV-3,107985,-2.353051363092625
T98G,16741245,3.037374982194141
SNU-C2A,vorinostat-navitoclax (4-1 mol-mol),1.2954145430440709
PaTu 8988t,selumetinib-GDC-0941 (4-1 mol-mol),1.0326932423441333
Ishikawa (Heraklio) 02 ER-,5282054,4.057233493104327
HCC1500,56649450,4.199956636233384
PE/CA-PJ34 (clone C12),46191454,1.75087551478746
RERF-LC-Ad1,serdemetan-SCH-529074 (1-1 mol-mol),2.637264034786848
NCI-H1395,67156097,2.84144563210516
ST486,56963564,-0.1655639992596672
MDST8,54649381,4.2434412709491385
SK-LMS-1,docetaxel-tanespimycin (2-1 mol-mol),-3.362972367128596
SK-CO-1,24772860,-2.764468608226056
SW1271,2708,3.697662973501111
COR-L105,25062766,2.3512127388642865
LMSU,navitoclax-gemcitabine (1-1 mol-mol),0.2056426446886963
ST486,23635314,-4.615019064826751
T98G,16725315,3.781528878332504
BICR 22,9826308,0.9832071992526458
SW48,navitoclax-piperlongumine (1-1 mol-mol),1.2226780800612655
KU-19-19,11404337,0.0275069311149896
PE/CA-PJ49,10074640,3.2196511192392254
Mino,serdemetan-SCH-529074 (1-1 mol-mol),0.9351346080504732
NCI-H1395,vorinostat-navitoclax (4-1 mol-mol),3.530315000383913
LS411N,decitabine-navitoclax (2-1 mol-mol),1.6875581183367745
LS411N,452548,1.178688753001054
KP-4,54686904,4.386725932550557
COR-L105,3025986,2.299444367217184
IGROV-1,25102847,1.7007012555618253
PaTu 8988t,24797083,1.3448554408655904
EB1,44489675,4.013473076226006
IGROV-1,46398810,2.003787621940583
SaOS-2,2749,2.484303950908632
RERF-LC-Ad1,3503,3.3659937623050222
WM115,7251185,2.999080033015298
SNU-1079,135984461,-0.6651362104222878
KP-4,73707371,2.537312209041087
IA-LM,151289,3.753931026261757
SW48,60168763,3.2354609354554924
NCI-H1395,52912189,3.2257776206607205
KHM-1B,168313047,1.841337582388115
YD-15,44489367,4.71886407548564
IGROV-1,168313016,4.807199318661473
KP-4,51039095,3.2736205630042736
KHM-1B,selumetinib-UNC0638 (4-1 mol-mol),2.050672890925013
MDST8,5351362,2.4401541198795726
SUP-T11,285033,-2.81019398144576
Hep-G2,439501,-0.8010222698535624
F-36P,3062316,2.069344335873667
RKO,5291,3.391339544898264
SNU-1079,4477,0.3992720870233657
SK-LMS-1,119607,5.904480567296046
LCLC-97TM1,23582824,0.7435680585464137
BICR 22,16725315,5.207801943730372
HCC1500,44632017,4.723480031494906
SNU-886,26596,-1.4881272997493236
SNU-1272,selumetinib-piperlongumine (8-1 mol-mol),5.23378922409154
F-36P,1714884,4.3216859955761215
MOLM-13,219104,1.3929442819191806
SNU-1272,31703,1.4762999099427376
SNU-1272,241158,4.382370259171122
BT 440,119182,2.7310895665421766
HuH-6,676352,1.7371761531273429
SaOS-2,44202524,1.4210473732360835
COR-L105,753704,5.105702577689745
BICR 22,216468,1.2752332856392885
RERF-LC-MS,445643,4.345437949323675
U-BLC1,44566777,-0.1793221226176986
F-36P,10322450,3.2432615470800883
BICR 22,selumetinib-UNC0638 (4-1 mol-mol),2.123491609761504
HuP-T3,44607531,1.7591062122540748
KMS-21-BM,1641662,2.31729306244873
KLE,44589607,1.3436468299943964
NCI-H1395,107970,2.4345825548290265
NCI-H1568,9915743,-0.8427224057935273
ALL-SIL,126941,-2.455728969669062
IGROV-1,168313047,1.93821625738322
LS180,100016,6.005443229591697
F-36P,11214940,1.5758051938742843
SaOS-2,60700,-2.625519230364934
KU-19-19,9907093,4.38040739031281
JHUEM-7,10302451,1.7373663186818131
SaOS-2,9935249,3.097116977919543
COR-L95,24821094,3.5692160345671335
PE/CA-PJ49,10427712,4.818708753366325
Daudi,327653,2.694862581871668
SaOS-2,65628,4.208345318362158
SW1271,navitoclax-piperlongumine (1-1 mol-mol),2.304332277449707
DLD-1,374536,3.2680730725929537
SNU-C2A,25150857,2.608478987063893
ML-1 [Human thyroid carcinoma],119182,-2.1546594526399647
LS411N,24772860,-2.6286287692739587
HCC1500,15983966,1.4595203856942676
DLD-1,5278396,3.652535836329468
COR-L95,46907787,3.807595772412777
BICR 22,24821094,3.82687279949815
BT 440,6184667,3.944803613864239
RERF-LC-MS,56946209,-3.4945734927118552
SK-LMS-1,24772860,-1.5940075969157808
NCI-H1395,73707398,1.4482642438908118
L3.3,5311,1.4084906886854671
Ishikawa (Heraklio) 02 ER-,5280436,4.342849342052085
IGROV-1,navitoclax-MST-312 (1-1 mol-mol),1.1838863893343448
MDST8,49793307,-1.5088082080905487
T98G,9903786,3.9737183240681153
KHM-1B,3825829,3.6551708099406
JHUEM-7,439501,-3.5721158792487646
RERF-LC-MS,tanespimycin-gemcitabine (1-1 mol-mol),-1.5952645398326415
SNU-C2A,23725625,5.103509321868021
SW1271,159324,2.241950485620868
YD-15,54613361,-1.6069743026097698
EB1,119182,-3.4608122726520683
Ishikawa (Heraklio) 02 ER-,23725625,4.767960358946382
Ishikawa (Heraklio) 02 ER-,25154868,3.214649435697115
F-36P,445091,4.242720143658069
LS180,doxorubicin-navitoclax (2-1 mol-mol),-2.003067068648065
KMS-21-BM,2874250,4.14284020058495
HCC1500,135398516,0.4161092034804287
SNU-1079,1641662,3.1945136941726555
HuH-6,BRD-A02303741-navitoclax (2-1 mol-mol),3.1075008311872705
KPL-1,carboplatin-UNC0638 (2-1 mol-mol),3.494519361011981
SNU-C2A,11507802,1.4166984975076906
T98G,JQ-1-navitoclax (2-1 mol-mol),0.911622095043238
Granta-519,46901937,3.6488183223471022
RERF-LC-MS,5328940,2.240356815676024
SNU-1272,5329102,2.930087391403409
BFTC-909,navitoclax-sorafenib (1-1 mol-mol),2.944260401271062
EB1,12003241,-4.025525342770554
Granta-519,400769,-1.7592122365530554
HuH-6,46199207,2.6689786465998666
BICR 22,135421197,2.0438055763788556
BICR 31,9967941,4.3746614656618865
Daudi,89928392,0.010222000273875
MOLM-13,151289,-0.2275053531847663
IGROV-1,2874250,4.893662837169153
SNU-626,73707398,1.6076526777595226
U-BLC1,441298,2.7924342485395615
MOLM-13,4261,-0.2853779042398361
SNU-626,216345,4.1318423301479275
MOLP-8,5280436,2.785612173209183
T98G,25183872,-1.3055029425176028
PE/CA-PJ34 (clone C12),24753719,4.157355819781257
KP-3,10127622,3.984264610718113
RKN,11427553,3.6372919842764424
YD-15,123631,-1.7178872821655349
LCLC-97TM1,2828334,6.057082646440782
EB1,4477,-0.4066863690250186
Daudi,11640390,2.7767455060282873
SW48,selumetinib-MK-2206 (8-1 mol-mol),-2.489387055809161
RKN,51039095,3.7797830340785694
JHUEM-2,selumetinib-navitoclax (8-1 mol-mol),1.480037413316592
HuP-T3,46398810,2.968900053185397
PK-1,navitoclax-MST-312 (1-1 mol-mol),2.62644635842085
SEM,9825149,0.5680322280051573
SK-LMS-1,4259181,1.6246211060463709
SW948,60700,1.1260701186231294
SNU-1079,5460769,0.9743779178913314
SK-LMS-1,56946209,-4.87344547296277
LCLC-97TM1,168313047,1.50715487575417
Panc 02.03,46174525,6.272327915554807
SW948,72193861,0.8788999866892542
HCC1500,6918638,0.5709126385335386
RERF-LC-MS,42642645,-0.4358765804877467
DLD-1,serdemetan-SCH-529074 (1-1 mol-mol),2.707131346723786
SEM,5494449,-4.399827227621216
KP-4,5746,-1.1735495681617156
LCLC-97TM1,selumetinib-vorinostat (8-1 mol-mol),2.6249327644586153
ALL-SIL,12001922,1.676377280214729
NCI-H2452,441298,2.247705741320954
BICR 22,46191454,1.6809351488377804
SNU-C2A,5311,1.1053198648182123
COR-L95,16013152,4.05038947229277
BFTC-909,72376,-1.4314875177558029
SUP-T11,tanespimycin-gemcitabine (1-1 mol-mol),1.2119666193423102
SU-DHL-6,15983966,-6.405792257227171
SNU-886,613000,2.2202815860905822
SNU-626,49836020,-1.879821731308555
PE/CA-PJ49,10302451,1.2868329863340626
ST486,66577038,2.632825585695111
SNU-1079,6918837,-5.192567312682423
K-562,11497983,3.839483588328175
F-36P,6610355,4.511719479094167
ML-1 [Human thyroid carcinoma],10184653,1.3933805894109417
IGROV-1,4477,1.1767656777594142
SK-CO-1,9444,4.465837668270579
SU-DHL-1,135999136,4.730243036337901
IGROV-1,54619267,3.9701367924453455
EB1,24785538,1.7438684279539585
HARA [Human squamous cell lung carcinoma],6852167,2.790696024551457
U-BLC1,168313200,1.5998883228525755
U-BLC1,26596,-0.9383285983925695
SK-MEL-2,16720766,0.6122666828133897
PE/CA-PJ34 (clone C12),5460769,-0.2838566207500756
SW948,31703,0.6983000463207195
PE/CA-PJ49,72376,-1.5815489184590188
SNU-1272,11404337,1.107901220459772
ST486,15983966,4.097476429011311
HEL,sirolimus-bortezomib (250-1 mol-mol),0.9395189968578028
SU-DHL-1,BRD-K03911514,2.3803066372148742
NCI-H1395,5280436,0.4598531683399105
HCC1500,46398810,2.5427546617930905
LS180,tanespimycin-gemcitabine (1-1 mol-mol),-3.220136839114834
WM115,51039095,2.786212621210589
TTC-709,25262965,-1.95165111076849
Granta-519,JQ-1-carboplatin (1-1 mol-mol),-0.0687085528306087
KMS-21-BM,9840324,5.2940308453785585
SNU-C2A,11640390,4.348057187593652
HCC1500,24772860,0.2838196702204312
BT 248,44589607,2.2150317514642635
NCI-H1395,3825829,4.5765318321652355
SU-DHL-1,71304818,1.6958772786188914
F-36P,16038120,0.8802402655466375
WM115,16736978,2.885535594388376
NCI-H1568,54618305,4.1006341963066255
RCC10RGB,11404337,1.763382313076518
BICR 31,navitoclax-MST-312 (1-1 mol-mol),1.028775915948256
HCC15,17755052,4.876160174226561
EB1,151289,0.2177407716656138
SNU-886,23725625,4.310392340682066
T98G,409805,5.844803307866975
PE/CA-PJ34 (clone C12),54143018,0.7240710800326328
PE/CA-PJ49,208908,1.8982859122138596
COR-L95,6610216,4.601423414679649
JHUEM-2,65628,2.577248815747806
LCLC-97TM1,10296883,3.762301074740285
Granta-519,753704,4.381381177541046
COR-L95,3825829,4.2210058836960265
HCC15,51039095,2.370618956781999
SNU-886,452548,-1.461802443454938
IGROV-1,erlotinib-PLX-4032 (2-1 mol-mol),3.0086678924768404
JHUEM-2,54649500,5.0408791549603515
ST486,216239,1.615349445963496
SUP-T11,5281321,-2.291131006117726
SK-OV-3,crizotinib-PLX-4032 (2-1 mol-mol),2.8845128579100456
JHUEM-1,decitabine-navitoclax (2-1 mol-mol),1.3443277131365892
ES-2,262093,2.44906158082759
K-562,9915743,1.457381054045144
Daudi,644241,1.4114598324864769
SNU-626,selumetinib-navitoclax (8-1 mol-mol),2.314316623244693
Mino,1317464,3.739113340319872
COR-L105,6610355,4.615259996363044
JHUEM-2,44589607,1.666337788333314
BT 440,285033,-1.4660469594059786
NCI-H1568,400769,-0.2296701698466811
SK-LMS-1,6852167,3.2249832474571893
HT-1376,46398810,2.700462347437417
PaTu 8902,4096211,3.3878786245174917
U-BLC1,168313016,5.063255605681815
IGROV-1,6610355,3.969940996770339
NCI-H1568,15547703,3.0519937502167744
BICR 22,11609586,1.2076158919216122
NCI-H1568,6918736,-3.5744965026463893
PE/CA-PJ34 (clone C12),tanespimycin-gemcitabine (1-1 mol-mol),-1.6336664164478074
Panc 02.03,2729026,3.1511226959620715
KPL-1,tretinoin-carboplatin (2-1 mol-mol),4.668980342557267
HuH-6,71466380,2.455646558011954
JHUEM-2,46943432,1.9094756808376605
RCC10RGB,73707438,4.14323951901879
SK-HEP-1,11609586,4.257559552037769
JHUEM-2,9911463,2.885358490635734
KU-19-19,piperlongumine-MST-312 (1-1 mol-mol),2.2377116602988187
MKN1,alisertib-navitoclax (2-1 mol-mol),1.788523464740971
WM115,9935249,2.3950107716018465
Hep-G2,24772860,-3.6408811512611137
F-36P,5311281,1.509160048617295
PE/CA-PJ34 (clone C12),16720766,1.060904595920648
KHM-1B,54143018,-0.2893377484312812
ALL-SIL,9929138,4.286241964174987
SU-DHL-1,452548,-2.7499107831448257
SNU-1272,12001922,1.7945381645240002
ALL-SIL,JQ-1-MK-0752 (1-1 mol-mol),0.2899712696196563
COR-L95,262093,1.2094317801688714
PK-1,6918328,0.436082029556173
ES-2,6918736,0.127537406692778
LCLC-97TM1,4788,5.877974617736734
LCLC-97TM1,11455910,0.6647050862050086
PK-1,5470400,-2.978275713329798
HARA [Human squamous cell lung carcinoma],5978,-4.046402058806829
IGROV-1,3025944,3.9702787396819503
COR-L105,44486219,4.2268301570583
HEL,6852167,2.7971477189216207
HARA [Human squamous cell lung carcinoma],6918837,-1.4537868658939308
KP-3,44484440,2.9520563964934565
KP-4,navitoclax-piperlongumine (1-1 mol-mol),2.3593661555540755
BFTC-909,SNX-2112-bortezomib (250-1 mol-mol),0.3698834200349636
MOLP-8,24753719,3.861578571306771
RKN,54649381,4.194319964969153
NCI-H2452,5738263,2.391583749104638
RERF-LC-MS,11612883,2.474683430971872
LS180,67156097,-0.3004464994297747
ALL-SIL,638278,2.4844738615144797
NCI-H2452,navitoclax-sorafenib (1-1 mol-mol),1.6826538344111892
ES-2,54143018,1.3692329984482663
JHUEM-1,tanespimycin-gemcitabine (1-1 mol-mol),-1.784363789931432
WM115,89928392,1.4475546317176564
NCI-H1568,4917,1.9457015565482707
Daudi,2746,0.9195319579001202
KHM-1B,148198,-5.169783546510426
RERF-LC-MS,136227924,4.560045704487339
KMS-21-BM,56973724,1.1540804888605822
F-36P,15953870,2.011519160758859
PE/CA-PJ34 (clone C12),5329102,2.622202287503012
Mino,4259181,-0.1308029844207646
SK-OV-3,400769,-0.3757443057400228
T98G,5113032,5.258313678685002
Daudi,2742550,2.6022450411597764
SNU-C2A,46907787,-0.3001977853137419
KMS-21-BM,16038120,-1.1590374906887604
SU-DHL-1,1242560,3.2887270842989285
JHUEM-2,168312962,2.2800330811271743
IGROV-1,1750826,-3.124548162001242
IGROV-1,3025986,-1.046010021597061
KHM-1B,176870,4.52912328100578
KPL-1,644241,3.1412957180316656
SK-CO-1,serdemetan-SCH-529074 (1-1 mol-mol),2.3873903217982155
KMS-21-BM,2733526,2.3029354063569487
F-36P,72193861,-0.5214112723589638
EB1,55508,3.077404697627829
HT-1376,BRD-K03911514,4.653287464318712
COR-L95,11178236,-1.511835887926392
F-36P,5282054,2.790703511495532
MDST8,15953870,3.886262261351445
SUP-T11,11427553,2.8637683751990677
P31/FUJ,71466578,3.434376258750051
SUP-T11,119182,-5.5703921388414805
SK-OV-3,navitoclax-pluripotin (1-1 mol-mol),-0.7992901012574275
HCC15,16038120,-0.3287102193479797
SU-DHL-1,selumetinib-JQ-1 (4-1 mol-mol),2.388331941434094
PE/CA-PJ34 (clone C12),107970,2.3192518543827476
TTC-709,60750,-4.967527362441655
WM115,44607531,1.8052962391610108
SK-CO-1,322968,3.708989182542924
IGROV-1,1716436,3.2816872421007375
IGROV-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1366391073371296
PE/CA-PJ49,11485656,1.6473553373420289
YD-15,176870,0.3708993510350585
SK-HEP-1,15953870,5.227718988850451
SW1271,10231331,-0.1974856956768426
HuP-T3,168312962,3.781886601468438
MKN1,3384730,3.6868774945418794
SEM,135875424,2.4848737039506426
Granta-519,11238147,3.49055902156802
L3.3,15953870,4.520919895902943
SNU-1079,9911463,2.811910172991152
F-36P,10113978,2.938429796709092
F-36P,16736978,0.9854298556490608
ST486,26596,-3.6953345637142063
KP-3,654092,-2.1271165007576323
ES-2,15547703,2.9667892008771557
SW1271,54678924,4.1367056407476595
Panc 02.03,89928392,1.630028817710481
BICR 31,148198,-3.2373882564770513
T98G,4578,5.236226990413865
JHUEM-2,51039095,-2.8840012378705935
IGROV-1,104842,-1.6690343627553987
K-562,erlotinib-PLX-4032 (2-1 mol-mol),2.919036789421011
SUP-T11,11396600,2.6585567591139245
HCC1500,10184653,1.0749855490236058
HCC15,44202524,2.021204517823952
T98G,1242560,3.945033986120641
JHUEM-7,sirolimus-bortezomib (250-1 mol-mol),-6.320695454237984
COR-L105,9866186,1.0648092573013754
HuH-6,49793307,-2.9730498599587083
COR-L95,285033,-2.430535969260308
COR-L95,23635314,-1.8010937940640896
SNU-1079,3385,3.115524530585201
SaOS-2,11364421,-5.8107581348158
BFTC-909,122327,4.590877432942681
IGROV-1,54618771,1.2456991772210466
ST486,24964624,1.9222689182793096
P31/FUJ,675434,4.075878142833804
HEL,tretinoin-navitoclax (4-1 mol-mol),-0.5211961958831923
LMSU,5328940,2.811876730497891
NCI-H2452,5328940,1.966899609603824
RCC10RGB,72376,3.207429090732714
LS411N,selumetinib-tretinoin (2-1 mol-mol),1.6361357934026397
NCI-H2452,4917,2.7944300449003907
BICR 31,1716436,3.7157300626912617
MOLM-13,1239801,3.478439984806631
U-BLC1,107985,-3.242236083428716
HuP-T3,10296883,4.266239948990751
HuH-6,15547703,2.890645174677009
KP-4,11964036,3.04555991921075
PaTu 8988t,107970,2.530920724052233
ALL-SIL,675434,4.0400251875066715
U-BLC1,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.387521569845494
PaTu 8988t,16736978,1.6582336139520693
T98G,51037431,1.46917993370071
LS180,5460769,0.3293841533128088
MDST8,11612883,2.4942536836786635
COR-L95,46191454,2.009346014708409
U-BLC1,3552672,3.115609848717652
MOLM-13,451668,-3.798095624109847
Daudi,168313016,3.9002026806644734
ALL-SIL,135411,-0.5620485907345016
RCC10RGB,46215462,3.684591481140594
KU-19-19,4917,3.607977283390518
F-36P,216468,-1.3268661185517077
Panc 02.03,71751553,4.925944110140211
HCC1500,5281321,-4.561246998431513
LS411N,44202524,4.412838675121289
LS411N,637858,2.7012095970179635
ML-1 [Human thyroid carcinoma],46191454,1.5014607148772898
SK-HEP-1,24797083,1.0035545042427043
ALL-SIL,navitoclax-gemcitabine (1-1 mol-mol),-4.146952784268296
HARA [Human squamous cell lung carcinoma],24951314,2.561199492034659
ST486,135659046,3.2413267660830316
MKN1,JQ-1-UNC0638 (2-1 mol-mol),3.2416236707502275
EB1,2871966,-2.20248405497768
BICR 31,387447,-3.4745770631768553
L3.3,3503,3.0907711446371
JHUEM-1,11228183,2.0764343272108023
SK-CO-1,452548,-1.5551413224098238
JHUEM-1,6914657,-4.070471262691046
U-BLC1,9823820,3.5344504380553863
SW948,6914657,-4.288216532991124
ST486,JQ-1-MK-0752 (1-1 mol-mol),-0.3259302264748271
PK-1,56946209,-4.163723504507934
F-36P,71466445,1.2079369849052677
SK-HEP-1,216468,4.223762462623231
RERF-LC-Ad1,65064,3.2062738089199176
KMS-21-BM,selumetinib-navitoclax (8-1 mol-mol),-2.296837371188103
ALL-SIL,71466380,3.7861137397034255
Ishikawa (Heraklio) 02 ER-,11485656,3.3351822196084937
EB1,23582824,-0.4322302877801252
ST486,451668,-3.227200496981336
ALL-SIL,66577038,2.592918053791083
SEM,23635314,-3.712591806997875
TTC-709,tretinoin-carboplatin (2-1 mol-mol),4.585702066562209
K-562,46174525,4.631327159993839
SK-HEP-1,11404337,1.0852289139958715
SW948,tanespimycin-gemcitabine (1-1 mol-mol),0.3148339676626304
COR-L105,156414,4.037454349539868
P31/FUJ,5351362,0.932451869978648
L3.3,doxorubicin-navitoclax (2-1 mol-mol),-0.9996417914636118
BICR 22,57519531,2.122776388957543
JHUEM-2,637858,1.722532316890112
HARA [Human squamous cell lung carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.0458249521104828
EB1,navitoclax-pluripotin (1-1 mol-mol),-2.99887049858763
DLD-1,9927531,4.358823264887286
SNU-886,24772860,-3.3986263976004913
KP-4,54454,1.6581389243409257
HT-1376,16722836,1.13803063235719
BT 440,docetaxel-tanespimycin (2-1 mol-mol),-0.8543684361630078
SW48,156414,-3.5613148313114293
BICR 31,24180719,3.9564262696237096
SNU-1272,5311,1.8395995002993613
KU-19-19,11222830,1.7129831318158657
HuP-T3,9911463,3.677427040789425
KHM-1B,54649381,3.5405814758079117
Granta-519,56649450,2.820913380280981
SNU-C2A,446155,3.2558711428887466
BICR 31,5328940,1.2878315189706533
HARA [Human squamous cell lung carcinoma],navitoclax-birinapant (1-1 mol-mol),1.3986072497708624
IGROV-1,19582717,6.764352444432722
KP-4,25062766,2.0544826822763604
SK-LMS-1,56649450,4.729430575758327
IGROV-1,24951314,0.9075718706849548
Granta-519,9911830,2.3469616146388033
RKO,3038522,3.342495330103654
KMS-21-BM,11175137,1.604154468837666
L3.3,5281321,2.3391738882410813
P31/FUJ,135440466,3.423250795887436
BT 248,5351362,1.0725587198101878
IGROV-1,6918878,1.6706182189896102
NCI-H2452,tanespimycin-bortezomib (250-1 mol-mol),1.699086924939448
SW1271,136227924,3.2074421772411372
SUP-T11,9826308,-0.14940473730288
IGROV-1,16722836,0.856484234547582
SNU-C2A,67156097,-1.076158219593068
WM115,piperlongumine-MST-312 (1-1 mol-mol),1.2080674757764085
HARA [Human squamous cell lung carcinoma],3025986,-0.8541128463962537
IGROV-1,168313016,4.807199318661473
Panc 02.03,9935249,3.920507280118285
UACC-812,19582717,5.3439559865445245
SK-CO-1,54619267,3.100073010472608
LCLC-97TM1,56973724,2.3842885859021985
BT 440,25195348,5.710535571085352
P31/FUJ,44185566,1.65624467652309
TTC-709,71751553,4.330479823321924
PE/CA-PJ49,9952709,3.470273688977996
BT 248,409805,5.374494739188799
LMSU,11152667,0.2226803323304874
Ishikawa (Heraklio) 02 ER-,16725315,4.616784128225617
PE/CA-PJ49,tretinoin-navitoclax (4-1 mol-mol),4.444657287953014
BICR 22,erlotinib-PLX-4032 (2-1 mol-mol),2.8586424250405784
LS180,568763,0.2796957344404436
PE/CA-PJ34 (clone C12),11647372,1.7004397362424115
HEL,5281321,0.1504430999261452
COR-L95,168313200,1.9910859109269063
NCI-H2452,100016,6.6405878618594985
SNU-886,11485656,2.594845566887895
SK-OV-3,vorinostat-navitoclax (4-1 mol-mol),1.2421133926861518
SNU-C2A,44137675,3.472575790162701
JHUEM-2,65064,4.066116292655437
SK-HEP-1,71751553,4.559763777433237
SEM,10296883,-0.6538100941325019
COR-L105,6450551,3.13458936271996
MOLP-8,227681,1.7901539797099055
LCLC-97TM1,24951314,1.6929873886763296
LCLC-97TM1,20959075,-3.5903877814282836
SNU-1079,6918328,-3.1018501377247976
T98G,613753,3.3612469619815126
TTC-709,piperlongumine-MST-312 (1-1 mol-mol),1.283145426794836
KP-3,6852167,3.3293836315268805
Panc 02.03,11964036,1.263021853424522
Granta-519,54596558,4.099782953798094
KMS-21-BM,2749,0.694172664041068
IA-LM,navitoclax-PLX-4032 (1-1 mol-mol),1.0143857311372344
P31/FUJ,navitoclax-gemcitabine (1-1 mol-mol),-2.2174176001996626
KHM-1B,sirolimus-bortezomib (250-1 mol-mol),0.0402110157809841
IGROV-1,246676,4.485924799339535
HCC15,25126798,3.760529318413009
P31/FUJ,67156097,-2.27730723064269
KU-19-19,4788,5.856744699338042
MOLM-13,44507138,0.4726740823031857
LMSU,2126,3.9441153876668
ES-2,42642645,1.9481348104306395
U-BLC1,BRD-A02303741-navitoclax (2-1 mol-mol),0.7753131633287742
EB1,tretinoin-navitoclax (4-1 mol-mol),3.1581555390621503
COR-L95,5281672,3.930459616892441
HT-1376,54618771,1.723140489486428
HEL,46191454,2.0114602406157487
SaOS-2,25227462,1.0053365829052552
NCI-H1568,327653,2.9538763640308403
MOLM-13,126941,-4.1996343959718665
SEM,107970,1.646444978651256
SW1573,23582824,0.5044187481506299
HuH-6,16013152,4.071601906125075
KPL-1,selumetinib-piperlongumine (8-1 mol-mol),5.027549076188454
KMS-21-BM,11964036,-0.1248951629717859
ES-2,4477,-0.3016511223524857
SNU-886,5566,3.303161938775539
SW1271,selumetinib-UNC0638 (4-1 mol-mol),0.1676161732677231
RKN,46199207,3.372714950884571
MOLP-8,2113511,4.489524818659998
K-562,selumetinib-decitabine (4-1 mol-mol),3.3977333997002215
MOLM-13,9907093,2.467705892800055
NCI-H1395,24797083,1.421721283570518
SUP-T11,151289,0.4498596163444748
BICR 31,135398516,1.997761003126595
SW1271,216345,3.992520329028928
DLD-1,72376,-2.1902201838072997
SW1271,49766530,-1.8216621121390524
T98G,JQ-1-MK-0752 (1-1 mol-mol),1.750575078353051
PE/CA-PJ34 (clone C12),135659046,3.607473265136562
BFTC-909,44819697,-0.8003395289407239
COR-L105,tretinoin-navitoclax (4-1 mol-mol),2.190606174961121
COR-L95,24951314,1.2848618182948477
Panc 02.03,11427553,3.85172253134883
SEM,9823820,2.1841309858683866
RERF-LC-MS,11955716,-2.426679724944883
KPL-1,216239,3.200920507088242
ST486,25195348,2.601233246141542
LCLC-97TM1,168312962,4.14705930417905
LCLC-97TM1,984333,1.7706091320352773
F-36P,135411,0.818269408267781
Ishikawa (Heraklio) 02 ER-,638278,3.4919632376772
F-36P,11625818,4.163837003749958
BT 440,25154868,5.23626395790397
JHUEM-1,6610216,4.023660929600166
RERF-LC-MS,3689413,0.4263782886644774
PK-1,11625818,4.981736096941818
SNU-626,3025944,4.350431839393406
HARA [Human squamous cell lung carcinoma],613753,4.606319217012033
SK-LMS-1,104842,-1.9221862175064584
BT 440,448949,1.5488515443911208
SNU-C2A,9935249,3.886157846226495
HEL,72734382,4.138558929268269
HuH-6,navitoclax-pluripotin (1-1 mol-mol),-0.4333168825332701
YD-15,49850262,4.056753571311991
U-BLC1,53495165,-0.4951550898397017
Daudi,5281672,3.0556000328651267
KHM-1B,409805,3.6418621708763945
JHUEM-1,6610355,3.551202679408389
Granta-519,73707438,4.294812737502366
RERF-LC-Ad1,crizotinib-PLX-4032 (2-1 mol-mol),2.9408300097194013
HARA [Human squamous cell lung carcinoma],23635314,-1.642514653884031
BFTC-909,3465537,1.8561429441463555
SNU-C2A,89183176,4.859762295737264
U-BLC1,11222830,1.1752435211266885
SNU-886,11152667,-0.5084903707284607
MDST8,53232,0.2243602329572143
PaTu 8988t,54618164,4.622822732421989
KP-3,11404337,-0.3315209931001077
ALL-SIL,decitabine-navitoclax (2-1 mol-mol),-2.660613413513553
SEM,135440466,0.4390195175312653
SEM,31703,-4.117081497210504
ES-2,11364421,1.0299695512107727
BICR 22,241158,4.423333712203234
IGROV-1,25150857,3.031865110078871
MDST8,2729026,2.783400494590182
SEM,12001922,1.121071645665963
KPL-1,64971,3.4858350276090344
IA-LM,56649450,5.159895082661475
RERF-LC-MS,44137675,3.373454428855253
JHUEM-1,5287620,-3.2308801902692763
HCC1500,11612883,3.8728122953700113
HuH-6,4477,2.4882129938472333
SNU-1272,16741245,3.8765356368768566
COR-L105,44491742,4.003695029376484
SU-DHL-1,17759555,3.5507610454949177
PaTu 8988t,2828334,6.317024230854033
PaTu 8988t,168312962,3.961414669504744
ST486,2729026,1.857732795675916
KLE,400769,-0.1230661741359576
KP-4,168313047,1.8447542895379816
NCI-H2452,15953870,1.9726746369071917
F-36P,72734382,3.3122529746268707
ST486,25022340,4.354279128857813
EB1,11317348,0.8989899474243234
LCLC-97TM1,54626689,4.751501808909531
PaTu 8902,136227331,5.567107594748722
NCI-H1395,10302451,4.201114377039751
SNU-1079,selumetinib-UNC0638 (4-1 mol-mol),-0.2707904635828767
SEM,6918638,-1.2521894984782256
KMS-21-BM,44491742,3.2404662940088205
HuH-6,24771867,3.3872458893316177
KHM-1B,36462,-0.5615447034427615
SUP-T11,24180125,1.2702519400611516
U-BLC1,322968,3.885651596940583
HARA [Human squamous cell lung carcinoma],445643,3.755641736641804
COR-L105,ISOX-bortezomib (250-1 mol-mol),0.2804376845822182
ML-1 [Human thyroid carcinoma],selumetinib-UNC0638 (4-1 mol-mol),-2.912510210684258
TTC-709,637858,0.9125312609404584
KP-3,3025944,4.126836183023836
Daudi,11317348,0.8828508555827204
BT 248,208908,1.7719462620560902
BT 440,387447,-4.343909187687206
IGROV-1,26596,2.910298792762654
K-562,2742550,1.8061055262772656
IGROV-1,25062766,2.144848161581278
ML-1 [Human thyroid carcinoma],439501,-1.5032891627146094
LMSU,6917907,2.90407541957411
KP-4,16741245,4.517888599440113
IA-LM,navitoclax-MST-312 (1-1 mol-mol),0.5208691605540192
KP-3,219104,2.974540129333194
SNU-626,448949,3.320076363001182
SW948,123631,3.5700289871060327
COR-L95,168312962,1.6965693753889812
IGROV-1,9956119,3.7231415872817024
RKO,doxorubicin-navitoclax (2-1 mol-mol),-1.0579033502847706
SEM,9935249,-3.4494441375925153
HCC15,23725625,4.984445415553906
KU-19-19,JQ-1-vorinostat (2-1 mol-mol),1.2174768050309406
RKO,2708,5.0364138660049935
HARA [Human squamous cell lung carcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.215632811452015
SNU-1272,107985,-3.786570861641408
IA-LM,148198,-11.384967135346804
PaTu 8902,44202524,5.539571067533291
BT 248,9866186,3.3997152825838515
F-36P,navitoclax-sorafenib (1-1 mol-mol),0.9327290112041924
SK-OV-3,10127622,6.3662035368843535
U-BLC1,19582717,2.9683618016156696
PaTu 8988t,16038120,1.6913300198770496
HCC1500,6610355,5.5539350619643395
SEM,9929138,6.8273209917060145
RKO,9956119,3.3077949428120195
SK-MEL-2,3503,1.8293327091202949
MDST8,8515,5.547245054967808
HCC1500,5978,-3.1049031694332183
U-BLC1,613753,3.1632000098618804
WM115,navitoclax-gemcitabine (1-1 mol-mol),-1.739473947075712
YD-15,10184653,-2.2925676477978287
U-BLC1,11656518,2.6653000271203093
BFTC-909,262093,3.5924629632259792
JHUEM-2,12003241,-3.1995756847172108
RKO,23635314,-2.140231911981244
LMSU,9866186,2.2286939019864813
MDST8,11626560,2.2403804115384207
COR-L95,UNC0638-navitoclax (1-1 mol-mol),-0.3776689942774316
COR-L95,44819697,-0.3616253875757693
BICR 22,5351362,1.2051272382141311
PE/CA-PJ49,5746,1.1840250110629396
K-562,9967941,4.015535149970178
SNU-1079,JQ-1-UNC0638 (2-1 mol-mol),-1.929161892732556
ST486,3025944,3.427852260600669
Panc 02.03,selumetinib-piperlongumine (8-1 mol-mol),3.9730948608994385
HARA [Human squamous cell lung carcinoma],42642645,0.3266919515257925
Ishikawa (Heraklio) 02 ER-,31703,-0.9306031873157388
UACC-812,25102847,4.053875686762356
SK-OV-3,6610355,6.222226160480143
PE/CA-PJ49,168313016,4.508662039314565
RERF-LC-Ad1,24889392,4.514749379565269
IA-LM,11152667,1.0642318645878492
BFTC-909,6918289,3.427790661189136
Granta-519,11167602,4.36712443545526
PE/CA-PJ49,4788,5.915803154330926
BT 440,10184653,1.8319454591870863
SNU-886,10127622,1.388505353743375
Hep-G2,5311,0.6170411040071866
KP-4,31703,-2.3064637721928745
BICR 22,60700,-0.4008092990404712
LS180,BRD-A02303741-carboplatin (1-1 mol-mol),4.457802595485306
RERF-LC-MS,241158,4.36087401910034
K-562,JQ-1-UNC0638 (2-1 mol-mol),0.4182690397422658
HCC1500,24951314,1.2674136228128516
SK-LMS-1,67156097,0.6683125434523579
NCI-H1395,168312962,2.594728459229535
ST486,42642645,-0.9245149010192216
K-562,65064,5.606410384518605
PaTu 8988t,6852167,4.186106645973286
NCI-H1568,BRD-A02303741-navitoclax (2-1 mol-mol),5.689804602568574
RERF-LC-MS,25154868,3.293982375318642
Mino,8515,3.2979107224105406
KLE,421610,3.1712689131891074
Daudi,11719255,1.9605498566152704
LCLC-97TM1,selumetinib-piperlongumine (8-1 mol-mol),3.449521534433945
P31/FUJ,9907093,4.323796399268767
RERF-LC-Ad1,3689413,-1.7788688033713365
T98G,66577038,3.0652231076886713
SK-HEP-1,56649450,4.110961369423777
SW948,11238147,1.5812364597614252
MOLM-13,60700,-3.6931560077615337
SNU-1079,452548,0.5454040435822819
Hep-G2,11175137,2.5182853193143813
BT 440,24180125,3.8960542559338167
BT 440,6450551,0.3928045904666091
SK-OV-3,54618164,4.236989567252486
WM115,53232,2.2909547616931243
KHM-1B,24753719,3.787412928700261
KMS-21-BM,5280436,3.496822032917437
KP-4,100016,6.84348879863886
KMS-21-BM,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.5158040085901563
PK-1,crizotinib-PLX-4032 (2-1 mol-mol),1.92559662218468
Granta-519,11213558,2.214733921051264
SNU-C2A,409805,4.9402914369912
T98G,46907787,2.563671389341863
HCC1500,12001922,1.110118640671234
PE/CA-PJ34 (clone C12),25161177,5.151345189753289
MDST8,12003241,0.3559193403256231
PE/CA-PJ49,4705,3.0123221957178017
ML-1 [Human thyroid carcinoma],452548,-2.1962617612927375
ST486,6914657,-9.000073829315493
MOLP-8,44819697,-0.0313402586892576
COR-L95,136227924,2.879022500990784
KPL-1,2945648,2.9960490231070063
JHUEM-7,6914657,-3.112365649276011
Granta-519,135421197,0.2234065586927925
PK-1,3503,2.4730818119692346
MOLP-8,SNX-2112-bortezomib (250-1 mol-mol),-3.1816176018347018
SW48,6505803,-3.5264924347891897
PK-1,11707110,-1.4339212593134842
HT-1376,2729026,3.035704676475354
TTC-709,ISOX-bortezomib (250-1 mol-mol),0.3540003018216795
BT 440,5287969,-1.2617248340244205
IGROV-1,8515,2.1861539315976053
ML-1 [Human thyroid carcinoma],10410894,4.287937298613586
SEM,JQ-1-navitoclax (2-1 mol-mol),-3.2274870101256306
RCC10RGB,doxorubicin-navitoclax (2-1 mol-mol),1.2475465934468772
MOLM-13,25102847,-4.845176201807707
SK-CO-1,selumetinib-JQ-1 (4-1 mol-mol),-1.696692082912101
BT 248,carboplatin-UNC0638 (2-1 mol-mol),3.451491217767034
JHUEM-1,9956119,3.945176004200916
SW1271,53481919,3.611390941951582
RERF-LC-MS,24964624,3.0594292113466515
LCLC-97TM1,969516,2.175595213634207
HT-1376,53232,3.365758198899429
WM115,JQ-1-carboplatin (1-1 mol-mol),1.8205622185822876
KHM-1B,3062316,-0.287496267646507
RKN,49793307,-1.2643121180608
SUP-T11,24785538,0.46040892294009
K-562,selumetinib-tretinoin (2-1 mol-mol),3.758766106216507
SU-DHL-1,15547703,1.7605543364675147
COR-L95,11625818,4.182153411947424
BICR 22,12003241,-0.4808187565312439
LCLC-97TM1,124202324,2.4863882679536133
BICR 22,24797083,1.5794716057353129
TTC-709,2858523,2.868487862584854
WM115,136227331,3.7917327546536983
MOLP-8,23725625,3.090240324780466
NCI-H1568,3552672,1.826953477138791
SK-MEL-2,24821094,4.0114427646580735
F-36P,44185566,1.4240664943948855
SU-DHL-1,selumetinib-navitoclax (8-1 mol-mol),2.4518113927127754
Ishikawa (Heraklio) 02 ER-,11152667,-0.2897968836684769
HuH-6,1716436,1.234135557259373
SNU-1272,60700,2.5786985411143797
KHM-1B,JQ-1-navitoclax (2-1 mol-mol),-1.1171420900170967
IA-LM,51039095,2.817946248906647
BT 440,44819697,-1.9999245034038573
JHUEM-1,10113978,1.8761654236602592
LMSU,9926054,1.9493229998791417
SEM,60750,-6.755912967661906
K-562,11964036,1.6077176524784418
PE/CA-PJ34 (clone C12),439501,-1.4242244228812553
SEM,9956119,1.5287909021793558
PE/CA-PJ49,9915743,0.4153900299925456
MKN1,3634881,3.5215839233077606
KP-4,36462,0.4570460544879974
HCC1500,5470400,-1.7385310235308598
SU-DHL-1,11396600,2.533401176626175
SNU-1272,17755052,3.726908872062008
BFTC-909,216345,4.226804426652683
SNU-1079,25062766,1.529053876252635
PE/CA-PJ34 (clone C12),ISOX-bortezomib (250-1 mol-mol),1.4521008685739432
Panc 02.03,71304818,4.256945507775637
Panc 02.03,219104,4.2068478561753375
SW948,23582824,0.2041553679799947
BT 248,55508,3.993579478299883
NCI-H2452,5287620,-2.107035322199283
HuH-6,11317348,2.7267510975433784
Mino,1716436,1.8287087640560211
NCI-H1395,9911463,3.814426972193391
SW1271,15953870,2.918493523161381
HuH-6,11214940,1.1311150695215195
IGROV-1,119182,0.2112476135388779
DLD-1,322968,4.252536232118012
SW1271,11656518,1.475105479065936
JHUEM-1,doxorubicin-navitoclax (2-1 mol-mol),-2.6009185892300644
Panc 02.03,49766530,0.9655059796360064
KP-4,11507802,0.4427590304942607
F-36P,9952709,2.731832265125769
SNU-886,9823820,0.0175156920594608
LS180,89928392,1.7442798189695845
SW1573,53495165,2.229023421141798
WM115,16659841,5.127619480623103
BT 248,25126798,4.2564362718884965
SW1271,3552672,3.981050843991283
Hep-G2,124202324,1.2953785205676314
SW948,9926054,1.8406028662949705
SUP-T11,2749,-0.0658192674402103
MOLP-8,JQ-1-MK-0752 (1-1 mol-mol),-1.2157281413611027
Hep-G2,4788,5.9429406045428586
SK-MEL-2,5281321,-2.884396164754634
RCC10RGB,71466445,4.397911896340776
WM115,7326481,2.374260909001927
SW948,44202524,1.7116279237548724
KPL-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.27324309908227
RCC10RGB,46907787,5.224507823938942
LS411N,9936388,1.997277136132151
SW1271,135423438,1.1699634662635283
SK-OV-3,ISOX-bortezomib (250-1 mol-mol),1.1042689402938264
COR-L105,123631,-0.3749766708664047
MOLM-13,52947716,-3.8827491455655694
HEL,36314,-3.7348038354216593
TTC-709,15983966,-3.60847272118343
KU-19-19,54454,2.6957608866389866
Granta-519,BRD-A02303741-navitoclax (2-1 mol-mol),-0.3585433064620935
MOLM-13,71680916,4.890723285268907
Hep-G2,6505803,-2.5933743398692894
SNU-626,216239,3.194908798242301
KMS-21-BM,tanespimycin-bortezomib (250-1 mol-mol),-3.1292569725831796
EB1,5470400,3.314265950845914
SW1573,65628,4.136448104244246
HuP-T3,11178236,-4.0067645508863174
ST486,227681,2.0379392342864366
WM115,11364421,-5.628114250516673
SUP-T11,11977753,-3.669841288255941
K-562,613753,3.252228295501032
IGROV-1,24771867,1.9944882740161016
ALL-SIL,11152667,-2.075218964097288
BICR 31,3081361,0.7844567898788304
SNU-626,2858523,3.075917906962486
SK-HEP-1,piperlongumine-MST-312 (1-1 mol-mol),1.9419225552023804
RCC10RGB,4788,6.17872638158586
BT 248,navitoclax-birinapant (1-1 mol-mol),0.9680614151724524
KP-4,156414,1.731574968381172
BT 440,6252,4.3704371587600575
Panc 02.03,11626560,2.1710424521283427
IA-LM,11175137,3.357915620650256
RCC10RGB,11626560,2.6825909392900376
SW1573,168313200,1.7327341920391253
Granta-519,2828334,6.191507302277889
SEM,24978538,-3.458194735771583
SK-CO-1,selumetinib-piperlongumine (8-1 mol-mol),0.2146036861774908
MOLM-13,5460769,1.2989705913507943
TTC-709,107970,1.8845253707265144
SU-DHL-1,216345,3.4378126257341406
Ishikawa (Heraklio) 02 ER-,168312962,-2.090684383571494
BT 248,135999136,1.3787773380664552
L3.3,26596,-0.871586326159775
JHUEM-1,65064,5.187893379765883
YD-15,2858523,3.147419184234143
SEM,7251185,0.9533100433474536
JHUEM-1,46191454,0.6052632651170511
WM115,vorinostat-navitoclax (4-1 mol-mol),2.428259860783612
SEM,156414,0.3224280721453019
MDST8,9926054,1.8075400364112937
KP-3,selumetinib-vorinostat (8-1 mol-mol),2.7675803183632155
SEM,57519531,1.3518150272189275
WM115,676352,1.7628184284101875
BFTC-909,55508,3.078625314561866
RKO,100016,5.817852214634293
MDST8,46943432,3.6174081091701886
BT 440,24775005,3.348968898199749
SW48,5978,-4.7084088584036525
ALL-SIL,44491742,3.700418914769662
ALL-SIL,navitoclax-piperlongumine (1-1 mol-mol),-1.3160613464557556
MKN1,doxorubicin-navitoclax (2-1 mol-mol),-1.787593284982696
SU-DHL-1,11178236,-5.1175240313736845
BICR 31,11955716,-3.162575487986667
HARA [Human squamous cell lung carcinoma],11364421,-4.71423157944935
TTC-709,126941,-5.375523858862778
KLE,11626560,2.541931063465937
PE/CA-PJ49,71680916,4.792524361784542
MOLP-8,374536,-0.3332412159105151
RERF-LC-Ad1,25150857,3.1338616756027173
KMS-21-BM,carboplatin-etoposide (40-17 mol-mol),0.4682257444852419
BICR 31,66577038,3.1838871840280745
HuH-6,439501,-1.8507525220603604
MDST8,409805,3.941558883413243
K-562,6918878,0.8571724386049573
ML-1 [Human thyroid carcinoma],56973724,3.438642865372283
LMSU,25154868,5.828737682964474
TTC-709,46926350,-4.2896695695473275
MKN1,navitoclax-sorafenib (1-1 mol-mol),2.9065265057638636
ST486,3062316,1.7430563433831985
COR-L95,crizotinib-PLX-4032 (2-1 mol-mol),1.858262555354691
NCI-H1568,5281321,-2.717480517336961
LCLC-97TM1,374536,2.574075324433214
SEM,4917,2.902637653661685
YD-15,10113978,2.8579252676280773
SEM,1641662,2.508220365497951
HCC1500,docetaxel-tanespimycin (2-1 mol-mol),1.2750885769824285
KP-3,54618305,4.754928976610576
HCC15,66577038,3.417660968254761
PK-1,57330099,4.440831224513127
IA-LM,9911463,2.6703246121465436
EB1,448949,0.0581632648863824
PE/CA-PJ34 (clone C12),10074640,3.6571343520395794
SNU-886,89928392,0.8718165666636013
SW1271,1566236,1.9677070098040983
F-36P,16725315,3.2108179170098854
L3.3,387447,-2.8513357804813553
IGROV-1,11238147,2.1723642292765084
SK-OV-3,11364421,-1.984047807336832
Hep-G2,17759555,2.554294160836156
SU-DHL-1,54613361,-0.1121754666598921
COR-L105,119182,0.6226208228567816
WM115,3384730,6.229532895174781
COR-L105,9967941,2.071649254258539
RKO,72193861,0.7735395045157347
COR-L95,753704,4.781559661696253
BT 248,25150857,2.3784591591930635
IGROV-1,49766530,-0.195540678413639
KP-4,3025944,4.776864859188652
BFTC-909,8515,4.73152093133166
PK-1,5280436,1.5336291825087525
Granta-519,31703,-4.611611754102639
SW48,19582717,4.381046957550593
P31/FUJ,selumetinib-GDC-0941 (4-1 mol-mol),0.2780140376369148
KMS-21-BM,46398810,1.937887380083987
KP-3,25195348,4.163904143890383
Ishikawa (Heraklio) 02 ER-,54454,2.5170293087952924
HCC15,15547703,3.515422457694346
HARA [Human squamous cell lung carcinoma],36314,-5.79294260923826
SU-DHL-1,BRD-K58730230,4.384837032763104
HuP-T3,2858523,3.211348955084378
LCLC-97TM1,24901704,3.846855123751057
SNU-886,72193861,1.870912317242216
NCI-H2452,44607530,1.9759156929339727
HuH-6,452548,1.21233639477629
HCC15,9936388,-3.3305479025951783
RKO,46191454,0.9841477576830012
SW1271,3081361,2.248142117307072
HEL,100016,4.260371486080393
Panc 02.03,327653,3.634511095206161
NCI-H2452,25062766,2.439590704022921
SNU-1079,44489127,4.317932605959938
SaOS-2,44607530,1.05170222821091
HEL,5335621,4.9483155198907225
EB1,54765302,3.3424692486937064
BFTC-909,6852167,2.133526407129769
HuH-6,3689413,1.6433341745909646
TTC-709,9911463,3.2608867997672935
Ishikawa (Heraklio) 02 ER-,navitoclax-MST-312 (1-1 mol-mol),1.1559299989129663
MOLM-13,638278,1.880317910461832
SW1573,selumetinib-GDC-0941 (4-1 mol-mol),3.5855850407433225
JHUEM-1,445643,3.9414172183168072
JHUEM-2,3854666,-1.0160197071128136
SK-CO-1,387447,-5.86001644251988
MOLP-8,10113978,2.697897563265303
SNU-886,11222830,1.0742925940982535
MOLP-8,216239,2.6519870661660803
SK-MEL-2,262093,3.2801506390546225
HuH-6,441298,2.109999907931208
NCI-H1568,46174525,4.305444868539079
HCC15,navitoclax-pluripotin (1-1 mol-mol),-1.3512127688258049
SK-LMS-1,5113032,4.854711943911216
TTC-709,11222830,1.3455631557883705
LCLC-97TM1,44607530,2.097748917507136
EB1,1317464,3.571469353092669
SaOS-2,9911463,4.168030006572111
BT 248,216239,2.185733710507839
Daudi,24889392,0.6157424479011876
PaTu 8902,51039095,3.3801139171258976
Panc 02.03,navitoclax-piperlongumine (1-1 mol-mol),3.4917646743182216
KLE,selumetinib-decitabine (4-1 mol-mol),3.7726080772360784
PK-1,2729026,3.0900724274707763
COR-L95,JQ-1-UNC0638 (2-1 mol-mol),1.8178477009164715
SK-LMS-1,3081361,3.433881373314138
ST486,11364421,-6.1810625705222915
Daudi,387447,-5.635352264179238
BT 248,448949,1.935087924253196
IGROV-1,5702613,4.420745339537274
JHUEM-7,71680916,4.772874327895641
SNU-626,2828334,8.43067568405975
SEM,122327,5.062595568788216
Mino,54618164,3.08934752103197
F-36P,5746,1.7141399363090042
LS180,375860,-0.0541765269880971
SEM,sirolimus-bortezomib (250-1 mol-mol),-0.6909485025943941
HuP-T3,tanespimycin-bortezomib (250-1 mol-mol),0.6963202387947334
YD-15,3854666,0.780361863126364
MOLP-8,241158,1.846975252387852
KP-3,2841722,4.276365961207118
KP-3,568763,-0.0803294122123086
BT 440,71751553,6.044533690123534
SW948,44819697,-1.5719383449848416
NCI-H2452,5951923,4.988154330604512
Ishikawa (Heraklio) 02 ER-,446155,2.267956510309626
DLD-1,JQ-1-carboplatin (1-1 mol-mol),2.485770842488409
JHUEM-7,53392493,1.8634549643352745
T98G,11238147,4.3519340621130524
PK-1,54618771,1.395529069214854
MOLM-13,54613361,-1.833470941599732
SW948,148198,-4.802987893737634
SUP-T11,49867926,3.383725905855264
JHUEM-1,selumetinib-PLX-4032 (8-1 mol-mol),4.540128413388839
U-BLC1,6450551,1.436411892394185
BFTC-909,4261,3.835594401773327
DLD-1,54454,2.703204711403241
BT 248,53495165,3.0905684330313803
Daudi,45100481,4.914271492759253
JHUEM-1,16038120,0.9090051696828798
MOLM-13,3384730,-1.9717967977442377
IGROV-1,5566,3.174346862827938
SUP-T11,57330099,3.210483301711341
LMSU,selumetinib-MK-2206 (8-1 mol-mol),3.140399649431559
PE/CA-PJ34 (clone C12),136227924,2.74058031223244
SU-DHL-1,10302451,2.2731723403274535
NCI-H1568,SNX-2112-bortezomib (250-1 mol-mol),1.539717951588267
RKN,24797083,0.944322820476056
ES-2,44241473,4.753442252855421
SK-HEP-1,148198,-3.434194259121147
L3.3,ISOX-bortezomib (250-1 mol-mol),1.440349868344241
LMSU,148198,-4.18626130759339
SW48,16736978,1.8227831775957584
HCC15,2708,6.122532058448304
SW48,5335621,4.0461877603353855
KHM-1B,44607531,1.2480469496992657
PK-1,12001922,2.4372916011863146
SW948,JQ-1-MK-0752 (1-1 mol-mol),3.431430026033012
RERF-LC-Ad1,25102847,4.445433024758021
U-BLC1,5460769,1.2363713333826207
NCI-H1568,71304818,2.2110745175145876
L3.3,25126798,4.136340325033448
HuH-6,135411,1.7993653644444905
LMSU,2858523,3.056643520102809
COR-L105,5311,1.9211659995219237
SK-OV-3,5328940,3.4311724872159903
RCC10RGB,1716436,3.489109378341682
MDST8,6918878,1.145593411739036
EB1,11647372,0.0475212390282184
RKO,11364421,1.233720517884939
P31/FUJ,65064,5.109694638799521
ST486,5470400,3.750271164560116
MKN1,644241,2.5919310202302532
HARA [Human squamous cell lung carcinoma],BRD-K27188169-navitoclax (2-1 mol-mol),2.401020533417727
BT 248,5494449,3.476308084030369
PaTu 8902,3025944,5.120505038776715
Panc 02.03,12001922,2.5444953584324193
PE/CA-PJ34 (clone C12),60750,-1.7641821181444215
SNU-1272,6610216,4.610007140028073
HARA [Human squamous cell lung carcinoma],135421197,2.918907943246249
ALL-SIL,54454,2.130103786841792
Daudi,11238147,1.1945947480643642
JHUEM-2,156422,3.744392527575932
L3.3,5311281,4.47128753759965
WM115,148124,-1.9357807696466565
PaTu 8988t,25262965,-2.4539636298097376
IA-LM,49766530,-3.412847117105243
SK-MEL-2,9911830,2.439526960003118
Granta-519,44185566,0.7632366174102183
PE/CA-PJ49,selumetinib-PLX-4032 (8-1 mol-mol),3.728065636713805
MOLP-8,44607530,1.0628729381864028
K-562,409805,3.7514940654800064
BICR 31,89928392,2.942196417475874
SW48,23725625,4.606874242451815
JHUEM-1,107985,-5.021141551070729
RCC10RGB,16038120,1.536821218292656
MDST8,UNC0638-navitoclax (1-1 mol-mol),0.0251885834350385
RKO,148198,-2.1467795088860875
BT 248,3854666,2.6170510866367955
SK-CO-1,409805,5.790109243945559
U-BLC1,navitoclax-MST-312 (1-1 mol-mol),0.6461101117404752
HuP-T3,7251185,1.9415241444855404
LS180,11612883,2.759028826688456
HuH-6,3384730,2.757877206793658
WM115,11507802,3.278245549501506
IA-LM,168313016,4.257474229118996
ML-1 [Human thyroid carcinoma],5566,3.147714437598846
MOLM-13,crizotinib-PLX-4032 (2-1 mol-mol),0.492576617206884
SNU-1079,selumetinib-tretinoin (2-1 mol-mol),-2.150447926544947
SW48,10302451,2.1638159560649157
Daudi,65064,2.8809848507042095
LS411N,11612883,3.0472980958623705
KP-3,2729026,1.3395123265794755
Ishikawa (Heraklio) 02 ER-,676352,3.012239531301171
NCI-H2452,11214940,1.2392722713501154
L3.3,24951314,1.4054712073944002
KLE,9866186,1.5006756729771336
SNU-1272,11964036,3.162546122356154
KPL-1,9915743,2.2588912198208595
ALL-SIL,984333,-1.3370961884574026
BT 440,7251185,2.9972260836492537
P31/FUJ,1641662,2.802136916275355
MOLM-13,25183872,-2.142456248879295
K-562,969516,2.7986550178028216
Granta-519,54143018,0.4327684951223574
SU-DHL-1,44819697,-0.3444138900100821
DLD-1,navitoclax-pluripotin (1-1 mol-mol),-0.7119836035155394
U-BLC1,216345,2.450978007696315
T98G,439501,-1.9696613143180952
KPL-1,568763,-0.2512443797629422
HEL,selumetinib-vorinostat (8-1 mol-mol),2.406012225394231
Daudi,9933475,1.2993243126142855
SK-CO-1,10427712,4.208191107568486
IGROV-1,selumetinib-decitabine (4-1 mol-mol),3.5551285698551225
HEL,2841722,4.805306475973069
PE/CA-PJ49,selumetinib-tretinoin (2-1 mol-mol),4.909206986371302
COR-L105,9926054,1.7310748902984938
SNU-626,24951314,2.5460387646705396
SUP-T11,6918878,3.780858605030287
RCC10RGB,15983966,2.263334704673794
COR-L105,JQ-1-carboplatin (1-1 mol-mol),-0.012244733852177
IGROV-1,46174525,4.5083762186279595
TTC-709,17755052,-0.7358288365561503
BICR 31,11175137,2.7548462189262817
COR-L105,11609586,4.426382611322312
Mino,135423438,1.6490290727182615
KHM-1B,67291369,-0.148329679394903
COR-L105,tretinoin-carboplatin (2-1 mol-mol),4.8464312209914056
IGROV-1,107985,-2.8971910842184516
SW48,selumetinib-tretinoin (2-1 mol-mol),-3.039219122646087
IA-LM,71466380,4.547922152882383
SUP-T11,navitoclax-sorafenib (1-1 mol-mol),1.6791816668350734
PE/CA-PJ49,24821094,2.237306000813724
Granta-519,navitoclax-sorafenib (1-1 mol-mol),-1.03945044820541
RERF-LC-Ad1,11152667,0.5366755842825199
T98G,53232,2.483248709568099
K-562,11612883,3.292128537791773
BT 440,135440466,0.8511809411433243
HuP-T3,15953870,4.533958601099395
BT 248,675434,4.340673839490162
TTC-709,6852167,1.9849494908807752
SK-LMS-1,selumetinib-GDC-0941 (4-1 mol-mol),2.0421958472836335
ES-2,3854666,3.173981203722866
BT 440,89928392,1.4971769362527518
F-36P,11257553,0.1743733377465893
Ishikawa (Heraklio) 02 ER-,107985,-3.239655509933191
NCI-H1568,219104,4.078417481216408
RKO,65064,4.5178366082525
NCI-H1568,9911463,2.564901149372131
L3.3,JQ-1-vorinostat (2-1 mol-mol),2.1502729900256807
T98G,44566777,-0.464047604210716
LMSU,2708,4.741018084625804
ES-2,12003241,0.0508402342945085
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384
DLD-1,65064,5.258056867953706
ALL-SIL,6852167,2.025737624061405
Daudi,16065773,1.627011760718674
KP-4,262093,2.717667187094357
MKN1,452548,-0.2657824784000414
MOLP-8,10410894,2.1334782114390425
RERF-LC-MS,73707371,5.9060077591992375
SNU-C2A,JQ-1-navitoclax (2-1 mol-mol),0.2146926637670294
Mino,6610216,4.52250684011298
RKN,1566236,1.687441004968786
BT 248,crizotinib-PLX-4032 (2-1 mol-mol),2.0944776626354145
ST486,52912189,-0.2774435482968419
IGROV-1,439501,-2.1510551928674557
MOLM-13,57519531,1.2030375936335158
SEM,72193861,-0.1864351946405744
DLD-1,25105715,4.025856796273298
HuH-6,3825829,4.141582300184341
NCI-H1395,JQ-1-carboplatin (1-1 mol-mol),2.36945639284839
Granta-519,11625818,4.458439944218401
WM115,JQ-1-navitoclax (2-1 mol-mol),1.0904660510926631
KHM-1B,11625818,2.7772036353291725
F-36P,25102847,2.172104661450956
L3.3,11485656,2.040790548836277
MOLP-8,3689413,-2.303477592076259
SK-HEP-1,54596558,4.485352352092043
SW1271,4705,3.86061099620112
Granta-519,9927531,4.885085469625254
KMS-21-BM,5113032,3.5841388867917345
SU-DHL-1,11427553,0.3775832797434548
ALL-SIL,15953870,2.429039509996585
COR-L105,4259181,2.2372065992854133
JHUEM-2,176870,1.9071502893056609
SNU-626,56946209,-4.072979545977951
HCC15,17759555,4.480266922784899
COR-L105,10184653,-3.6529884694455608
RKO,72376,-2.4980018930037673
L3.3,5329102,3.0035184311097245
F-36P,11707110,-3.101401039709538
RKN,vorinostat-carboplatin (1-1 mol-mol),3.833796397117187
Mino,67156097,-3.095827549462798
RKO,613753,3.427719504210608
MKN1,16736978,5.08692928345157
LCLC-97TM1,10302451,3.3699574981481217
Mino,122327,5.625532204627329
HT-1376,176870,2.52551550207985
HuH-6,11647372,1.0160058278725526
PaTu 8988t,JQ-1-UNC0638 (2-1 mol-mol),3.720997870166264
MOLP-8,3634881,2.730356562919761
SW948,11612883,1.2539645440532456
HCC1500,carboplatin-etoposide (40-17 mol-mol),4.564857215457985
BFTC-909,10074640,3.0053798884123837
KMS-21-BM,36462,-0.9677921947133352
LS411N,24901704,3.828527152917887
SW1271,51039095,2.010271277744507
NCI-H1395,doxorubicin-navitoclax (2-1 mol-mol),0.3327602651018742
K-562,9935249,0.8993678101188762
COR-L105,462382,1.111643181026989
Granta-519,10385095,0.7144131323279258
COR-L105,5281321,-2.635307184860664
KU-19-19,selumetinib-piperlongumine (8-1 mol-mol),2.2054937321135775
JHUEM-7,44607531,1.4804103640247843
SNU-C2A,24951314,1.1686919694219615
LS180,11234052,4.148077533652898
PK-1,11609586,2.3960928740995926
MOLM-13,sirolimus-bortezomib (250-1 mol-mol),0.2337551440217556
COR-L95,25154868,4.601001468087818
BT 248,322968,2.9090533378149535
Daudi,3025944,3.5610963405625267
SK-LMS-1,11625818,4.800925756736957
JHUEM-7,ISOX-bortezomib (250-1 mol-mol),0.2456218281827208
RERF-LC-Ad1,6852167,4.2610431072057695
YD-15,5329102,0.7724200665597792
KHM-1B,2729026,0.9110795955585352
SW48,24180125,2.6937498240420457
SW948,navitoclax-birinapant (1-1 mol-mol),2.127959258569347
PaTu 8902,168312962,5.583922762984923
COR-L105,5280436,1.8180108392693488
SU-DHL-1,44507138,1.5242294298964132
MOLM-13,10302451,1.7245492330691454
NCI-H1395,44566777,1.012205213932494
HARA [Human squamous cell lung carcinoma],72376,-2.3262904878865083
SNU-C2A,65064,3.0533695783298263
SK-HEP-1,44607531,1.6636821475505756
U-BLC1,1566236,1.8337532039015736
IA-LM,15983966,2.169762444969255
SK-LMS-1,9933475,2.3657628336253396
IGROV-1,56946209,-4.416985130578084
DLD-1,24771867,2.7180274798431947
P31/FUJ,25126798,3.55669651950966
HuH-6,piperlongumine-MST-312 (1-1 mol-mol),2.202844715264461
LS180,piperlongumine-MST-312 (1-1 mol-mol),1.6478111921038412
BICR 31,15983966,1.7355748159582445
KP-4,2949965,3.3875389698140412
ML-1 [Human thyroid carcinoma],carboplatin-UNC0638 (2-1 mol-mol),3.254418532258765
NCI-H1568,135421197,1.29303587511011
HEL,374536,0.3200488785786777
NCI-H1568,25161177,4.305259269080427
JHUEM-1,241158,3.61852207918387
Granta-519,24951314,0.3336244464551668
Mino,252682,5.80936574948766
LS180,400769,-0.7559227838025858
SNU-1079,9907093,3.131158084820356
DLD-1,10127622,5.60979100708014
PE/CA-PJ49,tanespimycin-bortezomib (250-1 mol-mol),-1.0553859212416536
BT 248,753704,4.567621051188063
MDST8,44607531,3.32682409463767
EB1,16722836,1.1210441313410229
SK-LMS-1,3503,2.124140890470344
WM115,46843906,3.7194943725295992
RKN,24771867,0.8860225124393014
HCC15,tanespimycin-gemcitabine (1-1 mol-mol),-1.7446538355575971
MDST8,72734382,4.130038178532864
SK-CO-1,1750826,-0.0283504159212216
MOLP-8,10184653,1.0374255182903005
Hep-G2,5282054,4.608034876508238
NCI-H1568,46398810,2.1853633940590966
KMS-21-BM,89183176,0.9235063133397152
PaTu 8902,6438330,3.32865710338655
K-562,60700,0.041873955903415
KU-19-19,23725625,4.865374475902274
KHM-1B,vorinostat-carboplatin (1-1 mol-mol),1.1385799517319026
KP-3,637858,2.0723058540314945
BFTC-909,6438330,3.0201113942824436
U-BLC1,4521392,4.099608518166667
PE/CA-PJ49,5460769,0.8323029326456293
JHUEM-2,11238147,1.344486918834089
KHM-1B,11964036,-0.558883521071404
SEM,11167602,1.6764895293096356
LMSU,119607,5.586825661807856
Panc 02.03,JQ-1-vorinostat (2-1 mol-mol),1.3831414404100788
JHUEM-2,54618305,4.313629109650022
PE/CA-PJ49,9887053,4.12500650202634
ST486,45279963,3.286780987450176
L3.3,654092,0.3260809528195456
HCC15,65064,4.883028365063005
HCC1500,285033,-0.4229420433590342
YD-15,73707398,0.9589848117776284
LCLC-97TM1,navitoclax-pluripotin (1-1 mol-mol),-0.4086079898924854
LCLC-97TM1,5479543,3.538440111241957
PaTu 8988t,613753,3.3970334474933495
MKN1,42642645,1.3849471116012968
KLE,5311281,3.4471397801732477
HuH-6,42611257,3.594914991326063
SU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8883081844697346
SW1271,2949965,2.7362256869687895
HT-1376,54619267,4.745619038462132
SaOS-2,4705,3.668938036329027
KU-19-19,11364421,2.01242470272022
TTC-709,5282054,2.824231743122166
EB1,49867926,3.555086092918609
SW1271,676352,2.2943086949623885
RKN,24856436,1.2279395925477072
Mino,11609586,0.4763203284393503
SW48,159324,-1.9628962598081805
ALL-SIL,568763,-1.7129740739789223
ST486,navitoclax-piperlongumine (1-1 mol-mol),-0.3672712547417002
SK-MEL-2,10184653,1.840677228292894
ML-1 [Human thyroid carcinoma],73707398,0.9772448893034968
WM115,9907093,3.0763750955907883
KHM-1B,3025986,-1.4274880637865957
EB1,637858,0.8330107296865988
SW948,637858,1.5262532123254355
SNU-886,60700,0.021220261997993
SNU-C2A,439501,-1.0520759407127591
PaTu 8988t,24901704,4.232615528659116
SU-DHL-1,11238147,0.4308170484254632
BICR 22,alisertib-navitoclax (2-1 mol-mol),0.0230518675395602
HT-1376,72734382,4.055877928875978
TTC-709,3025986,-2.2807043579772897
KP-3,10184653,1.0237143575145715
COR-L105,3634881,3.59150153069964
BICR 31,49766530,2.6564815829329236
SNU-626,441298,4.4234180986467715
SU-DHL-6,439501,-2.4303946334698057
SK-CO-1,6438330,2.884853035173295
KHM-1B,5284616,-7.181826614115283
HT-1376,selumetinib-UNC0638 (4-1 mol-mol),4.784990249535019
L3.3,16065773,3.089788322580725
RERF-LC-MS,tanespimycin-bortezomib (250-1 mol-mol),-0.8960063928147526
SW948,23635314,-3.685869994463448
KLE,10231331,5.289162464767698
ML-1 [Human thyroid carcinoma],24951314,0.9772476096511332
SNU-626,168312962,4.008696987299766
RCC10RGB,24753719,5.18895385781671
HT-1376,12001922,2.205490030105262
RKN,tanespimycin-gemcitabine (1-1 mol-mol),2.340236610046533
LMSU,72376,0.2338050828767356
HCC15,53481919,4.945944641956239
U-BLC1,25195348,3.420313790551449
ES-2,49793307,-1.8280451334885264
KMS-21-BM,446155,2.8292107491124456
HARA [Human squamous cell lung carcinoma],52947716,4.13690029570622
LMSU,2729026,3.1039498249859183
BICR 31,11612883,2.9886930364048387
HEL,20959075,-3.3486318540939535
U-BLC1,72193861,0.9308304275999576
KP-4,selumetinib-MK-2206 (8-1 mol-mol),2.8927851283420916
SU-DHL-1,24964624,1.891650824203322
F-36P,168313200,3.2109752739746886
JHUEM-1,12003241,-0.7244634318456832
RERF-LC-Ad1,42642645,1.4403465890046834
K-562,11609586,2.0906528510972775
SK-MEL-2,JQ-1-vorinostat (2-1 mol-mol),1.8581618097986792
SEM,2945648,0.1615373734566605
KU-19-19,89183176,4.239044338938638
MOLM-13,9927531,3.44947203831576
COR-L95,10302451,3.773437494355592
SW1271,10385095,1.244878723840673
PK-1,11964036,1.573011493717168
SK-HEP-1,navitoclax-MST-312 (1-1 mol-mol),0.5798914619314417
KHM-1B,1641662,3.357336532713352
IGROV-1,17755052,-1.0246415273055465
Daudi,3634881,1.264969339465191
PE/CA-PJ49,246676,4.881777870317724
MDST8,46224516,2.508010817025431
SK-OV-3,65064,5.055886881526936
KMS-21-BM,71304818,1.039651589080183
IA-LM,11364421,2.389092199855664
KP-4,448949,2.4235294348887733
P31/FUJ,6918878,-0.2487475841908946
JHUEM-7,selumetinib-PLX-4032 (8-1 mol-mol),4.4422752684891025
SaOS-2,426756,5.396474834861055
PE/CA-PJ34 (clone C12),46843906,2.5839561879544775
KP-3,3689413,-2.21572351958202
MOLP-8,25150857,0.9011737742745826
BFTC-909,11167602,2.8757137848929006
RD-ES,navitoclax-pluripotin (1-1 mol-mol),-2.170563616101317
Mino,doxorubicin-navitoclax (2-1 mol-mol),-4.161121173584363
RKO,10302451,3.926970734642152
KHM-1B,5311281,2.058534783362704
HCC15,6252,2.2097348223357396
PaTu 8988t,135421197,1.788370067257354
EB1,4788,4.630028073266191
KMS-21-BM,6505803,-3.224254978227179
SW48,42642645,-1.378549292450493
PK-1,erlotinib-PLX-4032 (2-1 mol-mol),3.591812727253287
IGROV-1,docetaxel-tanespimycin (2-1 mol-mol),-1.5830865659631668
U-BLC1,erlotinib-PLX-4032 (2-1 mol-mol),-1.5179351644007644
EB1,44137675,0.8362385356656726
ST486,6918837,-5.979347412796716
COR-L105,73707398,2.56355231698926
PE/CA-PJ34 (clone C12),9823820,3.875484528440309
JHUEM-1,JQ-1-navitoclax (2-1 mol-mol),0.4847464294265572
JHUEM-1,24978538,1.1205030004377876
Panc 02.03,3854666,5.373190444337423
WM115,11404337,-2.7813606850874595
ST486,1750826,-3.999326868033023
SUP-T11,24797083,1.6392300943107208
MDST8,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9743607330604616
DLD-1,5479543,4.53184799570807
K-562,9803433,4.389269041756261
JHUEM-1,123631,2.399471600391194
LCLC-97TM1,JQ-1-vorinostat (2-1 mol-mol),0.588169137305971
KHM-1B,2742550,3.1994406451662045
SW48,11152667,-1.5089069748808788
SNU-1079,2708,4.865454763333914
MOLP-8,BRD-K55473186,4.200306440270822
JHUEM-2,44486219,4.213113143999714
MOLP-8,3854666,0.8063321236158104
WM115,156422,4.742483160763306
SUP-T11,2733526,2.827610329582801
KMS-21-BM,9926054,0.3453207317075127
BICR 22,10302451,3.218470138701286
P31/FUJ,3815108,3.712799909664185
SK-CO-1,5280436,3.963354946284049
SaOS-2,11625818,4.3669462586555055
U-BLC1,11717001,3.810091918916642
JHUEM-7,5746,1.3503095363365143
SaOS-2,serdemetan-SCH-529074 (1-1 mol-mol),2.337619260674083
NCI-H1568,24856436,-0.7402646666066086
SEM,9884685,1.4949119152013906
MOLM-13,19582717,1.836192229041244
KP-3,1716436,2.492121125287185
SaOS-2,selumetinib-vorinostat (8-1 mol-mol),3.065255136374356
SNU-1079,25154868,2.663484755977717
LS411N,65064,5.143309491248943
MKN1,24978538,1.7600107306124924
HCC15,selumetinib-PLX-4032 (8-1 mol-mol),2.5653564815538075
SNU-886,2842253,5.3530946546481815
KHM-1B,6852167,0.7581222087853566
KHM-1B,44507138,1.4720976685290608
LMSU,46926350,-4.277372765646079
SW948,1716436,3.337695569228523
HEL,60750,-4.342121097179363
F-36P,15983966,-4.937765850847769
SW48,5738263,2.8832489904283207
SUP-T11,71466380,4.043562427263979
HARA [Human squamous cell lung carcinoma],216468,1.0737616041415703
JHUEM-7,89928392,1.1586048072991315
LS180,135984461,4.839780886141452
ML-1 [Human thyroid carcinoma],123631,2.4078761561490025
SW48,3634881,4.093042888484318
Mino,10184653,1.0889410916203577
T98G,6918837,-1.7371940748791022
WM115,82146,3.7974591517158
SNU-C2A,42642645,0.6667239374307586
MOLP-8,24901704,2.731912612856625
SU-DHL-1,9826308,0.1808938529022712
TTC-709,44185566,1.5709851483502786
SK-HEP-1,60700,1.3088528574816594
SW948,49793307,-5.1176222473357775
SK-MEL-2,44185566,3.0051699870646176
BICR 31,selumetinib-decitabine (4-1 mol-mol),4.509241156469813
P31/FUJ,15953870,2.7000087530897776
F-36P,piperlongumine-MST-312 (1-1 mol-mol),1.2295235789466332
SK-CO-1,24901704,3.265743022928408
SEM,613000,-0.3108787408101454
SEM,54618795,1.733111871979466
TTC-709,24772860,-2.218847020638614
SUP-T11,135440466,3.420585073977961
KP-4,45100309,5.819085816398243
NCI-H1395,4477,0.6354024043517065
K-562,selumetinib-UNC0638 (4-1 mol-mol),3.2530488329097698
Panc 02.03,100016,6.582809568040202
KP-3,9911463,3.5465517511972173
EB1,11152667,-2.271733256733806
PE/CA-PJ49,49793307,-5.06992611418174
PK-1,6914657,-3.452348461373533
SK-MEL-2,11494412,4.029789291760362
PE/CA-PJ49,JQ-1-vorinostat (2-1 mol-mol),0.4372186827616553
ES-2,46398810,3.15633051358666
KLE,11214940,0.7817459379434555
ST486,46215462,1.5195833637338223
RKO,168312962,-2.5117583451491012
RCC10RGB,25126798,4.759098567819552
HT-1376,11455910,0.3601219062444335
U-BLC1,11228183,1.0310516472956852
HuH-6,2729026,1.3696226717754232
TTC-709,SNX-2112-bortezomib (250-1 mol-mol),-2.499164172457959
F-36P,54143018,-1.3895975294341516
BT 440,135659046,3.614381775691437
SNU-1272,9936388,1.7321766128233604
JHUEM-2,72376,-2.2740737512859974
SW1271,24964624,2.7126751219569147
ALL-SIL,9444,2.1167841583667277
SK-LMS-1,vorinostat-navitoclax (4-1 mol-mol),0.9355333025959492
PE/CA-PJ34 (clone C12),4259181,0.3767954059641493
SW1271,1641662,3.842487885295187
BICR 22,676352,2.452861704781308
SNU-626,carboplatin-UNC0638 (2-1 mol-mol),3.477637385633104
K-562,54596558,4.166105900128149
SEM,54596558,4.142091338652408
Panc 02.03,9933475,2.3025810529048205
Ishikawa (Heraklio) 02 ER-,54143018,-0.6909514864549315
SK-LMS-1,46398810,3.17940895755664
NCI-H2452,374536,-3.751500666928139
SW48,9825149,0.0451584979105152
T98G,135999136,1.5843327150060262
MDST8,3634881,2.8722303311625006
LMSU,3025986,-1.1384200565557423
SW1573,24180125,4.83914798243841
NCI-H1395,10127622,5.295029189605721
WM115,42642645,1.5932691238490415
HuH-6,selumetinib-piperlongumine (8-1 mol-mol),2.7647561995199688
SaOS-2,24753719,4.762341084721446
SK-CO-1,25062766,1.7088187930933407
Daudi,71466445,1.7957550148901065
K-562,9903786,3.6050720376028105
MKN1,erlotinib-PLX-4032 (2-1 mol-mol),3.4506318886935397
EB1,462382,-0.1024802943549478
Mino,tanespimycin-gemcitabine (1-1 mol-mol),-5.004027944412501
MDST8,5281321,-0.743993786053836
WM115,216345,2.152490626678771
RKO,salermide-PLX-4032 (12-1 mol-mol),6.251314610722333
L3.3,656346,0.8770519202421161
KLE,441298,1.608704823737003
Panc 02.03,44566777,1.8066319547984584
JHUEM-7,24964624,1.3812203269919547
KP-4,8515,3.507883744965969
Daudi,carboplatin-etoposide (40-17 mol-mol),-0.43265013296543
KP-3,3025986,-0.2402974624298327
ES-2,navitoclax-gemcitabine (1-1 mol-mol),-0.957414544599688
JHUEM-1,9929138,5.0527545997933085
SW48,1716436,3.2732206570492512
SK-LMS-1,9967941,5.011647610882007
PE/CA-PJ34 (clone C12),11238147,2.027181576861032
KU-19-19,serdemetan-SCH-529074 (1-1 mol-mol),2.9806718783116337
PE/CA-PJ34 (clone C12),54618164,4.074052686035258
COR-L95,5281321,-5.086788267908354
ML-1 [Human thyroid carcinoma],2126,5.801287401499987
LS180,5287620,-2.159393408078438
HCC15,24856436,0.7194572205096856
HCC1500,JQ-1-UNC0638 (2-1 mol-mol),1.6511332544763542
RKO,BRD-A02303741-carboplatin (1-1 mol-mol),3.1646455891745084
K-562,54613361,-1.429503199294265
EB1,24771867,1.441441734129046
PaTu 8988t,5311281,3.776140248734943
SNU-1272,5566,3.0890958358012064
HCC15,10090485,4.457627969814505
LS411N,1242560,3.5784744482633526
T98G,25161177,5.283968321883457
P31/FUJ,JQ-1-carboplatin (1-1 mol-mol),-0.13727273351174
T98G,24821094,3.7770290259333055
MDST8,3854666,1.4298592595361392
JHUEM-7,5311,2.0992694237496203
KP-4,107970,2.3974989228996586
L3.3,36314,2.044128713808568
HEL,carboplatin-etoposide (40-17 mol-mol),1.8930260059492108
SNU-886,17755052,1.4860081485560532
BICR 22,doxorubicin-navitoclax (2-1 mol-mol),-2.5908889748637467
SaOS-2,448949,2.4147534872316916
K-562,44607531,1.5533391017282614
RKO,656346,1.2468664563159324
NCI-H1395,16065773,1.699191956744155
TTC-709,135984461,4.327447366032638
SW1271,54619267,4.215254166837184
PaTu 8988t,107985,-3.7439330143768106
SK-LMS-1,51039095,3.185085491657033
F-36P,16722836,-0.5703306684955751
Daudi,107985,-4.311158471957254
KP-4,3025986,0.0232409556769203
KMS-21-BM,25262965,-2.0042032081730525
K-562,89928392,1.1726799483120014
BICR 22,2828334,6.182973514514405
PaTu 8988t,462382,0.0850922030405946
SNU-626,SNX-2112-bortezomib (250-1 mol-mol),-0.238175063517317
KPL-1,122327,4.287148314907214
SNU-626,11964036,2.0946410623129283
TTC-709,119182,-2.035352026398536
COR-L95,54619267,4.025082196689936
LMSU,11175137,2.5387478659601324
KP-3,11427553,2.9595504593835127
SW48,44486219,4.521255071137468
MOLP-8,136227924,1.5113872866650588
SU-DHL-1,vorinostat-carboplatin (1-1 mol-mol),1.1997073903631768
LS180,176870,3.0513508415646644
Hep-G2,12001922,1.7010359951064702
PE/CA-PJ49,135398738,5.508952518580779
T98G,11497983,5.096016515777535
ML-1 [Human thyroid carcinoma],409805,4.766723032315811
NCI-H2452,60700,-2.076184021255351
SNU-1079,81146,4.33807513078271
ML-1 [Human thyroid carcinoma],3465537,2.728802739434878
Daudi,2749,-0.7661278600765006
SW1573,SNX-2112-bortezomib (250-1 mol-mol),0.5082376174745985
HCC15,11364421,-3.377820549130246
SEM,441298,2.8242609372288485
ALL-SIL,135984461,1.7193250250744925
SNU-626,4917,3.3528070697886223
HCC1500,1750826,-2.1124887265082255
PK-1,15983966,2.772460574497664
RKN,53392493,3.005817826052642
SK-MEL-2,107985,-2.782254692074657
P31/FUJ,JQ-1-UNC0638 (2-1 mol-mol),-0.0749230690326744
JHUEM-2,3503,1.394114442175932
BICR 22,5287969,-2.619429839358568
BFTC-909,24978538,2.589526114093726
SEM,11647372,1.226548693223236
SK-HEP-1,2828334,6.264472809398218
Mino,36462,-1.1921094192987896
Daudi,4705,2.565440722309658
BT 440,4378219,1.9559827950979
SNU-C2A,11427553,2.911293981705574
DLD-1,126941,-2.769517599406179
HEL,11485656,1.96241131365886
BICR 22,23582824,1.0399288647056628
ST486,55508,4.741330364600402
Daudi,doxorubicin-navitoclax (2-1 mol-mol),-4.527956590288398
HCC1500,navitoclax-gemcitabine (1-1 mol-mol),-1.5596806456791137
DLD-1,60700,1.1169860446735027
MOLP-8,11364421,-5.744944118703229
COR-L105,374536,-3.312479831607182
SK-CO-1,56973724,0.9140094173628892
HCC1500,135440466,3.12374064827048
COR-L105,24978538,1.189273057385404
SK-HEP-1,45279963,4.052806603396004
K-562,11317348,0.8853213314815674
LMSU,5351362,1.3918765572974243
RKN,6918837,-0.6134153399361431
LCLC-97TM1,285033,-3.3608842191269104
HCC15,11455910,-0.3399110905288865
BT 440,54618164,4.177836021580234
BT 248,10184653,1.5665149744328004
SK-HEP-1,176870,5.630942733934813
RKN,23635314,-1.997093039658799
HuP-T3,selumetinib-BRD-A02303741 (4-1 mol-mol),4.443167910893738
IGROV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.258983073493191
HuH-6,19582717,3.515216263615528
KMS-21-BM,54619238,4.201491677887809
SK-MEL-2,44589607,3.250793209659342
SW948,969516,2.384481795832599
WM115,24180125,3.7433275341391057
SK-HEP-1,135440466,3.4774178685499324
KU-19-19,11626560,2.7733848967135017
JHUEM-1,24856436,-1.990373195917556
SUP-T11,26596,-3.766256771827544
ML-1 [Human thyroid carcinoma],675434,4.374805668496918
SNU-1079,71680916,3.996797839684193
LCLC-97TM1,44507138,1.7278080476353117
SK-OV-3,25150857,2.8200349544845045
HCC15,44491742,4.47716804785037
SNU-1079,3503,2.1906892529969415
Hep-G2,2729026,2.3048811631927344
RERF-LC-Ad1,carboplatin-etoposide (40-17 mol-mol),3.9878410003386
MKN1,2749,2.2146113356416004
Hep-G2,66577038,2.115823311856728
NCI-H2452,carboplatin-etoposide (40-17 mol-mol),4.403260682335101
LCLC-97TM1,25150857,2.1625900659079296
P31/FUJ,124202324,0.9428129005296164
IA-LM,BRD-A02303741-navitoclax (2-1 mol-mol),1.2493454608743932
KMS-21-BM,54686904,4.358976461289104
SNU-1079,439501,-2.542024376307003
COR-L95,6505803,0.0712785503404296
HCC15,24964624,3.0755429715166063
JHUEM-2,11612883,-0.0466941007862746
DLD-1,11364421,1.6960122386484795
MOLP-8,11647372,0.2904161448795228
BICR 31,11977753,-1.0341786941527915
F-36P,9907093,3.8826352670288857
HARA [Human squamous cell lung carcinoma],216345,4.215325728716343
ES-2,4788,5.876088842594311
HuP-T3,5282054,2.779269170716028
SW948,54618771,1.4567685239775812
Granta-519,24797083,0.9051026865971544
PK-1,46191454,1.8562200279043704
SW48,73707398,0.6331221198690845
BFTC-909,135411,0.8518885281649031
PE/CA-PJ49,969516,2.635444891032022
MKN1,46199207,3.079521747985849
Hep-G2,168313016,5.1281820641860545
HCC1500,675434,3.977739266447536
LMSU,tanespimycin-bortezomib (250-1 mol-mol),0.1689419151943554
SK-HEP-1,6918328,0.8938731782790444
SNU-C2A,9911830,2.9981708324913727
ML-1 [Human thyroid carcinoma],2113511,5.6174346670931286
LS180,159324,3.258862193159196
SNU-C2A,11625818,4.639365796931641
MKN1,5328940,1.7787546272242352
HEL,168312962,0.5016152377841688
SEM,5284329,1.6736323396864567
SNU-C2A,11609586,2.990687699313256
SK-LMS-1,1641662,3.82758028546174
ES-2,9823820,4.449569204194236
KHM-1B,44185566,1.2108718099020337
SaOS-2,44607531,1.4975746891341548
Mino,JQ-1-carboplatin (1-1 mol-mol),-0.9180856967211396
Mino,5335621,3.5171379236679328
IA-LM,vorinostat-navitoclax (4-1 mol-mol),2.163605213189375
PE/CA-PJ49,11455910,0.6367427486190916
MOLP-8,6610216,4.187822370904977
YD-15,selumetinib-tretinoin (2-1 mol-mol),0.2161530226347134
ES-2,sirolimus-bortezomib (250-1 mol-mol),1.1433658443254404
HCC1500,5278396,3.6802956879537856
K-562,445643,4.07029800941494
KPL-1,11175137,3.2409596200594355
PE/CA-PJ34 (clone C12),navitoclax-pluripotin (1-1 mol-mol),-0.3375022038968858
MKN1,44607531,1.455874161506966
Mino,375860,-0.5060371680285715
HARA [Human squamous cell lung carcinoma],11178236,-2.833191042701781
Panc 02.03,5351362,2.6810485074832
ST486,9884685,0.3011062845226507
KP-4,5738263,3.4470838399922297
KP-4,JQ-1-carboplatin (1-1 mol-mol),3.935772405145619
BFTC-909,23725625,7.000464253417552
SK-OV-3,8515,5.143916520422132
YD-15,44819697,-1.0656672602304191
RKO,24779724,5.847036108864024
SEM,navitoclax-birinapant (1-1 mol-mol),-3.1404014425166777
MOLM-13,65064,3.286890258414819
Hep-G2,216345,3.0800650649903436
P31/FUJ,9868037,1.2869642230829814
SUP-T11,3854666,0.4319450798488521
MOLP-8,52912189,-0.8757353744499203
HCC15,2113511,6.327015395869061
IGROV-1,25183872,-0.4560099928976716
MOLM-13,44259,-1.8425758706378912
P31/FUJ,9911830,2.020541196825024
NCI-H1568,11455910,-0.0792581795853734
LMSU,49766530,-0.1291663690745916
Granta-519,409805,2.9966967612339417
IA-LM,7251185,3.003277248553597
T98G,44202524,5.996425773666815
LCLC-97TM1,24771867,-3.13973757551719
SaOS-2,387447,-3.480142635313653
F-36P,67291369,-0.7529423650283368
JHUEM-1,5311,1.9709234927776824
BT 440,24772860,-1.8405005285147795
F-36P,4378219,5.856796743395766
Mino,25126798,3.3820284274411767
EB1,71751553,2.2286483741209593
SNU-C2A,9936388,-5.314331610228823
SW1573,JQ-1-carboplatin (1-1 mol-mol),2.7673375122522
HCC15,71466380,4.492977556176778
T98G,selumetinib-JQ-1 (4-1 mol-mol),2.813131207617802
HT-1376,409805,6.134546024517547
F-36P,11178236,-5.377845501416466
SEM,135398738,-0.4705480766315878
KU-19-19,11178236,-2.578122805273377
KP-3,3062316,0.7965701280540384
SK-HEP-1,107970,2.7276242080982405
SW948,3503,2.019264798250741
MOLM-13,11455910,-0.3133362084586128
SNU-1272,10074640,3.618892542136291
COR-L95,216239,1.9606601522489808
Ishikawa (Heraklio) 02 ER-,1750826,-0.2156732013128532
RERF-LC-Ad1,124202324,3.7772146428282385
ES-2,4096211,3.92272338334034
MOLM-13,20959075,-3.627453597088981
U-BLC1,36314,-6.7177980686441865
SW1573,3543504,3.864321270652805
NCI-H2452,16722836,1.367876124233394
LCLC-97TM1,2949965,2.4577774402858203
KHM-1B,44489675,3.585809473125015
HARA [Human squamous cell lung carcinoma],5479543,3.520150804916199
SK-HEP-1,9911463,4.3683168964450125
KP-4,ISOX-bortezomib (250-1 mol-mol),0.4690866749839671
P31/FUJ,11404337,-0.879305702132212
JHUEM-2,135999136,3.462043848043772
KLE,navitoclax-piperlongumine (1-1 mol-mol),-2.7147471251118143
RERF-LC-MS,23725625,5.011639185934848
LS411N,alisertib-navitoclax (2-1 mol-mol),1.9281713469171404
HuH-6,46224516,1.2318315651176113
SW48,126941,-4.535727103151088
T98G,11364421,1.690319483571917
Hep-G2,44185566,1.2927959850835242
KMS-21-BM,5328940,1.0290161994892784
BFTC-909,6184667,3.207156937684644
KU-19-19,2945648,2.475372674219151
HuP-T3,387447,-4.787053098216054
SNU-1079,5280436,3.461804427204629
Panc 02.03,44493528,4.298055948100647
Daudi,4788,4.597613323137637
SK-LMS-1,9952709,2.023956399550252
K-562,46907787,1.0881737362577
HCC15,6505803,-2.813846830430111
MOLM-13,3503,1.2246558483585983
NCI-H1568,136227924,3.032081072579533
ES-2,637858,2.4124737052825975
KLE,4261,0.7692438055073919
DLD-1,3689413,0.9147561458684622
RKO,9444,4.448790979485227
Daudi,107970,1.216737596928884
Daudi,5311037,3.4563783042396015
SW948,10184653,-0.1197105127119604
YD-15,16720766,-0.7561657856059989
L3.3,25262965,-0.71498955679679
HEL,89928392,0.5480178499310975
SK-HEP-1,5566,3.210365271342881
NCI-H2452,44493528,4.324080951064212
ST486,44632017,0.5960732313690702
SW948,24753719,4.222068008445673
ST486,54613361,-1.2515024311455387
K-562,11717001,4.3318290739670555
HCC15,11647372,2.6612404016221824
EB1,9803433,4.426658959343484
COR-L95,11214940,4.129361910595318
P31/FUJ,57330099,4.216278217816623
COR-L95,24889392,4.336996294263524
ALL-SIL,16725315,3.2612856597636064
KP-4,322968,4.0363585521291965
DLD-1,3062316,2.7676251682314064
SU-DHL-1,2749,0.1348057545057474
SK-LMS-1,16725315,3.2291343894639803
IGROV-1,6918736,-0.950858733923241
HEL,46398810,0.908204113249262
COR-L105,969516,2.680370673187369
MOLP-8,613000,0.7667530859484226
HARA [Human squamous cell lung carcinoma],6252,0.9917938801151434
PK-1,docetaxel-tanespimycin (2-1 mol-mol),-4.658012062817381
SNU-886,vorinostat-navitoclax (4-1 mol-mol),-7.798745987828545
SW948,375860,-0.5776308885037049
KMS-21-BM,11507802,0.5937482369535511
EB1,11955716,-2.8202893110877256
Granta-519,6438330,1.446800550416973
T98G,4259181,0.7418471761834453
ST486,107970,1.035895385995704
EB1,vorinostat-carboplatin (1-1 mol-mol),1.9099776647600568
EB1,24856436,-1.4707638574935935
TTC-709,2749,1.8243530779481976
SaOS-2,3384730,0.9471099210722488
Mino,2708,2.604362376523167
COR-L105,navitoclax-pluripotin (1-1 mol-mol),-0.739242899323645
F-36P,44241473,6.465065982538859
SW948,10127622,1.0689347689119728
SK-OV-3,104842,-0.359869843998673
HCC15,2733526,3.237047771361035
ALL-SIL,9884685,1.523019065964201
HCC1500,31703,-0.1591983874970776
SEM,72199292,-0.295310917507193
KLE,135411,0.8012767106548482
BT 248,selumetinib-MK-2206 (8-1 mol-mol),1.8493949286996905
MOLP-8,24785538,-1.5077289265748457
COR-L95,6918328,0.296514622397876
SNU-C2A,3854666,1.1286378609784615
KMS-21-BM,656346,-0.4068732453788433
PE/CA-PJ34 (clone C12),9907093,4.32490374707387
JHUEM-1,6438330,2.850322109925325
LS180,24964624,2.8898766327054153
PaTu 8902,2945648,2.947030382730425
IA-LM,16038120,1.0865848932778794
Daudi,54619267,3.035333918034676
Daudi,5284373,1.725683673378691
YD-15,54618305,4.368712757775692
BT 440,24889392,2.237797507559801
SW948,56946209,-4.45606402023299
SU-DHL-1,9956119,2.7884192993685666
KP-4,119607,5.316399817953364
PaTu 8988t,3689413,2.4784022576221836
WM115,44241473,4.443917717257507
DLD-1,2729026,3.174702403711638
JHUEM-7,2729026,2.278155757312377
HEL,11507802,0.749942791895586
PE/CA-PJ49,5329102,2.072056563609684
LMSU,25102847,2.404236783403615
LS180,25150857,2.6595729662678846
ALL-SIL,11964036,0.9057184864624424
SW1271,5351362,2.529410314371741
KU-19-19,151289,4.45756440863607
SK-LMS-1,16013152,4.349323816725978
MDST8,24785538,2.8042557252914597
KP-3,6610216,4.430226203729176
PE/CA-PJ49,11626560,1.499452370410067
LCLC-97TM1,11228183,2.6499520646531254
NCI-H1568,10127622,5.078058454742808
JHUEM-1,9907093,3.847231935516947
SUP-T11,2113511,3.803070904776649
RKN,676352,2.5860960344205175
WM115,6505803,-4.475953396274594
MOLM-13,5278396,2.870927952465231
U-BLC1,36462,2.690560707412892
SW48,1641662,2.4016053281737544
Panc 02.03,5329102,3.1751218779490404
P31/FUJ,136227924,2.3905530687579497
LCLC-97TM1,5281321,-1.0764177966981967
SU-DHL-1,23635314,-2.2508595154996844
SNU-626,10410894,5.607730406046986
SK-HEP-1,navitoclax-pluripotin (1-1 mol-mol),-0.7942291093316414
SEM,25126798,3.9463817961224215
MOLM-13,44494015,-5.247330257185634
SK-OV-3,carboplatin-UNC0638 (2-1 mol-mol),3.7911977444327034
HCC1500,46199207,3.053954841618667
NCI-H1568,6610355,3.436001375430949
ST486,6450551,1.145972312308334
HCC15,54618164,4.329878027642837
RKN,969516,2.6409066030454804
LMSU,10184653,1.8439035095967675
JHUEM-2,54613361,-1.761919492814522
Mino,selumetinib-UNC0638 (4-1 mol-mol),3.4058404706720844
ES-2,3689413,-2.830682661734752
PE/CA-PJ49,11955716,-2.5163887082114753
Mino,11455910,-0.3204403040643599
KMS-21-BM,11625818,3.638753601166788
COR-L105,71680916,4.738410817171978
SU-DHL-6,3634881,2.3700422517918653
Daudi,374536,1.069903440531545
K-562,322968,4.0833948777840225
HCC15,tretinoin-navitoclax (4-1 mol-mol),0.5454082454604786
F-36P,3136844,2.947834525735439
K-562,136227924,2.737847329779252
HCC15,15953870,3.1000423449826275
BICR 22,6505803,-0.8504421983690468
BICR 31,409805,3.7719372874267982
SK-LMS-1,navitoclax-piperlongumine (1-1 mol-mol),0.9730805006136548
MOLM-13,navitoclax-pluripotin (1-1 mol-mol),-3.59227040291678
KU-19-19,71304818,1.8280747292346609
SEM,65628,2.5869900174043647
KHM-1B,54618771,-0.6219515555388266
L3.3,65628,4.284850303510067
SW1271,6917907,-6.616351101315701
SW48,44589607,2.4172125993075335
SNU-886,3815108,2.9264370464975817
HuH-6,208908,1.599190366869825
KP-4,25183872,-0.6810408036254354
MKN1,11228183,3.052450004947205
KU-19-19,3854666,3.1161318305167995
JHUEM-2,3476986,5.927417326358874
TTC-709,53232,-0.0878972013106072
Mino,carboplatin-etoposide (40-17 mol-mol),0.3240192692777656
MOLP-8,11404337,-0.9705317414577028
SK-OV-3,11152667,-0.6824217491873509
SNU-886,serdemetan-SCH-529074 (1-1 mol-mol),2.464759395102203
PE/CA-PJ34 (clone C12),176870,0.680065557462293
LCLC-97TM1,72199292,1.0139745528188595
HuH-6,4261,1.8107178492874336
SK-OV-3,5566,3.179406871626594
KP-3,56946209,-3.2276461969239834
JHUEM-7,45279963,3.810394630077175
PE/CA-PJ49,984333,1.495833138659802
SU-DHL-1,11683005,2.624367478757415
PaTu 8902,71466380,4.078142681912824
SEM,54143018,-0.980630372208269
Daudi,56963564,0.012925039709307
DLD-1,2945648,3.27779621967446
HARA [Human squamous cell lung carcinoma],656346,-0.3153592740671193
SU-DHL-1,25195348,1.1859308431356896
RERF-LC-MS,11494412,1.0302757077826894
EB1,107970,1.4399846214228276
YD-15,44202524,1.0054820095374657
KPL-1,46398810,2.8725098369347632
SUP-T11,5278396,2.4451137489951225
IGROV-1,3634881,2.769147818550815
Ishikawa (Heraklio) 02 ER-,409805,6.059507379777802
SW48,445643,3.7110082204631545
SK-LMS-1,11234052,4.728333340623987
IGROV-1,3854666,2.3355254440561137
BICR 31,tanespimycin-gemcitabine (1-1 mol-mol),0.6260798256664765
Mino,73707398,0.350796804562992
HARA [Human squamous cell lung carcinoma],49867926,4.231294833351195
T98G,25150857,3.08810216774414
JHUEM-2,66577038,2.587655599803357
U-BLC1,JQ-1-MK-0752 (1-1 mol-mol),3.4377955503111877
SNU-C2A,44507138,1.895341527805593
NCI-H1395,selumetinib-GDC-0941 (4-1 mol-mol),2.3368578075304463
KP-4,2945648,2.872287877926181
EB1,5282054,2.246518763077297
PE/CA-PJ34 (clone C12),11657048,5.70613373367465
U-BLC1,23725625,5.455676234241253
PaTu 8902,387447,-3.44390255134181
BICR 22,25150857,2.1797682691439233
SK-HEP-1,54618164,4.274964046269975
BICR 22,44493528,4.288893884195869
HT-1376,9967941,4.947945618019317
NCI-H1568,969516,2.3539842482072353
HEL,52912189,-0.3930066433927971
BICR 31,53392493,3.0187901836288824
Panc 02.03,6610216,4.56797737488032
PaTu 8988t,selumetinib-UNC0638 (4-1 mol-mol),4.596522805557342
PK-1,46843906,4.422450616404176
SaOS-2,445643,3.906030165734591
SU-DHL-1,9967941,3.123701665105139
HuH-6,9935249,3.1892050642519756
U-BLC1,selumetinib-tretinoin (2-1 mol-mol),-1.5181112365555942
KLE,1716436,1.7262214726363108
SK-MEL-2,11404337,0.550817025493175
P31/FUJ,10113978,2.718593007254544
K-562,54618771,1.1969173800987956
SW1271,445643,4.255849699563793
SU-DHL-1,16741245,1.9818901112506189
Granta-519,selumetinib-GDC-0941 (4-1 mol-mol),1.138104902542422
SU-DHL-1,9935249,2.376788737359572
HCC1500,doxorubicin-navitoclax (2-1 mol-mol),-1.8241267045237697
Daudi,11625818,2.088957631704298
KP-4,9868037,2.659555107849518
IGROV-1,11213558,0.52356811652227
JHUEM-2,3385,1.7780837536940584
SK-MEL-2,46191454,2.150362505084453
HCC1500,selumetinib-MK-2206 (8-1 mol-mol),4.693148185456232
LMSU,carboplatin-UNC0638 (2-1 mol-mol),4.1197571889036455
RERF-LC-Ad1,1750826,-2.353785617747723
SNU-626,5282054,3.839283945968047
ST486,10127622,4.613707792342488
SaOS-2,9907093,3.731287417721421
SK-LMS-1,5311281,1.8163928569648944
COR-L105,54618771,2.0419110046350135
RKO,9935249,5.020114551473781
RCC10RGB,54649381,5.891551456540707
RCC10RGB,11228183,3.0224846047699288
BFTC-909,selumetinib-navitoclax (8-1 mol-mol),4.610305702630868
SUP-T11,675434,3.8611672044848926
MKN1,ISOX-bortezomib (250-1 mol-mol),0.3245197826547291
U-BLC1,49793307,-3.403097169351666
ALL-SIL,11683005,2.0727325774258794
RKN,9935249,4.428036529076262
SK-HEP-1,6918837,-2.2229066751457345
Panc 02.03,36462,3.4500230117265933
NCI-H1395,9936388,2.8582059793440964
SU-DHL-1,9866186,-0.7631869517914462
Ishikawa (Heraklio) 02 ER-,11507802,1.7274893122424997
LCLC-97TM1,448949,2.0046135576158637
SW1271,2858523,3.03244629786768
SaOS-2,46398810,2.449640817433895
ML-1 [Human thyroid carcinoma],navitoclax-piperlongumine (1-1 mol-mol),1.771267146894677
COR-L105,16013152,4.074366111138725
DLD-1,107985,-3.352847665202384
SW1271,10127622,0.8769341404821704
PaTu 8902,24951314,1.6215809376037376
SEM,11175137,1.2728559618828204
EB1,322968,2.5790400469127652
P31/FUJ,navitoclax-birinapant (1-1 mol-mol),-0.4716815446348188
EB1,8515,1.7583266480090207
NCI-H2452,sirolimus-bortezomib (250-1 mol-mol),-3.2659140212788733
HuH-6,selumetinib-decitabine (4-1 mol-mol),5.95543166337258
Daudi,72199292,0.1565760694605324
SNU-C2A,49793307,-2.9514855608839867
PaTu 8902,409805,5.142449436796194
BFTC-909,16115403,-3.993091010962378
LS411N,serdemetan-SCH-529074 (1-1 mol-mol),2.4339981987212256
SK-MEL-2,107970,2.2508906285434143
ST486,5291,3.3460085876654055
NCI-H2452,6505803,0.3706171048891257
SNU-886,3081361,3.1313223505952132
JHUEM-7,11612883,1.3024764146581809
U-BLC1,11234052,4.258274347424644
LMSU,9927531,5.404187778104352
K-562,123631,1.7867714727142892
MKN1,3062316,1.184793996482021
ES-2,9903786,4.393151500832027
ST486,168313016,3.7452740241785847
SNU-626,2113511,6.023050758613085
KMS-21-BM,24901704,1.8043859748423776
SW948,selumetinib-vorinostat (8-1 mol-mol),-0.2109654118959779
SW948,56963564,0.1376223024943695
EB1,11485656,1.3368120139710602
P31/FUJ,doxorubicin-navitoclax (2-1 mol-mol),-2.963925883799113
BT 440,10385095,1.3562224236695042
KU-19-19,25183872,1.353604037781074
K-562,462382,0.6666012292356907
NCI-H1395,9803433,5.44811246769085
BICR 22,216239,3.622359576149126
SW948,72376,-2.235310823117723
SK-HEP-1,16736978,1.840110323821058
JHUEM-7,9911463,3.659236793496393
LS411N,135440466,2.8415058675889
BICR 31,2871966,0.8542621552894032
HuH-6,JQ-1-UNC0638 (2-1 mol-mol),1.464271535928535
U-BLC1,44489675,3.038575109321873
MKN1,25062766,2.4767937831200313
NCI-H2452,5311281,2.597680352332147
HEL,25195348,3.2451646073619416
MOLP-8,navitoclax-MST-312 (1-1 mol-mol),1.0636024254561756
SW48,24856436,-0.3608375787119608
COR-L95,23582824,1.713723586402061
ST486,navitoclax-PLX-4032 (1-1 mol-mol),0.0218640167546475
NCI-H2452,400769,-0.2625889565980605
Granta-519,6610355,5.056177796240837
TTC-709,151289,1.6959630420615608
T98G,vorinostat-carboplatin (1-1 mol-mol),4.1636905870102145
RKN,135984461,0.6080422026652917
IGROV-1,9956119,3.7231415872817024
Hep-G2,452548,1.6597392394544144
TTC-709,89928392,0.5726629702130689
SNU-1272,3854666,4.252561459564198
SU-DHL-1,24856436,-0.2626900450765423
MKN1,445091,4.319639575910345
BICR 31,9911463,4.617619725588035
ST486,selumetinib-PLX-4032 (8-1 mol-mol),4.599065842587771
BICR 31,2742550,4.742856926113666
KMS-21-BM,10385095,1.1305886144467554
Daudi,6450551,1.0042642679666238
HEL,57519531,1.593967479342305
SW948,sirolimus-bortezomib (250-1 mol-mol),0.0443839489335638
RKN,216345,4.602972623005823
SW48,46224516,2.362473255058207
KP-4,BRD-A02303741-navitoclax (2-1 mol-mol),3.6233365394469175
NCI-H1395,24821094,3.771001667275143
Ishikawa (Heraklio) 02 ER-,44632017,1.1398248872275398
RKN,10184653,1.939164173873933
MKN1,17755052,2.2688393196982433
MOLP-8,31703,-3.4249459011432912
T98G,216239,1.37994802988206
HCC15,9911830,1.9028880277746671
JHUEM-2,53232,1.1849114530479246
P31/FUJ,24180125,3.650250525491935
U-BLC1,42642645,0.9878731363014036
HCC1500,11427553,3.400784702269924
WM115,4378219,1.986798403927216
MOLM-13,445643,3.334033231716822
JHUEM-7,613753,2.971505518088734
SNU-626,54619267,4.304612049662611
HuP-T3,135440466,1.565116417651368
BT 248,4259181,0.8166391520482507
SNU-886,2126,2.9580246654622275
ML-1 [Human thyroid carcinoma],44491742,4.3341380025681175
SaOS-2,5284616,3.138246393599145
JHUEM-2,984333,2.7426357008608684
Hep-G2,219104,4.303712261907195
DLD-1,11178236,-1.411828082062708
LCLC-97TM1,156422,4.251965697410575
Granta-519,71680916,3.9040498639791226
SNU-C2A,9967941,4.9261768777124555
SU-DHL-1,16725315,3.3729799888412257
P31/FUJ,20959075,-3.3972839651855207
KLE,5284373,-1.0664955605853337
K-562,16720766,1.059873963232806
LMSU,9956119,4.695933157448729
WM115,9915743,2.6223908273409515
F-36P,24748573,1.636470275133907
COR-L105,11238147,3.8255779395664065
HCC15,6918878,1.2461206152093485
SK-OV-3,11427553,3.3243369937323877
RKN,6918736,-2.1202784612128416
LMSU,24753719,4.829555677738913
NCI-H1568,10385095,0.5241849666466598
LS180,6623618,2.712323731600185
SNU-626,135411,0.9155402165079763
COR-L105,BRD-A02303741-navitoclax (2-1 mol-mol),1.6973601808682428
L3.3,25154868,5.156852655599311
COR-L95,5287620,-3.7742892062529183
Daudi,11977753,-5.803293235753203
NCI-H1568,375860,-0.3746562160702436
Daudi,1242560,2.7879344365615633
ST486,9927531,3.885019702146961
RKN,2729026,3.0549768432694377
SUP-T11,9840324,5.478974193538764
KHM-1B,2749,0.8754642075989242
KP-3,52912189,-0.591071616638485
SEM,navitoclax-PLX-4032 (1-1 mol-mol),-1.6228685659579063
SU-DHL-1,56963564,-1.155496663147979
SK-LMS-1,44491742,4.239159149665423
KP-4,24951314,1.4509565754370062
SK-HEP-1,42642645,1.5394057036271682
COR-L105,9935249,3.5389604716579175
JHUEM-1,135398516,1.5171636389963654
SK-CO-1,107970,2.4721550322855843
Hep-G2,51037431,2.134327625147545
RKO,5113032,5.90165838842917
TTC-709,selumetinib-PLX-4032 (8-1 mol-mol),4.858015135256982
KMS-21-BM,BRD-K58730230,4.0136695176819135
SW1573,135411,2.599466343128946
WM115,selumetinib-GDC-0941 (4-1 mol-mol),-1.581349987351192
RCC10RGB,6610355,5.214940260192328
BICR 31,5287620,-1.513974949921974
HARA [Human squamous cell lung carcinoma],10427712,4.036967432982734
BT 248,31703,-0.7981868387763399
BT 248,11228183,2.0159399448324065
RERF-LC-MS,72376,-2.3536044208150644
UACC-812,7326481,2.606201441290427
KPL-1,441298,3.8950674592975383
ES-2,9825149,3.0834575074719903
U-BLC1,9887053,5.166701097686756
DLD-1,selumetinib-piperlongumine (8-1 mol-mol),4.552383083473649
MOLP-8,11717001,3.6554432811683824
P31/FUJ,1317464,4.709019850634407
BT 248,5479543,3.7849708026150406
MKN1,24748573,3.0262603275466
HARA [Human squamous cell lung carcinoma],9956119,4.138225192842101
PE/CA-PJ49,44137675,2.9964477729791787
PE/CA-PJ49,54765302,4.945952388263716
HARA [Human squamous cell lung carcinoma],5328940,0.878974684606101
SaOS-2,44507138,2.054017263478066
KP-4,navitoclax-MST-312 (1-1 mol-mol),1.073103176546053
KMS-21-BM,36314,-8.468041713391136
SK-LMS-1,66577038,3.208935464661633
PE/CA-PJ49,375860,-0.7510752719204733
IGROV-1,445091,5.8777802446160825
RERF-LC-MS,54613361,-1.445874788963763
RERF-LC-MS,72193861,1.0218744083195843
JHUEM-7,JQ-1-MK-0752 (1-1 mol-mol),0.4170318281290994
RKN,vorinostat-navitoclax (4-1 mol-mol),2.458310168873828
PE/CA-PJ34 (clone C12),9887053,4.7354636419859935
HEL,56963564,-0.4081404928481738
PaTu 8902,136227924,3.2072125986231117
PE/CA-PJ34 (clone C12),16219061,2.427956187970103
PE/CA-PJ49,44462760,5.03856691343424
BT 248,135875424,2.546043839111523
SW1271,25183872,-0.9123448839798644
RERF-LC-Ad1,24785538,2.8640497838765824
LS411N,navitoclax-MST-312 (1-1 mol-mol),1.1524396159944978
ST486,10077130,1.942347115541638
IGROV-1,25154868,4.833387840688245
ST486,56973724,1.5499732016928387
JHUEM-7,JQ-1-navitoclax (2-1 mol-mol),-1.3593352546723596
EB1,52912189,-0.8584665253447232
LS180,107970,2.4480125060803077
RERF-LC-MS,9840324,5.508232790936476
ST486,5311,0.1936779394531433
ES-2,25154868,3.0355298086449096
HARA [Human squamous cell lung carcinoma],55508,3.1590088041564752
ML-1 [Human thyroid carcinoma],6918736,-3.4697519345619843
EB1,10184653,0.1223376417543758
DLD-1,104842,-0.7169241698020532
COR-L95,60700,-2.695152938475503
LMSU,25161177,5.357505084661806
ES-2,171352865,4.375314916570656
JHUEM-1,2113511,4.9135060068657115
HCC15,24785538,0.0662714662573936
SNU-1272,49793307,0.8482167940358369
Ishikawa (Heraklio) 02 ER-,219104,4.233979669273785
JHUEM-7,46926350,-4.455736364930407
Mino,11626560,1.0907516570585627
U-BLC1,9825149,2.021908243968558
PE/CA-PJ49,navitoclax-sorafenib (1-1 mol-mol),3.038592174870093
IGROV-1,selumetinib-UNC0638 (4-1 mol-mol),2.5141275878807563
MKN1,25154868,5.237701462971223
ALL-SIL,73707398,-0.324762560862376
JHUEM-1,44566777,-0.8003705670200993
HuP-T3,23725625,5.187021863055133
L3.3,168313047,3.843757543685879
SNU-1272,168312962,-0.3156994107221632
SK-MEL-2,3136844,4.246241998610311
IGROV-1,selumetinib-piperlongumine (8-1 mol-mol),2.9206278268520163
ML-1 [Human thyroid carcinoma],53481919,4.335778865313171
BT 248,decitabine-navitoclax (2-1 mol-mol),1.3496925152518875
BT 248,439501,-2.3411963573363104
ST486,19582717,2.2042854724380736
MDST8,6505803,-0.0816923181525763
BT 248,JQ-1-vorinostat (2-1 mol-mol),2.5830463890167064
SK-OV-3,5351362,2.7626479495985765
IGROV-1,36462,2.313632721410001
NCI-H1395,5329102,2.4714501130754294
BICR 22,54618305,4.315554591509874
RERF-LC-Ad1,73707398,2.698751964761458
MDST8,5311281,0.3396864368094036
NCI-H1395,568763,0.9321190773221452
MDST8,9866186,0.4787443726889831
COR-L105,9840324,5.89386509883338
SU-DHL-6,9887053,3.723065049771557
SNU-626,36314,3.3312529286737256
ST486,2113511,3.5875938703315553
SU-DHL-1,10113978,2.4232665022526154
TTC-709,6252,-0.5485946595810436
PE/CA-PJ34 (clone C12),11178236,-3.1085754379858175
ES-2,375860,0.1597186252009672
K-562,6610216,3.734328570580528
U-BLC1,15547703,3.3973399267400417
BT 440,73707438,1.919816758244461
MOLM-13,9936388,-7.059788369591511
KP-3,5746,2.3079316144145037
YD-15,6852167,1.5234266215850325
Panc 02.03,vorinostat-navitoclax (4-1 mol-mol),1.4480782846728824
WM115,135659046,3.4373276092449667
KP-3,6610355,3.647818431996112
HARA [Human squamous cell lung carcinoma],16736978,1.7495486591528322
SNU-C2A,54618164,3.882205124522901
PK-1,16038120,0.9657493254281936
RCC10RGB,2708,5.228545547030361
SK-LMS-1,51037431,1.890462199856316
HuH-6,erlotinib-PLX-4032 (2-1 mol-mol),2.7048713387507948
MOLM-13,JQ-1-navitoclax (2-1 mol-mol),-1.828604943394028
JHUEM-7,44202524,1.495097381233924
JHUEM-1,10172275,4.352218994725648
T98G,46215462,2.71226651790537
HuP-T3,969516,2.913535439683091
P31/FUJ,135398744,5.7727848933678
SaOS-2,168312962,3.518591614256865
BICR 31,docetaxel-tanespimycin (2-1 mol-mol),0.9040464385667872
Panc 02.03,11364421,0.2085573081853932
SU-DHL-1,3385,0.1709309619587451
COR-L105,3854666,3.5309487733662923
K-562,3025986,-1.372296763308674
PaTu 8902,25183872,-0.4459453921876214
BICR 22,25022340,5.75714905141274
SK-CO-1,71466445,5.862416915369376
PE/CA-PJ34 (clone C12),9911830,2.0683867467094657
ES-2,126941,-2.905652392311656
SEM,11612883,0.3199155998762981
HEL,159324,1.7687894675630291
P31/FUJ,135411,-0.6620772647112111
K-562,11455910,-0.068399521398108
U-BLC1,navitoclax-piperlongumine (1-1 mol-mol),0.5792744807336905
KMS-21-BM,6918328,-1.992133081993976
BICR 31,doxorubicin-navitoclax (2-1 mol-mol),-0.8834140125072127
SaOS-2,135421197,3.6760992974277817
RKO,54678924,1.753529637740366
SNU-886,3825829,4.2404054797227735
LS180,9926054,2.059729849775666
PaTu 8902,3081361,4.091517551590367
HCC15,54618305,4.644823264977023
SK-LMS-1,24797083,1.4203781469683936
SK-CO-1,135421197,1.070123520764916
KLE,46907787,0.6768942529427939
MOLP-8,5282054,2.3704039128819603
Granta-519,2874250,5.483813332492178
SW948,15547703,2.460178853059974
RKN,11175137,3.1657803092866224
MKN1,6918328,0.8492000784019335
HCC1500,15547703,2.6330912213710693
PaTu 8988t,3503,2.8268609009838706
ST486,11228183,0.1279386260901297
P31/FUJ,JQ-1-navitoclax (2-1 mol-mol),-0.8945725612384452
NCI-H2452,409805,5.262030999116563
NCI-H1395,11717001,5.001255257039283
ML-1 [Human thyroid carcinoma],9927531,5.643924198323062
K-562,107985,-3.1543528536618175
Ishikawa (Heraklio) 02 ER-,216468,3.7247875690653953
RCC10RGB,6918837,-1.099435459858538
HuP-T3,2746,4.662800576379415
Granta-519,135928012,3.1328015926823065
HEL,2733487,3.1527152778808794
RCC10RGB,11175137,3.603105896683611
DLD-1,9907093,4.3341009181105745
RKO,51039095,3.7257826703811014
WM115,3689413,-0.1044392328624619
SaOS-2,25154868,5.397428200613107
RKO,25195348,3.4491832635970585
SK-LMS-1,crizotinib-PLX-4032 (2-1 mol-mol),2.072496392258814
Ishikawa (Heraklio) 02 ER-,15547703,3.498658285601613
BFTC-909,49850262,4.237463012213885
SW48,168313047,2.500888470511616
PK-1,54618305,4.508738372274147
WM115,444795,4.375682835505768
IGROV-1,5738263,4.037832478240785
MOLM-13,24748573,1.5626639761830592
ST486,65064,3.277739673869227
SEM,5394,4.006285802204493
KP-3,54618164,4.648325993327064
UACC-812,6917907,-5.293133909322777
YD-15,serdemetan-SCH-529074 (1-1 mol-mol),2.2826915957054363
IGROV-1,168313200,3.9938362637732983
HuH-6,969516,2.8548234275800626
PaTu 8988t,262093,3.2462588578894587
KU-19-19,selumetinib-navitoclax (8-1 mol-mol),1.098074451823129
BT 248,3543504,4.235039119755324
KP-4,135421197,2.59268452027494
F-36P,24901704,2.131485573625626
WM115,3543504,4.159835009416132
PK-1,216345,4.417588662978574
JHUEM-7,5113032,4.7199076302075875
Panc 02.03,selumetinib-MK-2206 (8-1 mol-mol),1.9117134680972272
KLE,613753,3.1630835497956884
SU-DHL-1,9903786,2.5464454731205777
ALL-SIL,6438330,0.5772640537372373
SNU-1079,11178236,-2.8178512235270383
SK-HEP-1,322968,4.726859452680793
MKN1,44589607,3.053689274287757
TTC-709,51039095,-0.7537598019095654
F-36P,44632017,-0.4733607400877447
KHM-1B,selumetinib-vorinostat (8-1 mol-mol),0.6358742405488887
KMS-21-BM,44589607,0.8250667525762433
ML-1 [Human thyroid carcinoma],1716436,2.512454049061402
WM115,2874250,4.6839306454467975
SEM,5282054,2.754283213849225
HEL,327653,2.969363674974165
JHUEM-1,1641662,3.2847002109436776
ST486,53325874,6.351640741401032
SU-DHL-1,11625818,3.655247454502854
U-BLC1,753704,4.532043997158847
F-36P,5566,2.9396690394541247
UACC-812,49766530,0.2629782697340875
SNU-1272,124202324,3.3198251305185975
SU-DHL-1,3815108,2.229733806447586
YD-15,24753719,4.654665275696266
IA-LM,71466445,4.189377103287156
HuP-T3,1716436,3.1901993610711092
SW948,44566777,0.0218128389697893
JHUEM-2,11507802,0.1393429799989516
SaOS-2,24821094,3.1556587771151117
Panc 02.03,135875424,4.996461687769912
COR-L95,3136844,6.4544258549997675
PE/CA-PJ34 (clone C12),9903786,2.211143495082886
KPL-1,11178236,-3.101749103034978
BT 440,439501,-2.9388364994679614
ML-1 [Human thyroid carcinoma],72193861,1.5092085092070135
LCLC-97TM1,3385,2.7516430893834696
PE/CA-PJ34 (clone C12),51037431,4.093871362794514
RD-ES,36462,-0.4809008818897318
JHUEM-7,60700,-1.134830771722302
PE/CA-PJ34 (clone C12),16659841,3.7885969371213704
K-562,135875424,2.7247406179323055
LS411N,5329102,2.797825403975713
BT 440,44589607,3.4477680654010348
U-BLC1,24785538,1.941420642403868
MDST8,24964624,1.7196440159479949
KU-19-19,10090485,5.355458016675434
HuP-T3,vorinostat-navitoclax (4-1 mol-mol),1.7749149652569187
YD-15,selumetinib-JQ-1 (4-1 mol-mol),1.1872540503704618
SNU-1079,44543605,5.029495892570948
TTC-709,702558,3.178593891008319
RKO,89183176,-5.254565057669901
JHUEM-7,6852167,1.350724801432494
WM115,decitabine-navitoclax (2-1 mol-mol),3.441832187102982
Daudi,24775005,2.5651956502981093
EB1,208908,1.521035596117557
SW948,46215462,1.7533079238953375
BICR 31,6610216,4.499990209090508
ALL-SIL,89928392,-0.8842785165403505
PK-1,136227924,2.8943441164421633
Mino,55508,2.217062239877633
MOLP-8,carboplatin-UNC0638 (2-1 mol-mol),1.5821453597747015
SaOS-2,9933475,1.7767718055197024
SUP-T11,11647372,0.1478910638611605
LCLC-97TM1,16722836,1.3652485758433368
LCLC-97TM1,49793307,-2.6941720612695814
L3.3,702558,3.3585745644546474
SW48,10127622,-3.686333454689576
Daudi,451668,-1.5751627659840317
F-36P,navitoclax-birinapant (1-1 mol-mol),0.6826800507816524
NCI-H1568,135398516,0.1447365774963497
SNU-1079,6918289,2.130196376398996
L3.3,5113032,6.1935482945866545
ST486,10113978,2.365795782421126
U-BLC1,selumetinib-UNC0638 (4-1 mol-mol),-0.5202084416383701
MOLP-8,11178236,-5.22072808334844
NCI-H1568,46907787,2.5747387573296425
PaTu 8988t,6914657,-5.535111189097384
Daudi,vorinostat-navitoclax (4-1 mol-mol),0.7138664459313301
SW948,3025986,-0.0730103520402185
SUP-T11,73707386,1.4307849373586292
YD-15,36462,1.1625892887713607
SNU-886,selumetinib-navitoclax (8-1 mol-mol),-7.607672884091839
IGROV-1,11612883,1.8715405446213529
RCC10RGB,3081361,3.5981013353753464
MKN1,11455910,-0.2869953117882883
SUP-T11,11717001,5.502128941519073
MOLM-13,73707398,-1.293008226929777
KPL-1,11964036,2.324528151703663
RCC10RGB,9915743,0.9759946846108524
LMSU,11396600,3.695024866246392
HCC1500,24771867,4.066345817331682
HT-1376,4477,1.2729739260162034
K-562,44137675,5.346911467461658
BICR 22,89183176,4.4276408454646
MOLP-8,tanespimycin-bortezomib (250-1 mol-mol),0.0565968388812305
EB1,6918837,-5.049387881433214
Mino,JQ-1-vorinostat (2-1 mol-mol),-2.134819462233736
EB1,5311037,3.600448849612844
SEM,45279963,3.71935630000701
SNU-C2A,11404337,1.3290101789179258
BFTC-909,54619267,3.991913685478571
RKO,71304818,0.9175289508752972
SW1271,selumetinib-navitoclax (8-1 mol-mol),0.9104447168636678
BICR 31,25161177,4.144120396566418
KP-4,445091,3.9007514105638186
L3.3,11507802,1.6932869737181035
SK-CO-1,6918328,0.4731277879927994
BT 248,54618795,3.2071840181570477
RERF-LC-MS,6914657,-3.1593675222943896
NCI-H1568,44185566,2.743919877007031
ES-2,54618164,4.408028245984097
L3.3,374536,1.2868097755844614
TTC-709,10184653,1.7324407180021464
ES-2,3815108,3.0666296154583135
BICR 22,navitoclax-pluripotin (1-1 mol-mol),0.259222956634469
TTC-709,6610355,3.944309312341827
COR-L95,6852167,3.112371536345172
P31/FUJ,5113032,4.875284905433655
PK-1,119607,5.6255088168219824
JHUEM-1,9823820,3.941546030629587
KHM-1B,16115403,-6.426338372507057
PK-1,104842,0.1565088553838001
YD-15,3025944,3.9058701178554616
BFTC-909,24180125,2.699370118217823
SU-DHL-1,6252,0.3334498529847555
ST486,219104,1.3133985457567512
K-562,tanespimycin-gemcitabine (1-1 mol-mol),-1.5492083628260829
SK-MEL-2,72376,-0.3175424925605319
LCLC-97TM1,322968,2.924684365208183
Daudi,60750,-4.624244800464318
Ishikawa (Heraklio) 02 ER-,2130404,3.710615322571876
NCI-H1568,3385,5.30334090203815
COR-L95,5978,-2.5997235685562026
Daudi,24856436,-0.3602858360333429
HARA [Human squamous cell lung carcinoma],54618771,1.4449475826214635
Ishikawa (Heraklio) 02 ER-,3503,1.3945277480644842
MOLM-13,445455,3.1473640199222386
SK-LMS-1,44241473,5.38031759835473
SW1573,135421197,1.3915330004591782
HCC1500,16065773,1.504426355167742
HARA [Human squamous cell lung carcinoma],54454,2.560964814308564
K-562,piperlongumine-MST-312 (1-1 mol-mol),1.115742811823549
JHUEM-7,6918736,-3.584037511653784
U-BLC1,9935249,1.956441197069186
T98G,71680916,6.119633503096597
Daudi,9826308,0.3207715704810925
RKN,17759555,4.047966260499275
RKO,navitoclax-piperlongumine (1-1 mol-mol),3.004924162452904
BT 248,selumetinib-piperlongumine (8-1 mol-mol),3.781064018131383
PaTu 8902,9911463,4.390925153080421
LS180,54613361,-0.777399447336216
COR-L95,11396600,3.695258257335492
SU-DHL-1,9911463,3.067527187401269
COR-L95,4477,0.8356196347588036
KPL-1,9936388,1.598306973451347
SK-CO-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.065917743830426
PK-1,44185566,2.494493126125251
COR-L105,12001922,2.476912212032941
SK-MEL-2,5566,2.990439672942584
SNU-1079,49850262,1.8843738855424692
ES-2,322968,3.1520318286175173
ST486,54596490,5.2508906493958625
BT 440,31703,-1.017389066921834
NCI-H1568,25154868,2.392234118098981
P31/FUJ,24964624,0.604485461730223
HuH-6,148198,-4.2090148459879275
RKN,11507802,1.1392194525963166
DLD-1,11485656,2.3568944712776565
Granta-519,2746,3.996696473436098
BICR 22,6918736,-3.590209831667407
IGROV-1,135423438,0.764137689665023
SEM,25105715,2.97048574375964
SaOS-2,5460769,2.263492155098724
MDST8,3025944,3.984610722170807
HuH-6,6505803,-0.5786152978547117
HuP-T3,9935249,3.692881062494191
DLD-1,54649381,3.965811040267792
BICR 31,54618164,5.999146696375086
MOLM-13,3552672,1.8354180523958712
ALL-SIL,24889392,1.2675997647257198
KHM-1B,24748573,1.6722296150954905
TTC-709,53393127,2.22314211735055
P31/FUJ,5470400,3.6840145170482383
RCC10RGB,68056272,3.770230744947895
ST486,23582824,0.0889691182121087
K-562,135440466,2.878154323162211
U-BLC1,4917,2.392240618126562
KU-19-19,16038120,2.2784541929956563
IGROV-1,969516,2.460805405371151
L3.3,135398516,2.485669059846241
KPL-1,11396600,3.5604078040671796
T98G,24856436,0.8140007129539264
SEM,176870,1.5033295083802505
RERF-LC-Ad1,72193861,4.30689015133483
HuH-6,9907093,3.087441798021952
RCC10RGB,54596490,4.957303932772775
SW48,54618771,0.2213541125267267
SK-LMS-1,2749,1.6237086623457104
SK-CO-1,56963564,-1.3743653333208103
HARA [Human squamous cell lung carcinoma],7326481,3.3732570103291657
BT 248,16725315,3.27587483179283
SK-LMS-1,44607531,1.6255294147035286
SaOS-2,4096211,1.593922478920674
JHUEM-1,3854666,0.8383851323648895
WM115,11317348,4.689716075377342
LCLC-97TM1,ISOX-bortezomib (250-1 mol-mol),0.9661454802906008
EB1,5746,-1.6002842443337284
T98G,1641662,3.763748535462867
LS411N,387447,-3.952629374311597
SK-LMS-1,57519531,3.451677062676746
SK-CO-1,11396600,4.255124433433546
RKO,2828334,5.934464187728916
NCI-H2452,6184667,2.981030320075281
MDST8,119182,-3.087899770061731
NCI-H1568,5282054,2.3545727551586744
SK-OV-3,selumetinib-UNC0638 (4-1 mol-mol),4.410799167981822
HuP-T3,navitoclax-sorafenib (1-1 mol-mol),3.5500030348393667
HARA [Human squamous cell lung carcinoma],56963564,-0.1933628562955875
KMS-21-BM,7326481,1.569280364411962
SEM,1242560,2.9052555910824025
ES-2,654092,-1.5109695276067932
L3.3,72193861,1.4096427828350668
LMSU,36462,2.6264812061116127
KP-3,107970,2.4048716428801677
MOLM-13,5311,-0.2452037316548625
Panc 02.03,119607,6.223236877281167
MKN1,selumetinib-JQ-1 (4-1 mol-mol),4.262768356267428
P31/FUJ,5566,2.621678413077409
RKN,5311281,3.300248210659573
HARA [Human squamous cell lung carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),2.096379077317258
K-562,11152667,-1.0937594737206502
L3.3,4259181,-1.5745308976200183
WM115,241158,3.4880777915567496
PE/CA-PJ34 (clone C12),45279963,3.8312353498990785
HARA [Human squamous cell lung carcinoma],176870,3.342277724847585
SW948,11707110,-5.12001559624384
MKN1,9907093,4.310888781708589
ML-1 [Human thyroid carcinoma],tanespimycin-bortezomib (250-1 mol-mol),-0.335060121238308
EB1,46215462,0.8101100225740934
U-BLC1,6918837,-3.23297696632627
RKO,3503,2.683687073265507
KP-3,25126798,4.021431904538916
BT 248,2871966,0.7814721484275546
DLD-1,JQ-1-vorinostat (2-1 mol-mol),1.264911337366627
SW48,tretinoin-navitoclax (4-1 mol-mol),1.442618908951043
TTC-709,10385095,1.138092247834034
SEM,2742550,2.6060865780770293
HCC15,3081361,2.87617011057776
SW1573,25102847,2.4268351657646874
SW48,24785538,-2.175303706573729
HT-1376,1566236,2.1181506136413635
ST486,208908,1.651873968018778
DLD-1,969516,2.8849327214006397
PE/CA-PJ34 (clone C12),11228183,3.283497353043469
NCI-H2452,5329102,1.9284891088724192
NCI-H1568,56946209,-4.312547212322036
SU-DHL-1,23939,4.934189555353841
IGROV-1,2708,4.438419625543199
COR-L105,JQ-1-UNC0638 (2-1 mol-mol),-0.3865258904960421
T98G,5351362,2.351497844484705
K-562,44489675,3.6585617881709585
SaOS-2,23582824,0.6839328831098858
WM115,1242560,3.734530534800184
BICR 22,89928392,1.801349914013067
TTC-709,24753719,4.2386311491710895
MDST8,375860,-0.0509298762434446
WM115,387447,-5.543981096917634
PaTu 8988t,46215462,1.6929329300119484
SK-CO-1,25150857,2.4521914239487965
RKO,46843906,3.289277038806309
SW48,sirolimus-bortezomib (250-1 mol-mol),0.5064948335670021
SU-DHL-1,3062316,2.138301047480956
LS180,31703,-0.5385699496513472
ES-2,44607531,3.052025453995107
PE/CA-PJ49,carboplatin-etoposide (40-17 mol-mol),1.478939712667842
KLE,3815108,3.3721583314849695
KHM-1B,246676,1.870399937828377
PE/CA-PJ34 (clone C12),9935249,1.3468495063678572
NCI-H1568,54619267,3.44714412714971
NCI-H2452,BRD-A02303741-navitoclax (2-1 mol-mol),3.2540850576086644
SK-HEP-1,5351362,3.433378240202124
Granta-519,119607,5.75770191278477
HCC15,2729026,2.745990777117554
BT 440,4578,5.029067068222703
ML-1 [Human thyroid carcinoma],5746,-1.0436745341015816
MOLP-8,24797083,1.4809895165463562
MDST8,446155,3.7715450651151854
SaOS-2,11317348,2.7618337203443377
SK-LMS-1,11494412,2.2164540785451106
SW948,67156097,-1.6378764151549952
ALL-SIL,448949,0.3821166271144734
SW948,5287620,-5.231918659547503
HCC1500,selumetinib-decitabine (4-1 mol-mol),6.513754829735322
Hep-G2,24951314,0.9482365858167474
U-BLC1,6918878,1.4438083974668092
PE/CA-PJ49,409805,3.747059655038111
RKN,159324,4.081844329649501
SU-DHL-1,6917907,-5.829381256855267
BFTC-909,3825829,4.25128930140834
F-36P,9825149,2.0951004475305055
SNU-1079,24951314,-0.7061142114754362
SK-CO-1,119607,5.49560679798916
LCLC-97TM1,6450551,2.230680139016655
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404
HARA [Human squamous cell lung carcinoma],644241,2.250939574369427
HCC1500,54626689,4.657243866783195
EB1,11977753,-5.358531173821682
LMSU,25150857,3.1228438520338253
IGROV-1,selumetinib-PLX-4032 (8-1 mol-mol),2.802309242721903
KP-3,doxorubicin-navitoclax (2-1 mol-mol),0.4547511598111908
HuH-6,11626560,1.3554055183390228
PE/CA-PJ49,675434,4.546524265845795
IGROV-1,9866186,0.4571266497661056
SNU-626,2708,4.930969216601779
K-562,24772860,-2.920105669473321
SW1573,9956119,4.0915863238100645
YD-15,11625818,3.292582092332551
BFTC-909,5280436,4.2143472852581025
KPL-1,3025944,4.3572034674441795
EB1,piperlongumine-MST-312 (1-1 mol-mol),1.0259725255533882
SK-MEL-2,6917907,-5.896607687827428
BT 248,12003241,-0.5635987052840526
BT 440,2828334,6.4266775607001705
SK-OV-3,5282054,5.04615494272688
YD-15,11404337,-0.8850670977234124
SW1271,24180125,2.511417012575286
KMS-21-BM,6914657,-5.137194312475328
MDST8,doxorubicin-navitoclax (2-1 mol-mol),-1.1540260466133785
ES-2,100016,6.579379467241575
LS180,46398810,2.878388522539818
KHM-1B,5746,0.0152063150708083
SNU-C2A,44185566,2.3804517865994166
JHUEM-1,400769,-0.944803958465317
P31/FUJ,2749,0.384854271149864
NCI-H2452,5281321,-2.0767365956379944
SaOS-2,9927531,5.410264314347966
L3.3,12001922,2.4292832661010557
WM115,156414,1.595819692541897
YD-15,11178236,-3.336493370568514
PE/CA-PJ34 (clone C12),6917907,-5.874012893273867
NCI-H1395,45279963,4.172255756410215
COR-L95,15983966,3.7167583960216897
SU-DHL-1,10322450,2.9485372728674473
ES-2,9935249,3.3722887493761857
HuP-T3,66577038,3.287519898796673
HuH-6,6610355,3.872376092278072
SNU-626,25062766,2.548427400094325
Daudi,6505803,0.7229387165377155
COR-L105,46926350,-4.1614749205792565
SNU-1079,67291369,-1.0949823085446284
JHUEM-1,serdemetan-SCH-529074 (1-1 mol-mol),2.328409674478081
SEM,selumetinib-PLX-4032 (8-1 mol-mol),4.899213225344207
LMSU,44491742,4.063120482610564
HARA [Human squamous cell lung carcinoma],36462,1.692464431977034
MOLM-13,tretinoin-carboplatin (2-1 mol-mol),-0.195663512171335
MDST8,24901704,2.355370692316459
IA-LM,navitoclax-piperlongumine (1-1 mol-mol),0.8087427714288938
NCI-H2452,25126798,3.2665335299764298
ALL-SIL,107985,-3.6188373708521495
P31/FUJ,5738263,2.6277017246063252
U-BLC1,9929138,7.10057481888197
ST486,11497983,-3.842801264452567
HCC1500,2742550,3.2494473825713026
T98G,selumetinib-vorinostat (8-1 mol-mol),4.3337419760383
LCLC-97TM1,54618771,0.7707104681824843
MDST8,3062316,2.63216781392049
K-562,100016,4.034095210213227
NCI-H2452,136227924,3.4253193575490695
IGROV-1,3025986,-1.046010021597061
SUP-T11,44632017,0.3172350077065949
L3.3,285033,-1.389904047242399
IGROV-1,135875424,3.3275053166921347
RCC10RGB,400769,0.8506758933165035
HCC15,44241473,5.510013950441446
SK-CO-1,26596,-2.200264316257102
HCC15,613000,1.6197134073445976
Granta-519,10427712,3.8202730219655496
HCC15,5479543,3.813478020040636
PaTu 8902,135423438,1.708930423466824
SNU-886,53232,-1.4461211490785335
Panc 02.03,24964624,3.328827283539013
YD-15,tanespimycin-bortezomib (250-1 mol-mol),-1.46921905291906
YD-15,selumetinib-navitoclax (8-1 mol-mol),4.5739285886887835
F-36P,2949965,2.03934423775658
KLE,6438330,2.393391106186865
HT-1376,51039095,3.318622563173382
JHUEM-7,navitoclax-gemcitabine (1-1 mol-mol),-2.6519969618816877
EB1,24978538,1.7100822952159975
L3.3,676352,2.5109454639647373
RERF-LC-Ad1,selumetinib-vorinostat (8-1 mol-mol),4.734189741537759
SNU-886,6918736,-1.3372974950718246
LCLC-97TM1,25154868,4.98783448400422
RERF-LC-MS,5113032,4.48589538963195
TTC-709,44241473,4.118831638383191
SK-CO-1,168313016,6.229837204453753
JHUEM-1,JQ-1-MK-0752 (1-1 mol-mol),1.500867811950525
SW1573,9926054,3.1618263718643513
MOLP-8,451668,-1.0880279758209197
Granta-519,doxorubicin-navitoclax (2-1 mol-mol),-4.791758111451553
KLE,24856436,-1.53848530026464
EB1,16219061,1.3642992234274065
SK-LMS-1,selumetinib-tretinoin (2-1 mol-mol),5.22300202696497
SW1271,46191454,0.8015154670027128
IGROV-1,156414,1.4212019235656712
IA-LM,vorinostat-carboplatin (1-1 mol-mol),4.059193114117947
NCI-H1568,11647372,0.9090690740398496
ALL-SIL,JQ-1-carboplatin (1-1 mol-mol),0.1765424524035188
HEL,5394,4.33544579006292
Daudi,23635314,-4.750280690911186
Mino,54626689,2.826693695384345
SK-OV-3,3543504,4.529917197725731
PE/CA-PJ49,16065773,2.3241222859602964
PE/CA-PJ34 (clone C12),24748573,1.6796934908276056
KP-4,6505803,-3.0608028116863464
SNU-886,9927531,4.416743823533711
NCI-H1568,51037431,4.33384460889792
SU-DHL-1,2708,2.612747958759665
SW48,151289,-0.0884278513227002
SW1271,24772860,-2.1080107772753607
SW1271,675434,4.352597318848774
Granta-519,44632017,0.2326960109936577
SaOS-2,11955716,-1.373693500458253
BT 248,2708,3.971792549478314
SNU-C2A,3062316,2.1981551286185774
KU-19-19,159324,4.255883770522122
KHM-1B,9936388,-7.3262126051433425
F-36P,4477,-0.3532860881346318
SNU-886,53392493,1.7509874369346907
SU-DHL-1,4261,-0.6665613942828803
L3.3,135440466,3.532632366582018
EB1,49867930,3.9123226878903625
COR-L105,10302451,1.2881684147693646
IGROV-1,navitoclax-MST-312 (1-1 mol-mol),1.1838863893343448
SNU-1272,11175137,2.9649563467216207
ALL-SIL,4096211,-0.2650943934034739
F-36P,5311,0.420593160532594
IGROV-1,216468,0.5330864756407336
Daudi,46907787,-0.707382985228944
ALL-SIL,11175137,2.2895463411974597
HuP-T3,7326481,3.4338903427833674
SK-OV-3,11626560,2.736987670099794
NCI-H1568,5978,-3.194054905017319
KMS-21-BM,decitabine-carboplatin (1-1 mol-mol),-2.3320922978684813
P31/FUJ,25062766,0.5108470478058419
LS180,4261,0.8191216854939201
SNU-1079,44202524,1.4175154654207651
HEL,71304818,2.1837189642761645
KMS-21-BM,426756,3.6642964075343976
F-36P,11612883,1.2098537814899393
KP-4,selumetinib-decitabine (4-1 mol-mol),6.119216280482745
Ishikawa (Heraklio) 02 ER-,9967941,2.9619779098103427
NCI-H1568,71466445,4.632148673172368
PE/CA-PJ34 (clone C12),56963564,0.4073431502200141
PaTu 8988t,5282054,4.412677005920707
SW1573,54686904,4.039437320121271
YD-15,148198,-2.3396960553231456
RKO,53392493,2.7606647137416616
JHUEM-1,10427712,3.8814474989137473
PaTu 8902,156422,4.606541116596145
T98G,3854666,3.005982982811289
Hep-G2,3689413,1.297693127771037
ST486,5566,2.6211602536986676
COR-L105,54454,1.772071227552003
SK-LMS-1,5329102,2.479505238119822
KU-19-19,9926054,2.3371072555508445
KHM-1B,46191454,-0.9954887816979984
IA-LM,3136844,4.47285753340146
SNU-C2A,2828334,6.329676148195077
Daudi,3854666,0.3283534306514684
KP-3,5281672,6.097432852037508
MDST8,tanespimycin-bortezomib (250-1 mol-mol),-0.1010970299548422
SU-DHL-1,72193861,-0.6645199564816581
SW1573,navitoclax-gemcitabine (1-1 mol-mol),-2.643981149214972
SK-CO-1,44202524,0.5946445627983161
K-562,1750826,1.7671131923879069
LCLC-97TM1,3854666,0.8191923722369518
SK-HEP-1,4477,0.3599343153867445
LMSU,5738263,3.8344484007304063
BICR 31,5282054,4.622453961920413
ALL-SIL,3025986,-1.187507928097146
BFTC-909,3062316,2.03384364484094
ML-1 [Human thyroid carcinoma],135875424,5.514442636506433
RERF-LC-Ad1,46199207,3.6404487316358014
Granta-519,444795,4.599812836973149
RERF-LC-Ad1,262093,3.285321037103647
TTC-709,65628,4.616344803397528
TTC-709,71729975,0.2001824127372914
HT-1376,25150857,3.522932407334297
UACC-812,piperlongumine-MST-312 (1-1 mol-mol),1.224354228260847
Hep-G2,54618164,4.2874336189086115
COR-L95,selumetinib-JQ-1 (4-1 mol-mol),4.793493423716469
RKO,1566236,3.4833841973625725
JHUEM-7,5311281,0.9593410501369758
BICR 31,navitoclax-piperlongumine (1-1 mol-mol),2.358684882853314
LS411N,carboplatin-UNC0638 (2-1 mol-mol),3.912215714956053
RD-ES,25262965,-2.201288484798722
ML-1 [Human thyroid carcinoma],JQ-1-carboplatin (1-1 mol-mol),0.7562453345428342
NCI-H1568,8515,2.0721444777555327
HuH-6,16038120,0.9687329343787526
JHUEM-1,6918837,-3.484647681110818
MOLM-13,24978538,-1.2743594434772367
JHUEM-2,322968,2.35155179173017
SNU-1079,5329102,1.9200365903359484
SW1573,23725625,4.357604161446221
HEL,15953870,2.2428109686656295
EB1,44632017,0.4631747442915667
PK-1,5282054,4.423713404118399
Daudi,52947716,0.9938257746380776
BFTC-909,44259,1.3269924163099676
SUP-T11,crizotinib-PLX-4032 (2-1 mol-mol),1.7157672244430766
ST486,5460769,4.068144147085423
MDST8,selumetinib-UNC0638 (4-1 mol-mol),2.2725517612456416
SaOS-2,6918328,0.1895131607356872
F-36P,11228183,0.9942171182975804
SUP-T11,24889392,3.2631590543255093
HARA [Human squamous cell lung carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),5.192132134204876
NCI-H1568,3503,1.1278876480867208
HT-1376,10410894,4.255989403889385
IGROV-1,72376,-2.111352545322758
SaOS-2,selumetinib-piperlongumine (8-1 mol-mol),3.928507120342424
SK-CO-1,654092,0.6285789884023978
SU-DHL-1,44589607,1.246014317818898
PaTu 8988t,3552672,2.097731757890035
T98G,44185566,3.1454932173030614
HCC15,5282054,3.6050373222028815
HARA [Human squamous cell lung carcinoma],1641662,3.0207416829742058
SNU-1079,702558,4.04579159907986
SK-LMS-1,135999136,4.540087324054403
SNU-886,3634881,3.0881138995018107
WM115,16013152,3.8161355323039
DLD-1,42642645,1.381636603396627
ALL-SIL,54618305,4.365324809283883
SEM,71680916,3.544265140998964
NCI-H1395,72199292,3.1887982930787575
SK-CO-1,25195348,3.743308569883415
BFTC-909,123631,2.8792987518934403
NCI-H2452,25022340,5.0430378131248785
BICR 31,11719255,5.311316415457661
BICR 22,JQ-1-vorinostat (2-1 mol-mol),0.486661425618767
JHUEM-1,53232,4.121841700513565
HuP-T3,568763,0.3762081962980199
SK-LMS-1,11175137,3.0563983886925485
Mino,445643,3.4726395175320612
Mino,100016,3.8828597807205023
PE/CA-PJ49,25062766,2.444834588438787
HuH-6,46907787,2.171713572401701
Panc 02.03,71680916,5.6819891784443595
BT 248,568763,0.252168352363544
SEM,66577038,2.939382481525851
SK-CO-1,44484440,3.788843022204708
HCC1500,60750,4.75355506285403
SK-CO-1,44607531,1.475264767684201
KMS-21-BM,216345,0.3423555551229005
MOLP-8,1317464,4.425962710369034
KHM-1B,24901704,2.862700156831434
BT 248,57330099,3.914766288587865
KMS-21-BM,10113978,1.4540170398900614
BFTC-909,107985,-3.700699007813787
SK-CO-1,3025986,-0.6416687634539443
BFTC-909,44493528,4.370300807083883
T98G,navitoclax-PLX-4032 (1-1 mol-mol),2.808451156778897
SNU-1272,2828334,5.899475603043714
KP-3,6918878,4.298092310764335
SUP-T11,123631,1.8212259562538384
SW48,49850262,3.202043440642355
SNU-1079,675434,4.70836745573517
BT 440,107970,1.846754761569568
HCC15,sirolimus-bortezomib (250-1 mol-mol),2.085701918672026
MOLM-13,5746,-2.6320399073484633
NCI-H1568,36462,0.6787379731584755
EB1,decitabine-navitoclax (2-1 mol-mol),1.3695987759642356
SW48,vorinostat-navitoclax (4-1 mol-mol),1.1280429303528072
Mino,46199207,2.059032191745762
LCLC-97TM1,31703,-1.7062756219896058
KHM-1B,10427712,2.4564060072092486
BFTC-909,54454,2.6967031082973527
BICR 31,5351362,2.0722735669158876
ML-1 [Human thyroid carcinoma],20959075,-2.269435131540743
HEL,3543504,3.6690825601144064
KPL-1,selumetinib-MK-2206 (8-1 mol-mol),4.542045352125904
Ishikawa (Heraklio) 02 ER-,135411,1.0348224013117624
Mino,49766530,-3.2030154452064696
IGROV-1,11178236,-2.8618715106425725
SW48,176870,1.305545107688616
KHM-1B,68056272,3.2538841376284973
EB1,3543504,2.131609194536098
LCLC-97TM1,3062316,0.5973926668956511
HCC1500,6852167,3.541859976914812
MOLM-13,54626689,4.673711949381485
RKO,11175137,2.9264569639519906
SK-OV-3,carboplatin-etoposide (40-17 mol-mol),4.59219202218907
SUP-T11,23725625,5.6335114127389385
BFTC-909,73707398,1.325657316242966
SK-HEP-1,11485656,3.3898088020096324
KMS-21-BM,24779724,5.254342909571376
KMS-21-BM,JQ-1-UNC0638 (2-1 mol-mol),-1.7415773830887826
SW1271,637858,1.8302889918552376
P31/FUJ,151289,0.3376751835645198
MOLM-13,6918289,0.5846893448973186
SUP-T11,6184667,2.5863559977310584
RKO,4096211,2.0568907070726397
KPL-1,969516,4.030965521388465
Ishikawa (Heraklio) 02 ER-,17759555,4.376728261208328
TTC-709,148198,-6.610156845026196
HCC15,42611257,3.545791426903468
EB1,JQ-1-vorinostat (2-1 mol-mol),0.4075997624761452
RKO,51037431,1.443783779144223
PE/CA-PJ34 (clone C12),44819697,-1.5115898426437493
PE/CA-PJ34 (clone C12),89183176,5.81670990965372
ST486,10322450,2.677792904621428
RKN,1716436,3.648262431092988
LMSU,702558,5.700567867563839
U-BLC1,44484893,1.3588663296414674
RKO,216345,4.0768365061219525
MKN1,3689413,-2.0686117581954537
MOLP-8,54454,2.3030156333842533
SUP-T11,16720766,2.7840656787182434
HuP-T3,JQ-1-carboplatin (1-1 mol-mol),1.982980925186552
U-BLC1,decitabine-navitoclax (2-1 mol-mol),0.7918233373315284
SW1271,11719255,2.0964009449704335
SK-HEP-1,5328940,3.1706915881362097
T98G,216468,3.490572719093157
HEL,6914657,-6.908409772348001
LCLC-97TM1,6918878,3.384977217975284
L3.3,44632017,1.809753180552785
SUP-T11,159324,0.229109625943877
HuP-T3,46943432,3.2592232125577665
KU-19-19,11152667,0.8748891502312
MOLP-8,5278396,3.6007551773478093
MOLP-8,71304818,1.8062780808091792
BICR 22,selumetinib-navitoclax (8-1 mol-mol),1.8614529515345275
KLE,navitoclax-MST-312 (1-1 mol-mol),-1.4508493438218537
KLE,1750826,-1.5621795259056923
SaOS-2,5280436,3.62212536353362
SEM,216239,-0.7466305411957983
IA-LM,71751553,4.579394980470846
COR-L95,374536,2.031472802797221
KMS-21-BM,54454,3.600693790198273
HCC1500,1716436,1.6304357372897462
HARA [Human squamous cell lung carcinoma],10385095,1.0837341672046903
SW1271,9967941,4.951865473173475
BT 440,54649381,4.029218777918959
JHUEM-1,3825829,3.769100376137878
KU-19-19,6918837,-3.3861016705907203
KP-3,serdemetan-SCH-529074 (1-1 mol-mol),2.3920415747472537
LCLC-97TM1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.91566117969414
YD-15,4261,1.973465373706541
RCC10RGB,54626689,5.11978438920743
COR-L105,24964624,2.7213287093015848
RERF-LC-MS,10184653,1.661334722418144
COR-L105,9907093,4.049740181744662
WM115,4917,1.7802954819592542
Daudi,25262965,-3.918146889356354
RKN,9926054,2.8101544562472056
COR-L95,969516,2.641832541585458
ML-1 [Human thyroid carcinoma],9868037,3.639883526106939
YD-15,6450551,1.6800422349774025
BT 440,5328940,1.9098458767354272
BT 248,10410894,2.478264779428893
JHUEM-7,135398516,1.61969532142052
PE/CA-PJ49,216239,3.0310910275366663
HuH-6,702558,4.998193795480256
LS180,60700,-0.831384616867798
HCC1500,25062766,2.7449885477672136
PK-1,4521392,4.28209294812531
KHM-1B,11213558,1.7651393697887354
PK-1,selumetinib-UNC0638 (4-1 mol-mol),2.4277583369873956
L3.3,3825829,3.356100526361819
COR-L95,11640390,2.478695805138082
EB1,3025944,3.630085581187154
Ishikawa (Heraklio) 02 ER-,11626560,3.103376247750202
SK-LMS-1,44486219,4.327912998611937
HuP-T3,54618164,3.3933985234085755
SaOS-2,25105715,3.6317688538247968
SNU-626,tanespimycin-bortezomib (250-1 mol-mol),0.974779826853052
YD-15,10427712,3.546012611619452
SW1271,5335621,2.365445027841909
KP-4,6917907,-4.3980947176178775
NCI-H1568,72193861,1.9818580959671683
ST486,969516,2.1075732112776455
HuP-T3,JQ-1-UNC0638 (2-1 mol-mol),1.1921000919454006
SW1573,10385095,0.5068001344623563
ALL-SIL,2841722,3.706104916487932
SUP-T11,25022340,5.170585759008319
P31/FUJ,71466445,3.0287439983851225
IA-LM,JQ-1-UNC0638 (2-1 mol-mol),3.2694867389724744
COR-L105,4917,3.658916006838
DLD-1,439501,-1.8196175209339427
RCC10RGB,9903786,5.708919982977709
HuP-T3,25161177,3.646148401953212
PE/CA-PJ49,252682,6.272416242169432
K-562,71466445,2.3693775657442373
K-562,11977753,-1.2336845020581693
NCI-H1395,5738263,4.098342920501159
LS180,16725315,4.563180557999628
NCI-H1568,66577038,1.9593359628641709
L3.3,selumetinib-UNC0638 (4-1 mol-mol),5.288673066884017
F-36P,erlotinib-PLX-4032 (2-1 mol-mol),3.074743235382559
SaOS-2,3465537,1.5281169625539155
ML-1 [Human thyroid carcinoma],11640390,3.608850000621235
BT 248,11404337,-1.3909400551472375
BT 440,9936388,1.094365580931073
MOLM-13,17755052,0.2343645648969551
U-BLC1,16725315,3.203913385963122
T98G,15547703,4.171686771935748
RERF-LC-MS,67156097,-1.006688958645714
L3.3,4261,2.1698969963780055
YD-15,23635314,-2.7961942846424925
SW948,5470400,-3.941225454290086
KPL-1,3503,4.114073563846199
L3.3,selumetinib-vorinostat (8-1 mol-mol),2.710739742780381
HEL,44185566,1.408371464536178
RCC10RGB,3503,3.522457107356278
BICR 22,9866186,0.6641273098552615
KMS-21-BM,3062316,-0.7688899976975221
T98G,1750826,0.2805061789590832
SK-MEL-2,11175137,3.892112171552428
MKN1,16219061,3.0864982481199896
SEM,148124,-5.566475057371884
K-562,52947716,-5.609155633475852
MKN1,JQ-1-vorinostat (2-1 mol-mol),2.0119822239241274
SaOS-2,1641662,3.0320316508312883
TTC-709,16065773,3.1187017249311126
SW48,5460769,-0.8804369809799648
MOLP-8,11625818,3.354870459420626
KU-19-19,3025986,-0.2897675094370045
K-562,9444,4.095192274458736
IGROV-1,5329102,1.2794664511054334
DLD-1,4259181,0.6000897890539907
LS411N,11427553,2.839596649209722
SU-DHL-1,10385095,0.4695713178913991
SNU-1272,11178236,-2.3936924408182265
SW1573,124202324,3.209850220678193
BFTC-909,2949965,3.0294119536880197
Panc 02.03,44589607,4.606435993835204
LS411N,25126798,4.124739072985443
SNU-1079,ISOX-bortezomib (250-1 mol-mol),-0.6963228452100961
RKN,24785538,4.869460471506453
ST486,piperlongumine-MST-312 (1-1 mol-mol),0.8090024198871936
JHUEM-1,4705,3.281034175975557
SU-DHL-1,31703,-2.5255735182995203
SK-LMS-1,49793307,-2.1486855233456796
KHM-1B,tanespimycin-bortezomib (250-1 mol-mol),-0.3010055650508828
ES-2,tanespimycin-bortezomib (250-1 mol-mol),0.7819342630175604
KU-19-19,6505803,0.0199416611110358
SK-LMS-1,25154868,3.229783914350985
Hep-G2,71466445,2.837099504530813
MDST8,5281672,5.754114909876849
U-BLC1,selumetinib-MK-2206 (8-1 mol-mol),-1.161725835096336
JHUEM-2,24964624,1.55572971761384
PaTu 8988t,9903786,4.140175125497243
KHM-1B,3136844,3.849321357179878
SNU-1272,51037431,3.3764674616808734
JHUEM-7,24821094,2.3762342489012047
SK-CO-1,11717001,2.027201802005241
SEM,9967941,3.0889750042554267
K-562,navitoclax-sorafenib (1-1 mol-mol),1.3368563864105187
HuP-T3,54454,3.567661200928428
MOLP-8,262093,0.615798330418347
F-36P,9933475,1.7265747265427065
SNU-C2A,9915743,0.5240422710487646
SW1573,6918328,0.8267852089643692
LCLC-97TM1,73707398,0.638027637531153
PE/CA-PJ49,25154868,5.401962162415612
SaOS-2,11719255,3.097989779485228
SNU-C2A,387447,-5.308265988306766
PK-1,6505803,-1.4956454507755823
JHUEM-7,25183872,-0.5022360342939903
YD-15,2749,1.4193397500575822
BT 248,42642645,1.464081071598135
SU-DHL-1,73707386,2.8817783064824773
PE/CA-PJ49,SNX-2112-bortezomib (250-1 mol-mol),-2.7085859350472945
HARA [Human squamous cell lung carcinoma],2841722,4.596341456340547
LS180,9915743,2.834892961755663
ML-1 [Human thyroid carcinoma],54143018,-0.4485048931823356
F-36P,11977753,-2.0202080021287743
BICR 22,4578,4.285603675470092
SaOS-2,24951314,1.4499530102948022
RKN,6918328,0.5495182279950256
NCI-H1395,10113978,4.152681883448846
IGROV-1,66577038,3.2148239132520455
KP-3,135984461,4.664901942241971
COR-L105,15547703,4.316721747481802
HCC1500,753704,5.032412058463686
ST486,426756,4.860046482401255
KP-4,1716436,3.507941691131362
JHUEM-7,selumetinib-GDC-0941 (4-1 mol-mol),0.8303698152358163
RKO,44819697,-0.2126149769206573
HuH-6,159324,3.549059872612121
SNU-1079,20959075,-3.4223318112772603
BT 248,44185566,1.9117845458549376
PE/CA-PJ34 (clone C12),9915743,-2.2300833448892985
HCC1500,16013152,3.952751911590144
KLE,6610216,4.690158924143472
SK-LMS-1,445455,4.838165389930102
MKN1,148198,-2.187340578141158
SW948,89183176,3.757757719513151
EB1,6184667,1.6981474747353709
IGROV-1,JQ-1-navitoclax (2-1 mol-mol),1.1306356566784013
ML-1 [Human thyroid carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),3.3397252964004593
ST486,51037431,3.1128641934598114
ML-1 [Human thyroid carcinoma],11427553,2.643507576643823
KHM-1B,54613361,-1.0335550774080653
IA-LM,44819697,3.529669119404179
PaTu 8988t,148198,-4.283282973565046
HCC1500,5287969,-0.1960949732639439
RERF-LC-MS,5460769,5.094680634820597
HT-1376,9911463,4.13018577448945
BICR 22,10113978,3.5652875556244923
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681
LCLC-97TM1,6184667,3.4160200622822736
L3.3,19582717,4.421931624871946
SK-OV-3,44507138,1.930427516054787
SW1271,54626689,4.884226988721356
COR-L105,25195348,2.918205578273492
MOLM-13,49850262,2.0503909100702873
SNU-1079,selumetinib-MK-2206 (8-1 mol-mol),-1.026009574568636
U-BLC1,3025944,6.045119131002454
DLD-1,SNX-2112-bortezomib (250-1 mol-mol),0.2795361668665382
SEM,16736978,3.717756753629991
SNU-886,navitoclax-gemcitabine (1-1 mol-mol),-7.729946623130621
LS180,104842,-3.608354535822108
Granta-519,6184667,3.6411271735359207
SEM,24856436,-2.546648725851104
JHUEM-7,73707398,0.8849918098478027
IGROV-1,49836020,5.658436828096057
JHUEM-7,16038120,-0.0246766201458601
LMSU,salermide-PLX-4032 (12-1 mol-mol),5.363735492393686
HuP-T3,54619267,3.893027602521098
SK-LMS-1,10184653,2.639504364404616
PK-1,66577038,3.0385901284086656
JHUEM-1,10410894,2.4957249337722223
EB1,36462,-1.26198957190765
SW1271,409805,4.993473873943069
SNU-1079,2729026,1.1459648996656209
NCI-H2452,2749,1.5209092727807076
SNU-886,piperlongumine-MST-312 (1-1 mol-mol),1.4218788713745412
MOLP-8,JQ-1-carboplatin (1-1 mol-mol),-0.7588683882378918
U-BLC1,46926350,-4.262471326245694
JHUEM-7,11238147,1.5963726140500234
Mino,24771867,-3.235629712313572
SK-OV-3,119607,5.6958068077620405
Granta-519,JQ-1-navitoclax (2-1 mol-mol),-0.9470910727061151
SU-DHL-1,6184667,2.253300303827536
KMS-21-BM,613753,2.8524647568545713
PE/CA-PJ49,46398810,2.870074478872764
SEM,5566,3.255060505668301
KPL-1,51039095,2.590534473189549
YD-15,25062766,1.3493604416157687
WM115,2871966,2.231269661110087
KP-3,135411,0.6280074036773945
DLD-1,135423438,2.617658821195633
SNU-886,24748573,0.9987877672847516
SK-HEP-1,219104,4.349330089087446
SW948,selumetinib-piperlongumine (8-1 mol-mol),0.6665506156446188
PE/CA-PJ34 (clone C12),44202524,1.483466179088964
KP-4,25154868,4.218317877549878
KLE,119607,4.152483536976257
SW48,8515,2.6507036204950256
MOLM-13,241158,1.7093626682651633
RCC10RGB,71576739,5.1028364410536735
EB1,24180125,1.0511946414672848
LS411N,54619267,4.196494516067777
Panc 02.03,637858,2.766769284687194
JHUEM-1,53392493,1.7235556473428677
P31/FUJ,25150857,2.053516150415863
U-BLC1,5351362,1.1872796004171695
P31/FUJ,24951314,0.294555023880993
L3.3,119607,5.267929584666067
SU-DHL-6,16736978,-0.092754907722646
RKO,151289,1.190219151105647
NCI-H1568,1716436,2.664872339798973
PK-1,11955716,-2.415862673421003
SK-CO-1,doxorubicin-navitoclax (2-1 mol-mol),-2.167378618505947
LCLC-97TM1,49836020,1.9924259842665932
HARA [Human squamous cell lung carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),1.441529788664552
HARA [Human squamous cell lung carcinoma],44137675,4.310894105428011
SW948,11647372,1.3621251009964823
SNU-886,49793307,-1.2846012118525447
SNU-1079,46398810,1.203329401927461
DLD-1,4477,0.8542141748947512
LCLC-97TM1,selumetinib-UNC0638 (4-1 mol-mol),3.547341579124928
LCLC-97TM1,56963564,-0.6229750501206363
IGROV-1,11427553,2.926316692603687
T98G,navitoclax-gemcitabine (1-1 mol-mol),-0.5590017564151127
TTC-709,selumetinib-UNC0638 (4-1 mol-mol),3.784777147367987
HARA [Human squamous cell lung carcinoma],54618305,5.079823174852019
F-36P,23582824,0.7691750448344935
SW48,24951314,0.6660870475429757
RCC10RGB,46398810,2.467266718263722
NCI-H1568,16720766,0.7309820541773976
TTC-709,navitoclax-gemcitabine (1-1 mol-mol),-4.318015077899847
F-36P,11167602,2.0610720557550755
K-562,decitabine-carboplatin (1-1 mol-mol),4.43725246072026
PK-1,387447,-3.905660984584684
HCC1500,6918878,3.8452122267855544
KPL-1,11626560,2.0080436440934126
MDST8,JQ-1-navitoclax (2-1 mol-mol),0.0958031568177067
SNU-626,44202524,4.1755024610786995
Ishikawa (Heraklio) 02 ER-,3025944,4.346382559998423
TTC-709,6918878,3.4254822690463116
BFTC-909,BRD-K27188169-navitoclax (2-1 mol-mol),3.3946327784578245
NCI-H1568,9840324,5.648333485386012
SaOS-2,24772860,-2.2454069761524416
NCI-H1568,12003241,-1.4870303892505918
SK-MEL-2,31703,0.7114191518361959
YD-15,5351362,0.4733781899705013
HuH-6,53392493,2.157264075757482
EB1,3689413,-2.432787849324627
EB1,2729026,1.7822006488511937
IGROV-1,135411,0.626702113064729
T98G,5278396,3.3897154576656248
SU-DHL-1,123631,2.2104669936854817
KP-3,11214940,1.020152445144494
SNU-1272,3038522,4.319393949707529
KMS-21-BM,15547703,2.5589044262317224
BICR 31,676352,2.5344425849235472
SEM,49867930,5.348327492184154
WM115,2828334,5.840169576442124
JHUEM-1,60750,-4.239802135047818
BICR 31,16722836,0.993439631718574
LS180,71304818,2.5144465721497573
U-BLC1,11977753,-1.8237492362866947
JHUEM-2,54618164,4.173544512136638
HCC15,176870,4.3801450304989835
KP-3,72193861,-0.2586612801583873
Mino,navitoclax-sorafenib (1-1 mol-mol),-2.8547610519419098
SaOS-2,44137675,2.8908105588075537
SW48,57519531,1.1891467216952898
KHM-1B,36314,1.0802720035135625
LCLC-97TM1,46943432,0.977611384475134
Ishikawa (Heraklio) 02 ER-,sirolimus-bortezomib (250-1 mol-mol),0.8957919072189129
JHUEM-1,2733526,4.169773668941837
PK-1,23725625,5.882185959935775
JHUEM-2,24771867,-3.419304338864635
SNU-886,24771867,1.589817907725939
SK-LMS-1,89928392,1.5380179268332728
LCLC-97TM1,selumetinib-tretinoin (2-1 mol-mol),4.0009002077883755
Mino,23582824,0.1492971367341559
KMS-21-BM,JQ-1-vorinostat (2-1 mol-mol),-2.033759741606474
MOLM-13,alisertib-navitoclax (2-1 mol-mol),-6.0299100304654365
BT 248,135659046,3.5168747963796636
PE/CA-PJ49,1242560,3.3811009298853083
SEM,3081361,1.342967789482049
KMS-21-BM,11427553,1.1734795501235116
KPL-1,3465537,2.5185436279370896
EB1,JQ-1-carboplatin (1-1 mol-mol),1.505411442976691
JHUEM-7,57519531,2.2164320410194063
SEM,9933475,1.6595519600408728
SNU-1079,19582717,1.928511127432967
PE/CA-PJ49,25102847,1.7536968430646858
UACC-812,52912189,-0.0403441295384107
HEL,638278,3.1804055556137394
ML-1 [Human thyroid carcinoma],135440466,2.0685655954708824
UACC-812,45279963,4.1756281682233185
YD-15,2729026,2.7742552764731316
MDST8,12001922,2.1068751805520423
L3.3,navitoclax-sorafenib (1-1 mol-mol),2.85899880302019
HuP-T3,11626560,2.4663043755994094
SK-MEL-2,4261,1.376400806242365
NCI-H1395,11238147,4.343547830393109
KP-4,vorinostat-navitoclax (4-1 mol-mol),2.553754020508292
HCC15,9884685,1.2743229964902805
Daudi,82146,3.751797413920901
SK-LMS-1,9549297,1.617547275845102
HT-1376,vorinostat-navitoclax (4-1 mol-mol),2.3261884560245263
IGROV-1,vorinostat-carboplatin (1-1 mol-mol),2.9918987847321645
BICR 22,969516,2.807563254821311
RKO,6917907,-7.36544436443182
LCLC-97TM1,BRD-A02303741-carboplatin (1-1 mol-mol),3.5226633114065407
TTC-709,44202524,1.3250865867864958
KMS-21-BM,3136844,3.136423422815638
KP-4,25195348,2.4820805966357034
P31/FUJ,54649381,3.661627004097492
P31/FUJ,15983966,-4.570279214878008
COR-L105,49793307,-0.7736136433109717
Hep-G2,89928392,3.967748323767258
HARA [Human squamous cell lung carcinoma],107970,2.425047737070786
YD-15,11175137,1.7484730549569507
TTC-709,JQ-1-carboplatin (1-1 mol-mol),1.695991072597723
DLD-1,5329102,2.955526044943588
SK-CO-1,57330099,5.774767561552264
JHUEM-7,doxorubicin-navitoclax (2-1 mol-mol),-2.086233890960524
JHUEM-2,67156097,-2.3174140693759537
SEM,135659046,3.5193041881341087
KP-4,erlotinib-PLX-4032 (2-1 mol-mol),3.77182029997156
SW48,navitoclax-gemcitabine (1-1 mol-mol),-2.8390563906078543
Daudi,36462,-1.782907247885185
HuH-6,tanespimycin-bortezomib (250-1 mol-mol),0.4881830883702249
HuH-6,23582824,1.0492346525145273
KP-3,44489367,4.890538998734305
SW1271,10077130,5.262255440725952
PaTu 8902,124202324,2.5191853508509823
EB1,136227331,3.874508283981952
SW1271,4261,2.1417567232825157
SW1271,568763,-0.4148311333850545
IGROV-1,44185566,2.2104732991243248
DLD-1,piperlongumine-MST-312 (1-1 mol-mol),2.100764967443581
PaTu 8988t,piperlongumine-MST-312 (1-1 mol-mol),1.7723365960000816
RERF-LC-MS,54678924,1.4734481784853186
LMSU,11455910,2.490355648913592
SW1271,17759555,2.4829827438054104
HCC1500,2871966,-1.8945265193529464
RCC10RGB,119607,6.074674808773517
MOLP-8,5566,2.8349074996791295
K-562,24901704,1.0460453676907424
Mino,753704,3.5464865657469753
SK-LMS-1,439501,-2.6023396475730967
SK-OV-3,44607530,2.4027946355264507
SNU-886,49846579,-0.4717946703025019
IGROV-1,44589607,3.0909001492794377
SU-DHL-1,44185566,1.07324922266726
MOLM-13,navitoclax-gemcitabine (1-1 mol-mol),-4.310291489660192
DLD-1,24964624,3.348601740544858
SaOS-2,42642645,-0.01972406793895
RERF-LC-Ad1,219104,4.500436139497514
SaOS-2,327653,4.165382989627235
HT-1376,2828334,6.78635347464091
SK-MEL-2,54618164,3.880613274058296
T98G,11977753,0.0293140881619223
RERF-LC-MS,44491742,4.380479941679622
EB1,2749,-0.5675955976756072
Granta-519,navitoclax-gemcitabine (1-1 mol-mol),-5.4729921992931665
K-562,3038522,1.918387146447148
HuP-T3,702558,5.633624519144866
YD-15,11497983,-2.4142920782844826
JHUEM-7,selumetinib-UNC0638 (4-1 mol-mol),6.50365850141335
ALL-SIL,2858523,2.9846374491002376
KHM-1B,3081361,2.464663283347417
WM115,44589607,3.0632481185375933
LCLC-97TM1,11977753,-2.2409153175434953
Granta-519,7251185,1.138949301849667
ES-2,135398744,8.06870751291861
HuH-6,73707386,2.841389478245076
MOLM-13,446155,1.5984418257641329
SW1271,11455910,0.4702460968788743
WM115,10184653,1.7306018843706388
PE/CA-PJ49,31703,-1.3164543555016257
SW1271,12003241,-1.4062779923685875
SK-LMS-1,11222830,1.0823072578010553
Mino,24772860,-3.581741223453769
T98G,4096211,2.5216058170986986
SU-DHL-1,3038522,3.3518104703058467
RERF-LC-MS,44819697,-0.3406635094896507
SK-LMS-1,446155,0.540245442261307
SNU-1272,441298,1.7337519477990695
SW948,tretinoin-navitoclax (4-1 mol-mol),4.012168549649723
SK-OV-3,piperlongumine-MST-312 (1-1 mol-mol),2.5779047815349627
BT 248,969516,3.2750512548532136
RERF-LC-MS,3825829,3.876424055067748
SU-DHL-1,208908,2.168834483257838
COR-L105,4378219,1.9356703916494296
SU-DHL-1,44489675,4.002710700308593
BICR 31,5329102,1.5123342757929257
U-BLC1,16219061,2.7930616302935265
BICR 22,72193861,1.1787223619968317
SK-CO-1,4259181,-0.2853622975740302
RKN,5278396,4.050807510430523
LMSU,24964624,3.0894427581884334
LS411N,3543504,6.407278726964401
Granta-519,2749,-0.6711865738648753
LCLC-97TM1,11222830,0.9756157307321038
HCC1500,49766530,0.4188049276678212
BICR 31,24821094,2.272776200428542
BT 440,65064,5.397133668570251
LS411N,15953870,3.79326986504028
HuH-6,644241,1.7181445887888465
T98G,54618771,1.1759260656480666
Ishikawa (Heraklio) 02 ER-,SNX-2112-bortezomib (250-1 mol-mol),-1.5625671079019574
KU-19-19,15547703,3.5460273004695364
KMS-21-BM,5281321,-3.4577848795154136
IGROV-1,10410894,3.2660402181528263
SK-HEP-1,9936388,2.725726666175631
PK-1,5287969,-1.7578644158840964
SU-DHL-1,68056272,2.8441937668208297
SNU-C2A,51037431,5.792859795029561
BICR 31,107970,2.625018410874988
RCC10RGB,24978538,2.2083570886635258
MOLP-8,42642645,0.4027543307161444
IA-LM,6438330,0.5920782597943414
HCC1500,25102847,3.871994319987046
SK-CO-1,9903786,1.8148473241522671
BT 248,25161177,3.821794472212993
SK-HEP-1,51037431,1.9503987957256583
U-BLC1,9933475,1.3290246407177366
SU-DHL-6,15547703,1.663295720719241
PaTu 8988t,42642645,1.5127014290808742
Daudi,4578,4.14840859618435
HEL,73707398,1.0006953763352662
RERF-LC-MS,3634881,4.923247717838372
HCC15,9907093,4.55737056946543
NCI-H1395,448949,2.6579762505133915
ES-2,984333,0.2394982079698159
SNU-886,446155,-1.7757385621733988
IGROV-1,16725315,4.890680859998698
RERF-LC-Ad1,44589607,3.7662280805427097
Hep-G2,53392493,3.106454846806137
COR-L105,navitoclax-PLX-4032 (1-1 mol-mol),0.9673135251369994
COR-L105,107970,2.936160881286492
PaTu 8902,11485656,3.4031855994132663
SNU-626,alisertib-navitoclax (2-1 mol-mol),-0.1323727817766557
BICR 31,5287969,-2.0848564793948423
SU-DHL-1,3503,1.2104794697541517
KP-4,24180719,5.26371468545235
Ishikawa (Heraklio) 02 ER-,6914657,-4.4920284110068005
PE/CA-PJ49,16722836,1.703221716045444
WM115,selumetinib-MK-2206 (8-1 mol-mol),-1.676879875544035
RCC10RGB,107970,3.009214725762471
KU-19-19,51039095,3.4730458815699743
SNU-1079,409805,6.036263178854899
KU-19-19,selumetinib-MK-2206 (8-1 mol-mol),2.230752575212941
IGROV-1,16038120,0.2864038103759729
P31/FUJ,selumetinib-UNC0638 (4-1 mol-mol),1.8703414483738705
PE/CA-PJ49,decitabine-navitoclax (2-1 mol-mol),3.184287268918302
SK-OV-3,1323703,3.751791158325908
TTC-709,11609586,2.1516974193557683
K-562,JQ-1-MK-0752 (1-1 mol-mol),2.296423482837328
LS180,56946209,-4.291807545115399
BICR 22,16741245,4.124711805224883
Granta-519,11396600,3.399615682634249
JHUEM-1,44486219,4.194790750953707
U-BLC1,3825829,4.042251798693961
LMSU,3552672,1.9414918603747835
L3.3,11964036,1.0452508880612652
LCLC-97TM1,4378219,2.0431586025336332
COR-L95,piperlongumine-MST-312 (1-1 mol-mol),1.3307800151979865
PaTu 8902,3062316,3.1999770976977966
ST486,613753,2.206902520176508
MOLM-13,9825149,-0.4975121245832732
LMSU,tretinoin-navitoclax (4-1 mol-mol),4.538664740757784
PaTu 8988t,36462,2.8739750906545263
WM115,4261,1.0617223830766982
L3.3,11175137,3.713617877823204
T98G,7326481,1.8509027031177303
BICR 31,54618771,0.3365869204450262
IGROV-1,6918837,-2.9804518885508635
TTC-709,71466380,3.4432328009154856
SK-CO-1,49850262,4.729060483840123
NCI-H1568,selumetinib-MK-2206 (8-1 mol-mol),2.137801357231392
SEM,decitabine-carboplatin (1-1 mol-mol),-2.5558539092772947
U-BLC1,676352,1.6497259951684045
MKN1,5311,1.888440844382256
SK-CO-1,49793307,-2.625714785229563
ALL-SIL,159324,0.7144692186053382
EB1,54143018,-0.0623430882604959
BICR 22,tanespimycin-bortezomib (250-1 mol-mol),-0.7202446559484896
DLD-1,11228183,1.2866025970218224
JHUEM-1,148198,-4.791795021050916
MKN1,2130404,2.834663158096979
RERF-LC-MS,24821094,3.899392046553833
PK-1,2858523,3.363949651087782
KPL-1,654092,2.372810826307559
NCI-H1568,selumetinib-decitabine (4-1 mol-mol),4.70224066359239
ALL-SIL,54613361,-1.2150310590443698
MDST8,54618771,1.2096098448968695
MOLP-8,26596,-2.4791577040777812
RKO,4788,5.372325515812119
Hep-G2,168313047,1.9779091798447304
F-36P,68056272,3.219612539659415
P31/FUJ,44589607,2.3901798108348533
SK-MEL-2,46398810,3.573271637439445
SK-OV-3,613753,3.56222269809742
SW1271,navitoclax-sorafenib (1-1 mol-mol),2.5597569107989457
Hep-G2,25126798,4.0487954098404755
SNU-886,123631,3.0273089025763817
SW1573,2858523,3.1892649395611556
SNU-C2A,carboplatin-etoposide (40-17 mol-mol),3.6322858176327686
LS180,72193861,-0.0461725132802377
JHUEM-2,56946209,-4.962335197785937
RKN,25126798,3.956068538327861
EB1,3825829,2.349268822943128
MOLM-13,6917907,-6.412365954060792
WM115,50905018,4.954075896774319
HCC1500,54619267,3.954111090910006
IGROV-1,6252,1.1284141516966473
Granta-519,49766530,-2.591856607816134
TTC-709,44507138,2.2838528804729363
RKO,400769,-0.364727826621167
SaOS-2,5113032,4.015669070835574
SNU-886,6918837,-1.8312241518150647
Mino,erlotinib-PLX-4032 (2-1 mol-mol),1.582344585689073
SEM,4378219,1.9889519046071171
MOLM-13,JQ-1-carboplatin (1-1 mol-mol),-1.1937671788026978
SK-MEL-2,9933475,2.361600620643174
SK-MEL-2,15547703,2.9186281854193545
HuH-6,navitoclax-birinapant (1-1 mol-mol),2.6991365022878044
SUP-T11,54686904,2.383375872182293
BICR 31,400769,0.3553213589698107
HARA [Human squamous cell lung carcinoma],16720766,-0.0810608938508249
MOLP-8,JQ-1-navitoclax (2-1 mol-mol),-1.8736660374722776
RKO,24901704,3.90150667551114
K-562,675434,4.134192231732703
F-36P,151289,0.0975773513046307
PaTu 8902,vorinostat-carboplatin (1-1 mol-mol),3.3056109148195936
U-BLC1,8515,3.4266677281329843
KP-4,16722836,2.23507470757676
IGROV-1,60700,0.4424479122017752
RERF-LC-MS,439501,-1.3704502050640626
LMSU,24771867,2.7605292141618945
PaTu 8988t,3081361,3.3861147832051004
PaTu 8988t,11507802,1.1782523393568187
RKN,25154868,3.091821445991922
SK-HEP-1,3384730,4.617019540739567
SNU-C2A,72734382,4.575118142213228
JHUEM-7,135421197,2.2083604774336973
KP-4,6918289,2.3270563261529276
IGROV-1,135411,0.626702113064729
PE/CA-PJ49,1750826,1.990183315257249
KHM-1B,44491742,4.066156285625521
LMSU,322968,4.855851656802344
RKN,44202524,1.6880658914716755
MDST8,10127622,1.4568360900186117
U-BLC1,123631,-2.3036259822035183
ALL-SIL,5978,-4.2912860791141725
BT 440,54678924,3.3882254238972425
LCLC-97TM1,25195348,3.14182472834864
MDST8,navitoclax-piperlongumine (1-1 mol-mol),-0.5700737020348542
HT-1376,vorinostat-carboplatin (1-1 mol-mol),3.559402453847487
JHUEM-2,25150857,2.1264883565954196
MOLP-8,2949965,2.304667717892232
IGROV-1,alisertib-navitoclax (2-1 mol-mol),1.5599487267475047
T98G,54618164,4.528778720409905
NCI-H2452,11485656,2.991875358712002
Panc 02.03,2708,5.654354843286421
F-36P,57519531,2.8558433563561247
T98G,2828334,5.87096497496934
SNU-886,5284616,2.6710721615639765
PE/CA-PJ49,44819697,0.1954599537080359
SEM,676352,1.684382877039761
ST486,568763,-1.111562986931813
KHM-1B,11234052,4.09724714531712
KMS-21-BM,44489367,4.17704374385352
NCI-H1395,11222830,1.7032197933937347
SNU-886,42611257,3.550012838833151
Mino,23939,5.8661621140675795
SaOS-2,15953870,3.7774839542606617
F-36P,selumetinib-UNC0638 (4-1 mol-mol),0.7530896389049895
LS411N,11238147,4.220683195687341
WM115,selumetinib-vorinostat (8-1 mol-mol),-1.5219389321344234
SNU-1272,6252,5.637284212439003
KP-4,24901704,1.8878672874550328
COR-L105,11404337,0.9270352493146456
RKO,20959075,-2.9107192765247536
MKN1,5280436,3.573087646417543
BT 440,17755052,2.1719185930178377
IGROV-1,452548,0.0422661560146271
SW1271,25062766,1.8071163488926476
PK-1,2749,2.298639610035574
BT 248,5284616,2.1714532824885473
SUP-T11,25102847,2.472099534545954
SK-OV-3,24180719,3.148638094054939
SUP-T11,1242560,3.494933472022299
KMS-21-BM,176870,4.610879926817575
SNU-C2A,navitoclax-gemcitabine (1-1 mol-mol),-2.229591183337276
SNU-1079,374536,1.7363083886043131
NCI-H1395,5311281,3.3268012915389047
SNU-1079,BRD-A02303741-navitoclax (2-1 mol-mol),1.7771019315839651
KMS-21-BM,54619267,2.4013385163915086
DLD-1,24978538,0.8723907873610822
IA-LM,doxorubicin-navitoclax (2-1 mol-mol),-0.2967430289420483
MDST8,sirolimus-bortezomib (250-1 mol-mol),1.3453299631576727
U-BLC1,6610216,4.090780023293868
SNU-1272,1750826,-1.393591916045707
SNU-886,51037431,2.211047490267374
Daudi,selumetinib-PLX-4032 (8-1 mol-mol),4.542051250808824
NCI-H2452,25150857,3.315566378385427
P31/FUJ,carboplatin-UNC0638 (2-1 mol-mol),3.2617545834686155
HT-1376,66577038,5.1275847730855295
JHUEM-7,6918328,0.5362707723228177
LS411N,216239,2.6090534487015953
SW948,2828334,6.27053385486612
HEL,25262965,-1.9607005706581808
SK-HEP-1,46398810,3.2056962377986333
NCI-H1395,54626689,4.483963070109989
KP-4,2828334,6.089733529975997
JHUEM-1,11647372,0.9364560859330836
P31/FUJ,46191454,0.7861082656977861
SNU-886,5311,1.5331540985514145
SaOS-2,11404337,-0.7935370479535776
LS411N,6918878,3.507421995092854
PE/CA-PJ34 (clone C12),4521392,4.437675700379316
ES-2,135411,0.5422018773217715
COR-L95,5566,3.0030322186541754
NCI-H1568,2729026,2.4592472427928795
HuH-6,613753,3.092837123472884
Granta-519,5566,3.1418180472473023
SNU-1079,24785538,1.3187748051686408
T98G,25262965,0.12598497107093
SW948,15953870,3.980690301912255
PK-1,piperlongumine-MST-312 (1-1 mol-mol),2.6845179509094548
SNU-1272,445091,5.878277369278403
IA-LM,selumetinib-navitoclax (8-1 mol-mol),1.3709865001695822
U-BLC1,9915743,-4.280634530876826
SaOS-2,tanespimycin-gemcitabine (1-1 mol-mol),-1.7775872222613356
COR-L105,decitabine-navitoclax (2-1 mol-mol),1.4499610580472069
PaTu 8988t,4096211,4.042256121680771
HCC15,638278,3.5096393014384346
LS411N,44185566,2.59688005994845
WM115,15547703,2.53174585982074
BT 248,53481919,4.127258509947241
LMSU,5978,-1.3012469579809125
SK-MEL-2,439501,1.1166422747690987
PE/CA-PJ49,5284616,3.20238900002261
RERF-LC-MS,46907787,3.883745984979501
SNU-886,10074640,3.87726874978677
F-36P,54678924,1.179428459556987
RERF-LC-MS,49793307,-1.4864117200972382
LS411N,6918837,-3.511331359252859
HEL,2729026,2.9938268289747394
SNU-1079,5311,-2.2648239286853142
SU-DHL-1,9911830,2.4926956672938543
RKO,6505803,-0.9276151073099124
Hep-G2,135875424,4.631021258019282
HEL,5351362,1.012542471793317
KLE,24978538,-2.416214785508645
LMSU,1566236,2.090789851327695
JHUEM-1,136227924,2.224041693066133
SW48,448949,2.118847083295334
BT 248,44607531,1.181861447118321
BT 248,9825149,2.247604687491298
JHUEM-2,2945648,2.2874490799496794
LS411N,3854666,3.592971008902542
F-36P,5351362,0.9986608253109048
PE/CA-PJ49,4261,1.1092622946797217
SK-MEL-2,ISOX-bortezomib (250-1 mol-mol),0.2286395369927496
Daudi,55283,2.1333092426313143
WM115,568763,0.4176363376103466
T98G,tanespimycin-gemcitabine (1-1 mol-mol),0.2357141160782361
JHUEM-2,31703,-4.11122124935784
ALL-SIL,JQ-1-navitoclax (2-1 mol-mol),-1.241318632460125
Hep-G2,sirolimus-bortezomib (250-1 mol-mol),1.7771755554565365
K-562,54143018,0.8143265967368298
ST486,216345,2.7015515398936016
WM115,6914657,-1.139050920215431
BICR 31,JQ-1-navitoclax (2-1 mol-mol),1.1041257622460865
SK-MEL-2,25227462,1.768371088261411
ML-1 [Human thyroid carcinoma],24821094,3.2142530929148982
Daudi,57519531,1.0816397392331083
MDST8,9840324,7.1320098113776185
SNU-1272,25195348,5.361331640653284
Ishikawa (Heraklio) 02 ER-,crizotinib-PLX-4032 (2-1 mol-mol),3.4065147100518542
SNU-626,46191454,2.237302364567475
ML-1 [Human thyroid carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.127776457092234
PE/CA-PJ49,11609586,3.094343334038443
YD-15,676352,2.6205472044073304
NCI-H2452,67156097,-0.4931697978204585
SNU-C2A,3689413,1.145907285408548
ALL-SIL,11507802,-0.6218585688390301
SNU-C2A,2742550,4.524601558141107
JHUEM-2,2841722,4.72540004520427
KP-3,selumetinib-MK-2206 (8-1 mol-mol),3.711369070858268
KLE,9927531,4.8057879583658405
MOLM-13,9926054,0.378361077880871
LCLC-97TM1,676352,2.332754642745106
JHUEM-7,65064,5.3351573700269
PK-1,10184653,1.1149878396902146
SW48,6450551,-0.0066484474606689
LS411N,tanespimycin-bortezomib (250-1 mol-mol),-0.7094268710043169
MDST8,vorinostat-carboplatin (1-1 mol-mol),3.0562610561977004
F-36P,52947716,-5.789736160824408
ML-1 [Human thyroid carcinoma],53232,3.218931075380609
KU-19-19,46191454,1.4474607873871597
BICR 31,135440466,1.3506373291640237
JHUEM-1,11234052,4.027814271460456
SW948,44632017,0.8619787858061628
ES-2,vorinostat-navitoclax (4-1 mol-mol),1.770361156245962
NCI-H2452,159324,4.677055932941875
SNU-1079,262093,2.756274169770221
KHM-1B,46943432,-0.0724756226448156
WM115,60700,0.0008203329731028
JHUEM-2,327653,2.730949132575015
HuP-T3,selumetinib-navitoclax (8-1 mol-mol),3.027921751084016
RKN,9936388,2.306220468641662
MOLM-13,2945648,3.0282797197343374
SNU-886,71304818,2.0640703956829003
P31/FUJ,135875424,3.622681212031297
HT-1376,448949,2.4463630975649866
SEM,49836020,0.2207243584754971
LS180,navitoclax-gemcitabine (1-1 mol-mol),-2.7206195218400007
Mino,445091,3.8337639981682297
BFTC-909,24964624,2.4776408698208003
HCC1500,3825829,4.205963950909598
KP-3,23635314,-2.586840709278856
P31/FUJ,selumetinib-MK-2206 (8-1 mol-mol),-0.6510792771612892
PE/CA-PJ49,16725315,3.2704146260359335
SU-DHL-1,135984461,1.9491307161872016
NCI-H1568,409805,3.8387714265583592
U-BLC1,24180125,2.445144330165959
COR-L95,2945648,2.3261820103406183
SEM,carboplatin-UNC0638 (2-1 mol-mol),2.079018969490806
U-BLC1,9952709,2.617971040599899
LS180,selumetinib-tretinoin (2-1 mol-mol),1.4682365811163622
IGROV-1,5746,1.9055212643377857
LMSU,9933475,1.3920899137371403
BICR 22,selumetinib-decitabine (4-1 mol-mol),2.485402962452582
HCC1500,104842,-2.1208898309536073
IGROV-1,148198,-2.659972993252853
ML-1 [Human thyroid carcinoma],4259181,0.3770562232502641
Mino,25195348,1.65866400673103
SUP-T11,72734382,3.751276918161004
K-562,crizotinib-PLX-4032 (2-1 mol-mol),0.2702262717922032
JHUEM-7,54618164,3.823825423336211
T98G,24180125,5.608131007588369
U-BLC1,148124,-4.12148794810048
IA-LM,5746,4.310443233142937
ES-2,24771867,1.680683877003192
WM115,10427712,3.357641117907952
WM115,31703,-1.493876478932265
JHUEM-2,54143018,-1.6137330556601197
F-36P,3854666,-0.4499689748762866
K-562,10296883,3.719487542859837
UACC-812,JQ-1-navitoclax (2-1 mol-mol),2.277260275544626
SW1271,selumetinib-BRD-A02303741 (4-1 mol-mol),1.6288124556214316
IGROV-1,10184653,0.79276129336756
K-562,5287969,-0.8630520858269013
MOLP-8,148198,-4.437033387624053
BICR 22,navitoclax-gemcitabine (1-1 mol-mol),-3.257857035264034
L3.3,71304818,3.108733273598676
BICR 31,24951314,2.26082148142024
U-BLC1,JQ-1-navitoclax (2-1 mol-mol),0.2047391554782706
COR-L95,9887053,2.0711365362831193
KLE,9936388,-3.639802417260702
SK-CO-1,2841722,4.495379043063509
COR-L95,54618164,3.8157010413732406
ML-1 [Human thyroid carcinoma],107970,2.5074769228196025
SaOS-2,25262965,1.6840235781335875
SNU-1272,446155,4.168307414617033
KPL-1,322968,4.892694188029653
MDST8,25150857,2.921484336528134
T98G,24785538,2.8747492411779945
SK-HEP-1,984333,0.8474815446030621
PE/CA-PJ34 (clone C12),12003241,-0.6178639171957262
COR-L105,5311037,4.270584574919318
SUP-T11,44197249,4.2195322273667495
P31/FUJ,selumetinib-navitoclax (8-1 mol-mol),-1.1281624183387444
ST486,12001922,0.9282775976329514
LCLC-97TM1,3825829,3.858617243526108
SK-OV-3,24951314,1.413681041410239
NCI-H2452,9903786,2.1501841215173396
PaTu 8902,56963564,4.5637436248697565
L3.3,44202524,1.4046743198353957
MKN1,2708,5.004720090270962
SaOS-2,262093,2.7398792490382244
HARA [Human squamous cell lung carcinoma],4788,5.847017929418924
BICR 31,3854666,2.26793763186435
SK-OV-3,15953870,4.452396287203901
HuP-T3,serdemetan-SCH-529074 (1-1 mol-mol),2.447475280373413
KHM-1B,445455,4.826586800965752
PE/CA-PJ34 (clone C12),24856436,0.073315127978312
BICR 31,24785538,2.8976650742045127
HuP-T3,9903786,4.0743016574038915
Granta-519,11175137,2.0306520437568767
Granta-519,25105715,3.663648488967505
NCI-H1568,49867930,4.553956635433513
HCC1500,16038120,1.5738549040879308
TTC-709,5280436,3.1596543913087145
JHUEM-2,5281321,-0.0946614607868494
SNU-C2A,51039095,2.8159687207177635
LCLC-97TM1,227681,3.759896348853487
BFTC-909,49867926,6.076136735210805
ALL-SIL,5278396,3.0589186731365814
L3.3,2729026,3.1026966432102863
HCC15,2742550,3.2685764522673972
SUP-T11,2828334,5.4316176762639605
SNU-626,9936388,2.473476131438239
JHUEM-1,11427553,2.920394245022016
RERF-LC-MS,44486219,4.018485879154908
T98G,selumetinib-decitabine (4-1 mol-mol),5.6785911737751915
JHUEM-1,2130404,3.8284162327534146
RERF-LC-MS,462382,0.9319597157341816
SK-MEL-2,66577038,3.333852219359522
SK-CO-1,selumetinib-UNC0638 (4-1 mol-mol),-0.0758878647184332
SW1573,3854666,2.927116287337192
U-BLC1,JQ-1-vorinostat (2-1 mol-mol),0.8881979131356286
KP-4,24772860,-2.8953644342348683
EB1,10427712,3.6063264564826256
Daudi,9935249,-0.0031627785077317
YD-15,216345,4.157315811109778
LMSU,135398744,6.91211293627059
MOLM-13,10231331,1.9024628033326092
SaOS-2,6918837,-2.9214939411920593
HCC1500,11507802,0.960722132601806
WM115,doxorubicin-navitoclax (2-1 mol-mol),-1.5072575260972283
BFTC-909,navitoclax-birinapant (1-1 mol-mol),3.573845080821179
LS180,9911830,2.83226076921101
BT 248,9927531,4.7076279917818225
KLE,25105715,3.782155123781723
RERF-LC-MS,11222830,1.7620759794741472
MOLP-8,6252,-2.041702184925406
SW1271,5978,4.916909360273371
MOLM-13,5479543,2.5400848053862264
SEM,135398516,2.1523456379103028
NCI-H2452,11612883,2.7546488169018963
NCI-H1568,44493528,4.1542795967274175
RKN,46398810,3.1612721401313792
ML-1 [Human thyroid carcinoma],676352,2.608959843452948
MOLM-13,ISOX-bortezomib (250-1 mol-mol),-0.222539624438373
ML-1 [Human thyroid carcinoma],31703,-3.706133682115605
TTC-709,135398516,1.6486689367632217
SW1573,31703,0.7694714266266048
KPL-1,44607531,1.7362423329052994
RERF-LC-Ad1,navitoclax-MST-312 (1-1 mol-mol),3.737696475545332
KMS-21-BM,44489675,3.906208891368516
JHUEM-2,46907787,-0.0354976865727375
BFTC-909,11238147,5.503103761619835
SUP-T11,1750826,-5.498919834113967
JHUEM-7,36314,3.1831920881425058
BT 440,11455910,0.0350443808128442
ST486,262093,0.8785422298451224
SK-HEP-1,637858,2.866868896175592
KMS-21-BM,16725315,3.4420263264403568
ST486,5284373,3.118631902320921
HARA [Human squamous cell lung carcinoma],12001922,1.8002757111950325
KU-19-19,2828334,6.071698785304069
SEM,tanespimycin-bortezomib (250-1 mol-mol),-2.121594680168012
RERF-LC-Ad1,51039095,3.4667294063138407
SW48,JQ-1-carboplatin (1-1 mol-mol),0.1401684728057108
KP-3,400769,-0.6333745035148951
NCI-H1395,9967941,3.3785918920686924
RERF-LC-MS,2828334,5.9123201087220325
SK-HEP-1,vorinostat-carboplatin (1-1 mol-mol),4.117273876837617
PaTu 8902,54649381,5.340946431274584
KMS-21-BM,31703,-3.4456645515927864
ES-2,6623618,1.9461031732890484
RCC10RGB,11214940,1.429625683961422
PE/CA-PJ49,148198,-3.4268639622300516
NCI-H1568,25195348,2.211268152441431
COR-L95,10184653,1.5221413196357014
BFTC-909,3634881,3.6308731463535704
U-BLC1,JQ-1-carboplatin (1-1 mol-mol),2.2972315497002156
IGROV-1,navitoclax-pluripotin (1-1 mol-mol),-0.9669423716100508
SaOS-2,24785538,-0.4134197784310965
Hep-G2,10231331,-0.8368419788063003
RERF-LC-MS,4705,3.292681011259135
SNU-C2A,1242560,3.78937613926492
KHM-1B,5281321,-2.452020874471456
BT 440,44566777,-1.2748779909925192
MOLP-8,10127622,1.9499981558353492
KPL-1,5738263,4.260814064258063
TTC-709,10296883,3.6532150982477503
SNU-1079,4259181,0.5490184048770516
F-36P,53393127,4.024744387389786
LMSU,6610355,5.0974562936039645
Daudi,11626560,0.3779689739853294
MDST8,168312962,1.677679532849221
IGROV-1,selumetinib-vorinostat (8-1 mol-mol),2.2605882474472057
T98G,5738263,3.697179929434906
KP-3,73707398,1.3853432761584183
MOLM-13,10113978,0.7724135376915046
KHM-1B,135421197,0.982032972009238
KMS-21-BM,6917907,-6.627389042747998
PaTu 8902,selumetinib-MK-2206 (8-1 mol-mol),3.282015538774474
L3.3,375860,0.2158630030269858
SUP-T11,selumetinib-vorinostat (8-1 mol-mol),2.479374773758299
HCC1500,216239,1.4805608336728902
SNU-626,3634881,3.799684770756396
T98G,11175137,3.2467162806932226
BT 440,3634881,3.029284107815977
ST486,11612883,1.2653804445183905
RKN,5281321,-0.4803497212669658
PaTu 8902,11175137,3.538788964844938
Daudi,10113978,1.6179427120332186
K-562,26596,-3.6076758496321832
UACC-812,tanespimycin-bortezomib (250-1 mol-mol),-2.245399368845158
Daudi,5291,1.8632614405000685
NCI-H1568,2874250,4.364133169191667
LMSU,11717001,4.418665943257039
TTC-709,1714884,3.5208709903156556
KP-3,12001922,1.9624704543542888
KHM-1B,2874250,4.780971307568023
LS411N,984333,1.2324204412799928
PaTu 8902,11222830,2.39915227633331
MOLP-8,54678924,1.6307832002497362
COR-L95,49793307,-5.549400502924621
PK-1,374536,2.728983903486566
JHUEM-2,3634881,2.0091211624307963
KHM-1B,1242560,-1.3628719812202528
HCC1500,45279963,3.5713917460093434
WM115,54765302,3.574934655958074
SaOS-2,136227924,4.496792726095474
F-36P,sirolimus-bortezomib (250-1 mol-mol),0.0498711406572633
NCI-H2452,107970,2.3345640718356364
LS411N,16720766,1.2713952174238143
MOLM-13,navitoclax-PLX-4032 (1-1 mol-mol),-1.1656285238385289
SNU-626,71680916,4.2578235399517235
KP-3,71466578,6.197300139241283
NCI-H1395,11228183,4.844045820829891
TTC-709,426756,5.009789191998808
MOLM-13,216239,-5.069803023561943
RERF-LC-MS,44241473,4.536869636330491
LCLC-97TM1,10074640,3.2021543880531156
LMSU,637858,2.7447242272748924
SK-LMS-1,387447,-4.300147473198931
NCI-H1395,selumetinib-piperlongumine (8-1 mol-mol),3.796978991433947
F-36P,568763,0.0975794581096625
F-36P,selumetinib-GDC-0941 (4-1 mol-mol),-0.222152579559036
U-BLC1,156414,-4.628968432164774
U-BLC1,54618795,2.5710808409755277
Panc 02.03,10296883,4.297264305827386
IA-LM,3689413,-4.432004355370191
MKN1,52947716,3.030743838220118
MKN1,216345,2.5736254549216055
RKO,375860,-0.2095842697906711
SNU-626,446155,1.6933273059669225
SUP-T11,11485656,1.9960376933984711
PE/CA-PJ34 (clone C12),25126798,3.781683390757729
HuP-T3,676352,1.9029965224961456
JHUEM-1,4096211,1.8076437241308272
PK-1,54613361,2.941270336069218
ST486,135999136,4.078215309645287
SW1271,5470400,4.349220092525355
NCI-H2452,656346,1.056906556032961
JHUEM-1,3465537,3.1283604264685403
BICR 31,56649450,1.7574149169243078
RERF-LC-MS,24785538,0.8057743011820994
PE/CA-PJ34 (clone C12),3025944,4.287194818492555
KHM-1B,136227924,1.9174951940989704
SaOS-2,9825149,0.8893885919981879
HARA [Human squamous cell lung carcinoma],51039095,3.2872110498619573
KHM-1B,448949,2.2712398362063575
RERF-LC-Ad1,15983966,3.1811444894910896
PaTu 8988t,carboplatin-etoposide (40-17 mol-mol),3.874190963823487
SK-CO-1,638278,3.4780853527987854
T98G,60700,1.7541814612400513
RERF-LC-Ad1,navitoclax-piperlongumine (1-1 mol-mol),2.3229899285484352
WM115,4096211,3.685037910266886
PE/CA-PJ34 (clone C12),135398516,2.5107066469062738
RKO,126941,-5.081226966265268
PE/CA-PJ49,613753,3.2015206560580407
RERF-LC-MS,54618771,0.9955970244631366
Daudi,50905018,3.9297282000687312
WM115,11609586,3.058244435077658
ST486,11625818,3.83438713793258
ST486,25262965,-2.2423366735983317
BICR 31,9926054,1.721382648019371
SNU-1079,44486219,3.0690175895929968
HuH-6,71466578,2.708457511473839
SK-LMS-1,71466445,5.876102346203037
SK-MEL-2,71304818,3.914661065987117
RKO,24821094,3.7157598247146977
IGROV-1,135440466,0.9791523710816318
T98G,11640390,4.578853207262359
HT-1376,9907093,5.844308491110661
SNU-1079,57330099,3.4980260836428583
NCI-H1568,44202524,1.0522971592210668
HuP-T3,9933475,3.0776536859408807
COR-L105,carboplatin-UNC0638 (2-1 mol-mol),4.035332544942737
NCI-H1395,11364421,1.3628820394407153
BICR 22,11612883,2.729453217725868
ST486,5746,0.8788637344474699
PE/CA-PJ49,navitoclax-gemcitabine (1-1 mol-mol),-3.329741193737403
MDST8,25154868,3.4078840547236333
WM115,12001922,1.1273981641266086
SW48,2742550,3.28553671385033
WM115,445091,3.8598878691820886
RKN,135875424,3.6230459419726526
BFTC-909,2708,5.254338200716292
KP-4,9956119,3.912879801668201
NCI-H1395,46191454,1.8704386563260864
Mino,11427553,0.4102586601648044
SaOS-2,2871966,1.7918423486815835
SW1271,serdemetan-SCH-529074 (1-1 mol-mol),2.3446355759055684
HCC15,44632017,0.3758817607479284
COR-L95,2729026,2.664378744829576
RERF-LC-Ad1,49766530,-0.8755533009144216
EB1,54618771,-0.3915386993254522
L3.3,9936388,-5.444309252993802
SaOS-2,1566236,1.7620742085681662
BICR 22,11955716,-1.4294009955010087
PK-1,5278396,3.9142807883896937
LMSU,44487872,4.479427716264116
DLD-1,11214940,3.5878270152951277
SEM,71751553,4.239243086655999
KMS-21-BM,11626560,0.246143563997703
SEM,tanespimycin-gemcitabine (1-1 mol-mol),-6.855613835545683
BICR 31,2729026,2.966794528433677
COR-L95,119182,-1.6347192148686482
HuH-6,26596,0.8914215652548961
LS180,5328940,1.742567210928755
Panc 02.03,46398810,3.420081587494409
RCC10RGB,60700,3.171193268028763
BT 248,71751553,4.279070264679743
Mino,selumetinib-piperlongumine (8-1 mol-mol),2.4695673161697593
SU-DHL-6,451668,-1.4332734905345434
Granta-519,16219061,2.116318709414125
BT 248,613753,3.1927723368663976
EB1,60750,-6.19816897327154
ML-1 [Human thyroid carcinoma],42642645,0.1882919364816784
HEL,53232,2.5038982548529747
LMSU,122327,5.769053061722797
RKO,44507138,3.480554434186059
NCI-H2452,3081361,2.98247650375621
KP-4,400769,-0.5865212071302118
SNU-C2A,24856436,0.0007078203041302
RERF-LC-MS,44202524,1.2785968032229695
SNU-886,4477,-0.049698052487978
RERF-LC-MS,16722836,2.4162442447682193
SK-MEL-2,148198,-4.089267246303032
JHUEM-2,24951314,-1.5593754834078355
SK-LMS-1,23725625,5.609537444639145
HCC15,637858,3.032734575357801
IGROV-1,11396600,3.99372654279783
BICR 22,44202524,1.658152527320416
MOLP-8,54618771,0.2679151571300236
NCI-H2452,navitoclax-gemcitabine (1-1 mol-mol),1.5021089136928458
LCLC-97TM1,54678924,1.535359034662644
KP-4,421610,4.182899126160872
SK-LMS-1,5328940,2.5570935904048606
BFTC-909,49793307,-2.946331542038894
F-36P,54613361,-1.6188973635870945
KPL-1,44491742,4.061678740812618
JHUEM-1,54626689,4.448202323630063
KU-19-19,5738263,3.812580710038467
PaTu 8988t,24821094,3.93253598055128
LS180,148198,-2.644013472885731
HEL,409805,5.92709656224454
LMSU,445091,4.667050820468158
PE/CA-PJ34 (clone C12),3384730,4.479323787915653
RKO,11612883,3.106052261550285
SW1271,122327,4.37632222345113
L3.3,6852167,2.807934515358382
MOLM-13,44241473,6.124350775268443
KP-3,11175137,4.186642684142347
HuP-T3,2126,5.715410620657667
JHUEM-1,71304818,1.598873791330509
Mino,57330099,4.503910071991802
K-562,5291,-1.1872539047134878
RKN,5282054,3.624299707956654
BICR 22,613000,2.6534426018316277
JHUEM-7,11955716,-2.804770203271417
HCC15,49850262,3.6300454046422774
SW948,613000,2.5939391420023212
KMS-21-BM,67291369,1.280530221543493
PE/CA-PJ49,crizotinib-PLX-4032 (2-1 mol-mol),1.4047955242788717
COR-L95,135440466,3.0574476104836914
SK-HEP-1,262093,3.158620019748703
UACC-812,sirolimus-bortezomib (250-1 mol-mol),-0.7676605385666967
MOLM-13,123631,1.0914116119684203
BICR 31,4378219,2.049792351388142
ES-2,44185566,2.9621885460189437
EB1,57519531,0.9446242934637136
JHUEM-7,46191454,0.2697350797052546
LS411N,16722836,1.825979837410603
YD-15,3384730,2.2668777327263814
L3.3,1750826,0.7937145951404149
SU-DHL-1,10074640,2.3568880289385654
MKN1,vorinostat-navitoclax (4-1 mol-mol),1.9621875729929412
ALL-SIL,6918328,-1.7903684912223865
SU-DHL-6,3384730,1.0298608560692932
SU-DHL-6,11485656,1.7981230616770194
U-BLC1,3384730,2.477690343530556
ML-1 [Human thyroid carcinoma],24785538,0.9232201957937346
NCI-H1395,3854666,3.0219534193280637
SNU-886,54613361,0.1365764016308465
SK-LMS-1,54454,1.964594890023988
KLE,31703,-0.6562509778186947
HuH-6,54618771,-1.3988584380495144
SEM,285033,-4.419553075317265
SUP-T11,72193861,-0.2445491226450934
PE/CA-PJ49,71466380,4.6952219405725435
ST486,4259181,0.03160083232378
BT 248,1750826,0.7778964775949998
JHUEM-2,6918289,-5.397727573399504
NCI-H1568,176870,1.641159934282528
HEL,5280436,3.9989145330348896
BFTC-909,5328940,1.2290524134113243
SNU-1272,16115403,-4.411665524606828
SK-CO-1,151289,0.7492352886663923
RERF-LC-MS,104842,-3.024577047260716
PaTu 8988t,46843906,4.444995617536364
HT-1376,5328940,0.824536501024272
SNU-1079,124202324,-0.2127872852264718
BICR 22,24856436,-0.0251718817877118
U-BLC1,3503,2.539884685678537
DLD-1,decitabine-navitoclax (2-1 mol-mol),0.9147586410658084
SK-MEL-2,7251185,3.090040795487297
HARA [Human squamous cell lung carcinoma],208908,3.016531266929929
IA-LM,67156097,4.3159050642226
PE/CA-PJ34 (clone C12),374536,3.765928674441179
HuP-T3,6438330,2.3942211080747837
ES-2,25062766,2.148721017050754
HCC1500,10296883,3.843895309810077
MKN1,135423438,3.025317436009671
YD-15,71466445,5.119296595757631
HARA [Human squamous cell lung carcinoma],3062316,1.9438846554207736
SK-CO-1,56946209,-3.7989193199280016
Granta-519,148198,-4.763660659469611
SUP-T11,327653,-0.0983618163081044
HEL,4917,2.9031193377759603
SK-LMS-1,10074640,3.661191985858004
Hep-G2,42642645,0.7845833845237471
RCC10RGB,66577038,3.312011612499516
PE/CA-PJ49,navitoclax-MST-312 (1-1 mol-mol),0.8896074539476759
JHUEM-7,23582824,-0.4134518845075093
Panc 02.03,3689413,0.2165954212360822
ML-1 [Human thyroid carcinoma],89928392,0.0943028098974214
EB1,53481919,3.8908060551132295
SEM,11222830,0.5269269081978375
PE/CA-PJ34 (clone C12),6914657,-4.423290668811461
SW48,241158,3.5185545260205364
ES-2,54618771,2.1434167327207954
KHM-1B,11507802,0.7645643199546858
ES-2,6610216,4.8266103176713155
KMS-21-BM,23635314,-3.3728771305355933
COR-L105,selumetinib-GDC-0941 (4-1 mol-mol),0.702191872416662
JHUEM-7,11214940,1.5777405725342055
HCC1500,navitoclax-birinapant (1-1 mol-mol),-3.387149505683513
K-562,11167602,1.4540526159902811
SEM,44632017,-0.1291219027701855
HEL,9911830,3.2406370139452134
SNU-1272,6610355,5.209635935326743
L3.3,16741245,2.275908063521695
SW948,25150857,2.687963392787196
SEM,selumetinib-BRD-A02303741 (4-1 mol-mol),2.811165590219853
WM115,44137675,0.4260207876885596
KHM-1B,11427553,0.8733560257670158
SaOS-2,4917,3.064827494863108
EB1,176870,1.5872480550361687
SaOS-2,3503,1.987605483793098
U-BLC1,89928392,1.3775043381549652
LMSU,5460769,3.9630418347665857
LCLC-97TM1,9840324,5.858053248657865
RKN,11178236,-3.061903912386503
COR-L95,46843906,2.16387123849571
K-562,46191454,1.7723208241237427
SUP-T11,54613361,-0.5605080620033617
LCLC-97TM1,5746,2.627938158922912
TTC-709,11656518,0.8166729624281758
ST486,JQ-1-vorinostat (2-1 mol-mol),-2.031559632933391
RERF-LC-MS,613753,3.34976336152667
HCC1500,9823820,4.617789125102065
JHUEM-2,3025944,3.54248196033213
PaTu 8902,49793307,-1.5016152541437175
BT 440,navitoclax-MST-312 (1-1 mol-mol),1.1345404929155738
T98G,89928392,4.062198836241301
LS411N,24964624,2.837560916730962
SNU-626,44494015,6.327875246768692
SNU-1272,46199207,3.241167347577687
Granta-519,42642645,-0.7384711962533689
Daudi,156414,0.7854974484116999
KMS-21-BM,23725625,3.3604633769729637
HCC1500,9840324,5.570797833564005
HuP-T3,6914657,-2.995276103152913
SW48,11178236,-2.976969958039468
Granta-519,11214940,1.149911870185247
SNU-1272,448949,3.345262663923222
Ishikawa (Heraklio) 02 ER-,65064,3.244346029256265
Granta-519,72734382,4.317814968690637
SK-HEP-1,selumetinib-JQ-1 (4-1 mol-mol),3.7826975046986697
JHUEM-1,6918878,4.919035638288985
SK-HEP-1,15983966,0.8278271069258164
JHUEM-7,4521392,4.016477728370682
TTC-709,11626560,1.8325637594010389
Hep-G2,2828334,6.110325188036079
BICR 22,6610355,3.5129220888937622
SK-LMS-1,4917,3.7233760792032338
HT-1376,11485656,2.207084161817658
HCC1500,44489675,3.6836892776405854
TTC-709,4788,4.419350072345849
IA-LM,3634881,3.385658224323674
SaOS-2,JQ-1-vorinostat (2-1 mol-mol),0.950161902916163
BT 248,53392493,1.7075191079379444
SNU-886,10113978,1.5939546192174308
NCI-H1395,navitoclax-pluripotin (1-1 mol-mol),0.5678965327909137
JHUEM-1,3552672,1.8419087992908072
COR-L95,4788,5.892645370038274
NCI-H1568,11717001,4.19629869858104
KP-4,42642645,-0.9361975871435074
U-BLC1,4578,4.600597524577203
BT 440,5280436,5.664976248628968
RKO,46224516,2.430810450928805
LS411N,6505803,-0.6536233604701492
HARA [Human squamous cell lung carcinoma],135423438,3.0787654328489986
HCC1500,16725315,3.090868252599208
Panc 02.03,5287620,-2.132468814908427
ML-1 [Human thyroid carcinoma],5470400,0.2567315670041485
LS411N,5351362,1.130738510814583
IA-LM,168312962,3.008218706470952
SW48,9887053,1.6385742110161594
HCC15,2945648,3.8992008266513305
WM115,10385095,0.3137764342063494
SW48,11213558,0.38171338020492
IGROV-1,9911830,1.9130562323799436
T98G,alisertib-navitoclax (2-1 mol-mol),2.8786252581146683
SNU-1272,400769,-0.1796926060476786
HARA [Human squamous cell lung carcinoma],6918736,-1.65788247009277
LCLC-97TM1,5284616,3.038958191933125
SW948,5311,0.5245292911924586
SK-LMS-1,navitoclax-pluripotin (1-1 mol-mol),-0.4259364139119853
PaTu 8902,2949965,3.498586647815041
KMS-21-BM,55508,1.6422179866797126
PaTu 8988t,53232,5.050646647161413
ML-1 [Human thyroid carcinoma],navitoclax-pluripotin (1-1 mol-mol),-1.2739160400163367
RERF-LC-Ad1,44185566,3.2196778571318356
KMS-21-BM,54639665,5.788754853748425
SEM,44607531,0.7149871957090602
P31/FUJ,2729026,1.895106624580685
SW48,568763,-0.0201118962331156
SW48,selumetinib-GDC-0941 (4-1 mol-mol),-3.255152499343646
SK-CO-1,docetaxel-tanespimycin (2-1 mol-mol),-5.721099284006835
SK-CO-1,54454,2.352526453014332
HT-1376,selumetinib-vorinostat (8-1 mol-mol),2.644964050552289
KHM-1B,44137675,2.3063788474236957
MOLP-8,tretinoin-navitoclax (4-1 mol-mol),4.347252260304068
SW948,151289,0.9927868711009586
RCC10RGB,676352,2.417271143726191
PE/CA-PJ49,3062316,-2.7015704700942313
LCLC-97TM1,15953870,3.316413299321368
LMSU,3825829,5.912113214968355
HCC1500,252682,6.335850466863892
SNU-1272,11234052,4.3028185789263045
LS411N,doxorubicin-navitoclax (2-1 mol-mol),-0.6349980356208603
F-36P,702558,3.4021679199463017
SW1271,702558,5.67814751001827
PE/CA-PJ34 (clone C12),selumetinib-UNC0638 (4-1 mol-mol),2.452138408704013
HEL,3503,1.2339935625044716
SW948,6918328,0.2458443826474451
JHUEM-1,25150857,2.498694385993274
U-BLC1,107970,1.5582659561874588
ALL-SIL,124202324,0.3755400921280209
SW1573,2729026,2.4001203305493397
SW948,57330099,4.403961221202979
KMS-21-BM,56963564,-0.8529789314641827
SEM,9866186,-1.7113396105566032
UACC-812,42642645,2.375397400257474
LS411N,tanespimycin-gemcitabine (1-1 mol-mol),-0.1859317712708109
PaTu 8902,984333,1.3011106079808883
P31/FUJ,135398516,1.7387657861081838
WM115,46224516,3.0669076127990276
SW1271,24771867,3.777194428597206
F-36P,44462760,5.063696789337612
HEL,73707438,4.0836720937600175
MOLM-13,16038120,-1.7825288578452578
HuH-6,25150857,1.527807499964403
IGROV-1,10427712,3.944243047938238
PE/CA-PJ49,6610216,4.338624993526508
LMSU,1716436,3.7603795285051818
SNU-626,65064,3.058143453928601
LS180,3815108,3.93048377981505
HT-1376,46901937,4.268935456759413
HCC15,1750826,-0.4775912601104041
IGROV-1,selumetinib-tretinoin (2-1 mol-mol),4.176281087704045
P31/FUJ,42642645,-1.1469220315427042
HEL,1750826,-3.7677259179114047
SNU-C2A,119607,5.047441617299913
SK-MEL-2,613753,3.2709653678821575
BT 248,11364421,0.4256883677591794
NCI-H1568,25183872,-0.3156837582718859
SW48,54143018,-1.2192841502688678
SaOS-2,441298,1.6833347099113902
SU-DHL-1,119607,3.7964753700545546
LS180,654092,0.275565618798522
EB1,387447,-5.6659241694602
SNU-1272,selumetinib-navitoclax (8-1 mol-mol),2.1860356940542087
RKO,6918736,-1.762610939534952
DLD-1,25150857,3.0323323337162083
ML-1 [Human thyroid carcinoma],6918837,-4.218663166819277
KPL-1,serdemetan-SCH-529074 (1-1 mol-mol),2.5337621763705287
KHM-1B,16736978,0.8941116844537789
SK-OV-3,168312962,4.003119281373622
SK-MEL-2,25150857,2.7623433272086575
JHUEM-1,5470400,-1.4282401862465308
KP-4,5702613,3.803419922999385
PaTu 8988t,3062316,1.6786738127042626
P31/FUJ,5746,-1.0128835373821496
ALL-SIL,46943432,1.7359798293614472
IGROV-1,119607,5.004384040905396
NCI-H1395,10296883,4.692616973111803
LS180,135440466,2.758543039731734
YD-15,navitoclax-gemcitabine (1-1 mol-mol),-2.1088745948690604
TTC-709,448949,1.937761126893882
ST486,BRD-K55473186,3.706148699530621
Mino,5329102,1.4500389242117429
HEL,15983966,-4.130179752932702
SW948,11228183,2.319596035574442
SEM,2871966,-1.3459801337867392
SK-CO-1,navitoclax-birinapant (1-1 mol-mol),0.739134837908099
NCI-H2452,219104,4.089454197150707
F-36P,12003241,-0.4333234421592413
LCLC-97TM1,24856436,-0.9719468010392746
SEM,2126,4.2087863854026
WM115,1716436,2.084402062067542
WM115,54596558,3.929397107249587
KP-3,6918328,0.9299376475581184
HCC15,selumetinib-GDC-0941 (4-1 mol-mol),-0.1827234466059498
LMSU,16065773,3.25664528889909
SW48,2828334,6.103861625006206
Granta-519,5335621,4.386788840750005
NCI-H1395,9444,4.051341414153912
NCI-H2452,25105715,3.487348959516136
BT 248,2742550,4.585670765822412
LS411N,11152667,-0.1489697958567156
ST486,445643,3.2199576512569066
SNU-1272,6917907,-2.5782962145708295
Mino,2742550,2.804646277870024
TTC-709,44819697,-3.333578661713859
HCC1500,4259181,0.9827468065480526
SW1271,1716436,3.164329770032204
KLE,44137675,4.105797549386638
PaTu 8902,tanespimycin-bortezomib (250-1 mol-mol),1.9395223164568671
KU-19-19,637858,2.3404288739792314
PE/CA-PJ34 (clone C12),54596558,4.3489795544634315
SK-OV-3,3081361,2.5908903164469317
BICR 22,10322450,4.612637955736889
ALL-SIL,44819697,-2.9345943950607136
LS180,4259181,0.5796574720850999
BT 440,11609586,3.1545844984225075
SUP-T11,52947716,-7.204131853182384
IGROV-1,6918328,-0.5330006254346346
F-36P,148198,-5.732875507822739
RERF-LC-MS,11178236,-5.98494163410248
KMS-21-BM,219104,2.285632694512919
SNU-1079,44632017,1.6287984421839865
BT 248,46215462,2.381699206499341
SK-HEP-1,SNX-2112-bortezomib (250-1 mol-mol),0.9629137048911888
IGROV-1,11485656,1.900409616013456
JHUEM-2,44202524,-0.7339885348933921
HARA [Human squamous cell lung carcinoma],5281321,-1.682952924947167
PE/CA-PJ34 (clone C12),16065773,2.5490560227958436
U-BLC1,11178236,-4.111911648258334
MKN1,5702613,3.04346876051324
BICR 31,16065773,3.973194001978765
PK-1,selumetinib-PLX-4032 (8-1 mol-mol),2.935607575627385
IGROV-1,6252,1.1284141516966473
SaOS-2,135398516,5.990406168261382
RCC10RGB,11485656,3.364959979667133
LMSU,6610216,5.122726082721053
SNU-1272,9903786,4.921324329124853
NCI-H1568,46926350,-5.085925204635643
SNU-626,5738263,4.192844694248629
LCLC-97TM1,123631,2.4246211789463445
BFTC-909,44185566,2.75887016136311
BT 440,24901704,2.3203262628906396
L3.3,9866186,0.5756442482063215
BFTC-909,124202324,2.9321657702899295
MKN1,navitoclax-gemcitabine (1-1 mol-mol),1.3645441553144189
JHUEM-7,docetaxel-tanespimycin (2-1 mol-mol),-6.631978799043623
LS411N,4917,3.429074291339912
BICR 22,135440466,2.8663984884678513
LMSU,tanespimycin-gemcitabine (1-1 mol-mol),1.1507117487410143
HCC1500,10127622,5.201205269222406
WM115,24748573,1.2650334763374356
SNU-1079,6852167,2.2180229891841723
LS180,17755052,1.7669119525953814
HEL,5278396,2.941082820113368
K-562,6917907,-5.621792844351372
WM115,11175137,1.8074191527620995
ALL-SIL,6610216,3.679901693613009
IGROV-1,3815108,1.915722485757852
Hep-G2,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1901606503524278
IGROV-1,44491742,4.406671418311328
JHUEM-2,208908,1.6618581073283396
NCI-H2452,11647372,3.7610160121318055
YD-15,selumetinib-piperlongumine (8-1 mol-mol),3.9419129052458057
SK-LMS-1,11152667,1.335730322583835
Granta-519,25262965,-5.6090339200635375
JHUEM-1,462382,-0.0231864849263063
HuH-6,56973724,1.6359461949443443
HT-1376,9935249,3.971188542533541
PE/CA-PJ34 (clone C12),2871966,-0.2106632494105586
PK-1,11175137,3.6384856791624487
DLD-1,25062766,2.32545411599887
HuP-T3,5287969,-2.0305885584054693
PE/CA-PJ49,7326481,3.2892077928478294
Panc 02.03,4578,4.394890119629889
PaTu 8902,46199207,3.581196343990194
MOLP-8,5329102,1.1360795478534944
PE/CA-PJ34 (clone C12),5287620,-1.7203346154702173
SW1573,24797083,0.9725439959134782
COR-L105,11507802,4.378208095645504
SK-HEP-1,10385095,2.0924930980552148
ML-1 [Human thyroid carcinoma],44185566,2.5450411112530475
L3.3,135398744,6.452563021638662
L3.3,36462,1.8942720792997911
SEM,navitoclax-MST-312 (1-1 mol-mol),-2.7304049147303764
KHM-1B,216345,3.77132854777876
HuH-6,6918328,-0.7559939683265758
MOLM-13,54618164,3.841266236609366
SW1573,5287620,-0.7347028317725576
SUP-T11,sirolimus-bortezomib (250-1 mol-mol),0.9294161353730758
Panc 02.03,24821094,4.183998590604807
SNU-1079,5394,4.379807554320853
NCI-H2452,11977753,-3.0535753971711617
MDST8,selumetinib-tretinoin (2-1 mol-mol),2.2380074013059086
PE/CA-PJ49,16219061,3.15705369329154
SUP-T11,ISOX-bortezomib (250-1 mol-mol),1.04665324090094
K-562,5278396,3.2143611477277325
MDST8,46907787,1.4338285439483007
MOLM-13,16219061,2.363003680724254
SNU-1079,vorinostat-carboplatin (1-1 mol-mol),0.7188939254535706
IGROV-1,3854666,2.3355254440561137
LS180,11175137,3.0855574956004506
F-36P,66577038,2.3349416842561697
PaTu 8902,24180125,3.5735575491444505
Granta-519,135440466,3.2501433765769097
ST486,25150857,0.8305056957481676
KP-4,2729026,3.051860412513106
Ishikawa (Heraklio) 02 ER-,262093,3.584751515027739
Granta-519,3634881,2.8250958488191533
KP-4,11612883,2.230891969991632
SEM,67156097,-2.63166512459064
JHUEM-7,selumetinib-MK-2206 (8-1 mol-mol),2.058966868877447
BFTC-909,24785538,3.0409365635840433
Daudi,9903786,1.3988461789185107
SK-LMS-1,vorinostat-carboplatin (1-1 mol-mol),4.079113586943524
TTC-709,11955716,-1.9066771182007451
IGROV-1,126941,-2.246216453812328
Ishikawa (Heraklio) 02 ER-,serdemetan-SCH-529074 (1-1 mol-mol),2.9825928207078265
HuP-T3,327653,2.4979616286385573
KU-19-19,24785538,4.6207321752497545
LMSU,selumetinib-GDC-0941 (4-1 mol-mol),1.8803724999664797
PaTu 8902,11238147,5.651020754323713
ST486,carboplatin-etoposide (40-17 mol-mol),1.2108569219449372
SNU-626,24856436,1.2967160655409131
P31/FUJ,24772860,-2.926152167827307
SW48,969516,2.6010409472277303
KP-4,46224516,3.0131005396183417
Ishikawa (Heraklio) 02 ER-,7326481,2.346559293778367
JHUEM-7,54618771,2.242796216513649
SEM,6436223,-5.97261058273431
KP-4,24785538,0.469913223575538
TTC-709,135999136,2.269842230246662
SUP-T11,73707398,0.4533846882446893
SNU-626,89928392,1.8937736454150995
NCI-H2452,11656518,-0.3763326461825258
LS180,156422,4.137124258725139
K-562,16038120,0.8140588279430221
HEL,9956119,2.2634866876643924
BT 248,9967941,3.931710866923424
MOLP-8,16013152,3.9032026583920656
PE/CA-PJ49,439501,-2.9475727314168174
KP-4,56963564,-0.5811650878612864
SNU-1079,10385095,2.438291597532159
Mino,9956119,1.2124790835608252
SEM,650361,3.800745597928697
SaOS-2,7251185,2.1177882155213488
SW1271,16722836,1.1489272284540188
SW1573,1750826,-4.895155026964416
COR-L105,6918878,5.053406021852451
KP-4,9911830,2.4137773940538487
HuP-T3,44566777,1.596285673654969
RCC10RGB,11167602,3.5267453541831695
KU-19-19,3689413,0.155027117273248
EB1,15547703,2.077168536664667
KMS-21-BM,erlotinib-PLX-4032 (2-1 mol-mol),3.2052322487874005
LS180,262093,3.1953995116592826
SEM,15953870,2.946140214563167
HEL,168313016,4.358661125075543
LS411N,448949,2.5849168666236273
SNU-626,72376,-0.9524164624963382
RERF-LC-MS,11507802,1.168612691302407
RKN,3025986,-0.1432368238740909
ES-2,16722836,2.644698623738753
KP-4,selumetinib-PLX-4032 (8-1 mol-mol),2.96077015046319
ES-2,6914657,-5.015538705379515
JHUEM-1,9840324,5.462122068102132
YD-15,159324,3.5154662615579486
DLD-1,3543504,4.314901311296446
LS411N,5566,3.1552423609786153
Mino,navitoclax-birinapant (1-1 mol-mol),-3.9613724351931054
MKN1,54618771,0.4952124443033494
MOLM-13,168312962,1.173226591058953
KU-19-19,16741245,1.8623441782077492
HuH-6,44819697,-0.4248316003587976
BICR 31,5746,2.9612823230829592
RERF-LC-MS,448949,1.7883798522328354
Ishikawa (Heraklio) 02 ER-,71304818,1.8773049966238269
Panc 02.03,piperlongumine-MST-312 (1-1 mol-mol),2.606918356339114
K-562,135411,0.731253239019591
WM115,3825829,3.803690072721518
PaTu 8988t,1566236,2.792784501487116
SK-HEP-1,25102847,3.375423501622406
MKN1,3676137,5.0317859396035685
SNU-886,selumetinib-vorinostat (8-1 mol-mol),0.3326918028445991
RCC10RGB,4378219,3.5112219508307017
IGROV-1,46907787,2.182756719431072
ML-1 [Human thyroid carcinoma],176870,3.163449715300446
COR-L105,9903786,2.948812050867326
SK-HEP-1,5287969,-1.6185163943497696
LS411N,66577038,3.114674219164565
LS180,11152667,-1.0678137233062412
SW1573,10322450,3.835483834832597
BT 248,25195348,5.391578709053811
ALL-SIL,4369359,5.632204520937589
P31/FUJ,6918289,5.395091759648689
BT 248,2858523,2.3138600326756436
NCI-H1568,carboplatin-etoposide (40-17 mol-mol),1.7182211320205656
BICR 22,54626689,4.975060177279609
RKO,11455910,0.1271196393609195
NCI-H1568,2749,1.8950065449811435
SK-HEP-1,2858523,3.173409588420467
HARA [Human squamous cell lung carcinoma],46907787,3.600628557962214
YD-15,9866186,0.2608332907656819
Hep-G2,6917907,5.1054062498915025
NCI-H1568,16736978,1.0202421307584555
KPL-1,11152667,3.5133536124099387
NCI-H1568,11640390,2.883529605834316
MKN1,2858523,3.0199910397209746
TTC-709,52912189,2.5137104880447407
SaOS-2,375860,-0.2844076074043694
Granta-519,9549297,1.4990763156673828
SNU-1079,serdemetan-SCH-529074 (1-1 mol-mol),1.8622795564216093
ML-1 [Human thyroid carcinoma],24772860,0.5673209260643837
MDST8,9915743,3.1722151191536607
ES-2,135984461,1.833276143203305
HCC1500,7251185,1.592161448601532
PaTu 8902,654092,0.4014878659730266
SEM,67291369,-2.94711830511694
HCC15,36462,0.276886424919507
KLE,24901704,2.3973635656707204
U-BLC1,66577038,1.004679224717017
SNU-886,44137675,2.6120412235311856
HEL,11222830,1.7664464656365049
ES-2,246676,5.247336749197189
HT-1376,16065773,2.6159310644341307
SNU-626,24180125,2.1450306590662636
LCLC-97TM1,6918328,0.5489211755624944
YD-15,11234052,5.686595382598262
MKN1,9926054,3.700935468951971
SW1271,11427553,2.280233400826346
MOLM-13,tanespimycin-bortezomib (250-1 mol-mol),-1.8317105130308673
SW1271,216239,2.3992651597700805
PE/CA-PJ34 (clone C12),6184667,2.6739231408415893
LS411N,52912189,2.124177170278397
EB1,19582717,2.357939824941679
KMS-21-BM,49793307,-4.877217474699305
BT 440,11955716,-0.3916340852854516
RKO,262093,2.7220373961576834
RKO,selumetinib-piperlongumine (8-1 mol-mol),2.2390647410806306
SU-DHL-1,24180125,2.3898229933344193
U-BLC1,docetaxel-tanespimycin (2-1 mol-mol),-3.613613196417308
SNU-1272,vorinostat-carboplatin (1-1 mol-mol),4.458352308548227
P31/FUJ,10231331,0.360402840185862
KP-3,3825829,4.167375675761747
HT-1376,44819697,-1.894323871405846
COR-L95,navitoclax-PLX-4032 (1-1 mol-mol),-1.058390181093963
HCC1500,4705,3.1720127097688073
ML-1 [Human thyroid carcinoma],16722836,0.1571893320134409
KLE,51039095,3.662417805217731
T98G,135875424,5.101346341382456
PE/CA-PJ34 (clone C12),17755052,1.133637594911045
ST486,9444,3.5211731543425167
KHM-1B,44202524,1.0053468169161075
EB1,135928012,4.675406076244616
ALL-SIL,49793307,-3.5976005593324607
Hep-G2,piperlongumine-MST-312 (1-1 mol-mol),2.8906524908682143
DLD-1,9936388,-0.5378287493970375
LS180,decitabine-carboplatin (1-1 mol-mol),4.499129095785504
PE/CA-PJ49,selumetinib-GDC-0941 (4-1 mol-mol),0.8657642866761842
KP-3,216345,4.239964571319956
JHUEM-7,23939,4.409621105076689
NCI-H1395,11404337,2.1973197619817832
KMS-21-BM,11485656,0.7331254638608181
BICR 31,selumetinib-PLX-4032 (8-1 mol-mol),3.623780948669338
HARA [Human squamous cell lung carcinoma],409805,4.942295126142001
ALL-SIL,44489675,3.868517697091687
YD-15,409805,3.695516943836326
JHUEM-2,44241473,4.3199413160415645
COR-L95,9825149,1.4009706639997015
ST486,5281321,-5.027044369268764
SK-CO-1,25102847,2.4259034566713087
JHUEM-2,6917907,-6.123893311393622
PE/CA-PJ49,24964624,2.6604502143456865
NCI-H1395,11964036,2.245588880269689
COR-L95,36314,-2.5383774872687743
F-36P,5460769,6.312488647887553
IGROV-1,1641662,3.5854177848263675
BICR 31,16720766,0.8786813091838682
HuH-6,216345,4.101833629949944
NCI-H1395,11977753,-2.444387577547746
BICR 22,51037431,2.6213243445689254
BICR 22,2742550,3.9616050819266326
Panc 02.03,46843906,3.852893526574364
NCI-H2452,2708,3.4614923437122704
KMS-21-BM,10231331,-2.04952218948576
SNU-626,104842,-3.120855490743422
KP-3,151289,0.8654353651458653
U-BLC1,5287620,-2.104013377578071
RCC10RGB,15547703,6.556615668020641
RCC10RGB,5311,2.218274000934613
Mino,11612883,1.124666050414393
ALL-SIL,erlotinib-PLX-4032 (2-1 mol-mol),2.6221278423473446
LCLC-97TM1,24964624,2.5877637900313384
KU-19-19,107985,-2.420790531142743
KP-3,68056272,4.287326902713343
T98G,5281321,-1.4816198576694333
PaTu 8902,67156097,4.866613623772486
KU-19-19,676352,2.681008284282423
NCI-H1568,67291369,4.628091486396258
T98G,72193861,3.8654747448812814
BFTC-909,54143018,0.6300785047889099
PK-1,4788,5.914055775395616
BICR 22,5329102,1.9183442886017033
LS180,JQ-1-carboplatin (1-1 mol-mol),1.5137098822728978
SU-DHL-1,1641662,2.0867851207635044
SU-DHL-1,54143018,-1.2287450259829942
PE/CA-PJ34 (clone C12),24771867,1.6845259930692984
SEM,4477,0.916929513987914
WM115,3552672,1.460151745141153
Granta-519,6505803,0.3707466177802866
BFTC-909,2733526,3.41724914482818
COR-L105,445643,5.447871607768224
SW1573,BRD-A02303741-navitoclax (2-1 mol-mol),1.994158389176884
COR-L95,135421197,1.4504202802892363
BICR 22,4096211,1.2113689067872688
Daudi,241158,1.9180708700138325
SK-LMS-1,10127622,5.304754918518943
PE/CA-PJ49,46224516,4.646092336237554
RKN,docetaxel-tanespimycin (2-1 mol-mol),1.659975764237714
KHM-1B,5328940,1.2346884816807109
EB1,73707438,3.6357500002618974
ES-2,selumetinib-GDC-0941 (4-1 mol-mol),6.130354899135342
COR-L105,44543605,3.798835657012519
NCI-H2452,1641662,5.47511848960003
KMS-21-BM,5284616,-0.7655726274330754
T98G,24951314,2.4853255324360815
IGROV-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6574753619864233
F-36P,alisertib-navitoclax (2-1 mol-mol),-0.5446087682083143
HARA [Human squamous cell lung carcinoma],9826308,0.352829852370258
NCI-H1395,46398810,3.2237740665235495
EB1,135421197,0.2915543489276729
KHM-1B,53232,4.4462743832167035
MOLM-13,44489367,5.70063080501961
SNU-886,16720766,-3.5476315542779364
SK-LMS-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.250412004550364
MDST8,9936388,-2.5080849755955485
Panc 02.03,5311281,4.827416145020449
BT 248,24797083,0.3482207661961916
DLD-1,73707398,0.9462775715159254
MOLM-13,carboplatin-etoposide (40-17 mol-mol),-1.2909434999313618
Panc 02.03,71466380,5.929652601038649
PE/CA-PJ34 (clone C12),44507138,2.9484181855986704
DLD-1,25126798,4.13117705206551
BICR 22,148198,-3.168643556299537
LS411N,salermide-PLX-4032 (12-1 mol-mol),5.97516001818146
SK-HEP-1,serdemetan-SCH-529074 (1-1 mol-mol),2.785522004432589
MOLP-8,36462,-1.3356090090333852
Hep-G2,5328940,1.8827970950468589
Ishikawa (Heraklio) 02 ER-,73707398,1.818794277396009
RKO,168313200,3.1169425006108455
SK-HEP-1,24951314,2.4991128927954063
SNU-1079,36462,1.5004158593347587
HARA [Human squamous cell lung carcinoma],654092,0.0602204093244996
COR-L105,71304818,2.509036292239667
BT 440,3543504,5.679172744194561
LS180,11485656,2.0322073649322716
SNU-886,3503,1.4984016938588718
BT 248,navitoclax-piperlongumine (1-1 mol-mol),1.2015082500214636
SW1271,44185566,2.531281599529394
JHUEM-1,67156097,-1.2666750754118004
P31/FUJ,49836020,4.674155414221834
HT-1376,124202324,3.2333902540923756
UACC-812,carboplatin-etoposide (40-17 mol-mol),1.4623710182991412
SW48,selumetinib-piperlongumine (8-1 mol-mol),-1.6389231751651676
SUP-T11,3062316,1.8190538248932469
RERF-LC-MS,9933475,2.253072026550434
SK-CO-1,24964624,3.1718881088721735
Daudi,serdemetan-SCH-529074 (1-1 mol-mol),0.5315798853273473
LCLC-97TM1,54619267,4.094508182091097
SW1271,53232,2.609582991635379
L3.3,carboplatin-etoposide (40-17 mol-mol),2.812808375332559
HuH-6,11497983,3.749806595945838
COR-L95,5282054,2.7623794331923293
LS180,navitoclax-MST-312 (1-1 mol-mol),2.264329466995316
ALL-SIL,2749,0.4174204822378836
MOLP-8,11455910,0.4759456923848041
SK-OV-3,5329102,2.1848030817162427
IGROV-1,5978,-1.5618214380165825
BICR 22,135411,0.5903998872112299
NCI-H1568,6610216,3.52063980115584
SK-CO-1,176870,3.965368978694832
KP-4,135440466,3.0532427161305655
BICR 22,selumetinib-GDC-0941 (4-1 mol-mol),0.9236459983080146
LMSU,navitoclax-birinapant (1-1 mol-mol),3.8096655259250167
BFTC-909,doxorubicin-navitoclax (2-1 mol-mol),-1.537563048544383
IA-LM,9936388,2.150111055311291
ALL-SIL,selumetinib-BRD-A02303741 (4-1 mol-mol),5.278969536899067
KMS-21-BM,104741,2.7327930772473663
KP-3,409805,5.570202879037171
ML-1 [Human thyroid carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),-0.2880991888537167
F-36P,11494412,-1.3209854958695244
JHUEM-7,vorinostat-carboplatin (1-1 mol-mol),3.6475944430152114
L3.3,46398810,3.0103098250539846
SW1573,navitoclax-MST-312 (1-1 mol-mol),-1.0459858342436132
YD-15,969516,2.551622819211174
PK-1,navitoclax-sorafenib (1-1 mol-mol),4.4971431386537795
P31/FUJ,11214940,0.6332731592867608
JHUEM-2,11497983,-4.17592184319756
WM115,421610,3.513747492259629
SaOS-2,227681,4.210698048028356
BICR 22,25102847,3.5270600092516444
BFTC-909,46199207,3.2760821272908753
IA-LM,25154868,2.8804249714329537
SaOS-2,5738263,2.656867973667437
BICR 22,5738263,3.828959854789421
U-BLC1,56649450,1.3655500198535406
JHUEM-7,51037431,4.159503637934766
IGROV-1,navitoclax-sorafenib (1-1 mol-mol),2.116164500809202
KP-3,374536,-3.681172393088042
BT 440,409805,5.991281028290434
DLD-1,decitabine-carboplatin (1-1 mol-mol),4.667153822651022
SW48,SNX-2112-bortezomib (250-1 mol-mol),-3.704667477676808
SNU-1272,44507138,4.148225527043363
Daudi,24771867,-1.2539165255857252
DLD-1,44491742,4.025001948780805
U-BLC1,4259181,-0.0351960911080245
Daudi,446155,1.8075236258569949
JHUEM-2,262093,2.369625461390079
NCI-H1395,navitoclax-piperlongumine (1-1 mol-mol),2.9868041104516245
JHUEM-2,4917,2.5193506426393086
LCLC-97TM1,56946209,-4.83981355951691
YD-15,241158,3.805397573173429
SUP-T11,JQ-1-UNC0638 (2-1 mol-mol),1.134721943115646
F-36P,119607,4.041722893470021
BFTC-909,702558,5.601571619782522
KHM-1B,44489367,4.908857615770495
TTC-709,decitabine-navitoclax (2-1 mol-mol),3.8263941976347065
LCLC-97TM1,24797083,1.6672233423539589
IA-LM,2945648,2.6647419367463794
LS180,11717001,4.39666521822979
KHM-1B,9911830,2.660270688725906
KP-3,54649381,3.7166707762390385
LS411N,42642645,1.4293896003043414
PE/CA-PJ49,11427553,2.342569802533504
SaOS-2,16038120,-0.4228492368909831
BT 440,3689413,1.7448809021086664
HCC15,387447,-3.5284625014182556
TTC-709,selumetinib-JQ-1 (4-1 mol-mol),2.9675969653518948
K-562,24785538,3.0712560410264436
PaTu 8902,6918289,3.1585202712855196
BT 248,docetaxel-tanespimycin (2-1 mol-mol),-0.0329319446366538
BICR 31,11404337,-0.6318210319309021
Ishikawa (Heraklio) 02 ER-,81146,4.498930387849174
Daudi,navitoclax-PLX-4032 (1-1 mol-mol),2.817343533206949
LCLC-97TM1,5460769,-2.8089441547625067
ST486,2871966,-2.2843206657570376
Mino,67291369,0.5092565195098104
YD-15,135398516,1.3351599822608016
YD-15,387447,-4.197267666691031
IA-LM,25150857,2.846024040084871
EB1,53392493,1.7897188858578852
SEM,104842,-5.92078969792144
F-36P,3689413,-1.7757563129439584
F-36P,25183872,-1.7486354967000737
HuH-6,vorinostat-navitoclax (4-1 mol-mol),0.9828741062572958
HCC15,56973724,1.575466068691269
ALL-SIL,3384730,0.9130815120154347
Daudi,426756,2.2442144831253383
NCI-H2452,6918328,0.3371182351616307
SW1271,11364421,-1.228057709924225
BT 248,54678924,1.5069949057557903
HCC1500,9911830,2.253316240952314
COR-L95,60750,-4.239654973449372
EB1,5113032,4.494073670193456
YD-15,56946209,-3.803618969124325
COR-L105,675434,4.897128449999278
RKN,5978,-1.5379865785523688
BICR 31,1641662,4.3069637553272715
SW48,5281321,-2.141746406212142
SK-LMS-1,5746,3.2197222747815877
SaOS-2,navitoclax-gemcitabine (1-1 mol-mol),-3.208051277471344
SW1271,vorinostat-navitoclax (4-1 mol-mol),2.219898250998274
MKN1,navitoclax-MST-312 (1-1 mol-mol),1.1554598287156606
Ishikawa (Heraklio) 02 ER-,56946209,-2.553802996373868
K-562,12003241,-5.632155645383806
L3.3,262093,4.054875705556861
SUP-T11,55508,2.107478979493379
F-36P,9915743,0.3844593263484804
IGROV-1,11455910,-0.2792640061206097
SUP-T11,navitoclax-MST-312 (1-1 mol-mol),1.6828534458908833
COR-L95,10410894,3.9632969340699735
SW48,5351362,1.0988845715277948
HuP-T3,9907093,4.467626530245781
Hep-G2,JQ-1-UNC0638 (2-1 mol-mol),2.605795560708836
IGROV-1,16065773,3.3717508464278585
SEM,9927531,4.847523560791686
ST486,136227924,1.8715049257554837
Panc 02.03,439501,0.4668648826805023
COR-L105,11427553,3.315123926488956
ES-2,168312962,-2.1024012922041213
SNU-C2A,637858,2.233207186626609
IGROV-1,119607,5.004384040905396
SNU-886,15983966,2.2650754807835622
U-BLC1,54618164,4.010954810772503
PK-1,262093,3.4724760266373087
JHUEM-1,10322450,3.3656679927658213
BICR 31,151289,1.9519908762907336
TTC-709,10410894,4.0877293337125105
SK-CO-1,60700,-2.5556595153787915
ML-1 [Human thyroid carcinoma],2828334,6.601742138030732
EB1,3552672,2.34237462160431
JHUEM-2,67291369,1.7381339483390563
BICR 31,3825829,4.543850483279072
NCI-H1395,216345,3.4712022210886824
KP-4,16219061,2.8645986536697965
KHM-1B,tanespimycin-gemcitabine (1-1 mol-mol),-0.6092153686857478
SNU-1272,216468,5.738566915129053
SNU-1079,10410894,1.793005841656448
Mino,445455,3.7050877064136207
SK-CO-1,65064,5.377201033407044
SUP-T11,25183872,0.6183493525080107
SUP-T11,9956119,3.584780013741945
Ishikawa (Heraklio) 02 ER-,3825829,3.6769006859587465
HuH-6,9884685,0.3084855166914031
JHUEM-1,252682,5.978567664532058
HuP-T3,613753,3.2946831222357233
SK-HEP-1,89928392,1.6602086186634375
NCI-H2452,5291,3.747673065274588
L3.3,67156097,-1.9530361511710264
NCI-H2452,24964624,2.8171716992687967
SU-DHL-1,654092,-1.6609972231677514
LCLC-97TM1,327653,3.202975625508304
SUP-T11,42611257,3.099956183466832
LCLC-97TM1,11507802,1.3666879232460134
MKN1,24964624,3.0434970519957276
U-BLC1,10385095,1.1292120884131938
SK-HEP-1,sirolimus-bortezomib (250-1 mol-mol),1.4424973508492578
KPL-1,44494015,4.459934814858864
BICR 31,selumetinib-UNC0638 (4-1 mol-mol),2.7430116861345977
SNU-1272,24951314,2.1913708545239543
JHUEM-7,11494412,0.4868890434989014
SK-CO-1,11222830,1.7982943188317977
U-BLC1,2858523,3.0732856841787854
WM115,24951314,1.781657055553587
NCI-H1395,375860,1.7808246881173873
WM115,135421197,2.9135607351561883
LCLC-97TM1,136227331,4.3740550996774745
KP-4,11222830,1.070476457199954
SEM,3384730,-0.188183167842947
RERF-LC-Ad1,637858,2.9001668968564953
BT 248,navitoclax-gemcitabine (1-1 mol-mol),0.2474795408705132
KLE,54649381,3.9923802992632687
BICR 22,24951314,1.8959621159637303
HT-1376,753704,5.259514702224165
HCC15,15983966,-4.250826265389746
KLE,navitoclax-gemcitabine (1-1 mol-mol),-1.442818690707718
Daudi,24964624,0.5895170730703193
JHUEM-7,11455910,0.2186713515547739
SaOS-2,11257553,0.2323229130258903
RKN,doxorubicin-navitoclax (2-1 mol-mol),-0.6554911641899885
KLE,11960529,3.6757240900091808
RKN,46191454,2.1430961760764897
KMS-21-BM,9868037,1.4447274996214214
ALL-SIL,navitoclax-sorafenib (1-1 mol-mol),-0.9804805399961952
TTC-709,selumetinib-decitabine (4-1 mol-mol),4.747556039152115
HARA [Human squamous cell lung carcinoma],24180125,3.640570848683534
BICR 22,10410894,2.962619033825151
NCI-H2452,168312962,2.634597095527088
MOLM-13,452548,-4.1979459883625045
HARA [Human squamous cell lung carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-1.5170547368842298
SW1573,44185566,2.872643000979188
Mino,54618305,3.884266825894896
SK-CO-1,5470400,-5.490738264790885
BICR 22,9933475,1.970614134756263
BICR 31,24753719,4.233476426959058
HuP-T3,4261,3.8165819220848767
SEM,24964624,1.6218762857386917
F-36P,73707398,-0.2227517759229556
COR-L105,7251185,3.034502689275401
ALL-SIL,selumetinib-MK-2206 (8-1 mol-mol),1.6757681784854677
SEM,52947716,1.1671680401864422
KP-3,vorinostat-navitoclax (4-1 mol-mol),1.6931046422688103
SW948,crizotinib-PLX-4032 (2-1 mol-mol),1.0252435682890393
SK-LMS-1,2828334,6.288537675968613
SK-OV-3,49793307,0.1269396758315965
ML-1 [Human thyroid carcinoma],11647372,1.3935699525801049
KU-19-19,216345,3.688803948438149
LS411N,638278,3.5631537252490917
SK-CO-1,374536,2.850215581982446
RERF-LC-Ad1,409805,6.089650612893954
SUP-T11,168313047,1.893357827934418
BT 248,51039095,3.103752706938284
ML-1 [Human thyroid carcinoma],25126798,4.037868296097697
TTC-709,54678924,2.022867088204685
SEM,25262965,1.0326177265018786
LMSU,107970,2.329788160301069
P31/FUJ,11178236,-2.454576103037029
SNU-626,6918837,-1.5200655223223951
SW948,439501,-2.1692174321648174
NCI-H2452,9911830,3.1691750432917645
PE/CA-PJ49,216468,2.357663395957277
Mino,44543605,5.040908133155415
SNU-626,selumetinib-UNC0638 (4-1 mol-mol),4.756378558589667
IGROV-1,9911463,4.195269991960018
PaTu 8988t,JQ-1-vorinostat (2-1 mol-mol),2.250446694675845
HuH-6,107985,-3.2482974624876175
KU-19-19,46199207,3.5920417522591723
IA-LM,25102847,3.5065737869109017
SaOS-2,10385095,0.9171223668306429
HuH-6,16725315,4.163346045822412
SK-HEP-1,285033,-0.6546577384402199
SUP-T11,selumetinib-JQ-1 (4-1 mol-mol),1.513032323882754
WM115,1566236,3.8332358430398847
U-BLC1,375860,-0.0684909455881561
DLD-1,1716436,3.214094982642395
LS180,3025986,-0.3657173630682503
HCC1500,11625818,4.269459310239442
HCC15,44259,1.006506996100477
ES-2,136227924,4.099714373678264
SUP-T11,9823820,3.073039890737761
RERF-LC-MS,285033,-2.0574538896256587
IGROV-1,241158,3.288496474515495
BFTC-909,6917907,-4.2174557642594035
BICR 22,375860,-0.6251605141105395
MKN1,5978,-0.4912125722051629
MKN1,piperlongumine-MST-312 (1-1 mol-mol),2.7687074907015896
BICR 22,119607,5.438520616053313
RERF-LC-MS,676352,1.6328584527608256
KP-3,4788,5.674879620376492
U-BLC1,439501,-3.0504776234222035
BT 440,11427553,1.4415318319032948
HCC15,6918289,2.816502870816243
RKN,241158,3.8611150596916577
U-BLC1,53232,2.676766711634211
KP-4,11404337,0.6488423054091234
COR-L95,3634881,3.005165393659793
IGROV-1,11626560,1.7276653519578558
LS180,3385,1.8718372753364907
SNU-1079,3025986,-1.0979269912639131
EB1,219104,2.3403814739751665
HuH-6,9823820,3.624090371144579
PE/CA-PJ34 (clone C12),11317348,4.808081492985304
SU-DHL-1,56946209,-5.3778659012875325
Panc 02.03,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1370964450490924
KMS-21-BM,15953870,1.9146916461850392
SNU-1079,2733526,4.55410861992659
PE/CA-PJ34 (clone C12),11955716,-2.415491990969517
PE/CA-PJ49,11494412,-0.4920931569097222
NCI-H2452,448949,2.771204919609998
Mino,25161177,3.7618528243559712
ST486,156414,0.7820846211489824
SW1573,5113032,6.532830278238065
HT-1376,44589607,3.4435825265219764
SK-OV-3,11485656,3.3782074628341894
BICR 22,81146,6.036644504914818
JHUEM-1,44607531,1.473714274610238
JHUEM-1,24753719,3.9307242908195272
SK-LMS-1,5951923,4.520329928618062
P31/FUJ,76446078,4.256026108364254
Daudi,2113511,3.606563716227827
Hep-G2,16720766,4.874988016159793
PK-1,9907093,4.765358372641374
HuP-T3,5328940,2.3682781464336147
SNU-626,2945648,3.155964611415248
KHM-1B,6438330,0.7214920302496746
RKO,6852167,3.601912647929868
SK-HEP-1,1750826,-4.478019715406424
BT 440,11364421,1.637475908141117
SU-DHL-1,25102847,1.7846654255237482
KU-19-19,2749,1.0704171129437314
COR-L105,136227924,2.729950058152846
RERF-LC-MS,crizotinib-PLX-4032 (2-1 mol-mol),1.247076899545937
ST486,25126798,3.255948726719714
ST486,navitoclax-MST-312 (1-1 mol-mol),0.0318419708748563
KMS-21-BM,60750,-5.053259018217451
KLE,6918837,-3.4864458388429416
HuH-6,135398516,3.1503610340314414
HuH-6,46843906,2.564980957649801
RKO,25154868,3.654559992823761
HCC15,5113032,5.023051877119823
LCLC-97TM1,3815108,3.2576294300862867
SU-DHL-1,6610216,4.061950863639378
LS411N,136227924,3.1900427132689724
BFTC-909,selumetinib-piperlongumine (8-1 mol-mol),4.839600666891057
KU-19-19,51037431,1.6044173216619535
KMS-21-BM,24951314,-0.5203037648820265
KMS-21-BM,54649381,2.8597103971231053
Ishikawa (Heraklio) 02 ER-,46398810,3.165672023721753
MOLM-13,637858,0.5048034575879493
SW948,5329102,1.476566645762777
NCI-H1568,tretinoin-carboplatin (2-1 mol-mol),4.637834792559274
Ishikawa (Heraklio) 02 ER-,2708,5.818927723833249
K-562,serdemetan-SCH-529074 (1-1 mol-mol),0.9314801413999184
SW1573,1566236,3.3872191513469025
IGROV-1,46174525,4.5083762186279595
KP-4,crizotinib-PLX-4032 (2-1 mol-mol),0.5203537061486859
SW948,9956119,4.230492181635778
SaOS-2,100016,6.565789067704999
WM115,11152667,0.9737214532192616
HCC1500,439501,-1.4156205398968564
YD-15,44259,0.6456566052891425
SU-DHL-1,selumetinib-UNC0638 (4-1 mol-mol),2.6727434521528894
NCI-H2452,49793307,-1.217787389832333
YD-15,24964624,2.383657259126004
JHUEM-1,11178236,-5.749168373491823
KMS-21-BM,12003241,-1.038159466289584
BICR 22,208908,1.938925459708866
Mino,3025944,3.883461647541772
JHUEM-7,135875424,3.03961944002969
KU-19-19,675434,4.307992798559183
SUP-T11,54143018,-1.5153047932654566
YD-15,23725625,3.3840868506825563
SU-DHL-6,168312962,-0.817402334599034
RKO,4705,3.750134101835121
PE/CA-PJ49,66577038,2.894241408654739
MOLM-13,72193861,-0.3301410770598842
SU-DHL-6,11497983,-4.838706392617486
PK-1,44137675,3.885064586842958
KLE,selumetinib-navitoclax (8-1 mol-mol),-0.4039228772243814
ST486,2708,3.2849722669757617
PE/CA-PJ34 (clone C12),selumetinib-MK-2206 (8-1 mol-mol),1.6855089164633987
IA-LM,6610355,7.432350505906943
HT-1376,2733487,7.213882200460792
SU-DHL-1,100016,4.0163007651424945
SW48,tanespimycin-gemcitabine (1-1 mol-mol),-4.429955017650206
NCI-H1395,387447,-2.916256020115362
ES-2,387447,-4.281981218202758
U-BLC1,tanespimycin-bortezomib (250-1 mol-mol),-2.071210678838922
ST486,11427553,0.3561712512849146
SUP-T11,53392493,1.1650900944939218
KHM-1B,navitoclax-pluripotin (1-1 mol-mol),-0.8283845367813834
Mino,24951314,-0.3531134794009772
BICR 31,11717001,4.942461846011657
KMS-21-BM,4788,3.867568957165291
MDST8,452548,1.517979290481689
SEM,10410894,0.6852786057514013
BT 440,54619267,4.219825016400461
SaOS-2,vorinostat-carboplatin (1-1 mol-mol),3.1714498028608573
Ishikawa (Heraklio) 02 ER-,selumetinib-vorinostat (8-1 mol-mol),2.5379736482823625
EB1,2708,1.6331378886358063
Mino,navitoclax-gemcitabine (1-1 mol-mol),-5.317459070076536
ML-1 [Human thyroid carcinoma],tretinoin-navitoclax (4-1 mol-mol),3.335416129341979
DLD-1,400769,-0.2993291579023639
BT 248,24951314,2.138284126904765
SNU-1079,5351362,1.1840650598679563
PE/CA-PJ49,2858523,3.1407591199690144
U-BLC1,2729026,2.142841988558096
HCC15,216239,2.699139377969599
SNU-886,9868037,2.869419012431549
KP-4,135999136,4.290505195277357
SW948,54143018,1.1269042701713536
PaTu 8988t,2871966,0.7913795837456433
HARA [Human squamous cell lung carcinoma],24889392,3.022552356394008
MOLP-8,702558,5.64086941386953
SK-CO-1,9926054,2.0008566323964576
KP-4,44137675,3.4268273488123393
NCI-H1395,2708,5.386847702037966
T98G,2729026,3.1993029783526854
NCI-H1568,208908,1.6425276108518176
BICR 31,11364421,0.6668909809197356
JHUEM-7,4917,3.1457767862931054
SNU-886,2708,4.666368688758876
RKO,6438330,2.4839059464581785
HCC1500,11717001,5.16685929391629
SUP-T11,10322450,3.259585661278822
NCI-H2452,5335621,2.361346054519045
JHUEM-7,vorinostat-navitoclax (4-1 mol-mol),2.5378629346574946
HT-1376,4261,1.9890308124805764
SK-HEP-1,168313200,3.8713243832650335
Mino,5280436,0.8101119000946707
MOLP-8,5281321,-3.090542457479921
LS411N,5287620,-2.7795044954925423
SEM,9952709,2.504756008215234
DLD-1,25154868,4.948545779215456
BFTC-909,42611257,4.384387627976705
MDST8,135421197,2.23565927197073
LCLC-97TM1,navitoclax-MST-312 (1-1 mol-mol),1.32635815912294
KP-3,6914657,-5.860460007512633
ML-1 [Human thyroid carcinoma],4261,2.09291450929782
SU-DHL-1,136227924,2.1802521862386395
KP-3,9887053,4.887376712089991
KP-3,71304818,2.7861228498307185
SK-MEL-2,6184667,2.892199384908145
HEL,9929138,6.278460484472286
KP-4,44607531,2.2938853216764987
BICR 22,100016,6.157225392196351
BFTC-909,6610216,4.898578232775107
SNU-626,3136844,4.356334294735604
ML-1 [Human thyroid carcinoma],327653,3.144384021244803
SEM,56649450,3.981802014132025
SK-MEL-2,56946209,-1.8475786839882544
P31/FUJ,2708,3.1798246734444535
PK-1,702558,5.5707718702946885
SK-HEP-1,11222830,2.864448489509693
L3.3,25183872,0.3957917888669793
SW948,6450551,1.190778779915613
P31/FUJ,3503,1.1912257572322915
SU-DHL-6,11214940,-0.480666123434414
Granta-519,3101542,4.848909880356854
COR-L105,JQ-1-vorinostat (2-1 mol-mol),0.2989866544918393
BT 440,24964624,2.6928510355129927
SK-OV-3,54613361,2.1799599530092597
SaOS-2,navitoclax-MST-312 (1-1 mol-mol),0.5918912917357866
HuH-6,56946209,-4.611240881048409
PaTu 8902,9866186,4.760639543290191
BFTC-909,selumetinib-UNC0638 (4-1 mol-mol),3.893293421232559
MOLP-8,445455,4.348825488954634
U-BLC1,16659841,4.151706577666149
LS180,327653,3.1909584751660973
KHM-1B,123631,2.5623362967553858
LS180,selumetinib-JQ-1 (4-1 mol-mol),-1.4901017430136672
WM115,24889392,3.868386170167097
SK-CO-1,54618771,-0.118181134306818
SaOS-2,9868037,3.691858985861763
ST486,selumetinib-MK-2206 (8-1 mol-mol),4.117228283235954
EB1,31703,-4.376231199236504
Granta-519,navitoclax-PLX-4032 (1-1 mol-mol),-1.627997667174391
SUP-T11,656346,0.3721210755167811
HCC15,10385095,2.335943691067567
MOLP-8,2874250,4.289349020932475
BT 440,46199207,1.667271391694573
IA-LM,selumetinib-PLX-4032 (8-1 mol-mol),3.550842721167267
SNU-886,4259181,0.9120616711669954
SU-DHL-1,44137675,2.905771721153928
SW948,16038120,-0.173493225813213
SK-MEL-2,25126798,4.248838874551961
F-36P,5113032,4.480699930422071
SW1271,387447,-4.431171658059158
ST486,9803433,4.329929032741333
HCC15,71304818,2.608087345638841
HuP-T3,navitoclax-pluripotin (1-1 mol-mol),0.368847097693027
SW48,44259,-0.1330653223053438
SNU-1079,17759555,2.6543037565820233
SK-CO-1,selumetinib-tretinoin (2-1 mol-mol),0.0609322450258742
SK-MEL-2,piperlongumine-MST-312 (1-1 mol-mol),1.4935345830806257
BFTC-909,216239,2.6603594422751136
MDST8,9825149,2.535214047656483
BICR 22,11625818,4.758067302616356
LS411N,6852167,3.3651093558735035
BICR 31,7251185,3.1852875333924415
ALL-SIL,25195348,0.8279476297727174
TTC-709,5460769,-2.125391207652167
KHM-1B,5329102,0.5280819798234874
U-BLC1,54649381,3.6511376697877806
SaOS-2,73707438,3.8840228628110336
BT 248,15983966,1.8194061419836256
Granta-519,selumetinib-MK-2206 (8-1 mol-mol),2.927373885066516
BFTC-909,17755052,1.7621152527207813
BT 248,selumetinib-PLX-4032 (8-1 mol-mol),4.4451180166492765
TTC-709,5494449,-0.4896193332244919
HuH-6,46191454,0.1403945637437633
F-36P,7326481,4.962276141349654
SNU-1079,JQ-1-vorinostat (2-1 mol-mol),-2.2513436662882396
KP-4,4788,5.576487975798441
U-BLC1,9903786,1.0981923916711085
MOLP-8,vorinostat-carboplatin (1-1 mol-mol),1.858459936032215
BT 248,24964624,0.9785580517881716
U-BLC1,60750,-0.1040049419534328
SK-CO-1,3815108,2.810447278858876
COR-L95,3025944,4.2211844332657344
RERF-LC-MS,9825149,2.3136516136403595
KU-19-19,72376,-1.7461965003174784
SNU-C2A,5951923,0.1819417747426109
K-562,568763,0.3044566284292496
SNU-626,15953870,3.7664057202558534
RERF-LC-Ad1,selumetinib-GDC-0941 (4-1 mol-mol),2.261809192633126
ML-1 [Human thyroid carcinoma],4521392,4.335063435629941
U-BLC1,9911830,2.345404263930682
Hep-G2,11427553,2.5788240600315686
Granta-519,6917907,-6.07944377191165
SK-OV-3,4788,6.178998906779571
JHUEM-1,11626560,1.4970385905639707
HARA [Human squamous cell lung carcinoma],3081361,3.3764732224556533
RERF-LC-MS,6852167,1.8897499878184068
RCC10RGB,2746,4.042085650474663
SaOS-2,54143018,-0.9786223984268784
SNU-1272,11485656,2.6947903691441795
SUP-T11,56946209,-4.786797512149852
HCC15,451668,4.7728580097586635
RKN,135999136,4.319110081529012
PE/CA-PJ49,45279963,3.800739735970884
ALL-SIL,11228183,-1.4217334963731665
JHUEM-7,53495165,-3.1314756111432236
RKO,568763,0.6942409100068829
JHUEM-7,46907787,-0.7019339701280191
SNU-626,400769,-0.2148716209020059
ES-2,452548,1.0267997327806584
SK-CO-1,71304818,2.179260281615582
SaOS-2,151289,0.9278405880660672
BICR 22,tanespimycin-gemcitabine (1-1 mol-mol),-1.0672550933922087
MDST8,241158,1.799926141571129
RERF-LC-Ad1,selumetinib-JQ-1 (4-1 mol-mol),3.573516405475977
BICR 22,11214940,1.8032425349242045
BICR 22,navitoclax-birinapant (1-1 mol-mol),0.9663061977057198
KHM-1B,3689413,-2.4012228391908783
LS411N,9825149,1.7370452341191267
K-562,72193861,0.1570904811456113
RKN,89928392,1.2442310560485252
HARA [Human squamous cell lung carcinoma],25150857,2.860855820493058
RERF-LC-MS,44493528,4.358183394704722
HuH-6,637858,1.0144806827186308
COR-L105,5738263,4.054674337055045
P31/FUJ,5280436,3.1830796623136832
L3.3,568763,0.380782352657369
Daudi,JQ-1-navitoclax (2-1 mol-mol),-0.7335137922261505
EB1,2733526,3.447260277924305
JHUEM-1,6918638,0.9428418212694492
LCLC-97TM1,135398516,2.1563049020997593
COR-L95,25102847,2.826830714185171
BICR 31,11427553,1.8414471938085448
KPL-1,5702613,4.684504126823282
P31/FUJ,navitoclax-MST-312 (1-1 mol-mol),-0.1859808943498902
NCI-H1395,4261,3.7287687859459377
IGROV-1,15547703,3.339928221860449
LS411N,navitoclax-PLX-4032 (1-1 mol-mol),1.1305163231038025
LS411N,6918328,-0.170211770014818
KHM-1B,selumetinib-navitoclax (8-1 mol-mol),1.5654531920852657
ST486,44607531,1.322576674301562
Daudi,3136844,3.4483363469146098
BT 248,46398810,1.9244684206215508
MOLP-8,10302451,3.559537910744256
BT 440,107985,-3.431835776853905
LCLC-97TM1,24772860,-2.203105978452304
SUP-T11,54626689,4.242369080519398
KP-3,23725625,6.634630648563009
SK-OV-3,selumetinib-GDC-0941 (4-1 mol-mol),2.556628673081414
ML-1 [Human thyroid carcinoma],637858,1.1825057393141218
Mino,9826308,-0.261908335215675
SW1271,119182,-0.4023310904747799
RERF-LC-MS,135398516,2.452363199699896
SK-CO-1,44495899,4.504236306700641
Ishikawa (Heraklio) 02 ER-,135423438,4.463987581910629
IGROV-1,10127622,3.2581804056600165
SK-CO-1,44491742,5.1736211152382285
MOLM-13,4477,0.1750371811238646
WM115,25183872,-1.8696572442850008
BFTC-909,JQ-1-navitoclax (2-1 mol-mol),1.710597904541152
PE/CA-PJ34 (clone C12),9866186,0.7220729418823932
LS180,JQ-1-MK-0752 (1-1 mol-mol),0.6783898145505391
NCI-H1395,72193861,3.743948008436619
HCC1500,5335621,4.362965892261437
P31/FUJ,1716436,3.053886593694114
Daudi,9915743,0.3665260221427978
UACC-812,selumetinib-MK-2206 (8-1 mol-mol),1.487616505543695
SK-CO-1,5311281,1.7217135985324663
IGROV-1,3503,2.453392942972796
SW948,17755052,0.6738246482480579
Granta-519,5329102,1.3717145166802862
U-BLC1,31703,-1.2568827316027975
HCC15,25183872,1.7330298559310635
HT-1376,71466380,5.432813837555697
PE/CA-PJ34 (clone C12),5281672,4.445747577315385
IGROV-1,23635314,-0.611739968448912
KLE,5281321,-2.410398691037867
HuP-T3,46174525,5.4457837824532245
IGROV-1,46199207,3.293579955374855
NCI-H1568,11656518,0.902462789439692
SW1573,12001922,2.294011710402099
KP-3,327653,2.831253990169757
HCC1500,navitoclax-sorafenib (1-1 mol-mol),-0.1825981932609776
ML-1 [Human thyroid carcinoma],6918289,2.565001109569917
JHUEM-7,637858,1.2462680133442194
SW948,2871966,1.833559506117821
SEM,71576739,-1.1799480290235729
RKO,42642645,1.3055497818976145
NCI-H2452,6450551,2.947106204512916
ES-2,16741245,2.515092709706159
P31/FUJ,10302451,4.186780329312711
F-36P,2749,1.5924157491502826
P31/FUJ,6918837,-4.676526715032863
SNU-626,219104,4.326082289782503
NCI-H1395,71304818,2.2994001148699414
HuP-T3,3552672,1.4793505278318
BFTC-909,25105715,3.3944682152224455
HEL,44197249,3.8651368484410056
HCC15,JQ-1-MK-0752 (1-1 mol-mol),3.1823820949476564
SNU-886,3025944,4.270077013000682
SNU-1079,387447,-4.985394780237214
JHUEM-7,44486219,4.165203149222617
BICR 31,46215462,1.6669957894505008
KP-4,656346,-0.2586646350408599
HuP-T3,9866186,1.729562359157257
HuP-T3,11717001,4.25253085122872
SK-MEL-2,vorinostat-navitoclax (4-1 mol-mol),1.004224473149691
HuH-6,89928392,1.6551411582020337
NCI-H1568,54618164,3.652866089784218
NCI-H1395,135411,0.822890110332085
DLD-1,navitoclax-gemcitabine (1-1 mol-mol),-0.2324606657432954
WM115,441298,3.225500618866892
U-BLC1,9956119,2.0617958873702302
PK-1,409805,3.919077042185541
LS411N,71304818,3.0616651991102697
NCI-H1568,navitoclax-sorafenib (1-1 mol-mol),1.4784994486098395
SK-HEP-1,10184653,3.249474772070569
BT 248,5738263,3.817096252163507
HuH-6,374536,-0.5041178583364099
SNU-1272,JQ-1-UNC0638 (2-1 mol-mol),2.22691909239422
BT 440,1716436,3.0638178772704663
BICR 31,12003241,-1.4237270953299652
NCI-H1395,49766530,-2.8850236043305792
RERF-LC-MS,25150857,3.1332692975488934
COR-L95,24964624,2.1587115359420994
YD-15,452548,-0.3099947674256629
SU-DHL-1,44241473,4.633491620971472
HARA [Human squamous cell lung carcinoma],72193861,-0.0489023079435419
SK-LMS-1,selumetinib-piperlongumine (8-1 mol-mol),4.535111432562131
ML-1 [Human thyroid carcinoma],11152667,-4.726499990059393
BT 440,5470400,2.0714108564658806
MOLP-8,6918878,0.495059053850733
ST486,12003241,-0.1204499968223502
KP-4,1285940,4.496309170142005
KP-3,5328940,1.36733478259693
PE/CA-PJ34 (clone C12),crizotinib-PLX-4032 (2-1 mol-mol),2.0573857462256124
RCC10RGB,448949,3.406339167429426
PE/CA-PJ34 (clone C12),54626689,4.8339545787356215
BT 440,400769,-0.4013118274716415
KPL-1,3081361,2.97567022702805
JHUEM-1,568763,-0.4287766600692369
HCC1500,148124,1.3380754252474834
HT-1376,9840324,6.149784887811458
MKN1,selumetinib-UNC0638 (4-1 mol-mol),5.332828067539163
HuH-6,56963564,1.848968297204233
HCC1500,5280436,1.8565158203383687
KMS-21-BM,66577038,2.016901797665878
KMS-21-BM,753704,3.635259602882489
IGROV-1,10302451,0.4135234554742116
Granta-519,285033,-4.09305161448312
PE/CA-PJ34 (clone C12),vorinostat-carboplatin (1-1 mol-mol),4.08253378532113
HT-1376,5329102,2.4747618598435213
PE/CA-PJ34 (clone C12),46926350,-5.351224463970161
HEL,JQ-1-navitoclax (2-1 mol-mol),-0.660921199279695
RERF-LC-Ad1,9936388,2.559895364863056
ES-2,BRD-K03911514,4.8703263552483
KHM-1B,54618164,3.3281109403552795
DLD-1,446155,2.707932045716472
Granta-519,71304818,1.7993370678919798
NCI-H2452,3689413,1.184555113675537
SEM,9549297,0.9674551206649342
IGROV-1,2708,4.438419625543199
PE/CA-PJ34 (clone C12),24964624,2.1602822275221354
ST486,36462,0.4017650011004973
SW1271,49850262,4.063818012025616
BT 440,322968,2.9597028863932513
LS180,6918736,-2.1262365465987907
U-BLC1,25102847,1.957760874104329
BT 440,11404337,-1.269417175966202
EB1,5479543,1.9273332349677403
U-BLC1,BRD9876-MK-1775 (4-1 mol-mol),-0.2967168988005757
PaTu 8902,10127622,6.3250626499292295
SW1271,57519531,1.4534695216386555
RERF-LC-Ad1,doxorubicin-navitoclax (2-1 mol-mol),0.6040282925735914
SK-LMS-1,71466578,6.071547313669305
HCC15,57519531,1.9577451103636032
SK-HEP-1,navitoclax-PLX-4032 (1-1 mol-mol),2.657614017988428
SW48,44185566,0.7812235367324193
Granta-519,navitoclax-birinapant (1-1 mol-mol),-1.2889388818955343
KLE,322968,2.787841827259593
Mino,44489675,3.4027989138594426
KU-19-19,241158,4.34083218708613
NCI-H1568,11404337,-0.63897934294681
Granta-519,219104,2.15431657191886
RERF-LC-Ad1,25183872,4.290443599779795
SK-CO-1,5746,-2.8271360432483035
KP-4,16720766,-1.213576786632785
WM115,6918837,-2.450050091846588
SK-CO-1,11152667,-1.1935109806009474
SW1271,9825149,2.2012182796133084
SaOS-2,208908,2.5337103611164893
JHUEM-7,446155,2.408217764237835
JHUEM-2,1242560,2.740477817380448
SW48,5470400,-1.7303817372543355
HT-1376,24821094,3.2907773358663386
JHUEM-7,11964036,0.7648051456612326
HT-1376,2708,5.152410367592072
NCI-H1568,JQ-1-UNC0638 (2-1 mol-mol),1.923479920407172
SW48,15547703,3.0370188863847414
SW948,46907787,2.3709287142369555
Hep-G2,11960529,4.314757049098683
F-36P,219104,2.5737623705635557
Daudi,5113032,4.739966647777949
KMS-21-BM,6918837,-5.713538444190362
SaOS-2,135984461,4.8186429168984475
MDST8,168313047,3.800021027786958
LMSU,73707398,1.6424339360302744
RCC10RGB,11964036,2.4986740771219673
SW1271,24785538,1.505278847517323
BFTC-909,3676137,5.055523871435828
SEM,6438330,0.6807940195950141
SW48,9868037,2.459515994210572
KU-19-19,10231331,0.2937024112037242
ALL-SIL,54619267,3.6744484896003713
ST486,44607530,0.9493425940733242
KMS-21-BM,3038522,2.690125573773153
BICR 22,selumetinib-BRD-A02303741 (4-1 mol-mol),2.600469012399248
SEM,3552672,5.542055720565402
Ishikawa (Heraklio) 02 ER-,656346,1.2848156729993665
Hep-G2,25150857,1.869528617252537
RCC10RGB,24951314,2.138755705452886
SEM,selumetinib-navitoclax (8-1 mol-mol),-0.6843578882476046
SU-DHL-6,26596,-1.882707371112463
COR-L105,46843906,1.9821208299636863
EB1,45100481,4.5527853199355865
T98G,11609586,3.6022873015417467
LMSU,JQ-1-vorinostat (2-1 mol-mol),2.553257799343416
EB1,2742550,2.859851248001829
RERF-LC-MS,4477,-0.1141702320643991
JHUEM-2,navitoclax-gemcitabine (1-1 mol-mol),-3.0728807368375866
MOLM-13,49766530,-2.4914272268054107
SK-CO-1,4917,2.9299888563447163
Daudi,72734382,3.17690285998388
SEM,1716436,1.599764996763199
LMSU,3025944,4.305577187870561
SK-LMS-1,9956119,3.722389147017188
T98G,46174525,5.284633861827749
SUP-T11,11152667,-4.45703936760011
LCLC-97TM1,11625818,5.063433550011292
LS411N,vorinostat-navitoclax (4-1 mol-mol),1.2590657469614004
U-BLC1,9884685,1.006082357042544
SEM,15983966,-4.919276038332578
ALL-SIL,451668,-1.1904263441284522
PE/CA-PJ34 (clone C12),25062766,1.9208580751990545
T98G,11625818,4.56891105621276
SK-CO-1,219104,3.537047767593632
Mino,374536,1.2898948128821337
NCI-H2452,65064,5.258935158123576
NCI-H1395,1750826,-3.702055011401398
BICR 31,25062766,2.0025728701089904
SUP-T11,vorinostat-carboplatin (1-1 mol-mol),2.6945706132708396
LCLC-97TM1,4261,1.8883571230172835
BFTC-909,54618164,4.281231487810877
NCI-H2452,16736978,0.9447398024439234
NCI-H2452,selumetinib-BRD-A02303741 (4-1 mol-mol),6.449127799684226
ML-1 [Human thyroid carcinoma],selumetinib-decitabine (4-1 mol-mol),4.367801531941202
WM115,6917907,-5.049795628811172
HuP-T3,5746,1.6464242063318688
BT 440,25150857,2.3550754454349345
MOLP-8,327653,2.384727852533787
SW48,72376,-3.1415011638088144
LMSU,135999136,4.828023886470807
SK-HEP-1,23582824,1.0257570544783106
K-562,12001922,1.1213264373636214
ST486,16659841,3.1301708015214063
Mino,44566777,-1.2832302862660665
WM115,10410894,3.2188686198907743
KHM-1B,10077130,2.7522927679914764
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681
ML-1 [Human thyroid carcinoma],49850262,3.5297334075235245
KU-19-19,44819697,-2.543386759740491
LS180,46199207,2.9384583216685023
LS411N,56946209,-3.80128700519076
LCLC-97TM1,6918289,3.014261251605047
KPL-1,119607,5.977049015026837
EB1,168312962,2.0731967141226746
KU-19-19,107970,3.004209688555129
SNU-1079,46174525,2.4458926098752167
DLD-1,156414,1.998485037364128
SUP-T11,9887053,1.8662970056119592
JHUEM-1,alisertib-navitoclax (2-1 mol-mol),-1.5654570972009862
MOLP-8,72376,-3.958595065171294
IGROV-1,5291,3.6852809555447985
KP-3,5278396,4.221246896581015
Granta-519,46191454,0.5060764897707477
ES-2,51037431,1.71795822072505
F-36P,6505803,-0.1070428944453584
SNU-886,UNC0638-navitoclax (1-1 mol-mol),-7.5974579555081725
SNU-1079,72734382,1.6208697480531455
COR-L105,24901704,3.8942422617258714
NCI-H2452,24797083,2.030715286150645
KHM-1B,55283,0.1410687049284859
SEM,53301938,6.1537936140173715
HT-1376,24901704,4.0645751727466894
KP-3,52947716,1.3547543214080018
NCI-H2452,124202324,3.032884210730814
LCLC-97TM1,4259181,-0.2611730486969081
F-36P,JQ-1-navitoclax (2-1 mol-mol),-0.882935111364826
KU-19-19,73707440,5.592820593626321
PE/CA-PJ34 (clone C12),11656518,2.490076098843588
SNU-1079,crizotinib-PLX-4032 (2-1 mol-mol),1.5297266240743137
RKN,5460769,5.79272629497122
SNU-1079,piperlongumine-MST-312 (1-1 mol-mol),2.0932421156472136
RKO,10184653,1.6814092199651305
PaTu 8988t,24180125,3.300808715406375
COR-L105,2858523,3.082532365215724
PE/CA-PJ34 (clone C12),6918328,0.8445281698362359
U-BLC1,2949965,2.0497308590009875
BICR 22,decitabine-navitoclax (2-1 mol-mol),1.4331437420597166
SNU-886,3038522,3.968715088935437
LCLC-97TM1,16065773,3.044024356255971
MOLM-13,16115403,-5.622868208190141
Daudi,104842,-7.567274671559235
JHUEM-2,crizotinib-PLX-4032 (2-1 mol-mol),0.3061519117768961
PaTu 8988t,3825829,4.270364787448243
HuP-T3,227681,2.514870644267688
ML-1 [Human thyroid carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.142388159439524
COR-L105,11964036,1.2117851204645589
SW1271,135659046,3.922158232881772
IGROV-1,4917,2.985904350427039
PE/CA-PJ34 (clone C12),1239801,5.087439693870939
HCC15,9826308,1.2579647962340863
SK-OV-3,46199207,3.479599233509405
KU-19-19,2729026,3.069520174525383
SK-LMS-1,12001922,2.30628088963523
COR-L105,25102847,1.810865395215699
SW1573,9935249,2.8664920450292852
COR-L95,1714884,3.7968274989469992
PaTu 8988t,7251185,3.286029674356028
SK-CO-1,24856436,0.7128954142297991
BT 440,46191454,2.139517382959351
HuH-6,68056272,2.2610599110639584
U-BLC1,10427712,3.694155129611972
HCC1500,5738263,2.955373895930653
SU-DHL-1,6914657,-4.020831804674196
SW48,638278,3.16751315896482
LCLC-97TM1,135421197,1.517750954289076
ML-1 [Human thyroid carcinoma],11404337,0.3501599152959295
HuH-6,2746,2.1362629951594396
PK-1,selumetinib-MK-2206 (8-1 mol-mol),1.8346296755800415
BT 248,erlotinib-PLX-4032 (2-1 mol-mol),2.9999117563905497
HT-1376,44507138,1.777436835199481
SNU-1079,49867926,4.301323176310995
Mino,1641662,2.553654686023489
HuH-6,57330099,3.538159459856302
EB1,216239,1.0454019095358082
RERF-LC-MS,selumetinib-decitabine (4-1 mol-mol),3.240984973519631
NCI-H1568,6914657,-5.120590256929669
NCI-H2452,3676137,5.703513737309888
DLD-1,4788,6.248254959247432
PaTu 8988t,11238147,3.9795465318298526
RCC10RGB,5113032,2.807854627845623
SNU-626,66577038,3.4159946573498545
IA-LM,44607531,1.5934898700442923
MOLP-8,BRD-A02303741-carboplatin (1-1 mol-mol),5.885720002784475
EB1,54678924,0.6093351442500052
T98G,selumetinib-BRD-A02303741 (4-1 mol-mol),7.193597379594884
PK-1,5281321,-2.200055188511965
ST486,1641662,2.68482692129872
BT 248,24772860,-1.8114686790878316
T98G,374536,-0.154456492909018
SW1271,docetaxel-tanespimycin (2-1 mol-mol),1.954654024202385
RKN,3815108,2.827407220517517
YD-15,124202324,2.1174247302685547
IGROV-1,448949,2.098499309472767
BICR 31,5426,4.483861121335425
Hep-G2,1750826,0.4131687532811144
F-36P,51039095,2.487902780352121
ES-2,11964036,3.418489657899656
JHUEM-1,46215462,1.541338188087761
DLD-1,3136844,4.367343669003209
PE/CA-PJ34 (clone C12),72376,-1.7240853207922306
SK-OV-3,322968,3.987773865251791
BFTC-909,15953870,3.192835350037467
BFTC-909,4378219,4.497242068417329
COR-L95,54143018,1.379812266453913
PE/CA-PJ49,56963564,-0.0152605899958885
SNU-626,36462,1.8578593274486852
SU-DHL-1,11612883,2.467580560997241
COR-L105,alisertib-navitoclax (2-1 mol-mol),1.2187125492955395
LS180,5978,-1.0800938866172374
NCI-H1568,44566777,1.438409258191859
BICR 31,42642645,1.5553576315566706
MOLM-13,654092,-2.113392174262404
LS411N,124202324,2.3656166654970137
RERF-LC-Ad1,10074640,3.528026148983471
SU-DHL-1,5329102,0.4187283879213827
F-36P,374536,0.4233765448194311
KP-3,25262965,-0.5859350687588153
PE/CA-PJ34 (clone C12),25150857,2.980955844336646
Mino,53392493,1.860544411834529
F-36P,BRD-K55473186,1.7794978116408715
SK-LMS-1,3854666,1.8023710888832385
NCI-H1395,16725315,5.329149992697811
Daudi,51037431,1.7669670215364446
RERF-LC-MS,45279963,3.7797867340420215
IGROV-1,49850262,4.068828647042517
BICR 31,12001922,2.662375748901725
IGROV-1,49793307,-2.5291790820063538
KHM-1B,navitoclax-gemcitabine (1-1 mol-mol),-2.36446973278894
PaTu 8902,2828334,6.440933390339598
SU-DHL-1,24951314,0.6018835624310062
MDST8,676352,2.6149374435458643
YD-15,56963564,-0.5458549296997978
HARA [Human squamous cell lung carcinoma],3503,1.5305596721968624
SEM,decitabine-navitoclax (2-1 mol-mol),-3.4991748591618026
MOLP-8,44185566,2.3020252385384747
RKN,44137675,5.459450119186335
T98G,25227462,2.1611049007909746
BT 440,25126798,4.665127437143434
SNU-626,tretinoin-carboplatin (2-1 mol-mol),4.7219253265207985
SU-DHL-1,216239,2.4334915471860064
RCC10RGB,5328940,2.5920229504771264
MOLP-8,5351362,0.578803181676615
SNU-626,navitoclax-PLX-4032 (1-1 mol-mol),2.037326178582341
SNU-1079,2742550,1.6275760819084113
SNU-1272,2733487,6.387054792356426
KU-19-19,4521392,6.281175440463305
HuP-T3,219104,4.090562015064086
KLE,SNX-2112-bortezomib (250-1 mol-mol),3.268766111238186
SNU-1272,119607,5.048435737669013
BICR 22,16722836,2.37465920140225
Granta-519,54678924,3.4908303220152512
TTC-709,7251185,1.487805929975793
SNU-886,selumetinib-PLX-4032 (8-1 mol-mol),2.129242673373235
SW948,5738263,3.889172676108031
HuH-6,135398738,4.323663215233769
SNU-C2A,25154868,4.207436372965709
SW1271,9549297,2.1335240165820606
PE/CA-PJ34 (clone C12),11485656,1.7983954039931191
SUP-T11,17759555,2.3804594400876997
BT 248,5278396,3.9189937549477545
MOLM-13,5280436,3.611781786093365
BICR 22,3062316,1.4778056821676904
U-BLC1,25227462,0.3621826452267034
KLE,72193861,1.934481049124771
HCC1500,46191454,2.281809335685502
PE/CA-PJ34 (clone C12),salermide-PLX-4032 (12-1 mol-mol),5.538851904722065
HARA [Human squamous cell lung carcinoma],445455,6.075035505832661
SK-LMS-1,selumetinib-PLX-4032 (8-1 mol-mol),3.876084734472564
SW48,9549297,0.4487326680785643
SK-OV-3,46843906,3.785109660734252
NCI-H2452,5351362,1.571040634520482
RKO,56946209,-3.445993729976747
SK-MEL-2,1641662,3.543782529063033
SaOS-2,56649450,2.657103116813459
KU-19-19,doxorubicin-navitoclax (2-1 mol-mol),-0.7241135755509572
LS411N,23725625,5.218761480016774
Ishikawa (Heraklio) 02 ER-,2828334,6.021759925612071
JHUEM-7,1641662,3.469626078091439
RERF-LC-MS,4578,4.625372786711685
Mino,24964624,2.588955626460596
MOLM-13,11507802,1.0337656748409854
SW48,65064,5.106206142410259
YD-15,375860,-0.9866922587532774
HCC15,2828334,6.579413009448801
HuH-6,156414,1.109377454710629
SaOS-2,4378219,3.572923749570723
BFTC-909,23939,4.493588141952023
TTC-709,5978,-3.1207384485278427
SEM,9915743,-2.2587042117517284
RCC10RGB,439501,-2.548266242367821
SW1271,3815108,3.2377532103389832
T98G,135440466,2.3458307113003154
P31/FUJ,5287620,-2.889875327880449
HARA [Human squamous cell lung carcinoma],448949,2.536052822584039
SEM,11497983,-3.9195966802486417
SUP-T11,82146,3.194106565397881
LS411N,5281321,2.872375461605106
ML-1 [Human thyroid carcinoma],4917,3.4875612389510184
MOLM-13,16736978,-0.7178102164081313
HuP-T3,24964624,2.5347495437600753
SW1271,3038522,2.6397404309625574
NCI-H1395,navitoclax-birinapant (1-1 mol-mol),3.789667753469327
PE/CA-PJ34 (clone C12),44486219,4.215930684165307
SK-OV-3,6852167,3.0870556066687076
BT 248,11175137,2.43855252671782
PaTu 8902,25262965,1.559985123462204
MKN1,9952709,3.2563420730369113
JHUEM-1,89183176,2.1561937867464835
PaTu 8988t,89928392,1.7442497788257625
RCC10RGB,5494449,5.764110819730859
ST486,15547703,2.946033757729673
LS411N,JQ-1-carboplatin (1-1 mol-mol),1.929098606006951
SUP-T11,24856436,-0.3280231706915338
Daudi,5282054,2.334684985175564
MKN1,4477,2.56939280324215
KP-3,262093,2.764663205540099
SUP-T11,54454,2.1246632815852156
F-36P,54618795,2.814651179040886
SK-LMS-1,9840324,5.765370049448171
KLE,637858,1.7560393431403896
SW1573,9866186,2.2605214925080035
SK-HEP-1,16013152,4.2454363352103925
IGROV-1,11647372,-0.6595372928368528
LMSU,1750826,-1.6926974789891744
RKO,60700,-0.2024014556335324
SaOS-2,66577038,3.461550546017496
SK-LMS-1,54626689,5.075089494785208
BICR 22,6918638,0.0558003797401064
YD-15,219104,3.860885680883743
Mino,6252,-3.978875801469766
SK-MEL-2,54618771,2.1400716929659045
JHUEM-2,119182,-2.845517432103176
NCI-H1568,6918878,3.5715267618547832
RKN,17755052,4.615024850417848
RKO,10385095,1.2981289243482117
SNU-C2A,17759555,3.6952984233362343
EB1,969516,2.013044307670012
NCI-H1568,25227462,1.3523005990409367
IGROV-1,168313200,3.9938362637732983
LS180,52912189,2.5201251776162454
SK-OV-3,446155,4.068831864004445
T98G,6917907,-4.363416532464491
SaOS-2,2729026,3.0079080963172573
Mino,44819697,-1.7257207544810818
ST486,126941,-4.4761821230083365
SNU-886,25154868,3.4253449790012804
COR-L105,24785538,1.9787344511962284
SEM,BRD9876-MK-1775 (4-1 mol-mol),-0.9190635288333102
WM115,9549297,1.875565618317202
COR-L95,53392493,1.7864953470488698
SaOS-2,219104,3.933074432676362
WM115,3854666,2.6196721416111024
TTC-709,107985,-3.8889296232752737
PaTu 8902,11626560,1.9806688551606229
P31/FUJ,24901704,1.8625310117446785
IGROV-1,9911463,4.195269991960018
LCLC-97TM1,216468,0.7418366776466117
MOLP-8,387447,-5.214034261316855
ST486,71466380,3.461409875337121
RCC10RGB,16722836,2.017391543442539
Mino,400769,-3.7996984437734858
IGROV-1,JQ-1-vorinostat (2-1 mol-mol),0.7179438393808574
SW48,5311281,1.5627745937535438
KPL-1,168312962,3.612461738667678
JHUEM-1,168312962,-0.2217536648144089
MOLM-13,11497983,-4.003769607545663
PE/CA-PJ49,46174525,4.261402269559326
SUP-T11,navitoclax-gemcitabine (1-1 mol-mol),0.0607702894205145
KLE,44185566,2.7760403729820085
ST486,72376,-4.671121338417478
KU-19-19,2858523,2.990442019675252
COR-L95,11626560,1.5180153972734145
WM115,123631,1.7981952102566006
RERF-LC-MS,2874250,4.628157945253743
SNU-C2A,6918328,0.0841329577663591
T98G,10184653,3.4203703557346925
MOLP-8,65064,3.020382379730844
RERF-LC-MS,3854666,0.8294073497518095
HCC15,3689413,0.3467742153458734
PK-1,24856436,2.255058867690895
HCC15,25150857,2.8177810894811786
LCLC-97TM1,46174525,4.403281113181967
SK-HEP-1,31703,0.3185055118054912
LMSU,49867930,4.439231756123768
BICR 22,123631,2.0553358195001383
MKN1,119607,5.819118619385113
BT 248,24779724,5.957496049021181
Panc 02.03,selumetinib-PLX-4032 (8-1 mol-mol),3.6013795626113163
ML-1 [Human thyroid carcinoma],JQ-1-vorinostat (2-1 mol-mol),1.0159563388217403
COR-L105,11213558,1.6245415685033464
KMS-21-BM,73707386,2.971597915568964
SNU-1079,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1061690504774735
Mino,60700,-3.897810408946044
Hep-G2,5278396,5.277054746379456
COR-L105,3689413,-2.1605707630353708
MOLP-8,4917,1.932746630984224
HEL,11238147,1.9261110470981635
HCC15,46907787,1.7788170946404287
HCC1500,3062316,2.994925150114549
PE/CA-PJ34 (clone C12),24821094,-0.2762581028984301
JHUEM-2,246676,4.384067932362518
MOLP-8,9935249,-5.983061984872936
T98G,serdemetan-SCH-529074 (1-1 mol-mol),2.4123174113839165
IA-LM,135398516,1.3190430503048431
RERF-LC-Ad1,5746,2.3313775446459326
NCI-H1568,6917907,-6.013699668749745
RERF-LC-Ad1,24964624,3.310681300814033
SUP-T11,241158,1.0042355726441765
PaTu 8988t,25062766,2.121196656552597
HARA [Human squamous cell lung carcinoma],49793307,-3.043253960744797
BICR 22,JQ-1-carboplatin (1-1 mol-mol),2.1312623877062125
JHUEM-1,45279963,3.7071800957412298
TTC-709,60700,-1.6146661198350285
HCC15,3825829,3.261310602619802
SaOS-2,36314,-6.649536011740597
BFTC-909,54613361,0.5481358040879688
HCC1500,navitoclax-MST-312 (1-1 mol-mol),-1.0378024218006647
NCI-H1395,462382,1.900499609260616
KU-19-19,135999136,4.912207411852192
HCC15,126941,-2.714458984381298
KP-3,5738263,3.1756712094586823
K-562,387447,-4.172741798582805
L3.3,1566236,3.261153981033622
BFTC-909,400769,-0.3884900564724624
HT-1376,3503,2.3470715675736864
DLD-1,navitoclax-PLX-4032 (1-1 mol-mol),0.7241411526753145
ST486,25105715,3.0268096154032187
SW948,serdemetan-SCH-529074 (1-1 mol-mol),2.314613339768124
PE/CA-PJ34 (clone C12),53495165,-1.0427588967994468
K-562,19582717,3.29667086675107
BT 248,tretinoin-navitoclax (4-1 mol-mol),2.6015159736685187
LS180,676352,2.815097827506973
SK-CO-1,5278396,2.886619996042885
SW1271,654092,-0.6724961197062129
PE/CA-PJ49,262093,3.242343498921695
TTC-709,serdemetan-SCH-529074 (1-1 mol-mol),1.4002586622419813
BICR 31,984333,1.688597902845401
Hep-G2,387447,-2.9195151512018427
ML-1 [Human thyroid carcinoma],3854666,0.5957604923029644
KHM-1B,11485656,1.807132568777105
HT-1376,387447,-2.8643924716279905
PaTu 8902,6918328,0.0837665640709721
KLE,68056272,3.842115579712106
KU-19-19,25126798,3.8528221502524262
SW48,BRD-K27188169-navitoclax (2-1 mol-mol),2.506636688150973
BT 248,BRD-A02303741-navitoclax (2-1 mol-mol),1.4606318161646668
T98G,17755052,2.806569308955455
SNU-1079,alisertib-navitoclax (2-1 mol-mol),0.0131319264131791
K-562,984333,1.160515473081413
KHM-1B,25126798,3.5572512627861053
SEM,25161177,4.0488319816215
BICR 22,4261,1.6582900308021409
SNU-1079,11222830,1.6873967904148457
P31/FUJ,24753719,3.279397605233023
RKO,89928392,1.6264666324972337
ML-1 [Human thyroid carcinoma],11364421,-5.159158552339723
MOLP-8,2746,0.9128995235322724
PaTu 8988t,44589607,3.069724280166482
Daudi,55508,3.074140286884227
SEM,11656518,-0.9335747644896384
PE/CA-PJ49,3025986,-1.5535145146447582
IGROV-1,53232,2.4872106086763393
HCC1500,11178236,-0.8618797474299623
KP-4,60750,-3.857385032944416
SW1573,11228183,1.3544411199442492
KPL-1,1716436,3.0436551779675134
SNU-626,sirolimus-bortezomib (250-1 mol-mol),0.2861431467696579
JHUEM-2,15983966,-3.794102532594791
KHM-1B,4788,4.7580664761718054
ALL-SIL,docetaxel-tanespimycin (2-1 mol-mol),-8.351495985477111
HCC15,151289,0.5818248951012718
Hep-G2,2858523,3.0476821102731977
KP-4,46398810,3.1557442071121606
RKN,navitoclax-sorafenib (1-1 mol-mol),2.725354143371073
LCLC-97TM1,9956119,3.701469228999412
TTC-709,23582824,0.8942004059365072
LS180,65064,5.333283055182179
Panc 02.03,1566236,1.9322803720882225
WM115,UNC0638-navitoclax (1-1 mol-mol),2.6292832027586783
COR-L105,5311281,2.5909348271223833
COR-L105,4261,1.037866526492344
PE/CA-PJ49,52947716,3.1703776332713076
ST486,3136844,2.8815145387316883
EB1,285033,-5.78591996070256
MOLM-13,6505803,-3.0527041000310255
SaOS-2,24797083,1.1743557883271736
NCI-H1568,selumetinib-GDC-0941 (4-1 mol-mol),1.6241640738587435
RERF-LC-Ad1,10385095,3.535917584536634
PaTu 8988t,44819697,-1.4855632158782932
IGROV-1,JQ-1-vorinostat (2-1 mol-mol),0.7179438393808574
EB1,46199207,1.6810006441161798
MOLM-13,136227924,1.704251401840426
K-562,11955716,-2.44804051648688
KMS-21-BM,2858523,2.1440542417878845
JHUEM-7,9887053,4.4427477773471145
L3.3,11612883,3.0937227516492767
Ishikawa (Heraklio) 02 ER-,54613361,-0.1781833955889748
PaTu 8988t,119607,6.161307312166748
COR-L95,71466380,4.385390307812106
SNU-626,11404337,1.6916289336018857
Hep-G2,72193861,3.225479457080403
SW48,400769,-1.161678790289576
SK-MEL-2,serdemetan-SCH-529074 (1-1 mol-mol),2.355751476848307
SUP-T11,54618771,1.250827086156436
SNU-1272,135421197,2.338787330458388
JHUEM-2,ISOX-bortezomib (250-1 mol-mol),-0.3997303648692711
BT 440,23582824,1.502242895568712
EB1,25195348,2.4444302112996787
SK-HEP-1,54618771,0.9570801540222316
SNU-1079,71304818,2.457957395727412
U-BLC1,71466380,4.0328942477361425
Daudi,10410894,2.7348964142664096
P31/FUJ,8515,2.4023085754769133
MOLP-8,12001922,1.340541943266141
SaOS-2,24180125,2.5037581025896896
HT-1376,2746,3.1690827101181736
LCLC-97TM1,11497983,-3.4928977535107872
KHM-1B,654092,-1.7753167598635085
KU-19-19,54618771,0.4920305765445359
BFTC-909,9826308,0.9467806471528852
HEL,6252,-2.3526628041976547
PaTu 8902,1750826,3.002378182351502
PK-1,9927531,5.928994406522703
JHUEM-1,60700,-0.539168935345839
HEL,375860,-0.4243086466742362
SK-CO-1,erlotinib-PLX-4032 (2-1 mol-mol),3.6761827416716737
LCLC-97TM1,44137675,2.6535109564984403
BFTC-909,4096211,2.208598833058293
SW948,piperlongumine-MST-312 (1-1 mol-mol),2.3670131047839496
SK-LMS-1,10427712,5.025364154165243
MDST8,serdemetan-SCH-529074 (1-1 mol-mol),2.3277787595180417
ML-1 [Human thyroid carcinoma],46215462,1.6577528274030604
ES-2,decitabine-navitoclax (2-1 mol-mol),3.9822555274611178
U-BLC1,44137675,2.871487804986424
SNU-886,11647372,1.0041621658196034
SK-CO-1,10231331,-0.7210930575000714
RERF-LC-MS,9908783,5.63449812951243
KP-3,1714884,3.70641046699709
SUP-T11,67156097,-3.0924499025849075
SNU-1079,navitoclax-gemcitabine (1-1 mol-mol),-2.1997456524190744
SW48,BRD-A02303741-navitoclax (2-1 mol-mol),2.3907101942881392
SaOS-2,navitoclax-birinapant (1-1 mol-mol),2.783475564423097
SNU-1272,16038120,1.164758471385012
SaOS-2,54618795,3.185724709117328
PaTu 8988t,637858,2.5993481939897314
HEL,984333,-1.1600295079037413
HCC15,2841722,4.4106331963661285
SW948,676352,1.6772543111300298
HuH-6,11152667,-2.162019568572356
BICR 31,24964624,2.1782924417506235
MDST8,984333,1.6302493723588198
SaOS-2,25102847,2.0054521503393956
NCI-H1568,11396600,3.496587037401377
SK-MEL-2,5978,4.555773696257843
L3.3,3384730,1.5710194033023062
SU-DHL-1,25126798,1.813712960287442
MOLM-13,445091,4.269392983422825
TTC-709,5351362,1.1694719298263472
IA-LM,6918328,0.468629569752011
U-BLC1,54619267,4.119368741028011
KP-4,613753,3.0855452721954326
RKO,16038120,2.1201165412688385
U-BLC1,50905018,4.3723794233984545
SUP-T11,654092,-1.6677568110323533
Daudi,3689413,-4.376822515219121
LS411N,1750826,2.0365622567800985
SU-DHL-1,selumetinib-GDC-0941 (4-1 mol-mol),2.071258944893258
SNU-626,11455910,1.8288059017639848
L3.3,44486219,4.220339607908531
JHUEM-1,216345,2.3705916516285157
LS411N,11640390,3.2208706785393972
KP-4,5351362,1.0460255800913
Hep-G2,3503,2.878453369176515
SK-OV-3,2729026,2.529477515357917
BICR 22,1317464,3.72634745746102
F-36P,71751553,4.682679613514395
JHUEM-2,100016,5.904304927611702
PaTu 8988t,6917907,-5.027469783550181
SUP-T11,9868037,1.5602991106462112
KP-4,4096211,1.045693693470395
JHUEM-7,5351362,1.1021792980329406
BICR 22,168313200,4.032164885313491
SNU-1079,71466380,2.4483408114130083
WM115,24180719,-0.1236916700903925
WM115,2708,4.839353437835411
SUP-T11,568763,-1.332410870735408
BT 248,9935249,2.246614582121965
Daudi,erlotinib-PLX-4032 (2-1 mol-mol),2.269531504347571
SW948,135398516,1.5329637117305952
Hep-G2,24180125,3.881955939132959
SK-HEP-1,15547703,3.182423809990023
F-36P,46926350,-4.248535974571272
HARA [Human squamous cell lung carcinoma],17755052,1.9898088824831797
U-BLC1,72734382,4.503495336902799
SW1271,400769,-0.393739366900267
ST486,BRD-A02303741-carboplatin (1-1 mol-mol),5.476629137745273
KMS-21-BM,6252,-0.527533950456954
COR-L95,11657048,4.451680892653422
NCI-H1395,BRD-A02303741-navitoclax (2-1 mol-mol),5.774765873736903
KU-19-19,5470400,0.4514058362673593
SU-DHL-1,46199207,2.2603615990150803
JHUEM-7,46843906,1.6266748117762575
JHUEM-1,66577038,3.039376601097779
LCLC-97TM1,452548,-0.620032222833134
HuH-6,25102847,1.2085519877989213
COR-L105,216345,3.681753487249753
SNU-1272,44489675,3.6917039980316297
SK-CO-1,6918736,-2.135863333000623
SK-CO-1,5351362,1.1244803572081656
Granta-519,451668,1.0102660805443675
RCC10RGB,71751553,5.18764953581067
KMS-21-BM,24771867,-3.5658839764452623
SW948,44137675,3.8395253943289553
JHUEM-1,9866186,0.2627284882433657
SaOS-2,JQ-1-navitoclax (2-1 mol-mol),0.6153479757572562
LS411N,654092,0.6196619744838121
EB1,135398516,0.205768417760893
HCC15,11222830,1.5967166138936082
RERF-LC-MS,54143018,1.1379926617289184
SEM,1566236,0.4832736150587708
MKN1,675434,4.681256202214525
HuP-T3,107970,2.2315719384591133
MOLP-8,462382,0.932516774133838
Mino,44620216,3.636708432484359
ES-2,67156097,0.9983594651275344
DLD-1,4261,2.3833740247102484
ES-2,54639126,4.466883416084495
ML-1 [Human thyroid carcinoma],24889392,3.5627585346619712
COR-L105,448949,1.923777772079977
BT 248,54649381,3.7327878949357394
SU-DHL-6,5311,0.0847535344452709
KLE,3025944,3.8646829194893546
JHUEM-7,11485656,1.7197285505227566
ES-2,11427553,3.808931975580244
COR-L105,65064,5.250674314711081
RKO,9908783,5.5436232623995805
Hep-G2,3025986,-0.5782752651876217
BICR 22,1566236,3.7080344976190434
SK-OV-3,2708,5.531711784720637
SNU-1272,11609586,3.189761140355052
RERF-LC-MS,148198,-3.5927713028936834
HuH-6,16722836,0.4269468733858674
RERF-LC-Ad1,selumetinib-navitoclax (8-1 mol-mol),2.177276245480509
K-562,10127622,4.587499993681003
MDST8,3543504,4.366917593553272
KMS-21-BM,124202324,0.388476458705525
NCI-H2452,675434,4.57874791360699
BICR 22,vorinostat-carboplatin (1-1 mol-mol),3.8807496375646937
K-562,73707398,1.1020172598138147
BICR 22,11178236,-2.3138277354389176
SEM,11657048,5.137852973890356
KU-19-19,53232,3.650570649303299
YD-15,10385095,1.276053613139171
COR-L105,2126,5.6436039579971045
MOLP-8,alisertib-navitoclax (2-1 mol-mol),-4.498852011390448
WM115,984333,1.7219326558446977
L3.3,9911463,4.128757247123474
SUP-T11,25262965,-5.196522607491021
Daudi,6918878,-0.3078198284611306
HCC15,16725315,4.804384009366738
Panc 02.03,tanespimycin-bortezomib (250-1 mol-mol),-0.3690940442428398
ALL-SIL,56946209,-4.755076906810128
YD-15,8515,2.6919898843278105
P31/FUJ,25195348,1.3039046822632598
NCI-H1568,4261,1.7177455985107426
KPL-1,6918736,4.229167232190599
KMS-21-BM,44507138,1.103584115941495
ST486,3543504,2.4404075912262138
KLE,decitabine-navitoclax (2-1 mol-mol),-1.0020457102212554
BT 440,73707398,1.96751487315396
BICR 22,11238147,2.160553784520482
SW48,decitabine-navitoclax (2-1 mol-mol),-0.1693110303669234
LCLC-97TM1,25126798,4.007107372760091
PaTu 8988t,11612883,3.2937262662044424
KP-4,44589607,2.085326438076347
TTC-709,6918638,1.4201492579902153
SW48,44507138,1.5733509414979852
SU-DHL-1,66577038,2.452346655400699
ALL-SIL,60168763,4.204461937910143
Daudi,25227462,-5.495402710114509
KHM-1B,135398738,4.5070735955788255
LCLC-97TM1,613000,2.0466318432711708
SNU-1079,6623618,1.1873974405775616
LS411N,2828334,6.327786282136184
IGROV-1,9866186,0.4571266497661056
ST486,135440466,3.095075080224005
SEM,4259181,-0.7975863762048068
BT 248,11427553,3.5134734510694687
SU-DHL-6,72376,-4.568822946856545
P31/FUJ,984333,-0.8646677641211812
COR-L95,123631,2.8240072692867915
IGROV-1,11497983,4.37450324471555
BFTC-909,5281672,4.401358042981416
KP-4,5291,4.117346796976003
DLD-1,241158,4.313425488580076
PaTu 8902,44607530,2.9609228636650826
PE/CA-PJ34 (clone C12),5291,4.131665147466615
HuP-T3,5566,3.0002994658008935
NCI-H2452,JQ-1-UNC0638 (2-1 mol-mol),2.3308008637008837
F-36P,UNC0638-navitoclax (1-1 mol-mol),0.5889836911302547
IGROV-1,2729026,2.3541792737160296
COR-L95,11222830,1.53452681839189
Hep-G2,JQ-1-vorinostat (2-1 mol-mol),1.308980455848885
SEM,5738263,2.206097409243099
LCLC-97TM1,66577038,1.6013450181273698
KPL-1,73707398,1.7074726811570569
IGROV-1,24772860,-3.2892316801587835
L3.3,23582824,1.1997888978910711
IGROV-1,navitoclax-gemcitabine (1-1 mol-mol),-2.4690208522715005
HCC1500,navitoclax-pluripotin (1-1 mol-mol),-1.6377620908642292
NCI-H1568,54678924,1.274078635657008
L3.3,52947716,-5.849313058865459
ML-1 [Human thyroid carcinoma],navitoclax-MST-312 (1-1 mol-mol),1.8932386957075495
RCC10RGB,9908783,5.908182650801537
IA-LM,66577038,3.3956332242260765
LCLC-97TM1,selumetinib-JQ-1 (4-1 mol-mol),1.553276046289172
COR-L95,9935249,2.976260244275784
SU-DHL-6,9868037,3.231553190440303
RCC10RGB,11640390,5.2605770793622275
KHM-1B,65064,3.270159834561764
KP-3,375860,0.992773842660452
Daudi,285033,-6.062056136351362
F-36P,5738263,2.491155610268282
L3.3,56649450,3.0657913461458564
PE/CA-PJ49,2945648,3.0846456774153315
BICR 22,11626560,2.057582050988773
NCI-H1568,60750,-4.838669884752028
NCI-H1395,11656518,2.2687803518385365
NCI-H1395,9866186,2.8046320736833894
MOLM-13,2708,1.6215518677504634
LS411N,crizotinib-PLX-4032 (2-1 mol-mol),1.3060638395576354
K-562,10385095,0.5975872383647969
KP-4,3038522,3.9168803347503105
P31/FUJ,tretinoin-navitoclax (4-1 mol-mol),0.2737114955755992
ALL-SIL,9887053,2.3955838154567703
YD-15,17755052,-0.3804625289919809
RERF-LC-MS,151289,1.06337646711186
LCLC-97TM1,71466445,2.7974721848465025
RKO,15983966,1.976330033309676
SU-DHL-6,54143018,-0.9166021499884252
Mino,5287969,-2.5376508899436647
MKN1,4378219,2.0634079852484084
WM115,sirolimus-bortezomib (250-1 mol-mol),-0.1340053181182992
EB1,73707398,0.2172431300056034
MOLM-13,vorinostat-carboplatin (1-1 mol-mol),0.7090489644750352
SNU-1079,10074640,2.309423999917995
IGROV-1,49793307,-2.5291790820063538
JHUEM-1,2742550,3.845716488362213
T98G,72376,2.8032768589010213
Mino,navitoclax-pluripotin (1-1 mol-mol),-4.005655781523301
COR-L105,crizotinib-PLX-4032 (2-1 mol-mol),2.1629523176516248
HuH-6,73707398,0.8885405709685146
JHUEM-1,56646779,5.05723679890927
SW48,9866186,-0.0602537260044697
ALL-SIL,24753719,3.3195109491118635
SNU-626,5284616,3.154284291238295
PaTu 8988t,409805,3.676693079768219
BICR 22,11175137,1.6412636442827269
PaTu 8988t,vorinostat-navitoclax (4-1 mol-mol),3.0451026382172732
KP-4,123631,2.9884823994831495
MOLP-8,9887053,1.3364969406129874
Daudi,81146,4.468898659357518
NCI-H2452,6438330,4.066979701794873
PE/CA-PJ34 (clone C12),151289,0.5971679831137401
BT 248,11960529,3.73553983344596
SU-DHL-6,73707438,4.161722925172636
SU-DHL-1,9825149,2.3972801394012415
PE/CA-PJ49,54618771,0.7503164660158113
SNU-C2A,24748573,2.6073522736728334
PE/CA-PJ49,navitoclax-birinapant (1-1 mol-mol),2.417341355887914
LMSU,9884685,1.8441382051797008
JHUEM-2,9936388,-5.407825047744209
JHUEM-1,56963564,0.357650417640931
JHUEM-7,11427553,1.505680425653513
LCLC-97TM1,1242560,3.1698209685240832
SEM,148198,-7.106649826649242
SUP-T11,9549297,1.4422252571290304
DLD-1,2841722,4.4213718075962065
RKO,44632017,0.9673312213076444
YD-15,erlotinib-PLX-4032 (2-1 mol-mol),-0.2865960783151026
ST486,44486219,2.5496461586827923
ALL-SIL,10184653,0.3156525087572682
MOLM-13,15953870,2.45012914744678
WM115,docetaxel-tanespimycin (2-1 mol-mol),-3.9058848396527464
HARA [Human squamous cell lung carcinoma],3038522,4.1452744027346045
KPL-1,15983966,2.582941139958158
DLD-1,6610216,5.046668272670703
SEM,135398744,6.34358667151958
Daudi,9908783,4.64363842559646
SNU-1079,60700,1.1418256451824311
BICR 22,2746,3.5358057095338404
SEM,44137675,3.2773016295912445
EB1,135423438,1.4973113179323292
SK-OV-3,9903786,2.611217845094376
SNU-C2A,448949,2.5443337726348516
Granta-519,446155,3.3236756015859266
HuP-T3,46843906,1.6260119885378777
RCC10RGB,25102847,4.4790627708666255
DLD-1,151289,1.2067862264788165
BT 440,11707110,-4.276298214260759
BT 440,1641662,4.488873823880536
SW1573,119607,3.675967979424282
NCI-H2452,36462,2.3648017756260327
RKO,9926054,1.883626680074333
UACC-812,11396600,4.679415745859403
LCLC-97TM1,67291369,2.1623476689900527
SEM,71729975,0.1111350195233953
SaOS-2,9926054,1.5065280757428428
T98G,crizotinib-PLX-4032 (2-1 mol-mol),1.975323443711798
SW1271,11485656,2.5257448561020053
SU-DHL-1,65628,3.0805404655500843
SNU-626,2749,2.3986440804475215
BT 440,16219061,3.533170750215666
KLE,5746,2.2077814730114373
RERF-LC-MS,24889392,5.73600211591012
IGROV-1,16720766,-0.0562020789376145
KMS-21-BM,6438394,-4.2807103286420665
L3.3,60750,-5.123801682120219
YD-15,119607,5.8594033324157895
ES-2,navitoclax-sorafenib (1-1 mol-mol),1.3584296689663955
SaOS-2,53392493,1.7453499080757628
Ishikawa (Heraklio) 02 ER-,11175137,3.4577844980974195
BICR 31,JQ-1-MK-0752 (1-1 mol-mol),2.163474213011291
LCLC-97TM1,71466578,4.4967812415195025
SK-LMS-1,44819697,-0.0573849235807142
HuH-6,65064,2.9825455403719148
ST486,3384730,1.6999775257259362
SNU-1079,54454,-0.6621194346205453
MOLM-13,135440466,-1.1165614244178856
L3.3,51039095,3.7013514518444617
IA-LM,1566236,2.064855820915055
SW948,3825829,4.076553662425885
HARA [Human squamous cell lung carcinoma],44491742,4.175098575791361
WM115,322968,4.566671406107956
SK-LMS-1,4261,1.4846635416850682
ST486,4705,3.1106371129539325
RKN,637858,2.0099352926359533
U-BLC1,carboplatin-etoposide (40-17 mol-mol),3.5075184624984015
COR-L105,135398516,1.4567379833558207
LS411N,15547703,3.407600768992332
SW948,6918878,-0.2941800388813576
SK-OV-3,31703,-0.6007067740148971
BICR 31,16038120,0.7865824758597759
SW1271,46943432,0.8939870827443378
Daudi,67291369,0.2775886597323658
SNU-886,16722836,1.47024614694785
U-BLC1,57330099,4.451961375632246
KPL-1,676352,2.3723678772998285
F-36P,9868037,2.720274888315988
WM115,SNX-2112-bortezomib (250-1 mol-mol),-3.3081919953178507
Ishikawa (Heraklio) 02 ER-,16741245,1.9407743846617116
BICR 31,11455910,2.0785566961581186
SEM,11317348,-1.664715379633235
KHM-1B,65628,3.60559222842334
MOLM-13,25150857,2.0975264071969075
COR-L105,46174525,5.553907170062061
COR-L105,piperlongumine-MST-312 (1-1 mol-mol),2.3163882961547086
SW48,serdemetan-SCH-529074 (1-1 mol-mol),1.5320240627835209
IGROV-1,135398516,1.9751898057484376
LMSU,11404337,0.046862413597458
PaTu 8902,3689413,3.662647678116459
Daudi,31703,-5.42156315939604
ST486,60700,-1.5724026622218903
IGROV-1,24785538,1.106246320450551
T98G,11234052,4.139277978358151
Daudi,navitoclax-MST-312 (1-1 mol-mol),0.6762626360352524
PK-1,4259181,0.605699115942288
PaTu 8902,676352,2.5672836386659625
MOLM-13,426756,3.5583078181784504
WM115,64971,1.594754361798162
HT-1376,16725315,3.257211680243115
SW1271,4521392,3.9428497415690713
SNU-C2A,168312962,2.1543933996115765
JHUEM-2,25126798,2.457219079312835
TTC-709,crizotinib-PLX-4032 (2-1 mol-mol),1.6094467570469138
HCC1500,19582717,3.689290387765622
SNU-1079,5278396,2.8935673327439333
BICR 22,71680916,5.5411632888305755
LMSU,decitabine-navitoclax (2-1 mol-mol),4.230073302056037
IA-LM,462382,0.6444148679919928
P31/FUJ,24856436,-2.072993507389728
LS180,135411,0.2951252953722391
ST486,4917,1.8163129971989915
KP-3,5311,1.5562824681992855
KLE,9903786,3.130074514321622
JHUEM-2,656346,-0.2434619202744507
MOLM-13,72376,-3.7215877343251456
RKO,6610216,3.958403220086871
RKN,452548,0.7515073582009456
P31/FUJ,navitoclax-sorafenib (1-1 mol-mol),0.3998417690889591
SK-MEL-2,3689413,2.4030655110444767
SK-LMS-1,11485656,3.417878040932413
SK-MEL-2,54678924,3.009288234241988
SaOS-2,3038522,3.0360203721983257
SK-HEP-1,409805,5.808157500863876
ST486,67156097,-2.803971366115042
BFTC-909,44137675,3.23817368119839
SW1573,25183872,-2.56928333929943
Hep-G2,10296883,3.682570839684776
HCC1500,23582824,1.5666293035108128
MOLM-13,11612883,-1.8374573083034769
MOLP-8,selumetinib-GDC-0941 (4-1 mol-mol),0.1535423507469189
ML-1 [Human thyroid carcinoma],445643,4.241689590807037
HuH-6,9967941,4.024623568883441
KU-19-19,135421197,1.2163789616721166
T98G,54596558,5.280804733766029
SK-HEP-1,49766530,-2.8567737760804324
KHM-1B,11647372,-0.566073234789779
Daudi,46843906,1.1534141628569738
SUP-T11,11609586,0.5049222885275294
HARA [Human squamous cell lung carcinoma],322968,4.828098936758316
JHUEM-7,5460769,0.024222502884872
IA-LM,11494412,5.732457488131999
KPL-1,selumetinib-UNC0638 (4-1 mol-mol),4.682761808958291
MKN1,UNC0638-navitoclax (1-1 mol-mol),3.1350259693808926
YD-15,168312962,3.2128391111814287
RKN,sirolimus-bortezomib (250-1 mol-mol),0.997863897964826
SNU-886,42642645,0.8705530909872051
Granta-519,selumetinib-piperlongumine (8-1 mol-mol),3.4654025033242712
Granta-519,46943432,2.0409318821812477
U-BLC1,53393127,5.6401162364590025
MOLP-8,46174525,3.423634821116614
RCC10RGB,19582717,5.580606305911862
NCI-H1568,71680916,4.3779497666633915
SW948,3689413,-2.2648112033429824
RCC10RGB,252682,6.528801566934436
Daudi,135875424,2.734623655159311
K-562,4788,4.09681667300412
BFTC-909,66577038,2.856590203747272
JHUEM-1,374536,1.0610482819163725
L3.3,24901704,4.5240834828138095
MKN1,5281321,-1.4553337357622749
BICR 22,56649450,1.894872176339528
LCLC-97TM1,23635314,-2.2617116518456792
LMSU,9911830,1.6369573582733428
SaOS-2,16013152,4.240825830990255
MOLP-8,5738263,2.3540234006064424
SEM,11609586,1.7151177095712813
HT-1376,285033,1.0426307332508795
SNU-1272,11625818,6.086171109339369
Ishikawa (Heraklio) 02 ER-,246676,3.9831360741159463
KP-3,216239,2.374250027754081
IGROV-1,3552672,2.134472496867482
BFTC-909,6505803,-2.7076869289136147
SEM,9911830,1.1725597754210613
SK-LMS-1,JQ-1-vorinostat (2-1 mol-mol),1.295857635010565
NCI-H2452,9952709,3.912471204941481
SW48,4477,0.2937974315698831
JHUEM-2,3038522,4.1058160742436405
ES-2,selumetinib-UNC0638 (4-1 mol-mol),4.84542584208786
KPL-1,25195348,4.423561230907606
IGROV-1,10113978,2.874171865860951
SNU-C2A,11364421,-3.955587934529686
Daudi,3465537,3.6729414318228697
PE/CA-PJ49,11396600,3.5050583522874637
TTC-709,navitoclax-piperlongumine (1-1 mol-mol),1.3005466461942568
HARA [Human squamous cell lung carcinoma],400769,-0.3643318812201842
SNU-1079,5470400,-0.0112381803162936
Hep-G2,11152667,-0.2869645192447481
WM115,60750,-0.3155979924811316
EB1,11222830,0.8066454104386575
LCLC-97TM1,3552672,1.9872160910848609
SNU-1272,51039095,3.39193895302749
MKN1,5284616,3.092411449063398
P31/FUJ,16720766,-1.2973124396101832
PaTu 8988t,16722836,1.7927006401716397
KLE,327653,1.7943752773136603
RCC10RGB,24785538,4.443576486987547
SNU-1272,445643,4.475083566650203
F-36P,135440466,-0.408831912253022
LCLC-97TM1,54454,2.264936650655555
SUP-T11,46191454,1.3527882488345095
KPL-1,10074640,2.8789911041630956
SNU-1079,11626560,1.4983053109006996
BFTC-909,44202524,2.4582417316930916
NCI-H2452,9956119,4.089312834038711
ES-2,10074640,3.585840919353815
TTC-709,9868037,3.9116830012775816
LCLC-97TM1,44589607,2.470818031732135
Mino,2729026,2.549193377947816
K-562,9911463,2.5078915917546336
NCI-H1395,3503,1.633865651752571
KPL-1,16725315,4.961175840606086
RKO,12003241,-0.2410566552434749
SK-CO-1,9887053,2.665990529661509
SUP-T11,9825149,2.3458828059587327
HEL,9444,3.6260707724362113
NCI-H1395,216239,1.7586314171989954
RERF-LC-MS,54618164,3.9158352593779377
Ishikawa (Heraklio) 02 ER-,148198,-2.3973242740422407
SW1271,vorinostat-carboplatin (1-1 mol-mol),3.5487525185295774
U-BLC1,10322450,3.651002961479182
MOLM-13,400769,-1.4398892181534526
RKO,54454,4.6965621210229225
JHUEM-7,10410894,4.599491297270876
HEL,3815108,1.7280464955300685
HuP-T3,400769,-0.02490432142157
COR-L105,439501,-1.395093001857319
P31/FUJ,11717001,4.27266863837082
Mino,168313200,2.290605070302401
KMS-21-BM,5460769,1.875881845654493
WM115,44566777,1.1755609042254629
Daudi,9823820,1.816535221490948
K-562,selumetinib-BRD-A02303741 (4-1 mol-mol),3.9452785747148233
F-36P,tanespimycin-gemcitabine (1-1 mol-mol),-0.5559323208493928
BT 440,54454,3.706970371635371
SaOS-2,11178236,-4.192404287761835
SNU-1272,675434,6.21056389373631
RKO,107970,2.3673735748138265
Granta-519,3384730,1.8851059301538475
Daudi,3081361,1.2348545680767924
COR-L105,11656518,2.8708923278875846
Mino,107970,1.374067690004091
SK-HEP-1,4261,2.0689452694586596
IA-LM,4261,0.3595729013120086
HuH-6,135928012,3.3984292164338776
SW1271,5282054,4.135247135343962
NCI-H1568,44491742,3.692908194165655
K-562,10074640,1.329135681779355
IGROV-1,9908783,5.873270433212515
PK-1,11507802,3.5578388208721443
PE/CA-PJ49,119607,5.897126928878016
LMSU,5287620,-1.1667958498443185
KMS-21-BM,SNX-2112-bortezomib (250-1 mol-mol),-3.372659494731443
MDST8,24951314,1.0921901869172437
ALL-SIL,3081361,0.1962192778787347
SaOS-2,4578,4.61303870633514
HARA [Human squamous cell lung carcinoma],3689413,3.203435099189031
KP-3,119607,5.5453154352771445
Mino,24748573,1.4256390123386682
JHUEM-7,71466380,4.245325443887442
SW1573,selumetinib-navitoclax (8-1 mol-mol),2.299465388888248
BT 248,148198,-3.920391313180545
IA-LM,25227462,1.9658589227885097
MOLP-8,71466578,1.6771539715617054
SNU-1079,176870,-1.168154461838119
NCI-H1395,3136844,4.616978313876093
HCC1500,11977753,-0.4307765862265268
HuH-6,5291,3.067804579544575
PE/CA-PJ49,10296883,4.094155197512124
BICR 31,vorinostat-carboplatin (1-1 mol-mol),4.357832771492993
BT 248,46907787,3.027762940742573
BFTC-909,568763,0.745825262149274
JHUEM-7,241158,3.726297808510672
KHM-1B,23725625,4.172132187038291
HuH-6,36462,4.673839664670026
KMS-21-BM,3025944,3.574286822495776
U-BLC1,11404337,-1.495782153452068
HARA [Human squamous cell lung carcinoma],16741245,4.4624437574750955
RCC10RGB,613753,3.3201179844199498
SUP-T11,7326481,2.625471066600047
BICR 22,421610,1.881248812005912
COR-L95,55508,1.7090560645840305
SaOS-2,2945648,3.259308629519986
LCLC-97TM1,selumetinib-GDC-0941 (4-1 mol-mol),1.4589950943419845
ST486,24180125,1.1737019727020874
RKO,409805,3.580644131410829
COR-L95,53495165,-2.3377393798516395
SK-MEL-2,984333,1.156848706202566
HT-1376,11404337,0.7952974713578591
ES-2,2945648,3.129693833635501
SK-HEP-1,25154868,3.1824362497542182
NCI-H2452,tanespimycin-gemcitabine (1-1 mol-mol),1.9681737644651764
SNU-626,selumetinib-BRD-A02303741 (4-1 mol-mol),5.202020037102138
SUP-T11,53481919,3.4301613533956563
SaOS-2,5978,-3.9287237947590494
KP-4,25126798,3.6651026061979
COR-L105,4096211,2.67395928769434
TTC-709,26596,-1.3495496110855745
LS180,15953870,3.325208983942858
Daudi,66577038,1.2731684674623205
HARA [Human squamous cell lung carcinoma],carboplatin-etoposide (40-17 mol-mol),3.125998778003278
RKO,6918328,0.803085247134139
SW48,4259181,-1.8199657809061969
SK-CO-1,44185566,2.2410285456889176
PE/CA-PJ49,67156097,-2.34887472187092
BT 440,71304818,2.3778303644946353
PE/CA-PJ49,53481919,5.670803300643561
SNU-1079,4521392,4.151138200633131
NCI-H1395,44486219,4.094426397743146
K-562,5978,-3.1400031562505393
SaOS-2,613000,1.0847199338514617
SNU-1272,25150857,3.4753548117910853
LCLC-97TM1,9826308,0.172966057550933
Granta-519,5311,0.5114694341413046
SaOS-2,carboplatin-etoposide (40-17 mol-mol),1.667562518729443
SW1573,4788,4.2029613497215195
L3.3,54618771,1.1558037208399272
SNU-886,2828334,8.007819818360458
PaTu 8988t,vorinostat-carboplatin (1-1 mol-mol),4.263432325084182
WM115,2729026,3.0250773642114175
SNU-1272,11683005,3.754967611266652
IGROV-1,23725625,5.712368491237602
ML-1 [Human thyroid carcinoma],8515,2.907082200923046
SK-OV-3,24964624,2.562140083880341
HCC15,navitoclax-PLX-4032 (1-1 mol-mol),0.321962590188161
PE/CA-PJ49,3465537,2.6771043941056254
KHM-1B,carboplatin-UNC0638 (2-1 mol-mol),1.8078700282440656
LMSU,11494412,2.9419044574604554
KP-4,3634881,3.205031601431634
MDST8,5278396,3.853168516309647
BT 440,3025944,4.328689152618165
RKO,119607,4.75876667689532
Ishikawa (Heraklio) 02 ER-,100016,6.479675962630039
Ishikawa (Heraklio) 02 ER-,3689413,0.6231985481364082
MDST8,65064,4.754326425577863
MOLP-8,54596558,5.109397009340411
WM115,9911830,1.4636751787761997
KLE,2828334,4.827132086641668
SK-HEP-1,44486219,4.3977685724309215
BFTC-909,15983966,-4.834157449814871
SU-DHL-1,24901704,2.0463171426909086
NCI-H1568,3025944,3.938114410703908
LS180,selumetinib-PLX-4032 (8-1 mol-mol),2.448756445045049
YD-15,2828334,6.281589292345015
F-36P,JQ-1-vorinostat (2-1 mol-mol),-0.445429902300179
SK-LMS-1,25195348,3.6018133416826283
ML-1 [Human thyroid carcinoma],4477,0.6808915512553289
RCC10RGB,16725315,5.2458056955252275
F-36P,24785538,1.7277135052687462
RKO,53495165,0.8925500623489324
HCC1500,71304818,1.489157695167493
PE/CA-PJ49,60750,-3.629491275028382
COR-L95,135398738,4.3251787986630195
HARA [Human squamous cell lung carcinoma],9903786,2.5216559880194263
T98G,6505803,0.2412993690877728
SaOS-2,56949517,5.721423210410403
ALL-SIL,644241,-6.056766449232899
HuH-6,11485656,2.2399247025675084
MOLM-13,42642645,-6.876168570605093
L3.3,selumetinib-BRD-A02303741 (4-1 mol-mol),5.501199697080603
SK-LMS-1,54618164,4.255927554001473
RERF-LC-Ad1,selumetinib-decitabine (4-1 mol-mol),6.00514087254069
ST486,5335621,3.5341985027029064
RCC10RGB,51039095,3.636696049778912
ST486,9887053,3.404821135742608
ALL-SIL,60700,-4.240130526526249
SNU-886,6505803,-0.0303295506780238
NCI-H1395,7251185,2.615518868498986
PaTu 8902,15547703,4.581249636071297
Ishikawa (Heraklio) 02 ER-,57519531,3.260489602351445
BFTC-909,11609586,2.9417391320909134
SW48,11455910,-0.1633281652990052
RERF-LC-Ad1,ISOX-bortezomib (250-1 mol-mol),1.1789049180677365
LS180,selumetinib-MK-2206 (8-1 mol-mol),1.4028786728536926
HARA [Human squamous cell lung carcinoma],JQ-1-navitoclax (2-1 mol-mol),2.200588179814963
MDST8,11364421,1.2673702676732186
BFTC-909,navitoclax-piperlongumine (1-1 mol-mol),2.723586959528991
IGROV-1,23939,4.412541857664819
HCC15,11626560,0.3588759938830249
PE/CA-PJ49,387447,-5.239888509178112
MOLP-8,1750826,-2.6273703880538166
RKN,crizotinib-PLX-4032 (2-1 mol-mol),3.0048201060690314
SaOS-2,3634881,3.4478485283346454
HuH-6,12003241,-0.3879852820159472
SK-MEL-2,4917,3.6880216374353103
Hep-G2,44819697,0.0700800273928934
KU-19-19,65064,5.4276979548790285
JHUEM-1,44489675,3.6042445753771086
YD-15,67156097,-1.9236623811667408
U-BLC1,71680916,4.4920838075946525
JHUEM-7,alisertib-navitoclax (2-1 mol-mol),-1.3911406571635951
SK-OV-3,53392493,2.9853646548342767
Mino,216468,3.1376537260490367
BFTC-909,44607531,1.7004331217528663
LMSU,11213558,1.28166790207028
SEM,387447,-5.877720306537758
SNU-1079,52947716,-4.945389152512535
HuH-6,navitoclax-MST-312 (1-1 mol-mol),2.253719657176497
RKO,9915743,2.8851858618766957
PK-1,9926054,1.83429012816666
WM115,969516,2.5733075045080405
Hep-G2,3543504,4.31839273313728
MOLM-13,navitoclax-MST-312 (1-1 mol-mol),-0.7732876947237494
HCC15,1641662,2.7903081608832743
JHUEM-7,409805,3.8541488067969785
PaTu 8988t,24856436,-1.0780184146975675
BICR 22,151289,1.1052603945032196
JHUEM-1,285033,-4.545212455210344
RKN,10302451,3.971829298943927
Daudi,9840324,5.326423492349393
Granta-519,24978538,-1.4483375486726318
Mino,156414,0.9048152948855052
LMSU,doxorubicin-navitoclax (2-1 mol-mol),0.2989425462047189
IA-LM,969516,4.593397144463051
LS411N,16741245,4.421981695824733
SEM,44589607,1.526364309080405
Mino,tanespimycin-bortezomib (250-1 mol-mol),-0.3113346740290634
SaOS-2,241158,3.6917409878316136
HCC1500,49846579,-4.075833194843517
LS411N,11626560,1.8283516183370416
HuH-6,49766530,0.8339176615571017
NCI-H1568,2746,2.7741418395417163
PE/CA-PJ34 (clone C12),89928392,1.3443265924415142
PaTu 8988t,375860,0.0559535091713014
YD-15,135398738,1.7442648475756404
SEM,vorinostat-carboplatin (1-1 mol-mol),1.1477550395391434
HT-1376,10074640,3.5151453257386147
BICR 22,613753,3.418897622092284
Mino,11213558,1.5378531509771507
ALL-SIL,52912189,0.8155728349845486
BICR 31,erlotinib-PLX-4032 (2-1 mol-mol),1.9143994783784697
BICR 22,3634881,3.8771660288779457
RKO,3543504,4.836700902585943
HT-1376,71680916,4.983643300315805
Granta-519,6918837,-5.331886820340028
SW48,56963564,-0.9893979738252238
DLD-1,3503,2.8906252576728932
KP-3,11626560,1.7887274459041371
Daudi,4259181,-0.0890599021012781
F-36P,11222830,1.0877280395075004
F-36P,19582717,3.2626311092950333
Granta-519,7326481,2.8185757173328927
ES-2,25126798,4.086905867611972
SK-OV-3,4096211,3.632564776557465
JHUEM-2,151289,-1.101128946774114
U-BLC1,53481919,5.859672260098257
SUP-T11,53232,2.4903410832956814
HARA [Human squamous cell lung carcinoma],11317348,1.2268055094863417
SK-OV-3,24856436,1.946601057004947
Daudi,613753,2.7401651571031618
ALL-SIL,navitoclax-pluripotin (1-1 mol-mol),-6.100095381264916
SNU-886,44507138,2.788331490062725
BFTC-909,452548,0.7682850038212578
HT-1376,135411,1.728406668868799
SNU-626,46224516,2.5344553605556204
BT 440,11257553,1.2677239239060298
P31/FUJ,409805,3.653161003579303
IGROV-1,11404337,-0.7659238947812715
SU-DHL-1,24753719,3.670729792524347
L3.3,3815108,3.6939531026178
BICR 22,24901704,3.9299918475898408
ML-1 [Human thyroid carcinoma],9911463,4.5829335325836436
NCI-H1568,135411,0.4069452326541798
SUP-T11,44607531,1.1816469943417884
EB1,9826308,-0.061728286846891
ML-1 [Human thyroid carcinoma],SNX-2112-bortezomib (250-1 mol-mol),0.4585620616557309
SUP-T11,136227924,2.659905722722051
K-562,126941,-4.461586339574126
Panc 02.03,2113511,6.868929428825361
NCI-H2452,44241473,5.273016525632626
KHM-1B,12003241,-0.9345261470540068
RERF-LC-MS,135984461,4.284403636339015
KU-19-19,5329102,2.6076401407195355
SaOS-2,49867930,4.412008076102657
HARA [Human squamous cell lung carcinoma],9926054,1.843677597683555
SNU-C2A,JQ-1-MK-0752 (1-1 mol-mol),1.81005119021523
IGROV-1,54618771,1.2456991772210466
BICR 22,7251185,3.2802016727508105
EB1,25183872,-2.873816420927786
HuH-6,3465537,0.6799951481772273
F-36P,24779724,4.9138855829975565
WM115,11178236,-3.130587173648645
PE/CA-PJ34 (clone C12),5282054,3.496383978879579
BICR 31,168312962,4.404506435623785
HuH-6,1566236,2.9155001663313542
BICR 31,135421197,2.236076370585341
K-562,72734382,4.39493075447737
Daudi,4521392,3.754955104648716
TTC-709,11234052,2.869653128464957
NCI-H1568,9903786,2.4011050725962115
Panc 02.03,1242560,3.876690059869664
HT-1376,11719255,4.731390613644887
SaOS-2,24771867,1.911103494547597
NCI-H1568,46224516,1.8217130718981496
PE/CA-PJ49,136227924,2.4190721025981987
HuP-T3,637858,1.096014734488476
HARA [Human squamous cell lung carcinoma],10184653,0.92256613856931
KP-4,12001922,1.8310999373499832
HCC15,9825149,1.99442718669858
SEM,3062316,2.096847795011344
ML-1 [Human thyroid carcinoma],1285940,4.2577484489413004
LS180,9967941,3.3265068520356227
BICR 22,15953870,4.283514914534557
ML-1 [Human thyroid carcinoma],124202324,2.283804161098842
EB1,11228183,1.570219146902305
SNU-C2A,44202524,1.5724321037378868
P31/FUJ,49766530,-2.577046245506879
COR-L95,erlotinib-PLX-4032 (2-1 mol-mol),3.78665088959685
KP-3,navitoclax-pluripotin (1-1 mol-mol),-0.4015323398432444
SNU-C2A,53232,2.624898590077714
IGROV-1,5470400,-0.2457809435208252
K-562,3025944,3.938999685525622
ML-1 [Human thyroid carcinoma],5282054,2.990899024296238
Panc 02.03,1641662,3.717230762709902
UACC-812,selumetinib-JQ-1 (4-1 mol-mol),2.304813012505874
WM115,tanespimycin-bortezomib (250-1 mol-mol),-3.082960536086858
SK-CO-1,613753,3.569116813952151
RKO,navitoclax-gemcitabine (1-1 mol-mol),-2.8709534482220196
LS411N,73707398,1.3643081745247092
RKN,60700,0.8209474049972991
P31/FUJ,52912189,-0.0654684439378525
Granta-519,49793307,-5.0235824363471675
LS180,439501,-1.9142457865624176
KP-4,11364421,-3.997085257757438
BICR 22,19582717,3.5857042125142247
SEM,24901704,-0.5071793762146407
P31/FUJ,11612883,1.4537759753270971
L3.3,31703,-1.9667249709147607
ES-2,49766530,-3.8492688352561055
F-36P,11485656,2.0495534401946647
RCC10RGB,135423438,4.4299924289236055
HCC1500,piperlongumine-MST-312 (1-1 mol-mol),1.4293216638390454
EB1,753704,3.929557319773159
YD-15,168313047,2.097579187900746
ST486,UNC0638-navitoclax (1-1 mol-mol),0.2279596514699741
IGROV-1,24797083,1.5319862293819655
T98G,71576739,6.3336054758851565
F-36P,375860,-1.097600146187803
WM115,11657048,4.298694485616108
SaOS-2,5328940,1.8581375817896455
K-562,11427553,0.716330793964625
MKN1,selumetinib-tretinoin (2-1 mol-mol),5.369921007721122
RERF-LC-Ad1,alisertib-navitoclax (2-1 mol-mol),3.5290493102127045
BFTC-909,60700,0.4554202898414442
TTC-709,375860,-0.1104220027434393
KMS-21-BM,49850262,0.902195025847326
SNU-626,10074640,3.194714130813297
SUP-T11,374536,1.8325318181406132
HARA [Human squamous cell lung carcinoma],24964624,2.781169175627229
HARA [Human squamous cell lung carcinoma],44259,0.8184068416156438
HEL,656346,0.4971755704716853
ML-1 [Human thyroid carcinoma],3384730,3.994618489141425
SK-HEP-1,25126798,3.9918710327668503
PE/CA-PJ34 (clone C12),107985,-3.5683543961091138
EB1,3081361,1.382745486562418
RERF-LC-Ad1,135440466,4.040059542632656
HARA [Human squamous cell lung carcinoma],sirolimus-bortezomib (250-1 mol-mol),1.6380791342220933
HCC1500,568763,-0.919346546730658
SW948,selumetinib-tretinoin (2-1 mol-mol),-0.8554904901249896
F-36P,1641662,2.007818199487881
NCI-H2452,71466578,5.120149615089657
U-BLC1,5738263,2.5031699415240447
NCI-H1395,9915743,5.704472879097531
SUP-T11,5280436,2.922105705056018
KP-3,navitoclax-birinapant (1-1 mol-mol),4.867400539565304
SNU-C2A,11178236,-2.692588272099374
COR-L105,2871966,0.4959639880090196
SW948,5746,1.511438037719251
SEM,11955716,-2.9812698149685626
SK-LMS-1,49766530,-1.7559370930712266
ST486,3854666,0.1902738125367225
WM115,10172275,3.759074377781229
PaTu 8988t,11964036,2.992263460840089
SW948,16219061,3.499504842183279
LCLC-97TM1,53495165,-0.6427926162361222
SNU-886,docetaxel-tanespimycin (2-1 mol-mol),-1.966397975894796
ES-2,54618305,5.3150029072751375
UACC-812,3081361,1.9829916627298712
SaOS-2,5287969,-1.655987163162804
IGROV-1,25183872,-0.4560099928976716
IGROV-1,44607530,1.2936443589937894
BICR 31,salermide-PLX-4032 (12-1 mol-mol),5.564689341846323
JHUEM-7,selumetinib-navitoclax (8-1 mol-mol),2.7635146626485256
SK-HEP-1,57519531,4.12625544642691
KHM-1B,11364421,-5.203168306963344
BICR 22,119182,-2.736639797021525
TTC-709,vorinostat-navitoclax (4-1 mol-mol),1.8336589087078792
KHM-1B,60750,-3.330865145118168
PaTu 8902,4521392,4.129468839379376
PE/CA-PJ49,11964036,1.1031989419108066
ES-2,25195348,3.0815046545507765
LCLC-97TM1,60700,-0.7670870439402468
ALL-SIL,44607531,0.7892287314343482
Ishikawa (Heraklio) 02 ER-,6505803,-0.7712031048650526
SW48,16720766,-1.213948450866439
LCLC-97TM1,9911463,3.937478558519083
SW1271,6918289,2.985913038733717
SK-HEP-1,25183872,-0.6604608842788147
Ishikawa (Heraklio) 02 ER-,5328940,2.177666679733807
EB1,441298,1.2193208824313289
P31/FUJ,5311281,0.8046363155731003
MOLM-13,107970,2.204740997332017
PaTu 8902,44607531,2.4953979740561136
MKN1,navitoclax-birinapant (1-1 mol-mol),3.012742203678699
BFTC-909,5978,-2.385180460490498
IGROV-1,9926054,1.8111808945519428
MOLM-13,JQ-1-UNC0638 (2-1 mol-mol),-0.7004023711482303
KHM-1B,241158,2.5921165995346565
SaOS-2,44632017,0.980304929421305
KLE,241158,1.9293702793301108
JHUEM-1,64971,3.3541466108247793
WM115,23582824,-1.5173797182891284
RKO,5746,2.147448518007633
SEM,5328940,-0.9125059164303356
SU-DHL-1,docetaxel-tanespimycin (2-1 mol-mol),-2.528242404368283
COR-L95,11234052,4.796206825131301
HuP-T3,navitoclax-gemcitabine (1-1 mol-mol),2.4880623143443965
ST486,72199289,4.347318676727556
HuH-6,168313047,1.6605296905525384
MOLM-13,46199207,1.8343479247638497
SK-CO-1,216345,2.2578794962248403
SK-MEL-2,23582824,1.813428901186736
LS180,24951314,1.284825385865239
DLD-1,54143018,0.094683186278062
SW1573,71680916,4.0865163925225385
LS180,11427553,3.214146965067504
HuP-T3,17755052,3.4304742988115366
KP-4,67156097,-1.9652796279366704
SNU-626,docetaxel-tanespimycin (2-1 mol-mol),1.8154165602178771
L3.3,11234052,5.199825372855332
BT 440,5978,2.664904213560599
IGROV-1,44607530,1.2936443589937894
HCC1500,11964036,2.769497384705972
LS180,446155,1.950458971830876
PE/CA-PJ34 (clone C12),16725315,5.214730305618214
F-36P,1716436,1.9099514352495048
PE/CA-PJ49,65064,5.397337839278479
PE/CA-PJ34 (clone C12),31703,-1.629082926616254
SK-OV-3,10385095,3.0219456492917485
PE/CA-PJ34 (clone C12),6918638,1.3328388585954094
BFTC-909,serdemetan-SCH-529074 (1-1 mol-mol),2.384231187993096
KP-4,52947716,-8.46314108741909
KP-4,6610216,4.774737819722466
LS180,23635314,-2.728761007932067
ALL-SIL,25262965,-0.0785584741633136
JHUEM-7,piperlongumine-MST-312 (1-1 mol-mol),1.1461002616382592
MOLM-13,9956119,3.465056755214706
U-BLC1,11626560,1.620116147028034
Panc 02.03,54619267,4.6873070757127335
SNU-1272,54618164,4.215546778710406
KP-4,44819697,-1.3019658221659052
SUP-T11,docetaxel-tanespimycin (2-1 mol-mol),-6.5377733930176944
MDST8,45100481,5.670163105184411
P31/FUJ,11427553,0.2126015278922564
RKO,navitoclax-sorafenib (1-1 mol-mol),2.2009176263452983
SW1271,123631,1.9601206845091983
HARA [Human squamous cell lung carcinoma],5738263,3.6004475982525825
SW1573,11626560,2.096503053081923
JHUEM-7,4261,0.9558193049766148
SK-LMS-1,11707110,3.3466757840367656
SNU-C2A,5351362,1.0436740697568037
PE/CA-PJ49,676352,1.6277548184976196
COR-L105,11717001,4.401406695561914
KPL-1,2113511,6.387856180863233
PE/CA-PJ49,46215462,1.5914258688265177
COR-L95,JQ-1-carboplatin (1-1 mol-mol),1.8062318254958765
IGROV-1,135984461,4.285945029851472
HuP-T3,16725315,3.145396972494799
SK-OV-3,5278396,4.0115131897954175
HARA [Human squamous cell lung carcinoma],9907093,5.03391680027973
RKN,piperlongumine-MST-312 (1-1 mol-mol),1.5374075036414252
SNU-886,navitoclax-pluripotin (1-1 mol-mol),-8.136657717634877
F-36P,54596558,4.3015158184928035
HCC1500,7326481,2.1911838281348897
YD-15,9926054,1.8520578861045605
ML-1 [Human thyroid carcinoma],6918328,-0.1732040518011542
PE/CA-PJ49,10322450,5.083749464761158
RKO,11485656,2.16906736756012
SEM,6610355,4.764894277791875
PK-1,11178236,-2.5983738644534924
JHUEM-1,446155,3.087769566416388
HCC1500,17755052,3.708779056995352
RKN,16720766,0.5941206863048918
TTC-709,vorinostat-carboplatin (1-1 mol-mol),2.201142315625312
SK-OV-3,49766530,0.1985460846164677
PE/CA-PJ49,89928392,1.256692231129512
NCI-H1568,11178236,-4.756412327662482
K-562,613000,2.5009117496842292
SUP-T11,446155,1.696081931969716
L3.3,216345,4.451682719982746
SK-HEP-1,doxorubicin-navitoclax (2-1 mol-mol),-0.2519782158989084
JHUEM-1,9967941,2.5616161504321027
NCI-H1395,400769,0.1156241429574924
SK-LMS-1,2871966,-0.1812763074571703
Daudi,49867930,3.141108082189553
Ishikawa (Heraklio) 02 ER-,6623618,2.4883091663995573
NCI-H1395,9927531,4.9557176619227015
ST486,5328940,0.9681344597553352
P31/FUJ,451668,0.4769801026955246
SU-DHL-6,2708,3.434249932793118
EB1,11719255,1.3569881590851731
SNU-886,BRD-K27188169-navitoclax (2-1 mol-mol),-4.5731831283745095
RKN,11497983,4.544575984994342
IGROV-1,23582824,0.3287266354391525
HCC15,2858523,2.7763462118547833
RERF-LC-MS,3025986,-0.71270364092759
HT-1376,400769,-0.5374503297245474
KP-3,42642645,1.348436123185398
JHUEM-1,5460769,1.70749298340363
LS180,984333,1.4840791700280882
COR-L95,24901704,3.9540534266274183
NCI-H2452,selumetinib-JQ-1 (4-1 mol-mol),2.500134928300083
MOLM-13,piperlongumine-MST-312 (1-1 mol-mol),1.1119295359137316
COR-L95,409805,3.71634228772174
PaTu 8902,9823820,4.420414335239228
Granta-519,24821094,2.4908648032560183
PE/CA-PJ49,135984461,4.387949775407799
SU-DHL-1,26596,-2.3613305357908625
SNU-886,11612883,1.6070499462687953
RKN,285033,-0.0275118271199953
BICR 22,sirolimus-bortezomib (250-1 mol-mol),4.6715609696805505
SEM,439501,-3.163159816591066
WM115,ISOX-bortezomib (250-1 mol-mol),0.2831832229570691
RD-ES,5470400,-4.702864105702524
SNU-626,tanespimycin-gemcitabine (1-1 mol-mol),2.3299604953801465
NCI-H2452,9936388,2.1806204942966803
HT-1376,100016,4.270787672820572
LS411N,54618771,1.0517408544895162
RKN,72193861,2.3331130274465313
MDST8,46843906,2.4704071908178844
HCC15,11485656,2.480533785053976
MDST8,11977753,-2.9914432786855305
PaTu 8902,168313047,2.1566405666580963
SNU-886,16736978,1.1893425576042655
MOLP-8,135928012,3.056644501758044
ML-1 [Human thyroid carcinoma],25062766,2.2645177949682775
U-BLC1,24771867,1.193236570951232
KHM-1B,151289,0.8227956110380268
MOLP-8,10074640,3.1436066614625173
PE/CA-PJ34 (clone C12),11612883,2.848187742516691
JHUEM-2,124202324,2.514541541001261
HCC15,12001922,1.9087360775911748
LCLC-97TM1,3025986,-2.553955076787079
NCI-H1395,219104,2.9305329834901768
BFTC-909,2842253,5.585220688564769
KP-4,57330099,3.669199751412474
KMS-21-BM,11214940,2.2091753760135493
RKO,216239,1.9979551619375524
SNU-C2A,11175137,3.2683325215292016
HARA [Human squamous cell lung carcinoma],241158,4.240217877475157
RERF-LC-MS,JQ-1-carboplatin (1-1 mol-mol),4.276053499927872
Granta-519,135398516,2.1425852334349575
KU-19-19,10385095,1.1563887024661463
LS411N,navitoclax-gemcitabine (1-1 mol-mol),0.4425335439188313
MKN1,11317348,3.290245187500898
SU-DHL-1,9803433,4.734138876460479
KHM-1B,46398810,2.0305727625963756
KLE,73707398,0.4840000511633914
PE/CA-PJ49,11656518,1.2217707692377924
HCC15,135999136,4.472611779685761
SW48,11238147,3.1100916590750045
HCC15,tanespimycin-bortezomib (250-1 mol-mol),-2.289156821264784
BICR 22,409805,3.8456212820768214
SW948,selumetinib-GDC-0941 (4-1 mol-mol),-3.896690328067956
P31/FUJ,24785538,-0.2737810661065927
TTC-709,49793307,-4.337142017244007
KLE,107970,2.4969694624001546
Mino,11497983,1.0995917005095155
Panc 02.03,176870,4.923826321280428
RCC10RGB,322968,3.1449149812629877
ST486,7251185,0.5309350915870239
HCC15,107970,2.678547076190946
Ishikawa (Heraklio) 02 ER-,3062316,2.956789611231251
JHUEM-1,25227462,-1.5159498023964817
EB1,5351362,0.6258809209929096
U-BLC1,46907787,2.215172875838617
SW1271,71304818,2.7682192858067385
JHUEM-2,16038120,-0.6688977049305911
LS180,3634881,3.5372782333734696
COR-L105,11214940,1.6414587299435788
SW1271,5287620,-1.7165830209074355
U-BLC1,2842253,6.116917931005216
HCC1500,navitoclax-piperlongumine (1-1 mol-mol),-1.489158158277352
HT-1376,ISOX-bortezomib (250-1 mol-mol),1.187053751605525
COR-L95,49766530,-0.268325836176492
Ishikawa (Heraklio) 02 ER-,10385095,1.7165210430114106
SNU-886,1716436,2.5748440651933766
P31/FUJ,6450551,0.3392586382091512
MKN1,568763,0.4531886629558682
TTC-709,JQ-1-UNC0638 (2-1 mol-mol),0.9402926082516788
PaTu 8902,5566,3.0665407385312182
SW1271,6610216,4.395476769861187
IA-LM,4477,0.1872236957364025
TTC-709,9935249,1.8024072456954583
F-36P,107985,-4.433418239536547
BICR 31,6917907,-2.0849244140580683
Daudi,56949517,3.615784656128556
SW948,selumetinib-navitoclax (8-1 mol-mol),-0.0800083599001994
Ishikawa (Heraklio) 02 ER-,136227924,3.2224664141246806
Granta-519,156414,1.3767921664113123
RD-ES,12003241,-1.2305184687153958
PK-1,navitoclax-PLX-4032 (1-1 mol-mol),3.57120122459622
SW1573,60700,0.5293530759970745
TTC-709,24951314,1.1506575550253606
PaTu 8902,11404337,0.5155229173062875
Mino,selumetinib-tretinoin (2-1 mol-mol),1.7342003651381972
PE/CA-PJ49,23635314,-4.290211790654201
BICR 22,52947716,-3.710960782083666
HARA [Human squamous cell lung carcinoma],5311,2.3146371221244184
SNU-1079,JQ-1-carboplatin (1-1 mol-mol),-1.464930217070614
PE/CA-PJ49,89183176,3.640347103490525
T98G,262093,3.081379180281475
ML-1 [Human thyroid carcinoma],135398516,0.6909808613935852
SW48,216239,2.7420558854204105
HCC15,136227924,3.0147456858017923
MDST8,400769,0.2052239388954162
JHUEM-2,25183872,-2.168461851500078
EB1,5738263,2.0809299539747403
SK-LMS-1,25062766,3.3547965546318324
IA-LM,navitoclax-sorafenib (1-1 mol-mol),0.7106711881893861
RCC10RGB,4917,3.4531775579708044
RERF-LC-MS,73707398,2.0319367406190483
PE/CA-PJ49,10231331,4.972087269175424
LS180,4917,2.9590600733191272
SNU-1272,erlotinib-PLX-4032 (2-1 mol-mol),3.2570907164419025
F-36P,25227462,-1.9338667335731956
Granta-519,46926350,-4.5411361861126
BICR 22,1716436,3.778329286476686
ST486,3689413,-2.784671548878338
LCLC-97TM1,55283,2.725406070596606
LS411N,BRD-K27188169-navitoclax (2-1 mol-mol),3.592750133273901
KP-4,2733526,3.3373615423632192
PE/CA-PJ49,135421197,1.7245990786454344
SNU-1272,JQ-1-navitoclax (2-1 mol-mol),0.2802121909183701
RKN,168312962,-2.199105388969794
MOLM-13,54619267,3.3881439662249657
HuH-6,1641662,3.376241324728251
Granta-519,sirolimus-bortezomib (250-1 mol-mol),-0.0602153873263711
SUP-T11,5479543,3.0737288917697727
NCI-H1395,44137675,3.7508448726513737
COR-L95,1239801,5.40725658561935
IGROV-1,10184653,0.79276129336756
U-BLC1,9911463,3.7218159913620887
Mino,637858,0.8453968503614813
HCC1500,16741245,3.4170657459529865
NCI-H1395,23582824,0.9688847884522048
LS411N,44491742,5.693616041532359
HARA [Human squamous cell lung carcinoma],5282054,3.837128949835148
Granta-519,24753719,3.151565571990212
MDST8,decitabine-navitoclax (2-1 mol-mol),-0.200661322464638
RKO,107985,-4.24085601271806
ST486,24771867,-2.404185708949454
KP-4,salermide-PLX-4032 (12-1 mol-mol),5.008447458182367
HEL,322968,3.0393820993226535
Granta-519,46224516,0.9242838162777752
LCLC-97TM1,9823820,4.2474508710721315
MOLP-8,23582824,0.4015956903029024
NCI-H2452,60750,1.245026450810127
NCI-H2452,piperlongumine-MST-312 (1-1 mol-mol),2.5229701837483263
COR-L95,54596558,4.049100773357865
Mino,387447,-5.275097956726417
SW948,135398738,3.916695667859345
JHUEM-1,44632017,0.5785396330455455
SK-CO-1,9936388,-6.4137542305703015
Daudi,60700,-3.752408099295295
SUP-T11,11222830,0.264618755044797
U-BLC1,24821094,-1.7354743349655468
SNU-626,54626689,4.772100003109828
L3.3,9907093,5.18450339753338
COR-L105,11612883,3.356288934915157
SNU-1272,navitoclax-gemcitabine (1-1 mol-mol),1.6228672225859768
KP-4,9903786,1.7495953596701077
NCI-H1395,135875424,3.644181585171065
HuH-6,15953870,3.0890536312720003
SNU-626,3503,3.0888045788044085
PaTu 8988t,10302451,4.044762571435361
SK-CO-1,44507138,1.8454813707467936
COR-L95,44486219,4.398500193784116
KHM-1B,10322450,2.734741066135324
LS180,1242560,3.670855291471482
HuH-6,24856436,-1.2980365617612315
MKN1,156414,2.004674973176418
ES-2,6438330,1.73062567766223
PaTu 8988t,25102847,3.84691315859083
SU-DHL-1,1750826,-3.9186889861650713
IGROV-1,4261,1.934016649932683
IGROV-1,9903786,1.7387584479757865
L3.3,navitoclax-piperlongumine (1-1 mol-mol),3.3771859534422703
IGROV-1,9935249,3.330117761231163
COR-L95,446155,4.383849487789403
COR-L95,9967941,2.195306027237361
BICR 31,49793307,-0.900639036765476
Daudi,52912189,-0.5619081020202099
MOLP-8,9911463,4.2009596294807245
U-BLC1,1239801,3.813777656092343
EB1,1242560,2.492591514359394
LS180,44589607,3.154958497437342
BT 248,9911463,2.7908107916357436
Daudi,24821094,0.7293316215174883
RKN,12003241,-0.3350096455718494
SNU-C2A,66577038,3.0722486513155634
SNU-626,BRD-K27188169-navitoclax (2-1 mol-mol),2.798301591450071
LS411N,148198,-2.2204558676981576
PE/CA-PJ34 (clone C12),3385,1.9835594525471536
BT 440,6610355,5.253864320302538
PE/CA-PJ49,3081361,0.9228632415234772
Mino,selumetinib-PLX-4032 (8-1 mol-mol),3.9671106010727217
RERF-LC-MS,446155,1.000000375050646
JHUEM-1,navitoclax-birinapant (1-1 mol-mol),1.9186873000584732
PE/CA-PJ34 (clone C12),24797083,1.4819806490602767
U-BLC1,219104,3.718120326936256
SNU-886,374536,0.8487393236537821
SNU-886,54143018,-0.1190337834405888
MOLM-13,10127622,2.24693559354045
SNU-C2A,SNX-2112-bortezomib (250-1 mol-mol),-1.2219865433866628
SU-DHL-1,decitabine-carboplatin (1-1 mol-mol),1.7663528844174463
DLD-1,navitoclax-sorafenib (1-1 mol-mol),1.247019536693719
P31/FUJ,72734382,3.508076038929844
SU-DHL-1,568763,-0.4525318049600722
SaOS-2,11977753,-0.3684170228919589
SEM,44486219,4.180288188212984
Mino,3038522,2.4167515752748145
U-BLC1,2749,1.1516260951440132
SaOS-2,969516,2.4754458532868067
T98G,54619267,3.841125998818513
KLE,107985,-4.625155684647364
SU-DHL-1,54619238,4.649416356939895
SK-OV-3,6623618,3.404966669354166
WM115,9952709,2.366340614566085
Panc 02.03,10184653,2.526680989613479
SW1271,3634881,2.897813479014186
KMS-21-BM,5746,-2.186848051467758
P31/FUJ,72376,-3.3088434861533704
P31/FUJ,46907787,-0.8407426122417735
SK-MEL-2,10231331,1.800532200590708
SK-LMS-1,11640390,3.725375695528182
IA-LM,5351362,3.020488284300014
NCI-H2452,676352,2.443862996701222
U-BLC1,2126,5.1237575105715845
SU-DHL-1,56973724,1.0008411647005613
PaTu 8902,1716436,3.3992265902353425
ML-1 [Human thyroid carcinoma],10074640,3.5607250325369812
BT 248,6918638,2.3802175448525844
MOLM-13,11717001,3.6418982852877457
MOLP-8,613753,2.6774354597179
PE/CA-PJ34 (clone C12),sirolimus-bortezomib (250-1 mol-mol),0.9308222519351572
SEM,selumetinib-JQ-1 (4-1 mol-mol),-1.6081049960911422
SNU-626,BRD-A02303741-navitoclax (2-1 mol-mol),2.413158827957848
IGROV-1,44137675,1.8406125640672395
P31/FUJ,6914657,-6.361388893160888
LS180,60750,-4.478139976515186
SW1271,3062316,-1.9256219632112692
ES-2,168313047,1.911157935462576
RCC10RGB,219104,3.453227771477981
TTC-709,53392493,1.6345357990546705
ST486,46843906,0.5529260024696058
YD-15,135421197,2.516828006554414
HuP-T3,6917907,-1.7519392074642692
PE/CA-PJ49,erlotinib-PLX-4032 (2-1 mol-mol),1.642024654705514
ES-2,erlotinib-PLX-4032 (2-1 mol-mol),5.5638211896568714
SU-DHL-1,11656518,1.4392799669460994
KP-4,20959075,-3.667563654536924
MDST8,54626689,6.955475194588027
HT-1376,24951314,1.6591427002780594
SW48,10410894,3.4061289364485794
HEL,72193861,0.4910118925931417
Panc 02.03,65064,5.367712415574159
DLD-1,16725315,4.58704904535796
L3.3,2708,4.48343396675343
BFTC-909,984333,1.0937084793466407
IGROV-1,426756,6.142776526139055
U-BLC1,16038120,1.0951013353583814
SUP-T11,1641662,2.521826479206653
RKN,11152667,0.0617927102225113
Hep-G2,3825829,5.065822708326793
BICR 22,3025944,4.210034761741456
SU-DHL-1,11640390,4.597120644825806
RKO,44589607,3.597229089573096
JHUEM-1,168313016,5.6992262147359805
JHUEM-2,24785538,-0.4517737783450485
JHUEM-2,5311,0.8349968494484642
IGROV-1,56963564,1.8260986108097368
Daudi,24180719,3.437659555986817
F-36P,6438330,1.055678334446746
BICR 31,45279963,4.353781648061694
HuH-6,44632017,2.655970363692535
JHUEM-1,navitoclax-sorafenib (1-1 mol-mol),1.3997691547282582
HT-1376,135421197,1.3113029615588312
KU-19-19,445455,4.442962740031222
Panc 02.03,5281672,4.500820026656837
Granta-519,675434,3.9057117034292976
EB1,135398738,1.9676411246940384
WM115,46398810,3.009678027858605
KMS-21-BM,11228183,0.6930324534712586
BICR 31,119607,5.814089022953436
BT 248,navitoclax-pluripotin (1-1 mol-mol),-1.2956772624371633
IGROV-1,23635314,-0.611739968448912
PE/CA-PJ34 (clone C12),168312962,3.0603880546719537
JHUEM-1,676352,1.6946050992839052
SNU-626,selumetinib-tretinoin (2-1 mol-mol),5.471559330403303
DLD-1,46398810,3.390901372687856
BT 248,984333,1.3539050434846691
HEL,44819697,-3.010940469478465
SK-LMS-1,5282054,4.21562772528494
ALL-SIL,5282054,2.788902246408387
WM115,5328940,2.031963430852867
SK-MEL-2,54626689,4.994958580964683
PK-1,11626560,2.5623456427653193
JHUEM-1,11640390,3.190817059566459
BICR 22,11455910,2.0554057071158303
SUP-T11,1566236,1.3558207096631127
PE/CA-PJ49,6438330,2.0005684835219633
COR-L105,serdemetan-SCH-529074 (1-1 mol-mol),2.960742836944571
P31/FUJ,4259181,-1.476581151251805
MOLP-8,54619267,3.766514987830834
P31/FUJ,44489367,5.126164790260484
RKN,11625818,5.974552631000589
SK-CO-1,alisertib-navitoclax (2-1 mol-mol),-2.923852550533504
BICR 31,5470400,2.045329114611378
KP-3,11152667,-0.1171632623198148
PE/CA-PJ34 (clone C12),135421197,2.056271924404355
LCLC-97TM1,5738263,3.894572665100205
SW48,2729026,2.3283979545053155
DLD-1,216239,2.6648043007686404
ST486,100016,6.384120256869386
HARA [Human squamous cell lung carcinoma],123631,2.9564926917309635
PE/CA-PJ34 (clone C12),42642645,1.4632083376153606
KPL-1,10113978,3.948336148476451
COR-L105,11167602,4.878993593502554
PE/CA-PJ34 (clone C12),15953870,4.1853998040231595
HCC15,9549297,1.5760835884765407
PE/CA-PJ49,400769,-0.7520887247331347
BT 248,2949965,2.620236046838219
HuP-T3,448949,2.1685596620814565
KP-4,23939,4.432143014879169
Granta-519,9915743,0.9460784198503543
MOLP-8,51039095,1.4019996450160122
COR-L105,56649450,3.0558986692826595
WM115,16038120,1.6321211746217177
YD-15,5311,1.5388833588237083
K-562,31703,-1.219746708928784
SNU-1272,10184653,2.951340324734288
KMS-21-BM,5311,-0.5911359314332633
DLD-1,71304818,3.4381681946761433
BT 248,76446078,4.2307608716074565
SK-LMS-1,9884685,0.6915267736542438
ML-1 [Human thyroid carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),1.7858982688933729
Ishikawa (Heraklio) 02 ER-,5470400,-1.7110072975424768
SU-DHL-1,11609586,1.5538406664396571
BICR 31,3025944,4.108701914406302
SW48,66577038,3.1598846844687545
Daudi,24180125,1.1000611971852634
SK-CO-1,6184667,4.676967004326267
Daudi,SNX-2112-bortezomib (250-1 mol-mol),-4.343389130323972
SEM,23582824,0.9375364224327816
SNU-626,24964624,3.1171558647070534
SU-DHL-1,67291369,2.039504043535649
MKN1,9840324,6.591865119475762
KHM-1B,72193861,0.3865062028609871
MKN1,2113511,5.16724209797701
IGROV-1,3815108,1.915722485757852
ML-1 [Human thyroid carcinoma],2708,2.4589573831191633
SW1271,selumetinib-GDC-0941 (4-1 mol-mol),0.8746912096343703
HuH-6,10113978,1.7018860441877892
PK-1,5460769,3.319049240944118
PE/CA-PJ49,1641662,3.1027101477617247
LCLC-97TM1,68056272,3.7652459105524585
NCI-H1568,9926054,1.8156743035592564
SU-DHL-1,2113511,3.6581551041454823
F-36P,9936388,-5.085386931503238
HCC15,3503,1.8764785687467953
SaOS-2,3062316,2.2990980703822115
K-562,16736978,2.075477087199636
SU-DHL-1,selumetinib-decitabine (4-1 mol-mol),2.598187269312087
ST486,11955716,-2.7023062265699
SK-LMS-1,6438330,1.5875052319389198
Mino,piperlongumine-MST-312 (1-1 mol-mol),0.9195115610138276
U-BLC1,5287969,-1.4963828583502408
RKN,135440466,3.1815161125023033
Hep-G2,5978,6.393090792335967
SK-CO-1,89928392,1.2451759556756246
SK-MEL-2,15953870,4.259716832213739
NCI-H1568,54596558,4.146513733670967
LCLC-97TM1,4477,1.1810793422928998
LS180,16741245,4.152630132762677
KLE,2733526,3.099087274855166
SK-CO-1,decitabine-navitoclax (2-1 mol-mol),-0.6610169057545121
BFTC-909,159324,4.114702101808939
PaTu 8988t,2113511,6.37119394515457
ML-1 [Human thyroid carcinoma],alisertib-navitoclax (2-1 mol-mol),-1.2100779480376045
TTC-709,15547703,3.151374785504423
IGROV-1,5291,3.6852809555447985
PaTu 8902,16038120,1.215016097060631
HT-1376,327653,3.1831063450087265
Mino,46926350,-6.0874143472177105
ALL-SIL,10302451,-1.1728976190372558
ES-2,9952709,3.5807033886792032
PE/CA-PJ49,15983966,-4.430083817298675
F-36P,25154868,4.282769924726218
UACC-812,tretinoin-navitoclax (4-1 mol-mol),2.4411364981876043
Hep-G2,tanespimycin-gemcitabine (1-1 mol-mol),-1.7096270961562854
LS180,vorinostat-navitoclax (4-1 mol-mol),1.6395407762655403
SK-MEL-2,16038120,2.2105555441084133
IGROV-1,docetaxel-tanespimycin (2-1 mol-mol),-1.5830865659631668
PE/CA-PJ34 (clone C12),168313200,2.559397227720179
P31/FUJ,vorinostat-navitoclax (4-1 mol-mol),-0.3847698718995038
ML-1 [Human thyroid carcinoma],7251185,4.28899372473645
SW948,7326481,3.486606738365962
HCC15,44507138,1.6295786006094204
RERF-LC-MS,16725315,4.583339442818838
DLD-1,136227924,3.626313463652563
SUP-T11,25105715,3.1007887119153357
KLE,446155,0.8514088628776029
P31/FUJ,148198,-3.664233852608881
HEL,49850262,3.2265871136708997
HARA [Human squamous cell lung carcinoma],25126798,3.0348047735223935
BFTC-909,60750,-1.7298046099952136
F-36P,123631,2.4818634169449862
SW48,doxorubicin-navitoclax (2-1 mol-mol),-4.619867397585904
JHUEM-1,54596490,4.836153565936757
NCI-H1568,675434,4.067969537829177
COR-L95,19582717,3.635233206850296
EB1,675434,3.8432204522700224
COR-L95,148198,-4.800055382400855
BICR 22,44819697,0.2156040754176
SK-OV-3,46224516,3.444215787907748
HCC15,5281672,5.6563329698974965
RERF-LC-Ad1,71304818,3.4677724486162753
HEL,6918328,-0.4966077251990671
JHUEM-2,60700,-3.709626171963236
KMS-21-BM,2733487,3.932034353072035
NCI-H1568,24785538,0.5698046292147018
JHUEM-1,136227331,3.9088223702445526
KP-4,BRD-K27188169-navitoclax (2-1 mol-mol),3.6878999698692776
RKN,23582824,1.7370647325872666
PaTu 8988t,navitoclax-gemcitabine (1-1 mol-mol),-0.4570432900108468
PE/CA-PJ34 (clone C12),53325874,4.873665514097965
F-36P,25062766,-0.2807474347511744
SU-DHL-1,322968,2.585334286015635
BICR 31,24797083,1.8361324304615187
SEM,7326481,2.7655671912091933
SEM,6450551,0.3475016834415761
SK-HEP-1,3062316,3.432714145613195
F-36P,serdemetan-SCH-529074 (1-1 mol-mol),1.828808135061463
BT 248,3384730,2.3830241448741987
PaTu 8902,2729026,2.7803221257085884
U-BLC1,3025986,-1.58953552363597
JHUEM-2,carboplatin-UNC0638 (2-1 mol-mol),3.0810663228526853
HuH-6,53481919,3.057327729311134
SK-OV-3,11609586,4.251063762376387
HARA [Human squamous cell lung carcinoma],3025944,5.227932597847333
ML-1 [Human thyroid carcinoma],156414,1.0547615836858202
Granta-519,44607530,1.7224857333943702
L3.3,53232,3.8050949011624806
NCI-H1568,15953870,3.42403550557497
RCC10RGB,carboplatin-UNC0638 (2-1 mol-mol),3.3801418218563337
SNU-886,168313047,3.810150500353015
MOLM-13,erlotinib-PLX-4032 (2-1 mol-mol),1.7877509525982431
MOLP-8,252682,6.161004481234046
SW1573,126941,-1.0305779796426808
BICR 31,9927531,5.661036072082279
JHUEM-2,11234052,1.867781502989469
KP-4,navitoclax-sorafenib (1-1 mol-mol),2.387001258454205
RCC10RGB,441298,3.7731685554529384
MOLM-13,387447,-5.119095777855545
Granta-519,216345,1.0997896286755158
LCLC-97TM1,107985,-4.222636663811031
LS180,3384730,2.894746509752001
HARA [Human squamous cell lung carcinoma],9936388,-6.286258703982233
ML-1 [Human thyroid carcinoma],2746,-1.478438692576885
KP-4,3503,1.291142260744515
KU-19-19,44493528,4.383684457454455
SUP-T11,156422,3.1959410672471265
PE/CA-PJ34 (clone C12),5426,4.4355205896905225
LS411N,53232,4.5193815700089655
ML-1 [Human thyroid carcinoma],46907787,2.3673247902218804
HuH-6,carboplatin-etoposide (40-17 mol-mol),3.81818925057539
PK-1,9840324,6.521993275481464
LS411N,6438330,3.3380693145982816
HARA [Human squamous cell lung carcinoma],5284616,3.060508834181737
BT 248,46199207,1.879415157386071
SUP-T11,46943432,2.7244636388334658
JHUEM-2,5738263,3.5366502925535563
EB1,11657048,4.149420180837624
NCI-H1568,JQ-1-carboplatin (1-1 mol-mol),3.4150339974619457
JHUEM-2,16722836,0.2886126498109723
BFTC-909,16725315,4.495652912061774
RKN,124202324,3.704376342602573
LCLC-97TM1,10127622,3.458194652659875
SW948,vorinostat-carboplatin (1-1 mol-mol),1.7834644899516086
YD-15,11609586,3.3039960238503387
JHUEM-2,613753,3.436070321922621
SaOS-2,5494449,1.7356769079300427
HEL,702558,3.166026376934585
T98G,16722836,2.398451511380003
SUP-T11,6610216,4.082537730275983
KU-19-19,11612883,2.975593545287462
HuH-6,5738263,2.975147120407866
BICR 31,6914657,-2.1990076047646703
BT 248,122327,5.08009478305936
EB1,tanespimycin-bortezomib (250-1 mol-mol),-0.3360954254075145
ST486,11626560,0.2657375413776535
PaTu 8988t,2858523,3.414247843041017
JHUEM-1,2949965,2.629059266451115
DLD-1,3815108,3.4023651323989883
KP-3,1750826,-2.891676476044356
SW48,9911830,1.5953282800372102
Daudi,11178236,-7.583909031047052
SNU-1079,23725625,2.319972906760898
KP-4,42611257,3.463003113916947
Granta-519,44819697,-1.094231558387569
MDST8,2828334,6.077771510152207
RKN,9911463,4.114615883902867
RCC10RGB,JQ-1-vorinostat (2-1 mol-mol),1.4034358595851535
SaOS-2,9903786,2.3206358959344264
RKO,44607530,2.6096687798301677
SK-CO-1,11455910,1.152685438196598
KMS-21-BM,navitoclax-piperlongumine (1-1 mol-mol),0.9145427939891292
SK-OV-3,25183872,-0.070614613180641
WM115,25227462,1.5125525407178182
HCC15,2126,5.047391044285817
HARA [Human squamous cell lung carcinoma],9823820,4.297752192216693
MKN1,16722836,1.7120041841079352
HuP-T3,11238147,3.6375005285241033
SU-DHL-1,168313047,2.0629090722275945
BICR 22,5335621,5.24838502551373
SK-OV-3,135398516,2.140261030425796
ML-1 [Human thyroid carcinoma],6852167,2.7131700239928316
RKO,11214940,1.6564081526645635
SW948,9935249,-1.8483271913214137
NCI-H1568,2871966,-1.5477941874243064
WM115,54626689,3.4845925362433
IGROV-1,46398810,2.003787621940583
KMS-21-BM,9903786,1.778157023990249
EB1,54619267,3.091437232956129
KP-4,tretinoin-navitoclax (4-1 mol-mol),3.646303274153599
PE/CA-PJ34 (clone C12),9952709,3.276837469660591
SNU-1079,4096211,2.012141116598032
NCI-H1568,alisertib-navitoclax (2-1 mol-mol),0.1984676648447771
Mino,119607,3.8332759469198248
PE/CA-PJ34 (clone C12),carboplatin-UNC0638 (2-1 mol-mol),3.7033637644797217
RCC10RGB,selumetinib-UNC0638 (4-1 mol-mol),4.208062457345683
SW1271,selumetinib-PLX-4032 (8-1 mol-mol),0.5021040652093107
Mino,11222830,0.964275075802594
BFTC-909,3025944,6.464154930724253
BFTC-909,10113978,3.8739618499623094
LS180,docetaxel-tanespimycin (2-1 mol-mol),-5.0888233311005795
SNU-C2A,44632017,1.5540718160403788
SEM,9868037,2.0923686689232137
BFTC-909,24748573,2.672786285704278
KP-3,135421197,0.5862918255078794
PE/CA-PJ34 (clone C12),25227462,0.7769258738291116
MDST8,23582824,0.3553467044538872
JHUEM-1,5329102,2.40728772917488
MDST8,navitoclax-MST-312 (1-1 mol-mol),0.0883996467230522
HT-1376,11427553,3.69688702211831
SW948,53392493,1.921137473015096
DLD-1,6438330,2.723256027854911
LCLC-97TM1,5287620,-2.537847801025228
Ishikawa (Heraklio) 02 ER-,23635314,-2.020385068128092
L3.3,10385095,1.3503663642800654
HCC1500,3552672,1.623977684405255
SNU-626,6852167,3.646098015968206
KLE,72376,-2.1064714455436855
SW1271,2113511,4.856200971437617
RKO,11238147,3.3996395604326977
MDST8,56963564,1.9609696235744132
RERF-LC-Ad1,44507138,3.8186397004948343
HEL,JQ-1-vorinostat (2-1 mol-mol),-0.5678151706430512
JHUEM-1,11955716,-2.616883489056162
ST486,tanespimycin-bortezomib (250-1 mol-mol),-0.6822883440168558
HT-1376,6438330,1.0941041074343645
KP-3,322968,3.1686208941787797
Ishikawa (Heraklio) 02 ER-,4261,2.2867923164425856
MDST8,73707398,0.930898424190815
SUP-T11,4477,1.0850465451161044
TTC-709,8515,2.8339402756906735
NCI-H1395,123631,3.1178254055309553
MKN1,11178236,-5.67872836374039
SaOS-2,selumetinib-GDC-0941 (4-1 mol-mol),1.0166144741288403
COR-L95,serdemetan-SCH-529074 (1-1 mol-mol),-0.7704324455951623
HT-1376,3062316,0.4736160650345824
Mino,135984461,1.4657661855370687
HCC1500,107970,1.6380228058856745
TTC-709,72376,-2.991970472596185
HARA [Human squamous cell lung carcinoma],262093,3.694607099499911
KHM-1B,135411,-0.0530336141709349
Mino,9825149,1.504280330631107
SK-LMS-1,11364421,1.259648760009216
ML-1 [Human thyroid carcinoma],5335621,2.3456257872682933
F-36P,5287969,-1.7559228223470844
MDST8,11222830,1.739834123793711
MOLM-13,11364421,-4.614262921489179
MDST8,89928392,1.3331112546959425
SW1271,doxorubicin-navitoclax (2-1 mol-mol),-1.1619625703073235
RERF-LC-MS,148124,-5.592640359076286
RD-ES,25195348,0.2831148755084631
PE/CA-PJ49,56649450,2.459480943641603
YD-15,54618164,4.077612524706247
PaTu 8988t,219104,4.30352428274638
SaOS-2,16659841,3.6368059645085737
ST486,285033,-5.850900901156603
SNU-626,10385095,1.227927473052019
BT 440,6918837,2.517553241603625
F-36P,100016,3.924028764616067
DLD-1,11167602,2.7796925101079015
HuP-T3,selumetinib-vorinostat (8-1 mol-mol),2.242647534898157
ALL-SIL,25183872,-1.1896517316661384
HuP-T3,3503,2.6961085729175465
JHUEM-2,5978,-2.5652449281503062
SaOS-2,148124,-5.379251304292956
SNU-626,ISOX-bortezomib (250-1 mol-mol),-0.0507107249878607
SW48,25102847,1.5289459974072863
PaTu 8902,6852167,4.282216220168943
ST486,46191454,-0.730401605001051
ALL-SIL,11396600,2.960335319566646
ST486,5479543,1.2697925273686157
LS411N,54649381,4.0879656113234315
KP-4,7251185,3.55509362765947
LCLC-97TM1,56649450,1.9268896253969057
Panc 02.03,42642645,1.4849485241267697
PaTu 8902,5328940,2.100447742300893
Daudi,10127622,5.05479511248997
KMS-21-BM,9907093,3.0560398847763355
SNU-C2A,selumetinib-decitabine (4-1 mol-mol),-2.4206479357154183
Mino,44202524,1.0712152555849994
JHUEM-2,JQ-1-carboplatin (1-1 mol-mol),1.384634873843588
SaOS-2,15983966,-4.612114381732812
SK-CO-1,selumetinib-decitabine (4-1 mol-mol),0.410871863589865
MOLP-8,11214940,2.188017762346292
SW48,44607531,-0.0703962424187993
SNU-C2A,3815108,3.3697032214045217
IA-LM,637858,2.795809218533269
LS180,119182,-2.2864715680735603
SK-CO-1,135411,-1.9906675184189948
SW1271,15983966,-1.9627382742922743
LCLC-97TM1,11485656,2.4293249862604913
DLD-1,9911463,4.0801300312150115
Daudi,135984461,3.9990978127252728
NCI-H1395,2871966,-1.8514751727384056
HARA [Human squamous cell lung carcinoma],11455910,0.2072973533181662
KPL-1,25102847,4.452185954171655
JHUEM-7,24772860,-2.354213215472605
SW1271,24180719,4.447587763279296
T98G,4261,3.374475287163911
PE/CA-PJ34 (clone C12),4096211,1.8873047656462525
RERF-LC-MS,4917,3.617944790726347
HARA [Human squamous cell lung carcinoma],1242560,4.08747373250943
COR-L105,44185566,3.03526972595121
MOLP-8,8515,3.727464051425151
Daudi,11656518,1.0836561052202376
Ishikawa (Heraklio) 02 ER-,6852167,3.9423721034653423
MDST8,10302451,4.267643132743765
L3.3,44543605,3.679570515799513
JHUEM-2,9907093,3.1994151966542472
Panc 02.03,tretinoin-navitoclax (4-1 mol-mol),6.083694650761559
MOLP-8,135398738,4.11621412508813
U-BLC1,46199207,3.037833197387433
RCC10RGB,568763,0.4218853975706897
SW1271,285033,0.340737243750418
Granta-519,67156097,-3.3327998752636483
WM115,11964036,0.4423113132234746
F-36P,6918837,-4.502105191229977
SK-CO-1,156414,0.1991331726980137
KLE,387447,-3.4483101569970804
SK-LMS-1,53392493,3.3529874770947714
BICR 22,568763,1.1340411223212885
P31/FUJ,176870,1.9707243184949097
U-BLC1,16013152,4.29696335846276
BT 248,4477,0.1181412005602309
SW1271,24748573,2.5868513601661336
MOLP-8,72199292,1.2541603744267094
LMSU,135440466,2.4580470994052916
RKO,5282054,3.8735499096789856
RKO,selumetinib-decitabine (4-1 mol-mol),2.541552473841643
HCC1500,16722836,2.402902940836366
Panc 02.03,46199207,3.8452319744534886
PaTu 8988t,71304818,2.8353343090304257
IGROV-1,241158,3.288496474515495
Daudi,71751553,3.830487233171358
DLD-1,vorinostat-carboplatin (1-1 mol-mol),3.389978857529766
COR-L95,46174525,3.763282126483136
NCI-H2452,2126,4.762499509878762
KMS-21-BM,54626689,2.4877028849611977
HCC15,11228183,0.6025691709173914
SNU-C2A,10184653,-1.0606055373049013
ST486,4096211,0.927957781813614
HCC1500,11404337,-1.1638452247583002
PaTu 8988t,16725315,5.4103858057829095
MDST8,4378219,1.9480435949418269
IGROV-1,5351362,1.961059142684053
HuP-T3,44489675,3.6946366435409352
SW1271,4259181,0.7411137136724786
T98G,navitoclax-pluripotin (1-1 mol-mol),0.2285492710571146
RKO,5978,-3.7617282032773582
MOLM-13,11485656,-3.968420003132376
K-562,24821094,1.908113699718487
SW1573,89183176,3.862510153781557
SK-MEL-2,241158,4.163944752728283
K-562,24180719,3.2747438118023533
LS411N,4788,5.997281207159956
IGROV-1,66577038,3.2148239132520455
SaOS-2,selumetinib-BRD-A02303741 (4-1 mol-mol),7.165298435960504
JHUEM-1,5278396,3.82185296387428
SNU-C2A,vorinostat-carboplatin (1-1 mol-mol),3.431433946882078
Daudi,9549297,1.403366421117492
U-BLC1,11238147,2.6920141456674336
YD-15,5311281,1.7838671385047098
UACC-812,11427553,3.574449796486334
MOLM-13,52912189,-1.0667663091505395
HCC1500,selumetinib-JQ-1 (4-1 mol-mol),2.938993597127826
JHUEM-2,6450551,-0.6170871445435329
PE/CA-PJ34 (clone C12),55283,4.2692019597898865
Mino,24753719,3.6621526674985416
SW948,erlotinib-PLX-4032 (2-1 mol-mol),3.457135081619971
DLD-1,568763,-0.1336724392691905
F-36P,56963564,-1.5146326698639885
PaTu 8988t,selumetinib-JQ-1 (4-1 mol-mol),1.6621315506186802
YD-15,10302451,0.0740355498774049
SNU-886,11214940,1.3041085761730546
PE/CA-PJ34 (clone C12),72734382,5.58441698552576
IGROV-1,24821094,1.720998716331183
Granta-519,11427553,-0.9723301484726812
MOLM-13,208908,2.7636340376000317
IGROV-1,9915743,-0.4757488934941289
Panc 02.03,241158,4.402915180139186
SNU-886,327653,2.660863736494067
IGROV-1,24748573,-1.0654275876710166
COR-L105,5287969,-1.8496230723467
MOLP-8,10296883,2.725727750190508
SW948,241158,4.5321951743877005
BT 440,4705,3.213211271406504
BT 440,54618771,0.7745514333639397
ML-1 [Human thyroid carcinoma],216239,2.965937740464059
MOLM-13,navitoclax-piperlongumine (1-1 mol-mol),-1.0908841522604569
RERF-LC-Ad1,9911463,4.614184078770455
EB1,5284373,2.2101940810619443
SU-DHL-6,10302451,3.370117636140473
IGROV-1,9936388,2.10108466287406
ES-2,409805,6.0186236492097365
SK-MEL-2,387447,-4.977672858008192
DLD-1,5311,1.473317438397464
NCI-H1395,5566,3.555593017937037
JHUEM-1,51037431,2.1902643856208064
SNU-C2A,123631,2.454023824912431
U-BLC1,vorinostat-carboplatin (1-1 mol-mol),2.279798742170791
JHUEM-7,25262965,-4.73461775117277
HCC15,72376,-1.512462057486854
COR-L95,6450551,2.8920154707175776
SNU-1272,1641662,4.135361121218487
NCI-H1568,5738263,3.2402226460817323
SUP-T11,387447,-3.8487936913403873
DLD-1,654092,0.6329502057139799
F-36P,57330099,4.197284693809706
SNU-1079,9915743,-4.016291754559019
RKO,54619267,4.028311361432676
BT 440,25062766,2.7984797368711365
RERF-LC-MS,4261,2.068565192175152
JHUEM-7,176870,2.1277798122521094
K-562,73707371,5.645446798773975
Hep-G2,11609586,2.605308217008377
PE/CA-PJ34 (clone C12),11175137,2.637065754924562
SK-HEP-1,carboplatin-etoposide (40-17 mol-mol),5.6878657292744075
P31/FUJ,ISOX-bortezomib (250-1 mol-mol),-0.0400156428773503
WM115,122327,3.780637240577924
WM115,25150857,2.4679229997528394
KHM-1B,119607,4.337560231303076
SK-LMS-1,44462760,4.2317756310447106
SK-CO-1,11178236,-3.2010052407962215
ES-2,5287620,-1.3312660201175053
RKN,753704,4.966407297087677
BFTC-909,selumetinib-PLX-4032 (8-1 mol-mol),5.555922755682714
SW1271,227681,3.2917347097405725
U-BLC1,216239,2.001843707595396
MDST8,568763,0.1407924711645573
BICR 31,5566,3.2898773587253096
LMSU,216345,4.559958439384078
SUP-T11,613000,3.1014726266229946
JHUEM-7,11396600,4.730722840017514
L3.3,44491742,6.349276489474054
HARA [Human squamous cell lung carcinoma],3385,4.962584280578164
RERF-LC-MS,6450551,1.967154760545028
SK-MEL-2,11238147,3.719914867098992
IGROV-1,2874250,4.893662837169153
JHUEM-7,322968,2.718046514914308
HuH-6,67291369,0.9000964703290105
ML-1 [Human thyroid carcinoma],ISOX-bortezomib (250-1 mol-mol),0.9716953544539896
HCC15,56946209,-3.385198311974778
BFTC-909,136227924,2.3418993883842134
Granta-519,1750826,-3.7858867937492984
P31/FUJ,11625818,3.2136174191857174
KP-4,54626689,4.142456533396149
COR-L105,10322450,4.112392966182136
JHUEM-7,9907093,2.991703648440714
HCC1500,5566,2.905130044911903
KLE,sirolimus-bortezomib (250-1 mol-mol),2.0698040575432572
JHUEM-1,246676,4.366062260954229
SW48,51039095,1.7096770563148074
TTC-709,2842253,6.293959985840507
DLD-1,6184667,3.359019720422835
SW1271,8515,5.208985199998064
KU-19-19,73707398,1.7453733414385195
MKN1,5351362,2.803842946909778
K-562,11707110,1.6681367726124623
COR-L95,16065773,1.8842547212847705
KP-3,5282054,3.4267608952562756
LS411N,docetaxel-tanespimycin (2-1 mol-mol),0.1660438979420715
YD-15,5470400,1.9851659247555216
IA-LM,11178236,-6.720771550362321
MOLP-8,54596490,4.413151323823571
KMS-21-BM,52947716,-6.026542741756858
ALL-SIL,44202524,-0.4119558263455749
NCI-H1395,serdemetan-SCH-529074 (1-1 mol-mol),2.764228376704601
WM115,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.6716900719045018
MDST8,6918328,-0.3527629143091293
BICR 31,104842,-0.0442586507462943
BICR 31,6852167,2.001013365002547
MDST8,vorinostat-navitoclax (4-1 mol-mol),-0.0959848783200281
L3.3,16736978,2.121770338408602
IA-LM,24821094,3.0699000024292293
IGROV-1,73707398,0.8848064516600974
SaOS-2,46191454,1.8159544721998524
NCI-H2452,selumetinib-GDC-0941 (4-1 mol-mol),2.2378905262634343
DLD-1,JQ-1-navitoclax (2-1 mol-mol),0.3171253372451748
LS411N,25150857,2.959758413524705
EB1,selumetinib-PLX-4032 (8-1 mol-mol),3.7279574042279977
HuP-T3,11175137,3.603877049706456
LS411N,135984461,5.061110843141604
SUP-T11,selumetinib-tretinoin (2-1 mol-mol),4.832130006258186
IGROV-1,4261,1.934016649932683
BT 440,11167602,1.2625640094474482
SK-CO-1,BRD-K27188169-navitoclax (2-1 mol-mol),1.3228586557967312
PE/CA-PJ49,5335621,5.293467271056006
HCC1500,9952709,2.298703589628035
SEM,24772860,-3.2932991831821767
BT 248,11257553,3.3794437157400754
JHUEM-2,387447,-5.581309296156035
SK-OV-3,176870,3.5610869734905255
PaTu 8902,9952709,4.3707417693645745
KPL-1,2858523,3.226187799895589
P31/FUJ,56973724,0.796880831995934
DLD-1,carboplatin-etoposide (40-17 mol-mol),4.399609636975519
MKN1,9866186,3.287625049022112
RKO,2729026,2.3662843020346753
RKO,387447,-4.452540898932811
TTC-709,3038522,1.896823451991841
KP-3,448949,1.5067921571071503
Mino,216239,1.5780248880701924
JHUEM-2,selumetinib-MK-2206 (8-1 mol-mol),2.2404889693537835
SK-CO-1,135398738,3.5773200936681584
KP-4,445455,4.614742729494546
JHUEM-7,462382,0.9048845181666758
BFTC-909,3552672,4.498195948808332
Hep-G2,11364421,-0.8819636691754982
Panc 02.03,7251185,3.0530850004567767
K-562,sirolimus-bortezomib (250-1 mol-mol),0.4974638580928024
RERF-LC-MS,serdemetan-SCH-529074 (1-1 mol-mol),2.886633168137992
SUP-T11,24978538,0.9807854871463908
NCI-H1395,11455910,1.7673103520073516
F-36P,44607530,2.028742001356227
Panc 02.03,53392493,3.617637281515077
KLE,9823820,3.7832200192550047
LCLC-97TM1,446155,3.780165105352184
Mino,10074640,3.0447839707381577
BICR 31,23725625,6.004496967521932
TTC-709,11175137,1.9589050557270875
YD-15,16736978,2.4934559516145245
RCC10RGB,11612883,4.41570881394896
SNU-886,375860,-0.100716733121392
WM115,5280436,2.216411919293008
Ishikawa (Heraklio) 02 ER-,15953870,3.735200947814725
RKO,selumetinib-JQ-1 (4-1 mol-mol),0.7539248953092096
NCI-H1568,10184653,1.3826991243685076
BT 440,25227462,1.251822294368348
LS180,10427712,4.740953715848998
SU-DHL-1,JQ-1-carboplatin (1-1 mol-mol),3.662871226226577
ML-1 [Human thyroid carcinoma],56963564,0.9868520726565888
HuP-T3,12003241,-0.2833744856936582
Daudi,9884685,-1.7998414591903729
SK-LMS-1,54765302,3.9619741673005584
SK-CO-1,44259,0.6005082969424771
NCI-H1395,31703,-0.5933376727422321
MDST8,10231331,0.2022855962524302
SK-CO-1,4261,0.7789911540114764
P31/FUJ,10074640,2.9862675466657764
SK-CO-1,12001922,1.782153173177779
SaOS-2,16720766,-1.9505026731708328
U-BLC1,11507802,1.889114997645565
F-36P,446155,1.8210679426416845
T98G,168313200,3.906117729639882
RCC10RGB,216239,3.3222265979679375
NCI-H1395,11175137,3.230418109330353
PE/CA-PJ49,2113511,6.499373647207172
BICR 31,navitoclax-pluripotin (1-1 mol-mol),-0.5418229135264367
Mino,6918638,-1.9893642721575304
SK-MEL-2,6450551,4.058466448990368
KU-19-19,sirolimus-bortezomib (250-1 mol-mol),2.2113915758762133
COR-L105,72734382,5.425179503032161
LS180,11640390,3.36619781023128
F-36P,9911463,3.056113876518826
NCI-H1395,135984461,4.376761136039875
K-562,25262965,-1.232298297425116
LMSU,5311281,1.1859008880059876
IA-LM,piperlongumine-MST-312 (1-1 mol-mol),2.1673101171047513
LCLC-97TM1,135411,0.5874500365845237
SEM,9903786,1.5227669871926164
SU-DHL-1,46398810,1.696894130738712
P31/FUJ,6610216,4.336076332167018
YD-15,vorinostat-carboplatin (1-1 mol-mol),3.4384221689119623
SEM,71304818,2.4443931751083254
LMSU,4261,2.446120037363317
Mino,24785538,-0.2127371350611869
PE/CA-PJ49,11167602,3.7054194129551736
BICR 22,5291,3.723640910280853
HEL,44632017,1.0842639602191189
Granta-519,4261,1.1412453306659267
Granta-519,56963564,-0.5609340564012296
KMS-21-BM,24785538,-0.5359837925346713
SEM,docetaxel-tanespimycin (2-1 mol-mol),-4.77446001640726
SNU-C2A,126941,-2.245789032687027
Hep-G2,241158,4.703758837360285
JHUEM-7,44137675,1.945241597383145
MDST8,53392493,2.9375507482716334
Ishikawa (Heraklio) 02 ER-,25150857,3.52195802323882
KHM-1B,72376,-2.838745131270772
JHUEM-7,119607,5.3622103716766905
Ishikawa (Heraklio) 02 ER-,637858,2.5781304421684847
LS411N,44819697,-0.923326266781905
F-36P,126941,-4.861525312035083
SNU-1079,216468,1.528332622046621
NCI-H2452,selumetinib-decitabine (4-1 mol-mol),5.979248786857892
KP-4,5311,1.654340953589235
KHM-1B,17755052,-0.5225933092645372
KLE,60700,-0.7910024773146103
Mino,135421197,1.5483687621841111
NCI-H1568,5291,3.770643134542437
BFTC-909,11612883,3.5324782187628827
RCC10RGB,11955716,4.4260489213830425
SW1271,11626560,1.376954486231794
BT 440,11175137,2.4333495618218244
SW48,46943432,0.8743166493146273
SNU-1079,16741245,3.4696022318722757
SNU-886,1285940,4.4592277116209775
HEL,3062316,2.2727573444408633
BT 440,644241,2.739700914223042
SEM,2858523,2.9325299148032413
KP-4,46199207,2.668096838486965
MDST8,JQ-1-carboplatin (1-1 mol-mol),1.720719180230483
RCC10RGB,5329102,2.357265375302505
ALL-SIL,9866186,-0.4181259896802407
JHUEM-1,11625818,3.61490253862518
SNU-886,6918289,1.884590673180862
JHUEM-1,9825149,2.6783386207737223
KHM-1B,3384730,0.7492899060268451
NCI-H1568,selumetinib-navitoclax (8-1 mol-mol),2.553812274921004
KHM-1B,piperlongumine-MST-312 (1-1 mol-mol),1.4082068245453034
HEL,23635314,-2.6594801266287154
KP-3,10231331,4.79345932538097
Daudi,10074640,1.7373836938395748
RKO,26596,-1.341584325458414
WM115,11167602,1.5239005360441813
HT-1376,52912189,5.055973288256478
IGROV-1,2746,2.8413672686351212
Daudi,24978538,2.467871482925033
RKO,2858523,3.1569923390566332
LMSU,JQ-1-MK-0752 (1-1 mol-mol),4.2327882239703
LS411N,15983966,2.6804451752833978
SK-OV-3,452548,0.7579906967862455
MOLP-8,25262965,-4.805551534468427
RERF-LC-Ad1,969516,3.975761175318136
SNU-1272,49850262,4.293787638544132
LCLC-97TM1,46215462,1.4949685345148778
TTC-709,12003241,-2.491438610606954
BICR 22,439501,-2.4052901035443
SUP-T11,10127622,5.432197270523235
SW48,10184653,-2.0074491437034094
P31/FUJ,168313016,4.690131242833582
KP-3,9911830,3.156441375051414
EB1,11427553,1.7773612686046738
PE/CA-PJ49,135440466,1.1829092944194737
PE/CA-PJ49,1566236,1.7621483938715563
NCI-H1568,selumetinib-tretinoin (2-1 mol-mol),5.145646184067631
SK-OV-3,selumetinib-JQ-1 (4-1 mol-mol),5.055306733015199
LS411N,54613361,3.867376577775082
COR-L105,24772860,-1.435746068442861
K-562,11222830,1.892206265748428
Daudi,10385095,0.347773175212431
F-36P,46943432,1.5782924322919043
HCC1500,44137675,4.199849963716895
SW1573,11404337,-1.3449252751203844
HT-1376,9887053,4.3872381433248755
KHM-1B,60700,-3.1057416609701463
SK-HEP-1,46191454,1.8876467264614776
Ishikawa (Heraklio) 02 ER-,11964036,2.3587584382176905
P31/FUJ,135999136,4.068676884464422
TTC-709,46215462,1.6060410317002878
JHUEM-1,675434,4.147386428095773
NCI-H1395,6918328,1.6549046673815768
RCC10RGB,25150857,2.370598483016253
L3.3,navitoclax-pluripotin (1-1 mol-mol),0.1565483194262438
L3.3,vorinostat-carboplatin (1-1 mol-mol),3.49555187429186
SUP-T11,2742550,3.0787021809680044
TTC-709,6918736,-3.085802889964574
HuH-6,5479543,3.7140778537352177
NCI-H2452,57330099,4.302779847582817
IGROV-1,10127622,3.2581804056600165
SNU-1079,16038120,0.3168104019474592
SNU-626,168313047,3.8260837539430983
COR-L105,5282054,3.9571885951378505
LCLC-97TM1,53481919,3.8027519676947232
KP-4,252682,6.9364694268072435
KP-3,6918837,-2.1662531046783777
SNU-1079,selumetinib-piperlongumine (8-1 mol-mol),0.0987185521537248
NCI-H2452,3025986,-0.5496531660815697
WM115,11955716,-2.4505472507691013
PE/CA-PJ49,26596,-2.486533753867605
BFTC-909,637858,2.264716830291231
COR-L105,selumetinib-JQ-1 (4-1 mol-mol),0.4359614379036839
Daudi,1641662,2.995591169153073
MOLP-8,446155,0.367312642153156
Mino,446155,1.9882483674298612
RERF-LC-MS,135999136,4.400683337930441
WM115,5738263,3.851280366828244
ES-2,9915743,3.6243790068274384
MOLM-13,65628,2.9573007313246924
SK-LMS-1,10385095,1.8771783160907216
HEL,9936388,-3.337900467930123
KHM-1B,selumetinib-MK-2206 (8-1 mol-mol),-1.0193788552435303
SK-MEL-2,selumetinib-BRD-A02303741 (4-1 mol-mol),2.3814029113977537
SW48,104842,-4.777281812432541
MOLP-8,ISOX-bortezomib (250-1 mol-mol),0.0006851036189058
Granta-519,11626560,0.2073830225530282
SK-CO-1,969516,2.7975557975376035
TTC-709,11455910,-0.0853911997786654
EB1,6914657,-7.34330309060219
SW948,11640390,3.051257470103826
HCC15,10302451,3.767869991537956
PE/CA-PJ34 (clone C12),72193861,0.4823673810594518
MDST8,crizotinib-PLX-4032 (2-1 mol-mol),1.604281792595084
PaTu 8988t,46943432,6.478561461465468
SEM,11626927,4.390660689868242
NCI-H1395,54619267,3.786802198247579
K-562,208908,1.7214906675478436
EB1,UNC0638-navitoclax (1-1 mol-mol),1.198480968859453
NCI-H1568,11612883,2.467781963295413
F-36P,60700,0.347286231231826
LCLC-97TM1,9884685,-0.6945268748645868
TTC-709,46398810,1.599092020340119
Granta-519,6918328,-2.2526378564537355
SNU-1272,vorinostat-navitoclax (4-1 mol-mol),1.588620831694009
Granta-519,5470400,-3.2597420844446163
BT 440,selumetinib-UNC0638 (4-1 mol-mol),1.6589214866553337
KP-4,doxorubicin-navitoclax (2-1 mol-mol),-2.0953056375586945
LS180,10231331,0.7625893939503741
SW1271,46199207,3.134892747913181
HEL,11404337,-0.835651629585067
SNU-1079,123631,-2.933783447597132
ST486,119607,3.89472018317273
Daudi,216345,1.872370108624604
MOLM-13,decitabine-navitoclax (2-1 mol-mol),-5.337552823003331
U-BLC1,44486219,3.569766421355331
HuH-6,3136844,4.044359303597411
RKN,54613361,0.2026815444056028
LS180,452548,0.7544699085550369
ST486,46926350,-6.183062780221234
RKN,44493528,4.408823872302737
SK-HEP-1,11238147,2.1467729161342524
MOLP-8,tanespimycin-gemcitabine (1-1 mol-mol),-4.944533339092102
F-36P,168312962,0.828010052090368
U-BLC1,25154868,4.658023245866651
HT-1376,53495165,2.6107239007396683
COR-L95,11364421,1.7062947816433405
KU-19-19,452548,1.4010535434747853
COR-L95,tretinoin-carboplatin (2-1 mol-mol),4.531796019532578
TTC-709,72193861,0.9348152845961964
YD-15,439501,-2.3800052899031985
NCI-H1395,6252,1.808154322431175
IGROV-1,44819697,-0.8326420176056434
L3.3,10184653,0.0220617179423389
MOLM-13,salermide-PLX-4032 (12-1 mol-mol),4.733891503361179
RERF-LC-MS,2729026,3.1361811776879644
LMSU,71751553,4.583903358050372
YD-15,25150857,2.593137635616237
TTC-709,36314,1.6907203687947638
YD-15,11238147,2.0141835542466753
DLD-1,BRD-A02303741-navitoclax (2-1 mol-mol),1.287817360894787
PK-1,25195348,1.431474248198361
KMS-21-BM,3503,1.89049690648389
JHUEM-1,12001922,1.684058505832667
RKN,4788,5.902938799554125
SUP-T11,5743,-3.9565397677305536
SNU-886,2113511,6.091216991292669
ST486,10385095,0.6554259467266613
K-562,216239,1.6121414929675577
HARA [Human squamous cell lung carcinoma],2729026,2.992927693558788
JHUEM-1,644241,3.1376628194237446
IGROV-1,2746,2.8413672686351212
IGROV-1,637858,1.814476597989254
NCI-H1395,17755052,2.034281994914555
EB1,navitoclax-gemcitabine (1-1 mol-mol),-5.011939826260467
JHUEM-7,11234052,3.906986952802379
KP-3,53232,0.96343310852112
L3.3,docetaxel-tanespimycin (2-1 mol-mol),-3.9282194992049546
JHUEM-1,9911830,1.6062370327593674
HuP-T3,11214940,1.8541641961456377
T98G,56649450,3.890245765478769
IGROV-1,46907787,2.182756719431072
P31/FUJ,445643,6.117258311867223
Granta-519,3854666,0.1662242620713641
MOLM-13,tretinoin-navitoclax (4-1 mol-mol),-1.997886556177749
KP-4,SNX-2112-bortezomib (250-1 mol-mol),-2.729591666452361
PE/CA-PJ49,44491742,3.950119634705539
JHUEM-1,122327,4.163709511411132
KP-4,9840324,5.370614226136491
LCLC-97TM1,135440466,1.105929023295497
EB1,11404337,-3.430704628521276
SK-LMS-1,7326481,2.353103661903814
BT 248,119182,0.6885021238666414
RERF-LC-MS,56649450,3.38813984116235
SK-CO-1,11612883,2.4661452350243493
SK-HEP-1,44137675,4.549525792934436
TTC-709,208908,2.2710321127880104
MKN1,2949965,3.886354330092947
HCC15,72193870,4.3690783386047025
SUP-T11,135875424,3.130261828756196
SNU-C2A,24180719,4.032890688004926
HCC1500,2746,2.6069735713089006
SEM,3676137,4.192581322448915
SNU-626,11683005,4.162672788657666
MOLM-13,decitabine-carboplatin (1-1 mol-mol),-2.1020710624228833
Daudi,11222830,0.8543881776084605
WM115,2749,6.3303951951253445
K-562,9840324,5.675524269237515
MDST8,10113978,3.624916965791189
NCI-H2452,44507138,2.753685109279225
MOLM-13,5282054,3.1361279245897857
EB1,11625818,1.843354376432759
BICR 31,9911830,2.2138272662609064
HEL,6917907,-5.38656193144065
IGROV-1,2858523,3.196384505087132
JHUEM-7,5281321,-3.009296919443196
KPL-1,JQ-1-UNC0638 (2-1 mol-mol),3.4480764849998136
KHM-1B,42642645,-0.1657476945294937
DLD-1,168313047,3.2762021509732357
MOLP-8,322968,-1.2094679469942695
BICR 22,3503,2.960513829073252
ALL-SIL,10113978,1.6173510565910796
HARA [Human squamous cell lung carcinoma],navitoclax-sorafenib (1-1 mol-mol),1.2625473684238606
RERF-LC-MS,119182,-0.645974794966856
LS411N,4261,1.591263829932159
SW948,4096211,1.12279899109382
F-36P,227681,3.7382992922650824
K-562,11485656,1.7795111963017332
SEM,5278396,2.924280160734611
BT 248,5282054,3.4340814823816324
PE/CA-PJ34 (clone C12),71466578,5.659709650891852
MOLM-13,53232,2.182263698942312
SNU-626,navitoclax-pluripotin (1-1 mol-mol),-0.1574142335728944
ML-1 [Human thyroid carcinoma],44819697,3.711954604060423
IGROV-1,3689413,-0.3633634632064185
LMSU,2828334,6.025176975178222
PK-1,44543605,5.046632687722642
RCC10RGB,12001922,2.277970650057297
RERF-LC-MS,246676,4.480243243269967
HCC15,374536,0.7951987879889547
MOLP-8,11977753,-4.876868381891939
Panc 02.03,2874250,4.438896474206821
COR-L95,613753,3.031049367391043
SW1573,9840324,5.095993559480237
SUP-T11,11497983,-4.260623234333405
SW48,24901704,1.780712261537264
MKN1,135398516,2.963440560068496
BICR 22,6918328,0.5113628660513942
Daudi,54613361,-0.5183638298018372
SUP-T11,2945648,2.0391348331264645
LCLC-97TM1,25102847,2.141917897082315
ES-2,16115403,-4.952865224080217
HuP-T3,3081361,3.872954779649628
JHUEM-7,SNX-2112-bortezomib (250-1 mol-mol),-2.50050098100693
SEM,50905018,3.665116846876204
YD-15,24951314,1.3230520141311322
SNU-1272,54618771,3.136436186338116
BT 440,168313016,5.661072033234367
SEM,navitoclax-sorafenib (1-1 mol-mol),-3.0874607200488975
LS180,969516,2.6818241036299275
SW1271,2945648,2.4921907486938646
BICR 31,25126798,3.691910729857057
RERF-LC-Ad1,49793307,-0.0254634862960308
KU-19-19,SNX-2112-bortezomib (250-1 mol-mol),-1.0111363937138018
T98G,16038120,1.6989745368394538
KMS-21-BM,11238147,1.3569624688498376
SNU-886,3025986,0.191528697071382
Daudi,262093,0.7533038243356376
SK-MEL-2,16065773,2.2843829100739206
SK-LMS-1,5287620,-0.2129368820184852
L3.3,49850262,4.243504406455669
RKN,20959075,-2.033811748726601
KU-19-19,702558,5.449368171937104
SEM,11213558,-1.899887205353697
SaOS-2,2842253,6.143936300195383
LMSU,168313200,4.186982561512388
PK-1,16720766,3.2558390072471632
RERF-LC-MS,26596,-1.2372341703529914
PaTu 8988t,5329102,3.3339986936080717
ML-1 [Human thyroid carcinoma],44607531,1.8496707927685447
KP-4,9866186,0.3799463798053679
SaOS-2,73707398,0.8491853151273433
SK-LMS-1,675434,4.534585488298608
K-562,JQ-1-carboplatin (1-1 mol-mol),0.3966707315482991
SaOS-2,984333,4.259432573695519
LCLC-97TM1,53232,3.007779101776312
KU-19-19,3503,3.0769201112014803
WM115,57330099,5.984461482923693
ST486,441298,2.817717813372474
SNU-626,445455,4.442434970216884
KPL-1,11238147,3.849730274583552
KHM-1B,984333,-0.473471772340059
JHUEM-1,262093,1.0562191495276867
T98G,44486219,4.312983721099698
NCI-H1395,60700,0.9119898603788574
ES-2,57519531,1.921975569584754
JHUEM-2,135984461,4.241514174817559
HARA [Human squamous cell lung carcinoma],82146,4.619283658647928
ST486,10302451,3.4096383084955004
LCLC-97TM1,44491742,4.237702230509644
SK-CO-1,9915743,2.0474134916136184
SNU-1079,135440466,0.1939387331341597
KLE,11238147,4.019419041110989
PE/CA-PJ49,doxorubicin-navitoclax (2-1 mol-mol),-1.9478418148635344
KMS-21-BM,126941,-3.433144609084401
HCC15,73707398,1.6988346513711203
HCC15,4477,-0.3802251277588812
TTC-709,136227924,1.406309539576174
BICR 22,26596,-1.8883514509946957
SK-MEL-2,5738263,4.141005306837072
SaOS-2,445091,4.479630914494518
SNU-1079,3543504,3.685162914647458
HuH-6,24772860,-0.2102155293606675
ST486,11656518,1.1126216162837452
JHUEM-7,135440466,2.2183951118949
NCI-H1395,60750,-2.362742731537794
SNU-1079,327653,3.396967278535857
HCC1500,3503,2.0705498046235817
SK-LMS-1,46199207,3.667357630180187
YD-15,6918736,-2.377254438838028
SK-CO-1,salermide-PLX-4032 (12-1 mol-mol),5.553578625312618
KPL-1,11222830,1.854543695140635
RCC10RGB,71304818,3.488257335656729
PK-1,51039095,3.0428415494279824
PE/CA-PJ49,135999136,4.298011402376219
RKO,241158,4.5302703569847305
JHUEM-1,54618771,0.4332987252464321
U-BLC1,984333,0.6204080271841751
SW1271,168313016,5.582938604018868
PE/CA-PJ49,135411,0.8247523784493911
KHM-1B,702558,3.340125476799818
SEM,3038522,-0.4118927159500882
SNU-1272,107970,2.7088030141342383
RERF-LC-Ad1,12003241,-0.821513059069255
SW948,10385095,1.3660359707166476
TTC-709,3385,2.1081238421602215
ST486,5287969,-2.7684873983458287
RERF-LC-MS,3543504,3.1700226881436193
U-BLC1,9967941,3.799385899096112
KHM-1B,5394,4.374287495449882
JHUEM-2,navitoclax-pluripotin (1-1 mol-mol),-3.0841520881556663
LS180,5311,1.1738972820475675
RERF-LC-MS,5291,3.9873816513243785
PE/CA-PJ49,25105715,3.847811291545487
KP-4,11238147,2.558252022651666
JHUEM-7,erlotinib-PLX-4032 (2-1 mol-mol),1.849076309987276
KP-3,5284373,-1.257942285034982
KLE,72734382,3.5646775287439505
RCC10RGB,53481919,4.9196370953200805
Daudi,44241473,5.233980827552566
SNU-886,15953870,3.508651864027871
Panc 02.03,10127622,3.4148938287456776
KPL-1,16038120,1.2274582668257046
MKN1,54143018,4.175885331413797
BICR 31,49836020,4.313223650735915
JHUEM-7,11507802,0.4184250140015549
Daudi,54618305,3.9105424608095847
F-36P,BRD-A02303741-carboplatin (1-1 mol-mol),6.404979858036225
SK-HEP-1,5746,3.319924463812582
LMSU,3062316,-2.3200924553246183
ALL-SIL,67156097,-2.3407546390754037
ML-1 [Human thyroid carcinoma],24797083,1.931228349809168
PE/CA-PJ49,5280436,2.0810163091034672
P31/FUJ,613753,2.9305719806169432
PaTu 8988t,1641662,3.634680635371761
SU-DHL-1,15953870,1.992339234699044
SNU-C2A,262093,2.4515351463373807
COR-L95,decitabine-navitoclax (2-1 mol-mol),-0.2234984214129892
SW1573,JQ-1-UNC0638 (2-1 mol-mol),2.8948762578833667
ST486,409805,3.877677170131383
RERF-LC-Ad1,selumetinib-piperlongumine (8-1 mol-mol),4.22277875723884
KLE,5282054,1.2490004235770853
P31/FUJ,navitoclax-PLX-4032 (1-1 mol-mol),0.0164871875305551
Daudi,vorinostat-carboplatin (1-1 mol-mol),1.6612162447966572
SK-CO-1,11364421,1.7180407971266538
KMS-21-BM,637858,0.4852193372876609
COR-L105,16722836,1.79329711252707
SEM,26596,-3.506968001766276
KMS-21-BM,6184667,3.2938760775332145
IGROV-1,439501,-2.1510551928674557
Mino,44491742,3.5991371763887616
ALL-SIL,50905018,3.9646846974495418
SW48,25126798,2.5731969050098993
PaTu 8988t,10113978,4.3652834043747335
SNU-C2A,BRD-A02303741-navitoclax (2-1 mol-mol),2.4466739994390863
SK-OV-3,12003241,-1.2313805329375749
SNU-886,2841722,5.058350864200372
YD-15,72193861,-0.1725983868670056
Daudi,1317464,3.6966432302020817
WM115,5978,4.185238310426041
RKN,carboplatin-etoposide (40-17 mol-mol),3.53893718453625
SNU-626,54686904,4.268904062720219
NCI-H1395,8515,4.661084548760473
ALL-SIL,24785538,-0.5874123218373029
COR-L105,sirolimus-bortezomib (250-1 mol-mol),-3.794916830429034
IGROV-1,9967941,2.9735049794712545
HuH-6,5287620,-2.3574910715402475
SK-HEP-1,11977753,-1.1270659898133608
PE/CA-PJ34 (clone C12),3038522,3.0123071564783777
SNU-C2A,219104,3.180966283507358
JHUEM-7,3025986,-1.7101726787729836
DLD-1,5280436,4.596953474010246
Mino,9952709,2.0285527321317787
COR-L105,676352,1.9469411585028615
SNU-626,navitoclax-birinapant (1-1 mol-mol),-2.0756755194426515
SUP-T11,11404337,-1.4432067175867065
MDST8,11485656,2.867381561993162
KHM-1B,15547703,2.9789166957763045
SW1271,selumetinib-piperlongumine (8-1 mol-mol),2.3808052258502705
SW48,6918736,-2.164113269607571
SK-HEP-1,445455,4.37046727572682
Daudi,4096211,1.4831417361144643
LCLC-97TM1,16038120,-0.9192372639718316
L3.3,9935249,4.2075706542966955
KMS-21-BM,10302451,2.292063608939571
BFTC-909,3384730,4.46542670181497
JHUEM-7,5328940,0.6709710255807081
K-562,36462,1.3855340321895664
SK-HEP-1,5329102,2.506246240472525
SNU-1272,5328940,2.3850434958560407
WM115,25161177,2.874219730459086
HCC1500,119607,4.730010050453825
KP-4,9927531,4.133132471869078
PE/CA-PJ49,selumetinib-JQ-1 (4-1 mol-mol),1.4139822071582016
IGROV-1,24964624,0.5052308994941754
HCC15,421610,3.960173561996767
ALL-SIL,4788,4.920956242868583
IGROV-1,49766530,-0.195540678413639
Mino,119182,-4.350200760936349
SK-HEP-1,11175137,3.0126176485486114
TTC-709,6505803,0.8575358462555939
MOLM-13,selumetinib-piperlongumine (8-1 mol-mol),2.118239948342191
HT-1376,23939,4.4619777207187195
KPL-1,4378219,2.1677219133521404
Hep-G2,4477,1.6560348387058257
SEM,6610216,3.5318840364079302
Mino,crizotinib-PLX-4032 (2-1 mol-mol),0.5449253612491881
K-562,54678924,1.7343444538293111
JHUEM-1,1716436,1.754733943954517
ML-1 [Human thyroid carcinoma],5281321,-2.300928121678764
ML-1 [Human thyroid carcinoma],11167602,2.9640815113410923
SEM,54613361,-1.7157995235006995
Mino,42642645,-0.9713328397694244
SNU-C2A,5280436,4.399251039882916
COR-L105,6505803,1.059348129706536
SK-LMS-1,24821094,3.80492364683607
P31/FUJ,25183872,-2.108478877482417
Daudi,navitoclax-birinapant (1-1 mol-mol),2.1928151248147194
KMS-21-BM,72193861,-0.5401754047957681
SUP-T11,439501,-2.327064015434822
NCI-H1568,9444,4.259676436179719
NCI-H2452,selumetinib-MK-2206 (8-1 mol-mol),2.148853035614541
KU-19-19,19582717,2.992815973528006
RKN,36462,2.460575122343829
P31/FUJ,3062316,2.2346133515561415
MOLM-13,36314,-7.769941141611737
KMS-21-BM,44259,-0.3048544732756655
JHUEM-2,11175137,0.0422083716532882
PE/CA-PJ49,24748573,1.2565986822042992
JHUEM-1,54618305,4.244696493525863
HEL,44484440,3.2564839193688524
KHM-1B,9866186,-0.1943937509034402
RERF-LC-MS,168313016,4.277512101574917
SNU-C2A,6918878,4.018878788536444
HCC1500,637858,1.1010846881251866
SUP-T11,2949965,2.242330398195191
COR-L105,11178236,-3.064044900311784
EB1,56963564,-0.4053872143102427
IGROV-1,44202524,1.8303703172382677
LS180,alisertib-navitoclax (2-1 mol-mol),1.1962644272537857
MOLP-8,11175137,1.914718066408171
LCLC-97TM1,1641662,3.5570250788057187
SK-HEP-1,46199207,3.772137058295689
HuH-6,6914657,-3.825140190749564
SW1573,6917907,-6.296104468024424
HEL,89183176,1.9576500820122449
HT-1376,44241473,5.995086046187869
SU-DHL-6,49793307,-4.306431914357451
KMS-21-BM,409805,3.562482933732855
K-562,6918837,-4.262812875828109
Daudi,44493528,3.680262260756896
RERF-LC-MS,5311281,3.366561586065275
IGROV-1,675434,4.336225379212549
EB1,44566777,-0.9666988619978416
NCI-H1395,crizotinib-PLX-4032 (2-1 mol-mol),2.536780809037994
NCI-H1568,216345,3.8344110950672823
U-BLC1,SNX-2112-bortezomib (250-1 mol-mol),-2.8771837728305503
SK-MEL-2,16722836,3.274518367444452
MKN1,122327,4.4857348087637945
SU-DHL-1,9926054,1.6936537424309908
Panc 02.03,9911830,3.8856260346392903
HCC1500,2729026,1.749867272011919
ALL-SIL,42642645,-2.33031271995146
T98G,46199207,3.2147229661642904
Daudi,9911463,2.4252044126403915
NCI-H1568,45279963,3.534456091536717
RKO,135999136,6.045591123054076
ES-2,219104,3.921787608172368
BT 440,16736978,3.198741294589096
MKN1,49766530,-2.302116655830655
SW948,JQ-1-UNC0638 (2-1 mol-mol),0.5184819522178918
SW948,9903786,1.6902329933335576
RCC10RGB,9956119,4.44093701823858
SW1271,25154868,5.0403607075499375
K-562,65628,4.517417686157834
RERF-LC-Ad1,89928392,3.1512603653574653
BT 440,vorinostat-carboplatin (1-1 mol-mol),5.886350438519718
KHM-1B,5282054,1.6499895899015693
F-36P,2828334,5.827212923410168
KP-4,10113978,3.65058716470038
SU-DHL-1,613753,2.797885663964736
ST486,89183176,2.923606141333665
SW48,ISOX-bortezomib (250-1 mol-mol),0.0957852828937709
Ishikawa (Heraklio) 02 ER-,11364421,-3.761750823923845
LMSU,89928392,1.5528019914558755
JHUEM-7,6505803,0.2461537124409258
HCC1500,44566777,0.0909506116020526
NCI-H1568,54454,3.61375646412465
YD-15,15547703,3.50536178946588
EB1,9884685,-2.5216345274961585
SW948,44507138,2.949706410080911
SK-CO-1,17759555,4.047587343089958
HEL,568763,0.2288469977463405
KPL-1,675434,4.79336556322622
KP-4,9887053,1.9086083825489089
HuH-6,5329102,1.359476259785794
BFTC-909,3815108,3.5118939741133075
ALL-SIL,24901704,-0.1489296834412312
MOLP-8,piperlongumine-MST-312 (1-1 mol-mol),0.7424689739493265
KU-19-19,24772860,-1.0696999794461075
MOLP-8,9866186,-0.5209158528959533
NCI-H1568,JQ-1-MK-0752 (1-1 mol-mol),3.5105249308751363
HuP-T3,71304818,3.5647709327393287
SUP-T11,9935249,2.2122809051591417
JHUEM-7,44185566,2.2115462684333855
MOLM-13,11683005,2.7238157220539345
HEL,54618771,0.7283869495698151
KMS-21-BM,46199207,2.1928711186777146
YD-15,246676,4.797554441862922
RKO,selumetinib-PLX-4032 (8-1 mol-mol),1.8013466074828854
LMSU,16736978,1.7346374327663163
JHUEM-1,25262965,-3.024263690820878
SNU-886,selumetinib-tretinoin (2-1 mol-mol),2.050620006893266
KMS-21-BM,5978,-5.003158312092759
SK-LMS-1,2126,5.096957646919912
HT-1376,5311,1.7054226644391202
L3.3,439501,-0.248470622878828
WM115,selumetinib-PLX-4032 (8-1 mol-mol),-2.130332393585934
NCI-H1568,25150857,2.4294918673251416
RKN,6438330,1.1013294242613172
HCC15,644241,2.326085716096255
LS180,2708,3.937371430907984
F-36P,4917,2.613020518555427
LS180,51037431,3.4786862718788747
K-562,16741245,3.9224206604880583
SUP-T11,5284616,-4.045109817494036
RERF-LC-MS,44185566,3.014427147988128
SNU-626,JQ-1-vorinostat (2-1 mol-mol),2.2626284963649637
SW48,navitoclax-MST-312 (1-1 mol-mol),0.8806321220589545
DLD-1,crizotinib-PLX-4032 (2-1 mol-mol),2.7406365017467245
RKN,5566,3.4992110401170944
LS411N,navitoclax-piperlongumine (1-1 mol-mol),2.36008373550467
NCI-H1395,25062766,3.463916813883382
MOLP-8,216345,2.155670358283386
HCC1500,BRD-A02303741-navitoclax (2-1 mol-mol),0.0071603230581946
HARA [Human squamous cell lung carcinoma],alisertib-navitoclax (2-1 mol-mol),-2.092897901371494
PaTu 8902,46224516,2.4477060426075723
RCC10RGB,241158,4.984223152954295
HCC15,11612883,1.9950389922708311
PE/CA-PJ49,17755052,1.5231529598705214
LMSU,16722836,2.691296467692663
HCC15,969516,3.14053560758236
LS180,9866186,-0.1716689837079009
Granta-519,decitabine-carboplatin (1-1 mol-mol),2.1725621434549582
RCC10RGB,24964624,2.93015987785669
SNU-1272,3503,2.878382710922879
MDST8,216345,3.5638732818875094
RCC10RGB,10302451,3.839480938635774
KHM-1B,54619238,4.434806888853119
HARA [Human squamous cell lung carcinoma],100016,5.315547253627084
WM115,44491742,3.78432787650886
SU-DHL-1,selumetinib-piperlongumine (8-1 mol-mol),2.378072265787347
KU-19-19,262093,2.7281718696395303
ML-1 [Human thyroid carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),2.7869393467132344
COR-L105,1242560,3.3237423881291233
MDST8,16736978,0.980275670291684
PE/CA-PJ49,5278396,3.6420002374977294
NCI-H1568,16722836,1.2045551605263336
WM115,5282054,2.577591804396212
IGROV-1,25195348,3.0698662305180275
JHUEM-2,676352,1.277152005396165
PaTu 8902,148198,-2.774580136562139
SEM,54619267,2.973964414484695
PE/CA-PJ49,44632017,0.7421325130952813
YD-15,46191454,1.0050588435937793
HEL,26596,-1.8679385890512872
PK-1,24772860,-1.503943368507487
PE/CA-PJ34 (clone C12),1641662,3.2339299238694066
JHUEM-2,5351362,0.9505734980248416
PE/CA-PJ49,2749,1.8530825541406395
Mino,3552672,3.474584960640692
Daudi,25126798,3.548189682848153
ST486,11317348,0.9075003533100116
PaTu 8902,selumetinib-piperlongumine (8-1 mol-mol),5.497989392681889
YD-15,44632017,1.0155815952297451
SaOS-2,decitabine-navitoclax (2-1 mol-mol),2.350842092351968
KP-3,tanespimycin-gemcitabine (1-1 mol-mol),-0.1354720492622221
PaTu 8988t,56946209,-4.946927234389905
SK-CO-1,2945648,3.4071568821077993
SK-CO-1,JQ-1-navitoclax (2-1 mol-mol),0.4682346666935782
BFTC-909,3136844,3.2427360302120403
IA-LM,71304818,3.3887828048220094
NCI-H2452,122327,4.606448802646307
LS180,12003241,-0.6460664270988897
SK-LMS-1,3062316,2.9928105534026774
BT 248,54618771,0.8718785044821341
JHUEM-7,navitoclax-piperlongumine (1-1 mol-mol),0.3587972188720395
SK-HEP-1,16741245,3.65273757252914
DLD-1,24951314,2.1005167853281455
KLE,9911830,2.855789588066899
KMS-21-BM,24180719,3.968248733018151
SNU-1272,5280436,4.574353860374468
RCC10RGB,6918638,2.235907203261483
BT 440,168312962,3.8065778482366217
MKN1,31703,-1.7361524695362138
WM115,16065773,1.4979025411384967
YD-15,tanespimycin-gemcitabine (1-1 mol-mol),-1.639983803955987
HARA [Human squamous cell lung carcinoma],9825149,2.481612932411
Daudi,54678924,0.8831010429483725
KHM-1B,216468,0.1436700661739532
MOLP-8,9903786,1.299688823902182
ML-1 [Human thyroid carcinoma],24180719,3.042356764984187
WM115,219104,4.514482202684108
SK-LMS-1,2113511,5.626213244355371
Daudi,25150857,0.8259987709661276
KU-19-19,selumetinib-BRD-A02303741 (4-1 mol-mol),2.399823528664379
DLD-1,9935249,3.699749001194777
LMSU,11955716,0.1089430802506861
BICR 22,25262965,-4.220207088048826
BICR 22,25126798,3.759096897040898
HuH-6,10385095,2.0589740741607496
Ishikawa (Heraklio) 02 ER-,selumetinib-MK-2206 (8-1 mol-mol),4.937900564286944
SNU-C2A,16741245,5.574123813040144
HCC15,11717001,5.339668805105819
KLE,2858523,2.55520856351848
Panc 02.03,JQ-1-MK-0752 (1-1 mol-mol),2.226829891800918
SEM,17755052,1.610064105024121
BICR 31,6918328,1.2499033439512497
DLD-1,638278,3.4872270025185115
ES-2,3552672,2.217060042005016
COR-L95,25150857,1.208080540357677
ALL-SIL,104842,-6.679847729141338
EB1,25154868,4.236043011467769
ML-1 [Human thyroid carcinoma],6450551,2.5869852554462622
MOLP-8,crizotinib-PLX-4032 (2-1 mol-mol),0.0452912472141007
SUP-T11,JQ-1-MK-0752 (1-1 mol-mol),1.4356050069961876
IGROV-1,11612883,1.8715405446213529
HEL,9926054,1.596813412273358
HCC15,11404337,-0.219975280966356
LS411N,168313047,3.2811764574410893
HuP-T3,168313200,4.289513738947004
RKO,216468,3.08027711257304
HCC15,5566,3.133848096057735
SaOS-2,2130404,2.752105467907615
PaTu 8902,6623618,2.257974787323956
Granta-519,45279963,2.8131243875516097
BICR 31,6918638,1.4401869695378149
T98G,107970,3.0789596512237978
IGROV-1,2729026,2.3541792737160296
ST486,54678924,1.126737323372233
Hep-G2,637858,2.4710681435790747
SaOS-2,decitabine-carboplatin (1-1 mol-mol),4.9062736540715735
KP-3,44507138,3.577234847384827
PaTu 8988t,126941,-4.347732149803542
BICR 31,44607531,1.4420456412349776
RKO,227681,3.9032876810461814
Granta-519,5278396,3.331153353007608
BT 440,9952709,2.820289294938081
KLE,5287620,0.9182057456501032
MOLM-13,11214940,0.2452206847669268
Granta-519,6914657,-5.464946920891912
SW1271,72199292,4.741032264194907
SUP-T11,5284373,1.46587967391518
LCLC-97TM1,3676137,5.47833794075875
SK-MEL-2,44566777,1.1693923855033086
BICR 31,6505803,0.2507928346620714
MKN1,11364421,-2.357615374680572
NCI-H2452,9927531,4.529523169776047
SK-LMS-1,16741245,3.6746390980011174
HEL,107970,2.2652057864285893
SNU-1272,11427553,3.4052745190282305
P31/FUJ,73707398,-0.9687174770786582
KHM-1B,322968,1.990474592363433
SK-CO-1,3634881,3.2176217097393867
ALL-SIL,71680916,4.0231197218666015
IA-LM,carboplatin-etoposide (40-17 mol-mol),4.857587432381165
T98G,5291,3.7214486314169126
KMS-21-BM,2113511,3.6684113560641647
NCI-H2452,54678924,3.78052585603054
SK-LMS-1,5566,3.6003036251951195
HARA [Human squamous cell lung carcinoma],20959075,-3.3968163713216657
RKN,9840324,5.059199694090175
LS411N,25195348,3.7393125277208608
ML-1 [Human thyroid carcinoma],171352865,2.7298814774275435
BICR 31,11497983,4.106423080888053
HT-1376,168313047,2.6345386597206724
EB1,100016,6.112181525197604
RKN,3825829,4.2934517576030276
Panc 02.03,104842,-1.6275579890051994
KPL-1,6623618,2.4501150337928923
U-BLC1,51039095,2.6451817389385157
F-36P,5291,3.4889891635837884
SNU-1079,15953870,2.2216848714755644
F-36P,6436223,-4.329523478491274
NCI-H1395,selumetinib-vorinostat (8-1 mol-mol),2.147255996625455
PE/CA-PJ49,44566777,0.2729786276106425
HuH-6,23635314,0.1154998902275007
SK-HEP-1,4378219,1.9889575503272792
ST486,676352,1.5544095894323295
NCI-H1568,11609586,2.169671625299293
NCI-H2452,24772860,-2.067021978185303
HT-1376,984333,1.4382864881567023
KLE,3384730,5.5798007151101325
HuH-6,11167602,1.354506813263299
HCC1500,2828334,6.090675120485649
ML-1 [Human thyroid carcinoma],15983966,-5.2151360937473
KHM-1B,11609586,2.3896686488847343
PK-1,3025986,-1.322526700090449
YD-15,12003241,-1.418070390851184
HuH-6,vorinostat-carboplatin (1-1 mol-mol),2.8593183179126664
KP-4,5311281,0.5350208098377819
SNU-1079,selumetinib-GDC-0941 (4-1 mol-mol),-2.187846560815933
HCC15,selumetinib-navitoclax (8-1 mol-mol),-1.9070047094364015
ML-1 [Human thyroid carcinoma],5291,4.042812106600411
SK-CO-1,426756,3.753929508081783
SaOS-2,46215462,2.3169135098646483
IGROV-1,216468,0.5330864756407336
RERF-LC-MS,25262965,-1.1343637554659964
NCI-H1568,53392493,1.829675716879907
WM115,6438330,2.009543324889134
KP-4,25150857,3.3627851710641177
KLE,46191454,0.8437389846099377
P31/FUJ,9908783,6.361014450142155
BT 248,54613361,5.122685224165604
SNU-886,9915743,1.7822621128192635
Mino,6610355,3.477910494331319
PE/CA-PJ34 (clone C12),11640390,3.424218782856885
HCC1500,5291,3.388112901698238
SEM,2746,-0.0565030951113346
HCC1500,216345,2.2086555393223293
JHUEM-2,126941,-1.1732961975576397
SK-CO-1,16722836,1.1930735523198912
MDST8,2858523,3.149165485885388
KP-4,2749,2.361168615001136
U-BLC1,262093,2.6001367621084306
KMS-21-BM,5311281,1.62681634086948
IA-LM,44486219,4.346993548383093
P31/FUJ,10427712,4.089067276268696
K-562,24771867,1.7261535062160185
SW948,2742550,2.6149964231270166
COR-L95,2113511,4.880906118348224
BFTC-909,82146,3.493415453952883
Mino,11364421,-5.761283261417625
BICR 31,4261,2.904745052497421
BFTC-909,119607,6.015893315993201
MDST8,JQ-1-MK-0752 (1-1 mol-mol),1.445543393100169
T98G,23725625,4.731314088365893
Granta-519,262093,1.5974758737964725
COR-L105,4521392,4.261553030698096
RERF-LC-Ad1,11404337,1.7320849295693297
YD-15,151289,0.734915486816281
U-BLC1,54765302,3.1656665045151384
SEM,10302451,1.800985187016429
BT 440,42642645,0.1106109031973179
HuP-T3,52912189,2.4400429797195065
HCC15,168313016,4.627209757330862
KP-3,2749,5.709851837562526
PE/CA-PJ34 (clone C12),25102847,1.9967626307461543
MDST8,15983966,1.9809932367095728
U-BLC1,6438330,2.065279579011853
Granta-519,9866186,-0.14818829969678
SK-HEP-1,462382,1.018219313736715
Daudi,7251185,0.6493905196982933
HEL,3385,2.274300648457042
SK-LMS-1,11955716,-1.5913671626842558
NCI-H2452,44185566,2.4757676958398824
KMS-21-BM,2708,2.7964566719352044
BT 248,9884685,-0.279602051509792
DLD-1,219104,4.142729597727973
SW1573,9884685,-1.2788581073527363
KHM-1B,15983966,1.6900305517060583
RKN,6505803,1.4092626649390017
COR-L105,selumetinib-piperlongumine (8-1 mol-mol),1.184006147072735
RERF-LC-MS,11427553,2.91041132641442
SW948,107985,-3.1361927230844255
IGROV-1,24951314,0.9075718706849548
NCI-H1395,2742550,4.633125791317317
IGROV-1,753704,6.461140333581179
HT-1376,4259181,-0.3817300080320475
Hep-G2,9915743,2.3547256655946542
LCLC-97TM1,54143018,-1.232378656007133
PE/CA-PJ34 (clone C12),66577038,3.169631550973707
SNU-1079,613753,2.493618601717066
ST486,71680916,3.2678837280396293
T98G,9444,4.285796096297503
SK-LMS-1,1716436,3.783902076496232
SU-DHL-1,16038120,-4.191759239414132
SK-HEP-1,65064,5.472205201006758
PE/CA-PJ34 (clone C12),262093,3.186494210920842
Mino,4521392,4.167665849502811
COR-L105,2733526,5.6711261994322
HuP-T3,56649450,4.499318873015619
F-36P,5281321,-1.3256823560764706
SW48,16741245,3.865069024996995
ST486,6610355,3.3744915038669725
KLE,676352,1.979256710786136
HCC15,89183176,3.7013914070621903
SU-DHL-1,135928012,2.7237506411412427
HCC1500,24901704,3.772063812557438
K-562,6505803,-1.797722788015983
P31/FUJ,docetaxel-tanespimycin (2-1 mol-mol),-5.9377835284500895
ALL-SIL,9936388,-6.364749169872344
SNU-886,25262965,-1.963536165555311
P31/FUJ,5284616,2.141886646431612
SUP-T11,6610355,4.892522569566467
SK-MEL-2,25183872,-1.7332559783932406
RKN,654092,-2.299209260296745
SW48,piperlongumine-MST-312 (1-1 mol-mol),1.3077982167208542
KLE,53232,1.234342412255229
Panc 02.03,462382,1.1832417961450334
P31/FUJ,11609586,2.709581392176905
COR-L105,322968,4.452130073523545
T98G,73707398,2.1109141148348254
RKO,135398516,4.318914396092429
Panc 02.03,44185566,3.1312758482446976
NCI-H1568,72376,-1.5373297187690371
Mino,5282054,2.2264353184224377
SNU-1272,676352,3.00667023527596
Daudi,11494412,-0.3802447608890573
SK-LMS-1,decitabine-navitoclax (2-1 mol-mol),1.4771354794174532
KMS-21-BM,119182,-2.2377738968162446
JHUEM-2,selumetinib-tretinoin (2-1 mol-mol),4.506798293726309
U-BLC1,5284373,0.9163540392956472
SW48,erlotinib-PLX-4032 (2-1 mol-mol),3.2399078814474924
SW1271,2126,5.27764055734565
BT 440,9549297,1.707376266598919
RERF-LC-MS,10296883,4.230661493555322
DLD-1,54618771,1.295500773429104
SEM,46843906,-1.2667030420519347
SK-CO-1,53232,1.9491581074450712
HCC1500,11222830,1.0956735100670385
F-36P,54619267,3.337793152208533
EB1,10296883,2.8926613623150685
SK-CO-1,vorinostat-navitoclax (4-1 mol-mol),1.5116374119241311
LCLC-97TM1,16219061,3.747043694071086
F-36P,16065773,1.877584922895811
HCC15,3543504,4.297283358198234
SW1271,6918837,-1.9255423784418917
SUP-T11,6918837,-4.283887541774121
SaOS-2,53301938,5.583232766578932
EB1,25227462,-3.132607648086322
UACC-812,9866186,1.6792636289805696
BT 248,4378219,1.4454405763629643
PE/CA-PJ34 (clone C12),9840324,5.6753199284891505
U-BLC1,15953870,3.155905606159002
SNU-1079,25183872,-1.281365783915137
HT-1376,6918837,-1.6286613784132915
TTC-709,2871966,0.0732590359631757
RKO,5278396,3.510721289362286
F-36P,10427712,3.928064204708117
K-562,16722836,1.308803334400655
JHUEM-1,52912189,2.601581239718817
HEL,selumetinib-tretinoin (2-1 mol-mol),7.234386750467808
ST486,9826308,-0.1882921723357713
HuH-6,44493528,4.083061527046497
P31/FUJ,9935249,2.700947453739227
JHUEM-2,SNX-2112-bortezomib (250-1 mol-mol),-2.567491271601247
MKN1,656346,3.82511311948538
IGROV-1,5351362,1.961059142684053
IGROV-1,44819697,-0.8326420176056434
HCC1500,5746,0.8617369744590151
HuH-6,54618164,3.300518310579967
BICR 31,15547703,3.2095649219178006
L3.3,2746,3.431089753490113
EB1,9915743,-0.0076946910500104
ST486,151289,0.2759705434939
P31/FUJ,72193861,-0.3659416399435479
PaTu 8902,24964624,3.11499425545507
PK-1,148198,-3.6704242534149296
BICR 31,vorinostat-navitoclax (4-1 mol-mol),1.4356739307232549
SK-OV-3,24901704,3.989938255280614
LCLC-97TM1,2113511,6.012866888022406
BT 440,3503,1.9758907009177675
LMSU,11625818,5.059170877046766
ES-2,71466445,5.483195455605914
SaOS-2,3081361,3.085781742119062
SNU-1272,9926054,2.4790221898932283
IGROV-1,15983966,1.7101486625531308
MDST8,6852167,1.3374988720553735
MOLM-13,67291369,-0.0488061328139809
SEM,168312962,2.860671737666069
K-562,JQ-1-vorinostat (2-1 mol-mol),0.1257253367868581
MOLP-8,9926054,1.7939353525170396
SU-DHL-1,168312962,-2.257405592485961
HuH-6,crizotinib-PLX-4032 (2-1 mol-mol),1.2656718974402377
TTC-709,54619267,4.176573330133014
PE/CA-PJ49,3689413,1.6027869787622069
LCLC-97TM1,219104,3.650486733954163
HuP-T3,984333,1.5721860041126483
F-36P,3825829,2.646240330618036
Panc 02.03,4477,0.984097917718396
Daudi,selumetinib-piperlongumine (8-1 mol-mol),2.587128104626929
IGROV-1,9929138,6.483056540257463
SK-MEL-2,sirolimus-bortezomib (250-1 mol-mol),0.4660061968632925
SaOS-2,11175137,1.9690729540796783
ES-2,selumetinib-piperlongumine (8-1 mol-mol),4.589887294528564
T98G,6184667,4.0662287271254485
YD-15,9929138,6.969661467519232
U-BLC1,421610,2.3747239482315323
SK-LMS-1,374536,5.368903896661628
LCLC-97TM1,9915743,-0.0836077976930932
EB1,11494412,-0.5591011576932087
KLE,tretinoin-navitoclax (4-1 mol-mol),0.0197424431924765
Ishikawa (Heraklio) 02 ER-,3854666,1.1543280454894709
BT 248,327653,3.4402013175237394
EB1,9887053,-0.1865767026593925
PaTu 8988t,9907093,4.39010034793255
LS180,73707398,1.191690395470446
U-BLC1,6918638,0.4166229945457058
ML-1 [Human thyroid carcinoma],25102847,2.935986325205898
Daudi,11960529,3.700971671461623
RKO,4259181,-0.4049041326260317
EB1,327653,2.3886030622482566
MOLM-13,31703,-4.683228669920675
F-36P,53392493,1.6104194986145994
SW1271,4477,0.3648589081307944
HuP-T3,216239,2.9976543037230665
HCC15,9903786,1.5576741113339283
IA-LM,selumetinib-JQ-1 (4-1 mol-mol),2.5487957947561544
U-BLC1,selumetinib-GDC-0941 (4-1 mol-mol),-2.579214218567442
Daudi,1239801,3.0112900662314717
KP-3,51039095,3.0052998284349317
U-BLC1,54618771,-0.2094086487307373
SUP-T11,126941,-2.0616116049512554
PaTu 8988t,25126798,4.088623680113087
HuH-6,2130404,3.340818393693296
RKN,227681,3.7901732699912585
LMSU,409805,5.989527903576905
MKN1,15953870,3.454153639130422
K-562,216468,1.7844503846326911
PK-1,24785538,2.8472745813191613
NCI-H1568,11234052,4.07711650557102
SUP-T11,24748573,1.432105268514433
RERF-LC-MS,17755052,1.8057357372617977
HEL,135999136,1.6019096984193502
HEL,9887053,3.0781159437380974
ES-2,216468,4.284048248219972
ES-2,5329102,2.9421007901315197
SNU-626,25183872,-1.2573094684165955
MKN1,11626560,2.4114866095146703
RKO,11625818,4.5581118700811105
HuP-T3,322968,2.6241189840020787
BFTC-909,11317348,4.568727931072339
LMSU,6918328,1.1714083340130723
SW48,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.5460315373913385
MKN1,46191454,5.634648258735239
F-36P,9444,4.08511047896454
MDST8,1716436,1.1500764778734351
ALL-SIL,16741245,1.8101156107911176
Granta-519,16722836,1.0937584859115594
PaTu 8902,10385095,2.391345219233966
WM115,3038522,1.9104775831242309
F-36P,navitoclax-MST-312 (1-1 mol-mol),0.2505662083694212
HCC15,decitabine-carboplatin (1-1 mol-mol),4.946381859305088
BT 440,219104,4.329679940377733
U-BLC1,5282054,2.88885185541126
RKO,11497983,5.954072388877685
U-BLC1,6610355,3.619439435673799
BICR 31,46174525,4.37434163277974
SEM,49766530,0.1216347460182048
IGROV-1,JQ-1-UNC0638 (2-1 mol-mol),1.7292829396313356
PaTu 8902,73707398,2.5949502925816397
SNU-886,navitoclax-piperlongumine (1-1 mol-mol),-7.772241665279227
MOLP-8,1641662,3.485304007232308
MKN1,selumetinib-MK-2206 (8-1 mol-mol),4.602517299756441
SNU-626,25126798,3.8920441618872426
PE/CA-PJ34 (clone C12),5351362,0.8158998641281501
HuP-T3,11640390,3.629059315953643
HARA [Human squamous cell lung carcinoma],53481919,4.643044937502802
LS411N,49850262,4.021647044836445
KP-4,11626560,0.2216664549729946
HARA [Human squamous cell lung carcinoma],9952709,3.695976506837269
SW1573,24951314,1.273840217876839
PE/CA-PJ49,JQ-1-MK-0752 (1-1 mol-mol),3.1427050678514608
RKO,441298,2.3183923582018107
COR-L95,5335621,4.389010810876702
MOLM-13,selumetinib-UNC0638 (4-1 mol-mol),2.1826018630699746
MOLM-13,24785538,0.0261170120397283
ES-2,6918289,3.42616011915782
Granta-519,374536,-1.3755413186728007
NCI-H1395,44185566,2.9760824770163756
HuP-T3,9911830,2.533690069517969
PK-1,11640390,4.483271104220931
HCC15,11640390,4.25082988279064
SEM,BRD-A02303741-navitoclax (2-1 mol-mol),-2.0492341390598368
JHUEM-7,148198,-3.5780143567355336
F-36P,12001922,1.376865879976315
MKN1,168312962,-2.574298844258664
SNU-886,24901704,3.3518234737220265
U-BLC1,448949,1.874257601550964
Daudi,375860,-0.7416229308895455
BFTC-909,16722836,1.424017650466323
EB1,11455910,-1.5299168268702652
BICR 31,selumetinib-JQ-1 (4-1 mol-mol),1.6620620003816966
EB1,5284616,-3.9670277084039984
BICR 31,crizotinib-PLX-4032 (2-1 mol-mol),1.5274046089824267
LS411N,46398810,3.253541487295017
SEM,25062766,0.2261975735754109
HuH-6,151289,2.8743966361586843
SW948,carboplatin-etoposide (40-17 mol-mol),4.008054530018911
HARA [Human squamous cell lung carcinoma],24748573,1.9169510591730587
BICR 31,136227924,2.8140968842668923
SK-CO-1,24753719,4.51149350773187
LS411N,JQ-1-MK-0752 (1-1 mol-mol),1.615286960946078
SUP-T11,9907093,3.0849005239844907
SW1271,57330099,4.656552081384507
F-36P,135421197,1.230502256000523
BT 440,10127622,1.2977106197134705
SK-LMS-1,42642645,1.473121102676234
SNU-886,241158,1.2144772988451973
ALL-SIL,60750,-4.149254188873004
JHUEM-1,135440466,2.5842280347002458
MDST8,42642645,1.1052716804296012
YD-15,72376,-2.416612369703147
PE/CA-PJ49,16659841,3.576645063445311
ALL-SIL,25062766,1.575972356073685
KMS-21-BM,JQ-1-navitoclax (2-1 mol-mol),-1.9267012520283355
JHUEM-1,erlotinib-PLX-4032 (2-1 mol-mol),2.842934086716984
LCLC-97TM1,salermide-PLX-4032 (12-1 mol-mol),6.666218718302321
SW948,11455910,0.6774609071475187
SK-CO-1,11485656,2.076616779710352
L3.3,56963564,0.8777502284965835
P31/FUJ,387447,-5.269499156732966
SaOS-2,54765302,6.138432086002101
KU-19-19,3384730,2.4463371108200995
SW48,56946209,-4.8342224094221455
RERF-LC-MS,71304818,2.1402027844306986
ST486,9956119,1.2118249564924508
DLD-1,navitoclax-birinapant (1-1 mol-mol),0.9189076869239504
ST486,25102847,1.8640708234916037
SaOS-2,5351362,1.054118918695375
JHUEM-1,72193861,0.922951289170376
SW1271,60700,-2.0966401571631805
SUP-T11,71304818,1.962740583143907
SK-OV-3,12001922,2.3689117655248197
BICR 22,11222830,2.7513096778080293
JHUEM-7,46215462,1.2748682455186626
HEL,637858,1.821308587756956
LS411N,11609586,3.7769222068832384
KMS-21-BM,navitoclax-pluripotin (1-1 mol-mol),-1.2578961384233724
PaTu 8988t,crizotinib-PLX-4032 (2-1 mol-mol),2.4555083865109197
SW1573,53392493,3.256582971351183
IGROV-1,71466380,4.863636874274779
SK-HEP-1,119607,5.888068080296772
K-562,5329102,1.5928854941533903
KP-4,135875424,3.69718795810946
RERF-LC-MS,24901704,2.6292316786888295
JHUEM-2,tanespimycin-bortezomib (250-1 mol-mol),-2.8441025270456097
PE/CA-PJ49,ISOX-bortezomib (250-1 mol-mol),0.160457655470904
KP-4,JQ-1-navitoclax (2-1 mol-mol),2.383966273580647
BT 440,7326481,4.636667527183211
RKO,54649381,4.449908747747005
PE/CA-PJ49,navitoclax-piperlongumine (1-1 mol-mol),2.610996953930581
TTC-709,327653,2.2719221156396223
KU-19-19,6438330,3.038685724131264
RERF-LC-MS,6917907,-5.461995819879327
Daudi,6852167,0.8630196090584432
RKN,2708,5.19327789915259
PE/CA-PJ49,446155,1.2823819658822335
U-BLC1,11364421,-0.8715557762639213
SK-CO-1,51039095,2.6345691844177006
KP-4,327653,3.0161374219123727
HEL,9935249,3.1121102066484827
Daudi,6184667,1.7615544136572183
ML-1 [Human thyroid carcinoma],24964624,3.117302997790913
SK-HEP-1,selumetinib-vorinostat (8-1 mol-mol),2.40344777828312
JHUEM-1,1242560,3.533572013138592
LCLC-97TM1,5978,-5.540378308178224
YD-15,doxorubicin-navitoclax (2-1 mol-mol),-2.058116273190066
SNU-886,135398744,6.3424886084429435
SaOS-2,135999136,4.306712196094447
T98G,3825829,3.773056601629321
IGROV-1,5311,1.0068816368200209
EB1,tretinoin-carboplatin (2-1 mol-mol),3.847615324211694
PaTu 8902,10184653,3.3664490630517023
ST486,tretinoin-carboplatin (2-1 mol-mol),3.457162610943218
IGROV-1,54678924,1.4704159748793169
HARA [Human squamous cell lung carcinoma],54613361,-1.6613115011598742
PK-1,6610216,4.445941439691273
IGROV-1,16720766,-0.0562020789376145
EB1,23939,4.350578560678079
RCC10RGB,31703,2.24368059098483
HuH-6,SNX-2112-bortezomib (250-1 mol-mol),-1.0258423776885073
KHM-1B,JQ-1-UNC0638 (2-1 mol-mol),-0.1764853483992549
NCI-H1395,6918837,-1.563832795621605
SW48,4261,1.3708847234833408
LCLC-97TM1,navitoclax-gemcitabine (1-1 mol-mol),-2.1258188281402757
KP-4,53232,2.3027476870683756
Hep-G2,409805,4.627773602187177
Granta-519,11494412,-1.422706675432074
ES-2,selumetinib-MK-2206 (8-1 mol-mol),4.459371578094814
JHUEM-1,tretinoin-carboplatin (2-1 mol-mol),5.331177503009289
BFTC-909,10302451,3.622269240471498
HARA [Human squamous cell lung carcinoma],452548,-0.3270885928487969
KMS-21-BM,51039095,2.1099293301965747
KP-4,387447,-4.423356409037355
SU-DHL-1,11497983,5.985793176782232
SNU-626,9826308,5.640498722139919
HEL,44486219,4.241945120616936
RERF-LC-Ad1,446155,3.5948238619356676
HuP-T3,9926054,1.9266750805140576
Granta-519,5281672,3.715092894597705
NCI-H2452,568763,0.2251625503779925
Daudi,15547703,2.9729250708388815
RERF-LC-MS,1566236,3.687566928717542
SW48,3689413,2.066117060158584
RKN,11396600,3.670395083293249
SNU-C2A,65628,5.099663069206163
BT 248,1716436,2.58950342299198
KP-4,9967941,3.485944840063267
DLD-1,9926054,3.0182242883731516
SNU-886,25062766,2.1597541933468176
COR-L95,25227462,1.0954609187473372
P31/FUJ,11497983,-3.9754433923569295
U-BLC1,71729975,2.20107347292816
COR-L105,11977753,-3.381629820862821
MKN1,11656518,2.464538663182087
SaOS-2,10302451,5.268852772808677
WM115,25126798,4.207732195436686
KLE,89928392,0.0725246038766898
HT-1376,613753,3.674714890332893
NCI-H1395,4378219,4.7590684323615635
JHUEM-2,tanespimycin-gemcitabine (1-1 mol-mol),-3.5425651681754564
PK-1,4261,2.727846760734548
SNU-1079,5743,-3.760398859113178
HEL,6918736,-2.4872933380365483
Ishikawa (Heraklio) 02 ER-,9868037,3.205963776347529
ALL-SIL,vorinostat-carboplatin (1-1 mol-mol),1.2348853562201922
KHM-1B,54454,3.744465591598654
F-36P,984333,-0.2854829807548078
MDST8,selumetinib-JQ-1 (4-1 mol-mol),-0.5732607032642526
BICR 31,11626560,1.5769037831027732
SaOS-2,53481919,3.9662352208904
PE/CA-PJ49,5291,3.890813201298036
EB1,5978,-6.554399415080365
NCI-H2452,4378219,4.095695943124218
RKO,135440466,3.093117295091816
ALL-SIL,selumetinib-decitabine (4-1 mol-mol),-0.1840409792284095
IGROV-1,4521392,5.131794979216607
SK-LMS-1,46224516,4.235136579585433
SEM,vorinostat-navitoclax (4-1 mol-mol),-1.6904002163702885
WM115,6610355,3.646348527159068
JHUEM-7,3081361,1.1903814732345688
BT 248,51037431,4.063284976838012
IA-LM,46199207,3.643614442277753
U-BLC1,5566,2.985674142251688
RERF-LC-MS,navitoclax-MST-312 (1-1 mol-mol),2.0546989000241367
SNU-626,10184653,1.5613661238701817
RERF-LC-MS,4259181,-1.273108977623296
ST486,24180719,3.812218433679387
COR-L95,selumetinib-PLX-4032 (8-1 mol-mol),5.035796466628604
LCLC-97TM1,9866186,0.636434294421894
PE/CA-PJ34 (clone C12),375860,-0.361568415532625
LS180,selumetinib-BRD-A02303741 (4-1 mol-mol),2.497004756461055
HuH-6,1750826,0.5499731561628332
NCI-H1395,66577038,3.726458763342507
BICR 31,285033,-1.6333817403557132
LMSU,11485656,2.410376154528579
KHM-1B,135999136,4.388497598108013
SW1573,24821094,3.391149888356164
KP-4,439501,-3.618807292682963
NCI-H1395,51039095,3.804794716936721
RERF-LC-MS,984333,0.876742343627688
PE/CA-PJ34 (clone C12),carboplatin-etoposide (40-17 mol-mol),3.8374450875844297
SW1573,2828334,5.538488922798482
BFTC-909,11214940,1.666026285351028
MOLM-13,SNX-2112-bortezomib (250-1 mol-mol),-3.9385993868290665
ML-1 [Human thyroid carcinoma],55508,1.8303716396385248
MOLM-13,16722836,-1.8349401857846608
ES-2,9840324,5.6159843797735505
MOLP-8,135398516,0.6877200142840878
KMS-21-BM,135411,0.2992289409183569
NCI-H1568,56649450,2.3390116545362956
EB1,15953870,2.2959529842546553
COR-L105,5329102,2.9490674090485007
MKN1,3465537,2.2988612958925656
F-36P,9926054,1.445748070072179
F-36P,44543605,4.123878115098561
BICR 22,104842,-5.460039616101889
KP-4,72193861,-0.3045152868469126
SNU-626,5460769,3.7499472406611334
SNU-1272,16720766,3.764344424348401
SK-MEL-2,448949,1.9137656912654937
ALL-SIL,44507138,0.0905903694215729
COR-L105,navitoclax-piperlongumine (1-1 mol-mol),1.1506089120324992
U-BLC1,ISOX-bortezomib (250-1 mol-mol),0.100295032322147
Daudi,252682,5.82526834825694
Mino,568763,-0.6526051531445236
SNU-C2A,52912189,2.880655087190624
RERF-LC-Ad1,4788,6.277207203808431
U-BLC1,52947716,2.428303070643526
BT 440,2949965,2.6346004594110592
SK-CO-1,24785538,-2.301834394825824
HCC15,4788,6.208189927463216
HARA [Human squamous cell lung carcinoma],54686904,4.432396143260886
YD-15,4788,5.865141393890467
HT-1376,sirolimus-bortezomib (250-1 mol-mol),1.0351777976040455
T98G,400769,-0.5827939407280885
SK-HEP-1,5282054,5.2464488654660935
U-BLC1,3062316,-4.283379558775255
KMS-21-BM,969516,1.5020154198037363
JHUEM-7,5287969,-2.561176724900928
SUP-T11,262093,-0.249572082043469
K-562,2729026,2.90327889883348
KP-4,71304818,2.4172206525635316
SNU-C2A,73707398,0.9848565358771032
HEL,docetaxel-tanespimycin (2-1 mol-mol),-3.324993936619335
IGROV-1,135398744,6.402844237905131
LMSU,16038120,1.0642114594696983
MKN1,654092,0.1266025871499362
Panc 02.03,44819697,-0.6097657869730747
KMS-21-BM,119607,3.747555857243305
COR-L95,6252,1.2572884944075156
HARA [Human squamous cell lung carcinoma],613000,1.7145271439199108
HARA [Human squamous cell lung carcinoma],54143018,-1.1176720961651934
KP-4,navitoclax-gemcitabine (1-1 mol-mol),-2.777259584730698
PE/CA-PJ49,11977753,-0.1070031812883785
RKO,135411,0.3039750611139232
SUP-T11,23635314,-2.2946313906332176
SW1271,5284616,3.4240840801047825
KMS-21-BM,9956119,0.5920206293361401
PK-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.3428687974510214
Daudi,9803433,4.921870042846492
LMSU,9908783,4.430691687580579
Ishikawa (Heraklio) 02 ER-,5978,-1.6873060331336611
HuP-T3,1566236,2.433067651410228
Mino,9967941,3.0523252398881207
T98G,676352,1.6869886766268043
NCI-H1568,11364421,1.3511041801335055
SK-MEL-2,navitoclax-PLX-4032 (1-1 mol-mol),3.4942967527041313
SaOS-2,54678924,2.353285364311993
NCI-H1395,vorinostat-carboplatin (1-1 mol-mol),4.5909845476881905
NCI-H1568,6438330,1.052967118553252
SK-MEL-2,462382,0.8673901408354348
EB1,49766530,-2.446229475307264
KP-3,selumetinib-PLX-4032 (8-1 mol-mol),5.060633129291673
SNU-626,6918328,0.7222079241394841
SaOS-2,56946209,-2.927880316628738
MDST8,71304818,3.102141708789901
MDST8,16722836,1.8236379945665244
COR-L95,5460769,3.3963309413836815
ES-2,3384730,2.3765402946748098
SW1573,5328940,2.8151731448483424
KP-4,docetaxel-tanespimycin (2-1 mol-mol),-6.012613986523793
P31/FUJ,44486219,4.066329818545256
KP-3,25183872,-0.6521585427488795
Mino,5284616,-4.806590873776145
Ishikawa (Heraklio) 02 ER-,24180719,4.095355158461072
SK-CO-1,44819697,-0.0659450585917303
NCI-H1568,3689413,-2.0602171008804935
SNU-1272,selumetinib-vorinostat (8-1 mol-mol),4.048227486527485
JHUEM-2,11152667,-0.7431230896020583
SNU-886,3854666,1.448080837770843
Hep-G2,16736978,0.6632271469742936
KHM-1B,6918878,3.029851495909813
SW48,4788,5.795432827385499
SNU-626,5311,1.9338558434638091
IGROV-1,11625818,2.877471533668122
MKN1,448949,2.733338789100469
HEL,5282054,3.8014373831294073
T98G,2746,4.022730778919953
Granta-519,2858523,3.0573334835342725
Granta-519,2708,2.6467102550113357
EB1,3503,0.7012541273432956
TTC-709,45279963,3.94888524082011
TTC-709,11427553,1.3456151287401603
SaOS-2,10074640,3.1546787022314264
Granta-519,alisertib-navitoclax (2-1 mol-mol),-1.8552810437041576
NCI-H1568,462382,0.4864277786958156
U-BLC1,208908,-0.9556350899193478
JHUEM-1,11612883,2.652687702105489
PaTu 8902,6450551,4.419968438595772
NCI-H1568,89183176,4.755399227223714
U-BLC1,24779724,5.444020620154264
SK-HEP-1,89183176,6.199387598364303
HuH-6,156422,5.139366624809299
COR-L95,3689413,-1.01311028513846
SW48,322968,2.620984302451229
Ishikawa (Heraklio) 02 ER-,JQ-1-vorinostat (2-1 mol-mol),2.35734859544929
NCI-H1568,2113511,4.994259934049027
KHM-1B,16720766,-1.5556975858527622
SEM,36462,-2.7360640601525845
RERF-LC-MS,10074640,3.277461458690314
SNU-1079,168313016,1.9938843500812935
SK-LMS-1,969516,3.148006643013655
P31/FUJ,11485656,1.9746673234827223
T98G,11494412,3.010368499943237
KMS-21-BM,16741245,1.7137337853338337
PK-1,24753719,4.344966881263849
NCI-H2452,24978538,1.4440845227299357
PE/CA-PJ34 (clone C12),10296883,4.08655394492647
PE/CA-PJ34 (clone C12),9884685,0.3333327844016708
ST486,11507802,0.2496302604433234
KP-4,carboplatin-etoposide (40-17 mol-mol),1.5121979530808032
U-BLC1,5746,3.7367665850541463
SW948,46398810,1.81837356763434
SW948,navitoclax-pluripotin (1-1 mol-mol),-1.6002032912556945
SW48,5280436,3.9386259808510737
NCI-H1568,16013152,3.794215458313736
K-562,JQ-1-navitoclax (2-1 mol-mol),0.4672607120603991
KPL-1,107970,2.5494857724802813
SaOS-2,72193861,0.3662001709486771
SW1271,6623618,2.240401111492455
SNU-C2A,selumetinib-BRD-A02303741 (4-1 mol-mol),5.593116453183739
BICR 31,11964036,0.7129684858082154
MOLM-13,71466445,2.28410988708537
SW1271,5280436,5.166796757102748
EB1,122327,3.4167450583940338
SNU-886,24951314,1.1149346729448562
Daudi,crizotinib-PLX-4032 (2-1 mol-mol),0.8611087114550048
SK-HEP-1,5470400,0.5577708849126581
SW1271,73707398,1.637161284255629
Panc 02.03,24771867,4.320948526904658
K-562,11494412,-0.907204058397288
T98G,446155,1.9648503934346624
HuP-T3,4477,0.7500067469313434
WM115,44489675,3.6522428576041888
L3.3,159324,3.32597872906173
IGROV-1,10074640,3.2681490579824426
EB1,tanespimycin-gemcitabine (1-1 mol-mol),-4.741276090381129
LCLC-97TM1,387447,-4.752686001320434
JHUEM-1,44462760,4.253952234593704
NCI-H2452,136227331,4.192235498443636
BICR 22,44566777,0.9464577594296588
Daudi,44462760,2.2846011846998184
PE/CA-PJ34 (clone C12),JQ-1-vorinostat (2-1 mol-mol),0.3742706792458093
HuP-T3,11222830,1.7699584455080513
KP-4,tanespimycin-bortezomib (250-1 mol-mol),-2.4280197504959107
BFTC-909,10184653,1.6906150005550105
SNU-1272,44486219,5.3170939881808605
YD-15,6914657,-4.430342679666237
SNU-1272,5282054,4.2528231243793755
HuH-6,4259181,-0.1636677698512317
COR-L105,navitoclax-sorafenib (1-1 mol-mol),1.5234919165461795
DLD-1,sirolimus-bortezomib (250-1 mol-mol),1.5948066539629249
SK-CO-1,5460769,-0.7722931098274061
IGROV-1,9884685,-0.088911709267569
PE/CA-PJ34 (clone C12),400769,-0.7071092107255599
SW948,10074640,3.6458957710098927
RCC10RGB,2729026,3.187414345119047
SU-DHL-1,25105715,2.6102250612439857
SaOS-2,2708,4.307882235107384
YD-15,carboplatin-UNC0638 (2-1 mol-mol),3.7214692150356754
PE/CA-PJ49,16038120,0.3848230880228235
SW48,11485656,-1.6768123952056315
LS411N,5738263,3.6843208102291127
LCLC-97TM1,89928392,0.9843618500255806
IGROV-1,5328940,0.347812751869877
EB1,3038522,1.4224395010135409
HuH-6,4917,2.310775241443782
KP-4,984333,0.8072210644040998
JHUEM-7,navitoclax-MST-312 (1-1 mol-mol),0.7965231198258467
BFTC-909,carboplatin-UNC0638 (2-1 mol-mol),3.28125381181505
PE/CA-PJ49,selumetinib-MK-2206 (8-1 mol-mol),2.3211771397352137
MOLP-8,6184667,3.7618917164892296
HEL,9907093,4.271492923268933
SU-DHL-1,409805,5.150132871505728
HuH-6,375860,0.7275713697842162
IGROV-1,5287620,-1.5394168430569777
HCC15,6184667,2.403880665872793
PK-1,135421197,2.4270856926792947
ML-1 [Human thyroid carcinoma],119607,6.010030667993389
SUP-T11,54649381,3.55477207532117
BFTC-909,11152667,-0.3524603871752078
SNU-1272,5311281,4.230708828078394
Hep-G2,3062316,2.0384050526370454
SNU-1272,JQ-1-vorinostat (2-1 mol-mol),1.5021778679128583
EB1,439501,-3.6025033052563553
SNU-1272,11238147,4.015797434617391
BICR 22,10427712,4.255154443676342
RCC10RGB,73707398,3.9170227295506304
SK-HEP-1,4788,5.857315027837397
KMS-21-BM,tanespimycin-gemcitabine (1-1 mol-mol),-4.728198238563642
SNU-886,navitoclax-birinapant (1-1 mol-mol),-7.871373993775583
BT 248,135411,2.4646623802818577
SaOS-2,11167602,3.026359974607451
PE/CA-PJ49,6918328,-1.1088201791469847
HuH-6,44607531,1.3034287954760966
IGROV-1,3825829,4.144093606877803
Daudi,53232,2.2893399383043116
SUP-T11,46224516,1.221144120695722
JHUEM-1,44137675,2.2452983247336475
HARA [Human squamous cell lung carcinoma],2828334,6.6956020196427115
LS180,5470400,-3.6342626980574657
NCI-H1568,322968,3.6220797151302673
KP-4,navitoclax-pluripotin (1-1 mol-mol),0.1818856971283002
U-BLC1,119607,5.173413372643881
KHM-1B,46907787,-1.0017805456317357
SU-DHL-1,25150857,1.7165355924738273
NCI-H2452,9926054,2.7849990975548726
RKO,5280436,4.655813696583822
DLD-1,135411,0.4984403552284953
Panc 02.03,25126798,4.246913180768056
BICR 22,5460769,-1.4539525700949456
RERF-LC-MS,4521392,4.229663793191115
BT 248,24775005,3.1653639365719553
COR-L95,65628,4.016533332946612
ML-1 [Human thyroid carcinoma],72199292,2.652505906746634
BFTC-909,11507802,1.7199271215311116
HCC15,16115403,-5.315255617661217
KP-4,54618771,2.957585816818264
Panc 02.03,24797083,1.7288458125332262
Granta-519,16065773,1.8580334509866892
TTC-709,135440466,1.66480618454592
Mino,ISOX-bortezomib (250-1 mol-mol),-0.1024660675942609
DLD-1,1750826,1.112841982016588
YD-15,11626560,1.337370040731381
PE/CA-PJ49,salermide-PLX-4032 (12-1 mol-mol),5.445436027747134
KLE,10074640,3.248880197029389
TTC-709,73707438,3.946432933841512
MOLP-8,67291369,0.6739245689833524
LCLC-97TM1,71304818,2.70820846116735
Mino,613753,2.5429304044634966
COR-L105,10113978,3.5062120769458907
IA-LM,selumetinib-GDC-0941 (4-1 mol-mol),3.6293192218894017
ALL-SIL,5460769,0.8731159867521163
MOLM-13,89928392,-0.0278317389216686
KHM-1B,11626560,-0.6143155119678699
ALL-SIL,selumetinib-PLX-4032 (8-1 mol-mol),4.528203505983491
SaOS-2,6852167,2.181246544986129
HuH-6,24951314,0.7973152923540853
U-BLC1,969516,1.9215174422210284
NCI-H1395,9933475,2.0762479324148435
SK-CO-1,135999136,4.853872243910513
JHUEM-1,24180719,3.64667749132653
LCLC-97TM1,5329102,1.5800226001590805
SNU-1272,selumetinib-PLX-4032 (8-1 mol-mol),6.285014325142589
KMS-21-BM,piperlongumine-MST-312 (1-1 mol-mol),1.1257462304963988
SK-LMS-1,5738263,4.396067245075149
BT 248,9936388,1.117792201973615
RCC10RGB,3825829,4.92777419243283
WM115,16722836,2.5522609953991577
KU-19-19,6610355,5.477302473020379
SNU-1079,637858,2.1328198031741494
Mino,selumetinib-BRD-A02303741 (4-1 mol-mol),4.878986734293034
MKN1,400769,-0.065312223230073
JHUEM-1,31703,-1.5685738505146902
HCC15,5311281,-0.1593612251340344
WM115,11656518,-0.7680829336702796
IGROV-1,675434,4.336225379212549
BICR 31,322968,4.229982613329669
PE/CA-PJ34 (clone C12),46907787,4.066257221145479
LCLC-97TM1,serdemetan-SCH-529074 (1-1 mol-mol),1.7773916595129422
EB1,156422,3.1156165815643715
JHUEM-7,selumetinib-tretinoin (2-1 mol-mol),5.22880395365309
JHUEM-7,2858523,3.1374488987928992
MOLM-13,409805,3.504188648592109
NCI-H2452,68056272,5.088176766324353
HuP-T3,JQ-1-vorinostat (2-1 mol-mol),0.3185506624165122
RERF-LC-MS,25102847,0.6953191965745218
SU-DHL-1,5278396,2.36959409949266
JHUEM-2,54454,0.3934028634579406
MKN1,637858,2.106169799801537
HCC1500,9935249,2.2800833668468266
SUP-T11,9866186,1.7776319488130905
HEL,46907787,-1.2802643066913908
Daudi,64971,1.9256728094608813
L3.3,53392493,3.3534830778032045
BT 440,11494412,3.9335430982852406
KU-19-19,168313047,3.3084179069540696
HCC1500,9903786,4.21203406645071
BFTC-909,3689413,0.9841636034152118
MDST8,9911830,3.786562744766562
WM115,262093,2.5199436905866905
F-36P,25150857,2.3824721304499525
BT 440,9935249,2.494987882874959
IGROV-1,5311281,3.3250623444804206
ALL-SIL,4261,-0.4593745111072439
ML-1 [Human thyroid carcinoma],25183872,1.7816002858265556
NCI-H1568,25105715,3.512540774448481
COR-L95,12001922,1.5177554079359803
Granta-519,25154868,5.041568583050757
MOLP-8,navitoclax-piperlongumine (1-1 mol-mol),0.7236562214911971
SK-HEP-1,3503,1.99172511033101
SNU-C2A,135411,0.5328935224556473
F-36P,6918878,-0.3157331643976424
Mino,vorinostat-navitoclax (4-1 mol-mol),-3.5102193934911066
BICR 22,2749,1.4483580801045477
SU-DHL-1,10231331,2.149159497852676
SU-DHL-1,132496,3.861580575323874
NCI-H1568,11955716,5.84501437277453
COR-L105,11647372,1.8386560750541856
PaTu 8988t,702558,5.248840045640507
RKO,219104,3.7756995047121658
RERF-LC-MS,119607,4.38818595494476
SK-OV-3,969516,2.624811361400939
ES-2,65064,5.212044100373949
SU-DHL-1,67156097,-2.1897423830418155
HARA [Human squamous cell lung carcinoma],25262965,-0.7160848382234604
MDST8,10296883,3.644541291105843
MKN1,6918289,2.706698140665152
KP-4,65064,5.182181693304659
BICR 31,135411,1.1842135795155395
JHUEM-2,11214940,1.0568440453413444
NCI-H1568,17755052,1.5920713080731803
BT 440,49793307,-2.737238635520943
K-562,selumetinib-JQ-1 (4-1 mol-mol),0.1487830644360653
SEM,selumetinib-tretinoin (2-1 mol-mol),0.5709175371364448
Granta-519,3062316,1.222650334372554
KHM-1B,10302451,3.4740404834517156
NCI-H1395,46843906,3.1516076694809994
MOLM-13,11609586,0.2693262849825738
MDST8,65628,4.39024768664476
SNU-626,46398810,2.9741889652455447
LS411N,11222830,1.85641131377126
P31/FUJ,5278396,3.2564464707559786
NCI-H2452,selumetinib-piperlongumine (8-1 mol-mol),3.871574708601934
EB1,54613361,-1.475325300208243
SK-MEL-2,10074640,3.96153005990111
U-BLC1,176870,-2.628642640390004
HCC1500,11228183,-3.1075364778620544
EB1,375860,-1.1817069193066
Panc 02.03,3503,2.8594786206641514
MOLM-13,12001922,1.648284949914827
SNU-626,452548,0.4874214143626486
SK-LMS-1,9866186,2.47967074493931
MKN1,6610216,4.5143406810013005
HuH-6,24779724,4.249580878490073
Daudi,decitabine-navitoclax (2-1 mol-mol),0.1880854613737136
HEL,tanespimycin-bortezomib (250-1 mol-mol),0.901321339562179
KU-19-19,selumetinib-UNC0638 (4-1 mol-mol),2.3716952230277313
U-BLC1,44819697,-1.746387943613111
KLE,11222830,1.1739941214880287
KP-3,24901704,2.7837543484136305
RCC10RGB,135875424,5.859031260595621
KMS-21-BM,44632017,0.2419410984900639
SNU-886,675434,3.265808885335484
LS180,44491742,4.531352051294965
Daudi,salermide-PLX-4032 (12-1 mol-mol),4.83725960729828
SW948,5460769,-0.6640669541383749
BFTC-909,9866186,1.150003196853964
LMSU,9444,4.315048701595099
KU-19-19,docetaxel-tanespimycin (2-1 mol-mol),1.4200175787881737
Daudi,322968,1.8489038189519929
KP-3,5460769,4.226589336768475
PE/CA-PJ34 (clone C12),46215462,1.5577121166656367
LS180,135999136,4.321194581518088
KP-4,9911463,4.220672229227994
SNU-1079,11213558,-1.7614933143847429
Hep-G2,54618771,-1.2901934533941846
HuH-6,656346,1.588100562920726
MOLP-8,4259181,0.2540996075245788
SNU-1272,71304818,2.26244025747745
SaOS-2,UNC0638-navitoclax (1-1 mol-mol),2.2506963685809676
BICR 31,17755052,0.616652074058669
KLE,9868037,3.52213609317776
Daudi,10427712,3.475831712716563
ST486,10427712,3.3483783100510487
ALL-SIL,6252,-2.462384672511242
KLE,135875424,3.394401628511705
SNU-886,24889392,3.4092549144778976
HT-1376,17759555,2.4623450169699708
U-BLC1,selumetinib-vorinostat (8-1 mol-mol),-1.468805400461474
IGROV-1,57330099,4.391385744785918
Mino,3689413,-3.624730843514525
T98G,216345,4.6675903183155265
PE/CA-PJ34 (clone C12),11455910,0.5657744918990928
ML-1 [Human thyroid carcinoma],5311,0.3887425314777955
U-BLC1,24901704,1.9798049860180835
LS411N,5746,2.615146419652584
HT-1376,9936388,2.4935299933788957
Mino,3854666,0.1564706607141011
LMSU,4705,3.840410851100799
WM115,11625818,2.666283825244439
SK-CO-1,17755052,1.6143754050867285
KP-4,969516,3.31483171154376
BFTC-909,4788,5.986704833543041
BFTC-909,613000,3.1980696015333137
RCC10RGB,9933475,1.608288384582936
L3.3,148198,-4.142602322676729
JHUEM-7,216345,1.7329243793640925
HuH-6,227681,3.4937982135516585
Hep-G2,676352,2.2206143636349287
COR-L95,11964036,1.1862097811542611
JHUEM-2,5329102,1.77588092613811
KMS-21-BM,53232,3.8363233106335826
JHUEM-2,49766530,-1.5038121113070972
IGROV-1,12003241,-2.0122972114546904
ML-1 [Human thyroid carcinoma],67156097,-0.9782117982072136
SNU-C2A,10074640,3.02927294115702
U-BLC1,navitoclax-sorafenib (1-1 mol-mol),1.3220700899086786
SK-CO-1,navitoclax-PLX-4032 (1-1 mol-mol),0.9904814430420492
LS411N,676352,3.0047981548436873
PE/CA-PJ34 (clone C12),12001922,2.3473594689504687
NCI-H1568,6918638,-0.3782949656582497
HCC15,654092,-0.5163256778254894
KPL-1,5291,3.690563873836563
MOLM-13,72193870,3.075841334601934
ML-1 [Human thyroid carcinoma],24180125,2.9342502769836263
SK-HEP-1,1716436,3.791424957504218
Mino,462382,0.2986283576908556
SUP-T11,3038522,2.953754682710328
IGROV-1,637858,1.814476597989254
EB1,53495165,-2.4991364677566463
KLE,5335621,6.0454813938491405
IA-LM,44137675,5.685431340913792
RKO,49793307,-1.4433237106321422
KP-3,46199207,2.723843900853901
Panc 02.03,1750826,-0.0877771412327358
EB1,5329102,1.101670912391011
P31/FUJ,216239,3.114152508734425
BICR 22,9911463,4.403388511465592
SNU-1272,135423438,5.060183017948369
F-36P,5311037,3.722518680926946
LS180,3503,2.1233569957286673
Ishikawa (Heraklio) 02 ER-,168313047,3.560742746409877
NCI-H1568,135440466,1.9451121966001212
JHUEM-1,5291,3.690057649627296
Ishikawa (Heraklio) 02 ER-,tanespimycin-gemcitabine (1-1 mol-mol),-1.35005460579952
KMS-21-BM,54143018,-1.5583460080794391
PK-1,1566236,1.9563055032628711
LS180,6917907,-5.898955627831861
JHUEM-2,11427553,0.5749551855939397
NCI-H2452,3503,2.8949427881039367
SEM,3854666,0.6904434014299387
JHUEM-7,carboplatin-UNC0638 (2-1 mol-mol),3.8228401587465273
LCLC-97TM1,9952709,3.284131025623194
L3.3,10074640,3.5317966219825414
PE/CA-PJ49,25126798,3.8968500748458794
SNU-886,1750826,-2.8015436455469493
PE/CA-PJ34 (clone C12),5311,2.204084588588605
MOLM-13,168313047,1.872191765635252
RKN,65064,4.855719732775604
SK-CO-1,1716436,3.109025551437123
JHUEM-1,702558,5.493915059143105
Panc 02.03,322968,4.613737356937267
SEM,445643,-5.7878039164156725
PE/CA-PJ34 (clone C12),JQ-1-MK-0752 (1-1 mol-mol),5.182119120511875
SU-DHL-1,16115403,-5.307217729681928
U-BLC1,148198,-4.602164076011155
Daudi,5738263,2.220866513982768
SW48,10074640,2.891302128524984
SW48,3552672,5.820012420560967
Daudi,568763,-0.9358982895655849
F-36P,322968,3.387114888877606
HCC1500,11234052,4.300499145525321
BT 440,60750,2.79747992090079
WM115,16741245,4.109793610684897
SK-CO-1,6917907,-6.103253673111458
SW48,100016,6.031440310304127
KMS-21-BM,BRD-A02303741-navitoclax (2-1 mol-mol),1.105632587080565
SW948,12003241,-1.7903806895013192
SK-HEP-1,9840324,5.848573782723059
ALL-SIL,5328940,-0.9694628184696558
BT 440,piperlongumine-MST-312 (1-1 mol-mol),1.9013261697950783
ES-2,2708,5.377409443179492
SNU-1079,2749,2.094847704949033
BICR 22,2858523,3.373464702278958
KLE,25126798,3.674885583881781
KHM-1B,5460769,1.8331932839616616
BT 248,637858,2.256250159493538
KP-3,675434,4.282223019896807
NCI-H2452,17755052,2.4746667711045514
F-36P,54649381,2.918510203679049
T98G,54678924,1.7654458617961617
TTC-709,25150857,1.7082709568211778
HEL,tanespimycin-gemcitabine (1-1 mol-mol),-4.465092392275179
ST486,1242560,1.6111309950581592
P31/FUJ,654092,-2.277731190350674
HCC15,selumetinib-BRD-A02303741 (4-1 mol-mol),4.266961603535723
BT 248,5311,3.0798190942417363
SNU-C2A,46398810,2.567645650809785
BICR 22,16736978,1.4452527998079976
HARA [Human squamous cell lung carcinoma],107985,-4.031127583701494
EB1,1716436,2.0553035928258105
SUP-T11,15547703,2.5413608553575875
RKN,SNX-2112-bortezomib (250-1 mol-mol),-0.3229299326159797
JHUEM-2,JQ-1-navitoclax (2-1 mol-mol),-0.3973123604867269
ALL-SIL,9843750,4.4328493438561845
IGROV-1,168313047,1.93821625738322
Panc 02.03,selumetinib-navitoclax (8-1 mol-mol),2.257139592520967
RCC10RGB,24797083,3.688734393817597
KLE,54454,0.96963930140172
IGROV-1,67291369,1.8066430555976296
SNU-C2A,selumetinib-piperlongumine (8-1 mol-mol),2.3782463383826182
SK-HEP-1,135875424,4.97106166770821
SK-OV-3,676352,2.4999853996447423
ST486,327653,2.3248651822642734
F-36P,135423438,1.517615115973094
IGROV-1,3689413,-0.3633634632064185
MOLM-13,2126,3.944929409626795
SW1271,25150857,2.216244024484901
DLD-1,11222830,1.115612360205937
Ishikawa (Heraklio) 02 ER-,11228183,3.862532073536606
PK-1,126941,-3.0712577138805432
P31/FUJ,piperlongumine-MST-312 (1-1 mol-mol),1.5235846843184453
T98G,1566236,4.934328741372893
Granta-519,3689413,-2.6080640580656977
UACC-812,11955716,-3.4049141440551765
WM115,6918638,1.2765614986990457
KHM-1B,3025944,3.5975685819410503
MOLM-13,119182,-3.013346002661584
MKN1,10322450,5.563545254073129
SK-LMS-1,44589607,3.255128289291538
SK-LMS-1,25227462,2.3062795616243643
SK-LMS-1,31703,0.7910398871556167
HuP-T3,25150857,2.779922499061356
PK-1,36462,2.8123461467673954
Hep-G2,11178236,-2.211780590989946
RKN,400769,-0.3685197718994141
L3.3,17755052,1.4516432874311858
RCC10RGB,navitoclax-birinapant (1-1 mol-mol),2.5525116990099015
KPL-1,JQ-1-vorinostat (2-1 mol-mol),4.04420756196994
COR-L95,9927531,5.207677506691081
RKO,439501,-1.8401322759847645
SNU-1079,vorinostat-navitoclax (4-1 mol-mol),-0.2652727009936681
COR-L105,135875424,4.584511127602178
MDST8,67156097,-2.036194319435593
SK-CO-1,11640390,3.1287755311468715
NCI-H2452,9915743,1.4140850498548845
COR-L95,54626689,4.626807564914302
SNU-1079,1716436,2.5518661326018424
ST486,JQ-1-carboplatin (1-1 mol-mol),-0.3320701641895573
JHUEM-1,6450551,2.124268641635045
NCI-H1395,44491742,3.9607165302769514
L3.3,10113978,3.760524207236511
ST486,53232,1.845610545147498
NCI-H1568,sirolimus-bortezomib (250-1 mol-mol),0.676282688891887
ES-2,11396600,4.145090695204245
SNU-C2A,navitoclax-MST-312 (1-1 mol-mol),0.6618949694963685
SW48,15983966,-4.810478602921179
RERF-LC-MS,53495165,1.4938275665549956
SW1573,10026128,4.237670104162456
BICR 22,5328940,1.2238467278980267
SNU-886,51039095,-2.8648807177568205
KLE,46174525,3.970027845055867
KP-4,23725625,5.2230373683189235
JHUEM-7,JQ-1-UNC0638 (2-1 mol-mol),-1.108952996086482
IGROV-1,25150857,3.031865110078871
KP-3,16720766,5.493699052054533
KMS-21-BM,26596,-2.3391795645360403
PE/CA-PJ49,71751553,4.17175921879406
SW48,54649381,3.6753624817280706
KP-4,44507138,4.316938927291668
RKN,11485656,2.343665915939472
Hep-G2,65064,4.407687978914002
TTC-709,11404337,-1.0402819998142765
IGROV-1,216239,2.21703825410177
ALL-SIL,selumetinib-JQ-1 (4-1 mol-mol),0.7996490760807272
SaOS-2,675434,4.709862103920263
SK-LMS-1,salermide-PLX-4032 (12-1 mol-mol),5.327577924761485
WM115,439501,-0.2667789802830004
RKO,11152667,-2.010180339323448
JHUEM-7,5738263,2.3845993272884027
KHM-1B,656346,0.4212696332998811
DLD-1,selumetinib-vorinostat (8-1 mol-mol),2.6727552723054755
BICR 22,702558,5.841545864846151
KHM-1B,4261,0.5935590694863259
SW948,navitoclax-piperlongumine (1-1 mol-mol),1.2480624926894286
IGROV-1,52912189,2.3966568144845666
SU-DHL-1,219104,2.7039031158758395
SW1271,19582717,5.373754052547774
JHUEM-1,4477,0.5403460324357204
L3.3,44489675,4.5650706631267175
IGROV-1,119182,0.2112476135388779
DLD-1,52947716,3.219889106712665
YD-15,46199207,3.104886058267181
SW1573,25150857,3.3863948467965717
LCLC-97TM1,1566236,1.804143498427706
U-BLC1,285033,-1.4667181248272922
SW48,6252,-1.782590172996294
Mino,56946209,-6.321322671061657
PE/CA-PJ49,selumetinib-decitabine (4-1 mol-mol),5.036707112558136
F-36P,11404337,-0.3828282129667895
BT 248,11455910,-0.0312737668402554
MOLP-8,168313200,3.062868142984741
BT 440,16065773,3.341805172989329
DLD-1,2130404,3.692442912479656
SU-DHL-6,969516,2.321858620209541
K-562,44632017,0.5936262556123562
BFTC-909,56973724,3.22598802973391
JHUEM-7,54619267,3.930692600684294
LMSU,navitoclax-MST-312 (1-1 mol-mol),1.1685647983741614
L3.3,2749,2.0470310524130717
PE/CA-PJ49,9967941,4.975191877613584
LMSU,5278396,3.836734271411514
Mino,3062316,-1.6625523975971268
NCI-H1568,24180125,3.319632294157453
HCC15,JQ-1-vorinostat (2-1 mol-mol),0.768732947542672
SNU-886,9825149,2.821873129999439
RKO,15547703,3.988071110220001
YD-15,613753,2.988296434113933
BT 248,25262965,0.9142276489527752
COR-L105,446155,1.2274898824574871
YD-15,66577038,2.8582834296964093
HuH-6,5978,-5.9572017471804894
WM115,25062766,1.993857010637035
HCC15,42642645,-0.8684016042996798
SUP-T11,selumetinib-decitabine (4-1 mol-mol),3.744732258109776
IGROV-1,3136844,5.214591389089975
COR-L95,16659841,4.2643844802603725
NCI-H1568,107985,-3.6136890416333665
SUP-T11,17755052,-0.0634018803397557
PE/CA-PJ34 (clone C12),navitoclax-sorafenib (1-1 mol-mol),3.0314337084555656
HEL,9967941,3.646907071964301
NCI-H1568,5311,0.289477139532769
SNU-626,navitoclax-gemcitabine (1-1 mol-mol),-1.5346040182849892
HCC1500,24964624,2.92457410282952
LCLC-97TM1,44185566,1.2712415312804253
HARA [Human squamous cell lung carcinoma],4259181,-0.0825087225465529
EB1,444795,3.792865279889192
RKO,135421197,1.472175761257966
BICR 22,UNC0638-navitoclax (1-1 mol-mol),4.356226198213725
WM115,vorinostat-carboplatin (1-1 mol-mol),3.7982137973374104
K-562,docetaxel-tanespimycin (2-1 mol-mol),-6.155798984221324
P31/FUJ,119607,5.165578068786105
SW1271,44507138,3.04083255973368
MOLP-8,72734382,2.92105223846654
TTC-709,49766530,-2.0613056502019407
COR-L95,selumetinib-tretinoin (2-1 mol-mol),5.25273224867287
U-BLC1,53392493,1.59602038209616
RKN,12001922,2.582060834791438
MOLM-13,3025986,-2.268401268397509
T98G,16013152,3.710932124367844
ML-1 [Human thyroid carcinoma],54613361,1.1529799235720395
HARA [Human squamous cell lung carcinoma],65064,5.174523602274789
BICR 22,387447,-3.632542993789297
SU-DHL-1,navitoclax-pluripotin (1-1 mol-mol),0.447892144567538
KLE,3062316,2.3443438252501183
Mino,JQ-1-UNC0638 (2-1 mol-mol),-1.8530853214277625
KLE,10184653,1.244487800757798
JHUEM-1,vorinostat-carboplatin (1-1 mol-mol),3.7063831162059904
BFTC-909,selumetinib-vorinostat (8-1 mol-mol),1.99531584260594
MDST8,44819697,0.5968481057166135
COR-L95,54613361,1.8571878459944453
PE/CA-PJ34 (clone C12),erlotinib-PLX-4032 (2-1 mol-mol),0.5526794928208874
PaTu 8988t,25183872,-1.065851307698322
SK-LMS-1,49867930,5.7921489783233655
JHUEM-1,50905018,4.339016743973293
HCC1500,969516,2.5012208253247374
SNU-626,135421197,2.600343807362106
KP-3,126941,-2.255953466035363
LS411N,51039095,3.380080993968732
JHUEM-1,9903786,2.799765938694702
PE/CA-PJ34 (clone C12),44607530,0.8156299641770444
IA-LM,10385095,1.8174613436578264
Daudi,JQ-1-vorinostat (2-1 mol-mol),-1.994208072819334
SNU-C2A,15547703,4.0992713112117976
MOLP-8,44589607,1.928632926439859
UACC-812,JQ-1-UNC0638 (2-1 mol-mol),0.7883661966359787
SK-HEP-1,5311,2.3418360503567386
NCI-H2452,24889392,3.037712354939189
JHUEM-2,9903786,1.0264930895087971
ST486,9911463,2.5005951178615775
SU-DHL-1,4378219,1.8683369375684944
NCI-H2452,2858523,2.6943426896823284
ML-1 [Human thyroid carcinoma],decitabine-carboplatin (1-1 mol-mol),4.481069697343496
IA-LM,119607,5.918153428689206
BT 248,2749,1.3146464590197295
ML-1 [Human thyroid carcinoma],11214940,1.6315509593699482
JHUEM-1,9927531,4.870867049217503
COR-L105,46224516,3.053099263199949
SW948,3062316,3.151526592835161
BICR 22,6610216,4.672862717569176
SW948,16736978,1.371465793072688
IGROV-1,2828334,6.070696247039626
SNU-C2A,1750826,1.1847678534704098
RCC10RGB,44185566,3.1564704709707856
SK-MEL-2,51039095,3.9609708573660254
Granta-519,135999136,4.28714374371566
BFTC-909,654092,0.6323398211983356
ES-2,11152667,-1.0665874566143538
SW48,selumetinib-PLX-4032 (8-1 mol-mol),-2.238777477327049
P31/FUJ,17755052,1.7010190253681206
DLD-1,12001922,2.3163646379177467
SU-DHL-1,2945648,2.120687124348465
LCLC-97TM1,16720766,-2.0806199642234704
HCC15,3025944,3.8616867083103648
ES-2,3543504,4.048261251036044
LCLC-97TM1,53392493,1.9813066602409652
WM115,selumetinib-piperlongumine (8-1 mol-mol),-2.154986024806584
COR-L95,675434,4.0325297307826125
SaOS-2,11213558,1.0641156085827448
Daudi,JQ-1-carboplatin (1-1 mol-mol),-0.7509851402821236
KU-19-19,1716436,3.531012736022478
SNU-1272,54618359,4.4674166850323624
SU-DHL-1,11485656,1.6397040363022437
JHUEM-1,151289,0.7541922737991524
SK-CO-1,16736978,2.1510378918389415
DLD-1,selumetinib-UNC0638 (4-1 mol-mol),5.125424598751303
ES-2,11214940,-0.2513140756749868
SW1573,selumetinib-JQ-1 (4-1 mol-mol),1.6562897469951037
HCC1500,136227924,2.675203690625814
LCLC-97TM1,sirolimus-bortezomib (250-1 mol-mol),0.527232919113557
RKN,BRD-A02303741-carboplatin (1-1 mol-mol),5.528038962892509
PaTu 8902,selumetinib-PLX-4032 (8-1 mol-mol),5.82901614817581
Daudi,219104,1.6178665476553538
TTC-709,2746,3.375818132682937
WM115,5284373,2.6004259651165644
SU-DHL-6,216345,3.116690602340157
HuP-T3,5460769,4.291069487745317
HARA [Human squamous cell lung carcinoma],54619238,4.4726064543510144
PE/CA-PJ34 (clone C12),3689413,1.240876822848384
Daudi,8515,3.193004700442435
HCC15,3815108,3.1337581441750277
IGROV-1,5280436,3.2616766817665086
SUP-T11,227681,1.440676227028465
PE/CA-PJ49,5287620,-1.2687739751971734
COR-L95,107970,2.0048060228155333
DLD-1,46907787,1.2209217762946305
LMSU,5566,3.0603699915448015
BICR 31,25150857,2.3687059872087217
SUP-T11,50905018,3.269095668482967
SK-LMS-1,327653,3.1438411129584933
KP-4,104842,-4.083786519426226
IA-LM,6918837,-2.975709639111599
WM115,3025986,-1.3268545497049868
SUP-T11,452548,-2.7219167241230173
JHUEM-2,5282054,3.289125579071398
DLD-1,3634881,3.645816500784125
KMS-21-BM,2126,3.7230132704894054
LMSU,navitoclax-piperlongumine (1-1 mol-mol),2.8977701094185586
KMS-21-BM,136227924,2.0166655260293487
EB1,6450551,1.074192386464657
HT-1376,3025944,4.762401213926018
WM115,BRD-A02303741-navitoclax (2-1 mol-mol),3.3998938295257632
SK-LMS-1,tanespimycin-gemcitabine (1-1 mol-mol),0.8145609085201625
SW48,17759555,2.861947497664063
SK-CO-1,selumetinib-vorinostat (8-1 mol-mol),-0.8201042282991368
F-36P,9935249,1.4854738782819463
SNU-1079,navitoclax-PLX-4032 (1-1 mol-mol),0.6371731342094784
SW1271,9956119,4.3828310926576375
ML-1 [Human thyroid carcinoma],piperlongumine-MST-312 (1-1 mol-mol),2.022291985496103
MDST8,24772860,-2.900176299695688
SaOS-2,4259181,-0.1317601722396107
ES-2,400769,-0.0141781286130544
YD-15,9915743,-2.405110430781952
TTC-709,alisertib-navitoclax (2-1 mol-mol),-0.5470963983376407
PaTu 8988t,5746,3.0775825889142543
SaOS-2,4521392,4.5837419847316845
SaOS-2,445455,5.662681927298568
IGROV-1,148198,-2.659972993252853
SK-CO-1,11404337,-0.5084033800481932
Granta-519,4578,4.680400709321271
L3.3,100016,6.042484334243821
PK-1,5566,3.135320839251277
RKO,4261,2.924548439505643
KP-4,11396600,3.580302793635078
BT 248,UNC0638-navitoclax (1-1 mol-mol),1.1596436088492943
SUP-T11,piperlongumine-MST-312 (1-1 mol-mol),1.426621577594938
MOLP-8,54618164,3.908946135671936
HCC15,24978538,-1.0517559532383662
U-BLC1,25161177,3.9781995075127177
YD-15,20959075,-3.331313223725758
COR-L105,2945648,3.0602962908492386
RCC10RGB,salermide-PLX-4032 (12-1 mol-mol),5.5053951487435775
KMS-21-BM,10410894,2.0175649887530556
NCI-H2452,4705,3.641149380662554
KLE,60750,-0.0537222566520801
F-36P,409805,3.912389253799608
SK-CO-1,54143018,-0.6826828748975821
MDST8,26596,-1.25574590011264
SNU-1079,16219061,3.6504112340956665
NCI-H2452,54454,2.511734775409603
HARA [Human squamous cell lung carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.088944743887487
RERF-LC-MS,16038120,1.5599846769821624
Mino,444795,1.9878842537418735
KMS-21-BM,11178236,-6.077020683685231
U-BLC1,49836020,5.6845894274854585
SK-OV-3,44185566,3.1295797630764266
YD-15,57519531,1.599328158790228
SK-LMS-1,4788,5.52968576004321
BICR 31,148124,2.7085675831815292
P31/FUJ,439501,-2.3575947617146475
BICR 22,11152667,-1.8276171650012312
SUP-T11,6852167,1.2603138165512704
F-36P,4096211,-1.055742957147646
ES-2,656346,2.6173118625696032
COR-L95,56973724,4.268430703602559
RERF-LC-MS,54626689,4.221264321270605
RERF-LC-Ad1,374536,2.042610785182273
IGROV-1,1641662,3.5854177848263675
MOLM-13,613753,2.871004682812888
EB1,11707110,2.730950307457448
SNU-626,11228183,2.3451750931581716
IGROV-1,11404337,-0.7659238947812715
SW48,219104,2.280685064057957
DLD-1,445091,4.298888167911286
U-BLC1,4261,1.1843441245066235
Panc 02.03,crizotinib-PLX-4032 (2-1 mol-mol),2.31663341207245
Granta-519,9935249,0.0212855082517002
MOLM-13,2749,0.3899767988765278
BT 440,44185566,1.192520436846858
Hep-G2,2746,2.5421699123058383
WM115,1750826,-0.9273267035114736
KHM-1B,753704,4.849440364052096
SK-OV-3,2858523,3.2787147644650716
COR-L95,selumetinib-GDC-0941 (4-1 mol-mol),2.521789990361809
U-BLC1,71466578,3.2529379808298517
U-BLC1,7326481,2.8482485813109717
ML-1 [Human thyroid carcinoma],969516,2.8184901812435923
SW948,25183872,-1.604238480901096
JHUEM-1,4521392,3.723509443320739
ST486,erlotinib-PLX-4032 (2-1 mol-mol),3.4353234010522105
HARA [Human squamous cell lung carcinoma],decitabine-navitoclax (2-1 mol-mol),1.7884131125603568
KP-4,9549297,1.1699591499626003
SUP-T11,11455910,1.655670582891713
BT 248,1714884,3.688077995610216
IGROV-1,6914657,-4.141311308759326
KP-3,9823820,5.493613069708307
BT 440,3025986,-0.255875296535679
SW1573,salermide-PLX-4032 (12-1 mol-mol),4.9189296859442315
Hep-G2,25154868,4.6149046547070816
HCC15,6610216,4.23435184261858
NCI-H1568,10074640,3.1711026687004855
SW48,4917,2.351047632498956
MOLP-8,46215462,1.266580776259001
TTC-709,2828334,6.173358863225552
WM115,erlotinib-PLX-4032 (2-1 mol-mol),0.1999561238865428
COR-L105,387447,-4.5302496546864885
MOLP-8,44462760,3.111101001788515
BICR 31,44819697,0.4590360698509347
HuP-T3,9956119,4.370077084995815
PaTu 8988t,sirolimus-bortezomib (250-1 mol-mol),0.5843474412149585
KU-19-19,66577038,3.864819378735941
BICR 22,5746,-1.0393569299451335
HARA [Human squamous cell lung carcinoma],6438330,2.871193568039211
SW48,67156097,-2.150931452918296
SK-MEL-2,1750826,2.708131758438896
SaOS-2,25150857,2.491525195617086
NCI-H1568,613753,3.056586098825006
LS180,44137675,2.850653785387247
SUP-T11,6623618,1.8417954884653576
KHM-1B,107985,-4.92843539421015
RKN,11364421,-3.590581417405073
JHUEM-1,2708,4.3274982573447245
HuP-T3,23582824,1.5911146583975455
SW48,446155,2.2181780639059907
MKN1,44819697,-1.4673333250216505
SU-DHL-1,44202524,0.8334918459072751
T98G,25126798,4.15775279163064
TTC-709,3062316,2.0517691345722517
RERF-LC-MS,11404337,1.609147033115388
YD-15,11396600,3.950136388858035
KHM-1B,135440466,-1.206578017984145
T98G,25154868,1.712910931589838
K-562,44486219,4.057183894108205
TTC-709,9903786,2.3304378522453866
KPL-1,5566,2.6979103847128636
PaTu 8902,serdemetan-SCH-529074 (1-1 mol-mol),2.396607903766339
PaTu 8988t,46199207,3.796589685342678
LS180,11964036,0.9251272605785624
PE/CA-PJ34 (clone C12),446155,2.4621784911192317
SW948,8515,3.759025323790885
SaOS-2,374536,3.743747938767685
KMS-21-BM,1239801,3.8570594042323254
PE/CA-PJ49,BRD-A02303741-navitoclax (2-1 mol-mol),3.846975912609384
PE/CA-PJ49,56946209,-4.669932218396141
SW948,135875424,4.663257041681152
SK-HEP-1,72376,-0.6035227354554765
SK-CO-1,1242560,3.64748499205759
SNU-886,6918328,-0.0533986128601594
SW48,selumetinib-vorinostat (8-1 mol-mol),-2.7312432821532724
MOLP-8,3025986,-4.599162344151263
SNU-C2A,44259,0.7897447778333557
SW48,25150857,2.2099211562472125
JHUEM-1,135875424,3.0885966905905433
ML-1 [Human thyroid carcinoma],10127622,2.646237824428173
LCLC-97TM1,3465537,1.1142431298706064
NCI-H1568,9887053,3.9549233487650666
SW48,5746,-2.6538895977275745
LS180,44484440,3.4848015178596343
Daudi,25183872,-3.2629659020313393
IGROV-1,984333,0.6618578113050116
T98G,4917,3.732623845948166
PE/CA-PJ34 (clone C12),44632017,0.8623565218793319
EB1,9866186,-0.7164855536683747
COR-L95,135999136,4.28146486500778
RERF-LC-MS,4788,5.0822281264538365
HuP-T3,2828334,6.159425491986346
RKN,3854666,2.132003481112045
JHUEM-2,568763,-1.5226778118840043
MKN1,446155,1.723249700465229
JHUEM-2,16741245,3.694065532973881
JHUEM-2,navitoclax-sorafenib (1-1 mol-mol),1.3100875964394478
HARA [Human squamous cell lung carcinoma],676352,2.7556636695973515
TTC-709,227681,1.891773988255265
KHM-1B,11214940,1.6917073338671202
PaTu 8902,54639665,4.483683562011812
Mino,9926054,1.8004792382140618
ALL-SIL,24180125,1.6553840753953686
SK-CO-1,12003241,-0.9578793579943758
KMS-21-BM,2945648,2.2193984348568776
KP-4,54649381,3.8790856388273776
BFTC-909,104842,-1.584917163766509
SUP-T11,89928392,-2.4861202973773775
SNU-626,9887053,4.686885424922037
MKN1,19582717,4.674019902403645
SNU-C2A,navitoclax-PLX-4032 (1-1 mol-mol),-0.9159590300817256
HARA [Human squamous cell lung carcinoma],60750,0.0702005032300629
MOLP-8,24772860,-3.493237790177901
SK-OV-3,49836020,-5.2191550029019025
K-562,46199207,1.8646546122938352
BT 440,44507138,4.9498472159275595
SaOS-2,BRD9876-MK-1775 (4-1 mol-mol),1.220945840769529
MOLM-13,6450551,0.4092106163446157
BICR 31,1566236,4.637821170940002
SW1271,54454,2.1914366041236204
HCC1500,selumetinib-PLX-4032 (8-1 mol-mol),4.771751115117369
SaOS-2,9952709,3.1448975558697545
JHUEM-1,73707371,3.865871672975358
KP-3,2708,5.865062247079506
KMS-21-BM,3854666,0.4771292097987486
HuP-T3,54618771,0.8132197250487964
YD-15,135440466,0.4111476415511286
JHUEM-7,3634881,2.904041587079114
RERF-LC-Ad1,3815108,3.6891446241117873
IGROV-1,6918736,-0.950858733923241
ML-1 [Human thyroid carcinoma],654092,0.5372247724983673
Granta-519,53392493,1.7904738197895116
SK-LMS-1,54619267,4.473937340383362
MKN1,4915,4.420982079687768
KHM-1B,3634881,2.028654365237279
SNU-1272,navitoclax-pluripotin (1-1 mol-mol),0.4939467184694363
NCI-H2452,445643,4.078319116283011
T98G,322968,4.567273173875759
SEM,24775005,3.6246781660471794
SUP-T11,tretinoin-carboplatin (2-1 mol-mol),3.635933650385818
SUP-T11,alisertib-navitoclax (2-1 mol-mol),-0.9448905884679444
KP-3,46907787,2.5590188315760956
HuP-T3,5281321,0.1098786391841839
NCI-H2452,654092,0.1220899319284023
ML-1 [Human thyroid carcinoma],135423438,1.332992654992983
MOLM-13,56973724,0.5307136138302019
JHUEM-2,24180125,2.3682289915123107
KHM-1B,46224516,1.9552041904833992
Mino,36314,-5.843937326950793
SNU-C2A,navitoclax-birinapant (1-1 mol-mol),-1.9264553333251704
BICR 31,439501,-2.4499261286992007
MOLP-8,44495899,4.403173191891281
Daudi,44632017,0.5148090574579154
SaOS-2,selumetinib-JQ-1 (4-1 mol-mol),2.075892545487755
YD-15,11612883,1.8785658568714565
SU-DHL-1,10077130,2.6641926349973875
Hep-G2,9911830,2.4259359362723147
KP-4,49793307,-3.288276813506919
HT-1376,9926054,2.913590047827676
SaOS-2,9549297,2.000544043325996
HuH-6,51039095,1.9002286562048312
LMSU,5329102,2.020452826888572
LCLC-97TM1,24785538,-0.7280489014481334
LMSU,15547703,4.748920610126263
HuP-T3,10302451,3.3244038223924868
F-36P,11238147,1.3988161261802263
Panc 02.03,73707398,1.687012904299387
ST486,JQ-1-navitoclax (2-1 mol-mol),-1.1097750690827477
T98G,10127622,5.626003985404022
SW948,25161177,4.032512886861284
ST486,11178236,-6.632659105856277
COR-L105,17755052,1.2153053156846572
HCC1500,11719255,2.4435237001116685
RERF-LC-MS,5287620,-3.2415128958876123
WM115,72193861,3.0084505907765795
K-562,2113511,5.3605896450220785
KP-4,24753719,4.448787857438118
RERF-LC-MS,24772860,-2.3078196081029136
SK-CO-1,navitoclax-gemcitabine (1-1 mol-mol),-3.3609230620799595
SNU-C2A,doxorubicin-navitoclax (2-1 mol-mol),-0.3133015867123082
SNU-C2A,11485656,2.2484892549692104
SNU-1079,445455,3.8040202870849606
HCC15,piperlongumine-MST-312 (1-1 mol-mol),2.732022929511258
F-36P,3676137,6.311128443133313
U-BLC1,44185566,1.7382479164966111
MOLP-8,15547703,2.3372930335131663
SK-MEL-2,vorinostat-carboplatin (1-1 mol-mol),3.8126311679317366
LS180,4378219,2.066313424484697
SW1271,168313047,1.8206519834924395
L3.3,6252,0.2429415263286948
Mino,71680916,3.571574649488516
RKO,123631,2.6120370559458155
NCI-H2452,3011155,5.255477653901917
SNU-1272,10322450,4.07877256776116
Daudi,16722836,0.8830828668869325
BT 248,46224516,2.5816980785990875
PaTu 8988t,6505803,-0.6279165545759258
SNU-886,10322450,3.968731934637612
HuH-6,16741245,2.0474346648259307
SW1573,5280436,3.0542460563059253
MOLM-13,262093,0.9014616367149992
IGROV-1,BRD-K55473186,4.387806234483854
SU-DHL-1,selumetinib-MK-2206 (8-1 mol-mol),2.1944562589821226
NCI-H1395,54618771,3.4411900765558125
SW948,5287969,-2.4513180825948515
P31/FUJ,54619267,3.5260071244925575
KP-4,72376,-2.015139867251827
IGROV-1,navitoclax-sorafenib (1-1 mol-mol),2.116164500809202
U-BLC1,644241,1.7323634588350438
TTC-709,6436223,-4.520683377842542
MKN1,49793307,0.9304356817771204
SW1271,11396600,3.626770708484224
ST486,9933475,1.725250428404329
IA-LM,676352,2.5463710414635696
BT 248,10427712,4.022427006719253
HuH-6,2828334,5.615295093789312
L3.3,66577038,3.645952100238679
ST486,44241473,3.631824742432312
SW48,148198,-2.7635683141359277
K-562,6918328,-1.3297822316036851
HARA [Human squamous cell lung carcinoma],25105715,3.4880191589222966
SNU-C2A,6438330,2.626145567196472
Daudi,135423438,1.6157885595086947
Daudi,6438330,0.2626238759101729
Daudi,44543605,5.193449926403497
LMSU,carboplatin-etoposide (40-17 mol-mol),5.006172673673393
BT 248,285033,1.6288115150650024
SaOS-2,71751553,4.337892909522829
ES-2,11507802,1.3175868081358568
KP-4,9825149,2.986048802019184
MOLP-8,23939,4.352572888875192
SW48,2858523,2.8468158768410965
SK-HEP-1,selumetinib-piperlongumine (8-1 mol-mol),4.719630045140052
COR-L105,9911463,4.222864246171191
ST486,serdemetan-SCH-529074 (1-1 mol-mol),0.929064408702781
TTC-709,3384730,0.7803548112502018
SK-LMS-1,219104,4.161341014769149
SW1271,11167602,2.369450835450289
JHUEM-1,2842253,4.374756829639725
SW48,135928012,3.696922095661256
Granta-519,53232,4.0944047749373915
MKN1,984333,0.2932500720442973
KPL-1,UNC0638-navitoclax (1-1 mol-mol),2.89421490403249
COR-L95,2871966,-0.8178907803151099
MOLM-13,17759555,3.648246486561575
HT-1376,15983966,2.2604162478123233
COR-L95,tretinoin-navitoclax (4-1 mol-mol),0.626714074175952
SK-OV-3,44589607,4.1377534493712265
RERF-LC-MS,44543605,4.169252612552019
Granta-519,49836020,3.8229564713378057
SEM,49793307,-5.17285060705878
TTC-709,54618771,0.1325833030612315
SW948,5278396,3.777624651516773
HCC15,400769,-0.8695567043490428
ALL-SIL,3038522,2.34327176020718
DLD-1,2742550,3.451094792104627
SW948,135440466,1.4177296224023617
PaTu 8902,400769,0.6580342998730634
KP-4,tanespimycin-gemcitabine (1-1 mol-mol),-3.176335740160863
SNU-C2A,6917907,-4.724131705830958
IGROV-1,5746,1.9055212643377857
SEM,5281672,3.3448340158126055
EB1,erlotinib-PLX-4032 (2-1 mol-mol),1.2888635563467394
ST486,702558,2.822548569660243
COR-L95,25195348,4.044301101066811
BICR 22,24180125,3.296229177015365
SW1271,carboplatin-UNC0638 (2-1 mol-mol),2.98870654666586
SNU-1079,11167602,4.298137640910785
RKO,73707398,0.9128481241529548
L3.3,54454,4.824648171697031
BICR 22,selumetinib-vorinostat (8-1 mol-mol),2.1163342168700936
HT-1376,81146,4.6863541353034295
RERF-LC-Ad1,11222830,1.8540425304510488
ES-2,71680916,5.392871989257792
HCC1500,decitabine-navitoclax (2-1 mol-mol),-0.2719438923490784
PE/CA-PJ34 (clone C12),10231331,3.045773235767836
IGROV-1,15953870,2.712793598656007
EB1,44491742,3.4704982889402545
WM115,71466445,4.303064097958205
L3.3,5280436,4.8128342001361
PK-1,1716436,3.838140183214959
COR-L105,9956119,4.279642090153805
BICR 22,168312962,0.5954564951508424
HT-1376,107970,2.532514719500574
KHM-1B,BRD-A02303741-navitoclax (2-1 mol-mol),3.1307381995393153
ES-2,44507138,3.528592697768762
NCI-H1395,36462,4.192459813965937
HT-1376,44493528,4.459541638540956
SK-LMS-1,637858,2.4121207019199074
SK-OV-3,navitoclax-piperlongumine (1-1 mol-mol),3.1171344026711147
LCLC-97TM1,46843906,2.6060669508648675
HCC15,9840324,6.2076616503129
PE/CA-PJ49,71466578,3.4798185838256424
YD-15,702558,5.2354994852060255
Ishikawa (Heraklio) 02 ER-,tanespimycin-bortezomib (250-1 mol-mol),-0.660556469573982
RKN,24964624,2.2448388370498704
KP-3,10113978,4.36466045727124
U-BLC1,400769,-0.9703903947239564
IGROV-1,selumetinib-navitoclax (8-1 mol-mol),2.4437934407587907
K-562,10410894,3.650757753763785
SK-LMS-1,11609586,3.6592183392420226
U-BLC1,67291369,1.3023141717797062
SW48,124202324,1.4616392816877528
IA-LM,15547703,3.104636726250569
SU-DHL-1,decitabine-navitoclax (2-1 mol-mol),1.6803027957585963
ML-1 [Human thyroid carcinoma],15547703,3.133536230544004
MDST8,49850262,3.692937134795778
TTC-709,613753,3.038022032387663
KLE,11228183,-0.1439343669453544
EB1,3384730,1.989989588573742
UACC-812,52947716,-6.767186414102593
YD-15,2708,4.333267456599628
MKN1,6623618,2.3976638221136968
ML-1 [Human thyroid carcinoma],9911830,3.383108057822615
SK-MEL-2,216345,4.726017609039073
HEL,11427553,2.263048189869726
IGROV-1,5281321,-1.4962463697398798
IGROV-1,135421197,1.96820638017286
JHUEM-2,piperlongumine-MST-312 (1-1 mol-mol),1.5079590117197763
LCLC-97TM1,104842,-3.469971777740615
RCC10RGB,374536,3.743226525407361
COR-L95,107985,-2.989419812710682
YD-15,3062316,-3.170307737536253
SK-LMS-1,409805,6.056363964674445
RCC10RGB,72199289,4.762339751475906
L3.3,2828334,6.9353242086196225
HT-1376,4788,5.198032370140271
NCI-H1568,11485656,1.8106242285910237
MOLP-8,9549297,1.4376511571672042
EB1,vorinostat-navitoclax (4-1 mol-mol),0.6309872615138995
Daudi,24951314,0.2263717121921743
BFTC-909,7326481,3.4905195575106527
Mino,54143018,0.7076567343942599
BFTC-909,6623618,2.802037410677928
TTC-709,2729026,2.147747676020344
KLE,JQ-1-MK-0752 (1-1 mol-mol),2.9937546834772375
JHUEM-1,9911463,4.030543660927087
HuP-T3,5287620,-3.5836939395445913
COR-L95,568763,-0.4949329271490838
SaOS-2,216239,3.028726771334262
PE/CA-PJ49,44185566,2.9892582778669503
RKN,navitoclax-piperlongumine (1-1 mol-mol),2.28018118974292
Daudi,5311281,1.0302556341787754
KP-4,11152667,0.9201986867468503
LS411N,3503,3.033347172376105
BICR 22,4705,3.4365696424802477
Granta-519,6918638,-1.0102021398050984
HARA [Human squamous cell lung carcinoma],11175137,1.814800704414418
SW48,54618164,3.7830586534540616
BT 248,alisertib-navitoclax (2-1 mol-mol),-0.6283307077190651
MOLM-13,25105715,3.5182090361281326
Daudi,11175137,1.084300991963852
BT 440,3825829,4.790902919975163
SW1573,42642645,1.1024283721976142
SK-LMS-1,5278396,4.082188120612068
P31/FUJ,11364421,-5.080526011220062
SNU-1079,25150857,1.9698570124517036
MOLP-8,12003241,-1.4499361325619826
ES-2,9911463,4.341533806603841
Granta-519,10410894,1.4137063553430784
RCC10RGB,57519531,5.003664553369681
KP-3,44185566,2.190069985543879
HEL,11625818,4.404342627749774
SNU-C2A,6918736,-1.6791694483053172
SK-HEP-1,1242560,3.752923936287399
BT 248,9868037,3.916296675967623
SW48,3062316,-0.5038339303633423
HEL,219104,3.0071408108258253
JHUEM-2,20959075,-4.522165063828813
SK-CO-1,3025944,4.807689572392986
SK-OV-3,52912189,0.2062426244094619
COR-L105,51039095,3.4251018662752073
HEL,65064,3.1933308972510113
Daudi,9929138,3.458684768924583
SK-OV-3,11404337,1.4011927232423718
ML-1 [Human thyroid carcinoma],7326481,3.5221044039257037
MDST8,11178236,-3.494725666780331
HCC1500,ISOX-bortezomib (250-1 mol-mol),0.4566996929358766
BT 440,637858,2.6000641094082635
WM115,119182,-0.4924283039006125
COR-L95,56649450,4.0191520211736895
HCC15,5278396,3.283293724206623
SNU-1079,11964036,0.2527193323851021
LS180,54143018,-0.5111931850291043
PE/CA-PJ34 (clone C12),15983966,4.022628798760432
MOLM-13,10427712,3.427914513597021
NCI-H2452,1566236,3.5735792412039022
ALL-SIL,452548,-3.3771532504793194
KU-19-19,409805,5.730069773001202
SK-CO-1,sirolimus-bortezomib (250-1 mol-mol),-0.6660837723392407
SUP-T11,24964624,1.1355878595504882
HARA [Human squamous cell lung carcinoma],17759555,3.7036804092868847
SW948,11955716,-2.1355637415890323
L3.3,erlotinib-PLX-4032 (2-1 mol-mol),3.685667045141098
NCI-H1395,selumetinib-PLX-4032 (8-1 mol-mol),5.142160466217897
JHUEM-1,16736978,1.1614745730678264
SEM,71466380,1.6371741531095363
KPL-1,15953870,4.274810061267122
RERF-LC-MS,11609586,3.546222239883878
IGROV-1,selumetinib-tretinoin (2-1 mol-mol),4.176281087704045
KPL-1,crizotinib-PLX-4032 (2-1 mol-mol),2.501919404323909
HuH-6,67156097,-1.794808579658981
ST486,3503,0.9217109632856938
WM115,5311,1.988201906885666
HCC1500,5311,1.250436307916732
KU-19-19,5282054,4.451216911386669
EB1,16065773,1.6390324633302775
PaTu 8902,4788,6.453607861068675
PaTu 8902,4261,2.3507697687761224
SW48,68056272,2.992212540747962
HCC1500,56963564,1.3630245510511625
Panc 02.03,25183872,-0.079390979301081
LS411N,11964036,1.3999141622104765
KLE,439501,-2.1797784747958477
TTC-709,409805,3.604457775701489
BFTC-909,135440466,2.535274686795805
SW48,selumetinib-UNC0638 (4-1 mol-mol),-2.2763178570350857
ML-1 [Human thyroid carcinoma],54619267,4.278122085164484
BT 440,9933475,-0.074141277285109
LS180,25183872,-0.6080839156226316
YD-15,5278396,2.4566481477557196
F-36P,637858,1.1543782344326252
PaTu 8902,71304818,2.9919229428361263
EB1,72376,-4.751981595802834
HT-1376,9825149,2.795327504201969
BICR 22,216345,4.525930969601246
NCI-H1568,374536,1.2941902477204823
SK-LMS-1,136227924,4.704854352606181
LCLC-97TM1,135423438,1.8911988038183152
JHUEM-1,salermide-PLX-4032 (12-1 mol-mol),5.007131900325333
SNU-626,16725315,4.360335734675799
NCI-H1568,56963564,0.2273202395709376
RERF-LC-Ad1,54618771,3.6047591405088673
PE/CA-PJ49,44493528,4.271726954290608
K-562,9927531,3.3022164605184763
SW948,2858523,3.1308292618704905
COR-L95,ISOX-bortezomib (250-1 mol-mol),0.3297770164947888
SK-OV-3,5287620,-0.5544150043477152
ML-1 [Human thyroid carcinoma],3676137,5.53606210778591
TTC-709,11485656,2.1468859036039327
SEM,JQ-1-UNC0638 (2-1 mol-mol),-2.509155551335313
HuH-6,4521392,4.1538324730897696
NCI-H1568,5311037,3.1621369524545155
WM115,15953870,3.7155207356015207
Daudi,445643,2.8458589584694307
HT-1376,446155,4.05699664297729
BICR 22,navitoclax-piperlongumine (1-1 mol-mol),2.368049525679639
HARA [Human squamous cell lung carcinoma],49766530,5.57937649881164
NCI-H2452,156414,1.7996451609117237
JHUEM-2,24772860,-2.5238722810003487
Daudi,53301938,4.372641532954565
PaTu 8902,9907093,4.385383441203628
SW48,136227924,1.7122170056378203
P31/FUJ,4096211,0.7441609883240002
PE/CA-PJ34 (clone C12),65064,5.4596992338484664
RERF-LC-Ad1,2858523,3.2226795457282735
IGROV-1,6610355,3.969940996770339
YD-15,100016,6.01418803247364
LMSU,24180719,3.8300426500348177
DLD-1,123631,2.766678821002868
NCI-H1395,54618164,4.0783729987601225
KP-4,10074640,3.3562516491812473
U-BLC1,5281321,-2.116592343444448
PaTu 8902,4917,3.0649190232675525
SNU-1079,638278,3.3432518175007155
IGROV-1,613753,3.483244781428779
KMS-21-BM,24772860,-3.020788150238138
SU-DHL-1,3136844,3.883215489826005
HEL,446155,2.11086977892158
HuP-T3,46907787,1.2763139172323097
ALL-SIL,2729026,2.163276094007301
KP-4,10302451,4.244768589994227
NCI-H2452,54613361,3.2620625907056744
BICR 22,448949,3.2035793217055124
SW948,5280436,1.724516723779293
BICR 31,25154868,5.458998944130281
LCLC-97TM1,44632017,0.6758650901814578
KLE,carboplatin-UNC0638 (2-1 mol-mol),5.218929523126634
SNU-1079,151289,1.232356175615026
BT 248,3025986,2.9298231166336297
PaTu 8988t,docetaxel-tanespimycin (2-1 mol-mol),-5.646992799561264
SK-HEP-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.819431075997551
HARA [Human squamous cell lung carcinoma],4261,3.400371454492322
HARA [Human squamous cell lung carcinoma],salermide-PLX-4032 (12-1 mol-mol),5.233652502193764
ML-1 [Human thyroid carcinoma],9866186,0.3108629746931657
SW948,409805,5.995103866916248
TTC-709,12001922,1.509100510592997
F-36P,72376,-3.222256822356651
P31/FUJ,16736978,2.2012912480094444
SK-CO-1,crizotinib-PLX-4032 (2-1 mol-mol),1.4696043946454187
PaTu 8902,19582717,4.67665303596855
L3.3,9926054,1.9335911906728165
SNU-1079,5311281,0.2290206306131142
F-36P,448949,1.3773610878049587
SaOS-2,24775005,3.5680490412807555
TTC-709,25227462,-4.696958698084011
SUP-T11,66577038,3.052968018449271
YD-15,11455910,1.434316032947977
KHM-1B,44632017,0.9077135445845732
Granta-519,327653,2.833903719231272
HT-1376,19582717,4.504154738521082
ALL-SIL,446155,2.369103686447931
HCC1500,445643,3.796669497386567
COR-L95,7326481,3.0640813007839105
KHM-1B,ISOX-bortezomib (250-1 mol-mol),-0.0879001565107233
JHUEM-2,9926054,1.5571026590008097
Granta-519,selumetinib-navitoclax (8-1 mol-mol),0.4649117531552323
LS180,53232,2.536426383073758
KP-3,navitoclax-sorafenib (1-1 mol-mol),3.3327970486975813
HT-1376,54639701,4.473625748295367
P31/FUJ,10127622,1.4388313131004449
HARA [Human squamous cell lung carcinoma],vorinostat-carboplatin (1-1 mol-mol),4.151404263307493
WM115,alisertib-navitoclax (2-1 mol-mol),1.935725956121268
SNU-1079,16736978,-1.0519324021257552
SNU-626,387447,-5.09988133415992
SaOS-2,11214940,4.2656495802712735
RKO,637858,2.400395947377078
NCI-H2452,3552672,4.527548939486843
Daudi,168312962,0.2834059413422853
P31/FUJ,216468,2.1049028903625673
KHM-1B,4259181,-0.2095303903157825
MOLP-8,11656518,1.844531268869525
MOLP-8,5426,4.334733303826167
SW48,54454,2.31662951125423
PE/CA-PJ34 (clone C12),decitabine-navitoclax (2-1 mol-mol),5.825207158072148
PE/CA-PJ34 (clone C12),6918837,-2.593805851370388
K-562,4521392,4.220123235241678
SU-DHL-1,selumetinib-PLX-4032 (8-1 mol-mol),2.801448892460394
RKO,1641662,3.3091455873155367
BICR 31,135875424,5.0736941678127945
SK-LMS-1,9911463,4.31771461226135
SW1573,BRD-K27188169-navitoclax (2-1 mol-mol),1.518643472033959
Daudi,44607530,0.9746569917988196
ST486,375860,-0.5687373512355877
SK-HEP-1,25150857,3.0587845310763297
COR-L105,tanespimycin-gemcitabine (1-1 mol-mol),0.318019061549867
SNU-1079,44241473,3.793438088949652
Granta-519,23635314,-4.977140911540282
SNU-626,5351362,1.1244272086992824
LCLC-97TM1,24753719,4.6973214087473405
DLD-1,4521392,4.320216746636234
P31/FUJ,11640390,3.1324724534083277
JHUEM-1,613753,2.78919310087577
KPL-1,421610,3.4826459110284547
HCC15,navitoclax-MST-312 (1-1 mol-mol),-0.227842438558318
K-562,6450551,-0.0734681627771844
Daudi,56946209,-7.191237665956405
Panc 02.03,25154868,5.464083731960118
P31/FUJ,5311,0.3390662723443479
L3.3,124202324,3.558321901620073
F-36P,9927531,3.277951098444252
JHUEM-7,3854666,0.7941739350816123
SaOS-2,11485656,2.155652122560971
IGROV-1,3025944,3.9702787396819503
COR-L95,docetaxel-tanespimycin (2-1 mol-mol),-3.340788273550256
PaTu 8988t,11494412,2.1257430484232525
T98G,148198,-3.089381534593653
IGROV-1,53495165,1.3981720287668329
LCLC-97TM1,42642645,0.0997949580151915
MKN1,2742550,4.9827202282235685
BT 440,15983966,1.8675281570306408
HCC1500,36314,3.7134374865247017
PE/CA-PJ34 (clone C12),135928012,3.818108144360031
HT-1376,25183872,-0.7939203216211891
L3.3,11238147,4.461700161811432
NCI-H2452,3815108,3.5712952235347455
DLD-1,26596,0.8453725223634535
WM115,11214940,3.8761690772861126
JHUEM-7,6918837,-3.184749956799345
JHUEM-1,2874250,-5.056561999827289
PE/CA-PJ49,5287969,-2.1626090287701114
SW48,676352,1.4830170410483523
MOLM-13,25262965,-3.0495150612642465
SK-LMS-1,676352,1.898915322770777
PE/CA-PJ34 (clone C12),5566,3.075370246500284
ALL-SIL,tanespimycin-gemcitabine (1-1 mol-mol),-4.457360880270642
Panc 02.03,148198,-4.053337817942692
SW1573,71466380,3.629171273590213
SU-DHL-1,151289,-1.0536473601541108
EB1,5335621,3.81058559654558
KPL-1,navitoclax-sorafenib (1-1 mol-mol),3.746519386522903
ES-2,6610355,5.279594666395224
YD-15,5746,-0.9430441023741636
YD-15,89928392,0.9841773753451948
L3.3,serdemetan-SCH-529074 (1-1 mol-mol),2.4729213733544366
SK-OV-3,JQ-1-vorinostat (2-1 mol-mol),1.4863340037373012
COR-L105,285033,-1.0049053408998423
PK-1,vorinostat-carboplatin (1-1 mol-mol),3.8619138079563458
SK-LMS-1,25262965,-2.583780574879674
SU-DHL-1,SNX-2112-bortezomib (250-1 mol-mol),-2.738100295775396
T98G,6918328,0.8799451723976952
Hep-G2,SNX-2112-bortezomib (250-1 mol-mol),-2.874949452723731
SEM,3136844,3.235068436368959
JHUEM-7,426756,5.918413566488646
PK-1,11455910,1.3401068508197878
ST486,6918328,-3.1368679966903885
Mino,SNX-2112-bortezomib (250-1 mol-mol),-3.943063699233405
Daudi,135440466,1.490781603812653
SUP-T11,969516,2.5705488025764347
ST486,11152667,-1.2094487766375612
NCI-H2452,6918878,3.5446658281374277
F-36P,208908,2.103294720422053
KP-4,24180125,3.869043701331771
PaTu 8902,123631,3.453096327622384
COR-L95,15547703,3.222652754514603
BT 248,54618164,4.1848059637542585
NCI-H1568,123631,1.2596294102093508
P31/FUJ,216345,2.9363986514954203
HEL,4261,0.4865008011530605
SK-HEP-1,5280436,-0.1709015599208282
SaOS-2,25062766,1.5016836694759386
JHUEM-1,54678924,1.6390264569568374
KPL-1,208908,3.354912079282177
F-36P,1566236,1.4994309826223562
LMSU,54613361,5.3504383264150235
RERF-LC-MS,51037431,2.0455212647735364
HCC15,11656518,2.9308462534519024
KHM-1B,73707398,-0.6689954941559422
SUP-T11,6450551,1.3442368973585788
RKO,10127622,3.209405126939437
COR-L105,9927531,5.197941564874311
NCI-H2452,6623618,2.534886377212576
Mino,168313016,3.695449207711372
JHUEM-2,104842,-6.656607009918475
SK-HEP-1,16725315,5.326615386804391
KLE,salermide-PLX-4032 (12-1 mol-mol),5.565306669496566
SW1271,11152667,-1.5987482479879582
BT 440,selumetinib-navitoclax (8-1 mol-mol),0.8519926407379078
PaTu 8902,selumetinib-GDC-0941 (4-1 mol-mol),3.4038309056959424
SU-DHL-6,3825829,3.5283611337160155
RCC10RGB,11656518,3.9855029209510215
Mino,11228183,-4.3465114919290455
SK-LMS-1,6610355,6.064160984405766
Hep-G2,135398516,2.8835237684961483
SUP-T11,65064,2.398065297161738
TTC-709,4096211,1.8221424400051116
SK-LMS-1,11656518,1.0446346440224212
T98G,9911830,1.7364710964395085
SaOS-2,67156097,-1.585481519484996
L3.3,44607531,2.464561691878258
BFTC-909,5566,2.8568699448622263
SW948,4788,6.033471365822279
LCLC-97TM1,1750826,-2.0890062190589544
MDST8,3689413,-1.6812703512916511
KMS-21-BM,3384730,-0.715966162110905
SW48,9926054,0.5681768331785455
BT 248,54454,4.901618168416747
Hep-G2,selumetinib-decitabine (4-1 mol-mol),0.775371272875809
MOLP-8,selumetinib-JQ-1 (4-1 mol-mol),-0.4981022967817401
PE/CA-PJ49,11640390,4.292577053675064
SU-DHL-1,262093,1.7952973078733698
KP-3,2113511,5.813704134045976
HT-1376,4378219,2.0379523360126988
SK-LMS-1,5281672,5.729460184884058
BFTC-909,439501,-2.4866456286351095
MKN1,262093,2.3312380194672353
HCC15,123631,2.7523193051058974
F-36P,6914657,-5.375535907634138
HuH-6,serdemetan-SCH-529074 (1-1 mol-mol),1.611499061148406
P31/FUJ,60750,-3.4241008025920396
SK-LMS-1,25150857,3.157289421707309
TTC-709,4259181,-0.3591071255089544
Daudi,9927531,3.2507934675389447
JHUEM-2,16720766,1.8188782911990145
MOLM-13,5281672,4.456656164404507
KP-4,82146,3.3218041213797185
IGROV-1,11222830,1.5703285223102077
SK-CO-1,5311,2.0479844637297617
COR-L105,15953870,3.0827686267342957
Mino,262093,1.013010854269816
PaTu 8988t,9866186,1.4965239773376473
PE/CA-PJ34 (clone C12),6438330,2.354249023140132
PE/CA-PJ34 (clone C12),navitoclax-piperlongumine (1-1 mol-mol),2.16883584787438
KP-4,10410894,3.2867527282339233
IGROV-1,124202324,2.2563058955522157
PK-1,10302451,3.287223466177899
PE/CA-PJ49,12003241,-1.496755728928347
SNU-C2A,2708,5.56923049045208
KLE,5470400,-2.677220539970202
HT-1376,119607,6.044934484658239
PaTu 8988t,9936388,-7.900053622036252
HCC1500,11152667,3.4439033763408644
MDST8,54618305,4.422279328619345
ES-2,selumetinib-vorinostat (8-1 mol-mol),2.4176750496579524
U-BLC1,11455910,1.1815633788614182
MOLM-13,3825829,3.189823245525434
BICR 22,3081361,1.798482521796042
SW1271,3854666,4.252835819462087
HuP-T3,285033,-3.1273004056463916
COR-L105,navitoclax-birinapant (1-1 mol-mol),1.1502985438361142
SK-OV-3,6610216,4.5015440272840275
BT 248,241158,3.909930885156875
ML-1 [Human thyroid carcinoma],56946209,-4.214217670545523
KMS-21-BM,5951923,6.049746276047884
SU-DHL-1,10090485,4.45721233802345
COR-L105,54765302,4.547071050564395
SaOS-2,44491742,4.263847553999534
RCC10RGB,BRD-K55473186,4.42890698658841
LMSU,3634881,3.35269539341832
KPL-1,3689413,3.184676645737856
JHUEM-7,72376,-2.504472205859212
SW1271,2742550,3.530952260660614
Daudi,148198,-7.679285276133229
RKN,104842,-2.3241286690000265
SNU-626,9926054,2.31791428562488
BT 248,4705,2.6318547262793386
MKN1,10074640,3.5233110063274053
BT 248,72199292,1.1105829108074048
SK-CO-1,3689413,1.2567954519757167
F-36P,9803433,6.317271663301622
Panc 02.03,24180719,3.694319415808187
MDST8,637858,1.7716899628344815
BICR 22,11404337,-1.5250786338229352
DLD-1,5281321,-1.6594943369940516
PE/CA-PJ49,72193861,0.3864361123852703
NCI-H1568,82146,4.486561599154294
PE/CA-PJ34 (clone C12),42611257,3.7997794760186654
PE/CA-PJ49,carboplatin-UNC0638 (2-1 mol-mol),3.667372427911613
LCLC-97TM1,52912189,1.3140510236946998
PE/CA-PJ49,3011155,4.495062274227112
BFTC-909,6918328,0.6354681535452512
IGROV-1,selumetinib-navitoclax (8-1 mol-mol),2.4437934407587907
L3.3,216239,2.590745343804584
SEM,25183872,-3.2065373842883687
SW48,10385095,0.7767009249070084
L3.3,400769,-0.1977482396353321
RKO,56649450,4.8662264096692684
SW948,45279963,3.8052773477912782
RCC10RGB,3038522,2.595581097335362
BICR 31,3689413,0.760898743899782
SNU-886,135999136,4.094662341834861
RERF-LC-MS,5282054,4.065617468844444
BT 440,10231331,0.8389226179977666
RERF-LC-Ad1,3062316,2.885097567128067
SEM,46215462,-0.5146100993456324
K-562,selumetinib-PLX-4032 (8-1 mol-mol),4.219594820991848
SNU-626,107970,2.4650135190130817
K-562,25161177,2.405708421255354
ALL-SIL,11497983,-4.396279985993102
SW1271,446155,1.3369653200346725
SK-LMS-1,4378219,1.9539135587059129
HARA [Human squamous cell lung carcinoma],568763,1.3363257274557196
KHM-1B,44589607,0.0686191939800993
Daudi,10296883,2.545577320776033
SK-MEL-2,11214940,4.164104783521612
KP-4,11178236,-5.8451036129411325
COR-L105,52912189,0.1952406080619365
SNU-1079,5328940,0.9578458250172478
NCI-H1395,56946209,-3.045135926894346
PK-1,9936388,-3.885789608116406
SNU-626,11485656,3.731914296666243
RERF-LC-MS,36314,3.6884025033565897
F-36P,10302451,3.5545884157395604
SU-DHL-1,25062766,2.372674975426994
BICR 22,126941,-2.054722221433598
P31/FUJ,46398810,1.6622931867453647
JHUEM-2,2828334,5.038864935565081
Mino,7251185,0.919792826844553
HuH-6,176870,3.6533303604019376
KMS-21-BM,452548,-2.424885939231105
K-562,15953870,3.5143251027161613
ST486,2746,0.9238009694882156
MOLP-8,89183176,2.6780353354925706
KP-4,26596,-2.006035898797214
Hep-G2,11404337,0.9907256098180968
PE/CA-PJ34 (clone C12),tanespimycin-bortezomib (250-1 mol-mol),-1.982258316980141
MOLM-13,9967941,3.903949930542719
SUP-T11,decitabine-navitoclax (2-1 mol-mol),1.600854952936629
BT 248,676352,1.654368845250315
L3.3,11152667,-1.6552573738209355
U-BLC1,568763,0.6159873400015815
ML-1 [Human thyroid carcinoma],57519531,1.467564757525082
SW1271,5291,3.239071539524422
K-562,56963564,-0.0263606087054764
LCLC-97TM1,54613361,-0.0023609252607709
SK-MEL-2,44197249,4.981669333138379
SUP-T11,selumetinib-MK-2206 (8-1 mol-mol),3.0660014580335115
Granta-519,24771867,-1.6352261980607803
HuH-6,2733526,2.7553087322519705
RERF-LC-MS,5287969,-2.0564845219287555
SW48,alisertib-navitoclax (2-1 mol-mol),-4.705705243079418
SNU-886,11167602,1.491891520160987
SUP-T11,54619267,3.5522836466782155
MKN1,11396600,3.1092750639740903
IGROV-1,168312962,3.022863957843741
JHUEM-7,135411,0.5518757066941595
SaOS-2,6505803,-1.001039194104569
F-36P,24856436,-0.3460726773190385
Panc 02.03,5460769,1.6540560754425335
SNU-C2A,3825829,3.7710879487261537
PK-1,45279963,3.965380850334685
BT 248,JQ-1-navitoclax (2-1 mol-mol),0.658869929233474
SK-MEL-2,44819697,0.2501364117398791
RCC10RGB,vorinostat-navitoclax (4-1 mol-mol),1.2015093799520282
HT-1376,3634881,3.6126026821111847
JHUEM-1,46199207,3.666319723387599
ML-1 [Human thyroid carcinoma],11175137,2.0792526924223735
Granta-519,crizotinib-PLX-4032 (2-1 mol-mol),0.3086247100875356
HCC15,135440466,1.473766152733558
Panc 02.03,448949,3.46549633046868
SK-LMS-1,24964624,3.0877384242952903
SW48,119182,-2.1563748503052103
SK-OV-3,36462,2.5052417836250496
LS411N,46199207,3.2917214979820506
Daudi,71466380,2.956949879575845
RCC10RGB,44566777,1.0790521939265936
P31/FUJ,446155,2.867326521256313
SEM,25195348,3.192775666849986
T98G,448949,1.4125691596038792
JHUEM-7,11222830,1.5565352005988358
SW948,navitoclax-PLX-4032 (1-1 mol-mol),3.63435849770784
PE/CA-PJ34 (clone C12),selumetinib-GDC-0941 (4-1 mol-mol),0.7203053018358525
SW1271,sirolimus-bortezomib (250-1 mol-mol),1.1899864031488736
Hep-G2,5281672,4.366631199734501
BICR 31,71576739,4.400142576070014
BT 440,52947716,1.976351568244784
SW1573,6623618,2.3278245092002936
ALL-SIL,969516,2.19071597716798
COR-L105,241158,4.618729119434587
JHUEM-7,2871966,0.3047669100796996
MKN1,6184667,3.1093959251061944
Daudi,24797083,-0.0937737057199073
HEL,5566,2.9283259495001133
SNU-626,54618771,3.903853524129119
BICR 22,44137675,4.05989667865121
BT 440,selumetinib-JQ-1 (4-1 mol-mol),1.436759754366273
ST486,11657048,4.339283955936058
Granta-519,3503,1.8528122642218805
HuH-6,49850262,2.758924944501625
TTC-709,25183872,-1.4053819485859695
EB1,9840324,5.3213400289000425
WM115,5287969,-2.3112325385791093
MKN1,3825829,4.385928470075506
KMS-21-BM,135928012,3.3009158839837003
NCI-H2452,3062316,-0.5574526988915461
EB1,selumetinib-MK-2206 (8-1 mol-mol),1.5669465194068937
JHUEM-7,168313200,3.430060131832228
PaTu 8988t,12003241,-0.7673639150441187
SNU-886,54626689,3.741397063281634
BT 440,3062316,2.8371622151109888
SK-CO-1,44589607,2.7511810771029213
RKN,23939,4.640348748177221
IGROV-1,72734382,4.633226130326536
F-36P,400769,-1.0160755777091484
SK-LMS-1,11612883,4.463968607595997
BICR 22,46215462,1.5294433170369757
MOLM-13,2949965,3.7040534246432624
HCC1500,46215462,1.5254849350202837
DLD-1,5351362,1.1740756457087729
K-562,25183872,-1.1768480549542706
KPL-1,52947716,3.231283588264774
SUP-T11,erlotinib-PLX-4032 (2-1 mol-mol),3.658275480910483
PE/CA-PJ49,2742550,3.734489746257058
SEM,46174525,1.2921885913164932
HARA [Human squamous cell lung carcinoma],5470400,2.3733756266777037
IGROV-1,3081361,0.99973562532788
BT 248,107970,1.564508535325896
NCI-H1568,9908783,4.863315848037401
LMSU,selumetinib-PLX-4032 (8-1 mol-mol),4.555801564467133
HEL,vorinostat-carboplatin (1-1 mol-mol),1.771793472925216
EB1,3385,1.9747411463292115
JHUEM-2,252682,7.876091422975939
SK-LMS-1,45279963,4.128111500577442
SW48,25195348,3.355247289110599
HCC1500,135411,2.801194317933856
BFTC-909,10410894,3.671861694905457
COR-L105,2708,5.5167338716905885
SW1271,9927531,4.558020454092029
NCI-H1568,44462760,4.02669785413772
COR-L95,11612883,2.9601999054336106
PK-1,637858,2.636074428434348
SNU-626,9823820,4.418522704287196
KU-19-19,selumetinib-tretinoin (2-1 mol-mol),2.7257099010203047
SaOS-2,46199207,3.779046434903352
MDST8,15547703,1.8320295844693912
U-BLC1,selumetinib-navitoclax (8-1 mol-mol),-1.2256172975299793
SNU-1272,56946209,0.3273283438568876
JHUEM-7,6450551,1.7942384478328788
SEM,JQ-1-carboplatin (1-1 mol-mol),-2.3661872454189634
EB1,SNX-2112-bortezomib (250-1 mol-mol),-3.459654610831285
JHUEM-1,9884685,-1.0339537431528274
MKN1,9868037,3.4608837590202746
SK-HEP-1,23725625,4.972795252846745
HuP-T3,JQ-1-MK-0752 (1-1 mol-mol),1.9324342474715044
YD-15,54639665,4.469393901086846
SaOS-2,doxorubicin-navitoclax (2-1 mol-mol),-1.9339656168793864
F-36P,3503,1.0513249627994985
HCC1500,24797083,1.1358144177435396
MOLM-13,11647372,-0.8512376057901615
SNU-C2A,46191454,1.4027564299677562
Daudi,navitoclax-sorafenib (1-1 mol-mol),1.4462190868370148
KHM-1B,25262965,-2.736326683370708
MKN1,12001922,2.1601219462493235
Hep-G2,107970,2.033740391106035
JHUEM-7,135398738,4.332846858207987
Ishikawa (Heraklio) 02 ER-,16720766,1.1696695251654898
KHM-1B,24772860,-4.094705330536473
K-562,5335621,4.97915810125604
COR-L95,2858523,3.028185885315027
HCC1500,9911463,3.4774936591741703
PE/CA-PJ49,2126,5.496885212346356
LMSU,11612883,3.4193736852271206
RKO,452548,0.942587279069954
SNU-1272,5284329,5.057648103020769
SNU-1272,5351362,3.155646522066241
JHUEM-1,23582824,0.3882812290079998
KP-4,6184667,2.1864211393774684
SNU-626,11427553,3.222414190322742
MOLP-8,126941,4.086011311839599
P31/FUJ,3384730,-0.5934712638177775
LCLC-97TM1,16725315,3.732120983026874
SEM,6918736,-2.5690877985953566
HuP-T3,60700,1.2793809884126126
SaOS-2,9956119,4.053594307296879
ES-2,24753719,4.95493894106221
SUP-T11,11507802,-0.1829645616607683
PE/CA-PJ49,6918638,-0.873109094603626
Ishikawa (Heraklio) 02 ER-,2945648,3.12938020774275
JHUEM-2,10231331,3.01921809921647
HEL,alisertib-navitoclax (2-1 mol-mol),-1.6663288612486489
SK-CO-1,46199207,2.9466484543003197
SK-OV-3,11175137,3.182781765506491
KLE,JQ-1-navitoclax (2-1 mol-mol),-1.1752020177182094
SNU-886,5329102,1.596812622524428
LS180,11222830,1.8684195070218452
SW1573,selumetinib-MK-2206 (8-1 mol-mol),4.390623431255029
Ishikawa (Heraklio) 02 ER-,1641662,3.5375112855478537
K-562,23582824,1.4169931108164455
JHUEM-2,11485656,1.361181565006939
COR-L95,3025986,-1.3264557881304966
SUP-T11,119607,4.191727944433045
YD-15,322968,3.882555646014854
SEM,68056272,3.037181097799154
PE/CA-PJ49,9866186,0.6761684743809719
NCI-H2452,16065773,1.9140766169124153
SEM,11719255,1.9160664785241357
PE/CA-PJ34 (clone C12),25105715,3.6718860986285975
SNU-1079,44607531,-0.5445908902934126
YD-15,89183176,-2.279707720145685
MOLM-13,54454,1.7928295036604598
LS180,119607,5.442141379439383
Granta-519,644241,4.377614733152813
YD-15,136227924,2.6934840054154834
IGROV-1,46199207,3.293579955374855
IGROV-1,3038522,3.6829378423722416
HuP-T3,135875424,4.261865095251217
IGROV-1,89928392,1.4824233552493276
NCI-H1395,selumetinib-MK-2206 (8-1 mol-mol),2.294517762393479
JHUEM-2,5460769,-3.615295030871829
KU-19-19,5280436,3.7375704611092657
SW1573,54678924,1.9184875438403524
K-562,selumetinib-MK-2206 (8-1 mol-mol),2.367030654184624
KP-4,1750826,-3.809159063509498
SK-HEP-1,11364421,3.0648019303900624
P31/FUJ,11507802,-0.4015560413947272
F-36P,135928012,3.654174626785145
MDST8,selumetinib-PLX-4032 (8-1 mol-mol),6.148002129111475
SEM,11404337,-1.9668178292815095
NCI-H1568,89928392,1.1949851991515912
WM115,11222830,1.2308018153574234
SU-DHL-6,9908783,5.938767725153886
KLE,vorinostat-carboplatin (1-1 mol-mol),1.9329749700220415
HCC1500,25150857,1.1801270031504156
ML-1 [Human thyroid carcinoma],9915743,-0.6180546405493912
SUP-T11,11317348,0.2766426454023778
NCI-H1568,4521392,3.7910777113602303
JHUEM-1,9933475,1.6154946238610142
ST486,60750,-6.324164232627724
MKN1,4261,2.0885716290873613
COR-L95,25183872,0.0728708482253017
SK-MEL-2,54143018,4.314913110704269
SNU-626,6438330,2.889621528666311
IGROV-1,227681,3.5439813498262347
PaTu 8902,6918878,3.691618711508776
K-562,1242560,3.4884556471232293
BICR 31,53495165,2.344314514368125
BT 248,644241,1.8454939937856112
BFTC-909,tretinoin-navitoclax (4-1 mol-mol),5.193173988671874
SEM,5311,-0.7681925912074375
BICR 22,17755052,1.4011116930942769
L3.3,5278396,3.196787051990793
JHUEM-1,135984461,4.231451308328731
Daudi,17755052,0.1512024273398794
JHUEM-1,crizotinib-PLX-4032 (2-1 mol-mol),1.43894252854807
ST486,241158,1.6334759620227712
YD-15,12001922,1.9828330012379096
MKN1,53232,1.9094849707614492
SNU-1079,24771867,0.8441166398955187
SNU-886,selumetinib-GDC-0941 (4-1 mol-mol),1.2837780593407424
HEL,67156097,-1.6398778776875675
PK-1,285033,-1.2564974671700428
SK-LMS-1,alisertib-navitoclax (2-1 mol-mol),1.0295022331839287
BICR 31,44486219,4.3544536670303025
SU-DHL-1,119182,-1.9070320733957784
KP-3,100016,6.07483479536675
WM115,135440466,3.0586385090162085
IGROV-1,11152667,-1.4116509977729443
DLD-1,6918289,3.144069514418112
KMS-21-BM,322968,2.616531785919172
Mino,66577038,2.530723915783821
BICR 31,10385095,1.3759128494100044
PE/CA-PJ34 (clone C12),11497983,5.068239933837802
RKO,969516,2.537841036798478
JHUEM-2,9935249,3.290906411802745
Granta-519,123631,2.886011281362197
YD-15,36314,1.7725422745529062
HEL,4477,0.140225607998234
SK-LMS-1,navitoclax-gemcitabine (1-1 mol-mol),-2.1368284485101814
HCC15,568763,0.562622735167329
HCC1500,9926054,1.7367797854287812
HCC15,vorinostat-navitoclax (4-1 mol-mol),-0.4329287763165494
Mino,71576739,6.461585428611278
SW948,444795,4.960330673315111
SW948,119607,5.410714093672246
RERF-LC-MS,9936388,-8.273067767637817
SW1271,alisertib-navitoclax (2-1 mol-mol),1.9083065334137317
KU-19-19,4261,0.7367611445661113
SU-DHL-6,387447,-5.553627026103078
SK-HEP-1,3825829,4.395950359013269
COR-L95,9903786,3.7357721387912513
KHM-1B,135875424,3.3101852288443276
SK-HEP-1,44185566,3.236949395761265
COR-L95,73707398,1.0347493154641954
SW1271,66577038,2.7134536861777807
RERF-LC-MS,36462,1.1230283698314445
LS180,5278396,3.460947025625347
PE/CA-PJ34 (clone C12),11507802,0.6950078471538325
U-BLC1,2871966,-0.2226618695128414
L3.3,16038120,1.9292348544241311
SK-LMS-1,24180719,4.466013942579335
SK-LMS-1,216345,4.485314060512248
BT 248,119607,5.038088774684491
EB1,navitoclax-sorafenib (1-1 mol-mol),1.3272528751888484
Daudi,3062316,-6.775500959037878
HT-1376,24753719,2.891583671664211
T98G,navitoclax-sorafenib (1-1 mol-mol),1.3366436175865406
Mino,2858523,2.969204475444126
K-562,107970,1.9304513771469212
U-BLC1,72199292,0.4465056823372405
HCC1500,3854666,1.4433352503078565
KPL-1,2130404,3.565044965507518
LCLC-97TM1,JQ-1-navitoclax (2-1 mol-mol),0.3092105032557149
HCC1500,11455910,0.2448151005088887
MOLP-8,46907787,-2.434163875600539
LS180,crizotinib-PLX-4032 (2-1 mol-mol),2.1034358212812867
RERF-LC-MS,53392493,1.949934555719578
JHUEM-7,crizotinib-PLX-4032 (2-1 mol-mol),1.0528686048988958
MDST8,6610216,4.3863838734153
COR-L105,navitoclax-MST-312 (1-1 mol-mol),1.0518954464197996
LS411N,216345,4.369072592416217
SNU-1272,selumetinib-MK-2206 (8-1 mol-mol),4.6345162541062495
KP-3,12003241,-0.3092638329597765
SEM,44202524,1.290193172725863
SW948,JQ-1-carboplatin (1-1 mol-mol),1.423261364200352
SW48,2841722,4.762546821441249
SW48,9956119,3.393025538441131
EB1,16736978,0.2702467816535739
PaTu 8988t,44607531,1.764787957031886
HCC15,16741245,4.574628343563009
F-36P,tretinoin-carboplatin (2-1 mol-mol),6.005914815255201
SW948,89928392,1.4444572178844948
SEM,11707110,1.3401031193099515
SK-OV-3,25126798,3.9960730178767
RKN,54143018,1.3184566027416504
KP-4,135411,0.2840057840675377
NCI-H2452,24180719,2.8480667171601852
KHM-1B,57519531,1.9307254851504612
KHM-1B,SNX-2112-bortezomib (250-1 mol-mol),-3.421333600529768
COR-L95,9915743,0.942320604231091
LCLC-97TM1,decitabine-navitoclax (2-1 mol-mol),2.9245922441873717
JHUEM-7,119182,0.6933164692379293
LS411N,selumetinib-PLX-4032 (8-1 mol-mol),1.7092095935664802
ALL-SIL,387447,-4.904935645240703
SW1271,54649381,4.56488530045006
KU-19-19,4259181,2.3072251676522835
JHUEM-1,5328940,1.3028004781290816
SW948,25105715,3.628389782970242
ST486,4521392,3.9672623506456386
SK-CO-1,tanespimycin-gemcitabine (1-1 mol-mol),-4.470227169685732
LS180,19582717,2.9052461851112565
EB1,42611257,1.3007229686042845
Daudi,676352,1.3635905677607614
NCI-H1395,6610216,4.652818435628847
KP-3,5280436,3.7613317976791425
SW948,SNX-2112-bortezomib (250-1 mol-mol),-2.424265268462928
JHUEM-7,2708,5.089129361016784
ML-1 [Human thyroid carcinoma],375860,0.003862862725961
ST486,3025986,-4.42787109602159
SK-MEL-2,11455910,1.0662653811839238
SW48,9915743,2.691515978939234
MDST8,BRD-A02303741-navitoclax (2-1 mol-mol),1.0671280155352338
P31/FUJ,navitoclax-piperlongumine (1-1 mol-mol),-0.4738069202441977
Ishikawa (Heraklio) 02 ER-,49793307,-2.7249248164875945
SK-CO-1,navitoclax-piperlongumine (1-1 mol-mol),0.7177098692298883
Granta-519,3025944,4.149663954634143
SNU-886,25126798,4.09091896335188
ML-1 [Human thyroid carcinoma],46174525,4.296155307906125
JHUEM-1,5282054,3.443011255425362
KP-3,44486219,4.292467007303418
LMSU,3689413,-0.2257013593388283
SW1271,2841722,4.036476035404804
SW948,53232,2.3961531254319466
SK-CO-1,25183872,-2.2315902989777725
KU-19-19,vorinostat-navitoclax (4-1 mol-mol),1.414230786423441
SK-CO-1,selumetinib-MK-2206 (8-1 mol-mol),-0.5781899978856783
P31/FUJ,6918328,-1.424420935100909
YD-15,3815108,3.18725300888999
HuP-T3,71680916,4.329506074723249
JHUEM-7,25154868,5.093350914915029
P31/FUJ,262093,1.035147161622815
SaOS-2,11228183,2.7080984165628754
NCI-H1568,6852167,2.376266672184036
RKO,4477,1.7070595719756474
Granta-519,46199207,2.493616790778817
Hep-G2,46843906,2.934188713214244
ST486,637858,0.4034485852671179
IGROV-1,5470400,-0.2457809435208252
HuH-6,11507802,1.7229100877643675
EB1,decitabine-carboplatin (1-1 mol-mol),3.790854408769928
U-BLC1,11609586,2.5540202440911455
IGROV-1,409805,5.990596261907717
BT 248,65628,4.438815715072134
PaTu 8902,15983966,2.4191743534269463
PE/CA-PJ49,53495165,-2.0273546331636223
RERF-LC-MS,31703,0.0184985959907658
NCI-H2452,SNX-2112-bortezomib (250-1 mol-mol),-1.5822620251622193
P31/FUJ,46224516,2.421293495972869
JHUEM-2,4788,4.612350209680435
F-36P,JQ-1-carboplatin (1-1 mol-mol),-0.2067996802850356
BFTC-909,10127622,5.216996592058982
HuP-T3,55508,4.397520768584908
HuP-T3,10385095,0.7178899916931367
KLE,675434,4.244667851386391
RKO,16013152,4.038378204585466
HuH-6,9903786,2.683606252138214
F-36P,25262965,-1.6391732709802074
RCC10RGB,6918328,1.0053978601828475
SW948,9444,4.221430823371368
ST486,445455,3.8929047917735073
JHUEM-2,24180719,2.542214228790043
SNU-C2A,107985,-3.3916676058064916
SNU-1079,42642645,-0.042181798323702
WM115,53392493,1.845382538513501
HCC15,44185566,3.08334642122707
KLE,46398810,3.130465535353637
LS180,JQ-1-navitoclax (2-1 mol-mol),0.8160001924760493
SNU-886,72199292,0.8312064221987397
UACC-812,25262965,-4.249514707304517
WM115,51037431,2.6247692404465868
SW948,5311281,0.0185560472432188
HT-1376,439501,-0.8291876191032579
SK-LMS-1,11238147,1.9919735936136431
HCC15,44607531,1.6724658843452191
ST486,16722836,0.9997761758378216
LMSU,2746,4.6094970791668315
MOLP-8,6450551,1.973885798572914
JHUEM-1,selumetinib-navitoclax (8-1 mol-mol),1.3461668557367412
MOLP-8,7251185,0.7855879803762651
SaOS-2,5479543,4.655800274360292
IGROV-1,4917,2.985904350427039
Hep-G2,3038522,4.124890793702152
Daudi,3825829,3.2006002080342544
UACC-812,148198,-2.7739066615342236
SNU-C2A,UNC0638-navitoclax (1-1 mol-mol),4.411481357734303
SUP-T11,44202524,1.009128004678723
Granta-519,1242560,3.55554960326222
HARA [Human squamous cell lung carcinoma],60700,-1.6734694813518207
HEL,17759555,4.966386069896687
KLE,piperlongumine-MST-312 (1-1 mol-mol),0.99514194367968
SW1271,119607,6.141140067390372
Daudi,3038522,1.648170780235362
EB1,50905018,4.082668853045364
PaTu 8988t,969516,4.442820223092304
HuP-T3,4521392,4.351966444408677
JHUEM-1,ISOX-bortezomib (250-1 mol-mol),0.3778783311933159
KLE,3038522,3.949469556770748
TTC-709,135411,0.6439502308609487
BFTC-909,2113511,5.65564772398506
JHUEM-7,54143018,1.2737177342737822
ST486,387447,-5.600747003706374
YD-15,6505803,-2.549779097055298
ML-1 [Human thyroid carcinoma],9903786,1.6234934744716731
HuH-6,UNC0638-navitoclax (1-1 mol-mol),1.0136391182455402
YD-15,3385,4.1493640406859
SW1271,24856436,1.0602186643720275
YD-15,216468,1.8636338221383209
HEL,24180125,3.3188099636510495
WM115,10077130,4.784184630126653
RERF-LC-Ad1,11626560,2.342625482561719
LMSU,42642645,1.4355208101232508
KLE,969516,4.2636253983089984
SK-HEP-1,5281321,-2.075735756673856
UACC-812,10184653,-4.111635019949291
ST486,6252,-3.1874830157001885
MKN1,54649381,3.7289863950529183
KP-4,219104,3.770509519899463
KP-3,9936388,-3.794861235698215
JHUEM-1,49867926,3.8647273339268664
F-36P,16659841,1.075528013399748
BICR 31,55283,4.60336009153674
MOLM-13,11178236,-3.317575610691226
COR-L105,57519531,4.553300256365288
ML-1 [Human thyroid carcinoma],3815108,2.9979183689426723
SUP-T11,135928012,3.2224056142960307
HuH-6,3081361,1.966684538105496
PE/CA-PJ49,10184653,1.5434849064288445
ML-1 [Human thyroid carcinoma],sirolimus-bortezomib (250-1 mol-mol),0.5199068018007997
ML-1 [Human thyroid carcinoma],vorinostat-carboplatin (1-1 mol-mol),2.0705525470951587
ALL-SIL,11317348,-1.373590167325895
LS411N,6914657,-4.299110458286086
NCI-H1395,46199207,3.5912826317512136
SK-MEL-2,25105715,3.7306135827212046
ML-1 [Human thyroid carcinoma],12003241,-1.866080903179476
HARA [Human squamous cell lung carcinoma],1716436,3.773793106717324
PK-1,5746,2.672279408670716
HuH-6,9936388,0.7826739866684046
LS180,57519531,1.9809210286085912
LCLC-97TM1,60750,-0.9490237417659374
BT 248,11612883,3.485439835170839
PE/CA-PJ34 (clone C12),5287969,-2.1859806545337888
SU-DHL-1,49850262,3.2383746822480384
SK-OV-3,9911830,2.8997016876614863
SEM,44819697,-3.860509167414776
BT 248,71729975,1.811306833980593
PaTu 8988t,alisertib-navitoclax (2-1 mol-mol),4.265397677389301
RERF-LC-MS,15983966,-4.090154567310139
SK-HEP-1,selumetinib-MK-2206 (8-1 mol-mol),4.11054762578972
NCI-H1395,16741245,6.143335067349052
RERF-LC-MS,24951314,1.4075693116182684
F-36P,carboplatin-etoposide (40-17 mol-mol),6.044383393273901
SK-HEP-1,11494412,3.332434654266433
BICR 31,51039095,3.0794813668201546
KMS-21-BM,11455910,-0.3641448488710944
KHM-1B,11178236,-5.183518181224002
Panc 02.03,11178236,-2.8028080099743624
SU-DHL-1,24772860,-2.736237819232434
LMSU,54626689,4.479048602124445
Daudi,6610216,3.2134188501838494
T98G,15953870,3.9159504449413687
SK-MEL-2,selumetinib-decitabine (4-1 mol-mol),2.4848629414986254
PK-1,tanespimycin-bortezomib (250-1 mol-mol),-1.3417753505365824
NCI-H2452,53392493,2.782389188766079
Ishikawa (Heraklio) 02 ER-,5329102,3.225884541641358
NCI-H1395,25161177,5.627463134287728
NCI-H1568,445091,4.097432324473231
K-562,9926054,1.8612748023096723
KMS-21-BM,17759555,2.7875333833210294
KLE,ISOX-bortezomib (250-1 mol-mol),1.0539315287787143
YD-15,17759555,3.1290042570358403
HCC1500,24978538,-1.6021545775061432
COR-L95,25126798,4.203058281978897
SNU-1272,72376,1.3199699316246591
LS180,44819697,-0.9723932292423276
KMS-21-BM,675434,3.4963310889674513
BICR 22,5281321,-1.7077192732848236
PaTu 8902,656346,4.145274855759625
BFTC-909,42642645,1.561027146692027
KP-4,JQ-1-vorinostat (2-1 mol-mol),2.215951107023166
BT 440,135411,2.759705487632876
IGROV-1,49836020,5.658436828096057
KHM-1B,6252,-0.4471831766807136
Daudi,168313200,1.4988300519601074
F-36P,crizotinib-PLX-4032 (2-1 mol-mol),1.0889569136706556
KHM-1B,156414,1.0383008800592366
MOLM-13,24779724,4.7751629548446894
IA-LM,docetaxel-tanespimycin (2-1 mol-mol),3.5360773084497494
PK-1,439501,-1.8745947720441176
ST486,9903786,1.7386739001111973
F-36P,135398744,6.4039586130062505
TTC-709,168313200,2.5540587155219385
K-562,doxorubicin-navitoclax (2-1 mol-mol),-1.4702798280033291
F-36P,11497983,3.947190340527199
RKN,2828334,5.965623907482328
JHUEM-2,49793307,-4.556006316286543
RERF-LC-Ad1,11178236,-2.382860044467462
JHUEM-7,375860,-0.5506223236134746
SK-LMS-1,44566777,-0.0913690248467498
SK-LMS-1,984333,1.1268410495571055
NCI-H2452,5280436,4.838161671645799
HARA [Human squamous cell lung carcinoma],25062766,2.285935640348263
BICR 22,637858,2.779101364791116
JHUEM-2,5280436,3.895646815030972
RERF-LC-MS,56963564,0.3267097404636779
ES-2,JQ-1-navitoclax (2-1 mol-mol),1.5810879249794307
PE/CA-PJ49,5113032,4.906572682560801
PE/CA-PJ34 (clone C12),JQ-1-navitoclax (2-1 mol-mol),1.827928126908855
RCC10RGB,2949965,2.9970768068045577
WM115,10074640,2.7921613557017473
KMS-21-BM,4096211,0.0051726050619795
KU-19-19,25154868,3.204596310046931
BICR 22,49793307,-5.020228152199773
SU-DHL-1,5460769,-0.475427190707336
NCI-H2452,9868037,3.199558399493599
SaOS-2,9823820,4.1201217228566565
SU-DHL-1,9444,2.825333870881758
YD-15,65064,5.212991952887543
HCC1500,53495165,1.6495193303321407
RCC10RGB,9952709,4.37754893062567
Granta-519,73707398,-0.348610297970246
SNU-626,5280436,4.618424971599992
HARA [Human squamous cell lung carcinoma],44632017,0.7187380309890276
MOLM-13,26596,-2.2068545341754295
K-562,52912189,0.5484446218637569
MKN1,44632017,3.933888174041529
Hep-G2,17755052,0.5179186148477235
BT 440,216239,2.36901502562343
MOLP-8,doxorubicin-navitoclax (2-1 mol-mol),-3.5664947897809207
IGROV-1,375860,0.7731558163124775
YD-15,selumetinib-vorinostat (8-1 mol-mol),3.259964348594559
IA-LM,11964036,4.998383188027045
MDST8,387447,-2.914953377887094
IA-LM,9915743,1.455667571666015
KP-3,3543504,4.20808934410366
LS180,6918328,-0.1069758097146191
PaTu 8988t,6610216,5.064895456595333
U-BLC1,46191454,0.3196499763972559
SNU-C2A,5287620,-2.6679032728072296
BT 440,16038120,-0.2439586025740275
SU-DHL-1,104842,-6.410970225096146
P31/FUJ,56946209,-4.67609529352027
LMSU,446155,-0.7885997290913209
L3.3,10427712,3.981964931961501
SW948,6917907,-5.884345700630281
BICR 22,53232,4.030024483575548
BT 440,JQ-1-UNC0638 (2-1 mol-mol),2.869213983756096
SNU-1272,23725625,5.0585620890398735
PaTu 8902,568763,1.8312011651342244
ALL-SIL,6505803,0.7073572306495796
SW1271,selumetinib-JQ-1 (4-1 mol-mol),-0.3516238001186607
U-BLC1,7251185,1.755815441244531
PE/CA-PJ49,9826308,0.3040528028280299
LS411N,10302451,4.220534629483678
SNU-886,BRD-A02303741-navitoclax (2-1 mol-mol),-5.741782833272406
RKN,11238147,3.9265768628415487
JHUEM-2,71304818,2.150833851719356
PaTu 8902,135440466,3.176809791892748
MOLM-13,119607,3.836878131829583
ES-2,10410894,3.144931484066117
HEL,11612883,1.9962168488272864
COR-L95,11485656,1.8696119642586884
HuH-6,6450551,2.064518890888157
MDST8,675434,4.4652962141660595
IGROV-1,11507802,1.5049911819213722
EB1,46926350,-5.887959287179859
SNU-886,400769,-1.7874528673919734
SK-HEP-1,2708,5.260013220141412
MKN1,3552672,3.399582722957873
LCLC-97TM1,BRD-K27188169-navitoclax (2-1 mol-mol),5.367919613117806
SU-DHL-1,5738263,2.757121948334044
ST486,11234052,3.814070601464942
Granta-519,54626689,4.523537450364534
SW948,135421197,1.7477185084776832
SW1573,ISOX-bortezomib (250-1 mol-mol),0.8486273919193054
PE/CA-PJ34 (clone C12),24180719,3.969047374225328
SNU-626,JQ-1-MK-0752 (1-1 mol-mol),1.970978624915572
KP-4,452548,-1.9659972775465684
TTC-709,5281321,-1.280271109138122
BFTC-909,tanespimycin-gemcitabine (1-1 mol-mol),0.2587370636739561
BICR 22,4917,3.6655313291566327
HARA [Human squamous cell lung carcinoma],2130404,2.6459509712703246
MOLP-8,16736978,0.6033273838828506
SW948,11396600,3.556168564723583
IGROV-1,2113511,5.982902824257526
SNU-886,3689413,-0.3695618539773043
Panc 02.03,16725315,5.289216895099664
K-562,9549297,1.810271401171294
SU-DHL-1,60700,-3.861884777487788
MDST8,89183176,5.515733421140453
LMSU,BRD-K55473186,4.503625931723464
F-36P,25126798,-0.7029765541824262
PE/CA-PJ34 (clone C12),216239,3.0316915626145726
LMSU,11427553,2.2667679897186757
KHM-1B,446155,3.672634684818232
PaTu 8988t,selumetinib-decitabine (4-1 mol-mol),5.718429611668687
WM115,10113978,3.3670712397266698
SW48,25154868,5.084018259884556
SK-MEL-2,60750,5.399063219277862
YD-15,selumetinib-decitabine (4-1 mol-mol),0.4583363274742318
KHM-1B,56946209,-4.323127458316883
Granta-519,107985,-5.079154139769343
IA-LM,15953870,4.160803294534019
RKO,19582717,4.345992572306107
WM115,selumetinib-decitabine (4-1 mol-mol),-1.8184529973078083
ALL-SIL,2742550,3.1857763586562577
SUP-T11,421610,2.195250373582973
COR-L95,375860,0.21091681928276
F-36P,11640390,2.9241471553218408
Daudi,JQ-1-MK-0752 (1-1 mol-mol),-0.2875395851345496
COR-L95,702558,5.203109308170341
ALL-SIL,5329102,0.5818325089631969
MDST8,9911463,4.372295154952754
SNU-C2A,5311281,2.122914204012259
EB1,selumetinib-vorinostat (8-1 mol-mol),1.9651507627888476
KMS-21-BM,2828334,5.056859887541492
LS411N,44607531,1.9881484499388475
Daudi,68056272,2.8001037652797818
JHUEM-7,46174525,4.16654361698855
MOLP-8,4521392,3.737637773211522
KP-4,9935249,4.396743844440814
TTC-709,71304818,1.9231007205012045
ST486,navitoclax-birinapant (1-1 mol-mol),3.729554532086605
MDST8,20959075,-2.855250986095604
PE/CA-PJ34 (clone C12),969516,2.522946376643246
IA-LM,400769,-0.2498086542393983
IA-LM,16722836,2.5380745713557893
HCC15,445091,5.451686926059382
HCC15,11507802,1.1916077520331714
MOLM-13,9903786,0.7109980532390177
KHM-1B,11497983,-3.4105993127539698
SW948,24901704,3.213341299668661
PK-1,2828334,6.270693039528231
ML-1 [Human thyroid carcinoma],46224516,1.5473988782080883
SU-DHL-1,10427712,3.576020229714379
SEM,1750826,-0.892835267111722
ML-1 [Human thyroid carcinoma],107985,-3.3059977696559204
SK-CO-1,piperlongumine-MST-312 (1-1 mol-mol),2.091052840490691
KHM-1B,24785538,-3.445065947322119
LMSU,252682,6.355540941087888
Granta-519,51039095,1.7779321154646133
RERF-LC-MS,65628,5.693639897620667
SaOS-2,2828334,6.074749772556143
SW48,3815108,2.5063295630391806
SK-CO-1,11626560,0.3943389380121196
LMSU,5113032,4.833258964444667
HEL,107985,-3.965696416470184
ES-2,148198,-2.2318104062196102
KU-19-19,60700,0.8700483452505813
SNU-1079,2907,4.96732749199328
Daudi,5280436,1.0789231424034973
MOLP-8,54613361,-0.8734170036218252
SNU-626,44185566,3.060664549200991
HARA [Human squamous cell lung carcinoma],439501,-2.358364257130844
SNU-1079,3384730,2.50528694885435
SNU-886,9936388,-5.3251547250946825
SK-CO-1,24978538,-0.5683899539074425
SU-DHL-1,54649381,3.644517842316546
SU-DHL-1,44493528,3.922242735424854
ST486,5113032,5.248892593379553
P31/FUJ,5282054,2.945149434876345
SK-OV-3,49850262,4.3958011115665006
TTC-709,11494412,1.1773331803884557
TTC-709,25102847,1.2449739194999685
IA-LM,10184653,0.8510906912410041
NCI-H1568,36314,4.092621701538515
BICR 22,46843906,2.889476079217857
BT 248,445643,3.6752138638176057
SU-DHL-6,9444,3.111459322097769
ALL-SIL,10410894,2.969142576372873
ALL-SIL,9549297,0.2429486516660708
MKN1,82146,3.7513627132790295
Daudi,46926350,-6.041265180126537
ES-2,4261,2.465951314017351
BT 248,25105715,2.686391114115495
TTC-709,984333,-1.558611426711261
SUP-T11,219104,1.0959067372073257
RKO,1750826,1.760307875609834
PaTu 8988t,4477,0.4312443696129938
F-36P,44566777,-0.6583463625680355
Granta-519,5282054,2.5814189459390957
SaOS-2,carboplatin-UNC0638 (2-1 mol-mol),3.570952437368873
TTC-709,BRD9876-MK-1775 (4-1 mol-mol),3.179756370819017
F-36P,3384730,1.3914993071875197
U-BLC1,104842,-2.3670998768575147
MKN1,135875424,4.434731625885322
SNU-C2A,5978,-1.7709604971037116
SK-MEL-2,2746,3.33396317139844
ST486,44137675,3.63325509805092
Ishikawa (Heraklio) 02 ER-,2874250,5.7101812906802465
IA-LM,16065773,2.795317455347302
RCC10RGB,156422,4.423389512885201
IGROV-1,11214940,1.360660548899077
Panc 02.03,16720766,4.473005389666903
Granta-519,3081361,1.7559432073327723
MOLP-8,52947716,-7.872176911001468
DLD-1,9915743,3.4458544437920784
KU-19-19,5281321,2.871465791170073
SNU-1079,5281321,-2.543144344350698
EB1,67291369,3.2908894156516846
IGROV-1,5282054,3.614574021382022
MDST8,4261,1.8348924416255383
MOLP-8,100016,7.090961588333011
U-BLC1,6505803,-1.6216028529729
Granta-519,168313200,2.290121636997186
SNU-1079,89928392,1.2795431027106694
HCC1500,462382,0.0787876699821948
IGROV-1,10113978,2.874171865860951
IGROV-1,BRD-K55473186,4.387806234483854
SNU-1079,selumetinib-PLX-4032 (8-1 mol-mol),-0.5241446910594008
SNU-1079,107985,-3.0381859059536387
PE/CA-PJ34 (clone C12),53392493,1.8170083800399903
HARA [Human squamous cell lung carcinoma],5291,4.037970789679042
TTC-709,16725315,3.054225976980593
P31/FUJ,10410894,5.368264014178215
SNU-886,156414,1.8221946579264756
BFTC-909,3025986,-2.0399601309440336
MOLP-8,24771867,-5.187641849515016
BICR 31,11214940,4.966543096658616
BT 440,9911463,3.153626294049379
Panc 02.03,selumetinib-JQ-1 (4-1 mol-mol),2.589155616289617
UACC-812,9936388,-5.022392750910281
ALL-SIL,24772860,-3.38763553354356
KP-4,sirolimus-bortezomib (250-1 mol-mol),1.5699611904925963
MOLP-8,11626560,-0.689912231097504
HARA [Human squamous cell lung carcinoma],selumetinib-JQ-1 (4-1 mol-mol),3.6659251122276015
BICR 22,navitoclax-PLX-4032 (1-1 mol-mol),4.097608134933257
PE/CA-PJ34 (clone C12),4917,3.437342838485429
TTC-709,navitoclax-sorafenib (1-1 mol-mol),1.894269248101899
KMS-21-BM,24889392,4.375244836171677
ST486,11167602,3.831852392866298
SW948,262093,3.1804911198162036
SNU-1272,11656518,1.8045520914389075
KMS-21-BM,451668,-4.060291824513866
SW948,216239,1.8650010893863176
SW948,11364421,-5.809742751249139
HEL,10302451,3.814274659252608
K-562,46398810,1.812730009869126
LMSU,9911463,4.298553287365515
SEM,11152667,-6.712483327053162
Daudi,216239,1.5780166370194677
SNU-626,44507138,1.622835018618475
LS411N,10231331,0.2083934704449227
T98G,3634881,5.056880039111395
T98G,285033,0.4097259162533684
MOLP-8,46926350,-5.986975596425451
SK-HEP-1,11964036,3.325100881793091
Granta-519,11485656,1.6660529916447626
DLD-1,16115403,-3.310526804197418
KHM-1B,vorinostat-navitoclax (4-1 mol-mol),0.9297533405267338
PE/CA-PJ34 (clone C12),11707110,-0.098789156222797
ST486,25062766,1.1975245323995038
YD-15,1750826,1.2098947690262072
K-562,2871966,0.96376622724181
P31/FUJ,54454,2.7341923640247123
BT 248,serdemetan-SCH-529074 (1-1 mol-mol),1.089631188997332
SNU-C2A,selumetinib-JQ-1 (4-1 mol-mol),1.4067421274631011
SW48,54613361,-1.8010952783890095
KP-3,5566,2.9181335458321427
NCI-H2452,46843906,4.012061875028764
HEL,135875424,2.9448279330391927
HARA [Human squamous cell lung carcinoma],16725315,4.551171651287005
SW1573,serdemetan-SCH-529074 (1-1 mol-mol),2.68378670703322
DLD-1,11964036,1.4531668364214465
ML-1 [Human thyroid carcinoma],51039095,1.326261900002616
P31/FUJ,decitabine-navitoclax (2-1 mol-mol),-1.2834649241305407
HCC1500,54678924,1.846277418486191
ST486,49793307,-5.355329148141241
TTC-709,24901704,2.081367780942686
KLE,5278396,3.889356862405411
SNU-626,322968,4.425904395434235
SU-DHL-1,UNC0638-navitoclax (1-1 mol-mol),-6.722227351020971
MOLP-8,9927531,5.438833274000949
SK-LMS-1,2708,5.723768268048996
ST486,1566236,0.5405681794856062
PaTu 8902,selumetinib-vorinostat (8-1 mol-mol),2.5580221704247403
HCC15,9952709,3.084010703088348
K-562,3503,1.244026999465694
SaOS-2,3689413,0.0712794264513353
MDST8,10427712,3.921886084986449
HARA [Human squamous cell lung carcinoma],11238147,2.905443405294126
KP-4,444795,4.300956807365333
SU-DHL-1,1716436,3.093009546519781
PE/CA-PJ49,11317348,4.262539229938768
PaTu 8902,25105715,3.5553172149604375
HuP-T3,24771867,4.228511460696379
Mino,5287620,-1.644304692772357
RKN,31703,-0.7196573309741882
MDST8,60700,1.1908209554887386
SW948,carboplatin-UNC0638 (2-1 mol-mol),3.7515115045005913
HEL,54454,2.1583735480761437
NCI-H1568,UNC0638-navitoclax (1-1 mol-mol),3.297813275168301
KMS-21-BM,9825149,1.1587851036356036
BICR 31,alisertib-navitoclax (2-1 mol-mol),3.3923193563221257
SK-LMS-1,1242560,3.3447561280118023
SU-DHL-1,135875424,2.8587183873170847
SU-DHL-1,36462,-1.6063137198477124
SNU-C2A,969516,2.750937372108966
SNU-C2A,5329102,1.947991280064284
MOLM-13,73707386,2.881964792667641
P31/FUJ,3854666,0.6136756098719494
LMSU,5746,2.5570316142886136
KLE,52912189,2.543092460133613
ML-1 [Human thyroid carcinoma],6505803,-0.5261965004955029
PE/CA-PJ34 (clone C12),1716436,3.718741146894734
MOLM-13,159324,-0.2587959593058327
SW948,19582717,2.742329976582949
SK-CO-1,444795,5.109688629113172
Daudi,400769,-1.3686052359334673
SK-HEP-1,10296883,4.4971190241998835
F-36P,46843906,1.6251282704795698
HARA [Human squamous cell lung carcinoma],12003241,-0.2443339656532688
SNU-C2A,6623618,2.3648590515416736
LS180,17759555,2.746757712453425
Mino,53232,2.4672323613595477
MOLM-13,156414,-0.1970532812518614
ALL-SIL,72376,-2.2514410459425043
BICR 31,selumetinib-MK-2206 (8-1 mol-mol),1.335551689205146
HARA [Human squamous cell lung carcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1045864370631683
Hep-G2,56946209,4.656180413694649
HCC1500,51039095,2.9997605815390935
SNU-626,49793307,-2.39683409261234
WM115,44185566,3.0030021210520794
COR-L105,4705,0.5312031062005766
U-BLC1,selumetinib-decitabine (4-1 mol-mol),-0.5921302438574547
Granta-519,8515,3.731909716775835
ALL-SIL,11234052,3.5011978223530926
COR-L95,tanespimycin-bortezomib (250-1 mol-mol),-0.3690826099539636
MKN1,159324,3.5689159418986005
ML-1 [Human thyroid carcinoma],44632017,3.256506939906626
KHM-1B,doxorubicin-navitoclax (2-1 mol-mol),-2.1386947262651907
PE/CA-PJ49,11214940,4.441072373529905
Granta-519,613753,3.0344429390603493
L3.3,1641662,3.117391597616944
KMS-21-BM,11609586,0.5403131023235455
LMSU,11609586,4.078801405634202
U-BLC1,446155,3.255049236332949
HuP-T3,5329102,2.4996480668272527
SU-DHL-1,2828334,5.462697908299577
SK-OV-3,51039095,2.3576173335626147
UACC-812,5470400,-2.2578344499942418
HCC15,9935249,4.091947122155354
EB1,44543605,4.174160936536248
KMS-21-BM,5278396,2.2500418635851234
T98G,24771867,3.67849039634948
UACC-812,JQ-1-vorinostat (2-1 mol-mol),-0.5213031534169104
SW1271,322968,3.7653444240208263
COR-L105,54678924,1.4327429630461548
Panc 02.03,31703,0.91391851070637
KPL-1,3062316,3.132410192141981
SEM,753704,2.726890937341564
T98G,6914657,-3.155493016419808
NCI-H1568,5329102,1.5348278867114138
F-36P,6918736,-3.201463398863563
SUP-T11,3676137,3.949375785745555
Granta-519,9887053,0.035640336798207
IA-LM,6610216,4.173583896241699
SK-MEL-2,676352,2.344694612320362
Mino,135440466,1.5309037639218337
SK-MEL-2,5311,1.803699116946934
KHM-1B,17759555,2.7813398800723914
NCI-H1568,119182,-0.8732650634834633
IGROV-1,159324,2.8766947154825044
NCI-H1568,5566,2.911706555521376
Granta-519,ISOX-bortezomib (250-1 mol-mol),-0.0076351128807997
NCI-H2452,10385095,2.425738192808243
HuP-T3,16065773,2.155269900494742
SNU-886,25183872,0.04916046112461
EB1,89183176,5.5376624247315025
SW948,448949,1.5714288146717783
NCI-H2452,107985,-2.625758680845612
DLD-1,19582717,4.438743271250004
RCC10RGB,1750826,-3.277944046627699
Granta-519,16736978,1.0160166250823044
F-36P,136227924,2.476842028434826
SK-LMS-1,6184667,1.7547566715976322
HEL,104842,-4.135712202151618
MOLP-8,71466445,1.892906464336944
MDST8,262093,2.389063867163299
Ishikawa (Heraklio) 02 ER-,135984461,4.462174661404989
COR-L95,4259181,0.8580425806970188
SK-LMS-1,selumetinib-UNC0638 (4-1 mol-mol),4.073478284718911
Daudi,45279963,2.6753649589319854
U-BLC1,11175137,1.787131415657052
IGROV-1,656346,1.6285470744333117
Hep-G2,60700,1.3225339846103372
SEM,9444,3.4451798115030705
SK-HEP-1,10427712,4.527720982072863
TTC-709,16659841,1.773423365438862
SaOS-2,11647372,0.6261520317366223
ST486,5351362,0.3694075677046157
KLE,5291,4.081072995426117
PE/CA-PJ49,24951314,0.8809030509786389
BT 440,5287620,-1.8909760098131536
COR-L105,53495165,0.9627099148057476
PK-1,44493528,4.319827010327948
U-BLC1,11427553,2.4428527327182685
SNU-1272,3025986,2.0429499224913927
Granta-519,11404337,-2.8078628280004048
KHM-1B,6184667,4.636571439855277
ST486,753704,2.940686834415163
SW1573,25154868,3.281093993360062
RCC10RGB,crizotinib-PLX-4032 (2-1 mol-mol),2.89623675646366
T98G,8515,4.706991436731757
BICR 31,3503,3.4488620791118993
SK-CO-1,3062316,0.5910144260309655
RKN,6917907,-6.438038185084336
LS411N,23635314,4.011909681168236
SNU-1079,11625818,3.474658627000328
WM115,11234052,4.1182935305671435
Granta-519,tanespimycin-gemcitabine (1-1 mol-mol),-7.490554088908799
KHM-1B,452548,-2.125621480774164
U-BLC1,2733526,2.7182337044029956
SW948,JQ-1-navitoclax (2-1 mol-mol),0.5901277786092829
SUP-T11,tretinoin-navitoclax (4-1 mol-mol),1.7243646590912465
RERF-LC-MS,11485656,1.5190166417661397
TTC-709,tretinoin-navitoclax (4-1 mol-mol),4.586206074075149
MKN1,crizotinib-PLX-4032 (2-1 mol-mol),2.897540970267357
PaTu 8988t,46224516,2.924922546378164
Granta-519,JQ-1-vorinostat (2-1 mol-mol),0.0738956362017292
SK-CO-1,5287620,-2.837552470898679
PaTu 8988t,24772860,-1.5593380796956875
PaTu 8988t,6184667,3.5063575702163345
SK-MEL-2,444795,5.015543431579257
KP-4,72193870,3.911224578217445
BICR 22,36462,0.4717839486114671
RKN,16722836,2.340122812915413
Panc 02.03,54618164,4.482290203520866
SNU-1079,navitoclax-pluripotin (1-1 mol-mol),-2.6270800854345917
F-36P,tanespimycin-bortezomib (250-1 mol-mol),-0.3225177069442169
BFTC-909,2841722,4.3094465275997536
COR-L105,2746,3.1035280268076217
IGROV-1,9929138,6.483056540257463
SEM,100016,5.238818929389881
SEM,5470400,1.0027675108194032
HCC1500,2708,5.151987441269929
JHUEM-7,1242560,3.5007407035321285
MOLM-13,11238147,1.4582306649534449
RERF-LC-MS,11364421,-3.8493036468537265
ML-1 [Human thyroid carcinoma],100016,6.6260589736745015
KMS-21-BM,135440466,0.8624587471080704
LMSU,vorinostat-navitoclax (4-1 mol-mol),3.537964387470637
RERF-LC-MS,16736978,2.30801467798398
U-BLC1,44507138,1.539075765950521
LS180,44241473,4.435457667187811
SW48,16722836,0.2197322523934369
KLE,24951314,0.9154688182188032
NCI-H2452,9444,3.5242093703527697
SU-DHL-1,5284616,2.4488241799592143
K-562,54454,3.689215856042272
Hep-G2,400769,-0.0290927499508633
HEL,2945648,2.719646445320408
ML-1 [Human thyroid carcinoma],selumetinib-JQ-1 (4-1 mol-mol),1.6383064835611996
SNU-C2A,20959075,-3.228730062166683
HuP-T3,9936388,0.6940852338085793
LCLC-97TM1,10427712,4.124790087544491
ES-2,56946209,-2.425806993878322
LMSU,crizotinib-PLX-4032 (2-1 mol-mol),1.7173193927866348
T98G,piperlongumine-MST-312 (1-1 mol-mol),3.1297474091235618
SK-CO-1,navitoclax-sorafenib (1-1 mol-mol),1.5561836215711824
L3.3,5978,-0.2603821575839845
SW1271,135398738,5.657599080768866
RKN,216468,4.351451769225332
SEM,5284616,2.3626206201017292
SW1271,46224516,1.263100640010589
SK-OV-3,60750,-4.210978436614257
SU-DHL-1,11455910,0.1271925880707346
Granta-519,25161177,3.429453868131532
PaTu 8902,SNX-2112-bortezomib (250-1 mol-mol),1.6303309640570394
SEM,451668,-2.438792361971123
COR-L105,erlotinib-PLX-4032 (2-1 mol-mol),-0.0740461614956173
UACC-812,16065773,1.9582746458630844
MOLP-8,2858523,3.112163707938977
ML-1 [Human thyroid carcinoma],6252,2.036085666454029
KMS-21-BM,44241473,4.497358254483185
IGROV-1,6505803,-0.2382223795960626
HEL,24772860,-2.0205510075596425
HCC15,4917,3.2753021602409267
HEL,ISOX-bortezomib (250-1 mol-mol),0.0125517502363375
KP-3,JQ-1-navitoclax (2-1 mol-mol),-0.7188723962167386
P31/FUJ,6184667,2.9500590386465393
MOLP-8,46843906,0.174682801852784
PE/CA-PJ49,11175137,3.1314905920742455
KLE,selumetinib-GDC-0941 (4-1 mol-mol),2.44507657684364
NCI-H2452,54618305,4.302077073898344
SNU-626,44259,1.945603979901704
JHUEM-7,168312962,3.604501244150348
BICR 22,8515,4.348804794701894
TTC-709,135928012,3.664410481857117
COR-L105,24821094,-1.121187296223131
HCC1500,4788,5.676843976237076
KLE,5329102,2.881910158775446
SK-HEP-1,2746,4.04921422913523
HuH-6,9929138,4.876929493574036
SEM,4521392,4.258271706242731
Granta-519,tanespimycin-bortezomib (250-1 mol-mol),-0.1680583743842791
YD-15,11507802,1.1213694026202092
SK-MEL-2,3081361,3.50261592652662
COR-L95,46199207,3.11604668311128
MOLM-13,1641662,2.418131669664625
L3.3,11640390,3.7293417266479905
Hep-G2,11612883,2.6533620783645935
WM115,135984461,4.094268409164816
BT 440,25262965,0.3946823652462949
SNU-886,24753719,3.844666745133929
LS411N,10127622,0.4126946340819594
YD-15,60750,-2.9092059205045264
HARA [Human squamous cell lung carcinoma],11497983,-2.5330413808054333
ALL-SIL,11364421,-5.245070547120315
HT-1376,654092,-0.1457262155674299
NCI-H1568,44607531,1.2688225542701184
SW1573,navitoclax-pluripotin (1-1 mol-mol),-0.8972243214684317
SW948,104842,-0.6555530305877334
LMSU,9903786,3.928631993031556
JHUEM-1,3503,1.2922966298686496
JHUEM-1,11964036,0.8028232405792006
KLE,selumetinib-UNC0638 (4-1 mol-mol),3.976187739409722
SK-CO-1,46907787,4.316773762169295
HuP-T3,104842,-2.1883971380944054
KMS-21-BM,16219061,1.7270412477516754
IGROV-1,11178236,-2.8618715106425725
PE/CA-PJ49,65628,4.299223683644022
BT 440,15953870,4.656274496952199
KLE,11427553,3.3715856930539316
HCC1500,71751553,4.671922723370954
SW1271,54618771,-0.1319273231055389
KMS-21-BM,25126798,3.2528646246897375
SNU-1272,24856436,1.090216568071402
F-36P,56649450,5.044332168880629
SUP-T11,49850262,3.016833911139639
HuH-6,25183872,-0.8430971460749143
SNU-C2A,156414,1.9531845574719549
ML-1 [Human thyroid carcinoma],9952709,4.669340472029816
IGROV-1,654092,-1.340387623873854
F-36P,46224516,2.4732424760607117
HCC1500,44819697,2.691999336982048
F-36P,3634881,2.9926990074647266
HEL,44137675,4.224171499328968
MOLM-13,tanespimycin-gemcitabine (1-1 mol-mol),-4.499081483016427
L3.3,selumetinib-piperlongumine (8-1 mol-mol),4.6860683758170145
KP-3,6623618,2.3974496839813897
COR-L95,5328940,2.113977806947162
SK-OV-3,3825829,4.139200001280225
ST486,2749,-0.7953734395880836
F-36P,71576739,4.326981219717783
KHM-1B,11238147,1.9683528585931505
Panc 02.03,216468,3.8655539989600176
SEM,5978,-6.46174172667932
SW948,25195348,3.534636067330416
MOLM-13,9444,3.2439366633039426
NCI-H1568,24821094,1.7576462865100984
MOLP-8,1566236,0.7132031003128095
ST486,72199292,0.5994138995543464
SUP-T11,637858,1.0076857486222597
LMSU,10127622,5.3178116835445195
HuP-T3,11455910,1.0919804440303738
MDST8,44185566,3.0590843033834116
NCI-H2452,216345,4.1608899350266615
KHM-1B,54618305,4.409714485426553
KPL-1,11167602,3.344088823698267
SaOS-2,23635314,-2.530968731721941
MOLP-8,selumetinib-MK-2206 (8-1 mol-mol),0.6863734484808788
LS180,168312962,-1.039638615515642
KP-4,7326481,3.199087253558539
BFTC-909,crizotinib-PLX-4032 (2-1 mol-mol),2.7598509436067906
T98G,2708,5.5833460783973035
ES-2,9936388,2.136137651865657
SNU-1079,12001922,1.6663555364591485
BT 248,24753719,4.394714770526552
T98G,12003241,-0.2247982599387034
BICR 22,322968,4.6496227244818416
JHUEM-1,11707110,3.02510139776913
PE/CA-PJ49,7251185,2.6979125423033743
NCI-H1568,vorinostat-carboplatin (1-1 mol-mol),1.5719417416558872
RKO,6918837,-1.4612228483082623
PK-1,navitoclax-pluripotin (1-1 mol-mol),-0.4841623002602266
MDST8,selumetinib-navitoclax (8-1 mol-mol),0.5901837965573531
EB1,25161177,3.4451323359609356
SW48,613753,3.5910736246612323
IGROV-1,44507138,2.359177395411688
WM115,52947716,-6.8465929822900815
RKN,73707398,1.136221501718042
SEM,2708,2.117173016792575
HCC1500,4477,0.2789780560390432
Granta-519,11719255,2.4006867045586953
HCC1500,6918736,0.2919336581768246
IGROV-1,4477,1.1767656777594142
IA-LM,11609586,4.073174168632335
NCI-H2452,11404337,-0.3859535574072682
SNU-626,11152667,0.4022575570601642
Daudi,136227924,1.3476403322374937
SUP-T11,10302451,3.4427567109360573
SK-OV-3,387447,-3.0618968905277164
Mino,11640390,2.9754145364619493
Mino,navitoclax-piperlongumine (1-1 mol-mol),-4.020329741894284
ST486,9825149,1.5508805572650044
ES-2,5746,1.4456234079970014
MOLM-13,3854666,0.5101644656521153
RKN,46843906,3.906010302389018
ALL-SIL,1641662,2.105441320822025
KPL-1,65064,3.126663500929914
MKN1,44137675,4.5781533866271795
MOLP-8,46199207,3.622115707782432
HEL,17755052,2.5427584711612554
F-36P,SNX-2112-bortezomib (250-1 mol-mol),-2.8512531965978467
MOLP-8,9915743,0.5160575940701332
BT 248,9549297,1.6274014594604191
NCI-H2452,135398516,0.2354885350790482
NCI-H2452,JQ-1-vorinostat (2-1 mol-mol),1.361868366541758
F-36P,8515,2.752757057086389
SW1573,9911463,3.734935340044018
P31/FUJ,selumetinib-vorinostat (8-1 mol-mol),0.1511350548351421
IGROV-1,23725625,5.712368491237602
IGROV-1,54143018,0.8385018685685798
WM115,135875424,2.968517855352779
SW948,16659841,2.968981271202921
KMS-21-BM,702558,5.10274176080169
SW48,25183872,-1.521332471338628
ALL-SIL,selumetinib-GDC-0941 (4-1 mol-mol),1.4850584156304236
RKN,selumetinib-JQ-1 (4-1 mol-mol),2.2117221190324323
COR-L105,UNC0638-navitoclax (1-1 mol-mol),1.0855753959105363
T98G,148124,3.910493124351062
Ishikawa (Heraklio) 02 ER-,135999136,1.8759825202501337
WM115,5284616,2.9108529677003565
SW948,4705,1.720002028261835
Ishikawa (Heraklio) 02 ER-,5746,1.6591878070365718
KMS-21-BM,159324,0.3673742600745772
HCC1500,71680916,4.362866442203444
PaTu 8902,17755052,3.1533076581920936
PE/CA-PJ49,2729026,3.098127456645034
HuH-6,216239,1.527323018093016
COR-L95,11427553,2.745819698220539
MOLP-8,11707110,-0.9708482925672104
HCC15,5351362,1.1207822529279785
LMSU,72193861,3.006947657487573
SaOS-2,11234052,4.364959006359101
SK-OV-3,6918837,-1.7709381590236568
RKN,10113978,4.430129932581481
L3.3,54618164,4.298111449535211
Panc 02.03,5566,2.8367562997211815
PE/CA-PJ34 (clone C12),9927531,5.274687585125943
IGROV-1,crizotinib-PLX-4032 (2-1 mol-mol),2.0296160065449858
PE/CA-PJ49,25150857,2.9621771571272246
Mino,9935249,1.3209410835927553
BT 440,selumetinib-piperlongumine (8-1 mol-mol),1.5684735933575908
Granta-519,4096211,0.4087245803445845
SK-HEP-1,72193861,3.0367238048594603
KP-4,409805,5.81471054655713
SK-MEL-2,navitoclax-MST-312 (1-1 mol-mol),1.1625570837116823
PK-1,10074640,3.4965313156927693
SNU-626,568763,0.4067723872817963
U-BLC1,15983966,1.523790527053231
YD-15,54649381,3.7380840478684183
JHUEM-1,55508,1.8606795474826463
SW948,9933475,1.7222383900333498
KLE,tretinoin-carboplatin (2-1 mol-mol),4.643010553497707
SW48,9936388,-6.68623848822316
NCI-H1568,11222830,1.5738139714037271
IGROV-1,24856436,0.4840146383282276
SW1271,25105715,2.9104912505007143
IA-LM,11238147,3.064975348903814
KPL-1,66577038,3.1283983341096393
SNU-1272,11222830,2.080284552032401
PaTu 8988t,23635314,0.3317794086663004
BT 440,227681,3.921425272704461
SNU-886,9907093,3.676979603066549
Granta-519,3136844,3.153984140395424
PE/CA-PJ34 (clone C12),71576739,4.786546039193674
KMS-21-BM,9915743,0.1101239094873029
YD-15,53232,1.0787547438377594
COR-L105,24951314,2.139685821030411
SK-MEL-2,67291369,5.211406139033099
HuH-6,9825149,1.7329165587543107
IGROV-1,135398744,6.402844237905131
LCLC-97TM1,156414,1.5907536031970133
LMSU,44137675,3.873281140485592
U-BLC1,sirolimus-bortezomib (250-1 mol-mol),-1.829710592484544
BICR 22,46926350,-6.042960620867506
DLD-1,navitoclax-piperlongumine (1-1 mol-mol),0.8943337512383943
Granta-519,387447,-5.4996124066637435
BFTC-909,51039095,2.7594177275421403
Panc 02.03,5746,2.615751109567445
SW948,71466380,3.8629020707603914
SW1573,tanespimycin-gemcitabine (1-1 mol-mol),5.2364436023498815
BT 248,16219061,2.5057647005845354
COR-L105,24856436,1.5602990639828938
K-562,327653,3.3038748071855175
SNU-1079,44819697,-2.092711584973936
T98G,168312962,-2.8443093145779685
BT 248,navitoclax-PLX-4032 (1-1 mol-mol),1.075952259913776
Daudi,16725315,3.035985748437892
LCLC-97TM1,6917907,-8.098980466082804
NCI-H2452,4261,1.8682088943565944
HuH-6,16736978,1.579124317756683
KPL-1,5329102,2.1907797755345375
JHUEM-7,12003241,-3.5765771521887246
HT-1376,54618164,4.43635672332215
YD-15,208908,0.8977694819663774
MKN1,56963564,3.299078310391665
KP-4,4378219,5.374060110087321
SU-DHL-6,241158,1.5794519300851928
F-36P,675434,3.58895421560475
Ishikawa (Heraklio) 02 ER-,16038120,2.572715910505068
SNU-C2A,44489367,4.3606755880784105
IGROV-1,9840324,5.720969888694302
COR-L95,10074640,3.0551355702246292
ALL-SIL,navitoclax-birinapant (1-1 mol-mol),-2.9890180212020265
KP-4,1641662,2.8680613425765435
BICR 31,5460769,3.9433617709959696
WM115,navitoclax-pluripotin (1-1 mol-mol),-1.858334672155358
T98G,11964036,2.3354121444114284
ALL-SIL,171352865,4.1926931777749346
PaTu 8988t,5351362,2.286773409161727
COR-L105,54618164,4.149947168538197
K-562,168312962,1.3008721680360658
NCI-H2452,3634881,3.1517111283550854
SW48,crizotinib-PLX-4032 (2-1 mol-mol),0.8715368349247399
LS411N,2858523,3.1062955336512603
NCI-H1568,65628,3.926137474064237
SUP-T11,46843906,2.3364941135202195
SW1573,25126798,4.147065453172024
SU-DHL-1,9868037,1.568771805047012
HCC15,46174525,4.292402667650191
YD-15,alisertib-navitoclax (2-1 mol-mol),-2.1992534087778317
KMS-21-BM,44202524,-0.1897884950738554
HCC15,54626689,4.436341034968849
K-562,241158,3.183928650435804
JHUEM-2,52912189,1.5837141967418469
U-BLC1,702558,5.167086295611443
HEL,400769,-1.0010167847558078
Ishikawa (Heraklio) 02 ER-,52912189,4.8748873520604805
MOLP-8,24180125,2.8280981087253605
TTC-709,57519531,1.9050673559775664
SNU-886,5738263,4.1230602968372585
SUP-T11,selumetinib-piperlongumine (8-1 mol-mol),2.552437686295228
SNU-1079,10427712,4.383281666050305
SK-LMS-1,5311,2.961845688790093
LCLC-97TM1,6918837,-2.241539398034031
JHUEM-7,4578,4.2382968636831535
SK-LMS-1,carboplatin-UNC0638 (2-1 mol-mol),4.686207896901682
SW948,52947716,2.6983492764143984
JHUEM-2,decitabine-navitoclax (2-1 mol-mol),0.2421397447687992
HuP-T3,11609586,3.0975126346448056
ML-1 [Human thyroid carcinoma],44589607,3.064794245292079
SUP-T11,selumetinib-BRD-A02303741 (4-1 mol-mol),5.665671867210259
K-562,9911830,-1.954559593888618
Panc 02.03,54454,5.027619058009229
Daudi,9967941,1.9498714635628245
U-BLC1,3038522,1.835372100438169
SK-CO-1,46224516,2.9108482414820833
IGROV-1,56963564,1.8260986108097368
Ishikawa (Heraklio) 02 ER-,54649381,3.9004704347279566
JHUEM-1,1750826,-0.0049740362174126
JHUEM-1,11656518,0.9431794289784804
SNU-C2A,10231331,2.052823285789936
PaTu 8902,119607,6.110313748168657
SK-OV-3,1750826,-0.3132155362058529
NCI-H1568,11507802,1.223292685938289
SU-DHL-1,6918736,-2.1290482192432396
MOLM-13,6252,-1.803091878000868
HuP-T3,16659841,4.694527425679891
PE/CA-PJ49,selumetinib-piperlongumine (8-1 mol-mol),4.461234490795515
SEM,73707398,-1.1402705015945305
COR-L105,135440466,2.282908830244017
U-BLC1,126941,-4.70206941784366
KLE,46199207,2.9361016730339697
COR-L105,36462,5.237060103367249
LS180,16038120,0.768362963165676
EB1,10385095,0.173257887720905
YD-15,navitoclax-piperlongumine (1-1 mol-mol),2.152589048401097
PE/CA-PJ34 (clone C12),doxorubicin-navitoclax (2-1 mol-mol),-1.5110947353726836
COR-L95,11719255,2.8113582651389684
K-562,71466380,4.109476883218819
JHUEM-1,42611257,3.298850072547284
LS411N,selumetinib-GDC-0941 (4-1 mol-mol),0.0319239505994205
LCLC-97TM1,65064,4.239331302053654
ALL-SIL,11626560,-1.2475078800938888
IGROV-1,9903786,1.7387584479757865
RERF-LC-Ad1,5282054,4.000708411224595
PE/CA-PJ34 (clone C12),426756,4.422998932397389
HARA [Human squamous cell lung carcinoma],119607,5.240910567943734
LMSU,8515,4.269991680871031
L3.3,11364421,-3.724172704719069
UACC-812,3025944,3.7003704595595894
HCC15,52912189,2.9796194932949875
SK-CO-1,24951314,2.193758155281627
IGROV-1,208908,2.822483792004996
BICR 31,2945648,3.0787524499283023
Mino,168312962,1.3879343762134344
SK-LMS-1,1566236,1.8712285641000048
WM115,11485656,3.738489726762909
IGROV-1,126941,-2.246216453812328
KU-19-19,135411,0.3258457054887789
PaTu 8988t,tanespimycin-gemcitabine (1-1 mol-mol),0.132721029617077
P31/FUJ,BRD-K27188169-navitoclax (2-1 mol-mol),0.0086353275600694
MOLP-8,25105715,3.7016775455761968
IGROV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0361645465839266
NCI-H1568,25126798,3.633705991567496
LCLC-97TM1,3689413,0.1289764847745495
L3.3,135421197,2.5730452840447415
BT 248,tanespimycin-gemcitabine (1-1 mol-mol),-1.6636234476811602
SW48,5311,0.4861581581750583
LS180,409805,6.164182483443964
ES-2,23635314,-1.1826434002020858
ALL-SIL,17759555,3.7861470032844418
K-562,7326481,2.6072018104551824
SK-CO-1,8515,5.207883928071115
Ishikawa (Heraklio) 02 ER-,702558,5.602486252148638
NCI-H1568,439501,-2.6831567396736022
SNU-886,2742550,3.913973677845718
BICR 31,3634881,3.594506321194918
KU-19-19,656346,4.826208082880011
JHUEM-1,24964624,1.092857964633043
SW1271,10410894,3.9794007270318903
ML-1 [Human thyroid carcinoma],3689413,0.6725245747839163
SK-MEL-2,9927531,5.603550958927875
SK-HEP-1,16722836,2.576451725849178
RERF-LC-MS,10113978,3.210216765519601
LS180,54454,2.0147485365690945
NCI-H1568,9866186,-0.23967308205821
ES-2,17759555,3.753383150292029
DLD-1,159324,3.5449234505854617
SNU-1272,doxorubicin-navitoclax (2-1 mol-mol),1.2550263816124974
IGROV-1,10302451,0.4135234554742116
BT 440,5351362,1.6083738532082363
ST486,56649450,2.8393289579122265
KP-3,docetaxel-tanespimycin (2-1 mol-mol),-4.050413146410149
SK-LMS-1,73707398,1.7151608604294482
PaTu 8988t,9935249,3.4642640806067897
HuP-T3,65064,5.168937665689206
UACC-812,JQ-1-carboplatin (1-1 mol-mol),1.7132070182589942
SK-LMS-1,2729026,3.0741249685189564
YD-15,10231331,1.0782876966297934
KHM-1B,5351362,0.671182618644872
LMSU,4521392,4.5371268680912715
LCLC-97TM1,44543605,5.020704141539917
KU-19-19,3062316,3.300727237006398
IA-LM,54143018,6.360653223606267
HuH-6,6918837,-4.3994554580915635
SK-MEL-2,5329102,3.2571933996041778
HCC15,JQ-1-carboplatin (1-1 mol-mol),2.0328384477438477
SNU-886,49766530,-1.8017914460493445
T98G,11222830,2.678415479738944
EB1,2874250,4.4611678654559865
PaTu 8988t,11497983,4.771256524847766
IA-LM,7326481,3.2597510497719964
MOLP-8,57519531,1.794840771759573
Panc 02.03,387447,-4.21908064053878
Panc 02.03,9866186,1.4364847380387245
BFTC-909,56946209,-2.8280109825858943
K-562,46843906,1.6079735978006011
IGROV-1,3038522,3.6829378423722416
JHUEM-2,8515,1.9041010044405784
COR-L95,9933475,1.8209744616881691
NCI-H1568,54613361,-1.9115789745186575
U-BLC1,613000,1.1863048151740705
MKN1,89928392,3.2577399837426055
PaTu 8988t,11178236,-5.843883599227575
SNU-1079,5284616,2.5769122780902296
MKN1,387447,-4.833530002955664
IGROV-1,24856436,0.4840146383282276
HEL,5746,-1.0378501544368317
NCI-H1395,613753,3.1434817827730126
LS180,216345,2.343571728213523
MOLM-13,11234052,1.8885372726820036
HuH-6,56649450,3.603251341445418
Mino,navitoclax-PLX-4032 (1-1 mol-mol),-3.680255642878147
ES-2,151289,4.793001662093722
KMS-21-BM,5329102,1.0923990592487922
PE/CA-PJ49,9911463,4.148173895384107
IGROV-1,656346,1.6285470744333117
KPL-1,12001922,1.6797775385183875
IGROV-1,613753,3.483244781428779
SUP-T11,57519531,1.317983427818355
JHUEM-1,navitoclax-gemcitabine (1-1 mol-mol),-3.7548343935956456
RERF-LC-MS,44632017,0.7768655843829712
LCLC-97TM1,10113978,4.598206277837053
LS180,136227924,2.415770069388299
Granta-519,5978,-7.678617575463935
HT-1376,9911830,2.852403545688706
MOLM-13,2828334,5.861258184508348
ALL-SIL,3815108,1.81429533281988
DLD-1,44185566,2.811135200166793
KP-3,60700,0.3100676828218605
NCI-H2452,serdemetan-SCH-529074 (1-1 mol-mol),2.3569369644908535
LS180,10385095,1.937933801431244
SW1271,7326481,3.1173859417421985
COR-L105,176870,-0.2151307909405896
IGROV-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1366391073371296
HEL,6918878,-0.4197772532459504
RCC10RGB,44589607,3.0966280095343777
RKN,ISOX-bortezomib (250-1 mol-mol),1.0286936108605995
SW48,89183176,5.513741245898386
KU-19-19,168312962,-2.211081322704064
HT-1376,10296883,4.451130716286632
LCLC-97TM1,11656518,-4.424964199082896
ML-1 [Human thyroid carcinoma],426756,5.157831333984941
SW48,decitabine-carboplatin (1-1 mol-mol),4.347409294464919
WM115,6918328,0.4200257259119496
BT 248,5566,1.2795658146577915
RKO,44491742,4.905526099010324
SU-DHL-1,5280436,3.4353188558540895
SW1271,BRD-K27188169-navitoclax (2-1 mol-mol),3.98136464619854
P31/FUJ,702558,3.294053878414949
KP-3,44137675,4.427212794850303
KMS-21-BM,168313047,1.4363273339695688
MDST8,322968,3.292336134337166
BT 440,753704,4.950533803828191
MOLP-8,66577038,2.4807994544381997
HT-1376,5278396,3.7669393819764823
NCI-H2452,216239,2.289885444542123
PE/CA-PJ34 (clone C12),SNX-2112-bortezomib (250-1 mol-mol),-3.0590637711179745
TTC-709,11257553,-0.8131051227687436
LS411N,24951314,1.1768436480242177
HCC15,5291,3.948819619575577
RERF-LC-MS,11152667,0.0782441689403026
ES-2,5328940,1.859721793728659
NCI-H1568,285033,-1.965656578387781
K-562,119607,4.708269214175102
MOLM-13,6918328,-1.6668605659600593
KP-3,navitoclax-gemcitabine (1-1 mol-mol),0.6027161328228624
HuP-T3,51039095,3.318948357155543
COR-L105,3025944,3.915005293474353
KPL-1,3552672,2.1892318240826376
SEM,24951314,-1.2286603360441832
SK-CO-1,carboplatin-UNC0638 (2-1 mol-mol),2.9632424574107157
NCI-H2452,42642645,0.8357005775142816
JHUEM-7,24785538,0.0330026249712562
PaTu 8988t,67156097,0.822255948885768
SUP-T11,2746,2.7508028515684457
U-BLC1,tanespimycin-gemcitabine (1-1 mol-mol),-1.5705928550505033
TTC-709,1750826,-3.242771164481537
P31/FUJ,44507138,1.0120664141515707
SK-OV-3,sirolimus-bortezomib (250-1 mol-mol),1.4473324892897623
KLE,4259181,-0.0203780302150134
DLD-1,119607,6.054477005887703
COR-L95,vorinostat-navitoclax (4-1 mol-mol),-0.3281165082224372
Ishikawa (Heraklio) 02 ER-,135875424,3.942443711237878
ST486,5287620,-1.993928263418247
HCC15,10074640,3.1199478074334106
IGROV-1,53392493,2.352084848618059
SNU-C2A,docetaxel-tanespimycin (2-1 mol-mol),-4.878719718471239
EB1,2945648,1.2258603616537027
JHUEM-2,5278396,2.3746292485034624
KMS-21-BM,JQ-1-carboplatin (1-1 mol-mol),-1.6939988291679535
SNU-626,navitoclax-MST-312 (1-1 mol-mol),1.0574029794758384
SUP-T11,216345,3.6918544121726975
MKN1,135440466,2.7498911773134864
SK-HEP-1,135398516,1.8011759760648425
KPL-1,9911463,4.601591010161613
JHUEM-1,16725315,3.2288191751295687
KHM-1B,54626689,4.681502909310955
HCC1500,tretinoin-navitoclax (4-1 mol-mol),-0.6846797821009611
JHUEM-2,10302451,3.19057171364304
HuH-6,3038522,2.688784684462247
SUP-T11,10385095,2.0290179128287007
BT 248,56649450,1.4607260014057133
KP-3,11364421,-2.308711634729733
IGROV-1,1242560,3.902441161940491
BT 248,5329102,2.143317374155595
MKN1,9927531,4.774967251580727
IGROV-1,24901704,3.0789156375765936
T98G,44607531,1.7337343242448844
RERF-LC-MS,23635314,-3.639251677232653
KU-19-19,56946209,-3.434845070293707
SK-CO-1,11427553,2.3636745936222177
JHUEM-2,11626560,-0.5749699268365027
KMS-21-BM,56946209,-5.051963270946794
T98G,JQ-1-vorinostat (2-1 mol-mol),1.426628741893284
PK-1,5311,2.50359623507105
SU-DHL-1,erlotinib-PLX-4032 (2-1 mol-mol),3.622151043319632
JHUEM-1,54143018,0.8018738829157932
PE/CA-PJ49,60700,-1.538607521999755
Panc 02.03,6852167,4.143336119644561
SEM,tretinoin-carboplatin (2-1 mol-mol),1.6069371738870424
NCI-H1568,26596,-1.690126811671561
SNU-1079,136227924,2.5648904820695693
ALL-SIL,100016,4.099229681419155
EB1,6610355,3.41827000102518
SW1271,navitoclax-pluripotin (1-1 mol-mol),-0.6532328489926583
KP-3,2858523,2.682785783367065
BICR 22,219104,4.618531153522784
HuP-T3,4378219,2.0668857590794767
IGROV-1,11647372,-0.6595372928368528
EB1,135875424,2.5798652139486262
T98G,9936388,2.8447022467541956
KPL-1,2949965,3.4532679037376135
HuH-6,docetaxel-tanespimycin (2-1 mol-mol),-0.1435637008128255
Ishikawa (Heraklio) 02 ER-,10074640,3.7564128770227128
BICR 31,46843906,2.802485697538939
KLE,252682,6.230481421217852
SW1573,navitoclax-piperlongumine (1-1 mol-mol),1.792577527221854
HARA [Human squamous cell lung carcinoma],44202524,1.300312464104863
DLD-1,10074640,3.49796281607235
KMS-21-BM,9967941,3.3416900704621892
NCI-H1395,984333,2.1058514684040373
PaTu 8902,65064,4.553320484088526
NCI-H1568,10410894,1.924104691976128
SUP-T11,44491742,3.738526329456195
L3.3,3038522,4.529448646795259
SU-DHL-1,72376,-3.386078956410557
SEM,10184653,-0.2676312474090645
BFTC-909,JQ-1-UNC0638 (2-1 mol-mol),2.2684379316791112
NCI-H1568,16659841,3.88074746768202
SNU-626,969516,3.2987212456413983
LS180,selumetinib-vorinostat (8-1 mol-mol),0.5678514609289822
LS411N,54618164,4.167426775220608
MOLP-8,5287969,-2.4943575090146903
Granta-519,24856436,-2.399051702227432
SK-OV-3,JQ-1-navitoclax (2-1 mol-mol),0.6239682404577798
BICR 22,3689413,1.1307119933583345
SW948,11494412,0.3616963479580831
RCC10RGB,3552672,3.073432883089278
KP-4,2841722,2.399493182490819
LCLC-97TM1,72376,-4.375427192181232
BT 440,crizotinib-PLX-4032 (2-1 mol-mol),2.304194720852551
NCI-H1395,44589607,3.310256586301432
SW948,11234052,4.776317924055416
P31/FUJ,89928392,-0.2575535361410093
JHUEM-2,5284616,-5.292653335073235
JHUEM-7,2874250,4.229178527781167
SK-HEP-1,ISOX-bortezomib (250-1 mol-mol),0.2987916672751671
PE/CA-PJ34 (clone C12),5978,-4.144154525901269
MDST8,piperlongumine-MST-312 (1-1 mol-mol),2.167739236118489
HuP-T3,selumetinib-JQ-1 (4-1 mol-mol),1.2883856318712232
EB1,2949965,2.498098378788564
KP-4,11167602,1.7428553982677493
NCI-H2452,2742550,5.209305166760603
SW48,9884685,-1.5395746259931604
SU-DHL-1,16722836,1.4294085247204618
KP-3,44607531,1.6245069102773584
MOLP-8,11640390,2.6566405323234057
F-36P,60750,1.9702196024292824
RKN,5113032,5.131058822839954
TTC-709,selumetinib-piperlongumine (8-1 mol-mol),2.734040339854076
Panc 02.03,5311,2.7910052639268415
Mino,2749,1.4659801307247888
HuP-T3,36462,3.380707637397105
IGROV-1,tanespimycin-gemcitabine (1-1 mol-mol),-0.5447128478899342
K-562,6852167,3.2696177089982807
KU-19-19,16725315,4.810213458660102
SNU-626,9866186,1.710437745008194
KHM-1B,navitoclax-MST-312 (1-1 mol-mol),1.4754840901416553
Daudi,44819697,-3.048561633253287
SUP-T11,BRD-A02303741-navitoclax (2-1 mol-mol),2.8627646198065593
DLD-1,12003241,-0.215038024432674
NCI-H2452,73707398,1.4673083704761625
JHUEM-7,16659841,3.5134635694670524
SU-DHL-1,6438330,0.8462618394668467
PaTu 8902,carboplatin-etoposide (40-17 mol-mol),6.0931927841576385
IGROV-1,400769,-0.5589612210030486
PK-1,44589607,3.1512466627677043
KHM-1B,969516,2.482442021285449
PaTu 8988t,6918736,-0.015847459349983
NCI-H2452,12003241,-1.7557808561862691
SEM,11485656,1.8495119352561953
SW48,89928392,0.7467993581529679
U-BLC1,16722836,0.7525696969876507
HARA [Human squamous cell lung carcinoma],135875424,5.177992671051203
NCI-H2452,71466380,5.164331301376758
Mino,45279963,2.5079787628894095
SEM,4705,3.2789499070594816
L3.3,151289,1.4499844825237675
SNU-1272,6918328,1.7738060965296416
Panc 02.03,4917,3.7856869354758342
SW48,25062766,1.0755009410821956
IGROV-1,4259181,0.1937358171291443
BICR 31,46926350,-4.294934659479777
Granta-519,72199292,2.8103945289975623
HT-1376,5280436,4.9332457975722255
HARA [Human squamous cell lung carcinoma],216239,2.4828561148565256
MOLM-13,11222830,0.9845802392597008
KMS-21-BM,11612883,1.4885315512381632
SK-HEP-1,676352,1.798347685811885
TTC-709,9911830,1.1400887698585542
SK-CO-1,36314,-5.371942323616045
ES-2,carboplatin-etoposide (40-17 mol-mol),4.526573896050496
P31/FUJ,71466380,4.574945433624961
PaTu 8988t,11427553,3.005069211450264
ML-1 [Human thyroid carcinoma],1566236,3.1920996771286783
SEM,44620216,4.3298868043431975
NCI-H1568,151289,0.8908355813530987
F-36P,46199207,2.368310242564922
SK-MEL-2,4378219,3.1510075145048644
NCI-H1395,44493528,4.373197971838804
SW48,216345,1.323366684487305
SK-HEP-1,44819697,-0.1381867301228731
BFTC-909,24951314,2.3445794180209565
SK-CO-1,107985,-2.728069079888901
BICR 22,168313016,4.910867780923905
BT 248,400769,-0.0166923245796401
SW48,3025986,-2.1875732043663048
HEL,SNX-2112-bortezomib (250-1 mol-mol),-2.046606544409741
UACC-812,erlotinib-PLX-4032 (2-1 mol-mol),1.674253271447935
EB1,11213558,1.3510910525816116
HCC15,446155,0.1844871361320988
SNU-886,5328940,2.5802660020848696
SEM,navitoclax-piperlongumine (1-1 mol-mol),-2.550226748715502
Hep-G2,67291369,4.476639132471762
LS180,sirolimus-bortezomib (250-1 mol-mol),1.3360442889009512
KPL-1,5280436,3.9032634384023743
BFTC-909,56963564,-0.1720168824982637
MOLP-8,151289,0.9447515089929442
HEL,11609586,2.7821230127549663
ML-1 [Human thyroid carcinoma],66577038,3.490614785347513
F-36P,4705,3.5916410235221914
F-36P,selumetinib-decitabine (4-1 mol-mol),-1.3332642026766797
SW948,46174525,3.747184504681747
SNU-886,46215462,1.5878302383488252
HCC15,11964036,0.8100768326008368
ES-2,11222830,1.3693170327807695
KP-3,104842,1.565525323326621
L3.3,11455910,1.84757483649511
SK-OV-3,53232,3.610813443380856
NCI-H2452,9884685,3.2183676658345868
JHUEM-2,JQ-1-UNC0638 (2-1 mol-mol),0.8927043841340346
SK-LMS-1,135398516,2.231011064072704
SNU-1079,5566,2.050710363209893
ST486,selumetinib-decitabine (4-1 mol-mol),-2.2697868205556246
RKO,navitoclax-MST-312 (1-1 mol-mol),1.4157691797100402
K-562,44241473,4.342180714885996
ST486,44202524,0.9490798425716136
KLE,6918878,2.1026972133129616
HCC1500,65628,4.452955395596753
LMSU,44819697,-1.5946135282515452
SNU-1079,11238147,1.9497965944049616
KMS-21-BM,doxorubicin-navitoclax (2-1 mol-mol),-2.647301540184773
MOLM-13,24771867,-2.755307399303063
KMS-21-BM,9929138,2.832243377547389
U-BLC1,16720766,0.7781478113221788
RERF-LC-MS,168312962,0.3496483928324376
PE/CA-PJ34 (clone C12),56646779,4.7380779869722565
SU-DHL-1,carboplatin-UNC0638 (2-1 mol-mol),2.541711165237938
SNU-C2A,6918837,-2.7431403449963616
NCI-H1568,44589607,2.521775448277625
ALL-SIL,selumetinib-UNC0638 (4-1 mol-mol),2.881146238835363
Granta-519,5280436,1.7342596657129103
BT 248,135421197,1.5349499708791383
NCI-H1568,72199292,0.3941551729128716
SK-CO-1,439501,-2.410857533331093
EB1,5287620,-2.285493379573639
Daudi,selumetinib-decitabine (4-1 mol-mol),-0.4974612156096017
BT 248,11955716,-0.8129800870812356
PaTu 8902,3038522,3.855914834510199
SU-DHL-1,159324,0.2044468524757833
BFTC-909,46398810,2.674147192871529
LCLC-97TM1,148198,-1.8422045751990368
MOLM-13,selumetinib-MK-2206 (8-1 mol-mol),0.4118015123896347
SNU-1079,11364421,-1.691429911719842
LMSU,445455,5.438135882086382
Mino,12003241,-3.278689335869641
DLD-1,tretinoin-navitoclax (4-1 mol-mol),1.183729340050916
DLD-1,11427553,3.4621884891025645
LS180,5351362,1.0497784443121565
BT 440,10410894,4.394694630492757
NCI-H1568,5311281,2.6261557759532974
F-36P,54626689,5.186614622996473
NCI-H1395,1566236,2.7287407900944056
EB1,64971,1.8404065827281355
SW1271,44589607,3.6432775089048888
RKO,54143018,-0.3751060369564643
F-36P,31703,-0.6948335920003059
COR-L105,44607530,0.5885750535327339
RKO,navitoclax-pluripotin (1-1 mol-mol),0.0128409422156563
KP-4,44632017,0.4169327779251814
SNU-1079,3689413,-2.2789240635037182
YD-15,3689413,2.243668996765499
Granta-519,serdemetan-SCH-529074 (1-1 mol-mol),-1.751418488769959
SW948,387447,-4.931777613053621
BICR 31,168313016,4.3680397842259095
LS411N,36314,3.823716751686664
KLE,448949,0.9264382828941904
IA-LM,JQ-1-vorinostat (2-1 mol-mol),1.5927237168826456
F-36P,selumetinib-BRD-A02303741 (4-1 mol-mol),0.9142285794551278
MDST8,67291369,1.5579520311273356
RERF-LC-MS,3062316,3.070306969339253
NCI-H1395,4788,5.899577984060707
LMSU,53325874,5.502506435516271
COR-L95,doxorubicin-navitoclax (2-1 mol-mol),-3.6271325367233977
ML-1 [Human thyroid carcinoma],navitoclax-gemcitabine (1-1 mol-mol),0.4874661343054459
JHUEM-7,100016,7.782886537779513
WM115,JQ-1-vorinostat (2-1 mol-mol),1.1090035526940631
MOLP-8,11964036,0.2292639686830329
RKN,66577038,3.4891743358782104
U-BLC1,6184667,2.85232076203662
PaTu 8988t,5978,-2.779195325360685
ST486,11494412,-0.4970972218954756
RKO,8515,4.32265921632429
ST486,4477,-0.0068179595424039
PK-1,5311281,1.0400183204235465
BT 248,11656518,0.6524098808252552
SU-DHL-1,46907787,0.92481130470373
KP-3,selumetinib-navitoclax (8-1 mol-mol),2.211509493209915
COR-L95,216468,4.837628080392179
F-36P,5470400,3.982294766439691
KHM-1B,54686904,3.578603716754377
SW948,462382,0.505941174695894
NCI-H1568,448949,1.6827994040181535
SEM,UNC0638-navitoclax (1-1 mol-mol),-2.575766799282578
Mino,selumetinib-MK-2206 (8-1 mol-mol),2.9443567582650565
KMS-21-BM,448949,-0.828417634129244
ST486,11647372,3.197564701661412
ML-1 [Human thyroid carcinoma],11626560,2.2482240841306123
JHUEM-2,1750826,-0.8084473826797756
NCI-H2452,10184653,1.4868368660739673
NCI-H2452,1285940,4.318373702463549
ES-2,doxorubicin-navitoclax (2-1 mol-mol),-0.3131769481215617
YD-15,25102847,2.8760891538152684
SW48,52912189,0.0060801339095902
RERF-LC-MS,46926350,-4.177207395055215
P31/FUJ,5978,-3.805650321394954
Daudi,4917,1.6956741153412938
PE/CA-PJ49,25227462,0.930346704481828
KLE,49836020,-2.0520357560351714
SNU-1079,9936388,-2.1340211532610636
LS411N,44507138,1.8249335905604152
MKN1,11964036,1.5257236423871017
RERF-LC-MS,10231331,0.9954911948227504
HCC15,4261,-0.2961876318733478
U-BLC1,11152667,-2.158849665870786
P31/FUJ,16722836,0.3472605187822769
MOLP-8,45279963,3.839697844480557
KP-3,16038120,0.6576831184951375
NCI-H2452,446155,1.665772886963468
PE/CA-PJ34 (clone C12),44566777,1.0686416610033969
YD-15,51039095,2.088207446291658
NCI-H2452,11609586,3.752552997604344
F-36P,49836020,5.768901368593018
ML-1 [Human thyroid carcinoma],54618771,2.3801125351223105
KPL-1,11485656,3.597830436123724
SNU-886,107970,2.7037771874608034
IA-LM,9933475,1.89794527933904
LMSU,25195348,4.0264247432996365
KMS-21-BM,11234052,2.808205267318747
LMSU,5281321,-2.8892706249231512
MOLP-8,4477,0.6768027916096236
SK-LMS-1,445643,5.376306507638801
HuH-6,71304818,0.9049083356963504
IGROV-1,42642645,0.3750175292659389
IGROV-1,6852167,1.5305143027352028
Daudi,5287969,-2.32062356362434
WM115,44607530,1.3586937130527126
PK-1,9911463,3.7695460947373784
PK-1,44486219,4.390979591513839
SU-DHL-6,5291,3.0098231219330422
IA-LM,53392493,3.818463276064527
JHUEM-2,vorinostat-navitoclax (4-1 mol-mol),-0.222805583889726
MOLP-8,5328940,1.3442597724286955
PE/CA-PJ49,49867926,3.991551266826087
EB1,44202524,0.6042218152637404
KMS-21-BM,44493528,3.35720206113814
JHUEM-1,JQ-1-UNC0638 (2-1 mol-mol),2.1134146661867694
Hep-G2,9956119,4.422188514955625
NCI-H1568,11626560,1.7284579168385834
NCI-H1568,9967941,2.084939505363619
BICR 31,24856436,1.9770307243044476
BT 440,11213558,-0.1333691938077855
SEM,BRD-A02303741-carboplatin (1-1 mol-mol),3.6880829932604247
LS411N,6918289,4.168112514533401
JHUEM-2,135440466,0.8817545740336474
SK-CO-1,49766530,2.416603727276247
KP-3,ISOX-bortezomib (250-1 mol-mol),0.9487064821537566
JHUEM-7,5278396,3.6718347402198614
KMS-21-BM,4378219,1.5147595639547715
LS180,15547703,3.0095925001469577
PK-1,135875424,4.5989103647070655
SK-CO-1,24771867,2.6665073598645086
MOLP-8,17755052,-0.3093261728985458
KP-4,46907787,2.8983323327312185
HARA [Human squamous cell lung carcinoma],SNX-2112-bortezomib (250-1 mol-mol),-1.7614271905544292
NCI-H2452,6610216,4.12804282735119
HuH-6,5280436,2.9275981120441914
KP-3,135440466,2.589306452051924
SNU-626,60750,-1.9130183412328177
RERF-LC-MS,16065773,2.958049600168222
SaOS-2,6610216,4.351676798413151
SNU-C2A,alisertib-navitoclax (2-1 mol-mol),1.585762295181068
JHUEM-2,374536,0.0061662785812
RERF-LC-MS,navitoclax-sorafenib (1-1 mol-mol),1.552996311194731
COR-L95,BRD-A02303741-carboplatin (1-1 mol-mol),4.777626447761979
BT 440,5566,2.820994828751823
SUP-T11,decitabine-carboplatin (1-1 mol-mol),2.7668599588299685
NCI-H1568,3854666,0.7326561551321923
DLD-1,11507802,1.3645838508030357
MKN1,3854666,3.3252090270596777
SU-DHL-1,11404337,-0.9851913382580488
KMS-21-BM,25195348,2.6027570158244746
HARA [Human squamous cell lung carcinoma],2708,4.268843127757034
ES-2,54626689,4.486863219854404
K-562,2746,2.4328857060914797
JHUEM-7,53232,2.6111749392558985
SEM,3503,1.134942375896238
JHUEM-7,49793307,-5.223906833613333
YD-15,SNX-2112-bortezomib (250-1 mol-mol),-2.7745345900255405
BT 440,16722836,1.263789066380882
Daudi,16038120,0.2901991168563289
TTC-709,46199207,1.8770300667411073
PK-1,11427553,2.9727347194864917
MOLM-13,71466380,3.777949844495899
Panc 02.03,11955716,-1.8470517927785437
PE/CA-PJ34 (clone C12),9826308,-1.235624594971424
LCLC-97TM1,2858523,3.382646598163124
T98G,2871966,0.731673517379508
PE/CA-PJ49,3854666,0.40608223824848
SK-HEP-1,11234052,4.66363668535284
Mino,5281672,4.71014536336946
DLD-1,5282054,3.832789586870085
HCC1500,322968,2.559368987278369
ES-2,52947716,-5.215887067196087
DLD-1,alisertib-navitoclax (2-1 mol-mol),-0.5215358119684363
COR-L95,24772860,-0.7858558168975444
HuH-6,selumetinib-navitoclax (8-1 mol-mol),3.0671761792821632
RKN,selumetinib-navitoclax (8-1 mol-mol),4.166323835760914
SW1271,89928392,3.428275427880058
BT 440,16659841,1.5360362531463712
RCC10RGB,24821094,3.8097926200280225
HEL,24753719,3.7144242054355985
LMSU,71304818,3.266059532186748
K-562,445091,4.14956176193418
MKN1,decitabine-navitoclax (2-1 mol-mol),3.366532141361876
HEL,136227924,2.725456875957553
IGROV-1,carboplatin-etoposide (40-17 mol-mol),3.2860353297411256
LCLC-97TM1,159324,3.194316902825419
KP-4,89928392,1.096858092986786
SNU-1079,104842,-0.3441480968338176
RERF-LC-MS,57519531,1.5399611647939
KP-3,44632017,1.0979422072818712
KHM-1B,89183176,4.960393231670367
PE/CA-PJ49,24856436,0.2032813709378295
PE/CA-PJ49,285033,-1.8662670095848188
T98G,selumetinib-MK-2206 (8-1 mol-mol),3.634856449650381
BT 248,3062316,2.7315660903773606
RKO,JQ-1-navitoclax (2-1 mol-mol),1.6431758808285295
BT 440,4261,5.087140126871593
SW1573,navitoclax-birinapant (1-1 mol-mol),1.5026164736180645
T98G,6610216,4.441401687083466
HCC1500,51037431,2.242858518427135
ALL-SIL,12003241,-5.746631994241774
Ishikawa (Heraklio) 02 ER-,151289,0.7029912025232622
PE/CA-PJ49,4521392,3.9756678286917775
SNU-886,navitoclax-sorafenib (1-1 mol-mol),-7.4083537328702365
P31/FUJ,44819697,-1.8374306821299025
SU-DHL-1,tanespimycin-gemcitabine (1-1 mol-mol),-4.4382165085850405
MDST8,107970,2.8941750874079744
SNU-1079,11485656,2.444580254592115
SK-OV-3,3503,3.0304882575129497
HuP-T3,selumetinib-piperlongumine (8-1 mol-mol),4.093853736240695
RERF-LC-Ad1,676352,3.2240701362689204
HCC1500,9927531,5.051014893697188
NCI-H1395,alisertib-navitoclax (2-1 mol-mol),4.525296331369141
NCI-H2452,selumetinib-tretinoin (2-1 mol-mol),6.004763322543325
HCC15,5328940,2.162982624771584
JHUEM-1,969516,2.670782448729073
Panc 02.03,11626927,4.481877662185247
SU-DHL-1,navitoclax-gemcitabine (1-1 mol-mol),-3.283553666087357
PE/CA-PJ49,53232,2.090832638191268
ST486,135928012,3.203233778229845
EB1,10302451,0.5796206365832764
TTC-709,4917,2.4910816218197573
Ishikawa (Heraklio) 02 ER-,119607,3.862626387874781
SNU-1079,decitabine-navitoclax (2-1 mol-mol),1.240129033829544
SU-DHL-6,2749,-0.5951367082815587
HARA [Human squamous cell lung carcinoma],15547703,3.5023955614710633
SNU-1079,46943432,-0.9154654720433444
ST486,119182,-3.857205631074195
Ishikawa (Heraklio) 02 ER-,docetaxel-tanespimycin (2-1 mol-mol),-5.003723507939257
LMSU,6918837,-1.4182367040159407
MDST8,135398516,1.8788362071916904
MOLM-13,5328940,0.1532905912336842
WM115,4477,-0.2872762876800434
ALL-SIL,5746,-1.6673474530311534
PaTu 8902,25150857,2.644837375624729
MDST8,219104,3.7181204954875864
DLD-1,445643,4.0114801248547955
Daudi,11228183,2.4864875823277557
ML-1 [Human thyroid carcinoma],613753,2.773006926215127
Daudi,984333,-2.2486456844128333
Granta-519,12003241,-2.1147517064841925
Granta-519,BRD-A02303741-carboplatin (1-1 mol-mol),4.5159158584764745
Hep-G2,24797083,1.3035755936637026
SW48,387447,-4.885505238560258
TTC-709,54618795,3.0637419166326607
COR-L105,36314,4.185071185075879
KP-4,159324,2.838161812781853
NCI-H1395,11427553,4.002864688694153
HuP-T3,4705,2.7233440783632608
F-36P,BRD9876-MK-1775 (4-1 mol-mol),-0.0751422311220989
Panc 02.03,54678924,2.4878586568917536
JHUEM-1,25105715,3.4721536451173107
SNU-1079,72193861,1.702963495334008
LMSU,23582824,1.2634743444733094
KP-4,11175137,3.1941644849091024
SW1573,16065773,3.287625611468905
KP-4,24978538,2.208867172081004
PE/CA-PJ49,11647372,1.87277527539183
ML-1 [Human thyroid carcinoma],15953870,3.8046885468141016
COR-L95,10385095,1.3959867651371194
LMSU,285033,0.1916696238645653
KP-4,navitoclax-birinapant (1-1 mol-mol),2.981041559584989
PE/CA-PJ49,46926350,-4.40046738056835
P31/FUJ,2945648,2.3869646223252365
PaTu 8902,55283,3.4956890773009097
COR-L105,89183176,5.033590250009003
HEL,navitoclax-MST-312 (1-1 mol-mol),-0.4450786060493964
HCC1500,445091,4.393350110080019
SK-CO-1,11175137,2.477148698701912
SUP-T11,73707438,4.502164723236933
T98G,docetaxel-tanespimycin (2-1 mol-mol),0.5943259538816176
SK-CO-1,navitoclax-MST-312 (1-1 mol-mol),0.863563965470539
SNU-C2A,3385,5.845966499682454
BFTC-909,54618771,2.8225313881877545
HCC1500,73707398,0.9868057798362108
BT 248,72376,-0.6579483524735774
Mino,44137675,2.4793232831617944
LMSU,26596,2.3008598244356935
PE/CA-PJ34 (clone C12),5738263,2.3523932159562144
WM115,135398516,0.1940094116062491
SW948,11977753,-4.015233583581633
KU-19-19,446155,2.785852834205258
BFTC-909,3854666,1.1654585644167257
ALL-SIL,327653,2.0915878780614623
RERF-LC-MS,2749,2.1448012118135176
SK-CO-1,3503,2.662166466999906
PE/CA-PJ34 (clone C12),73707398,0.9457530769963428
JHUEM-1,119182,1.1087450300274668
IA-LM,60700,0.8821511316384938
Panc 02.03,10302451,3.706546166543765
SUP-T11,10296883,3.5958048269755114
YD-15,9935249,4.133669624082237
SaOS-2,45279963,3.893370234288743
HARA [Human squamous cell lung carcinoma],2858523,2.980861882613042
RKO,tanespimycin-gemcitabine (1-1 mol-mol),-1.448163850865836
K-562,11626560,-0.7477726232652755
PaTu 8902,252682,7.782026892174048
HARA [Human squamous cell lung carcinoma],24856436,-1.2762108597510684
HCC1500,9887053,4.8738692747205175
SUP-T11,SNX-2112-bortezomib (250-1 mol-mol),-1.3180695580223916
KMS-21-BM,6852167,0.4278382768265162
SNU-C2A,ISOX-bortezomib (250-1 mol-mol),0.185311390365168
KMS-21-BM,135421197,0.9217420053482288
SNU-C2A,5470400,-1.1018485790248675
SUP-T11,4915,4.370013268129443
SUP-T11,11364421,-6.54059335772735
IGROV-1,11717001,4.394306548697183
NCI-H2452,9911463,3.657985193851277
KHM-1B,219104,1.6531557302016933
HuP-T3,11707110,2.782188957571083
PE/CA-PJ49,5470400,0.1521447371968943
COR-L105,5287620,-2.2558017577268665
KMS-21-BM,11640390,0.2919735383310118
HT-1376,24964624,3.981542865524311
K-562,9907093,4.115761716505682
KPL-1,89928392,3.2578808369163927
SW1573,53245473,3.5468633352222287
YD-15,5287620,-2.947346188391371
COR-L95,100016,6.620829555802918
SNU-886,387447,-3.9367278767128617
Granta-519,11178236,-5.517610268531398
IA-LM,3503,2.293282991199797
JHUEM-1,2749,1.7226649701508672
BFTC-909,tanespimycin-bortezomib (250-1 mol-mol),0.7192435114334943
SNU-C2A,3025944,4.672632341489267
SEM,6918328,-4.219248553628803
KLE,219104,3.394006961912336
JHUEM-1,24748573,1.6763818276881657
HuH-6,387447,-4.605349328210036
IGROV-1,navitoclax-gemcitabine (1-1 mol-mol),-2.4690208522715005
MOLM-13,23635314,-2.1464398793300408
WM115,45100481,5.666571363096329
ALL-SIL,doxorubicin-navitoclax (2-1 mol-mol),-2.2880067679034526
COR-L105,5351362,1.5942690709113274
YD-15,26596,-1.9516647022251905
PE/CA-PJ34 (clone C12),10302451,1.6517506382371558
Hep-G2,81146,5.451523711608541
KLE,6917907,-6.139157013602895
IGROV-1,6610216,4.310938387105607
NCI-H1395,56649450,3.261892320114533
SK-CO-1,4521392,4.292734672993078
SNU-1272,crizotinib-PLX-4032 (2-1 mol-mol),2.5958559456556025
RERF-LC-MS,53232,1.207294902086358
TTC-709,3689413,-2.3273701449747985
NCI-H2452,16038120,1.767482091574877
LS180,107985,-4.080313435814333
SU-DHL-1,24785538,0.8988368126388477
NCI-H1395,54618305,4.493399620925908
IGROV-1,11977753,-2.2284230058029433
JHUEM-1,72199292,0.6868616091352236
ML-1 [Human thyroid carcinoma],6623618,2.7004595127938686
JHUEM-7,72193861,0.706328795322279
SW48,24964624,1.8073600797801577
RKO,9911830,2.9376280530386123
JHUEM-7,9933475,1.5880397804267905
SU-DHL-1,navitoclax-PLX-4032 (1-1 mol-mol),4.469831301175806
Panc 02.03,navitoclax-pluripotin (1-1 mol-mol),3.190516365419919
HEL,5287620,-1.51108604946339
MDST8,11964036,-0.5107320494490124
SUP-T11,613753,2.735533523259856
SNU-1079,10113978,1.7030304533668603
SUP-T11,navitoclax-piperlongumine (1-1 mol-mol),1.418159356873394
HCC1500,10385095,0.8648832931247582
SW48,702558,4.851481027043998
BICR 22,15547703,3.054989624104991
PE/CA-PJ49,6918878,0.932833861290764
LCLC-97TM1,375860,-0.9613247940016756
RERF-LC-Ad1,selumetinib-MK-2206 (8-1 mol-mol),3.552195149911139
EB1,71680916,3.898489281487085
BICR 22,5566,3.0896765386345244
PE/CA-PJ49,25262965,-1.5780417973805605
JHUEM-1,24951314,2.0502193482739637
SW948,36462,2.9711779559511604
SNU-C2A,5282054,3.5521336854492453
SaOS-2,135411,0.7043200334589346
TTC-709,1566236,1.4753512072750776
SW1271,24889392,3.729104653817525
MKN1,219104,4.099287432219748
K-562,4917,1.7461656699737091
MOLM-13,11964036,-0.3903680086882432
KPL-1,16722836,2.474281412075073
SU-DHL-1,9907093,3.802209526559384
KHM-1B,89928392,-0.1592315561663482
MOLP-8,44507138,3.0437239609683515
HCC15,441298,2.404091830829315
IGROV-1,246676,4.485924799339535
IGROV-1,3136844,5.214591389089975
Daudi,119182,-1.0022442636317743
SK-CO-1,2742550,3.074063089907043
JHUEM-2,73707386,2.660139253253633
COR-L95,5291,3.794551144961864
ML-1 [Human thyroid carcinoma],6184667,3.426764234055379
WM115,16219061,2.9198343751130036
RERF-LC-MS,2871966,0.0193381278585586
ES-2,15983966,0.0990348517819151
SW1271,44607531,2.0262821909932964
NCI-H2452,53495165,2.6100799702143824
YD-15,carboplatin-etoposide (40-17 mol-mol),2.447092449480168
SK-MEL-2,72193861,3.374874194476354
SaOS-2,3825829,3.573326366415088
HEL,1242560,2.170830105823081
SU-DHL-1,selumetinib-tretinoin (2-1 mol-mol),1.6823534410792318
KMS-21-BM,JQ-1-MK-0752 (1-1 mol-mol),-1.69622808858333
ES-2,73707398,1.4813259801983545
MOLM-13,135423438,-5.2048777869707035
RKO,3815108,2.4813915623878264
JHUEM-7,327653,3.126202180618715
SK-CO-1,57519531,1.3464743023672243
SU-DHL-1,2729026,1.1961155288156848
EB1,4521392,3.985991038013245
MOLP-8,57330099,4.408814311331857
SK-HEP-1,25262965,-1.9202339310426983
KLE,11364421,-3.6177571319013455
SUP-T11,135999136,4.940178246919182
HCC15,71466445,3.952377160133232
Daudi,49793307,-5.375388093698208
RCC10RGB,52947716,3.397847809230189
SK-LMS-1,ISOX-bortezomib (250-1 mol-mol),0.2560089101624855
COR-L95,selumetinib-vorinostat (8-1 mol-mol),2.598334256861724
MOLM-13,10074640,2.6694741782411975
HCC1500,16736978,0.2362509616809698
WM115,11228183,1.7654096487865938
SNU-626,126941,-1.3566311224614735
SNU-C2A,JQ-1-UNC0638 (2-1 mol-mol),0.6359771027590772
Granta-519,25150857,0.8022216450857215
RERF-LC-MS,2858523,3.0171071482923826
K-562,71466578,3.85538032532176
L3.3,3025986,-0.2391966335119921
RKO,135875424,3.829354185480349
HEL,4096211,2.9626104821001524
T98G,387447,-4.912504065747704
LCLC-97TM1,67156097,-2.339870774569048
KHM-1B,24856436,-0.1873560944062299
COR-L95,3503,2.5200783295079834
SW48,11609586,2.634017068041322
SU-DHL-1,375860,-0.8487932986720208
MKN1,54454,1.2219066687231763
JHUEM-1,44491742,3.7957056019779345
SU-DHL-1,5351362,0.9282229173955964
TTC-709,73707398,-0.1314880855632042
SK-OV-3,6917907,1.1533351492785058
PaTu 8988t,65064,5.1728218990125
RKN,3503,2.6546301780010144
IA-LM,23582824,0.7235929041173603
U-BLC1,409805,3.947099920887272
IGROV-1,54143018,0.8385018685685798
Daudi,11214940,1.5157277988308535
JHUEM-2,6623618,2.059207528731228
SW948,4261,0.2066749270482282
HuP-T3,15547703,4.355520728687953
SNU-886,5287620,-2.170628852003526
NCI-H2452,24748573,1.1942514329138498
IGROV-1,159324,2.8766947154825044
SUP-T11,5291,3.0269090217722576
BT 248,3503,0.874016545693445
MOLP-8,JQ-1-vorinostat (2-1 mol-mol),-1.65297675500665
MOLP-8,navitoclax-birinapant (1-1 mol-mol),3.3062400198752195
SU-DHL-1,3465537,3.713885766889003
NCI-H1568,60700,-0.8736945480852499
SEM,444795,1.9334021981472231
Mino,3503,0.9290014010441238
JHUEM-1,11497983,3.215191793005684
SNU-1079,3081361,-1.138753687477054
Mino,54613361,-2.2252179837952664
P31/FUJ,3689413,-2.495432751898851
F-36P,25195348,1.1127392098506137
ST486,11222830,0.5301431183349191
PaTu 8902,16722836,2.3982166809874768
SW1271,452548,-0.0979853591066759
L3.3,12003241,-0.3315333583144895
SNU-886,656346,1.184079596970836
HCC1500,9444,4.370086947523025
IA-LM,navitoclax-pluripotin (1-1 mol-mol),-1.626939018948189
KHM-1B,10113978,2.248565849983048
SEM,16065773,1.5866010830455777
SK-MEL-2,123631,3.616973123734504
MDST8,44137675,1.8173250203578384
IGROV-1,5460769,1.6083174601829917
SK-CO-1,10302451,2.4520332675877605
IA-LM,sirolimus-bortezomib (250-1 mol-mol),1.6120597722062386
SU-DHL-1,3384730,1.173741268518712
LS411N,11178236,-2.533537215148808
JHUEM-1,2858523,3.149555483264086
JHUEM-2,11396600,2.4680372971734372
COR-L105,216239,2.81147830727615
MDST8,1750826,-3.2078848487443716
HARA [Human squamous cell lung carcinoma],tanespimycin-gemcitabine (1-1 mol-mol),0.469334809183726
KPL-1,452548,3.6009006984095
L3.3,107970,2.7957953106701305
SW1573,3025986,2.659291536752942
T98G,51039095,2.271406223558156
SK-OV-3,73707398,1.4890038437616029
YD-15,25126798,3.1807660058106144
PK-1,1750826,-0.1673543419227612
SNU-886,3676137,3.017985964934311
KP-4,11214940,0.8001776072875577
SEM,crizotinib-PLX-4032 (2-1 mol-mol),0.5423441096655561
LCLC-97TM1,12003241,-0.8351557307101188
BFTC-909,1750826,-0.1726466566192349
BT 440,11612883,1.9332300032308292
HuH-6,3025986,-2.2404267593629417
WM115,44819697,0.4217395821242636
PK-1,6918837,-1.737995795085947
KLE,25150857,3.036039064371872
PE/CA-PJ49,2733526,4.226770868795057
Daudi,57330099,4.348234162675926
HCC15,6852167,3.485797740848402
T98G,11485656,2.7510926894657977
DLD-1,89928392,1.1309311495866414
IGROV-1,23939,4.412541857664819
Daudi,carboplatin-UNC0638 (2-1 mol-mol),1.637238274504332
PE/CA-PJ34 (clone C12),5284616,3.3084044044013017
PE/CA-PJ34 (clone C12),67156097,-1.858213748948673
MDST8,159324,4.143261975826356
HuH-6,5311,0.5789287645746569
IGROV-1,9840324,5.720969888694302
Mino,44462760,1.7675264265550543
ST486,10074640,2.453489933909147
HT-1376,219104,4.167002297749596
PE/CA-PJ34 (clone C12),285033,-2.1264465291275476
Ishikawa (Heraklio) 02 ER-,52947716,-5.108376694448824
SNU-1079,10302451,-0.8712691050913255
LCLC-97TM1,36314,-6.600382606146434
PE/CA-PJ49,6918837,-5.282958299099714
UACC-812,11494412,1.976870257251046
Mino,6184667,0.8884232010285161
KMS-21-BM,46907787,-2.184676378105775
LS180,24785538,2.36344296814186
JHUEM-2,17755052,0.0929943811089265
SW1271,46398810,2.1181317502001864
COR-L95,8515,4.297389552329342
JHUEM-1,421610,1.713333416633466
BT 440,148198,-3.676636651938413
HEL,67291369,-0.0398574366947598
JHUEM-7,9884685,-1.60078111934439
WM115,65064,5.519507799834776
K-562,11178236,-5.937287665657859
MOLM-13,46398810,-0.3461491770759903
SUP-T11,5351362,1.0546877881403087
Daudi,49836020,3.49644839546437
SaOS-2,135659046,3.828911922642458
MOLM-13,156422,2.6570896066322054
IGROV-1,11222830,1.5703285223102077
TTC-709,5566,2.179709592082328
MOLM-13,3062316,-0.5121609334560062
Ishikawa (Heraklio) 02 ER-,11178236,-3.0689222531931875
RCC10RGB,24775005,3.7293513155953737
Daudi,135411,0.411387979123234
LMSU,5282054,4.011761884092238
HEL,6623618,1.8836955043929509
IGROV-1,5702613,4.420745339537274
SEM,107985,-4.245084684067336
BICR 31,3025986,-1.7152493432112506
ALL-SIL,crizotinib-PLX-4032 (2-1 mol-mol),-0.8453908934030238
HuP-T3,46926350,-3.9956296104835447
SW948,11964036,0.9329377934210036
SNU-1272,10385095,3.7094210277095274
HEL,navitoclax-pluripotin (1-1 mol-mol),-0.6457207254934652
EB1,984333,-0.984456124542231
BICR 31,168313200,4.293337148285007
JHUEM-1,5351362,1.1023787443720892
LCLC-97TM1,613753,3.2994086878019693
NCI-H1568,2858523,2.9099207435493306
K-562,selumetinib-piperlongumine (8-1 mol-mol),3.695022326832345
KLE,9915743,0.4681181116614699
WM115,168312962,-0.8720769549309708
Hep-G2,24901704,2.3159858819340817
SK-LMS-1,3689413,-2.0473825870324935
COR-L105,3136844,4.323289843330604
SaOS-2,24964624,2.194529135867758
IGROV-1,322968,4.140599241163106
JHUEM-7,104842,-3.6182664698495928
SU-DHL-1,44259,0.9870469643742532
PE/CA-PJ34 (clone C12),122327,5.619503436222374
Ishikawa (Heraklio) 02 ER-,4096211,1.7596203562054105
HuP-T3,erlotinib-PLX-4032 (2-1 mol-mol),4.371591161861475
LMSU,3854666,2.6863801842781863
Daudi,7326481,2.37278983949268
YD-15,44589607,2.6141833708168005
PK-1,2871966,1.9789907288867543
KHM-1B,selumetinib-piperlongumine (8-1 mol-mol),1.0909589836207738
HCC1500,5284616,3.2143502285360395
MKN1,5566,3.16347479871956
Granta-519,6918736,-3.0470654964091346
K-562,53232,2.317344808959498
KLE,12001922,1.8770805284945848
KP-4,5278396,3.298974733874376
JHUEM-1,3081361,2.285691914366894
SNU-1272,25154868,3.807572464361502
KU-19-19,6914657,-4.990300196809823
Granta-519,72376,-3.0273971733074463
SW948,54678924,1.3690911042909353
SNU-626,5746,0.3652842894870843
SNU-1272,135875424,4.314381098584833
LMSU,374536,2.9263574161338046
PK-1,4578,4.795816696462242
HARA [Human squamous cell lung carcinoma],135999136,4.433628677785179
SU-DHL-1,2858523,2.096941494706986
SEM,24797083,0.5724609501787771
U-BLC1,44589607,2.7286579495552723
F-36P,613000,1.342172826912998
JHUEM-1,2746,3.5357921784869775
HCC15,11427553,0.4296382841284133
HCC1500,UNC0638-navitoclax (1-1 mol-mol),-0.3841073877308503
PaTu 8902,9444,4.223556509018044
RERF-LC-Ad1,54618164,4.2675139031657325
JHUEM-1,navitoclax-piperlongumine (1-1 mol-mol),0.6214720899887336
Granta-519,10074640,3.4462174196318864
NCI-H2452,11213558,2.927858740250081
HARA [Human squamous cell lung carcinoma],10302451,4.803964333247322
KLE,10302451,4.42053427640389
SU-DHL-1,17755052,1.573040093702568
HCC1500,44185566,2.7833515387265435
BFTC-909,107970,2.2861723254681774
WM115,46191454,1.770414974730312
Panc 02.03,selumetinib-decitabine (4-1 mol-mol),4.111945447475948
SW948,JQ-1-vorinostat (2-1 mol-mol),0.5761489017255973
SW48,984333,0.702746968378095
MOLM-13,4378219,1.3750720877022855
JHUEM-1,216239,1.616447283654056
KMS-21-BM,19582717,0.4537586958204175
SK-CO-1,104842,-6.47047720162668
HARA [Human squamous cell lung carcinoma],135440466,2.4398826683273165
SU-DHL-1,753704,3.8222320630358344
NCI-H2452,11640390,3.686004280320225
IA-LM,44185566,3.1900951690600596
SW948,24748573,3.0928652753553685
HCC15,16722836,0.9313515315756092
SK-CO-1,2858523,3.0692168261278345
BICR 22,984333,1.5288435331300914
ST486,135411,0.6201857418977628
EB1,4261,0.2817305174362591
WM115,46907787,1.8634039559333693
F-36P,5280436,2.7648016483569253
K-562,135398516,2.1877631842117315
JHUEM-7,JQ-1-carboplatin (1-1 mol-mol),-0.0092802597518256
U-BLC1,374536,3.48938370269045
PaTu 8988t,navitoclax-pluripotin (1-1 mol-mol),-0.085365931635351
SW1271,56649450,5.123918884487689
MOLM-13,73707438,4.222752629567675
BICR 31,navitoclax-PLX-4032 (1-1 mol-mol),3.597223758742863
HuH-6,71466445,1.898975323859935
NCI-H1395,JQ-1-MK-0752 (1-1 mol-mol),2.3863379692228976
U-BLC1,227681,3.907473702099333
IGROV-1,9908783,5.873270433212515
COR-L105,100016,7.1590039780101895
MOLP-8,2733487,6.371854996101937
HuP-T3,40482356,5.071639396405957
YD-15,6918328,0.2803530026390615
SEM,327653,3.0255719016474605
Daudi,10231331,6.134507235467236
BT 248,216345,4.501699374414374
IGROV-1,JQ-1-navitoclax (2-1 mol-mol),1.1306356566784013
ALL-SIL,135398738,2.8388897343309214
SK-MEL-2,3634881,3.4291754860690866
KHM-1B,73707438,4.044668520699287
KP-4,5281321,-2.10713627328183
Granta-519,15953870,3.078322892664931
SUP-T11,5566,2.586332303713457
SUP-T11,135398516,-0.6894383606037454
JHUEM-2,25262965,-2.506367331053001
SW1573,16722836,2.4665820842388606
RKN,262093,2.5285063130840344
T98G,10302451,3.1795793433623634
PE/CA-PJ34 (clone C12),208908,0.4778342169619697
LMSU,675434,4.968873655762188
COR-L105,16736978,0.0668136597141226
PE/CA-PJ49,11222830,1.7141113097768597
SU-DHL-1,3854666,0.5155348387571919
SaOS-2,docetaxel-tanespimycin (2-1 mol-mol),-4.954749121249774
SK-LMS-1,selumetinib-decitabine (4-1 mol-mol),6.678783247365014
NCI-H1395,5287969,-1.6108462512694277
HCC15,1242560,4.141842055686159
TTC-709,5702613,4.233141660713624
Daudi,227681,2.3413610492173533
BICR 22,9825149,1.9632507246672848
KU-19-19,57519531,2.7709295903751987
U-BLC1,5311281,0.7792242336710679
F-36P,9967941,3.6395502360167655
HEL,675434,4.82305615478698
LCLC-97TM1,9927531,5.703886109604247
HCC1500,60700,0.3261825799377537
T98G,135421197,2.3831918060045663
DLD-1,5566,3.180068456585325
SK-HEP-1,3025986,-0.7748266135658505
SEM,135423438,-3.9763751688577527
NCI-H1395,119182,1.588983658397695
HuH-6,51037431,1.4986092049933375
SNU-1079,6252,0.4873624059630005
LS180,5281321,-2.3743222213125703
RERF-LC-MS,11234052,4.094456859515875
COR-L95,JQ-1-navitoclax (2-1 mol-mol),-0.0986281743436248
RERF-LC-MS,753704,5.128075002459309
Ishikawa (Heraklio) 02 ER-,alisertib-navitoclax (2-1 mol-mol),2.271404512793382
TTC-709,tanespimycin-gemcitabine (1-1 mol-mol),-4.8729368698485525
ALL-SIL,71304818,1.8469641946240791
EB1,3136844,2.9947888141791186
LCLC-97TM1,2733526,4.142341185184233
ST486,decitabine-carboplatin (1-1 mol-mol),-1.9329151089905916
SW1271,6918328,0.5991052607451842
JHUEM-7,11404337,0.6000529311141187
HT-1376,crizotinib-PLX-4032 (2-1 mol-mol),2.7199590210749873
SW1271,24901704,3.681572165465946
ST486,6918638,-1.4802112864016868
SNU-626,11612883,4.473963101055914
JHUEM-7,107985,-5.321387186988869
SNU-C2A,135999136,5.3185913230589925
KLE,104842,-3.354831620063557
Granta-519,11656518,1.6452745070498538
PE/CA-PJ49,11364421,-5.75476179784462
T98G,3689413,-0.3099040936553002
NCI-H1395,25183872,0.7237859951347151
Ishikawa (Heraklio) 02 ER-,11404337,-0.8066309120452816
NCI-H2452,3025944,3.797054601848671
Hep-G2,11485656,-0.7210069253709863
SEM,400769,-1.6212646015616712
Mino,44607531,0.0871259315343507
COR-L95,navitoclax-sorafenib (1-1 mol-mol),-0.3721439158461418
ST486,selumetinib-JQ-1 (4-1 mol-mol),0.8621591965055626
RKN,24951314,1.3743916622304369
SW1271,25126798,3.686543071113652
IGROV-1,6450551,2.579641476451469
T98G,119607,3.702408795040591
IGROV-1,54454,2.453541831966438
COR-L95,9936388,1.0197606854481494
Daudi,42611257,3.0497080994784307
BICR 22,54618771,-1.5156377594303725
LCLC-97TM1,23939,4.339779460008714
NCI-H2452,46191454,2.4313233431346366
COR-L105,42642645,1.1549939076973508
SNU-626,25102847,3.38278764105008
Hep-G2,23582824,2.7643164311321584
DLD-1,vorinostat-navitoclax (4-1 mol-mol),1.3499022254901816
DLD-1,2733526,3.610805478787703
DLD-1,17759555,4.183961330791069
MOLP-8,11609586,0.3617141221652126
SUP-T11,3634881,2.0160477059470563
Mino,441298,2.9453116748883312
BICR 31,613753,3.1747241586791772
SU-DHL-1,5328940,1.3431964509037
HARA [Human squamous cell lung carcinoma],5287620,-1.762699468398793
SW48,carboplatin-UNC0638 (2-1 mol-mol),2.888292790339682
BFTC-909,11455910,1.958059547603208
U-BLC1,9927531,5.132450103816796
RERF-LC-MS,322968,4.758979615786181
U-BLC1,73707438,6.394945252402452
KU-19-19,5351362,1.814646406429004
LMSU,25227462,1.468686757541464
EB1,71304818,1.965508582937141
MOLM-13,54649381,3.864277780400009
PK-1,ISOX-bortezomib (250-1 mol-mol),1.232537682842845
KLE,16038120,1.5676746205851106
RKO,selumetinib-MK-2206 (8-1 mol-mol),2.0156387563640337
JHUEM-7,navitoclax-PLX-4032 (1-1 mol-mol),2.564492004109999
NCI-H2452,72199292,1.1345413256627164
EB1,24779724,4.283325009913098
MOLP-8,676352,1.5936675202889017
HCC1500,676352,1.5631676801704226
SNU-1079,11234052,4.128383828034555
COR-L95,51037431,4.395819234826154
Daudi,5328940,0.4604914818199462
SU-DHL-1,ISOX-bortezomib (250-1 mol-mol),0.1782734065105105
DLD-1,124202324,2.891435520925823
SNU-1079,4788,4.267381310297457
IA-LM,168313200,3.804941602819176
PE/CA-PJ34 (clone C12),2828334,6.063143036105902
RERF-LC-MS,navitoclax-gemcitabine (1-1 mol-mol),-4.0027913936317026
RKO,119182,-2.4803685643523
Panc 02.03,selumetinib-vorinostat (8-1 mol-mol),2.158693436679715
PaTu 8988t,25227462,0.2940996568558364
SU-DHL-1,9929138,3.6810672504095385
JHUEM-1,53481919,3.679319625592389
SU-DHL-1,12003241,0.0778318253848937
RKN,15547703,3.1395613683678287
MDST8,selumetinib-vorinostat (8-1 mol-mol),1.0590621941896752
MOLP-8,375860,-0.9263291950812266
PaTu 8988t,11234052,5.58672838892775
TTC-709,400769,-0.9429647418916074
U-BLC1,445091,4.381869440687873
LS411N,piperlongumine-MST-312 (1-1 mol-mol),2.10220496247882
DLD-1,10385095,2.044160408314856
SK-CO-1,126941,-2.257482818819106
PE/CA-PJ49,11625818,4.5984764373289435
KU-19-19,selumetinib-GDC-0941 (4-1 mol-mol),1.3867335606828617
LS180,3038522,3.8311766422201727
JHUEM-7,navitoclax-pluripotin (1-1 mol-mol),-2.7805642205903593
LMSU,44589607,3.054254488130367
BT 248,44566777,-0.50911829246694
SW948,1566236,2.0550116218076235
KP-3,19582717,4.675110092223906
KLE,25062766,1.4887652323177143
SNU-1079,421610,4.817867698257911
BT 248,168312962,0.3799536225395565
BT 248,5460769,4.810999932000391
F-36P,42611257,3.2131530635037935
Granta-519,89928392,0.2978525114312038
MOLP-8,19582717,2.2376953494036624
HCC1500,vorinostat-navitoclax (4-1 mol-mol),-0.8820209164506474
ES-2,124202324,2.9629658374822827
K-562,2874250,4.395305106833161
SU-DHL-1,11234052,1.0073590907004168
BICR 22,73707398,1.4183060149157571
TTC-709,10302451,3.507934781987639
KLE,16722836,1.577901881910007
COR-L95,46926350,-4.41571269577794
KLE,11964036,2.71484537703424
YD-15,11222830,1.7018447623232598
Daudi,25154868,2.925803317483448
HEL,16725315,4.4825385691379145
IGROV-1,67291369,1.8066430555976296
HT-1376,10385095,2.277565827704352
KP-4,374536,4.362306924413596
ES-2,676352,2.746604127064204
PaTu 8988t,11404337,-0.5897258437911538
SK-CO-1,9911463,3.850014047184169
LS411N,89928392,2.6081309937571655
SW948,374536,1.478775672326772
ST486,462382,0.1364845500190361
TTC-709,4261,1.231442001964702
DLD-1,23725625,5.220847177204555
Daudi,3543504,2.1992036346279997
NCI-H2452,5746,2.2152642195731818
K-562,451668,2.928523807666895
HuH-6,55283,0.7115563615002919
RERF-LC-MS,71680916,4.2559060280924665
KP-4,5287620,-1.8879437684025624
BFTC-909,5311281,3.2468587214362175
HCC15,54649381,3.779002151510325
LMSU,262093,3.167641110749879
SUP-T11,168312962,-0.2838968753074626
SaOS-2,6252,5.899001284083339
EB1,135411,-0.6581562133084127
TTC-709,15953870,3.8418974591012702
SUP-T11,3503,2.6907365605074207
F-36P,49766530,-1.869404688444432
PK-1,JQ-1-vorinostat (2-1 mol-mol),1.3527565450876802
SK-CO-1,2828334,6.603893313093487
JHUEM-2,638278,3.381403506486312
HARA [Human squamous cell lung carcinoma],8515,3.1956320485149265
RKN,56946209,-4.407104587623599
P31/FUJ,54618164,3.783909273991047
P31/FUJ,46943432,0.8368365469264624
SU-DHL-1,24180719,4.350105317542874
PE/CA-PJ34 (clone C12),44137675,3.7024298491160095
SK-CO-1,10113978,3.831664495659769
Granta-519,16659841,3.0104726191973756
SK-MEL-2,2742550,4.157489560725976
NCI-H1395,navitoclax-PLX-4032 (1-1 mol-mol),3.577675870608842
NCI-H1395,5281672,6.220750867773061
HCC15,5329102,1.9423862085433257
RKO,9903786,4.184024439899693
Daudi,76446078,6.274042769130843
F-36P,11507802,0.4820601188446026
BT 440,tanespimycin-bortezomib (250-1 mol-mol),-2.7167133192176394
ES-2,25150857,2.8860500708993
Mino,selumetinib-JQ-1 (4-1 mol-mol),-0.0896875125298877
KHM-1B,11612883,4.120699306463628
SU-DHL-1,5113032,6.615586057729586
ML-1 [Human thyroid carcinoma],carboplatin-etoposide (40-17 mol-mol),0.3624432437862623
EB1,54626689,2.4548321666727255
TTC-709,11238147,1.8099894566421015
IA-LM,219104,4.299166533144503
P31/FUJ,5329102,0.6917422477571054
PaTu 8988t,5278396,4.086122365965545
LCLC-97TM1,8515,3.105500626842055
JHUEM-1,208908,2.9569858389343646
JHUEM-1,73707398,0.9079210855488236
ALL-SIL,36314,-6.574209880787115
HEL,JQ-1-MK-0752 (1-1 mol-mol),-0.9106796249442436
SU-DHL-1,252682,6.908372017357921
MOLM-13,24753719,4.086009941734247
LS411N,119607,5.818355117504778
L3.3,54649381,4.658116253691046
SUP-T11,11625818,2.656031330208199
SEM,16038120,-1.4644891288976194
JHUEM-2,navitoclax-MST-312 (1-1 mol-mol),0.7527030501845504
MOLM-13,66577038,2.3893764671204853
TTC-709,25062766,1.0864451751854742
HT-1376,serdemetan-SCH-529074 (1-1 mol-mol),0.9274437540230104
HCC1500,25183872,-1.4621663438631347
KU-19-19,6917907,-4.52253618895935
MOLM-13,11396600,-0.7885098330267027
SW1271,25195348,2.4923805554625407
NCI-H2452,15983966,-3.826639310361129
BICR 22,6184667,3.547514920621151
IGROV-1,11396600,3.99372654279783
KHM-1B,54619267,2.762925132943408
PE/CA-PJ34 (clone C12),5746,0.2373694033857969
PaTu 8902,24748573,3.607230896648149
MKN1,36462,1.8541033449175903
MDST8,54613361,0.3905773320508885
SW948,136227924,2.9576701343794145
ST486,5278396,3.137190361585815
PK-1,selumetinib-piperlongumine (8-1 mol-mol),4.039384695426005
HEL,135411,-2.1892340188273836
RKN,322968,3.2277505791227776
HARA [Human squamous cell lung carcinoma],15953870,3.428154571209005
RCC10RGB,alisertib-navitoclax (2-1 mol-mol),1.3902469753656497
COR-L105,444795,5.02091820523187
RERF-LC-MS,11175137,3.6286013190581503
RKN,54619267,4.894700718514424
SUP-T11,46199207,3.0739170687910424
MDST8,54143018,0.2489025697900608
LCLC-97TM1,4917,2.8423920861921803
BT 248,6918837,-0.6138774965830072
Granta-519,60700,-4.015034522335836
MOLP-8,56649450,1.2499213171679169
SNU-1272,5746,2.042902676289699
RERF-LC-MS,11719255,3.775646564562419
BFTC-909,12001922,1.803559970478093
ST486,4788,4.277044653391657
MOLP-8,3384730,1.892166165987978
RKO,176870,5.862868084879783
SNU-C2A,serdemetan-SCH-529074 (1-1 mol-mol),2.3243885357858325
HCC1500,SNX-2112-bortezomib (250-1 mol-mol),0.5561082321817433
PaTu 8988t,navitoclax-MST-312 (1-1 mol-mol),1.1129030049458837
IGROV-1,24772860,-3.2892316801587835
Ishikawa (Heraklio) 02 ER-,54618771,0.8456906583173794
SUP-T11,2126,3.6589472226592856
IA-LM,6450551,2.2909353415785403
HARA [Human squamous cell lung carcinoma],441298,0.3301976976056055
BFTC-909,6252,5.031852570794812
BICR 31,9907093,4.585915925811977
MDST8,285033,-1.9150900594470792
SNU-C2A,56946209,-3.7246011611239895
MOLM-13,375860,-1.005106987112833
KP-3,446155,1.1140358835365098
P31/FUJ,16725315,4.109597365862544
IGROV-1,216345,3.498629789107092
SW1271,208908,1.7498569635536685
COR-L95,11507802,0.9381723124038672
RERF-LC-MS,6918328,0.3946668064090056
SEM,selumetinib-UNC0638 (4-1 mol-mol),3.022170285595094
NCI-H1568,426756,4.294080241318686
K-562,67156097,-2.769244311294464
HuH-6,11175137,1.803741212221432
NCI-H1395,3025944,4.281266699042143
SNU-886,216239,1.293630546683639
LS411N,2729026,2.9791300415919646
JHUEM-2,3062316,0.8142380862939161
Mino,9907093,3.3998483837898323
SUP-T11,54618305,4.5643588933895956
SK-HEP-1,2729026,3.094345392685322
Panc 02.03,54618771,1.0884531427161812
SNU-1079,51037431,2.885445614972641
MKN1,6917907,-4.319030455349297
KMS-21-BM,9911830,1.8558490159042795
Ishikawa (Heraklio) 02 ER-,11455910,1.4574745929250947
MDST8,5282054,3.0885738072945776
HARA [Human squamous cell lung carcinoma],31703,-1.5277652674394486
HEL,54143018,-0.2807045945993052
JHUEM-7,16736978,0.2612625302248401
MKN1,57330099,3.743295858660293
COR-L105,5278396,3.038896363429305
SK-LMS-1,24951314,2.160829965238104
SU-DHL-6,6450551,1.9173550036200224
LCLC-97TM1,1716436,2.9898763561132276
L3.3,9903786,3.5860218860878263
K-562,54619267,3.679496217482672
U-BLC1,24180719,3.264940033062701
KP-4,654092,-1.6065035678404882
Granta-519,1641662,2.857235389717828
PK-1,10296883,4.277974392891681
PaTu 8902,219104,4.25826825351418
NCI-H2452,24779724,6.409137734448782
KP-4,54618164,4.199260962007676
DLD-1,24748573,2.1908765569252413
RCC10RGB,2126,5.809199309072596
HuP-T3,24753719,4.122061219367772
EB1,2113511,4.805810153296592
RKN,44197249,3.9607888926275217
MKN1,24951314,1.891031040329588
PE/CA-PJ34 (clone C12),16722836,1.614238744479456
SU-DHL-1,44543605,4.013392575246718
HEL,11455910,0.7002369428142345
KP-4,17755052,3.700899087296149
SK-HEP-1,5281672,4.68841423543723
SW1271,navitoclax-gemcitabine (1-1 mol-mol),-0.9038417813496232
BICR 31,23582824,0.6119811525421108
SNU-626,12003241,0.7059762795421864
SW48,57330099,4.121753491452113
Mino,11625818,3.7490369857614914
MOLP-8,3825829,4.0673932001437
BT 248,navitoclax-sorafenib (1-1 mol-mol),1.2094722993885498
Granta-519,5746,-3.467826904777232
K-562,46215462,1.6076592131491731
Daudi,alisertib-navitoclax (2-1 mol-mol),-1.1022910082635888
NCI-H1395,3025986,0.7160390395986832
BT 440,71729975,2.1411771875170196
MOLM-13,6852167,0.0474303723036755
PaTu 8902,44819697,-0.6077719001286086
MKN1,carboplatin-etoposide (40-17 mol-mol),2.872400134643047
P31/FUJ,selumetinib-BRD-A02303741 (4-1 mol-mol),2.927335699972257
HCC15,135875424,4.57405525423842
BFTC-909,6918736,-1.9066217610366931
MOLP-8,25195348,2.8158250690550215
KU-19-19,11175137,2.6409229524549858
MOLP-8,selumetinib-vorinostat (8-1 mol-mol),0.5192774432453199
SK-LMS-1,5281321,0.0710073739545425
SU-DHL-1,15983966,-4.109397573586815
Granta-519,4705,3.4024179319436483
PE/CA-PJ49,11657048,4.471135079465252
SaOS-2,6450551,2.5324870379200113
BT 440,BRD-K55473186,1.8369775850540844
Hep-G2,6918837,-3.422320688651726
SU-DHL-1,6918837,-2.995399398295858
RKN,selumetinib-BRD-A02303741 (4-1 mol-mol),7.036223119013143
Mino,176870,1.702419593624116
SW1573,159324,2.9705070550476274
LS180,11625818,4.457813695022962
Granta-519,10296883,3.749738066673353
Panc 02.03,285033,-1.023489563814438
SNU-C2A,11152667,-1.3590856917202871
SU-DHL-1,11175137,1.828860424721981
HEL,124202324,1.0355607531680788
NCI-H1568,702558,5.469457182473135
TTC-709,5287969,-1.8156943371068477
IGROV-1,46191454,1.3777495915525844
KP-3,49850262,5.166256753861956
WM115,55283,3.7426713954425415
ES-2,BRD-K27188169,4.458573104800434
SW948,7251185,1.827873481109932
MDST8,4521392,4.294685623216763
KP-3,vorinostat-carboplatin (1-1 mol-mol),4.061540115833001
HuP-T3,selumetinib-GDC-0941 (4-1 mol-mol),0.9673243203252392
JHUEM-2,54619238,4.418578309660822
LS180,11455910,2.088798844266998
SUP-T11,24821094,3.248226720950813
T98G,984333,1.033383318647826
NCI-H2452,151289,3.721937933525537
LCLC-97TM1,11214940,1.4536772193180694
RKO,25062766,2.7314931301361476
L3.3,44819697,-3.2466678771673427
F-36P,4788,3.754579692530656
PE/CA-PJ49,3825829,3.9547991089939383
NCI-H1395,241158,4.2689573120798165
BT 248,123631,2.103805835203493
Hep-G2,969516,2.730535591005145
EB1,45279963,2.7536800859556916
SU-DHL-1,navitoclax-piperlongumine (1-1 mol-mol),1.5701555779120346
COR-L105,3385,6.244906352702261
IGROV-1,375860,0.7731558163124775
KP-4,65628,4.537508539882641
SU-DHL-1,9936388,0.846879508636978
MOLP-8,11955716,-2.2423093620343666
BT 440,JQ-1-vorinostat (2-1 mol-mol),2.2823957664707075
IGROV-1,11455910,-0.2792640061206097
HEL,216468,1.594172428774628
TTC-709,135421197,1.6212603414567397
K-562,216345,3.9110155346915088
SNU-1079,65064,3.0523349997291604
SK-HEP-1,6450551,3.663777137244395
ES-2,104842,-2.543395692237841
BT 440,10427712,4.431582026177626
Daudi,5460769,0.2326576177581661
KMS-21-BM,44137675,3.8703229661001153
KP-4,3136844,3.746119336549442
BICR 22,1750826,0.8880077925102622
RERF-LC-MS,11238147,2.4729298726299147
SEM,9826308,-1.408975626974659
SEM,12003241,-3.075217153076431
BFTC-909,54649381,4.487285574329416
U-BLC1,4788,3.983032890069623
KP-4,44493528,4.395451461814576
KLE,24785538,1.6849105600387455
RERF-LC-MS,9926054,1.8051014319834384
IA-LM,1750826,-4.675530321169698
JHUEM-1,104842,-2.0292455410758516
F-36P,54618164,3.98982096718309
BICR 22,46398810,2.733805979632988
WM115,445643,3.76443753653658
JHUEM-1,441298,3.26283845836026
LS411N,3689413,2.701640891749041
SW48,71304818,2.1411626536950323
HuP-T3,5291,4.150853397708747
SW48,9911463,3.374803590447597
ST486,24901704,1.9305870897220687
Daudi,16219061,1.2860438148144782
YD-15,4259181,-0.9565744428001864
SaOS-2,9911830,2.995519789289086
BFTC-909,5329102,1.9658448878596055
NCI-H1568,53495165,-0.6133813456223128
BICR 22,6918878,1.3704913724877863
SK-OV-3,4259181,0.9080230343390464
HCC15,BRD-A02303741-navitoclax (2-1 mol-mol),0.3796712498058268
BFTC-909,445091,4.3207806819680625
WM115,2130404,3.451007656106494
RCC10RGB,11152667,2.8531679730856268
HEL,5460769,3.63888115942649
PE/CA-PJ34 (clone C12),6610216,4.323795888758034
HEL,969516,2.4495484774391296
MDST8,11152667,-1.6082048518025778
KMS-21-BM,638278,1.585945536712124
WM115,54596490,4.400808012137458
NCI-H2452,1716436,2.783046357832639
MOLM-13,4917,2.9272389210025955
ALL-SIL,119182,-4.503247338331098
MDST8,3552672,1.9687663546279843
HCC15,16720766,-0.3160262480808965
ML-1 [Human thyroid carcinoma],12001922,2.2640831281012916
MOLM-13,12003241,-3.578107028375036
SW948,24856436,-0.402936098482521
HCC1500,44202524,3.676243999694772
Daudi,4261,-0.6156785773872924
KPL-1,219104,4.275526718176494
MDST8,11507802,0.9258202338292296
TTC-709,16038120,0.3691497739153434
KHM-1B,51037431,2.291600805718332
SUP-T11,tanespimycin-bortezomib (250-1 mol-mol),1.9096696973942504
SK-LMS-1,5351362,1.0221811076234175
BFTC-909,54626689,4.365294423210906
JHUEM-7,9903786,1.8726211891462523
NCI-H1568,16741245,4.262204040009308
HCC1500,25154868,1.8923567203600569
HCC15,navitoclax-piperlongumine (1-1 mol-mol),-0.4364560874228035
COR-L105,3825829,4.424164708702568
HEL,10074640,3.098757234686198
Mino,carboplatin-UNC0638 (2-1 mol-mol),3.2007380668801564
SNU-626,2841722,4.319354964656764
RKO,44202524,1.4476976505001866
PE/CA-PJ34 (clone C12),9956119,3.8571372412004954
SK-HEP-1,6852167,5.53454213252302
